data_2f2d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f2d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.407 1.1 mm-40 . . . . . 0 CA--C 1.576 1.979 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -104.37 162.96 12.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.997 1.319 . . . . 0.0 110.052 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.59 107.55 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 109.488 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.09 129.7 54.79 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 121.644 0.735 . . . . 0.0 111.744 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.64 -48.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.003 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.22 -70.3 0.25 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 120.111 1.323 . . . . 0.0 113.982 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.79 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.28 -52.19 13.03 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.6 -124.03 0.7 Allowed Glycine 0 CA--C 1.54 1.599 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . 0.377 5.3 mp 72.93 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.115 1.366 . . . . 0.0 112.481 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.98 95.72 10.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -109.38 90.13 3.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -97.37 96.82 8.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.587 -0.696 . . . . 0.0 110.572 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.61 103.11 7.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.488 -0.758 . . . . 0.0 110.415 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.4 m -83.21 100.74 10.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.37 -65.36 1.02 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.616 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -84.2 128.28 62.96 Favored Pre-proline 0 CA--C 1.575 1.931 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 167.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.77 -56.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.953 2.435 . . . . 0.0 116.26 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.72 101.29 0.89 Allowed Glycine 0 CA--C 1.547 2.034 0 CA-C-O 116.71 -2.161 . . . . 0.0 107.887 -162.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.21 162.75 40.53 Favored 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 122.631 3.215 . . . . 0.0 116.42 -164.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.36 130.64 22.91 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.243 2.629 . . . . 0.0 113.701 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.79 -69.16 0.21 Allowed Glycine 0 CA--C 1.542 1.744 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -160.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -82.05 94.16 7.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.397 0.679 . . . . 0.0 111.165 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.0 m -128.09 166.49 18.35 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.983 0.897 . . . . 0.0 111.813 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 134.87 33.73 Favored Pre-proline 0 CA--C 1.577 2.0 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -165.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.33 144.84 11.78 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.133 2.556 . . . . 0.0 114.765 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.4 156.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 124.019 0.927 . . . . 0.0 109.32 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.83 89.09 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -160.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.11 61.15 0.01 OUTLIER Glycine 0 CA--C 1.546 1.988 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.989 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -151.16 144.43 24.76 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.08 94.19 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.78 141.66 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.603 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -124.09 128.21 48.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.579 -167.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.67 150.42 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.3 1.047 . . . . 0.0 110.5 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -96.63 107.55 20.01 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 tt -112.25 106.24 14.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -104.77 120.08 40.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -91.58 126.31 36.61 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -124.3 162.77 23.06 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.132 0.968 . . . . 0.0 110.563 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -83.58 153.27 24.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.326 -0.858 . . . . 0.0 111.815 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -50.86 -45.17 59.76 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 163.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -124.62 63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.44 0.564 . . . . 0.0 110.348 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.39 -116.52 0.59 Allowed Glycine 0 CA--C 1.538 1.485 0 O-C-N 121.178 -0.951 . . . . 0.0 112.128 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.6 t -158.01 -169.38 2.79 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.713 0.805 . . . . 0.0 111.168 -164.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.4 111.67 1.17 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.09 -52.13 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.009 1.324 . . . . 0.0 111.34 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -150.52 107.59 3.58 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -97.45 100.7 12.13 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.523 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.31 90.4 42.05 Favored Pre-proline 0 CA--C 1.572 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.77 -6.16 15.07 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 N-CA-C 120.055 3.06 . . . . 0.0 120.055 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -127.64 102.84 7.01 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.45 1.477 . . . . 0.0 110.071 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -126.8 97.65 5.07 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.69 136.58 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.924 0.889 . . . . 0.0 109.308 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -164.87 154.32 13.12 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.607 0.763 . . . . 0.0 111.032 -169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.8 m -76.75 137.97 39.64 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.393 0.616 . . . . 0.0 110.398 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.04 115.93 11.85 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.974 0.909 . . . . 0.0 109.98 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.54 73.01 0.97 Allowed Glycine 0 N--CA 1.481 1.639 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.724 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.99 149.5 19.68 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.873 0.844 . . . . 0.0 110.624 -168.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 76.9 m -77.49 80.71 3.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.58 1.181 . . . . 0.0 112.113 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.49 -65.27 0.24 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.856 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -81.08 164.73 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-O 122.437 1.113 . . . . 0.0 112.397 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.84 159.35 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.514 1.126 . . . . 0.0 113.983 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -55.52 -40.23 71.52 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -44.48 71.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.96 -67.67 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 117.199 -1.382 . . . . 0.0 111.616 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -46.48 -42.43 15.52 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.86 -51.51 66.71 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.3 p -77.48 -4.51 45.88 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.304 1.6 t -68.26 -45.64 38.8 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 114.892 -2.48 . . . . 0.0 114.976 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.93 -30.14 91.06 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 CA-C-N 126.77 3.454 . . . . 0.0 117.489 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -100.49 70.66 1.48 Allowed 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.213 1.005 . . . . 0.0 111.146 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -136.32 107.65 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.26 136.52 37.07 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.997 0.903 . . . . 0.0 111.63 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.93 114.17 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.883 -158.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.29 44.75 2.5 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.571 -1.195 . . . . 0.0 115.496 -166.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.39 167.28 12.39 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 118.837 1.318 . . . . 0.0 113.713 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 95.3 m -143.31 108.38 4.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.94 121.34 15.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.315 0.246 . . . . 0.0 110.751 -166.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 ttt -81.57 115.99 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.853 0.461 . . . . 0.0 110.168 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.99 100.61 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.0 p -84.41 97.65 9.62 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.35 32.05 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.343 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 119' ' ' LYS . 9.5 t70 -61.67 144.91 53.81 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 169.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.434 ' HG ' ' HA ' ' A' ' 134' ' ' HIS . 8.3 t -58.56 -38.63 78.24 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 117' ' ' ASP . 8.5 pttm -69.71 -37.46 76.57 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.23 -44.15 92.76 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 169.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.9 t -91.24 -179.66 5.48 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 123.062 1.41 . . . . 0.0 111.49 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.25 113.79 3.41 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.022 158.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.41 -89.38 0.08 OUTLIER Glycine 0 CA--C 1.546 1.986 0 CA-C-O 116.792 -2.115 . . . . 0.0 109.077 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.15 -57.14 0.13 Allowed 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 122.307 3.053 . . . . 0.0 114.295 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -89.13 103.21 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.57 -118.75 0.47 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.051 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -141.9 60.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.875 0.845 . . . . 0.0 111.877 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.9 p -87.85 150.64 48.42 Favored Pre-proline 0 CA--C 1.572 1.808 0 C-N-CA 124.214 1.005 . . . . 0.0 113.129 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.12 -7.33 46.59 Favored 'Cis proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.552 2.866 . . . . 0.0 119.552 11.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.83 -57.71 9.93 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 120.278 1.399 . . . . 0.0 113.854 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.1 mt -90.28 117.84 68.34 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.47 161.4 9.57 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.875 2.383 . . . . 0.0 116.095 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 131.83 21.4 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.138 2.559 . . . . 0.0 112.62 168.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 118' ' ' SER 0.29 92.0 m-70 71.13 174.65 0.3 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 123.729 0.812 . . . . 0.0 112.306 -170.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.72 118.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.054 1.342 . . . . 0.0 111.964 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.51 97.9 8.67 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.43 149.12 21.85 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.526 0.679 . . . . 0.0 112.749 -171.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -87.77 147.05 25.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.371 0.668 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.58 109.31 3.25 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.59 120.65 26.6 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.797 0.808 . . . . 0.0 111.917 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.6 t -103.3 109.23 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.6 m -116.17 104.48 11.57 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.1 113.87 7.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.398 0.679 . . . . 0.0 110.664 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -85.16 -61.07 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.1 p -142.8 133.27 24.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.21 100.94 10.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.94 132.38 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.119 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.94 73.22 10.36 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.27 1.033 . . . . 0.0 113.766 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.344 0 CA-C-O 116.787 -2.119 . . . . 0.0 114.472 177.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 87.8 m95 72.57 134.05 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.504 1.122 . . . . 0.0 113.526 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.53 93.98 7.1 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.17 112.63 17.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.483 0.713 . . . . 0.0 111.265 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -64.03 -49.88 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.746 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.1 -61.07 2.91 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.8 -71.41 0.26 Allowed Glycine 0 N--CA 1.48 1.576 0 CA-C-N 118.632 0.651 . . . . 0.0 111.763 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -66.62 -72.7 0.15 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.785 0.834 . . . . 0.0 112.025 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.78 72.64 0.03 OUTLIER Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.517 0.599 . . . . 0.0 112.684 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.82 -72.98 0.66 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.31 143.71 31.09 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.999 0.92 . . . . 0.0 110.614 172.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -141.19 161.84 36.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.002 0.921 . . . . 0.0 112.473 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.87 37.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 112.182 164.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -173.48 2.34 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 122.009 0.909 . . . . 0.0 111.591 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -140.8 97.19 3.14 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 164.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.15 -69.09 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.609 0.764 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -101.78 131.63 22.62 Favored Pre-proline 0 CA--C 1.573 1.836 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 160.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 175.17 11.7 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.106 2.538 . . . . 0.0 114.53 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.73 115.34 4.96 Favored Glycine 0 CA--C 1.556 2.64 0 CA-C-O 116.879 -2.067 . . . . 0.0 112.066 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.27 169.36 15.52 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 CA-C-N 122.602 3.201 . . . . 0.0 115.597 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.68 -38.6 76.87 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 123.326 2.684 . . . . 0.0 118.182 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.7 87.61 0.94 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 118.968 0.804 . . . . 0.0 111.597 163.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.7 p -144.4 95.53 2.73 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 p -91.66 108.62 20.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.944 0.878 . . . . 0.0 110.598 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -76.41 126.67 86.02 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.59 -172.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.44 149.62 56.65 Favored 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 115.55 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.85 166.87 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.127 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -62.52 118.77 8.02 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.118 0.567 . . . . 0.0 112.438 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.58 58.41 1.13 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.287 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -143.89 135.65 26.22 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.28 101.8 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 m -122.68 128.24 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.789 0.804 . . . . 0.0 109.249 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.468 ' HG1' HG21 ' A' ' 87' ' ' VAL . 23.2 m -95.13 137.42 34.2 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.913 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 144.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.831 0.824 . . . . 0.0 109.461 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -92.05 100.66 13.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 163.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 tp -86.38 107.05 17.84 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.001 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -102.83 80.25 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 109.519 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.9 m -75.83 129.34 36.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.792 0.837 . . . . 0.0 109.991 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -139.86 164.87 28.82 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.473 1.13 . . . . 0.0 111.621 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.1 tp -78.9 161.68 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.985 0.914 . . . . 0.0 111.992 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -49.37 -42.08 41.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.61 -68.47 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.596 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.83 83.35 0.05 OUTLIER Glycine 0 N--CA 1.479 1.53 0 CA-C-N 119.117 0.871 . . . . 0.0 112.03 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -159.44 122.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.52 115.02 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.29 -45.89 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -145.43 109.16 4.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -94.33 101.64 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.458 0.647 . . . . 0.0 110.113 164.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -92.65 109.29 37.74 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.645 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.14 -51.45 0.6 Allowed 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.026 2.484 . . . . 0.0 117.308 -165.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -121.57 94.91 4.47 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.983 0.896 . . . . 0.0 111.551 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -97.23 102.98 14.87 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG21 ' HG1' ' A' ' 67' ' ' THR . 88.2 t -103.15 123.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -169.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -149.7 149.21 30.26 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -170.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -75.77 124.27 27.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.34 114.89 8.0 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.536 0.734 . . . . 0.0 111.004 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.11 18.44 77.9 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 119.64 2.616 . . . . 0.0 119.64 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -132.85 66.25 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.661 1.73 . . . . 0.0 111.587 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.6 t 58.9 78.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -149.78 -66.71 0.21 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 m -97.58 167.27 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.733 1.254 . . . . 0.0 112.256 -166.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -61.09 159.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.946 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.46 -41.34 89.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.86 -46.21 71.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 168.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.7 -57.53 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.345 168.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -46.58 -58.05 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.35 -32.82 74.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.5 p -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.264 1.7 t -64.22 -49.19 74.35 Favored Pre-proline 0 N--CA 1.505 2.295 0 CA-C-N 122.391 2.36 . . . . 0.0 113.71 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.99 1.08 3.65 Favored 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 125.119 2.864 . . . . 0.0 118.61 169.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -97.27 -25.78 15.14 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 156.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 12.0 tpp -81.9 105.38 12.97 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.851 1.205 . . . . 0.0 110.441 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.34 167.48 20.83 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 122.146 0.974 . . . . 0.0 112.095 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.96 107.36 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 108.746 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 14.01 52.14 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.148 2.019 . . . . 0.0 118.148 -166.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.27 110.15 22.12 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 119.971 1.885 . . . . 0.0 109.561 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.9 m -94.29 120.36 34.41 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.22 135.31 49.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.553 0.741 . . . . 0.0 109.535 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.403 ' SD ' ' HB2' ' A' ' 140' ' ' GLU . 6.8 tpt -80.86 103.72 10.88 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.8 t -90.96 94.03 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.5 p -89.14 91.43 8.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.822 0.82 . . . . 0.0 109.487 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.71 134.87 41.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.843 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.9 132.57 47.59 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.908 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.489 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . 26.7 t -74.32 75.09 1.86 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 123.26 1.505 . . . . 0.0 112.723 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -172.17 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.481 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -87.87 -56.94 3.13 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.614 1.166 . . . . 0.0 110.179 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 118' ' ' SER . 20.1 p -46.28 -57.18 4.81 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 168.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -124.94 -46.16 1.85 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.609 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.97 144.46 17.21 Favored Glycine 0 CA--C 1.555 2.541 0 CA-C-O 117.677 -1.624 . . . . 0.0 112.255 -168.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.88 87.91 1.36 Allowed 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 122.184 2.992 . . . . 0.0 113.05 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -144.67 -66.92 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.75 86.0 1.84 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.604 0.621 . . . . 0.0 111.594 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -91.96 152.47 20.01 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.2 m -68.03 140.16 93.38 Favored Pre-proline 0 CA--C 1.573 1.83 0 CA-C-O 117.707 -1.139 . . . . 0.0 112.729 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.71 -50.25 0.2 OUTLIER 'Cis proline' 0 CA--C 1.562 1.923 0 N-CA-C 117.238 1.976 . . . . 0.0 117.238 11.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -149.92 76.47 1.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 119.506 1.048 . . . . 0.0 109.208 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.77 118.11 49.15 Favored Pre-proline 0 CA--C 1.57 1.73 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.59 142.03 12.71 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 122.877 2.385 . . . . 0.0 114.303 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 125.33 10.66 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.131 2.554 . . . . 0.0 112.103 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.278 97.6 m-70 70.0 172.18 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.708 0.803 . . . . 0.0 112.883 -171.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.18 111.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.999 1.32 . . . . 0.0 111.15 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.23 117.25 8.26 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.43 128.11 33.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.819 0.448 . . . . 0.0 109.8 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.11 98.45 8.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.601 0.761 . . . . 0.0 109.355 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 107.0 18.03 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.572 0.749 . . . . 0.0 110.575 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.403 ' HB2' ' SD ' ' A' ' 113' ' ' MET . 31.2 tt0 -83.4 107.9 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.126 0.965 . . . . 0.0 111.276 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.84 105.97 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.9 m -101.34 122.39 43.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -73.07 -74.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.1 p -147.45 131.9 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.776 0.716 . . . . 0.0 109.113 -169.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.47 112.51 25.55 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.209 0.604 . . . . 0.0 109.579 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.2 143.4 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.624 0.77 . . . . 0.0 110.109 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.67 79.43 4.26 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.074 0.94 . . . . 0.0 113.124 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 2.937 0 N-CA-C 116.568 1.387 . . . . 0.0 116.568 173.647 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 122.088 0.947 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.322 14.9 m0 68.92 -135.94 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.362 1.065 . . . . 0.0 111.581 168.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 tt -138.25 119.31 14.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.64 108.81 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.39 0.676 . . . . 0.0 112.207 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.29 45.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -58.45 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 125.272 1.429 . . . . 0.0 110.213 172.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.52 -91.3 0.51 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.95 -36.32 64.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.08 1.35 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -167.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mp 15.82 63.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 165.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 tp -157.99 117.37 3.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -148.76 115.22 5.89 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 -161.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -117.03 133.64 55.75 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -171.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -73.7 143.74 46.07 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.978 0.911 . . . . 0.0 111.661 159.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.5 m -93.45 92.13 7.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 159.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.73 -60.98 2.11 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.774 0.829 . . . . 0.0 113.044 -167.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -113.82 130.2 24.04 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 157.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.84 170.03 21.27 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.088 2.526 . . . . 0.0 114.97 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 152.39 49.65 Favored Glycine 0 CA--C 1.561 2.925 0 CA-C-O 118.376 -1.236 . . . . 0.0 115.345 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.95 164.58 31.24 Favored 'Trans proline' 0 CA--C 1.574 2.486 0 CA-C-N 121.433 2.616 . . . . 0.0 115.556 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.14 113.58 2.68 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 123.201 2.601 . . . . 0.0 113.038 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.6 -96.27 0.94 Allowed Glycine 0 CA--C 1.539 1.557 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -163.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.268 82.9 p 53.96 85.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -79.9 120.62 24.36 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.424 0.63 . . . . 0.0 111.534 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -81.61 124.01 80.25 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.746 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.52 147.9 65.45 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.1 2.533 . . . . 0.0 115.567 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.16 152.74 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.059 0.944 . . . . 0.0 111.842 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.81 118.42 8.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.06 60.48 0.55 Allowed Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.71 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -146.86 146.0 30.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.364 1.078 . . . . 0.0 108.559 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.3 101.39 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.81 125.49 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 ' HG1' HG21 ' A' ' 87' ' ' VAL . 14.1 m -107.4 140.29 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.371 0.668 . . . . 0.0 109.308 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.27 141.32 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.801 0.841 . . . . 0.0 109.023 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -83.82 101.32 11.54 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 158.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.6 tp -86.26 100.56 12.35 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -93.68 101.38 13.52 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -81.03 117.51 21.69 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -142.58 154.36 44.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.656 0.783 . . . . 0.0 109.566 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.21 141.54 49.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.858 0.837 . . . . 0.0 111.206 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -57.63 -45.63 85.17 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 157.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.18 -58.01 3.96 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.83 54.13 0.75 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.472 2.5 t 50.92 -157.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 163.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -79.97 107.37 12.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.211 1.004 . . . . 0.0 111.973 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.2 -71.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.378 0.671 . . . . 0.0 111.26 -165.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.92 111.18 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -163.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.25 113.11 25.23 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.133 0.573 . . . . 0.0 110.739 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.92 91.89 16.48 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.498 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.08 -61.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.36 2.707 . . . . 0.0 116.047 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -92.36 86.33 5.66 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.663 1.12 . . . . 0.0 110.625 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.8 tp -106.88 92.6 4.16 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 165.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.485 HG21 ' HG1' ' A' ' 67' ' ' THR . 8.8 p -95.2 139.44 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.533 0.733 . . . . 0.0 110.395 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -159.6 154.65 24.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.516 0.674 . . . . 0.0 111.748 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -74.87 133.1 41.9 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 171.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.18 111.3 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.129 0.972 . . . . 0.0 111.409 -172.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.35 77.96 0.33 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.015 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.84 157.7 27.12 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.28 1.038 . . . . 0.0 111.228 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.47 83.56 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.274 1.035 . . . . 0.0 112.253 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -151.39 -66.44 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.32 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.61 169.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.702 1.239 . . . . 0.0 113.44 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 pt -52.27 151.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 114.131 -1.395 . . . . 0.0 114.053 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -60.73 -36.78 79.74 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.14 83.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.32 -57.78 7.54 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 117.406 -1.283 . . . . 0.0 113.289 165.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -52.49 -39.9 61.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.6 p -104.54 61.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.96 -61.02 0.17 Allowed Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 115.543 -2.17 . . . . 0.0 108.987 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.97 -25.08 59.67 Favored 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 124.986 2.816 . . . . 0.0 117.542 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -6.27 5.72 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 167.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.2 mtt -114.44 119.8 38.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.935 1.243 . . . . 0.0 109.017 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -64.45 163.3 13.57 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.62 99.72 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 49.28 3.09 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 118.352 1.076 . . . . 0.0 110.741 163.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.3 m -93.5 142.28 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.29 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.83 123.17 13.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.727 0.411 . . . . 0.0 110.705 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.3 tpt -84.02 101.78 12.01 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.47 125.63 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 p -106.35 96.42 6.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.843 0.83 . . . . 0.0 109.219 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.19 167.69 15.46 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.965 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.45 42.91 1.12 Allowed 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.7 p 35.34 54.79 0.81 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.424 ' HD2' ' HD1' ' A' ' 134' ' ' HIS . 33.2 mtpt -151.86 -58.86 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.821 -159.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.9 -45.61 92.98 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 157.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.6 t -90.78 113.6 25.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.821 0.848 . . . . 0.0 111.173 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.287 81.0 m-85 65.2 14.46 9.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.17 179.1 25.31 Favored Glycine 0 CA--C 1.559 2.824 0 N-CA-C 116.523 1.369 . . . . 0.0 116.523 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -83.46 62.56 7.34 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 122.921 2.414 . . . . 0.0 113.407 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.54 -70.69 0.07 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.84 132.82 7.67 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 118.22 0.464 . . . . 0.0 112.038 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -111.34 52.42 0.75 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.9 m 65.46 143.77 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 170.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.03 -40.39 0.85 Allowed 'Cis proline' 0 CA--C 1.563 1.932 0 CA-C-N 122.687 1.996 . . . . 0.0 116.472 -1.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -132.81 67.33 1.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.2 mt -115.77 119.64 37.13 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -85.54 159.81 10.87 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 C-N-CA 123.157 2.571 . . . . 0.0 115.196 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.08 -39.51 0.87 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 122.959 2.44 . . . . 0.0 117.291 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.424 ' HD1' ' HD2' ' A' ' 119' ' ' LYS . 96.7 m-70 -147.87 72.34 1.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.021 0.828 . . . . 0.0 109.04 -173.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.19 21.3 0.25 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 72.68 134.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 tt -138.75 123.48 18.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -99.48 97.3 8.32 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.877 0.846 . . . . 0.0 110.138 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.66 125.59 39.41 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.284 1.034 . . . . 0.0 109.602 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -98.54 103.48 15.43 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.878 0.847 . . . . 0.0 110.298 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.23 109.17 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.7 m -105.26 121.61 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.09 105.83 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.449 ' HZ1' ' CD ' ' A' ' 85' ' ' GLU . 40.3 mtpt -76.91 -66.9 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.5 p -135.06 135.41 41.26 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.44 0.696 . . . . 0.0 109.219 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.86 104.07 11.82 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.03 154.48 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.742 0.782 . . . . 0.0 109.915 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.19 -170.05 0.89 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.614 0 CA-C-O 116.874 -2.07 . . . . 0.0 115.021 -173.249 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.317 98.5 m95 86.54 106.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.709 1.204 . . . . 0.0 109.596 -161.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.27 107.33 19.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -83.48 116.03 22.35 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.527 0.679 . . . . 0.0 112.193 -165.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.46 -48.83 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 123.909 0.884 . . . . 0.0 111.413 170.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.38 -60.3 3.75 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.413 1.006 . . . . 0.0 113.143 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.78 -72.63 0.29 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-N 118.912 0.778 . . . . 0.0 112.446 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -69.56 -70.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.687 0.795 . . . . 0.0 112.353 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.82 64.06 0.09 OUTLIER Glycine 0 N--CA 1.481 1.644 0 CA-C-N 118.393 0.542 . . . . 0.0 111.863 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB3' ' HH ' ' A' ' 120' ' ' TYR . 71.1 mt -137.04 -78.74 0.4 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.894 -163.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 tp -88.27 124.72 34.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 121.022 1.737 . . . . 0.0 107.988 166.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -154.95 113.19 3.49 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.477 -164.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -119.2 115.99 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.339 1.056 . . . . 0.0 109.127 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -103.8 141.18 36.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.819 -0.551 . . . . 0.0 111.081 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.9 m -80.18 115.35 19.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.9 -69.08 0.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.539 0.736 . . . . 0.0 109.293 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.6 134.09 24.72 Favored Pre-proline 0 CA--C 1.578 2.035 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.021 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.04 149.83 29.08 Favored 'Trans proline' 0 CA--C 1.558 1.686 0 C-N-CA 122.851 2.368 . . . . 0.0 114.11 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 114.49 4.0 Favored Glycine 0 CA--C 1.555 2.578 0 CA-C-O 116.872 -2.071 . . . . 0.0 113.127 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.83 164.17 36.53 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 CA-C-N 122.775 3.287 . . . . 0.0 116.0 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.09 109.56 2.6 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.272 2.648 . . . . 0.0 111.74 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.81 -66.0 0.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.026 -158.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -65.49 135.03 54.65 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -138.67 146.66 41.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.702 0.763 . . . . 0.0 110.004 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.59 112.46 6.63 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-O 117.998 -1.001 . . . . 0.0 113.362 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.42 166.25 29.88 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.499 2.133 . . . . 0.0 115.942 -161.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.66 162.82 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.22 -168.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 107.52 4.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.391 0.676 . . . . 0.0 110.223 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.45 -47.84 0.8 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 115.415 -0.811 . . . . 0.0 113.919 -163.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -63.36 124.05 20.28 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.708 0.803 . . . . 0.0 111.739 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.49 99.25 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.49 140.35 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.863 0.839 . . . . 0.0 110.557 -172.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 m -114.41 124.04 50.95 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.15 142.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.794 0.837 . . . . 0.0 110.288 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -94.67 99.52 11.62 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 165.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.25 106.01 18.1 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.9 87.92 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.6 m -71.48 125.07 26.08 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.149 0.58 . . . . 0.0 110.562 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 t -131.38 155.34 47.44 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.098 0.952 . . . . 0.0 110.329 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.1 146.93 30.34 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.612 165.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.59 -33.33 60.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -68.16 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.96 0.8 . . . . 0.0 112.059 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.5 77.27 0.03 OUTLIER Glycine 0 N--CA 1.479 1.502 0 CA-C-N 119.117 0.871 . . . . 0.0 113.147 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 m -149.34 106.61 3.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -82.65 105.96 14.12 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.1 m -96.79 -45.3 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -165.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -136.1 87.99 2.35 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.847 1.203 . . . . 0.0 110.101 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.38 115.07 26.85 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.322 0.582 . . . . 0.0 111.671 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.13 102.41 48.84 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.726 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -87.22 77.17 2.02 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.633 2.222 . . . . 0.0 114.073 -166.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.461 8.7 pt-20 133.36 94.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 127.401 2.281 . . . . 0.0 110.047 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.33 99.56 7.1 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.31 138.22 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.693 -169.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -164.54 149.88 10.1 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.253 0.621 . . . . 0.0 110.683 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -79.46 128.62 33.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.64 135.1 52.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.563 0.745 . . . . 0.0 112.115 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 52.38 18.4 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.32 -16.71 0.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.255 17.0 t 76.2 86.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.44 1.496 . . . . 0.0 110.558 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -132.84 -70.63 0.54 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.062 0.545 . . . . 0.0 110.541 -174.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.68 178.81 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 123.795 0.838 . . . . 0.0 112.521 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -54.76 144.2 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.361 1.064 . . . . 0.0 113.671 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -57.32 -27.88 62.59 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.37 -47.58 85.19 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -62.59 1.33 Allowed 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.853 170.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.15 -51.5 42.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.66 -36.14 81.89 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.6 p -74.48 -10.15 59.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.556 2.799 . . . . 0.0 118.556 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -59.88 -50.29 87.28 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 115.391 -2.243 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.16 -30.59 61.64 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 CA-C-N 125.362 2.951 . . . . 0.0 118.283 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.28 65.54 1.43 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 119.057 0.844 . . . . 0.0 111.176 163.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.0 ttm -160.23 109.65 1.76 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 157.71 20.44 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.071 0.938 . . . . 0.0 112.566 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.14 121.62 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.354 -0.841 . . . . 0.0 111.405 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.72 -3.69 83.32 Favored Glycine 0 CA--C 1.552 2.364 0 N-CA-C 118.49 2.156 . . . . 0.0 118.49 -167.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.5 114.26 12.69 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 121.25 2.525 . . . . 0.0 112.147 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.5 m -84.14 124.24 30.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 133.19 21.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.421 0.689 . . . . 0.0 109.579 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.438 ' SD ' ' SG ' ' A' ' 138' ' ' CYS . 26.9 tpp -83.75 137.9 33.52 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.86 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.8 t -128.48 125.22 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.5 p -102.74 95.49 6.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.81 127.25 32.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.297 172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.73 59.46 4.66 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.8 p 33.35 64.09 0.32 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -173.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -176.6 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.899 -155.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.439 ' HH ' ' HB3' ' A' ' 44' ' ' LEU . 58.3 m-85 -79.64 -38.76 33.02 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.288 1.435 . . . . 0.0 112.745 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.8 t -62.3 -63.92 1.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 163.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -137.16 -69.41 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.87 0.868 . . . . 0.0 109.665 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 119.63 -166.15 13.37 Favored Glycine 0 CA--C 1.555 2.549 0 CA-C-N 118.938 0.79 . . . . 0.0 113.17 -167.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -64.38 -10.46 24.05 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 N-CA-C 118.573 2.49 . . . . 0.0 118.573 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -105.47 103.27 12.76 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -122.7 157.63 17.3 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 123.685 0.66 . . . . 0.0 112.356 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -87.75 78.21 8.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.1 p -75.69 142.59 73.91 Favored Pre-proline 0 CA--C 1.568 1.668 0 CA-C-O 117.819 -1.086 . . . . 0.0 113.096 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.31 -15.29 32.51 Favored 'Cis proline' 0 CA--C 1.565 2.027 0 N-CA-C 119.397 2.807 . . . . 0.0 119.397 10.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -64.22 -47.86 78.09 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.25 101.01 53.92 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 171.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.34 145.82 66.92 Favored 'Trans proline' 0 CA--C 1.572 2.387 0 C-N-CA 122.525 2.15 . . . . 0.0 113.387 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.69 -34.55 62.19 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 123.196 2.597 . . . . 0.0 118.343 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -125.36 157.04 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.85 0.86 . . . . 0.0 109.905 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.262 . . 81.05 128.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.151 1.38 . . . . 0.0 111.569 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.99 153.44 33.8 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.374 1.991 . . . . 0.0 116.374 -169.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.77 134.62 54.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.69 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 113' ' ' MET . 42.3 t -90.92 91.93 8.55 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.988 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -79.66 121.12 24.9 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.049 0.928 . . . . 0.0 110.443 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -99.46 88.35 3.85 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.839 1.255 . . . . 0.0 109.053 -170.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.0 t -84.14 126.25 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -166.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -115.33 118.21 32.62 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.56 108.83 12.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -81.69 -70.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -145.28 135.65 24.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -167.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.87 95.57 5.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.512 0.673 . . . . 0.0 109.301 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.53 158.14 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 124.013 0.925 . . . . 0.0 109.785 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.04 -177.7 3.01 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.651 0 CA-C-O 116.906 -2.052 . . . . 0.0 113.502 179.503 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -109.79 136.43 49.13 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.158 0.983 . . . . 0.0 109.774 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 tp -145.64 113.44 6.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.98 161.37 27.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.9 mm -90.16 -67.74 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.427 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.255 2.4 pt? -70.28 -52.96 19.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -171.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.77 56.64 0.05 OUTLIER Glycine 0 N--CA 1.483 1.824 0 C-N-CA 123.73 0.681 . . . . 0.0 113.232 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -150.51 -55.84 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.973 0.909 . . . . 0.0 110.706 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.32 57.77 0.38 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 124.24 0.924 . . . . 0.0 111.693 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.7 mt -141.18 -59.75 0.49 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.081 0.953 . . . . 0.0 108.896 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.9 tp -92.07 89.13 6.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.222 0.919 . . . . 0.0 108.553 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -101.13 96.93 7.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.565 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 13.8 tmtt? -91.77 99.72 12.55 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.61 0.764 . . . . 0.0 112.185 -175.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -86.37 127.34 34.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.474 -0.766 . . . . 0.0 109.806 164.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.2 m -87.47 112.89 22.67 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.67 -68.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.82 0.848 . . . . 0.0 110.242 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.03 117.88 66.04 Favored Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.89 167.58 16.29 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.956 2.438 . . . . 0.0 114.937 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.45 170.47 50.58 Favored Glycine 0 CA--C 1.564 3.109 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 170.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.38 169.19 17.56 Favored 'Trans proline' 0 CA--C 1.575 2.549 0 C-N-CA 122.972 2.448 . . . . 0.0 115.844 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.86 113.42 3.22 Favored 'Trans proline' 0 CA--C 1.558 1.723 0 C-N-CA 123.039 2.493 . . . . 0.0 112.326 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.35 -86.1 0.44 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -164.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.285 81.7 p 63.05 113.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.6 m -92.22 135.93 33.6 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.135 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 143.06 26.01 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.04 145.96 22.55 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.525 2.15 . . . . 0.0 115.764 -162.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.47 HG21 ' H ' ' A' ' 62' ' ' LYS . 8.3 p -95.71 -179.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 124.578 1.151 . . . . 0.0 111.759 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.47 ' H ' HG21 ' A' ' 61' ' ' VAL . 25.6 tttm -63.66 119.95 10.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.73 47.05 2.0 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.88 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.45 124.83 26.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 HG21 ' HG1' ' A' ' 89' ' ' THR . 57.5 t -84.54 99.87 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -103.72 126.54 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.747 0.819 . . . . 0.0 109.17 -171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -100.86 113.4 26.31 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.69 140.76 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.821 0.848 . . . . 0.0 109.014 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -92.56 100.52 13.03 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.68 106.31 17.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.78 99.82 11.39 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -78.22 119.26 21.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -132.24 145.73 51.52 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.753 0.787 . . . . 0.0 109.945 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.96 148.78 48.49 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.704 172.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -55.15 -31.34 61.25 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -63.6 -68.04 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.97 0.805 . . . . 0.0 111.682 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.02 77.04 0.02 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -147.57 117.9 7.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -74.1 95.74 2.6 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 122.624 1.202 . . . . 0.0 112.903 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.04 -45.39 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -125.11 150.27 47.02 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.313 1.054 . . . . 0.0 109.822 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -147.35 79.26 1.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.566 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.89 98.43 5.39 Favored Pre-proline 0 CA--C 1.579 2.069 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.28 -43.92 1.98 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.176 2.584 . . . . 0.0 115.865 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.9 77.27 8.53 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.312 1.053 . . . . 0.0 110.067 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.0 tp -100.33 98.01 8.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.92 135.56 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -158.56 142.24 15.26 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.459 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.475 ' HG1' HG21 ' A' ' 65' ' ' VAL . 6.7 m -80.24 133.3 35.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.46 138.6 57.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.967 0.507 . . . . 0.0 111.97 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.2 -66.01 0.25 Allowed Glycine 0 N--CA 1.478 1.484 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.65 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 104.48 5.68 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.312 0.577 . . . . 0.0 110.037 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.82 82.84 6.18 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.797 0.808 . . . . 0.0 112.803 -161.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.89 -50.8 14.0 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.122 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.64 161.05 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.1 pt -54.59 151.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 124.829 1.252 . . . . 0.0 114.222 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -65.41 -17.12 64.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -36.98 85.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.98 -71.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.378 -1.296 . . . . 0.0 111.641 159.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.74 -44.34 27.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 -168.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.26 -50.18 72.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -75.49 -12.0 60.15 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.272 5.7 t -67.79 -46.48 44.5 Favored Pre-proline 0 N--CA 1.497 1.923 0 CA-C-O 115.214 -2.327 . . . . 0.0 114.023 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.22 35.14 0.38 Allowed 'Trans proline' 0 CA--C 1.579 2.74 0 CA-C-N 125.415 2.969 . . . . 0.0 116.672 165.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.3 mt -138.89 -38.75 0.5 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 126.525 1.93 . . . . 0.0 110.495 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 42.3 mtt -63.65 123.82 19.82 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.814 1.246 . . . . 0.0 112.768 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.67 159.96 23.83 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.661 1.22 . . . . 0.0 112.836 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.57 105.15 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.6 62.42 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.685 -1.064 . . . . 0.0 114.296 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' CD ' ' HZ3' ' A' ' 47' ' ' LYS . 3.3 pt-20 -140.27 129.04 23.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.477 1.138 . . . . 0.0 112.194 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.9 m -85.62 130.14 34.65 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.98 127.75 14.34 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.643 0.259 . . . . 0.0 111.284 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.4 tpp -84.06 108.92 17.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.02 106.58 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 66.0 p -94.69 93.51 7.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.42 18.06 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -74.46 153.9 38.96 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.688 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.3 t -75.12 83.82 2.33 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.782 1.277 . . . . 0.0 110.623 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -178.02 -61.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.047 -155.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -77.69 -53.2 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.582 1.153 . . . . 0.0 111.793 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m -81.76 107.75 14.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.86 0.864 . . . . 0.0 110.243 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.305 23.8 m-85 70.12 -0.04 2.94 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.27 -179.91 48.24 Favored Glycine 0 CA--C 1.559 2.823 0 CA-C-N 120.26 1.391 . . . . 0.0 115.649 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.95 -46.05 9.24 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.286 2.657 . . . . 0.0 116.325 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -95.43 102.52 14.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.71 -152.9 11.75 Favored Glycine 0 CA--C 1.548 2.11 0 N-CA-C 116.713 1.445 . . . . 0.0 116.713 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -82.75 66.11 8.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 124.114 0.966 . . . . 0.0 112.182 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.5 p -80.21 146.97 63.79 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.384 -175.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.1 -11.98 29.93 Favored 'Cis proline' 0 CA--C 1.565 2.073 0 N-CA-C 119.637 2.899 . . . . 0.0 119.637 7.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -60.55 -58.02 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -96.5 105.03 20.0 Favored Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.29 160.8 48.3 Favored 'Trans proline' 0 CA--C 1.573 2.432 0 C-N-CA 122.711 2.274 . . . . 0.0 113.986 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.98 112.61 2.76 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 123.031 2.488 . . . . 0.0 112.965 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 88.6 m-70 72.92 86.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.71 1.204 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.88 121.74 4.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.65 122.98 25.44 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.015 0.526 . . . . 0.0 111.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 mt -97.84 139.95 32.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.696 0.76 . . . . 0.0 111.92 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -102.2 90.74 4.02 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.832 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.86 118.81 37.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.706 0.802 . . . . 0.0 110.227 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.5 107.43 19.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.041 0.924 . . . . 0.0 110.901 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.23 111.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -108.98 117.11 33.35 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.07 108.81 10.41 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.45 -59.72 2.14 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.254 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 76.1 p -132.93 139.3 47.27 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.654 0.781 . . . . 0.0 109.114 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.67 112.75 17.13 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -128.46 132.16 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.49 119.44 23.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.125 0.488 . . . . 0.0 111.619 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.673 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.75 0.786 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 m0 67.91 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.425 1.49 . . . . 0.0 112.928 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -80.22 128.23 33.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -109.73 148.35 31.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.132 0.973 . . . . 0.0 113.589 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.53 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 tp -166.07 -70.73 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.29 -75.01 0.27 Allowed Glycine 0 CA--C 1.54 1.594 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -164.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.6 -84.75 0.08 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.464 0.706 . . . . 0.0 110.694 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.21 84.53 0.05 OUTLIER Glycine 0 N--CA 1.476 1.363 0 CA-C-N 118.825 0.739 . . . . 0.0 111.68 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.08 -58.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.803 0.841 . . . . 0.0 109.61 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.5 96.0 7.89 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.142 0.883 . . . . 0.0 108.895 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -118.1 90.04 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.075 0.95 . . . . 0.0 109.071 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.263 17.1 ptmt -83.49 123.8 30.08 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.78 138.35 32.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 161.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 m -98.62 109.06 21.88 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.52 -77.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.92 125.44 34.56 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.78 -168.49 0.59 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 123.54 2.827 . . . . 0.0 113.312 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.62 Favored Glycine 0 CA--C 1.563 3.089 0 CA-C-O 118.959 -0.911 . . . . 0.0 115.103 163.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.35 167.28 22.71 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 C-N-CA 123.085 2.523 . . . . 0.0 114.931 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.8 109.6 1.5 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.125 2.55 . . . . 0.0 111.854 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.07 81.56 1.49 Allowed Glycine 0 CA--C 1.543 1.782 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.992 -157.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.2 p -141.05 116.05 9.82 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 144.53 31.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.462 0.705 . . . . 0.0 112.053 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -93.27 111.81 53.59 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.384 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.4 169.31 22.01 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 123.196 2.597 . . . . 0.0 115.938 -165.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.6 160.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 123.808 0.843 . . . . 0.0 112.429 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -69.5 110.37 4.73 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 122.938 0.495 . . . . 0.0 109.995 162.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.51 -60.36 0.64 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.887 -157.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.87 119.84 17.67 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.233 0.613 . . . . 0.0 110.874 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.01 112.53 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.83 139.51 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.295 0.569 . . . . 0.0 110.985 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -101.52 131.41 47.69 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.9 138.92 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.032 0.533 . . . . 0.0 111.345 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.72 98.7 9.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.55 127.74 33.63 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 164.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -116.5 87.36 2.67 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.4 ' HG1' ' HB3' ' A' ' 139' ' ' LEU . 23.0 m -85.75 116.44 24.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -170.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.7 m -138.61 33.62 2.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.258 10.3 mt 55.59 167.05 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.91 -43.91 97.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.35 -60.72 2.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.99 73.94 0.03 OUTLIER Glycine 0 CA--C 1.543 1.783 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -174.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 m -152.87 117.03 4.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -76.58 111.01 11.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -83.69 -63.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 124.034 0.934 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -146.94 103.13 3.59 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -91.96 90.34 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.706 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -100.08 107.12 45.51 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.892 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.0 -49.84 0.12 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.277 2.652 . . . . 0.0 117.041 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -107.56 84.16 1.92 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.371 0.669 . . . . 0.0 110.316 -175.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.9 tp -103.09 92.19 4.43 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.79 128.71 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -157.9 149.09 21.25 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.213 0.605 . . . . 0.0 111.057 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -73.28 126.82 30.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.2 tp -59.67 117.0 4.43 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -159.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.61 40.27 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.08 178.51 6.97 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.726 1.251 . . . . 0.0 111.483 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 77.4 m -78.19 68.11 4.15 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -167.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.89 -54.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.676 1.59 . . . . 0.0 109.278 172.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.09 164.65 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 122.545 1.164 . . . . 0.0 112.917 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.9 pt -62.69 154.77 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.824 1.25 . . . . 0.0 113.276 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.39 -32.53 71.4 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.2 74.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 168.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.34 -50.97 63.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 169.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -51.66 -45.83 63.55 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.26 -36.36 79.31 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -72.65 -19.07 61.5 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.27 2.1 t -52.35 -51.33 73.41 Favored Pre-proline 0 CA--C 1.578 2.044 0 CA-C-O 115.125 -2.369 . . . . 0.0 116.627 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.08 -41.84 68.95 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 125.216 2.898 . . . . 0.0 118.066 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -89.81 16.24 8.4 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.9 mtm -81.47 102.45 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 121.023 1.738 . . . . 0.0 110.314 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.96 152.8 35.12 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.044 0.926 . . . . 0.0 111.814 167.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -67.04 111.36 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.5 12.68 55.62 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 116.69 17.03 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.709 2.755 . . . . 0.0 112.519 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.0 m -100.23 102.78 14.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 125.19 22.88 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 -166.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.6 tpp -68.14 102.6 1.37 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.773 0.829 . . . . 0.0 111.698 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.72 96.16 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.5 t -114.65 116.08 28.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.538 0.735 . . . . 0.0 109.045 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.33 155.35 21.29 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.509 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -58.19 152.8 16.29 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.235 150.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.573 ' HG ' ' HA ' ' A' ' 134' ' ' HIS . 78.6 p -70.04 77.23 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.326 1.06 . . . . 0.0 112.493 171.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -52.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.638 -165.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.27 -51.38 8.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.063 1.345 . . . . 0.0 111.328 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -64.01 -62.9 1.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -133.31 -58.32 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.52 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.66 179.05 47.89 Favored Glycine 0 CA--C 1.558 2.721 0 CA-C-N 119.319 0.963 . . . . 0.0 114.955 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.45 100.97 0.82 Allowed 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 123.138 2.559 . . . . 0.0 112.57 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -158.08 -71.26 0.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.621 -165.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.94 83.74 1.08 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 118.601 0.637 . . . . 0.0 112.13 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -89.95 152.48 21.2 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-O 121.919 0.866 . . . . 0.0 111.696 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -75.36 140.67 72.73 Favored Pre-proline 0 CA--C 1.571 1.761 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.892 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.54 -58.68 0.07 OUTLIER 'Cis proline' 0 CA--C 1.563 1.935 0 CA-C-N 122.85 2.053 . . . . 0.0 116.156 10.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -137.44 67.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mt -103.49 114.08 65.14 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.21 137.93 24.37 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.403 2.068 . . . . 0.0 114.694 -166.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.58 -45.88 8.14 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 123.207 2.605 . . . . 0.0 116.343 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.573 ' HA ' ' HG ' ' A' ' 118' ' ' SER . 17.3 p80 -128.22 85.78 2.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.697 0.799 . . . . 0.0 109.85 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.77 125.19 3.15 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.66 101.66 5.84 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.067 0.547 . . . . 0.0 111.392 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -103.3 143.92 32.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.2 m -92.89 136.21 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.637 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 1.6 pt? -149.83 106.92 3.58 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.067 0.547 . . . . 0.0 110.478 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -87.31 117.63 26.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.486 1.136 . . . . 0.0 113.806 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.78 114.99 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -169.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -96.26 121.9 38.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.26 104.8 11.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 85' ' ' GLU . 34.1 mtpt -81.4 -63.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 -171.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 58.5 p -144.25 132.24 21.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.21 103.63 15.59 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 168.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.53 123.24 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -171.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.75 124.4 28.16 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 112.464 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.796 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.173 -169.084 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 CA--C 1.572 1.816 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -55.08 121.26 8.36 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -167.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 tp -175.01 154.43 1.82 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.037 -159.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.6 t0 68.78 119.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 149.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 mm -118.02 -54.66 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.072 0.949 . . . . 0.0 109.23 167.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.14 -63.77 1.11 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.48 -61.7 0.01 OUTLIER Glycine 0 N--CA 1.483 1.809 0 CA-C-N 119.448 1.022 . . . . 0.0 115.259 -171.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -90.23 -78.58 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 117.734 0.767 . . . . 0.0 110.777 -172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 177.0 72.24 0.06 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 mt -122.11 -66.32 1.04 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -163.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -80.06 98.54 7.29 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.19 96.46 7.49 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.946 0.498 . . . . 0.0 110.017 -164.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -105.47 132.93 51.02 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -113.36 145.61 40.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.806 -0.559 . . . . 0.0 110.249 152.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.9 m -88.74 108.45 19.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.29 -67.96 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.586 0.755 . . . . 0.0 111.45 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.05 122.29 62.14 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 167.83 19.41 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 114.586 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.66 123.42 6.68 Favored Glycine 0 CA--C 1.556 2.643 0 CA-C-O 117.049 -1.973 . . . . 0.0 113.351 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.45 167.92 22.64 Favored 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 122.53 3.165 . . . . 0.0 115.607 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.05 112.96 3.1 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.105 2.537 . . . . 0.0 111.869 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 76.81 1.34 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.473 -160.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 t -159.4 108.45 1.85 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 m -128.71 118.29 22.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.41 1.1 . . . . 0.0 110.368 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -64.13 132.94 95.45 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.86 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 164.09 35.25 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.91 2.407 . . . . 0.0 116.31 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.9 t -82.24 150.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.947 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -59.09 104.12 0.22 Allowed 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.971 1.308 . . . . 0.0 113.31 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.29 62.54 0.34 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.032 -165.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -155.44 138.66 15.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.48 106.89 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.329 -0.857 . . . . 0.0 109.671 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.16 118.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 124.128 0.971 . . . . 0.0 108.765 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.5 m -100.31 124.2 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.57 137.29 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.208 0.528 . . . . 0.0 110.459 -173.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -88.71 106.98 18.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 165.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -103.52 121.67 43.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.161 0.585 . . . . 0.0 110.094 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -103.44 99.17 8.99 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -93.64 99.44 11.87 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.037 0.535 . . . . 0.0 110.7 -165.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -104.57 -169.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.3 0.64 . . . . 0.0 111.359 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 tp -114.88 147.82 39.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.705 1.202 . . . . 0.0 109.513 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.322 4.2 pt-20 -60.44 -29.99 69.37 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 117.527 2.418 . . . . 0.0 117.527 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -64.64 -68.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.896 161.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.08 0.05 OUTLIER Glycine 0 N--CA 1.482 1.756 0 CA-C-N 119.53 1.059 . . . . 0.0 113.107 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.3 m -153.33 122.58 6.6 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -76.52 97.15 4.26 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.041 0.924 . . . . 0.0 111.301 171.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -84.99 -47.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.138 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -125.04 156.78 37.64 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.842 1.306 . . . . 0.0 110.503 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.86 93.0 2.87 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 161.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -85.24 116.7 66.61 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.622 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.86 -49.46 0.15 Allowed 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.938 2.426 . . . . 0.0 116.56 -168.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -137.84 93.66 2.8 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.134 0.879 . . . . 0.0 109.423 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 tp -85.4 104.42 15.19 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.74 96.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -125.42 147.57 49.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.598 0.759 . . . . 0.0 109.32 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.0 m -100.38 66.51 1.28 Allowed 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 123.012 0.525 . . . . 0.0 110.019 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . 0.401 7.6 mp 61.17 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.25 -94.4 0.18 Allowed Glycine 0 N--CA 1.483 1.816 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.448 165.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 68.1 150.11 0.07 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.2 t -82.26 72.73 9.32 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.58 1.181 . . . . 0.0 113.445 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.74 -61.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.251 1.42 . . . . 0.0 108.982 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.6 152.98 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.829 1.3 . . . . 0.0 113.147 -151.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.1 pt -68.94 165.7 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.876 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -57.97 -34.65 70.17 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 171.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.21 86.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.15 -45.77 62.84 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -66.79 -32.36 73.6 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.11 -15.09 57.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.3 p -71.05 -36.39 72.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.233 1.833 . . . . 0.0 115.37 164.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.0 -53.33 39.21 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 115.897 -2.001 . . . . 0.0 115.027 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.44 -15.0 42.54 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 123.644 2.896 . . . . 0.0 119.104 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.33 48.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 120.341 1.428 . . . . 0.0 112.869 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.8 mtp -143.12 100.15 3.58 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.38 176.05 8.09 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.244 1.021 . . . . 0.0 110.829 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.84 105.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.798 -1.189 . . . . 0.0 109.874 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.14 61.16 0.86 Allowed Glycine 0 CA--C 1.546 1.978 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.737 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -140.49 122.19 15.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.656 0.782 . . . . 0.0 110.08 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.1 m -94.6 136.24 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 160.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.08 113.73 9.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 53.3 ttm -84.84 115.01 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.88 128.14 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.0 p -94.64 87.53 5.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.09 19.16 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.222 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.85 144.74 8.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.6 p -54.87 -19.28 6.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -59.24 -51.3 70.55 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 161.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -77.89 -48.84 15.45 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.83 1.252 . . . . 0.0 113.511 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.46 174.56 7.48 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.092 1.357 . . . . 0.0 112.94 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -73.69 100.89 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.593 0.757 . . . . 0.0 110.711 166.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.93 -87.78 1.96 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 116.147 -2.474 . . . . 0.0 108.317 163.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.54 52.61 4.15 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 122.675 3.237 . . . . 0.0 114.722 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -132.41 -77.81 0.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.55 112.1 2.02 Favored Glycine 0 N--CA 1.48 1.617 0 CA-C-N 119.685 1.13 . . . . 0.0 113.507 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -104.08 127.49 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 157.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 145.64 89.84 Favored Pre-proline 0 CA--C 1.571 1.767 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -91.23 -64.99 0.03 OUTLIER 'Cis proline' 0 CA--C 1.565 2.047 0 CA-C-N 122.689 1.996 . . . . 0.0 116.701 8.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -115.48 43.95 1.95 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -165.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.2 mt -80.31 118.21 71.35 Favored Pre-proline 0 CA--C 1.58 2.121 0 O-C-N 120.643 -1.286 . . . . 0.0 108.113 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.28 160.65 26.11 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 122.933 2.422 . . . . 0.0 116.242 -166.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.1 136.23 24.29 Favored 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 123.292 2.662 . . . . 0.0 114.251 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.285 97.1 m-70 73.65 162.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.688 1.195 . . . . 0.0 113.828 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 77.24 148.07 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.075 1.35 . . . . 0.0 113.436 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.53 148.02 47.14 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.4 mt -100.65 123.38 44.78 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.017 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.5 84.48 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.335 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.65 120.86 43.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.389 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.69 147.81 50.08 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.343 160.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 t -134.21 100.12 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -95.69 123.3 39.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.31 104.62 13.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -88.61 -56.81 3.15 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.781 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.1 p -140.15 134.69 31.58 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.381 0.673 . . . . 0.0 109.558 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.82 105.3 12.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.5 m -136.5 131.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.422 0.689 . . . . 0.0 109.249 -166.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.88 118.6 30.88 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.046 0.538 . . . . 0.0 110.297 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.087 0 CA-C-O 117.091 -1.95 . . . . 0.0 111.88 177.488 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.26 7.5 tp10 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 m95 73.36 99.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.901 1.281 . . . . 0.0 110.111 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -83.86 114.07 21.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.76 101.33 6.64 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.866 0.841 . . . . 0.0 111.066 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.46 -51.89 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 123.982 0.913 . . . . 0.0 111.407 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -66.11 -63.96 0.97 Allowed 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.24 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.479 1.561 0 CA-C-N 118.96 0.8 . . . . 0.0 112.102 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.37 -66.22 0.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.178 0.591 . . . . 0.0 112.539 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.7 70.15 0.04 OUTLIER Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.401 0.546 . . . . 0.0 112.601 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -124.71 -70.32 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -81.91 120.18 24.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 118.822 0.737 . . . . 0.0 109.762 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.17 152.37 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.322 1.049 . . . . 0.0 111.443 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.37 117.74 14.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 0.0 112.504 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.83 121.14 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.993 . . . . 0.0 108.776 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -86.85 115.79 24.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.77 -65.56 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.777 0.831 . . . . 0.0 110.638 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -116.37 140.44 26.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 119.12 0.873 . . . . 0.0 109.27 165.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.98 171.73 16.73 Favored 'Trans proline' 0 CA--C 1.563 1.958 0 C-N-CA 123.072 2.515 . . . . 0.0 114.443 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.3 103.41 3.04 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-O 116.787 -2.118 . . . . 0.0 109.835 164.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 163.48 35.42 Favored 'Trans proline' 0 CA--C 1.571 2.355 0 CA-C-N 122.734 3.267 . . . . 0.0 116.252 -164.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.41 127.27 15.42 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.273 2.649 . . . . 0.0 113.156 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 -71.36 0.39 Allowed Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -159.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.1 p -75.24 102.46 5.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.402 0.681 . . . . 0.0 111.183 168.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -113.09 147.46 37.25 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.969 0.89 . . . . 0.0 111.287 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -60.34 128.6 88.06 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.56 160.14 47.29 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.041 2.494 . . . . 0.0 115.022 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.4 m -85.23 166.43 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.451 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -53.2 131.13 36.54 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.66 46.76 2.06 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 114.123 -1.398 . . . . 0.0 114.716 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.58 136.23 32.6 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.82 100.74 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 m -92.47 110.02 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -92.47 112.55 24.54 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.36 142.08 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.69 0.757 . . . . 0.0 110.44 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.05 107.26 11.68 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 162.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.45 107.19 17.95 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -103.61 111.89 24.57 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.98 117.44 28.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 t -133.98 152.66 51.94 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.064 0.935 . . . . 0.0 110.048 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.62 139.79 49.47 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.563 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.83 -37.95 77.58 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.99 -53.05 56.12 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 167.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.743 1.156 . . . . 0.0 114.881 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -63.87 137.75 58.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -160.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -61.56 117.01 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.28 35.6 m -81.59 -47.71 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.672 176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -145.23 119.79 9.74 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 165.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -106.96 83.6 1.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.542 0.686 . . . . 0.0 110.105 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.57 101.84 51.92 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.651 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.64 50.27 3.5 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.644 2.23 . . . . 0.0 115.905 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' CD ' ' HZ2' ' A' ' 144' ' ' LYS . 5.4 tp10 -161.51 117.05 2.08 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.809 0.844 . . . . 0.0 109.281 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.49 103.91 3.17 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.54 114.26 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.6 142.11 32.08 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -78.46 121.26 24.32 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.29 133.59 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.32 0.509 . . . . 0.0 112.31 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.37 -70.34 0.74 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.925 -167.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -90.71 77.95 6.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.77 0.795 . . . . 0.0 110.215 172.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.36 126.64 53.02 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.628 -163.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -97.72 70.29 2.19 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.477 1.132 . . . . 0.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.03 177.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.411 1.1 . . . . 0.0 110.331 -163.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.59 150.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.833 0.853 . . . . 0.0 112.441 170.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.35 -29.76 71.01 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.09 81.87 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.93 -54.62 35.78 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.436 -1.269 . . . . 0.0 113.96 167.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -53.31 -49.0 67.93 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.6 p -79.3 -8.85 59.37 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 117.684 2.476 . . . . 0.0 117.684 168.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.263 12.8 t -52.44 -48.79 88.67 Favored Pre-proline 0 N--CA 1.501 2.094 0 CA-C-O 115.264 -2.303 . . . . 0.0 114.449 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.74 0.59 1.44 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 CA-C-N 125.114 2.862 . . . . 0.0 119.314 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.253 2.0 pt? -149.21 65.81 1.02 Allowed 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.079 1.309 . . . . 0.0 111.581 167.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.2 mmt -138.35 99.96 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.39 164.04 12.81 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.146 0.974 . . . . 0.0 113.101 -168.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.27 114.73 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.63 -6.78 45.23 Favored Glycine 0 CA--C 1.552 2.381 0 N-CA-C 117.905 1.922 . . . . 0.0 117.905 -167.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.41 126.27 33.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 121.132 2.466 . . . . 0.0 113.396 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.9 m -100.45 127.98 46.64 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 158.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.94 124.08 6.3 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.577 0.351 . . . . 0.0 110.165 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.9 ptm -77.8 131.94 37.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.124 0.57 . . . . 0.0 110.791 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.8 t -113.23 96.2 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.3 p -85.65 102.21 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.2 138.7 54.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.106 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.61 153.24 0.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.9 p -70.67 76.51 0.6 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.921 1.344 . . . . 0.0 112.153 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -179.03 -61.54 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.867 -152.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.17 -50.71 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.443 1.097 . . . . 0.0 112.674 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.24 -68.33 0.4 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -138.82 -66.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.798 0.726 . . . . 0.0 109.31 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.4 -147.93 19.78 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.391 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -72.72 112.71 3.55 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.253 51.3 mt-30 69.37 92.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.891 1.276 . . . . 0.0 110.271 -164.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.81 54.8 Favored Glycine 0 CA--C 1.547 2.049 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -101.39 60.09 0.9 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -163.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 40.7 m 66.95 141.78 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 167.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.45 -45.85 0.4 Allowed 'Cis proline' 0 CA--C 1.564 1.992 0 CA-C-N 122.627 1.974 . . . . 0.0 115.705 -3.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -134.42 63.26 1.63 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.703 0.801 . . . . 0.0 110.489 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.1 mt -91.32 121.35 67.72 Favored Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.47 162.4 35.98 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.918 2.412 . . . . 0.0 116.303 -170.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.85 -46.3 6.78 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 123.215 2.61 . . . . 0.0 116.598 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -97.39 -166.73 1.43 Allowed 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 124.498 1.119 . . . . 0.0 111.689 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.28 128.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.248 1.419 . . . . 0.0 113.106 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.25 101.91 12.91 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.137 0.575 . . . . 0.0 110.921 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.87 143.11 44.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -164.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.7 m -84.7 115.5 22.71 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.002 0.921 . . . . 0.0 110.706 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.19 98.86 6.37 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -82.94 107.36 15.49 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.238 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.7 93.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.4 m -99.99 112.42 24.71 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.53 102.91 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HZ2' ' CD ' ' A' ' 85' ' ' GLU . 42.0 mtmt -73.86 -65.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.155 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.0 p -144.72 130.61 19.25 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.37 103.35 15.28 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.11 153.27 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.543 0.737 . . . . 0.0 110.13 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.39 145.73 55.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.097 0 CA-C-O 117.178 -1.901 . . . . 0.0 111.981 -174.625 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.569 1.693 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -76.76 128.42 34.61 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.515 0.726 . . . . 0.0 109.809 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.89 114.2 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.332 0.653 . . . . 0.0 110.692 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.69 127.13 44.52 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.084 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.37 74.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.281 0.632 . . . . 0.0 109.679 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -157.58 -72.75 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.66 0.784 . . . . 0.0 109.018 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.77 -83.34 0.11 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -164.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.55 -70.26 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.239 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.52 85.02 0.05 OUTLIER Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.966 0.803 . . . . 0.0 112.971 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.55 -59.34 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -74.17 114.26 12.3 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.15 0.886 . . . . 0.0 110.489 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -143.46 105.54 4.38 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.716 0.807 . . . . 0.0 109.782 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -101.93 101.42 11.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 112.316 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.26 120.0 23.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.852 -1.155 . . . . 0.0 109.515 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.4 m -78.9 115.66 18.73 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.358 0.599 . . . . 0.0 110.141 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.03 -69.0 0.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.733 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.48 106.82 52.03 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.45 175.14 11.67 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 122.651 2.234 . . . . 0.0 114.655 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.94 123.46 24.14 Favored Glycine 0 CA--C 1.558 2.74 0 CA-C-O 117.133 -1.926 . . . . 0.0 112.466 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.4 161.19 44.33 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 CA-C-N 122.321 3.06 . . . . 0.0 115.29 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 106.74 1.22 Allowed 'Trans proline' 0 CA--C 1.558 1.722 0 C-N-CA 123.181 2.588 . . . . 0.0 112.171 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.72 76.29 1.32 Allowed Glycine 0 CA--C 1.545 1.95 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.591 -159.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -147.96 117.24 6.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -79.71 142.37 35.53 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.056 0.542 . . . . 0.0 112.261 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -91.4 116.3 66.16 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.186 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.93 144.86 31.0 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.703 2.269 . . . . 0.0 114.665 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.18 169.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.196 0.999 . . . . 0.0 112.645 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -64.54 120.32 12.12 Favored 'General case' 0 CA--C 1.568 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 112.084 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.0 40.67 3.72 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -138.26 115.55 11.09 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -72.26 109.46 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 123.285 0.634 . . . . 0.0 110.099 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.5 123.98 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.616 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.7 m -102.61 121.32 42.16 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.94 142.46 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.389 0.675 . . . . 0.0 110.783 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -82.72 104.59 13.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 161.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.35 125.43 47.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -133.3 122.15 23.45 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.489 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.8 p -93.0 131.37 38.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.08 0.952 . . . . 0.0 111.558 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.9 m -155.57 131.5 9.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.579 0.751 . . . . 0.0 109.708 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.03 157.28 19.15 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -52.7 -40.56 63.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -73.36 -64.73 0.92 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.537 0.735 . . . . 0.0 111.142 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.35 0.05 OUTLIER Glycine 0 N--CA 1.478 1.466 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.2 m -146.15 120.82 9.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -80.14 119.4 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.864 0.866 . . . . 0.0 111.974 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.0 t -97.41 -69.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.585 -166.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -143.83 122.11 12.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -167.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -85.52 94.68 9.08 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.456 0.702 . . . . 0.0 110.591 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.12 68.32 46.58 Favored Pre-proline 0 CA--C 1.579 2.068 0 O-C-N 121.384 -0.823 . . . . 0.0 113.163 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 -39.65 3.05 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.355 2.703 . . . . 0.0 117.58 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 76.73 1.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.575 1.079 . . . . 0.0 110.391 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.18 95.96 7.44 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.5 t -101.89 114.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.27 152.51 40.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 111.323 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -75.29 128.32 35.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.94 124.89 21.6 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.032 0.933 . . . . 0.0 111.979 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.64 -41.24 3.06 Favored Glycine 0 CA--C 1.547 2.079 0 N-CA-C 117.505 1.762 . . . . 0.0 117.505 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.91 107.77 18.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.012 1.406 . . . . 0.0 109.562 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -85.98 81.42 8.51 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -150.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.98 -47.37 52.58 Favored 'General case' 0 CA--C 1.574 1.899 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.105 156.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.08 179.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.602 1.161 . . . . 0.0 114.108 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.01 152.09 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.648 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -64.19 -33.46 75.84 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.31 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 167.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -53.09 38.64 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.23 -42.63 86.71 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.86 -34.31 77.66 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -72.82 -22.99 60.72 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.2 t -57.38 -49.94 90.99 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 114.871 -2.49 . . . . 0.0 115.996 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -53.28 -34.58 70.71 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 126.12 3.221 . . . . 0.0 118.424 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -101.01 63.74 1.02 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.598 0.759 . . . . 0.0 111.579 168.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.28 113.32 6.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -97.02 168.12 10.65 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.878 0.847 . . . . 0.0 111.915 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.76 118.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.852 -1.155 . . . . 0.0 108.403 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.09 6.04 72.28 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.144 2.018 . . . . 0.0 118.144 -165.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.12 108.4 19.84 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 120.5 2.15 . . . . 0.0 109.625 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.592 HG21 ' HG1' ' A' ' 142' ' ' THR . 97.7 m -109.19 119.71 40.34 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.06 136.93 34.14 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.776 0.798 . . . . 0.0 111.075 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.9 ttm -84.0 103.14 13.0 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.062 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.95 92.6 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.9 p -81.41 126.55 31.77 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.282 0.633 . . . . 0.0 109.769 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.1 136.88 17.08 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.316 -175.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -46.02 133.33 8.96 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 124.785 1.234 . . . . 0.0 113.983 168.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.4 m -74.55 84.83 2.05 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.279 1.038 . . . . 0.0 110.983 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -179.55 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -142.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -68.62 -36.52 78.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 162.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.1 m -72.22 -75.12 0.14 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.17 0.895 . . . . 0.0 111.179 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.92 -67.71 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.263 0.938 . . . . 0.0 110.774 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.7 170.72 27.94 Favored Glycine 0 CA--C 1.553 2.45 0 CA-C-N 119.036 0.834 . . . . 0.0 115.088 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.22 10.03 0.35 Allowed 'Trans proline' 0 CA--C 1.571 2.348 0 N-CA-C 119.375 2.798 . . . . 0.0 119.375 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -131.53 -76.65 0.52 Allowed 'General case' 0 CA--C 1.561 1.376 0 CA-C-N 119.527 1.058 . . . . 0.0 108.258 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.56 124.08 1.11 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 119.69 1.132 . . . . 0.0 112.545 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -93.05 39.09 1.04 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.6 m 66.72 139.25 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.79 -50.46 0.17 OUTLIER 'Cis proline' 0 CA--C 1.563 1.964 0 CA-C-N 123.097 2.142 . . . . 0.0 115.896 4.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -132.4 71.76 1.48 Allowed 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.891 0.877 . . . . 0.0 108.855 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.6 mm -99.72 134.55 20.98 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.927 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.32 162.31 33.88 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.203 2.602 . . . . 0.0 116.215 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.77 -94.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 123.358 2.706 . . . . 0.0 113.094 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -136.51 80.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.109 1.322 . . . . 0.0 109.542 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.75 38.55 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 60.14 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tt -96.58 130.04 43.85 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.8 t -100.37 113.36 26.03 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.872 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.15 108.69 20.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.32 97.38 9.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.003 -0.436 . . . . 0.0 110.189 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.79 111.43 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -168.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.592 ' HG1' HG21 ' A' ' 111' ' ' THR . 89.1 m -113.79 113.28 24.72 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.04 103.51 9.97 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 120.942 0.401 . . . . 0.0 110.052 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -80.88 -64.46 1.18 Allowed 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -141.78 137.33 31.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.725 0.81 . . . . 0.0 109.008 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.56 107.95 18.65 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.11 125.43 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -81.39 91.04 6.21 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.203 1.001 . . . . 0.0 112.957 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.344 0 CA-C-O 116.876 -2.069 . . . . 0.0 113.851 179.07 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.505 2.286 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -141.4 117.43 10.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -100.03 107.82 19.85 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.57 123.94 30.27 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.448 0.642 . . . . 0.0 111.676 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.44 -58.84 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.664 0.786 . . . . 0.0 110.735 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.258 3.7 pp -66.48 -17.63 64.91 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.45 55.86 4.49 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 119.948 1.249 . . . . 0.0 116.034 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -156.13 -81.18 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.33 59.62 0.03 OUTLIER Glycine 0 CA--C 1.541 1.689 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.172 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.76 -70.98 0.45 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.0 tp -88.29 102.81 15.2 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.495 1.043 . . . . 0.0 108.84 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.411 HH21 ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.0 117.58 31.01 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.363 0.665 . . . . 0.0 110.004 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -122.36 103.62 8.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 0.0 110.266 -168.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -81.02 141.22 34.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.461 -0.775 . . . . 0.0 109.729 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -81.65 96.48 7.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 159.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.39 -63.08 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.824 1.25 . . . . 0.0 113.218 -170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.97 123.89 23.75 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 162.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.61 165.42 24.96 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 C-N-CA 123.117 2.545 . . . . 0.0 114.844 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.3 171.3 55.17 Favored Glycine 0 CA--C 1.562 2.98 0 N-CA-C 115.35 0.9 . . . . 0.0 115.35 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.41 162.72 39.42 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 123.257 2.638 . . . . 0.0 115.827 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.78 -42.2 48.08 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 123.423 2.749 . . . . 0.0 116.743 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.97 -176.21 50.58 Favored Glycine 0 CA--C 1.552 2.365 0 CA-C-N 119.04 0.836 . . . . 0.0 113.711 161.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m 62.36 86.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.376 1.071 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.0 p -98.71 153.67 18.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -165.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -45.13 128.39 5.65 Favored Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.38 165.88 28.48 Favored 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 122.948 2.432 . . . . 0.0 115.843 -173.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -102.63 159.06 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.444 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -63.77 132.79 52.03 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 113.588 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.34 14.28 9.92 Favored Glycine 0 CA--C 1.557 2.717 0 CA-C-N 113.82 -1.536 . . . . 0.0 115.564 -153.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -138.65 114.87 10.29 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.88 109.55 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.75 134.88 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.594 0.758 . . . . 0.0 110.737 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -92.71 127.98 38.41 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.2 126.15 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -71.55 107.0 4.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.879 0.872 . . . . 0.0 110.38 171.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.35 131.72 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.055 0.931 . . . . 0.0 108.975 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -137.66 91.8 2.63 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -87.2 123.76 32.57 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -132.63 179.24 6.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.144 0.978 . . . . 0.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.0 tp -94.37 149.27 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.099 -1.001 . . . . 0.0 110.074 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.3 tt0 -60.48 -20.87 61.48 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 173.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.04 -71.79 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.223 0.92 . . . . 0.0 110.494 161.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.28 81.75 0.04 OUTLIER Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.494 1.043 . . . . 0.0 112.917 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.3 m -152.9 114.32 4.24 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.298 19.8 ptp180 -78.08 105.54 9.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -81.14 -48.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -137.79 89.88 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.14 96.93 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.817 0.818 . . . . 0.0 110.192 168.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.14 89.72 17.94 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.88 2.59 6.4 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 N-CA-C 120.139 3.092 . . . . 0.0 120.139 -159.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.301 9.2 pt-20 -151.84 148.75 28.2 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.824 2.102 . . . . 0.0 113.214 154.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.7 tp -142.1 106.44 4.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -165.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.3 t -98.56 106.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -137.55 155.77 48.85 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.4 m -80.75 130.29 35.0 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.366 0.667 . . . . 0.0 109.659 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.61 119.23 10.1 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 62.25 3.49 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -152.52 144.46 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.148 0.979 . . . . 0.0 110.261 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.15 74.8 2.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -126.61 -59.44 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.093 1.357 . . . . 0.0 109.858 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.16 178.14 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.593 1.157 . . . . 0.0 113.074 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.54 137.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.757 0.823 . . . . 0.0 112.011 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -62.07 -29.23 70.16 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.11 84.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 165.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -53.48 57.33 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -66.31 -33.92 76.83 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.37 -34.92 79.04 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 165.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 p -79.82 2.01 24.72 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 167.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.262 2.5 t -53.08 -48.83 90.54 Favored Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 115.262 -2.304 . . . . 0.0 114.787 170.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.04 -18.33 22.48 Favored 'Trans proline' 0 CA--C 1.566 2.121 0 CA-C-N 125.38 2.957 . . . . 0.0 119.012 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.84 70.78 0.74 Allowed 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.295 0.952 . . . . 0.0 108.741 166.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.1 mmt -149.44 90.35 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.36 161.07 18.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.294 1.045 . . . . 0.0 111.994 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.83 104.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.706 . . . . 0.0 109.098 -165.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.75 29.78 Favored Glycine 0 CA--C 1.556 2.63 0 CA-C-O 117.002 -1.999 . . . . 0.0 117.952 -164.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.64 113.72 14.59 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 121.39 2.595 . . . . 0.0 112.761 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -88.73 117.81 27.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.28 132.88 28.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.416 0.286 . . . . 0.0 111.465 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.3 tpp -82.19 106.83 14.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.53 87.55 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -106.06 108.8 20.5 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.2 176.74 4.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.36 1.076 . . . . 0.0 112.167 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.13 157.94 29.9 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.9 t -75.36 78.5 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.631 1.205 . . . . 0.0 110.991 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 179.95 -67.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.555 -1.657 . . . . 0.0 106.964 -152.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.65 -41.89 36.71 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.249 1.02 . . . . 0.0 113.082 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 66.7 m -58.55 -63.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.596 1.089 . . . . 0.0 113.011 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.71 -76.05 0.32 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.413 1.006 . . . . 0.0 108.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.47 162.96 21.61 Favored Glycine 0 CA--C 1.557 2.714 0 CA-C-O 118.918 -0.935 . . . . 0.0 113.148 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.26 60.83 5.58 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 CA-C-N 121.151 2.475 . . . . 0.0 114.964 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -158.46 -77.14 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.0 95.76 0.27 Allowed Glycine 0 CA--C 1.536 1.396 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.64 48.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m 65.68 135.24 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.22 -51.05 0.16 OUTLIER 'Cis proline' 0 CA--C 1.562 1.92 0 CA-C-N 123.001 2.107 . . . . 0.0 116.271 3.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -141.66 77.87 1.61 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.335 1.064 . . . . 0.0 108.481 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mt -99.57 120.69 56.98 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 144.09 34.09 Favored 'Trans proline' 0 CA--C 1.571 2.357 0 C-N-CA 122.729 2.286 . . . . 0.0 114.349 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 122.31 8.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.078 2.519 . . . . 0.0 113.026 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.36 32.1 p80 51.86 67.84 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.08 108.27 3.59 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.66 126.75 28.4 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -167.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 tp -111.45 127.27 55.63 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.3 -155.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.1 m -74.75 152.2 39.08 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.12 113.55 3.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.08 0.552 . . . . 0.0 109.866 167.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.53 112.13 20.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.153 0.977 . . . . 0.0 111.374 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.62 107.7 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.3 m -106.53 117.65 34.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.31 109.87 6.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.176 0.591 . . . . 0.0 110.291 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -78.52 -68.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.457 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.1 p -141.8 131.69 24.41 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.044 0.838 . . . . 0.0 109.752 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.94 109.48 21.84 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.58 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.537 0.684 . . . . 0.0 110.507 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.0 145.52 52.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.665 0 CA-C-O 117.01 -1.994 . . . . 0.0 114.587 -176.236 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.329 27.8 tt0 . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -123.02 106.96 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.47 108.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.69 122.01 23.36 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.554 1.169 . . . . 0.0 114.028 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.43 74.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.078 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.44 -64.73 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.87 0.868 . . . . 0.0 109.514 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.85 -81.52 0.19 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -160.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -76.22 -76.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.036 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.02 79.94 0.03 OUTLIER Glycine 0 N--CA 1.478 1.44 0 CA-C-N 118.874 0.761 . . . . 0.0 112.087 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.65 -58.91 1.03 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.435 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.1 tp -81.17 123.15 28.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.087 1.312 . . . . 0.0 108.606 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -142.71 131.97 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 123.387 0.675 . . . . 0.0 111.864 -167.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -122.4 132.19 54.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 0.0 113.392 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -110.61 125.34 53.3 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.593 -0.692 . . . . 0.0 109.642 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -81.04 124.41 29.16 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.311 0.505 . . . . 0.0 111.078 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HB2' ' HZ3' ' A' ' 48' ' ' LYS . 13.8 tp -87.32 -71.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.509 0.724 . . . . 0.0 110.058 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.89 100.65 53.83 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.14 160.67 42.23 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.741 2.294 . . . . 0.0 113.842 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.22 151.26 52.09 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.987 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.56 165.07 28.58 Favored 'Trans proline' 0 CA--C 1.572 2.382 0 C-N-CA 123.132 2.555 . . . . 0.0 115.852 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 115.49 3.93 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 123.139 2.56 . . . . 0.0 112.68 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.11 -103.97 1.04 Allowed Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -167.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.4 m 59.34 100.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.4 m -80.66 128.63 33.84 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.151 0.501 . . . . 0.0 110.126 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -93.12 113.73 60.76 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.808 -1.092 . . . . 0.0 110.495 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.81 150.88 68.47 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.972 2.448 . . . . 0.0 115.274 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.8 166.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.857 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -73.09 99.75 2.86 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.762 0.825 . . . . 0.0 110.656 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.03 -52.36 0.56 Allowed Glycine 0 CA--C 1.549 2.176 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.333 -155.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -73.76 140.16 45.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.764 0.825 . . . . 0.0 112.201 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.7 t -90.17 112.62 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.63 142.88 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.52 1.152 . . . . 0.0 110.481 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -106.43 116.32 31.73 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.37 126.61 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 122.72 0.408 . . . . 0.0 110.21 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -73.62 103.77 4.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 161.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 tp -102.14 100.3 10.51 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -93.62 90.28 6.57 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -90.57 121.68 32.71 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -167.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -124.11 175.88 6.73 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.312 1.045 . . . . 0.0 110.843 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -80.31 -83.54 0.1 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.661 0.784 . . . . 0.0 109.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.05 -69.94 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.602 0.761 . . . . 0.0 109.366 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.16 66.63 1.82 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.399 0.619 . . . . 0.0 110.901 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.22 65.28 3.47 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -132.45 104.35 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.63 107.11 3.76 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.6 0.714 . . . . 0.0 112.514 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.25 18.9 m -87.11 -52.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.856 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.66 82.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.16 114.12 14.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.379 0.609 . . . . 0.0 112.452 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -125.63 97.22 36.72 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.765 -158.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.4 109.01 2.24 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 123.804 3.003 . . . . 0.0 111.037 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.476 ' CD ' ' HZ3' ' A' ' 144' ' ' LYS 0.574 1.2 pm0 67.51 81.03 0.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.59 103.32 6.51 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 156.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.1 t -96.87 121.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 148.67 28.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.719 -168.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.5 m -66.8 124.8 23.93 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.06 103.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.358 1.063 . . . . 0.0 112.952 -163.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.04 -42.89 2.91 Favored Glycine 0 CA--C 1.549 2.162 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -55.62 5.98 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.09 108.32 15.47 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.468 0.576 . . . . 0.0 111.675 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.294 2.7 t70 81.01 -51.6 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 170.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.78 158.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -150.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 168.9 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 113.528 -1.669 . . . . 0.0 113.977 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -61.03 -26.8 67.87 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.81 75.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 168.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.68 -49.74 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -56.98 -44.6 82.84 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.6 mt -71.4 -50.77 28.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.6 p -71.91 -45.08 62.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -175.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.46 -39.68 51.3 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 114.919 -2.467 . . . . 0.0 115.462 -169.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.05 -33.09 92.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 126.412 3.326 . . . . 0.0 116.573 168.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.64 -26.49 64.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 69.2 mmm -71.31 129.87 39.95 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 120.003 1.274 . . . . 0.0 111.393 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.44 158.57 33.62 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 122.752 1.263 . . . . 0.0 113.614 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.74 108.22 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.019 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.35 23.62 23.86 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 117.476 1.751 . . . . 0.0 117.476 -163.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -98.05 129.59 44.89 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.812 1.806 . . . . 0.0 111.184 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.6 m -107.33 123.03 47.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.49 131.53 9.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 0.0 110.736 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.91 104.68 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.415 0.686 . . . . 0.0 109.369 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.1 t -93.62 96.27 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 79.5 p -90.16 102.26 14.98 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 124.35 38.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.972 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -63.61 164.78 9.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.1 p -74.83 74.16 2.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.525 1.155 . . . . 0.0 113.004 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp 176.96 -65.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.508 1.523 . . . . 0.0 107.113 -158.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -75.18 -34.11 61.53 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.284 1.434 . . . . 0.0 114.031 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' A' ' 137' ' ' LEU . 34.7 t -68.42 -76.94 0.08 Allowed 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.381 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -133.93 -80.74 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.25 -105.13 0.26 Allowed Glycine 0 CA--C 1.547 2.062 0 CA-C-O 116.881 -2.066 . . . . 0.0 111.427 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.0 -47.7 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 122.266 3.033 . . . . 0.0 116.399 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -148.33 117.26 6.74 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 133' ' ' PRO . . . -92.46 -120.07 2.7 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 123.205 0.431 . . . . 0.0 112.312 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -128.73 72.01 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.359 0.664 . . . . 0.0 110.103 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 t -73.85 135.35 77.58 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.783 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.06 -22.18 15.63 Favored 'Cis proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.294 2.767 . . . . 0.0 119.294 9.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -56.06 -41.66 75.41 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 104.39 50.67 Favored Pre-proline 0 CA--C 1.574 1.881 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.83 157.07 58.38 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 C-N-CA 123.038 2.492 . . . . 0.0 114.726 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.476 ' HA ' ' H ' ' A' ' 126' ' ' GLY . 47.7 Cg_endo -70.88 -68.93 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.613 2.209 . . . . 0.0 116.623 -157.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -121.77 76.66 1.29 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.28 154.07 48.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.345 1.058 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.3 8.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.43 HD23 ' SG ' ' A' ' 121' ' ' CYS . 9.0 mp -69.05 134.79 49.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.726 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 77.5 m -104.25 99.67 9.39 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.16 106.85 10.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.557 0.743 . . . . 0.0 109.713 -167.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.15 117.52 24.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.803 0.811 . . . . 0.0 112.162 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.3 t -88.52 108.02 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.0 m -115.82 108.28 16.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.48 106.87 5.45 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.064 0.546 . . . . 0.0 110.4 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.476 ' HZ3' ' CD ' ' A' ' 85' ' ' GLU . 44.3 mtmt -87.53 -53.01 5.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.168 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.4 p -145.82 131.97 19.4 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.21 0.914 . . . . 0.0 108.936 173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.12 118.64 37.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.187 0.595 . . . . 0.0 109.453 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.26 165.46 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.225 1.012 . . . . 0.0 109.687 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.35 -179.11 4.32 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.219 0 CA-C-O 116.939 -2.034 . . . . 0.0 110.797 172.161 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.661 0.267 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.264 17.1 m0 84.46 120.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.287 1.435 . . . . 0.0 109.504 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.21 117.42 28.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.098 0.475 . . . . 0.0 110.779 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.25 150.75 25.98 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.47 -54.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.488 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.05 -63.2 1.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.82 0.78 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -127.63 -82.67 0.6 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.844 1.822 . . . . 0.0 106.195 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.08 76.78 0.05 OUTLIER Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.446 0.566 . . . . 0.0 111.869 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.88 -67.21 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 tp -85.83 112.31 21.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.739 0.815 . . . . 0.0 108.818 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -134.9 112.91 11.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.202 0.525 . . . . 0.0 111.386 -170.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -91.79 100.95 13.55 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 111.687 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -94.45 120.07 34.13 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.38 0.672 . . . . 0.0 109.791 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.4 m -80.14 114.96 19.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.298 0.57 . . . . 0.0 110.126 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.56 -71.87 0.5 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.124 0.97 . . . . 0.0 109.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.51 126.09 61.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.3 162.15 43.42 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.066 2.511 . . . . 0.0 114.817 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.85 122.83 7.2 Favored Glycine 0 CA--C 1.555 2.542 0 CA-C-O 116.964 -2.02 . . . . 0.0 112.941 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.57 165.89 21.51 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 CA-C-N 122.541 3.171 . . . . 0.0 115.51 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.31 120.95 8.42 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.179 2.586 . . . . 0.0 114.002 -170.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.91 -111.65 3.83 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m 58.99 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 m -117.72 125.76 51.25 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.379 1.085 . . . . 0.0 109.979 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -68.17 136.47 91.54 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 114.287 171.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.16 179.56 4.85 Favored 'Trans proline' 0 CA--C 1.568 2.187 0 C-N-CA 122.947 2.431 . . . . 0.0 115.449 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.0 m -93.65 175.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 124.19 0.996 . . . . 0.0 112.325 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 59.4 tttp -63.28 128.08 34.19 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.563 0.745 . . . . 0.0 112.856 168.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.96 4.5 Favored Glycine 0 CA--C 1.548 2.156 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.793 -167.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -148.22 138.81 22.9 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.51 118.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -172.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.04 134.09 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.812 0.845 . . . . 0.0 109.351 170.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -99.44 118.21 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.6 130.95 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -91.64 100.5 13.22 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.657 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -96.51 131.99 42.54 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.196 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -127.57 104.88 8.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -82.23 132.8 35.23 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.049 -169.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -131.03 116.13 17.38 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.21 94.51 9.68 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 12.1 pt-20 -70.39 -26.34 63.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.07 -41.43 96.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 160.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.33 -104.53 2.89 Favored Glycine 0 CA--C 1.544 1.852 0 CA-C-N 119.398 0.999 . . . . 0.0 112.159 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.3 m -131.31 146.4 52.28 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.019 0.928 . . . . 0.0 108.92 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -62.8 118.46 7.74 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.89 -45.67 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.272 13.8 mm100 75.3 92.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.879 1.671 . . . . 0.0 110.442 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.45 159.5 16.11 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-O 122.518 1.152 . . . . 0.0 112.703 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.2 139.69 95.17 Favored Pre-proline 0 CA--C 1.58 2.11 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -167.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.34 -13.04 16.98 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 119.862 2.985 . . . . 0.0 119.862 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.13 75.43 1.59 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.908 1.685 . . . . 0.0 110.682 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.34 106.31 18.33 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.05 135.56 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.192 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -159.76 157.85 30.12 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -91.3 131.48 36.78 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.112 0.965 . . . . 0.0 109.729 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.55 142.29 58.48 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.618 0.767 . . . . 0.0 113.061 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.66 -60.15 4.84 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 114.354 0.502 . . . . 0.0 114.354 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.41 ' CG ' ' HZ3' ' A' ' 62' ' ' LYS . 8.6 m-20 -67.79 115.46 7.36 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.748 1.219 . . . . 0.0 111.407 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.7 77.62 6.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.698 1.237 . . . . 0.0 113.492 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.72 -50.46 17.4 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.882 162.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.4 m -82.29 -178.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 C-N-CA 124.815 1.246 . . . . 0.0 113.254 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -60.87 161.04 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 124.713 1.205 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -61.0 -36.63 79.98 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -44.64 97.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 169.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.3 mt -65.3 -55.8 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 117.741 -1.124 . . . . 0.0 113.496 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -50.67 -48.81 58.29 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.28 -32.54 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.1 p -80.13 1.96 25.98 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 166.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.17 -52.49 74.23 Favored Pre-proline 0 N--CA 1.499 2.002 0 CA-C-O 115.044 -2.408 . . . . 0.0 112.683 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.37 39.35 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.517 0 CA-C-N 124.848 2.767 . . . . 0.0 116.827 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.2 mt -144.99 -46.04 0.23 Allowed 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 125.618 1.567 . . . . 0.0 110.631 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -76.41 113.44 14.0 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.804 1.184 . . . . 0.0 112.35 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.9 163.89 12.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.76 1.267 . . . . 0.0 111.882 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.49 115.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.294 -0.879 . . . . 0.0 112.155 -166.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.82 -40.19 2.4 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 117.091 1.596 . . . . 0.0 117.091 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.47 134.9 46.88 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.58 1.69 . . . . 0.0 115.459 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -90.98 125.29 35.74 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 154.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.61 121.89 13.06 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.4 ptp -75.8 125.88 29.92 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.404 1.097 . . . . 0.0 110.706 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.9 t -102.08 95.2 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.8 p -89.62 102.87 15.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.5 143.9 49.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.128 -161.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.82 162.37 4.12 Favored 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.1 p -54.02 -34.89 61.14 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 160.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.12 -43.91 82.76 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 161.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -86.56 63.91 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.899 0.772 . . . . 0.0 110.664 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.6 t -171.5 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -137.8 5.47 2.62 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.74 145.79 19.26 Favored Glycine 0 CA--C 1.56 2.885 0 CA-C-N 120.867 1.667 . . . . 0.0 111.892 -160.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.0 80.21 2.73 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 CA-C-N 122.558 3.179 . . . . 0.0 112.279 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -138.21 -74.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.16 0.584 . . . . 0.0 110.022 -164.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.42 96.48 0.12 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 140.75 49.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.287 0.635 . . . . 0.0 110.821 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.2 p -66.86 138.87 95.42 Favored Pre-proline 0 CA--C 1.573 1.831 0 CA-C-O 117.678 -1.153 . . . . 0.0 113.662 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.35 -44.82 0.45 Allowed 'Cis proline' 0 CA--C 1.563 1.934 0 N-CA-C 117.106 1.926 . . . . 0.0 117.106 8.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -155.18 88.73 1.17 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 83.4 mt -121.92 86.36 46.1 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.66 163.47 31.63 Favored 'Trans proline' 0 CA--C 1.572 2.421 0 C-N-CA 122.68 2.253 . . . . 0.0 115.424 -171.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.84 119.87 6.49 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.162 2.574 . . . . 0.0 113.232 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.258 96.1 m-70 66.8 76.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.796 1.239 . . . . 0.0 111.49 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.49 116.78 2.99 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.28 127.48 33.68 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.967 0.889 . . . . 0.0 112.844 -171.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.49 129.76 49.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.264 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.72 94.7 5.34 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.271 0.629 . . . . 0.0 109.372 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.37 121.64 45.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.445 0.698 . . . . 0.0 110.441 -170.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.9 100.41 6.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.011 0.524 . . . . 0.0 111.586 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.44 109.0 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.9 m -113.86 121.65 44.63 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.66 102.03 10.43 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -84.05 -59.55 2.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 60.1 p -122.46 149.5 43.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.658 0.783 . . . . 0.0 109.749 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.51 107.93 8.32 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.79 170.24 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.24 1.016 . . . . 0.0 110.096 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.56 -161.46 0.19 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.538 0 CA-C-O 116.728 -2.151 . . . . 0.0 112.701 178.735 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 . . . . . 0 CA--C 1.561 1.38 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 91.6 m95 76.09 94.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.692 1.197 . . . . 0.0 111.564 168.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.87 113.2 26.55 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.93 110.45 5.04 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.016 0.912 . . . . 0.0 113.348 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.17 -42.11 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.806 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -73.95 -63.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.501 1.046 . . . . 0.0 111.274 165.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.5 -89.64 0.15 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -83.57 -40.53 18.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.04 82.12 1.49 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.093 0.861 . . . . 0.0 115.25 -163.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp 40.55 63.31 1.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 162.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 tp -162.29 92.74 0.83 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -117.16 117.78 30.54 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.509 0.724 . . . . 0.0 109.247 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.79 105.83 17.18 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.51 -0.744 . . . . 0.0 111.331 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 101.48 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 166.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.5 p -84.45 110.48 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.56 -59.51 2.72 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.601 0.76 . . . . 0.0 111.827 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.34 103.44 54.99 Favored Pre-proline 0 CA--C 1.57 1.729 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.65 87.07 1.55 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.989 2.459 . . . . 0.0 112.963 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.04 88.41 0.11 Allowed Glycine 0 CA--C 1.553 2.451 0 CA-C-O 116.339 -2.367 . . . . 0.0 113.286 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.82 167.84 16.63 Favored 'Trans proline' 0 CA--C 1.576 2.607 0 CA-C-N 123.154 3.477 . . . . 0.0 115.336 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.46 127.68 21.53 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 123.211 2.608 . . . . 0.0 114.86 -168.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.58 -123.12 6.63 Favored Glycine 0 CA--C 1.546 1.988 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -160.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m 59.43 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 164.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -123.4 127.28 48.22 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.705 1.241 . . . . 0.0 110.12 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -69.93 122.32 85.64 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 113.1 -1.864 . . . . 0.0 113.225 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.45 171.82 16.29 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.795 2.33 . . . . 0.0 115.352 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.95 174.65 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -60.57 133.09 55.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.13 51.1 4.57 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.284 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -146.63 131.87 18.45 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.76 113.45 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.67 124.77 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 ' HB ' ' HG1' ' A' ' 145' ' ' THR . 59.9 m -92.97 133.55 36.01 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 m -127.92 145.37 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.629 0.728 . . . . 0.0 110.16 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.73 98.28 8.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 165.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.51 125.72 31.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -103.98 73.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' HG1' ' HB3' ' A' ' 139' ' ' LEU . 18.8 m -79.46 119.45 22.48 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.9 m -146.91 133.9 20.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 tp -67.18 151.91 46.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.662 0.785 . . . . 0.0 113.001 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.14 12.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -77.65 -63.82 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.587 1.085 . . . . 0.0 112.529 168.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.07 76.38 0.02 OUTLIER Glycine 0 N--CA 1.48 1.583 0 CA-C-N 118.786 0.721 . . . . 0.0 111.533 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -149.39 113.91 5.29 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -74.6 104.23 5.21 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.248 0.477 . . . . 0.0 111.633 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.58 -61.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.003 -165.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.85 85.81 1.43 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -100.03 91.56 4.85 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.845 0.458 . . . . 0.0 110.231 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -98.97 116.33 65.31 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.087 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.73 -53.36 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.875 2.384 . . . . 0.0 115.079 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -98.73 81.25 2.64 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.252 0.933 . . . . 0.0 111.192 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.72 98.79 11.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.73 109.93 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -165.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -137.46 151.73 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -88.08 118.98 28.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.86 145.56 32.67 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.77 -50.0 4.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.71 -2.81 0.89 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 58.2 m 75.41 90.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.985 1.314 . . . . 0.0 111.46 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.76 -63.01 1.1 Allowed 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.297 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.88 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 124.28 1.032 . . . . 0.0 113.396 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 pt -56.57 148.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 125.06 1.344 . . . . 0.0 113.171 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -61.7 -26.69 68.2 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.45 69.84 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 120.29 1.405 . . . . 0.0 114.74 165.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -44.17 93.3 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.34 -40.35 95.7 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.91 -30.97 72.0 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 167.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -77.62 -0.17 25.53 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.64 -55.41 45.25 Favored Pre-proline 0 N--CA 1.502 2.125 0 CA-C-O 115.329 -2.272 . . . . 0.0 112.708 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.36 24.57 0.23 Allowed 'Trans proline' 0 CA--C 1.574 2.483 0 CA-C-N 124.683 2.708 . . . . 0.0 118.249 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.92 -39.14 1.23 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.97 1.308 . . . . 0.0 111.825 168.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -75.45 123.42 25.39 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.883 1.219 . . . . 0.0 113.566 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.92 170.27 8.18 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.76 1.267 . . . . 0.0 111.771 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.29 111.99 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.313 -0.867 . . . . 0.0 110.112 -157.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.89 2.14 57.22 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 -166.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -75.32 123.42 25.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 121.27 2.535 . . . . 0.0 111.961 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.8 m -103.82 116.73 32.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.53 128.16 10.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.4 tpp -80.79 113.71 19.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.756 0.823 . . . . 0.0 109.569 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.13 93.3 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -91.28 109.53 20.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.96 147.04 30.33 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -48.15 150.79 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 t -70.52 78.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.627 1.203 . . . . 0.0 111.491 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -179.76 -67.34 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.455 -1.702 . . . . 0.0 106.639 -156.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -65.87 -55.47 16.84 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.95 0.9 . . . . 0.0 111.718 159.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 71.6 m -73.21 111.5 8.39 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.768 0.713 . . . . 0.0 110.367 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.323 75.7 m-85 80.08 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.242 1.017 . . . . 0.0 112.036 170.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.45 162.99 26.33 Favored Glycine 0 CA--C 1.557 2.687 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.085 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.21 -22.16 47.17 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 123.183 2.589 . . . . 0.0 118.411 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -80.54 -45.04 18.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.92 97.98 1.37 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -171.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -84.14 178.66 7.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.366 1.079 . . . . 0.0 112.757 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -75.03 138.1 72.65 Favored Pre-proline 0 CA--C 1.57 1.745 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.643 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.67 -56.36 0.14 OUTLIER 'Cis proline' 0 CA--C 1.562 1.891 0 CA-C-N 122.316 1.863 . . . . 0.0 115.704 6.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -145.96 70.82 1.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.14 0.882 . . . . 0.0 109.386 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.7 mm -90.6 119.06 69.1 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.423 -1.275 . . . . 0.0 107.933 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.65 121.41 5.94 Favored 'Trans proline' 0 CA--C 1.571 2.36 0 C-N-CA 122.716 2.277 . . . . 0.0 112.253 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.64 132.73 20.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 123.012 2.475 . . . . 0.0 112.704 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.273 14.9 m170 78.86 148.28 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 124.61 1.164 . . . . 0.0 110.748 -166.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.26 . . 78.93 136.26 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.841 1.257 . . . . 0.0 112.514 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.32 136.49 33.88 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.54 136.15 37.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.816 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.9 m -101.11 102.91 13.96 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.441 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 0.7 OUTLIER -113.01 109.36 18.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.289 0.636 . . . . 0.0 111.22 -175.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.32 98.74 9.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.486 0.66 . . . . 0.0 110.377 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.82 111.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.8 m -110.77 114.32 27.58 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.56 120.18 18.81 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.057 0.543 . . . . 0.0 111.014 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.11 -65.41 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.488 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.471 ' HG1' ' HB ' ' A' ' 67' ' ' THR . 46.6 p -124.77 150.59 46.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.852 0.834 . . . . 0.0 109.847 -166.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.79 98.67 4.24 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.24 164.59 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.934 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.65 -160.58 0.19 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.195 0 CA-C-O 117.075 -1.959 . . . . 0.0 110.824 172.413 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -156.4 146.59 21.35 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.625 1.17 . . . . 0.0 109.371 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 tp -74.31 136.15 42.58 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.259 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -83.47 -178.27 7.0 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-O 123.452 1.596 . . . . 0.0 114.928 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 -74.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.36 -39.9 58.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.39 67.94 0.57 Allowed Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -146.94 -65.54 0.28 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.71 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.43 -50.32 0.83 Allowed Glycine 0 CA--C 1.545 1.957 0 CA-C-N 118.907 0.776 . . . . 0.0 114.074 -164.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.69 -56.74 8.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.68 112.83 24.9 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.861 0.755 . . . . 0.0 109.076 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -133.73 148.65 51.45 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.127 0.971 . . . . 0.0 111.444 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -108.55 127.16 53.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.647 -0.658 . . . . 0.0 111.511 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.92 -43.1 95.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.269 19.5 m 73.5 95.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 174.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.78 -65.62 0.99 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.889 . . . . 0.0 110.166 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.46 113.01 33.85 Favored Pre-proline 0 CA--C 1.569 1.689 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.3 78.99 3.01 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.87 2.38 . . . . 0.0 113.095 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.34 160.95 17.09 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.14 170.2 20.08 Favored 'Trans proline' 0 CA--C 1.574 2.499 0 C-N-CA 123.266 2.644 . . . . 0.0 114.39 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.35 108.28 1.97 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.031 2.487 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.06 83.34 0.96 Allowed Glycine 0 CA--C 1.544 1.88 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -159.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -100.51 123.63 44.98 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.884 0.474 . . . . 0.0 111.961 -166.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -92.33 138.85 31.17 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.335 0.654 . . . . 0.0 112.218 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -113.12 107.19 54.3 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.4 148.22 29.77 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.022 2.482 . . . . 0.0 114.53 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.39 147.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.0 0.92 . . . . 0.0 112.576 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 86.3 2.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.74 62.79 0.01 OUTLIER Glycine 0 CA--C 1.54 1.634 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.158 172.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.07 0.938 . . . . 0.0 110.596 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.45 109.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.77 112.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.455 ' HG1' HG21 ' A' ' 87' ' ' VAL . 70.8 m -93.1 106.84 18.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 173.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.35 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -171.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -74.41 112.45 10.6 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 165.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.69 105.8 7.74 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -167.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.29 100.66 11.97 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -79.47 112.48 16.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.3 t -135.88 149.13 48.89 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.094 0.949 . . . . 0.0 110.306 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.94 142.32 51.25 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.269 1.028 . . . . 0.0 112.218 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.29 -38.7 28.2 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -66.21 -66.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.598 0.759 . . . . 0.0 111.959 168.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.64 79.61 0.03 OUTLIER Glycine 0 N--CA 1.479 1.536 0 CA-C-N 119.012 0.824 . . . . 0.0 112.005 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.2 m -151.04 112.96 4.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 102.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.64 -45.83 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -145.08 105.91 4.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.26 124.54 31.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.431 0.634 . . . . 0.0 109.681 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -130.58 78.43 74.03 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -170.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.81 -44.3 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.095 2.53 . . . . 0.0 116.443 -171.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.12 83.15 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.197 0.908 . . . . 0.0 109.803 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.4 tp -101.05 98.51 8.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG21 ' HG1' ' A' ' 67' ' ' THR . 58.1 t -103.76 111.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -165.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.8 166.14 33.84 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.755 -175.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -82.06 136.02 35.26 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.234 0.613 . . . . 0.0 110.398 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 tt -68.37 114.13 6.55 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.222 1.009 . . . . 0.0 112.828 -164.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.92 34.8 77.75 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 118.0 1.96 . . . . 0.0 118.0 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.44 169.11 14.7 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.44 1.114 . . . . 0.0 110.028 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.77 89.91 2.87 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.603 1.192 . . . . 0.0 113.205 -167.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.44 -67.55 0.21 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.846 -1.524 . . . . 0.0 107.998 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.85 165.29 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 124.605 1.162 . . . . 0.0 112.988 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 159.92 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -30.18 63.77 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.82 80.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 170.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.3 -38.4 65.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -43.29 -48.48 6.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.72 -45.46 58.63 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.6 p -90.27 45.94 1.31 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.67 -55.95 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.913 0 CA-C-O 115.013 -2.423 . . . . 0.0 107.235 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.73 83.32 1.95 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 CA-C-N 125.421 2.972 . . . . 0.0 112.802 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.317 4.4 pp 163.0 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 127.194 2.197 . . . . 0.0 111.821 -167.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.23 140.73 38.9 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.98 1.264 . . . . 0.0 112.04 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.27 159.81 33.93 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.618 163.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.68 97.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 143' ' ' LEU . . . 99.06 39.17 3.61 Favored Glycine 0 CA--C 1.552 2.379 0 CA-C-O 118.494 -1.17 . . . . 0.0 115.981 -162.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.42 99.91 11.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.064 1.432 . . . . 0.0 109.076 173.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.9 m -83.69 118.05 23.61 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 128.31 6.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.768 0.427 . . . . 0.0 110.223 -173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.4 tpp -85.51 107.16 17.32 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.75 99.05 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -91.5 104.26 16.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.15 160.64 15.46 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.164 0.983 . . . . 0.0 113.303 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 159.04 22.19 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.663 164.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.3 p -73.95 68.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -175.9 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.452 1.501 . . . . 0.0 108.405 -168.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -59.62 -51.03 71.56 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.651 1.18 . . . . 0.0 114.113 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.5 m -66.11 -70.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.821 0.737 . . . . 0.0 112.582 170.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -144.48 -65.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.938 0.79 . . . . 0.0 109.39 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.64 -167.93 30.16 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.14 102.47 1.6 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.081 2.521 . . . . 0.0 112.441 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -152.95 -69.45 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.716 -169.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.72 95.29 1.23 Allowed Glycine 0 CA--C 1.541 1.683 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -167.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -132.82 148.65 52.31 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.201 1.0 . . . . 0.0 110.667 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.4 m -76.8 140.85 67.7 Favored Pre-proline 0 CA--C 1.57 1.74 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.22 173.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.02 -47.35 0.26 Allowed 'Cis proline' 0 CA--C 1.563 1.939 0 CA-C-N 122.377 1.885 . . . . 0.0 116.909 9.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.33 77.16 1.43 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.76 117.37 46.64 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.8 151.33 27.97 Favored 'Trans proline' 0 CA--C 1.571 2.358 0 C-N-CA 122.813 2.342 . . . . 0.0 114.417 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.15 119.59 6.55 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.128 2.552 . . . . 0.0 111.931 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 93.9 m-70 76.8 101.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.222 1.409 . . . . 0.0 109.478 -165.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.83 88.86 3.0 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.171 0.588 . . . . 0.0 109.634 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.6 76.15 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 153.33 20.59 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.443 1.115 . . . . 0.0 112.243 -165.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -91.75 109.6 20.92 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.661 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.37 117.79 32.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.304 1.042 . . . . 0.0 108.217 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.16 99.2 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.398 -0.814 . . . . 0.0 110.196 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.06 125.6 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.5 m -142.14 124.33 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' HB2' ' H ' ' A' ' 109' ' ' GLY . 3.2 mm? -76.47 111.32 11.81 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.384 0.674 . . . . 0.0 110.021 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -84.01 -55.95 3.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 118.659 -0.686 . . . . 0.0 112.745 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 69.7 p -135.94 133.61 37.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -117.68 106.96 13.63 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 167.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.93 133.48 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 123.439 0.696 . . . . 0.0 110.078 -170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -86.17 103.96 15.29 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.964 0 CA-C-O 116.801 -2.111 . . . . 0.0 112.08 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 122.693 1.235 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -79.41 115.44 19.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 153.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.46 103.61 15.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -163.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.97 103.04 12.13 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.072 0.939 . . . . 0.0 112.331 -176.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 pt -84.23 -176.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.648 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.357 2.6 tt 90.46 -75.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.343 1.457 . . . . 0.0 110.624 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.98 -72.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.377 0.535 . . . . 0.0 112.708 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.74 -75.36 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.179 0.592 . . . . 0.0 111.462 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.94 73.54 0.04 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 mt -141.73 -62.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.092 0.957 . . . . 0.0 108.753 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.77 130.51 38.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.101 0.96 . . . . 0.0 110.753 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -133.41 74.95 1.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -159.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -92.17 86.58 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.037 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -75.51 116.88 16.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 111.071 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 m -74.89 104.62 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.209 0.603 . . . . 0.0 109.404 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.79 -79.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.644 0.777 . . . . 0.0 110.077 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.93 113.38 63.67 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 169.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.17 175.63 8.97 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.873 2.382 . . . . 0.0 114.889 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 119.37 10.85 Favored Glycine 0 CA--C 1.558 2.738 0 CA-C-O 116.948 -2.029 . . . . 0.0 112.62 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.65 161.91 36.7 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 CA-C-N 122.498 3.149 . . . . 0.0 115.327 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.84 113.64 2.07 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.175 2.584 . . . . 0.0 113.562 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.4 71.67 1.09 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.711 -159.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -157.86 114.52 2.89 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 m -126.06 117.74 23.84 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 122.273 1.035 . . . . 0.0 110.086 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -59.4 134.06 88.46 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.01 144.89 43.71 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.783 2.322 . . . . 0.0 116.568 -158.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -72.16 155.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.002 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -70.17 110.99 5.49 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.72 65.08 0.47 Allowed Glycine 0 CA--C 1.544 1.863 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.548 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -150.01 140.74 22.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.19 108.04 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 m -117.87 121.6 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -109.75 134.46 51.98 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.63 153.15 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.254 1.026 . . . . 0.0 110.278 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -102.44 91.58 4.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.343 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.406 HD11 ' HG1' ' A' ' 72' ' ' THR . 2.1 pp -86.94 147.38 25.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.311 0.576 . . . . 0.0 110.383 163.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.01 92.5 2.88 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.406 ' HG1' HD11 ' A' ' 70' ' ' LEU . 36.8 m -83.11 122.11 27.93 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.661 0.743 . . . . 0.0 109.889 -175.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 m -140.93 136.62 32.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.529 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.19 131.81 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -52.23 -46.82 65.87 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.37 -44.26 12.95 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.81 80.78 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 120.783 3.073 . . . . 0.0 120.783 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.0 m 77.65 117.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.143 1.972 . . . . 0.0 112.839 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.252 7.3 ttt85 38.86 53.91 2.01 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 160.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 21.1 m -74.77 -40.96 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -159.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -146.96 76.3 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.561 1.073 . . . . 0.0 109.055 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -73.39 111.05 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.609 0.719 . . . . 0.0 111.56 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -130.94 84.06 59.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.91 -46.58 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.906 2.404 . . . . 0.0 117.248 -164.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.95 92.95 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.876 1.216 . . . . 0.0 110.702 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 tp -111.57 81.13 1.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.53 -172.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -89.84 136.44 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.406 0.682 . . . . 0.0 110.884 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -162.81 150.48 13.62 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.947 0.899 . . . . 0.0 110.345 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -80.77 140.97 35.21 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.94 104.81 5.68 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.38 70.83 0.85 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.032 -159.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -156.63 -66.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.734 0.814 . . . . 0.0 110.478 -176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.351 4.8 t 65.94 40.87 3.94 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.59 -47.68 80.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.878 -1.139 . . . . 0.0 113.217 152.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -55.04 166.85 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 125.282 1.433 . . . . 0.0 114.321 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.462 HG13 ' H ' ' A' ' 99' ' ' LEU . 46.4 pt -60.34 151.19 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -35.99 65.93 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.35 94.54 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 117.176 2.288 . . . . 0.0 117.176 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' H ' HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -63.89 -56.54 14.57 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.907 -1.044 . . . . 0.0 113.138 178.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -49.98 -43.24 50.17 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.38 -39.87 94.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.1 p -77.91 -4.11 45.16 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.79 -53.05 68.03 Favored Pre-proline 0 N--CA 1.502 2.138 0 CA-C-O 115.388 -2.244 . . . . 0.0 112.62 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.48 0.34 1.47 Allowed 'Trans proline' 0 CA--C 1.569 2.254 0 N-CA-C 119.483 2.839 . . . . 0.0 119.483 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 99.4 mt -128.57 73.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 119.993 1.27 . . . . 0.0 107.982 158.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 38.9 ttm -164.29 96.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.06 167.64 17.68 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.322 1.058 . . . . 0.0 113.282 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -70.41 108.29 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.578 0.751 . . . . 0.0 109.691 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.78 20.2 41.0 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 117.912 1.925 . . . . 0.0 117.912 -167.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 107.59 18.66 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 120.387 2.093 . . . . 0.0 110.476 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.4 m -78.75 113.07 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 163.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.79 121.49 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 ttt -83.68 108.12 16.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.024 0.529 . . . . 0.0 110.239 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.34 118.38 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 t -129.07 77.04 1.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.61 145.92 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.715 0.769 . . . . 0.0 112.044 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.86 164.65 0.36 Allowed 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -69.54 81.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.832 1.301 . . . . 0.0 111.595 172.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.888 -147.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -120.11 57.99 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.399 0.68 . . . . 0.0 111.938 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -110.37 -100.38 0.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -136.14 63.13 1.6 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 119.047 0.84 . . . . 0.0 109.414 168.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.24 -156.12 30.42 Favored Glycine 0 CA--C 1.562 2.977 0 N-CA-C 116.671 1.428 . . . . 0.0 116.671 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.25 102.64 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.95 2.433 . . . . 0.0 110.783 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.272 58.7 tp60 73.24 120.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.088 1.355 . . . . 0.0 111.16 -168.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.24 -139.95 10.54 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.8 158.85 15.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.293 1.044 . . . . 0.0 111.856 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.8 m -64.52 137.32 97.1 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 117.789 -1.1 . . . . 0.0 112.756 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.78 -42.56 0.68 Allowed 'Cis proline' 0 CA--C 1.563 1.96 0 N-CA-C 117.661 2.139 . . . . 0.0 117.661 10.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -168.21 100.69 0.44 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.43 105.63 56.86 Favored Pre-proline 0 CA--C 1.571 1.77 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.86 146.72 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.667 2.244 . . . . 0.0 114.747 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.61 -54.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.292 2.661 . . . . 0.0 115.272 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -65.24 145.61 56.01 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.521 1.128 . . . . 0.0 112.915 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.18 128.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.796 1.238 . . . . 0.0 111.886 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.72 114.08 8.44 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.603 0.761 . . . . 0.0 111.988 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.85 125.49 29.77 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 120.967 0.413 . . . . 0.0 111.301 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.55 118.29 31.98 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.097 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.53 121.72 27.76 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.402 0.681 . . . . 0.0 109.677 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -87.6 98.33 11.35 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.2 0.6 . . . . 0.0 110.768 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.82 126.08 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -133.31 125.32 28.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.59 111.16 5.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.57 0.748 . . . . 0.0 111.184 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -77.37 -66.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -132.81 143.22 49.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.619 0.723 . . . . 0.0 109.321 -168.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.54 96.95 4.25 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.72 129.06 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -170.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.2 111.48 22.67 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.277 0.56 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.104 0 CA-C-O 116.764 -2.131 . . . . 0.0 110.633 -175.392 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 . . . . . 0 CA--C 1.574 1.868 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -48.79 120.57 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.447 1.099 . . . . 0.0 113.778 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.6 tp -80.36 109.81 15.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.439 0.696 . . . . 0.0 110.99 -164.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.56 101.78 13.52 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.355 1.074 . . . . 0.0 112.634 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -29.84 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 170.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.23 -48.95 71.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.159 1.345 . . . . 0.0 113.68 158.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 -36.12 4.44 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -73.1 -71.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.397 1.099 . . . . 0.0 111.961 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.11 61.27 0.03 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 mt -143.83 -76.2 0.24 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.4 tp -88.15 119.69 28.78 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.65 0.78 . . . . 0.0 109.203 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -137.79 121.63 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.644 0.778 . . . . 0.0 109.681 -172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 110.5 16.09 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 110.485 -164.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -116.94 130.85 56.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.214 . . . . 0.0 110.009 172.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.9 m -93.2 119.25 32.17 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.858 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.86 -68.32 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.517 0.727 . . . . 0.0 110.117 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.4 t -85.08 122.79 74.05 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 156.56 42.42 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 122.925 2.417 . . . . 0.0 114.699 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 121.14 5.32 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-O 116.924 -2.042 . . . . 0.0 113.071 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.22 144.64 52.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.597 3.199 . . . . 0.0 115.0 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.43 119.01 5.74 Favored 'Trans proline' 0 CA--C 1.558 1.693 0 C-N-CA 123.241 2.627 . . . . 0.0 112.643 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.28 -81.88 0.22 Allowed Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -88.71 98.64 11.8 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 m -148.86 133.23 17.52 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.763 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.273 19.2 mtm180 42.44 74.68 0.72 Allowed Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.97 161.49 32.9 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.726 2.284 . . . . 0.0 114.251 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.19 170.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.283 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 69.2 tttt -71.26 115.9 10.95 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.881 0.848 . . . . 0.0 111.902 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.64 -63.4 0.44 Allowed Glycine 0 CA--C 1.54 1.649 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -155.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -70.67 114.99 9.31 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.433 0.693 . . . . 0.0 110.028 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.34 114.04 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 m -92.52 135.74 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.444 -169.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -120.06 126.11 49.97 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.45 141.43 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.696 0.76 . . . . 0.0 110.98 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -89.92 93.67 9.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 161.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.34 143.19 28.34 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.782 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -126.93 90.41 3.15 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -74.53 115.55 14.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -140.92 119.15 12.06 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -162.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.08 137.13 45.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.669 0.387 . . . . 0.0 110.573 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.63 87.41 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.619 1.199 . . . . 0.0 112.608 -170.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -171.25 -75.59 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -170.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.14 71.0 0.05 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.2 t -162.75 141.34 8.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.26 0.624 . . . . 0.0 110.05 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 113.63 25.24 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.264 23.5 m -78.25 -51.18 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -141.02 81.22 1.78 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 119.226 0.921 . . . . 0.0 109.198 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.76 119.39 30.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.66 94.34 47.65 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.095 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.64 -44.82 0.63 Allowed 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.084 2.523 . . . . 0.0 117.202 -172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.8 76.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.783 1.174 . . . . 0.0 110.238 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -99.68 92.67 5.45 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.22 132.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.737 0.78 . . . . 0.0 109.24 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -155.62 142.99 19.42 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.954 -174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.5 m -74.17 133.51 42.75 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.917 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -70.83 109.05 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.336 -165.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.27 67.79 1.48 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.493 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 62' ' ' LYS . 16.1 m-20 -148.72 145.16 27.53 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.239 1.018 . . . . 0.0 109.739 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 75.8 m -75.72 76.72 2.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.647 1.213 . . . . 0.0 111.829 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -129.69 -63.44 0.92 Allowed 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.657 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.16 176.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.005 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.71 140.9 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.052 0.941 . . . . 0.0 112.443 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -61.47 -33.72 74.23 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.07 -40.93 70.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 167.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -56.69 10.65 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.931 0.892 . . . . 0.0 113.037 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.57 -39.72 94.59 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.5 mt -61.09 -34.8 75.52 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.1 p -74.35 -11.94 60.39 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 167.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -56.01 -50.45 87.25 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 115.292 -2.29 . . . . 0.0 115.092 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -53.32 -26.57 35.27 Favored 'Trans proline' 0 CA--C 1.567 2.165 0 CA-C-N 125.659 3.057 . . . . 0.0 118.549 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -110.09 73.21 0.83 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.087 0.955 . . . . 0.0 109.709 164.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 53.0 tpp -149.61 107.45 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.39 161.85 15.39 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.681 1.229 . . . . 0.0 113.066 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 t -81.96 103.15 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 59.17 1.31 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.932 -170.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -126.06 123.76 39.11 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.57 0.748 . . . . 0.0 109.829 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -91.49 103.54 16.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.1 120.74 14.27 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.976 0.417 . . . . 0.0 110.433 -164.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.4 ttm -83.6 141.25 31.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.99 0.9 . . . . 0.0 110.802 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.27 96.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.6 p -81.72 104.87 12.42 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -135.68 139.23 43.53 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.511 0.724 . . . . 0.0 111.024 -168.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -63.23 149.49 45.38 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.8 m -71.32 81.73 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 123.273 1.511 . . . . 0.0 110.8 167.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -172.78 -68.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.961 -1.927 . . . . 0.0 106.446 -159.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -73.85 -45.61 50.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.638 0.775 . . . . 0.0 112.477 161.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.1 m -58.98 -56.55 20.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.2 -84.41 0.23 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.465 1.029 . . . . 0.0 108.713 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.82 -175.35 28.99 Favored Glycine 0 CA--C 1.557 2.718 0 CA-C-N 119.014 0.824 . . . . 0.0 114.651 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.53 105.13 1.83 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.483 2.788 . . . . 0.0 112.591 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.463 ' H ' ' HA ' ' A' ' 133' ' ' PRO . 2.5 tm0? 57.84 85.57 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.202 1.401 . . . . 0.0 112.908 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.66 -88.53 1.54 Allowed Glycine 0 CA--C 1.539 1.59 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -122.35 81.66 1.87 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.667 0.787 . . . . 0.0 109.96 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.1 p -73.44 145.29 84.97 Favored Pre-proline 0 CA--C 1.571 1.78 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.995 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.8 -16.38 30.09 Favored 'Cis proline' 0 CA--C 1.564 1.984 0 N-CA-C 119.437 2.822 . . . . 0.0 119.437 9.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -64.21 -42.69 96.5 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.73 118.43 68.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.32 163.51 27.41 Favored 'Trans proline' 0 CA--C 1.576 2.62 0 C-N-CA 122.84 2.36 . . . . 0.0 114.082 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 125' ' ' GLN . 56.2 Cg_endo -69.09 -64.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.107 2.538 . . . . 0.0 115.488 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -136.03 94.05 3.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.24 125.69 8.81 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.95 108.31 14.51 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.566 0.698 . . . . 0.0 112.385 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 157.84 16.16 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.736 176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.52 104.73 16.78 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.092 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -104.57 118.7 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.42 148.5 51.78 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.293 0.568 . . . . 0.0 112.383 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.96 99.96 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.5 m -102.44 109.39 21.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 104.15 8.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -80.88 -58.47 3.07 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 70.7 p -137.46 134.17 35.51 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.287 0.635 . . . . 0.0 109.64 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.16 94.94 4.86 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -166.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.08 115.31 22.81 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.412 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.7 0 CA-C-O 119.325 -0.708 . . . . 0.0 114.528 -178.076 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 . . . . . 0 CA--C 1.561 1.371 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -99.78 133.59 43.91 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.618 161.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER 68.25 163.13 0.21 Allowed 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 171.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.268 14.2 t0 73.19 111.7 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -127.29 -59.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -60.59 -37.46 81.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.78 51.85 0.22 Allowed Glycine 0 CA--C 1.548 2.129 0 C-N-CA 124.621 1.105 . . . . 0.0 113.116 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -166.83 -71.84 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.24 61.67 0.07 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.317 0.961 . . . . 0.0 111.36 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.0 mt -142.48 -53.87 0.41 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.841 0.856 . . . . 0.0 109.593 -163.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.0 115.28 20.4 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 154.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -122.61 70.45 1.0 Allowed 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -162.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -88.77 120.08 29.85 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.636 -1.29 . . . . 0.0 113.06 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.15 114.57 24.66 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 161.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 m -75.57 121.2 22.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.65 -69.18 0.34 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.771 0.828 . . . . 0.0 111.791 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.07 121.89 26.24 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.42 169.02 23.45 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.811 2.341 . . . . 0.0 113.682 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.02 176.42 40.44 Favored Glycine 0 CA--C 1.562 3.018 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.73 163.45 35.21 Favored 'Trans proline' 0 CA--C 1.573 2.437 0 C-N-CA 123.047 2.498 . . . . 0.0 115.36 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.46 107.81 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.219 2.613 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.98 89.85 1.55 Allowed Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -164.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -133.08 109.48 9.54 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.7 p -77.99 129.76 35.68 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.176 0.512 . . . . 0.0 112.134 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -92.14 113.0 57.77 Favored Pre-proline 0 CA--C 1.577 2.002 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.818 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -68.67 155.02 70.24 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 122.956 2.437 . . . . 0.0 117.511 -161.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.66 165.31 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.897 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.55 105.23 5.57 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.737 0.779 . . . . 0.0 111.534 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.73 48.6 0.84 Allowed Glycine 0 CA--C 1.55 2.235 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.391 -164.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -154.84 110.95 3.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.03 115.16 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.429 0.691 . . . . 0.0 109.826 -163.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.89 129.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.528 0.731 . . . . 0.0 110.863 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.429 ' HG1' HG21 ' A' ' 87' ' ' VAL . 33.9 m -89.73 129.76 36.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 168.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -144.9 129.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -170.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -99.01 101.76 13.25 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.21 1.004 . . . . 0.0 108.463 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.32 127.54 55.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.149 0.58 . . . . 0.0 109.742 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -108.97 80.87 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.908 0.483 . . . . 0.0 110.214 -166.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.531 ' HG1' ' HB3' ' A' ' 139' ' ' LEU . 11.8 m -78.83 127.45 32.05 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.437 0.637 . . . . 0.0 110.49 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -148.87 151.18 34.26 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.287 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.32 145.01 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.57 76.78 8.48 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 122.414 1.102 . . . . 0.0 110.277 168.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -172.22 -63.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.197 1.399 . . . . 0.0 107.27 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.62 -62.59 0.16 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 119.516 -0.602 . . . . 0.0 113.193 -173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 133.98 33.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 117.502 0.651 . . . . 0.0 110.149 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 142.68 46.39 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.88 -74.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -145.12 118.66 9.1 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -97.86 93.0 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 109.948 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mp0 -72.92 113.59 23.01 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.818 -172.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -53.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.991 2.46 . . . . 0.0 116.111 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 144' ' ' LYS . 3.2 tp10 -125.82 70.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 118.947 0.794 . . . . 0.0 110.705 -172.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.92 113.83 26.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG21 ' HG1' ' A' ' 67' ' ' THR . 96.6 t -106.76 100.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -174.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -113.06 146.57 38.9 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.042 0.537 . . . . 0.0 111.08 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.1 m -80.08 128.15 33.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.72 110.33 8.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.47 -67.1 0.25 Allowed Glycine 0 N--CA 1.48 1.583 0 CA-C-O 119.406 -0.663 . . . . 0.0 112.955 -167.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.42 85.94 7.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.523 0.678 . . . . 0.0 109.961 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 83.9 m -95.38 115.31 27.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.432 0.634 . . . . 0.0 112.373 -158.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -58.73 -38.41 78.31 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 159.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.3 m -71.13 164.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.639 1.209 . . . . 0.0 114.157 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.39 171.6 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.569 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -57.16 -40.06 76.49 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.85 -43.63 86.02 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.92 -49.07 61.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.559 -1.21 . . . . 0.0 114.111 170.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -49.54 -49.84 44.47 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.0 -44.31 94.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.1 p -87.23 49.41 1.81 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.3 t -96.56 -57.41 0.19 Allowed Pre-proline 0 CA--C 1.572 1.827 0 CA-C-O 115.226 -2.321 . . . . 0.0 109.195 163.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.85 -7.7 11.91 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.497 2.999 . . . . 0.0 118.776 174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.88 -34.84 15.09 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.77 1.168 . . . . 0.0 113.728 162.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.86 116.51 7.81 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.216 1.371 . . . . 0.0 112.806 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -85.73 149.46 25.27 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.129 0.966 . . . . 0.0 112.009 167.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.73 105.32 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.84 -33.4 2.84 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.763 -164.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.31 132.37 43.01 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 120.818 2.309 . . . . 0.0 115.047 -170.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -96.86 122.96 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 162.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.42 122.33 9.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 120.892 0.377 . . . . 0.0 111.415 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.5 ttt -82.83 105.79 14.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.327 0.651 . . . . 0.0 109.834 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.14 119.51 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.5 p -94.35 78.22 3.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.41 144.3 49.83 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 152.48 45.34 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.2 t -76.89 69.15 3.18 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.672 1.225 . . . . 0.0 111.689 167.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -176.45 -64.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.477 1.511 . . . . 0.0 108.001 -164.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -79.27 -31.56 43.44 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.5 t -69.0 -75.98 0.1 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.166 1.348 . . . . 0.0 112.064 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.97 43.7 2.93 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.281 1.4 . . . . 0.0 112.55 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.09 176.25 6.69 Favored Glycine 0 CA--C 1.56 2.86 0 N-CA-C 116.467 1.347 . . . . 0.0 116.467 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.6 67.59 8.55 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 CA-C-N 120.979 2.389 . . . . 0.0 111.709 160.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -158.7 -66.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.498 1.119 . . . . 0.0 108.072 -169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.17 120.19 2.91 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 118.775 0.716 . . . . 0.0 111.776 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.04 67.42 1.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m 67.39 143.53 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 166.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.81 -42.62 0.78 Allowed 'Cis proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.804 2.037 . . . . 0.0 117.111 -1.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -138.15 68.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.42 1.009 . . . . 0.0 109.913 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.81 117.07 44.81 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 172.57 13.78 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 C-N-CA 123.006 2.471 . . . . 0.0 114.075 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.0 2.35 2.7 Favored 'Trans proline' 0 CA--C 1.567 2.126 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -148.56 90.24 1.77 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.27 114.28 3.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.99 107.57 13.92 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.2 125.04 35.85 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.015 0.912 . . . . 0.0 110.703 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 29.4 m -97.81 95.4 7.51 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.927 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.531 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -99.7 119.01 37.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.196 0.599 . . . . 0.0 110.091 174.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -88.49 103.61 16.04 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.275 1.036 . . . . 0.0 109.841 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.38 103.63 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.295 -1.32 . . . . 0.0 107.653 -170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -94.06 108.52 20.34 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.02 105.88 12.59 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 85' ' ' GLU . 62.3 mttt -77.88 -72.27 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -144.77 135.84 25.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 118.8 0.727 . . . . 0.0 109.886 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.64 111.12 23.31 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.96 138.77 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.05 148.5 50.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.302 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.151 -174.516 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.723 0.296 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.25 82.2 m95 75.51 103.11 0.07 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.924 1.289 . . . . 0.0 110.099 -176.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.1 97.48 9.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.27 129.79 37.19 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.593 1.187 . . . . 0.0 113.365 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 pt -103.42 66.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.867 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 tp -163.0 -60.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.399 0.68 . . . . 0.0 110.187 -164.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.4 44.49 3.72 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -161.05 -80.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.65 58.01 0.01 OUTLIER Glycine 0 CA--C 1.543 1.808 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.248 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 mt -131.06 -54.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.843 0.857 . . . . 0.0 110.978 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.9 tp -87.01 102.35 14.32 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 108.991 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.73 90.06 3.18 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 122.885 0.474 . . . . 0.0 111.375 -161.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.04 93.79 8.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.814 -1.179 . . . . 0.0 111.106 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -99.32 122.91 43.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.356 0.662 . . . . 0.0 109.251 168.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.9 m -80.58 117.03 20.93 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.131 0.572 . . . . 0.0 109.916 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -79.87 -71.68 0.44 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.957 0.903 . . . . 0.0 110.512 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.14 123.18 45.87 Favored Pre-proline 0 CA--C 1.573 1.845 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.74 157.59 51.77 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.921 2.414 . . . . 0.0 114.85 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.37 116.56 4.25 Favored Glycine 0 CA--C 1.55 2.233 0 CA-C-O 116.807 -2.107 . . . . 0.0 112.9 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.11 142.02 37.34 Favored 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 122.658 3.229 . . . . 0.0 114.315 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 113.19 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.045 2.497 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.81 -85.92 0.11 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 t -85.12 109.21 18.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.1 p -111.17 172.11 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.085 0.945 . . . . 0.0 112.907 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -50.64 122.7 16.62 Favored Pre-proline 0 CA--C 1.582 2.182 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.02 162.09 37.66 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.089 2.526 . . . . 0.0 115.799 -171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 167.56 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.465 1.126 . . . . 0.0 112.22 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -64.57 126.72 28.77 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.729 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.31 59.79 1.08 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.251 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -146.27 139.69 25.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.38 102.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.65 120.6 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.505 ' HB ' ' HG1' ' A' ' 145' ' ' THR . 10.0 m -100.03 142.62 31.27 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.39 0.676 . . . . 0.0 109.444 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.98 141.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.589 0.756 . . . . 0.0 109.638 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -83.16 109.67 17.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 160.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -95.62 113.18 24.8 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -94.02 91.27 6.78 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 m -82.94 116.94 22.44 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HG ' ' HA ' ' A' ' 79' ' ' ARG . 70.8 m -145.19 171.59 14.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.303 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.21 130.94 55.75 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.61 -38.92 79.04 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -65.29 -48.18 74.04 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 163.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.89 -116.51 4.14 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 119.245 0.929 . . . . 0.0 112.564 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.584 ' HG1' ' H ' ' A' ' 79' ' ' ARG . 5.5 t -153.69 -176.39 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.77 0.795 . . . . 0.0 111.909 -168.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.584 ' H ' ' HG1' ' A' ' 78' ' ' THR . 35.8 ptt180 -61.53 122.69 15.86 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.49 -49.88 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.45 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -146.59 103.42 3.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -84.88 82.04 8.62 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.346 1.069 . . . . 0.0 111.459 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.49 112.02 58.75 Favored Pre-proline 0 CA--C 1.576 1.947 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.533 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.33 -61.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.181 2.588 . . . . 0.0 116.364 -169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -97.82 74.08 2.33 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.222 1.374 . . . . 0.0 111.18 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.23 92.39 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.16 139.07 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.048 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.45 155.39 33.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.59 -172.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.7 m -77.97 131.22 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.42 116.27 4.17 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.825 0.85 . . . . 0.0 112.467 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.6 55.26 8.73 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -152.28 150.82 30.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.261 1.029 . . . . 0.0 110.081 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -74.89 81.96 2.16 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 122.824 1.297 . . . . 0.0 114.033 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -130.92 -60.48 0.97 Allowed 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.222 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.52 172.21 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.513 1.125 . . . . 0.0 113.138 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.67 161.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.28 -45.56 90.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.67 77.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -54.53 17.83 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.998 0.919 . . . . 0.0 112.863 172.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -49.28 -50.92 36.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.5 -39.98 77.69 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.2 p -84.22 22.91 1.14 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -74.0 -54.84 3.37 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.382 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.05 61.4 8.19 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 CA-C-N 125.39 2.961 . . . . 0.0 114.642 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.6 mt -155.96 -48.31 0.08 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.628 1.571 . . . . 0.0 109.66 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -76.54 107.12 8.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.523 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.79 169.88 17.28 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.961 167.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.05 106.88 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.884 -1.135 . . . . 0.0 108.413 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 10.34 46.19 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -163.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.98 93.99 6.05 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.504 2.152 . . . . 0.0 109.812 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.3 m -88.54 136.38 33.02 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.168 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.75 138.19 8.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.936 0.494 . . . . 0.0 110.112 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.1 ptm -83.04 124.77 30.75 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.03 71.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -84.93 113.76 21.64 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.6 -0.687 . . . . 0.0 109.414 -164.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.11 154.23 26.94 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.855 0.862 . . . . 0.0 112.051 -167.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -52.33 147.98 7.25 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 168.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.0 p -68.89 78.14 0.31 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.84 1.305 . . . . 0.0 112.619 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -176.12 -60.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.797 -151.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.02 -51.81 23.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.9 m -67.35 -80.34 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -158.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.12 72.3 1.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.32 -142.87 47.75 Favored Glycine 0 CA--C 1.562 3.01 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.78 -164.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.78 50.58 1.91 Allowed 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 122.892 2.395 . . . . 0.0 113.661 165.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 56.0 85.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.905 1.282 . . . . 0.0 113.769 -168.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 162.0 74.06 0.02 OUTLIER Glycine 0 N--CA 1.481 1.687 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.544 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 69.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.7 m 68.53 127.9 0.03 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 166.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.82 -44.8 0.36 Allowed 'Cis proline' 0 CA--C 1.565 2.029 0 CA-C-N 123.009 2.11 . . . . 0.0 116.39 2.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.29 82.35 1.42 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.57 99.08 46.36 Favored Pre-proline 0 CA--C 1.57 1.745 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.34 134.08 12.42 Favored 'Trans proline' 0 CA--C 1.567 2.175 0 C-N-CA 122.828 2.352 . . . . 0.0 113.799 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.66 154.31 64.26 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.137 2.558 . . . . 0.0 115.297 -172.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.256 15.5 m170 82.2 137.61 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.41 1.084 . . . . 0.0 112.069 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.258 . . 73.29 136.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.843 1.257 . . . . 0.0 113.236 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.88 169.73 11.01 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -158.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tt -115.3 125.6 53.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.349 1.06 . . . . 0.0 110.33 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -87.3 118.45 26.74 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.105 0.962 . . . . 0.0 110.971 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.22 111.88 11.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.73 103.67 15.59 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.119 0.485 . . . . 0.0 110.726 -169.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.25 101.18 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.0 m -109.19 121.89 46.14 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.23 105.59 11.6 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.626 0.37 . . . . 0.0 110.162 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -78.61 -69.73 0.54 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.505 ' HG1' ' HB ' ' A' ' 67' ' ' THR . 29.8 p -132.37 143.57 49.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.334 0.588 . . . . 0.0 109.59 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.32 100.13 5.27 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.44 149.66 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.963 0.905 . . . . 0.0 109.002 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -65.59 163.56 15.96 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 CA-C-O 117.225 -1.875 . . . . 0.0 113.529 -175.611 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.268 14.7 tp10 . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -69.76 151.76 45.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.913 167.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.34 98.81 9.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.037 0.535 . . . . 0.0 109.992 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.06 120.89 20.27 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 122.058 0.933 . . . . 0.0 112.146 171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.21 -80.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -165.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.64 120.9 23.45 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.85 2.74 0.07 OUTLIER Glycine 0 CA--C 1.543 1.81 0 CA-C-O 117.51 -1.717 . . . . 0.0 116.701 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.364 12.5 p30 49.01 56.86 7.13 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 120.281 2.04 . . . . 0.0 114.727 -165.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 54.61 6.57 Favored Glycine 0 CA--C 1.546 1.991 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 99.4 mt -126.21 -66.47 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.478 1.139 . . . . 0.0 110.299 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 tp -82.86 111.44 18.76 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.444 1.02 . . . . 0.0 109.921 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -115.81 144.27 44.23 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.502 0.721 . . . . 0.0 112.606 -173.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HZ2' ' HA ' ' A' ' 102' ' ' SER . 0.9 OUTLIER -131.02 136.07 48.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 0.0 112.095 176.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.8 121.14 40.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 158.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.2 m -75.63 109.16 8.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.19 -61.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.736 0.815 . . . . 0.0 112.592 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.68 108.02 56.41 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.66 148.44 17.95 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.952 2.435 . . . . 0.0 113.989 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.49 118.76 7.37 Favored Glycine 0 CA--C 1.555 2.562 0 CA-C-O 116.986 -2.008 . . . . 0.0 114.882 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.33 168.35 23.69 Favored 'Trans proline' 0 CA--C 1.573 2.472 0 CA-C-N 122.306 3.053 . . . . 0.0 115.452 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.7 116.72 4.1 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 123.195 2.597 . . . . 0.0 113.021 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.27 69.75 1.18 Allowed Glycine 0 CA--C 1.545 1.91 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.319 -163.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -150.9 117.51 5.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -70.53 140.31 51.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -117.64 121.27 32.08 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-O 117.73 -1.129 . . . . 0.0 109.389 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.0 145.92 40.69 Favored 'Trans proline' 0 CA--C 1.558 1.689 0 C-N-CA 122.606 2.204 . . . . 0.0 114.657 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.28 154.68 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.63 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.24 107.89 1.16 Allowed 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.898 0.879 . . . . 0.0 112.425 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.37 69.12 0.87 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.391 -158.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -153.75 127.29 8.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -77.61 100.12 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.43 140.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.945 0.898 . . . . 0.0 109.437 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.43 ' HB ' ' HG1' ' A' ' 145' ' ' THR . 61.9 m -89.22 127.26 35.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 164.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.41 130.3 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.151 0.977 . . . . 0.0 109.244 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -98.12 95.25 7.31 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.7 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.59 131.45 55.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.547 0.739 . . . . 0.0 109.297 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' HA ' ' H ' ' A' ' 82' ' ' GLU . 13.3 mm-40 -139.08 116.09 10.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.8 m -88.06 119.08 28.09 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.296 -168.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -88.95 129.16 35.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.711 0.804 . . . . 0.0 110.599 170.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.76 140.82 37.09 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.444 0.64 . . . . 0.0 109.854 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -52.79 -45.92 67.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -93.16 90.89 7.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.06 69.12 1.4 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 117.411 1.724 . . . . 0.0 117.411 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.409 1.7 t 53.51 -168.09 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 158.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.364 9.2 ptp180 -77.14 104.9 7.9 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -170.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.79 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-N 112.214 -2.266 . . . . 0.0 116.086 165.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 80.02 112.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' H ' ' HA ' ' A' ' 71' ' ' GLN . 5.3 mm-40 -116.92 69.03 0.75 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 72.43 96.57 0.04 OUTLIER Pre-proline 0 CA--C 1.578 2.054 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 167.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.13 -19.09 39.61 Favored 'Trans proline' 0 CA--C 1.56 1.819 0 N-CA-C 119.047 2.672 . . . . 0.0 119.047 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.02 86.03 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.297 1.408 . . . . 0.0 109.259 164.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -87.53 116.68 25.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.1 133.53 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 123.434 0.694 . . . . 0.0 109.404 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.93 148.93 19.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.119 0.568 . . . . 0.0 111.185 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -70.42 130.35 41.69 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.39 0.676 . . . . 0.0 109.563 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 tp -51.27 -36.93 44.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -161.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.69 -102.65 0.55 Allowed Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.472 162.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.42 0.5 OUTLIER 62.2 169.48 0.12 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.16 17.89 23.27 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.37 -51.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 120.288 1.404 . . . . 0.0 113.318 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.0 167.06 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.412 1.101 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.0 pt -68.08 160.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.295 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.58 -36.69 76.72 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.8 73.11 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 167.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -48.98 58.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.44 -37.28 67.5 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.48 -32.66 60.65 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.4 ' HA ' ' HZ2' ' A' ' 47' ' ' LYS . 86.7 p -75.27 -11.93 60.17 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 165.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.287 1.3 t -54.66 -49.58 90.49 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 115.477 -2.202 . . . . 0.0 115.255 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.19 -13.46 32.21 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 125.127 2.867 . . . . 0.0 119.514 175.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.12 77.96 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.523 1.51 . . . . 0.0 108.886 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -162.45 109.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -88.69 168.36 12.57 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.166 0.984 . . . . 0.0 112.283 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.49 124.86 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.13 88.4 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -110.39 130.04 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.833 2.316 . . . . 0.0 113.244 -159.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 m -78.05 133.5 37.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.009 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.7 tpt -80.53 106.63 12.69 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.9 115.24 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 p -94.58 100.9 12.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.01 125.84 36.86 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.89 -172.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.79 165.24 17.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.4 p -53.12 -42.77 66.34 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 162.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.75 -43.87 87.62 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 164.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -103.36 67.34 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.398 0.679 . . . . 0.0 110.175 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.8 t -148.15 -93.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.59 42.21 3.32 Favored 'General case' 0 CA--C 1.574 1.879 0 CA-C-N 119.758 1.163 . . . . 0.0 111.527 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 56.98 -109.17 1.52 Allowed Glycine 0 CA--C 1.557 2.71 0 CA-C-O 117.454 -1.748 . . . . 0.0 115.109 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.34 -50.46 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 CA-C-N 121.439 2.619 . . . . 0.0 115.782 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -152.05 133.2 14.36 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.162 0.985 . . . . 0.0 108.54 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.15 -124.6 5.21 Favored Glycine 0 N--CA 1.481 1.643 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.865 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -88.02 68.08 9.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.43 0.692 . . . . 0.0 111.775 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -75.4 137.11 71.42 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.116 -172.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.04 -6.15 53.88 Favored 'Cis proline' 0 CA--C 1.568 2.216 0 N-CA-C 119.494 2.844 . . . . 0.0 119.494 9.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -57.94 -51.83 68.02 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.45 98.71 11.27 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 167.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.25 164.06 37.04 Favored 'Trans proline' 0 CA--C 1.572 2.389 0 C-N-CA 122.703 2.269 . . . . 0.0 114.137 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.47 111.25 2.27 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 123.072 2.515 . . . . 0.0 113.375 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 70.71 99.29 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.656 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.6 132.77 16.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.252 0.621 . . . . 0.0 110.364 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.89 85.11 4.68 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 109.908 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.11 147.5 41.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.014 0.911 . . . . 0.0 112.642 -161.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.2 m -76.55 152.2 36.06 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.84 129.72 4.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.809 0.843 . . . . 0.0 110.218 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.67 98.74 11.6 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.588 . . . . 0.0 110.852 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.4 100.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.1 m -109.17 123.98 50.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.97 117.37 17.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -82.63 -66.19 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.43 ' HG1' ' HB ' ' A' ' 67' ' ' THR . 44.3 p -131.26 147.57 52.6 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 -169.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.18 107.72 11.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 167.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.58 147.31 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.474 -170.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.62 144.39 49.47 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.6 0 CA-C-O 116.923 -2.043 . . . . 0.0 114.671 -173.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 CA--C 1.564 1.514 0 CA-C-O 121.643 0.735 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' HB2' ' HE ' ' A' ' 46' ' ' ARG . 50.2 m95 73.11 134.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.383 1.073 . . . . 0.0 111.516 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.612 0.765 . . . . 0.0 109.724 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.92 104.46 8.49 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.083 0.953 . . . . 0.0 111.927 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -98.52 130.41 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.436 0.6 OUTLIER 101.15 -66.5 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.231 1.812 . . . . 0.0 111.641 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.57 -70.62 0.08 OUTLIER Glycine 0 N--CA 1.484 1.835 0 CA-C-N 120.034 1.288 . . . . 0.0 114.33 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -73.26 -71.0 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.65 0.78 . . . . 0.0 111.341 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.89 61.28 0.05 OUTLIER Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.31 -0.717 . . . . 0.0 112.321 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.2 -58.72 2.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.638 0.719 . . . . 0.0 110.924 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.51 114.79 29.18 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 36' ' ' TRP . 22.7 mtp85 -115.03 108.87 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.84 0.456 . . . . 0.0 111.197 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -99.48 116.0 30.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.992 -1.067 . . . . 0.0 111.987 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -85.77 119.69 26.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.01 -1.057 . . . . 0.0 108.681 158.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.7 m -90.46 108.66 19.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -71.61 -65.45 0.76 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.166 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.46 136.4 21.47 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.166 164.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.17 176.91 9.4 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 123.0 2.467 . . . . 0.0 114.605 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.9 116.16 5.86 Favored Glycine 0 CA--C 1.558 2.729 0 CA-C-O 117.061 -1.966 . . . . 0.0 111.335 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.64 167.12 27.37 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 CA-C-N 122.55 3.175 . . . . 0.0 115.626 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.98 111.96 2.35 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.072 2.515 . . . . 0.0 112.334 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.54 76.3 1.32 Allowed Glycine 0 CA--C 1.544 1.868 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.661 -161.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.1 p -155.28 131.42 10.19 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.423 0.689 . . . . 0.0 109.744 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -117.27 119.93 36.69 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.457 1.123 . . . . 0.0 112.327 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -73.92 116.67 54.46 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.143 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.03 162.63 40.92 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 122.867 2.378 . . . . 0.0 116.047 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.01 158.7 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.213 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.63 77.74 9.8 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.13 0.966 . . . . 0.0 113.356 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.32 47.07 0.01 OUTLIER Glycine 0 CA--C 1.551 2.315 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.053 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.43 25.4 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.581 1.19 . . . . 0.0 109.269 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.86 103.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.691 0.796 . . . . 0.0 109.858 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.53 113.26 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.9 m -88.48 105.33 17.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.77 141.86 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.64 108.25 3.78 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 109.346 165.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.76 92.57 3.84 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 HE22 ' HG ' ' A' ' 73' ' ' SER . 1.5 tm0? -94.39 105.8 17.77 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -172.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -85.26 101.96 12.95 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.162 0.506 . . . . 0.0 109.743 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.475 ' HG ' HE22 ' A' ' 71' ' ' GLN . 36.8 m -121.65 157.07 31.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.381 1.073 . . . . 0.0 109.818 171.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.89 103.8 15.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.601 -0.687 . . . . 0.0 109.962 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.396 26.3 tt0 68.27 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 169.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.53 61.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.291 0.636 . . . . 0.0 111.482 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.43 66.29 2.46 Favored Glycine 0 CA--C 1.543 1.804 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -126.02 96.9 4.9 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 173.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -78.38 96.46 5.34 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -165.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 m -81.99 -50.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -152.75 134.73 14.8 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.909 0.861 . . . . 0.0 109.169 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.09 112.79 24.85 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.687 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.33 69.06 3.88 Favored Pre-proline 0 CA--C 1.585 2.289 0 O-C-N 121.446 -0.784 . . . . 0.0 110.953 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.96 -54.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.255 2.637 . . . . 0.0 115.487 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.83 76.61 6.51 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 121.4 1.909 . . . . 0.0 112.536 164.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.58 97.83 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.59 109.01 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -136.05 139.64 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 m -69.28 132.6 46.71 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 tt -69.57 109.68 4.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 80.24 0.98 Allowed Glycine 0 CA--C 1.54 1.644 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.552 -162.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -149.34 160.7 43.19 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.275 1.036 . . . . 0.0 110.793 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.6 p -79.93 71.0 6.6 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.268 1.032 . . . . 0.0 113.433 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -150.58 -62.91 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.479 1.111 . . . . 0.0 110.092 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.84 158.9 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 CA-C-O 123.173 1.463 . . . . 0.0 112.216 -161.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -66.3 152.99 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.726 177.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -57.89 -33.55 68.84 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.51 -46.76 57.42 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -57.65 5.54 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 112.473 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -58.52 -34.24 70.75 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.37 -38.0 77.84 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 167.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -70.49 -20.49 62.85 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.258 54.7 t -62.73 -52.45 64.46 Favored Pre-proline 0 CA--C 1.577 1.995 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.629 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.41 10.47 0.44 Allowed 'Trans proline' 0 CA--C 1.572 2.393 0 CA-C-N 124.703 2.715 . . . . 0.0 118.521 171.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.06 -46.28 5.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.245 1.018 . . . . 0.0 111.59 158.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.0 128.92 35.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.637 1.108 . . . . 0.0 113.013 -173.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -94.97 -147.71 0.28 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 123.153 0.581 . . . . 0.0 111.187 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.97 123.79 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.629 -1.294 . . . . 0.0 110.363 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.77 -103.07 2.97 Favored Glycine 0 CA--C 1.54 1.608 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -168.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 32.57 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -168.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.598 ' HA ' ' HG1' ' A' ' 142' ' ' THR . 30.5 m -82.06 115.71 21.32 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.58 123.35 11.91 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.324 0.583 . . . . 0.0 110.01 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.9 ttp -76.98 104.97 7.77 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.705 0.802 . . . . 0.0 110.544 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.91 97.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.3 m -99.37 104.22 16.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.18 37.26 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.794 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -48.91 134.24 17.0 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 165.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -51.04 -39.01 54.92 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.254 14.5 pttp -58.69 -41.26 85.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -66.9 -49.79 64.48 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 171.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.03 -160.71 0.34 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.822 0.849 . . . . 0.0 112.295 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -85.73 101.52 12.84 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.91 -91.6 1.78 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 116.866 -2.075 . . . . 0.0 109.66 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.59 -46.53 3.69 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 122.073 2.936 . . . . 0.0 116.253 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -91.3 98.64 11.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -90.42 134.43 12.34 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 115.336 -0.847 . . . . 0.0 115.117 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -113.51 91.44 3.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.889 0.476 . . . . 0.0 109.848 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.4 m 72.68 103.58 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.763 0 CA-C-O 117.476 -1.249 . . . . 0.0 112.003 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.63 -70.07 0.01 OUTLIER 'Cis proline' 0 CA--C 1.565 2.061 0 CA-C-N 122.923 2.08 . . . . 0.0 112.032 8.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.02 78.69 1.62 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 168.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.2 mt -67.29 121.96 80.87 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 -162.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.13 155.17 29.42 Favored 'Trans proline' 0 CA--C 1.569 2.267 0 C-N-CA 122.762 2.308 . . . . 0.0 115.214 -170.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.55 146.6 44.37 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.238 2.626 . . . . 0.0 113.459 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.267 22.4 m170 77.09 157.7 0.19 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.458 1.103 . . . . 0.0 112.245 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.12 127.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.984 1.314 . . . . 0.0 111.705 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.14 114.93 15.35 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.684 0.394 . . . . 0.0 112.038 -174.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.14 130.23 34.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.523 0.729 . . . . 0.0 110.895 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.6 p -85.66 93.33 8.81 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.564 0.746 . . . . 0.0 112.444 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.13 107.91 19.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.743 0.817 . . . . 0.0 109.01 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -85.36 105.99 16.41 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.663 0.744 . . . . 0.0 111.184 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.5 t -90.74 123.44 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.521 1.128 . . . . 0.0 107.969 -173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.598 ' HG1' ' HA ' ' A' ' 111' ' ' THR . 7.9 m -135.94 126.6 27.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 tp -75.45 109.89 9.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.913 -0.492 . . . . 0.0 110.229 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -81.18 -59.54 2.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.382 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.0 p -140.28 132.35 27.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.366 0.667 . . . . 0.0 109.388 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -105.52 112.61 25.77 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.48 138.13 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.516 0.674 . . . . 0.0 109.608 -170.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.52 155.95 35.61 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.195 0.997 . . . . 0.0 113.643 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.795 0 CA-C-O 116.963 -2.021 . . . . 0.0 114.189 -179.4 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.55 0.975 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 11.0 mpt_? 64.71 61.9 0.79 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.407 1.1 mm-40 64.49 -173.24 0.17 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 172.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -104.37 162.96 12.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.997 1.319 . . . . 0.0 110.052 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.59 107.55 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 109.488 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.09 129.7 54.79 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 121.644 0.735 . . . . 0.0 111.744 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.64 -48.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.003 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.22 -70.3 0.25 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 120.111 1.323 . . . . 0.0 113.982 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.79 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.28 -52.19 13.03 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.6 -124.03 0.7 Allowed Glycine 0 CA--C 1.54 1.599 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . 0.377 5.3 mp 72.93 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.115 1.366 . . . . 0.0 112.481 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.98 95.72 10.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -109.38 90.13 3.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -97.37 96.82 8.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.587 -0.696 . . . . 0.0 110.572 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.61 103.11 7.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.488 -0.758 . . . . 0.0 110.415 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.4 m -83.21 100.74 10.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.37 -65.36 1.02 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.616 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -84.2 128.28 62.96 Favored Pre-proline 0 CA--C 1.575 1.931 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 167.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.77 -56.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.953 2.435 . . . . 0.0 116.26 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.72 101.29 0.89 Allowed Glycine 0 CA--C 1.547 2.034 0 CA-C-O 116.71 -2.161 . . . . 0.0 107.887 -162.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.21 162.75 40.53 Favored 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 122.631 3.215 . . . . 0.0 116.42 -164.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.36 130.64 22.91 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.243 2.629 . . . . 0.0 113.701 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.79 -69.16 0.21 Allowed Glycine 0 CA--C 1.542 1.744 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -160.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -82.05 94.16 7.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.397 0.679 . . . . 0.0 111.165 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.0 m -128.09 166.49 18.35 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.983 0.897 . . . . 0.0 111.813 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 134.87 33.73 Favored Pre-proline 0 CA--C 1.577 2.0 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -165.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.33 144.84 11.78 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.133 2.556 . . . . 0.0 114.765 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.4 156.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 124.019 0.927 . . . . 0.0 109.32 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.83 89.09 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -160.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.11 61.15 0.01 OUTLIER Glycine 0 CA--C 1.546 1.988 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.989 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -151.16 144.43 24.76 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.08 94.19 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.78 141.66 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.603 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -124.09 128.21 48.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.579 -167.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.67 150.42 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.3 1.047 . . . . 0.0 110.5 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -96.63 107.55 20.01 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 tt -112.25 106.24 14.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -104.77 120.08 40.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -91.58 126.31 36.61 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -124.3 162.77 23.06 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.132 0.968 . . . . 0.0 110.563 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -83.58 153.27 24.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.326 -0.858 . . . . 0.0 111.815 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -50.86 -45.17 59.76 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 163.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -124.62 63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.44 0.564 . . . . 0.0 110.348 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.39 -116.52 0.59 Allowed Glycine 0 CA--C 1.538 1.485 0 O-C-N 121.178 -0.951 . . . . 0.0 112.128 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.6 t -158.01 -169.38 2.79 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.713 0.805 . . . . 0.0 111.168 -164.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.4 111.67 1.17 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.09 -52.13 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.009 1.324 . . . . 0.0 111.34 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -150.52 107.59 3.58 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -97.45 100.7 12.13 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.523 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.31 90.4 42.05 Favored Pre-proline 0 CA--C 1.572 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.77 -6.16 15.07 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 N-CA-C 120.055 3.06 . . . . 0.0 120.055 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -127.64 102.84 7.01 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.45 1.477 . . . . 0.0 110.071 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -126.8 97.65 5.07 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.69 136.58 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.924 0.889 . . . . 0.0 109.308 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -164.87 154.32 13.12 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.607 0.763 . . . . 0.0 111.032 -169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.8 m -76.75 137.97 39.64 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.393 0.616 . . . . 0.0 110.398 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.04 115.93 11.85 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.974 0.909 . . . . 0.0 109.98 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.54 73.01 0.97 Allowed Glycine 0 N--CA 1.481 1.639 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.724 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.99 149.5 19.68 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.873 0.844 . . . . 0.0 110.624 -168.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 76.9 m -77.49 80.71 3.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.58 1.181 . . . . 0.0 112.113 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.49 -65.27 0.24 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.856 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -81.08 164.73 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-O 122.437 1.113 . . . . 0.0 112.397 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.84 159.35 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.514 1.126 . . . . 0.0 113.983 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -55.52 -40.23 71.52 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -44.48 71.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.96 -67.67 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 117.199 -1.382 . . . . 0.0 111.616 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -46.48 -42.43 15.52 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.86 -51.51 66.71 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.3 p -77.48 -4.51 45.88 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.304 1.6 t -68.26 -45.64 38.8 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 114.892 -2.48 . . . . 0.0 114.976 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.93 -30.14 91.06 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 CA-C-N 126.77 3.454 . . . . 0.0 117.489 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -100.49 70.66 1.48 Allowed 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.213 1.005 . . . . 0.0 111.146 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -136.32 107.65 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.26 136.52 37.07 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.997 0.903 . . . . 0.0 111.63 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.93 114.17 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.883 -158.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.29 44.75 2.5 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.571 -1.195 . . . . 0.0 115.496 -166.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.39 167.28 12.39 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 118.837 1.318 . . . . 0.0 113.713 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 95.3 m -143.31 108.38 4.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.94 121.34 15.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.315 0.246 . . . . 0.0 110.751 -166.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 ttt -81.57 115.99 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.853 0.461 . . . . 0.0 110.168 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.99 100.61 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.0 p -84.41 97.65 9.62 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.35 32.05 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.343 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 119' ' ' LYS . 9.5 t70 -61.67 144.91 53.81 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 169.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.434 ' HG ' ' HA ' ' A' ' 134' ' ' HIS . 8.3 t -58.56 -38.63 78.24 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 117' ' ' ASP . 8.5 pttm -69.71 -37.46 76.57 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.23 -44.15 92.76 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 169.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.9 t -91.24 -179.66 5.48 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 123.062 1.41 . . . . 0.0 111.49 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.25 113.79 3.41 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.022 158.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.41 -89.38 0.08 OUTLIER Glycine 0 CA--C 1.546 1.986 0 CA-C-O 116.792 -2.115 . . . . 0.0 109.077 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.15 -57.14 0.13 Allowed 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 122.307 3.053 . . . . 0.0 114.295 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -89.13 103.21 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.57 -118.75 0.47 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.051 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -141.9 60.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.875 0.845 . . . . 0.0 111.877 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.9 p -87.85 150.64 48.42 Favored Pre-proline 0 CA--C 1.572 1.808 0 C-N-CA 124.214 1.005 . . . . 0.0 113.129 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.12 -7.33 46.59 Favored 'Cis proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.552 2.866 . . . . 0.0 119.552 11.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.83 -57.71 9.93 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 120.278 1.399 . . . . 0.0 113.854 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.1 mt -90.28 117.84 68.34 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.47 161.4 9.57 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.875 2.383 . . . . 0.0 116.095 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 131.83 21.4 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.138 2.559 . . . . 0.0 112.62 168.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 118' ' ' SER 0.29 92.0 m-70 71.13 174.65 0.3 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 123.729 0.812 . . . . 0.0 112.306 -170.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.72 118.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.054 1.342 . . . . 0.0 111.964 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.51 97.9 8.67 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.43 149.12 21.85 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.526 0.679 . . . . 0.0 112.749 -171.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -87.77 147.05 25.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.371 0.668 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.58 109.31 3.25 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.59 120.65 26.6 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.797 0.808 . . . . 0.0 111.917 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.6 t -103.3 109.23 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.6 m -116.17 104.48 11.57 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.1 113.87 7.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.398 0.679 . . . . 0.0 110.664 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -85.16 -61.07 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.1 p -142.8 133.27 24.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.21 100.94 10.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.94 132.38 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.119 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.94 73.22 10.36 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.27 1.033 . . . . 0.0 113.766 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.5 83.35 0.55 Allowed Glycine 0 CA--C 1.552 2.344 0 CA-C-O 116.787 -2.119 . . . . 0.0 114.472 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.76 106.83 1.5 Allowed 'Trans proline' 0 CA--C 1.56 1.793 0 CA-C-N 122.259 3.029 . . . . 0.0 112.017 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.91 119.52 31.18 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.168 0.587 . . . . 0.0 111.202 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.69 110.17 4.23 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 123.229 1.49 . . . . 0.0 111.013 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 118.845 -0.597 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -77.3 -73.55 0.29 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.964 0.802 . . . . 0.0 111.538 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.31 116.92 6.18 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 87.8 m95 72.57 134.05 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.504 1.122 . . . . 0.0 113.526 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.53 93.98 7.1 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.17 112.63 17.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.483 0.713 . . . . 0.0 111.265 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -64.03 -49.88 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.746 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.1 -61.07 2.91 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.8 -71.41 0.26 Allowed Glycine 0 N--CA 1.48 1.576 0 CA-C-N 118.632 0.651 . . . . 0.0 111.763 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -66.62 -72.7 0.15 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.785 0.834 . . . . 0.0 112.025 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.78 72.64 0.03 OUTLIER Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.517 0.599 . . . . 0.0 112.684 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.82 -72.98 0.66 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.31 143.71 31.09 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.999 0.92 . . . . 0.0 110.614 172.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -141.19 161.84 36.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.002 0.921 . . . . 0.0 112.473 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.87 37.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 112.182 164.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -173.48 2.34 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 122.009 0.909 . . . . 0.0 111.591 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -140.8 97.19 3.14 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 164.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.15 -69.09 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.609 0.764 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -101.78 131.63 22.62 Favored Pre-proline 0 CA--C 1.573 1.836 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 160.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 175.17 11.7 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.106 2.538 . . . . 0.0 114.53 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.73 115.34 4.96 Favored Glycine 0 CA--C 1.556 2.64 0 CA-C-O 116.879 -2.067 . . . . 0.0 112.066 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.27 169.36 15.52 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 CA-C-N 122.602 3.201 . . . . 0.0 115.597 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.68 -38.6 76.87 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 123.326 2.684 . . . . 0.0 118.182 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.7 87.61 0.94 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 118.968 0.804 . . . . 0.0 111.597 163.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.7 p -144.4 95.53 2.73 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 p -91.66 108.62 20.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.944 0.878 . . . . 0.0 110.598 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -76.41 126.67 86.02 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.59 -172.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.44 149.62 56.65 Favored 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 115.55 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.85 166.87 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.127 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -62.52 118.77 8.02 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.118 0.567 . . . . 0.0 112.438 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.58 58.41 1.13 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.287 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -143.89 135.65 26.22 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.28 101.8 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 m -122.68 128.24 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.789 0.804 . . . . 0.0 109.249 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.468 ' HG1' HG21 ' A' ' 87' ' ' VAL . 23.2 m -95.13 137.42 34.2 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.913 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 144.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.831 0.824 . . . . 0.0 109.461 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -92.05 100.66 13.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 163.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 tp -86.38 107.05 17.84 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.001 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -102.83 80.25 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 109.519 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.9 m -75.83 129.34 36.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.792 0.837 . . . . 0.0 109.991 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -139.86 164.87 28.82 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.473 1.13 . . . . 0.0 111.621 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.1 tp -78.9 161.68 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.985 0.914 . . . . 0.0 111.992 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -49.37 -42.08 41.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.61 -68.47 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.596 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.83 83.35 0.05 OUTLIER Glycine 0 N--CA 1.479 1.53 0 CA-C-N 119.117 0.871 . . . . 0.0 112.03 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -159.44 122.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.52 115.02 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.29 -45.89 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -145.43 109.16 4.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -94.33 101.64 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.458 0.647 . . . . 0.0 110.113 164.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -92.65 109.29 37.74 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.645 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.14 -51.45 0.6 Allowed 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.026 2.484 . . . . 0.0 117.308 -165.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -121.57 94.91 4.47 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.983 0.896 . . . . 0.0 111.551 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -97.23 102.98 14.87 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG21 ' HG1' ' A' ' 67' ' ' THR . 88.2 t -103.15 123.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -169.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -149.7 149.21 30.26 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -170.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -75.77 124.27 27.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.34 114.89 8.0 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.536 0.734 . . . . 0.0 111.004 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.11 18.44 77.9 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 119.64 2.616 . . . . 0.0 119.64 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -132.85 66.25 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.661 1.73 . . . . 0.0 111.587 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.6 t 58.9 78.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -149.78 -66.71 0.21 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 m -97.58 167.27 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.733 1.254 . . . . 0.0 112.256 -166.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -61.09 159.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.946 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.46 -41.34 89.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.86 -46.21 71.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 168.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.7 -57.53 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.345 168.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -46.58 -58.05 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.35 -32.82 74.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.5 p -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.264 1.7 t -64.22 -49.19 74.35 Favored Pre-proline 0 N--CA 1.505 2.295 0 CA-C-N 122.391 2.36 . . . . 0.0 113.71 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.99 1.08 3.65 Favored 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 125.119 2.864 . . . . 0.0 118.61 169.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -97.27 -25.78 15.14 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 156.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 12.0 tpp -81.9 105.38 12.97 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.851 1.205 . . . . 0.0 110.441 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.34 167.48 20.83 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 122.146 0.974 . . . . 0.0 112.095 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.96 107.36 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 108.746 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 14.01 52.14 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.148 2.019 . . . . 0.0 118.148 -166.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.27 110.15 22.12 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 119.971 1.885 . . . . 0.0 109.561 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.9 m -94.29 120.36 34.41 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.22 135.31 49.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.553 0.741 . . . . 0.0 109.535 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.403 ' SD ' ' HB2' ' A' ' 140' ' ' GLU . 6.8 tpt -80.86 103.72 10.88 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.8 t -90.96 94.03 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.5 p -89.14 91.43 8.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.822 0.82 . . . . 0.0 109.487 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.71 134.87 41.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.843 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.9 132.57 47.59 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.908 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.489 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . 26.7 t -74.32 75.09 1.86 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 123.26 1.505 . . . . 0.0 112.723 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -172.17 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.481 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -87.87 -56.94 3.13 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.614 1.166 . . . . 0.0 110.179 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 118' ' ' SER . 20.1 p -46.28 -57.18 4.81 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 168.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -124.94 -46.16 1.85 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.609 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.97 144.46 17.21 Favored Glycine 0 CA--C 1.555 2.541 0 CA-C-O 117.677 -1.624 . . . . 0.0 112.255 -168.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.88 87.91 1.36 Allowed 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 122.184 2.992 . . . . 0.0 113.05 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -144.67 -66.92 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.75 86.0 1.84 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.604 0.621 . . . . 0.0 111.594 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -91.96 152.47 20.01 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.2 m -68.03 140.16 93.38 Favored Pre-proline 0 CA--C 1.573 1.83 0 CA-C-O 117.707 -1.139 . . . . 0.0 112.729 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.71 -50.25 0.2 OUTLIER 'Cis proline' 0 CA--C 1.562 1.923 0 N-CA-C 117.238 1.976 . . . . 0.0 117.238 11.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -149.92 76.47 1.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 119.506 1.048 . . . . 0.0 109.208 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.77 118.11 49.15 Favored Pre-proline 0 CA--C 1.57 1.73 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.59 142.03 12.71 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 122.877 2.385 . . . . 0.0 114.303 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 125.33 10.66 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.131 2.554 . . . . 0.0 112.103 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.278 97.6 m-70 70.0 172.18 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.708 0.803 . . . . 0.0 112.883 -171.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.18 111.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.999 1.32 . . . . 0.0 111.15 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.23 117.25 8.26 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.43 128.11 33.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.819 0.448 . . . . 0.0 109.8 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.11 98.45 8.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.601 0.761 . . . . 0.0 109.355 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 107.0 18.03 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.572 0.749 . . . . 0.0 110.575 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.403 ' HB2' ' SD ' ' A' ' 113' ' ' MET . 31.2 tt0 -83.4 107.9 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.126 0.965 . . . . 0.0 111.276 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.84 105.97 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.9 m -101.34 122.39 43.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -73.07 -74.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.1 p -147.45 131.9 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.776 0.716 . . . . 0.0 109.113 -169.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.47 112.51 25.55 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.209 0.604 . . . . 0.0 109.579 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.2 143.4 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.624 0.77 . . . . 0.0 110.109 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.67 79.43 4.26 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.074 0.94 . . . . 0.0 113.124 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.15 159.26 27.2 Favored Glycine 0 CA--C 1.561 2.937 0 N-CA-C 116.568 1.387 . . . . 0.0 116.568 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.11 164.91 21.96 Favored 'Trans proline' 0 CA--C 1.563 1.941 0 C-N-CA 123.178 2.585 . . . . 0.0 114.335 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.24 96.9 8.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.54 0.686 . . . . 0.0 109.994 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -158.01 113.35 2.7 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.32 10.1 pt-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -132.12 -76.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.447 175.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -145.96 95.27 2.6 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.747 1.158 . . . . 0.0 111.766 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.322 14.9 m0 68.92 -135.94 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.362 1.065 . . . . 0.0 111.581 168.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 tt -138.25 119.31 14.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.64 108.81 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.39 0.676 . . . . 0.0 112.207 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.29 45.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -58.45 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 125.272 1.429 . . . . 0.0 110.213 172.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.52 -91.3 0.51 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.95 -36.32 64.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.08 1.35 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -167.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mp 15.82 63.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 165.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 tp -157.99 117.37 3.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -148.76 115.22 5.89 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 -161.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -117.03 133.64 55.75 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -171.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -73.7 143.74 46.07 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.978 0.911 . . . . 0.0 111.661 159.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.5 m -93.45 92.13 7.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 159.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.73 -60.98 2.11 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.774 0.829 . . . . 0.0 113.044 -167.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -113.82 130.2 24.04 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 157.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.84 170.03 21.27 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.088 2.526 . . . . 0.0 114.97 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 152.39 49.65 Favored Glycine 0 CA--C 1.561 2.925 0 CA-C-O 118.376 -1.236 . . . . 0.0 115.345 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.95 164.58 31.24 Favored 'Trans proline' 0 CA--C 1.574 2.486 0 CA-C-N 121.433 2.616 . . . . 0.0 115.556 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.14 113.58 2.68 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 123.201 2.601 . . . . 0.0 113.038 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.6 -96.27 0.94 Allowed Glycine 0 CA--C 1.539 1.557 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -163.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.268 82.9 p 53.96 85.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -79.9 120.62 24.36 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.424 0.63 . . . . 0.0 111.534 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -81.61 124.01 80.25 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.746 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.52 147.9 65.45 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.1 2.533 . . . . 0.0 115.567 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.16 152.74 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.059 0.944 . . . . 0.0 111.842 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.81 118.42 8.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.06 60.48 0.55 Allowed Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.71 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -146.86 146.0 30.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.364 1.078 . . . . 0.0 108.559 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.3 101.39 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.81 125.49 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' HG1' HG21 ' A' ' 87' ' ' VAL . 14.1 m -107.4 140.29 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.371 0.668 . . . . 0.0 109.308 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.27 141.32 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.801 0.841 . . . . 0.0 109.023 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -83.82 101.32 11.54 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 158.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.6 tp -86.26 100.56 12.35 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -93.68 101.38 13.52 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -81.03 117.51 21.69 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -142.58 154.36 44.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.656 0.783 . . . . 0.0 109.566 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.21 141.54 49.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.858 0.837 . . . . 0.0 111.206 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -57.63 -45.63 85.17 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 157.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.18 -58.01 3.96 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.83 54.13 0.75 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.472 2.5 t 50.92 -157.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 163.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -79.97 107.37 12.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.211 1.004 . . . . 0.0 111.973 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.2 -71.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.378 0.671 . . . . 0.0 111.26 -165.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.92 111.18 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -163.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.25 113.11 25.23 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.133 0.573 . . . . 0.0 110.739 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.92 91.89 16.48 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.498 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.08 -61.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.36 2.707 . . . . 0.0 116.047 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 144' ' ' LYS . 0.4 OUTLIER -92.36 86.33 5.66 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.663 1.12 . . . . 0.0 110.625 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.8 tp -106.88 92.6 4.16 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 165.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG21 ' HG1' ' A' ' 67' ' ' THR . 8.8 p -95.2 139.44 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.533 0.733 . . . . 0.0 110.395 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -159.6 154.65 24.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.516 0.674 . . . . 0.0 111.748 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -74.87 133.1 41.9 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 171.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.18 111.3 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.129 0.972 . . . . 0.0 111.409 -172.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.35 77.96 0.33 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.015 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.84 157.7 27.12 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.28 1.038 . . . . 0.0 111.228 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.47 83.56 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.274 1.035 . . . . 0.0 112.253 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -151.39 -66.44 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.32 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.61 169.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.702 1.239 . . . . 0.0 113.44 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 pt -52.27 151.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 114.131 -1.395 . . . . 0.0 114.053 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -60.73 -36.78 79.74 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.14 83.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.32 -57.78 7.54 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 117.406 -1.283 . . . . 0.0 113.289 165.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -52.49 -39.9 61.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.6 p -104.54 61.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.96 -61.02 0.17 Allowed Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 115.543 -2.17 . . . . 0.0 108.987 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.97 -25.08 59.67 Favored 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 124.986 2.816 . . . . 0.0 117.542 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -6.27 5.72 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 167.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.2 mtt -114.44 119.8 38.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.935 1.243 . . . . 0.0 109.017 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -64.45 163.3 13.57 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.62 99.72 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 49.28 3.09 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 118.352 1.076 . . . . 0.0 110.741 163.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.3 m -93.5 142.28 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.29 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.83 123.17 13.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.727 0.411 . . . . 0.0 110.705 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.3 tpt -84.02 101.78 12.01 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.47 125.63 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 p -106.35 96.42 6.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.843 0.83 . . . . 0.0 109.219 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.19 167.69 15.46 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.965 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.45 42.91 1.12 Allowed 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.7 p 35.34 54.79 0.81 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.424 ' HD2' ' HD1' ' A' ' 134' ' ' HIS . 33.2 mtpt -151.86 -58.86 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.821 -159.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.9 -45.61 92.98 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 157.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.6 t -90.78 113.6 25.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.821 0.848 . . . . 0.0 111.173 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.287 81.0 m-85 65.2 14.46 9.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.17 179.1 25.31 Favored Glycine 0 CA--C 1.559 2.824 0 N-CA-C 116.523 1.369 . . . . 0.0 116.523 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -83.46 62.56 7.34 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 122.921 2.414 . . . . 0.0 113.407 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.54 -70.69 0.07 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.84 132.82 7.67 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 118.22 0.464 . . . . 0.0 112.038 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -111.34 52.42 0.75 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.9 m 65.46 143.77 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 170.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.03 -40.39 0.85 Allowed 'Cis proline' 0 CA--C 1.563 1.932 0 CA-C-N 122.687 1.996 . . . . 0.0 116.472 -1.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -132.81 67.33 1.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.2 mt -115.77 119.64 37.13 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -85.54 159.81 10.87 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 C-N-CA 123.157 2.571 . . . . 0.0 115.196 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.08 -39.51 0.87 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 122.959 2.44 . . . . 0.0 117.291 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.424 ' HD1' ' HD2' ' A' ' 119' ' ' LYS . 96.7 m-70 -147.87 72.34 1.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.021 0.828 . . . . 0.0 109.04 -173.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.19 21.3 0.25 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 72.68 134.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 tt -138.75 123.48 18.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -99.48 97.3 8.32 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.877 0.846 . . . . 0.0 110.138 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.66 125.59 39.41 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.284 1.034 . . . . 0.0 109.602 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -98.54 103.48 15.43 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.878 0.847 . . . . 0.0 110.298 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.23 109.17 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.7 m -105.26 121.61 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.09 105.83 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.449 ' HZ1' ' CD ' ' A' ' 85' ' ' GLU . 40.3 mtpt -76.91 -66.9 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.5 p -135.06 135.41 41.26 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.44 0.696 . . . . 0.0 109.219 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.86 104.07 11.82 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.03 154.48 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.742 0.782 . . . . 0.0 109.915 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.19 -170.05 0.89 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -80.85 117.38 4.41 Favored Glycine 0 CA--C 1.556 2.614 0 CA-C-O 116.874 -2.07 . . . . 0.0 115.021 -173.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.73 147.22 19.33 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 CA-C-N 122.58 3.19 . . . . 0.0 113.774 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.03 168.47 19.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.54 159.19 22.86 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.276 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 123.813 0.845 . . . . 0.0 112.146 -171.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.8 ttp-105 -146.84 127.69 14.43 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.162 0.585 . . . . 0.0 111.081 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.27 122.62 20.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.173 0.589 . . . . 0.0 109.746 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.317 98.5 m95 86.54 106.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.709 1.204 . . . . 0.0 109.596 -161.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.27 107.33 19.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -83.48 116.03 22.35 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.527 0.679 . . . . 0.0 112.193 -165.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.46 -48.83 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 123.909 0.884 . . . . 0.0 111.413 170.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.38 -60.3 3.75 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.413 1.006 . . . . 0.0 113.143 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.78 -72.63 0.29 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-N 118.912 0.778 . . . . 0.0 112.446 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -69.56 -70.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.687 0.795 . . . . 0.0 112.353 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.82 64.06 0.09 OUTLIER Glycine 0 N--CA 1.481 1.644 0 CA-C-N 118.393 0.542 . . . . 0.0 111.863 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB3' ' HH ' ' A' ' 120' ' ' TYR . 71.1 mt -137.04 -78.74 0.4 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.894 -163.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 tp -88.27 124.72 34.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 121.022 1.737 . . . . 0.0 107.988 166.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -154.95 113.19 3.49 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.477 -164.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -119.2 115.99 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.339 1.056 . . . . 0.0 109.127 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -103.8 141.18 36.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.819 -0.551 . . . . 0.0 111.081 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.9 m -80.18 115.35 19.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.9 -69.08 0.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.539 0.736 . . . . 0.0 109.293 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.6 134.09 24.72 Favored Pre-proline 0 CA--C 1.578 2.035 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.021 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.04 149.83 29.08 Favored 'Trans proline' 0 CA--C 1.558 1.686 0 C-N-CA 122.851 2.368 . . . . 0.0 114.11 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 114.49 4.0 Favored Glycine 0 CA--C 1.555 2.578 0 CA-C-O 116.872 -2.071 . . . . 0.0 113.127 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.83 164.17 36.53 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 CA-C-N 122.775 3.287 . . . . 0.0 116.0 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.09 109.56 2.6 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.272 2.648 . . . . 0.0 111.74 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.81 -66.0 0.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.026 -158.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -65.49 135.03 54.65 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -138.67 146.66 41.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.702 0.763 . . . . 0.0 110.004 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.59 112.46 6.63 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-O 117.998 -1.001 . . . . 0.0 113.362 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.42 166.25 29.88 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.499 2.133 . . . . 0.0 115.942 -161.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.66 162.82 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.22 -168.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 107.52 4.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.391 0.676 . . . . 0.0 110.223 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.45 -47.84 0.8 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 115.415 -0.811 . . . . 0.0 113.919 -163.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -63.36 124.05 20.28 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.708 0.803 . . . . 0.0 111.739 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.49 99.25 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.49 140.35 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.863 0.839 . . . . 0.0 110.557 -172.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 m -114.41 124.04 50.95 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.15 142.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.794 0.837 . . . . 0.0 110.288 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -94.67 99.52 11.62 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 165.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.25 106.01 18.1 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.9 87.92 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.6 m -71.48 125.07 26.08 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.149 0.58 . . . . 0.0 110.562 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 t -131.38 155.34 47.44 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.098 0.952 . . . . 0.0 110.329 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.1 146.93 30.34 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.612 165.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.59 -33.33 60.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -68.16 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.96 0.8 . . . . 0.0 112.059 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.5 77.27 0.03 OUTLIER Glycine 0 N--CA 1.479 1.502 0 CA-C-N 119.117 0.871 . . . . 0.0 113.147 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 m -149.34 106.61 3.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -82.65 105.96 14.12 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.1 m -96.79 -45.3 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -165.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -136.1 87.99 2.35 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.847 1.203 . . . . 0.0 110.101 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.38 115.07 26.85 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.322 0.582 . . . . 0.0 111.671 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.13 102.41 48.84 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.726 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -87.22 77.17 2.02 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.633 2.222 . . . . 0.0 114.073 -166.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.461 8.7 pt-20 133.36 94.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 127.401 2.281 . . . . 0.0 110.047 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.33 99.56 7.1 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.31 138.22 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.693 -169.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -164.54 149.88 10.1 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.253 0.621 . . . . 0.0 110.683 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -79.46 128.62 33.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.64 135.1 52.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.563 0.745 . . . . 0.0 112.115 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 52.38 18.4 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.32 -16.71 0.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.255 17.0 t 76.2 86.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.44 1.496 . . . . 0.0 110.558 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -132.84 -70.63 0.54 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.062 0.545 . . . . 0.0 110.541 -174.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.68 178.81 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 123.795 0.838 . . . . 0.0 112.521 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -54.76 144.2 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.361 1.064 . . . . 0.0 113.671 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -57.32 -27.88 62.59 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.37 -47.58 85.19 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -62.59 1.33 Allowed 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.853 170.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.15 -51.5 42.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.66 -36.14 81.89 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.6 p -74.48 -10.15 59.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.556 2.799 . . . . 0.0 118.556 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -59.88 -50.29 87.28 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 115.391 -2.243 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.16 -30.59 61.64 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 CA-C-N 125.362 2.951 . . . . 0.0 118.283 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.28 65.54 1.43 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 119.057 0.844 . . . . 0.0 111.176 163.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.0 ttm -160.23 109.65 1.76 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 157.71 20.44 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.071 0.938 . . . . 0.0 112.566 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.14 121.62 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.354 -0.841 . . . . 0.0 111.405 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.72 -3.69 83.32 Favored Glycine 0 CA--C 1.552 2.364 0 N-CA-C 118.49 2.156 . . . . 0.0 118.49 -167.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.5 114.26 12.69 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 121.25 2.525 . . . . 0.0 112.147 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.5 m -84.14 124.24 30.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 133.19 21.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.421 0.689 . . . . 0.0 109.579 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.438 ' SD ' ' SG ' ' A' ' 138' ' ' CYS . 26.9 tpp -83.75 137.9 33.52 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.86 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.8 t -128.48 125.22 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.5 p -102.74 95.49 6.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.81 127.25 32.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.297 172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.73 59.46 4.66 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.8 p 33.35 64.09 0.32 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -173.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -176.6 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.899 -155.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.439 ' HH ' ' HB3' ' A' ' 44' ' ' LEU . 58.3 m-85 -79.64 -38.76 33.02 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.288 1.435 . . . . 0.0 112.745 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.8 t -62.3 -63.92 1.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 163.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -137.16 -69.41 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.87 0.868 . . . . 0.0 109.665 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 119.63 -166.15 13.37 Favored Glycine 0 CA--C 1.555 2.549 0 CA-C-N 118.938 0.79 . . . . 0.0 113.17 -167.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -64.38 -10.46 24.05 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 N-CA-C 118.573 2.49 . . . . 0.0 118.573 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -105.47 103.27 12.76 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -122.7 157.63 17.3 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 123.685 0.66 . . . . 0.0 112.356 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -87.75 78.21 8.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.1 p -75.69 142.59 73.91 Favored Pre-proline 0 CA--C 1.568 1.668 0 CA-C-O 117.819 -1.086 . . . . 0.0 113.096 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.31 -15.29 32.51 Favored 'Cis proline' 0 CA--C 1.565 2.027 0 N-CA-C 119.397 2.807 . . . . 0.0 119.397 10.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -64.22 -47.86 78.09 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.25 101.01 53.92 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 171.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.34 145.82 66.92 Favored 'Trans proline' 0 CA--C 1.572 2.387 0 C-N-CA 122.525 2.15 . . . . 0.0 113.387 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.69 -34.55 62.19 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 123.196 2.597 . . . . 0.0 118.343 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -125.36 157.04 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.85 0.86 . . . . 0.0 109.905 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.262 . . 81.05 128.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.151 1.38 . . . . 0.0 111.569 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.99 153.44 33.8 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.374 1.991 . . . . 0.0 116.374 -169.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.77 134.62 54.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.69 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 113' ' ' MET . 42.3 t -90.92 91.93 8.55 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.988 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -79.66 121.12 24.9 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.049 0.928 . . . . 0.0 110.443 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -99.46 88.35 3.85 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.839 1.255 . . . . 0.0 109.053 -170.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.0 t -84.14 126.25 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -166.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -115.33 118.21 32.62 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.56 108.83 12.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -81.69 -70.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -145.28 135.65 24.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -167.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.87 95.57 5.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.512 0.673 . . . . 0.0 109.301 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.53 158.14 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 124.013 0.925 . . . . 0.0 109.785 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.04 -177.7 3.01 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.15 120.2 5.22 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-O 116.906 -2.052 . . . . 0.0 113.502 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.46 148.63 26.61 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 CA-C-N 122.589 3.194 . . . . 0.0 114.244 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.35 -30.95 66.77 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 118.47 2.767 . . . . 0.0 118.47 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.98 121.83 25.97 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.268 0.94 . . . . 0.0 109.832 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 123.209 1.48 . . . . 0.0 111.093 179.598 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.267 80.9 mtp180 57.76 37.57 27.19 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.43 -17.84 60.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -109.79 136.43 49.13 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.158 0.983 . . . . 0.0 109.774 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 tp -145.64 113.44 6.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.98 161.37 27.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.9 mm -90.16 -67.74 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.427 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.255 2.4 pt? -70.28 -52.96 19.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -171.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.77 56.64 0.05 OUTLIER Glycine 0 N--CA 1.483 1.824 0 C-N-CA 123.73 0.681 . . . . 0.0 113.232 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -150.51 -55.84 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.973 0.909 . . . . 0.0 110.706 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.32 57.77 0.38 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 124.24 0.924 . . . . 0.0 111.693 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.7 mt -141.18 -59.75 0.49 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.081 0.953 . . . . 0.0 108.896 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.9 tp -92.07 89.13 6.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.222 0.919 . . . . 0.0 108.553 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -101.13 96.93 7.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.565 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HZ3' ' CD ' ' A' ' 110' ' ' GLU . 13.8 tmtt? -91.77 99.72 12.55 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.61 0.764 . . . . 0.0 112.185 -175.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -86.37 127.34 34.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.474 -0.766 . . . . 0.0 109.806 164.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.2 m -87.47 112.89 22.67 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.67 -68.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.82 0.848 . . . . 0.0 110.242 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.03 117.88 66.04 Favored Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.89 167.58 16.29 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.956 2.438 . . . . 0.0 114.937 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.45 170.47 50.58 Favored Glycine 0 CA--C 1.564 3.109 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 170.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.38 169.19 17.56 Favored 'Trans proline' 0 CA--C 1.575 2.549 0 C-N-CA 122.972 2.448 . . . . 0.0 115.844 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.86 113.42 3.22 Favored 'Trans proline' 0 CA--C 1.558 1.723 0 C-N-CA 123.039 2.493 . . . . 0.0 112.326 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.35 -86.1 0.44 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -164.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.285 81.7 p 63.05 113.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.6 m -92.22 135.93 33.6 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.135 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 143.06 26.01 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.04 145.96 22.55 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.525 2.15 . . . . 0.0 115.764 -162.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.47 HG21 ' H ' ' A' ' 62' ' ' LYS . 8.3 p -95.71 -179.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 124.578 1.151 . . . . 0.0 111.759 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' H ' HG21 ' A' ' 61' ' ' VAL . 25.6 tttm -63.66 119.95 10.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.73 47.05 2.0 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.88 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.45 124.83 26.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 HG21 ' HG1' ' A' ' 89' ' ' THR . 57.5 t -84.54 99.87 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -103.72 126.54 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.747 0.819 . . . . 0.0 109.17 -171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -100.86 113.4 26.31 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.69 140.76 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.821 0.848 . . . . 0.0 109.014 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -92.56 100.52 13.03 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.68 106.31 17.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.78 99.82 11.39 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -78.22 119.26 21.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -132.24 145.73 51.52 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.753 0.787 . . . . 0.0 109.945 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.96 148.78 48.49 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.704 172.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -55.15 -31.34 61.25 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -63.6 -68.04 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.97 0.805 . . . . 0.0 111.682 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.02 77.04 0.02 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -147.57 117.9 7.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -74.1 95.74 2.6 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 122.624 1.202 . . . . 0.0 112.903 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.04 -45.39 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -125.11 150.27 47.02 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.313 1.054 . . . . 0.0 109.822 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -147.35 79.26 1.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.566 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.89 98.43 5.39 Favored Pre-proline 0 CA--C 1.579 2.069 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.28 -43.92 1.98 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.176 2.584 . . . . 0.0 115.865 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.9 77.27 8.53 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.312 1.053 . . . . 0.0 110.067 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.0 tp -100.33 98.01 8.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.92 135.56 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -158.56 142.24 15.26 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.459 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.475 ' HG1' HG21 ' A' ' 65' ' ' VAL . 6.7 m -80.24 133.3 35.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.46 138.6 57.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.967 0.507 . . . . 0.0 111.97 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.2 -66.01 0.25 Allowed Glycine 0 N--CA 1.478 1.484 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.65 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 104.48 5.68 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.312 0.577 . . . . 0.0 110.037 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.82 82.84 6.18 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.797 0.808 . . . . 0.0 112.803 -161.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.89 -50.8 14.0 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.122 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.64 161.05 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.1 pt -54.59 151.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 124.829 1.252 . . . . 0.0 114.222 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -65.41 -17.12 64.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -36.98 85.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.98 -71.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.378 -1.296 . . . . 0.0 111.641 159.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.74 -44.34 27.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 -168.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.26 -50.18 72.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -75.49 -12.0 60.15 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.272 5.7 t -67.79 -46.48 44.5 Favored Pre-proline 0 N--CA 1.497 1.923 0 CA-C-O 115.214 -2.327 . . . . 0.0 114.023 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.22 35.14 0.38 Allowed 'Trans proline' 0 CA--C 1.579 2.74 0 CA-C-N 125.415 2.969 . . . . 0.0 116.672 165.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.3 mt -138.89 -38.75 0.5 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 126.525 1.93 . . . . 0.0 110.495 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 42.3 mtt -63.65 123.82 19.82 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.814 1.246 . . . . 0.0 112.768 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.67 159.96 23.83 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.661 1.22 . . . . 0.0 112.836 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.57 105.15 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.6 62.42 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.685 -1.064 . . . . 0.0 114.296 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' CD ' ' HZ3' ' A' ' 47' ' ' LYS . 3.3 pt-20 -140.27 129.04 23.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.477 1.138 . . . . 0.0 112.194 171.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.9 m -85.62 130.14 34.65 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.98 127.75 14.34 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.643 0.259 . . . . 0.0 111.284 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.4 tpp -84.06 108.92 17.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.02 106.58 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 66.0 p -94.69 93.51 7.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.42 18.06 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -74.46 153.9 38.96 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.688 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.3 t -75.12 83.82 2.33 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.782 1.277 . . . . 0.0 110.623 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -178.02 -61.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.047 -155.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -77.69 -53.2 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.582 1.153 . . . . 0.0 111.793 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m -81.76 107.75 14.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.86 0.864 . . . . 0.0 110.243 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.305 23.8 m-85 70.12 -0.04 2.94 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.27 -179.91 48.24 Favored Glycine 0 CA--C 1.559 2.823 0 CA-C-N 120.26 1.391 . . . . 0.0 115.649 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.95 -46.05 9.24 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.286 2.657 . . . . 0.0 116.325 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -95.43 102.52 14.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.71 -152.9 11.75 Favored Glycine 0 CA--C 1.548 2.11 0 N-CA-C 116.713 1.445 . . . . 0.0 116.713 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -82.75 66.11 8.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 124.114 0.966 . . . . 0.0 112.182 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.5 p -80.21 146.97 63.79 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.384 -175.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.1 -11.98 29.93 Favored 'Cis proline' 0 CA--C 1.565 2.073 0 N-CA-C 119.637 2.899 . . . . 0.0 119.637 7.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -60.55 -58.02 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -96.5 105.03 20.0 Favored Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.29 160.8 48.3 Favored 'Trans proline' 0 CA--C 1.573 2.432 0 C-N-CA 122.711 2.274 . . . . 0.0 113.986 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.98 112.61 2.76 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 123.031 2.488 . . . . 0.0 112.965 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 88.6 m-70 72.92 86.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.71 1.204 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.88 121.74 4.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.65 122.98 25.44 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.015 0.526 . . . . 0.0 111.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 mt -97.84 139.95 32.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.696 0.76 . . . . 0.0 111.92 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -102.2 90.74 4.02 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.832 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.86 118.81 37.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.706 0.802 . . . . 0.0 110.227 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.5 107.43 19.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.041 0.924 . . . . 0.0 110.901 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.23 111.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -108.98 117.11 33.35 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.07 108.81 10.41 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.45 -59.72 2.14 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.254 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 76.1 p -132.93 139.3 47.27 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.654 0.781 . . . . 0.0 109.114 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.67 112.75 17.13 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -128.46 132.16 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.49 119.44 23.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.125 0.488 . . . . 0.0 111.619 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -166.88 172.45 42.02 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.4 162.61 25.05 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.151 2.567 . . . . 0.0 114.594 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.39 -57.58 11.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp 74.78 117.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.262 1.425 . . . . 0.0 113.587 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.496 1.842 0 C-N-CA 124.622 1.169 . . . . 0.0 113.883 170.661 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -151.73 116.28 5.09 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.117 0.567 . . . . 0.0 110.894 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -136.95 89.97 2.49 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.75 0.786 . . . . 0.0 109.065 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 m0 67.91 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.425 1.49 . . . . 0.0 112.928 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.25 0.0 OUTLIER -80.22 128.23 33.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -109.73 148.35 31.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.132 0.973 . . . . 0.0 113.589 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.53 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 tp -166.07 -70.73 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.29 -75.01 0.27 Allowed Glycine 0 CA--C 1.54 1.594 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -164.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.6 -84.75 0.08 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.464 0.706 . . . . 0.0 110.694 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.21 84.53 0.05 OUTLIER Glycine 0 N--CA 1.476 1.363 0 CA-C-N 118.825 0.739 . . . . 0.0 111.68 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.08 -58.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.803 0.841 . . . . 0.0 109.61 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.5 96.0 7.89 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.142 0.883 . . . . 0.0 108.895 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -118.1 90.04 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.075 0.95 . . . . 0.0 109.071 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.263 17.1 ptmt -83.49 123.8 30.08 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.78 138.35 32.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 161.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 m -98.62 109.06 21.88 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.52 -77.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.92 125.44 34.56 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.78 -168.49 0.59 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 123.54 2.827 . . . . 0.0 113.312 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.62 Favored Glycine 0 CA--C 1.563 3.089 0 CA-C-O 118.959 -0.911 . . . . 0.0 115.103 163.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.35 167.28 22.71 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 C-N-CA 123.085 2.523 . . . . 0.0 114.931 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.8 109.6 1.5 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.125 2.55 . . . . 0.0 111.854 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.07 81.56 1.49 Allowed Glycine 0 CA--C 1.543 1.782 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.992 -157.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.2 p -141.05 116.05 9.82 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 144.53 31.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.462 0.705 . . . . 0.0 112.053 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -93.27 111.81 53.59 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.384 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.4 169.31 22.01 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 123.196 2.597 . . . . 0.0 115.938 -165.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.6 160.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 123.808 0.843 . . . . 0.0 112.429 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -69.5 110.37 4.73 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 122.938 0.495 . . . . 0.0 109.995 162.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.51 -60.36 0.64 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.887 -157.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.87 119.84 17.67 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.233 0.613 . . . . 0.0 110.874 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.01 112.53 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.83 139.51 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.295 0.569 . . . . 0.0 110.985 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -101.52 131.41 47.69 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.9 138.92 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.032 0.533 . . . . 0.0 111.345 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.72 98.7 9.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.55 127.74 33.63 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 164.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -116.5 87.36 2.67 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.4 ' HG1' ' HB3' ' A' ' 139' ' ' LEU . 23.0 m -85.75 116.44 24.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -170.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.7 m -138.61 33.62 2.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.258 10.3 mt 55.59 167.05 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.91 -43.91 97.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.35 -60.72 2.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.99 73.94 0.03 OUTLIER Glycine 0 CA--C 1.543 1.783 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -174.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 m -152.87 117.03 4.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -76.58 111.01 11.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -83.69 -63.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 124.034 0.934 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -146.94 103.13 3.59 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -91.96 90.34 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.706 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -100.08 107.12 45.51 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.892 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.0 -49.84 0.12 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.277 2.652 . . . . 0.0 117.041 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -107.56 84.16 1.92 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.371 0.669 . . . . 0.0 110.316 -175.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.9 tp -103.09 92.19 4.43 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.79 128.71 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -157.9 149.09 21.25 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.213 0.605 . . . . 0.0 111.057 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -73.28 126.82 30.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.2 tp -59.67 117.0 4.43 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -159.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.61 40.27 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.08 178.51 6.97 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.726 1.251 . . . . 0.0 111.483 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 77.4 m -78.19 68.11 4.15 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -167.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.89 -54.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.676 1.59 . . . . 0.0 109.278 172.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.09 164.65 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 122.545 1.164 . . . . 0.0 112.917 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.9 pt -62.69 154.77 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.824 1.25 . . . . 0.0 113.276 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.39 -32.53 71.4 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.2 74.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 168.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.34 -50.97 63.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 169.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -51.66 -45.83 63.55 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.26 -36.36 79.31 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -72.65 -19.07 61.5 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.27 2.1 t -52.35 -51.33 73.41 Favored Pre-proline 0 CA--C 1.578 2.044 0 CA-C-O 115.125 -2.369 . . . . 0.0 116.627 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.08 -41.84 68.95 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 125.216 2.898 . . . . 0.0 118.066 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -89.81 16.24 8.4 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.9 mtm -81.47 102.45 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 121.023 1.738 . . . . 0.0 110.314 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.96 152.8 35.12 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.044 0.926 . . . . 0.0 111.814 167.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -67.04 111.36 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.5 12.68 55.62 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 116.69 17.03 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.709 2.755 . . . . 0.0 112.519 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.0 m -100.23 102.78 14.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 125.19 22.88 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 -166.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.6 tpp -68.14 102.6 1.37 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.773 0.829 . . . . 0.0 111.698 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.72 96.16 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.5 t -114.65 116.08 28.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.538 0.735 . . . . 0.0 109.045 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.33 155.35 21.29 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.509 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -58.19 152.8 16.29 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.235 150.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.573 ' HG ' ' HA ' ' A' ' 134' ' ' HIS . 78.6 p -70.04 77.23 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.326 1.06 . . . . 0.0 112.493 171.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -52.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.638 -165.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.27 -51.38 8.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.063 1.345 . . . . 0.0 111.328 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -64.01 -62.9 1.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -133.31 -58.32 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.52 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.66 179.05 47.89 Favored Glycine 0 CA--C 1.558 2.721 0 CA-C-N 119.319 0.963 . . . . 0.0 114.955 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.45 100.97 0.82 Allowed 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 123.138 2.559 . . . . 0.0 112.57 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -158.08 -71.26 0.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.621 -165.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.94 83.74 1.08 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 118.601 0.637 . . . . 0.0 112.13 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -89.95 152.48 21.2 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-O 121.919 0.866 . . . . 0.0 111.696 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -75.36 140.67 72.73 Favored Pre-proline 0 CA--C 1.571 1.761 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.892 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.54 -58.68 0.07 OUTLIER 'Cis proline' 0 CA--C 1.563 1.935 0 CA-C-N 122.85 2.053 . . . . 0.0 116.156 10.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -137.44 67.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mt -103.49 114.08 65.14 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.21 137.93 24.37 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.403 2.068 . . . . 0.0 114.694 -166.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.58 -45.88 8.14 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 123.207 2.605 . . . . 0.0 116.343 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.573 ' HA ' ' HG ' ' A' ' 118' ' ' SER . 17.3 p80 -128.22 85.78 2.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.697 0.799 . . . . 0.0 109.85 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.77 125.19 3.15 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.66 101.66 5.84 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.067 0.547 . . . . 0.0 111.392 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -103.3 143.92 32.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.2 m -92.89 136.21 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.637 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 1.6 pt? -149.83 106.92 3.58 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.067 0.547 . . . . 0.0 110.478 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -87.31 117.63 26.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.486 1.136 . . . . 0.0 113.806 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.78 114.99 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -169.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -96.26 121.9 38.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.26 104.8 11.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 85' ' ' GLU . 34.1 mtpt -81.4 -63.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 -171.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 58.5 p -144.25 132.24 21.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.21 103.63 15.59 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 168.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.53 123.24 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -171.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.75 124.4 28.16 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 112.464 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.96 164.5 35.28 Favored Glycine 0 CA--C 1.559 2.796 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.173 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.54 115.98 4.53 Favored 'Trans proline' 0 CA--C 1.559 1.733 0 C-N-CA 123.071 2.514 . . . . 0.0 113.173 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.64 119.4 24.71 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.455 0.702 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.0 tp -137.8 -77.42 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.184 0.594 . . . . 0.0 109.693 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.95 0.881 . . . . 0.0 109.569 -174.794 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -113.2 107.97 16.64 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 168.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.64 167.38 13.21 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -55.08 121.26 8.36 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -167.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 tp -175.01 154.43 1.82 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.037 -159.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.6 t0 68.78 119.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 149.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 mm -118.02 -54.66 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.072 0.949 . . . . 0.0 109.23 167.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.14 -63.77 1.11 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.48 -61.7 0.01 OUTLIER Glycine 0 N--CA 1.483 1.809 0 CA-C-N 119.448 1.022 . . . . 0.0 115.259 -171.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -90.23 -78.58 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 117.734 0.767 . . . . 0.0 110.777 -172.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 177.0 72.24 0.06 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 mt -122.11 -66.32 1.04 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -163.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -80.06 98.54 7.29 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.19 96.46 7.49 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.946 0.498 . . . . 0.0 110.017 -164.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -105.47 132.93 51.02 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -113.36 145.61 40.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.806 -0.559 . . . . 0.0 110.249 152.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.9 m -88.74 108.45 19.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.29 -67.96 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.586 0.755 . . . . 0.0 111.45 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.05 122.29 62.14 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 167.83 19.41 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 114.586 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.66 123.42 6.68 Favored Glycine 0 CA--C 1.556 2.643 0 CA-C-O 117.049 -1.973 . . . . 0.0 113.351 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.45 167.92 22.64 Favored 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 122.53 3.165 . . . . 0.0 115.607 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.05 112.96 3.1 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.105 2.537 . . . . 0.0 111.869 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 76.81 1.34 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.473 -160.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 t -159.4 108.45 1.85 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 m -128.71 118.29 22.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.41 1.1 . . . . 0.0 110.368 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -64.13 132.94 95.45 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.86 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 164.09 35.25 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.91 2.407 . . . . 0.0 116.31 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.9 t -82.24 150.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.947 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -59.09 104.12 0.22 Allowed 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.971 1.308 . . . . 0.0 113.31 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.29 62.54 0.34 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.032 -165.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -155.44 138.66 15.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.48 106.89 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.329 -0.857 . . . . 0.0 109.671 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.16 118.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 124.128 0.971 . . . . 0.0 108.765 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.5 m -100.31 124.2 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.57 137.29 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.208 0.528 . . . . 0.0 110.459 -173.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -88.71 106.98 18.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 165.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -103.52 121.67 43.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.161 0.585 . . . . 0.0 110.094 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -103.44 99.17 8.99 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -93.64 99.44 11.87 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.037 0.535 . . . . 0.0 110.7 -165.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -104.57 -169.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.3 0.64 . . . . 0.0 111.359 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 tp -114.88 147.82 39.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.705 1.202 . . . . 0.0 109.513 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.322 4.2 pt-20 -60.44 -29.99 69.37 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 117.527 2.418 . . . . 0.0 117.527 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -64.64 -68.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.896 161.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.08 0.05 OUTLIER Glycine 0 N--CA 1.482 1.756 0 CA-C-N 119.53 1.059 . . . . 0.0 113.107 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.3 m -153.33 122.58 6.6 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -76.52 97.15 4.26 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.041 0.924 . . . . 0.0 111.301 171.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -84.99 -47.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.138 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -125.04 156.78 37.64 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.842 1.306 . . . . 0.0 110.503 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.86 93.0 2.87 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 161.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -85.24 116.7 66.61 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.622 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.86 -49.46 0.15 Allowed 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.938 2.426 . . . . 0.0 116.56 -168.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -137.84 93.66 2.8 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.134 0.879 . . . . 0.0 109.423 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 tp -85.4 104.42 15.19 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.74 96.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -125.42 147.57 49.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.598 0.759 . . . . 0.0 109.32 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.0 m -100.38 66.51 1.28 Allowed 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 123.012 0.525 . . . . 0.0 110.019 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . 0.401 7.6 mp 61.17 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.25 -94.4 0.18 Allowed Glycine 0 N--CA 1.483 1.816 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.448 165.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 68.1 150.11 0.07 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.2 t -82.26 72.73 9.32 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.58 1.181 . . . . 0.0 113.445 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.74 -61.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.251 1.42 . . . . 0.0 108.982 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.6 152.98 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.829 1.3 . . . . 0.0 113.147 -151.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.1 pt -68.94 165.7 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.876 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -57.97 -34.65 70.17 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 171.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.21 86.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.15 -45.77 62.84 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -66.79 -32.36 73.6 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.11 -15.09 57.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.3 p -71.05 -36.39 72.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.233 1.833 . . . . 0.0 115.37 164.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.0 -53.33 39.21 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 115.897 -2.001 . . . . 0.0 115.027 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.44 -15.0 42.54 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 123.644 2.896 . . . . 0.0 119.104 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.33 48.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 120.341 1.428 . . . . 0.0 112.869 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.8 mtp -143.12 100.15 3.58 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.38 176.05 8.09 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.244 1.021 . . . . 0.0 110.829 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.84 105.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.798 -1.189 . . . . 0.0 109.874 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.14 61.16 0.86 Allowed Glycine 0 CA--C 1.546 1.978 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.737 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -140.49 122.19 15.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.656 0.782 . . . . 0.0 110.08 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.1 m -94.6 136.24 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 160.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.08 113.73 9.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 53.3 ttm -84.84 115.01 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.88 128.14 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.0 p -94.64 87.53 5.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.09 19.16 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.222 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.85 144.74 8.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.6 p -54.87 -19.28 6.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -59.24 -51.3 70.55 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 161.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -77.89 -48.84 15.45 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.83 1.252 . . . . 0.0 113.511 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.46 174.56 7.48 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.092 1.357 . . . . 0.0 112.94 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -73.69 100.89 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.593 0.757 . . . . 0.0 110.711 166.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.93 -87.78 1.96 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 116.147 -2.474 . . . . 0.0 108.317 163.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.54 52.61 4.15 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 122.675 3.237 . . . . 0.0 114.722 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -132.41 -77.81 0.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.55 112.1 2.02 Favored Glycine 0 N--CA 1.48 1.617 0 CA-C-N 119.685 1.13 . . . . 0.0 113.507 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -104.08 127.49 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 157.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 145.64 89.84 Favored Pre-proline 0 CA--C 1.571 1.767 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -91.23 -64.99 0.03 OUTLIER 'Cis proline' 0 CA--C 1.565 2.047 0 CA-C-N 122.689 1.996 . . . . 0.0 116.701 8.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -115.48 43.95 1.95 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -165.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.2 mt -80.31 118.21 71.35 Favored Pre-proline 0 CA--C 1.58 2.121 0 O-C-N 120.643 -1.286 . . . . 0.0 108.113 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.28 160.65 26.11 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 122.933 2.422 . . . . 0.0 116.242 -166.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.1 136.23 24.29 Favored 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 123.292 2.662 . . . . 0.0 114.251 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.285 97.1 m-70 73.65 162.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.688 1.195 . . . . 0.0 113.828 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 77.24 148.07 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.075 1.35 . . . . 0.0 113.436 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.53 148.02 47.14 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.4 mt -100.65 123.38 44.78 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.017 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.5 84.48 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.335 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.65 120.86 43.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.389 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.69 147.81 50.08 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.343 160.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 t -134.21 100.12 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -95.69 123.3 39.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.31 104.62 13.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -88.61 -56.81 3.15 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.781 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.1 p -140.15 134.69 31.58 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.381 0.673 . . . . 0.0 109.558 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.82 105.3 12.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.5 m -136.5 131.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.422 0.689 . . . . 0.0 109.249 -166.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.88 118.6 30.88 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.046 0.538 . . . . 0.0 110.297 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.38 82.49 0.08 OUTLIER Glycine 0 CA--C 1.547 2.087 0 CA-C-O 117.091 -1.95 . . . . 0.0 111.88 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.22 103.02 0.79 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 CA-C-N 121.796 2.798 . . . . 0.0 112.336 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -81.52 124.39 29.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.576 . . . . 0.0 111.414 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.378 6.0 mp 79.37 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.844 1.258 . . . . 0.0 110.297 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -128.61 -74.51 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.282 0.633 . . . . 0.0 109.92 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.26 7.5 tp10 55.9 84.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 m95 73.36 99.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.901 1.281 . . . . 0.0 110.111 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -83.86 114.07 21.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.76 101.33 6.64 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.866 0.841 . . . . 0.0 111.066 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.46 -51.89 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 123.982 0.913 . . . . 0.0 111.407 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -66.11 -63.96 0.97 Allowed 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.24 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.479 1.561 0 CA-C-N 118.96 0.8 . . . . 0.0 112.102 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.37 -66.22 0.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.178 0.591 . . . . 0.0 112.539 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.7 70.15 0.04 OUTLIER Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.401 0.546 . . . . 0.0 112.601 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -124.71 -70.32 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -81.91 120.18 24.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 118.822 0.737 . . . . 0.0 109.762 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.17 152.37 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.322 1.049 . . . . 0.0 111.443 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.37 117.74 14.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 0.0 112.504 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.83 121.14 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.993 . . . . 0.0 108.776 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -86.85 115.79 24.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.77 -65.56 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.777 0.831 . . . . 0.0 110.638 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -116.37 140.44 26.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 119.12 0.873 . . . . 0.0 109.27 165.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.98 171.73 16.73 Favored 'Trans proline' 0 CA--C 1.563 1.958 0 C-N-CA 123.072 2.515 . . . . 0.0 114.443 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.3 103.41 3.04 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-O 116.787 -2.118 . . . . 0.0 109.835 164.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 163.48 35.42 Favored 'Trans proline' 0 CA--C 1.571 2.355 0 CA-C-N 122.734 3.267 . . . . 0.0 116.252 -164.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.41 127.27 15.42 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.273 2.649 . . . . 0.0 113.156 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 -71.36 0.39 Allowed Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -159.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.1 p -75.24 102.46 5.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.402 0.681 . . . . 0.0 111.183 168.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -113.09 147.46 37.25 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.969 0.89 . . . . 0.0 111.287 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -60.34 128.6 88.06 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.56 160.14 47.29 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.041 2.494 . . . . 0.0 115.022 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.4 m -85.23 166.43 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.451 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -53.2 131.13 36.54 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.66 46.76 2.06 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 114.123 -1.398 . . . . 0.0 114.716 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.58 136.23 32.6 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.82 100.74 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 m -92.47 110.02 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -92.47 112.55 24.54 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.36 142.08 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.69 0.757 . . . . 0.0 110.44 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.05 107.26 11.68 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 162.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.45 107.19 17.95 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -103.61 111.89 24.57 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.98 117.44 28.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 t -133.98 152.66 51.94 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.064 0.935 . . . . 0.0 110.048 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.62 139.79 49.47 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.563 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.83 -37.95 77.58 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.99 -53.05 56.12 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 167.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.743 1.156 . . . . 0.0 114.881 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -63.87 137.75 58.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -160.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -61.56 117.01 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.28 35.6 m -81.59 -47.71 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.672 176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -145.23 119.79 9.74 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 165.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -106.96 83.6 1.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.542 0.686 . . . . 0.0 110.105 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.57 101.84 51.92 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.651 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.64 50.27 3.5 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.644 2.23 . . . . 0.0 115.905 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' CD ' ' HZ2' ' A' ' 144' ' ' LYS . 5.4 tp10 -161.51 117.05 2.08 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.809 0.844 . . . . 0.0 109.281 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.49 103.91 3.17 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.54 114.26 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.6 142.11 32.08 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -78.46 121.26 24.32 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.29 133.59 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.32 0.509 . . . . 0.0 112.31 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.37 -70.34 0.74 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.925 -167.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -90.71 77.95 6.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.77 0.795 . . . . 0.0 110.215 172.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.36 126.64 53.02 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.628 -163.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -97.72 70.29 2.19 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.477 1.132 . . . . 0.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.03 177.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.411 1.1 . . . . 0.0 110.331 -163.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.59 150.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.833 0.853 . . . . 0.0 112.441 170.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.35 -29.76 71.01 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.09 81.87 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.93 -54.62 35.78 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.436 -1.269 . . . . 0.0 113.96 167.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -53.31 -49.0 67.93 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.6 p -79.3 -8.85 59.37 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 117.684 2.476 . . . . 0.0 117.684 168.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.263 12.8 t -52.44 -48.79 88.67 Favored Pre-proline 0 N--CA 1.501 2.094 0 CA-C-O 115.264 -2.303 . . . . 0.0 114.449 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.74 0.59 1.44 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 CA-C-N 125.114 2.862 . . . . 0.0 119.314 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.253 2.0 pt? -149.21 65.81 1.02 Allowed 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.079 1.309 . . . . 0.0 111.581 167.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.2 mmt -138.35 99.96 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.39 164.04 12.81 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.146 0.974 . . . . 0.0 113.101 -168.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.27 114.73 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.63 -6.78 45.23 Favored Glycine 0 CA--C 1.552 2.381 0 N-CA-C 117.905 1.922 . . . . 0.0 117.905 -167.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.41 126.27 33.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 121.132 2.466 . . . . 0.0 113.396 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.9 m -100.45 127.98 46.64 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 158.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.94 124.08 6.3 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.577 0.351 . . . . 0.0 110.165 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.9 ptm -77.8 131.94 37.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.124 0.57 . . . . 0.0 110.791 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.8 t -113.23 96.2 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.3 p -85.65 102.21 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.2 138.7 54.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.106 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.61 153.24 0.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.9 p -70.67 76.51 0.6 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.921 1.344 . . . . 0.0 112.153 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -179.03 -61.54 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.867 -152.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.17 -50.71 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.443 1.097 . . . . 0.0 112.674 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.24 -68.33 0.4 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -138.82 -66.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.798 0.726 . . . . 0.0 109.31 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.4 -147.93 19.78 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.391 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -72.72 112.71 3.55 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.253 51.3 mt-30 69.37 92.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.891 1.276 . . . . 0.0 110.271 -164.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.81 54.8 Favored Glycine 0 CA--C 1.547 2.049 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -101.39 60.09 0.9 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -163.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 40.7 m 66.95 141.78 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 167.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.45 -45.85 0.4 Allowed 'Cis proline' 0 CA--C 1.564 1.992 0 CA-C-N 122.627 1.974 . . . . 0.0 115.705 -3.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -134.42 63.26 1.63 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.703 0.801 . . . . 0.0 110.489 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.1 mt -91.32 121.35 67.72 Favored Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.47 162.4 35.98 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.918 2.412 . . . . 0.0 116.303 -170.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.85 -46.3 6.78 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 123.215 2.61 . . . . 0.0 116.598 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -97.39 -166.73 1.43 Allowed 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 124.498 1.119 . . . . 0.0 111.689 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.28 128.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.248 1.419 . . . . 0.0 113.106 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.25 101.91 12.91 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.137 0.575 . . . . 0.0 110.921 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.87 143.11 44.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -164.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.7 m -84.7 115.5 22.71 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.002 0.921 . . . . 0.0 110.706 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.19 98.86 6.37 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -82.94 107.36 15.49 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.238 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.7 93.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.4 m -99.99 112.42 24.71 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.53 102.91 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HZ2' ' CD ' ' A' ' 85' ' ' GLU . 42.0 mtmt -73.86 -65.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.155 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.0 p -144.72 130.61 19.25 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.37 103.35 15.28 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.11 153.27 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.543 0.737 . . . . 0.0 110.13 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.39 145.73 55.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.72 90.0 0.43 Allowed Glycine 0 CA--C 1.548 2.097 0 CA-C-O 117.178 -1.901 . . . . 0.0 111.981 -174.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.31 160.25 17.49 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 121.657 2.729 . . . . 0.0 114.389 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.04 125.06 25.67 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.589 0.756 . . . . 0.0 112.712 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -90.69 101.84 14.58 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.384 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 N--CA 1.495 1.803 0 C-N-CA 124.622 1.169 . . . . 0.0 113.873 176.53 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.1 ttm . . . . . 0 CA--C 1.556 1.177 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -99.56 104.11 15.89 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.801 0.728 . . . . 0.0 110.532 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.89 148.93 45.62 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -76.76 128.42 34.61 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.515 0.726 . . . . 0.0 109.809 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.89 114.2 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.332 0.653 . . . . 0.0 110.692 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.69 127.13 44.52 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.084 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.37 74.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.281 0.632 . . . . 0.0 109.679 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -157.58 -72.75 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.66 0.784 . . . . 0.0 109.018 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.77 -83.34 0.11 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -164.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.55 -70.26 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.239 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.52 85.02 0.05 OUTLIER Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.966 0.803 . . . . 0.0 112.971 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.55 -59.34 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -74.17 114.26 12.3 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.15 0.886 . . . . 0.0 110.489 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -143.46 105.54 4.38 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.716 0.807 . . . . 0.0 109.782 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -101.93 101.42 11.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 112.316 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.26 120.0 23.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.852 -1.155 . . . . 0.0 109.515 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.4 m -78.9 115.66 18.73 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.358 0.599 . . . . 0.0 110.141 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.03 -69.0 0.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.733 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.48 106.82 52.03 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.45 175.14 11.67 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 122.651 2.234 . . . . 0.0 114.655 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.94 123.46 24.14 Favored Glycine 0 CA--C 1.558 2.74 0 CA-C-O 117.133 -1.926 . . . . 0.0 112.466 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.4 161.19 44.33 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 CA-C-N 122.321 3.06 . . . . 0.0 115.29 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 106.74 1.22 Allowed 'Trans proline' 0 CA--C 1.558 1.722 0 C-N-CA 123.181 2.588 . . . . 0.0 112.171 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.72 76.29 1.32 Allowed Glycine 0 CA--C 1.545 1.95 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.591 -159.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -147.96 117.24 6.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -79.71 142.37 35.53 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.056 0.542 . . . . 0.0 112.261 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -91.4 116.3 66.16 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.186 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.93 144.86 31.0 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.703 2.269 . . . . 0.0 114.665 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.18 169.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.196 0.999 . . . . 0.0 112.645 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -64.54 120.32 12.12 Favored 'General case' 0 CA--C 1.568 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 112.084 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.0 40.67 3.72 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -138.26 115.55 11.09 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -72.26 109.46 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 123.285 0.634 . . . . 0.0 110.099 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.5 123.98 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.616 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.7 m -102.61 121.32 42.16 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.94 142.46 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.389 0.675 . . . . 0.0 110.783 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -82.72 104.59 13.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 161.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.35 125.43 47.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -133.3 122.15 23.45 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.489 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.8 p -93.0 131.37 38.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.08 0.952 . . . . 0.0 111.558 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.9 m -155.57 131.5 9.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.579 0.751 . . . . 0.0 109.708 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.03 157.28 19.15 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -52.7 -40.56 63.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -73.36 -64.73 0.92 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.537 0.735 . . . . 0.0 111.142 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.35 0.05 OUTLIER Glycine 0 N--CA 1.478 1.466 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.2 m -146.15 120.82 9.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -80.14 119.4 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.864 0.866 . . . . 0.0 111.974 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.0 t -97.41 -69.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.585 -166.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -143.83 122.11 12.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -167.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -85.52 94.68 9.08 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.456 0.702 . . . . 0.0 110.591 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.12 68.32 46.58 Favored Pre-proline 0 CA--C 1.579 2.068 0 O-C-N 121.384 -0.823 . . . . 0.0 113.163 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 -39.65 3.05 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.355 2.703 . . . . 0.0 117.58 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 76.73 1.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.575 1.079 . . . . 0.0 110.391 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.18 95.96 7.44 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.5 t -101.89 114.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.27 152.51 40.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 111.323 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -75.29 128.32 35.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.94 124.89 21.6 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.032 0.933 . . . . 0.0 111.979 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.64 -41.24 3.06 Favored Glycine 0 CA--C 1.547 2.079 0 N-CA-C 117.505 1.762 . . . . 0.0 117.505 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.91 107.77 18.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.012 1.406 . . . . 0.0 109.562 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -85.98 81.42 8.51 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -150.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.98 -47.37 52.58 Favored 'General case' 0 CA--C 1.574 1.899 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.105 156.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.08 179.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.602 1.161 . . . . 0.0 114.108 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.01 152.09 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.648 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -64.19 -33.46 75.84 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.31 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 167.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -53.09 38.64 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.23 -42.63 86.71 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.86 -34.31 77.66 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -72.82 -22.99 60.72 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.2 t -57.38 -49.94 90.99 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 114.871 -2.49 . . . . 0.0 115.996 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -53.28 -34.58 70.71 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 126.12 3.221 . . . . 0.0 118.424 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -101.01 63.74 1.02 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.598 0.759 . . . . 0.0 111.579 168.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.28 113.32 6.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -97.02 168.12 10.65 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.878 0.847 . . . . 0.0 111.915 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.76 118.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.852 -1.155 . . . . 0.0 108.403 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.09 6.04 72.28 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.144 2.018 . . . . 0.0 118.144 -165.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.12 108.4 19.84 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 120.5 2.15 . . . . 0.0 109.625 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.592 HG21 ' HG1' ' A' ' 142' ' ' THR . 97.7 m -109.19 119.71 40.34 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.06 136.93 34.14 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.776 0.798 . . . . 0.0 111.075 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.9 ttm -84.0 103.14 13.0 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.062 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.95 92.6 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.9 p -81.41 126.55 31.77 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.282 0.633 . . . . 0.0 109.769 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.1 136.88 17.08 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.316 -175.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -46.02 133.33 8.96 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 124.785 1.234 . . . . 0.0 113.983 168.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.4 m -74.55 84.83 2.05 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.279 1.038 . . . . 0.0 110.983 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -179.55 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -142.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -68.62 -36.52 78.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 162.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.1 m -72.22 -75.12 0.14 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.17 0.895 . . . . 0.0 111.179 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.92 -67.71 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.263 0.938 . . . . 0.0 110.774 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.7 170.72 27.94 Favored Glycine 0 CA--C 1.553 2.45 0 CA-C-N 119.036 0.834 . . . . 0.0 115.088 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.22 10.03 0.35 Allowed 'Trans proline' 0 CA--C 1.571 2.348 0 N-CA-C 119.375 2.798 . . . . 0.0 119.375 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -131.53 -76.65 0.52 Allowed 'General case' 0 CA--C 1.561 1.376 0 CA-C-N 119.527 1.058 . . . . 0.0 108.258 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.56 124.08 1.11 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 119.69 1.132 . . . . 0.0 112.545 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -93.05 39.09 1.04 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.6 m 66.72 139.25 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.79 -50.46 0.17 OUTLIER 'Cis proline' 0 CA--C 1.563 1.964 0 CA-C-N 123.097 2.142 . . . . 0.0 115.896 4.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -132.4 71.76 1.48 Allowed 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.891 0.877 . . . . 0.0 108.855 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.6 mm -99.72 134.55 20.98 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.927 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.32 162.31 33.88 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.203 2.602 . . . . 0.0 116.215 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.77 -94.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 123.358 2.706 . . . . 0.0 113.094 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -136.51 80.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.109 1.322 . . . . 0.0 109.542 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.75 38.55 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 60.14 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tt -96.58 130.04 43.85 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.8 t -100.37 113.36 26.03 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.872 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.15 108.69 20.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.32 97.38 9.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.003 -0.436 . . . . 0.0 110.189 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.79 111.43 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -168.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.592 ' HG1' HG21 ' A' ' 111' ' ' THR . 89.1 m -113.79 113.28 24.72 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -173.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.04 103.51 9.97 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 120.942 0.401 . . . . 0.0 110.052 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -80.88 -64.46 1.18 Allowed 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -141.78 137.33 31.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.725 0.81 . . . . 0.0 109.008 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.56 107.95 18.65 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.11 125.43 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -81.39 91.04 6.21 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.203 1.001 . . . . 0.0 112.957 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.32 86.32 0.82 Allowed Glycine 0 CA--C 1.552 2.344 0 CA-C-O 116.876 -2.069 . . . . 0.0 113.851 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 130.86 8.29 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 122.224 3.012 . . . . 0.0 112.556 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.76 -77.33 0.12 Allowed 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -99.18 104.1 16.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.72 0.772 . . . . 0.0 109.333 178.876 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -81.73 -3.68 54.35 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -171.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 64.07 86.0 0.13 Allowed 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.607 2.003 . . . . 0.0 113.279 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -141.4 117.43 10.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -100.03 107.82 19.85 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.57 123.94 30.27 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.448 0.642 . . . . 0.0 111.676 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.44 -58.84 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.664 0.786 . . . . 0.0 110.735 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.258 3.7 pp -66.48 -17.63 64.91 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.45 55.86 4.49 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 119.948 1.249 . . . . 0.0 116.034 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -156.13 -81.18 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.33 59.62 0.03 OUTLIER Glycine 0 CA--C 1.541 1.689 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.172 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.76 -70.98 0.45 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.0 tp -88.29 102.81 15.2 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.495 1.043 . . . . 0.0 108.84 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.411 HH21 ' CD ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -115.0 117.58 31.01 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.363 0.665 . . . . 0.0 110.004 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -122.36 103.62 8.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 0.0 110.266 -168.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -81.02 141.22 34.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.461 -0.775 . . . . 0.0 109.729 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -81.65 96.48 7.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 159.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 tp -64.39 -63.08 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.824 1.25 . . . . 0.0 113.218 -170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.97 123.89 23.75 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 162.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.61 165.42 24.96 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 C-N-CA 123.117 2.545 . . . . 0.0 114.844 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.3 171.3 55.17 Favored Glycine 0 CA--C 1.562 2.98 0 N-CA-C 115.35 0.9 . . . . 0.0 115.35 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.41 162.72 39.42 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 123.257 2.638 . . . . 0.0 115.827 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.78 -42.2 48.08 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 123.423 2.749 . . . . 0.0 116.743 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.97 -176.21 50.58 Favored Glycine 0 CA--C 1.552 2.365 0 CA-C-N 119.04 0.836 . . . . 0.0 113.711 161.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m 62.36 86.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.376 1.071 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.0 p -98.71 153.67 18.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -165.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -45.13 128.39 5.65 Favored Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.38 165.88 28.48 Favored 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 122.948 2.432 . . . . 0.0 115.843 -173.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -102.63 159.06 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.444 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -63.77 132.79 52.03 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 113.588 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.34 14.28 9.92 Favored Glycine 0 CA--C 1.557 2.717 0 CA-C-N 113.82 -1.536 . . . . 0.0 115.564 -153.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -138.65 114.87 10.29 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.88 109.55 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.75 134.88 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.594 0.758 . . . . 0.0 110.737 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -92.71 127.98 38.41 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.2 126.15 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -71.55 107.0 4.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.879 0.872 . . . . 0.0 110.38 171.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.35 131.72 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.055 0.931 . . . . 0.0 108.975 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -137.66 91.8 2.63 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -87.2 123.76 32.57 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -132.63 179.24 6.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.144 0.978 . . . . 0.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.0 tp -94.37 149.27 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.099 -1.001 . . . . 0.0 110.074 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' CD ' HH21 ' A' ' 46' ' ' ARG . 24.3 tt0 -60.48 -20.87 61.48 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 173.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.04 -71.79 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.223 0.92 . . . . 0.0 110.494 161.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.28 81.75 0.04 OUTLIER Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.494 1.043 . . . . 0.0 112.917 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.3 m -152.9 114.32 4.24 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.298 19.8 ptp180 -78.08 105.54 9.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -81.14 -48.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -137.79 89.88 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.14 96.93 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.817 0.818 . . . . 0.0 110.192 168.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.14 89.72 17.94 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.88 2.59 6.4 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 N-CA-C 120.139 3.092 . . . . 0.0 120.139 -159.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.301 9.2 pt-20 -151.84 148.75 28.2 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.824 2.102 . . . . 0.0 113.214 154.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.7 tp -142.1 106.44 4.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -165.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.3 t -98.56 106.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -137.55 155.77 48.85 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.4 m -80.75 130.29 35.0 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.366 0.667 . . . . 0.0 109.659 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.61 119.23 10.1 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 62.25 3.49 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -152.52 144.46 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.148 0.979 . . . . 0.0 110.261 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.15 74.8 2.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -126.61 -59.44 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.093 1.357 . . . . 0.0 109.858 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.16 178.14 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.593 1.157 . . . . 0.0 113.074 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.54 137.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.757 0.823 . . . . 0.0 112.011 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -62.07 -29.23 70.16 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.11 84.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 165.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -53.48 57.33 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -66.31 -33.92 76.83 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.37 -34.92 79.04 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 165.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 p -79.82 2.01 24.72 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 167.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.262 2.5 t -53.08 -48.83 90.54 Favored Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 115.262 -2.304 . . . . 0.0 114.787 170.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.04 -18.33 22.48 Favored 'Trans proline' 0 CA--C 1.566 2.121 0 CA-C-N 125.38 2.957 . . . . 0.0 119.012 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.84 70.78 0.74 Allowed 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.295 0.952 . . . . 0.0 108.741 166.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.1 mmt -149.44 90.35 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.36 161.07 18.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.294 1.045 . . . . 0.0 111.994 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.83 104.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.706 . . . . 0.0 109.098 -165.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.75 29.78 Favored Glycine 0 CA--C 1.556 2.63 0 CA-C-O 117.002 -1.999 . . . . 0.0 117.952 -164.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.64 113.72 14.59 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 121.39 2.595 . . . . 0.0 112.761 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -88.73 117.81 27.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.28 132.88 28.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.416 0.286 . . . . 0.0 111.465 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.3 tpp -82.19 106.83 14.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.53 87.55 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -106.06 108.8 20.5 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.2 176.74 4.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.36 1.076 . . . . 0.0 112.167 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.13 157.94 29.9 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.9 t -75.36 78.5 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.631 1.205 . . . . 0.0 110.991 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 179.95 -67.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.555 -1.657 . . . . 0.0 106.964 -152.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.65 -41.89 36.71 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.249 1.02 . . . . 0.0 113.082 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 66.7 m -58.55 -63.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.596 1.089 . . . . 0.0 113.011 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.71 -76.05 0.32 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.413 1.006 . . . . 0.0 108.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.47 162.96 21.61 Favored Glycine 0 CA--C 1.557 2.714 0 CA-C-O 118.918 -0.935 . . . . 0.0 113.148 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.26 60.83 5.58 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 CA-C-N 121.151 2.475 . . . . 0.0 114.964 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -158.46 -77.14 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.0 95.76 0.27 Allowed Glycine 0 CA--C 1.536 1.396 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.64 48.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m 65.68 135.24 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.22 -51.05 0.16 OUTLIER 'Cis proline' 0 CA--C 1.562 1.92 0 CA-C-N 123.001 2.107 . . . . 0.0 116.271 3.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -141.66 77.87 1.61 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.335 1.064 . . . . 0.0 108.481 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mt -99.57 120.69 56.98 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 144.09 34.09 Favored 'Trans proline' 0 CA--C 1.571 2.357 0 C-N-CA 122.729 2.286 . . . . 0.0 114.349 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 122.31 8.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.078 2.519 . . . . 0.0 113.026 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.36 32.1 p80 51.86 67.84 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.08 108.27 3.59 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.66 126.75 28.4 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -167.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 tp -111.45 127.27 55.63 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.3 -155.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.1 m -74.75 152.2 39.08 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.12 113.55 3.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.08 0.552 . . . . 0.0 109.866 167.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.53 112.13 20.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.153 0.977 . . . . 0.0 111.374 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.62 107.7 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.3 m -106.53 117.65 34.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.31 109.87 6.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.176 0.591 . . . . 0.0 110.291 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -78.52 -68.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.457 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.1 p -141.8 131.69 24.41 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.044 0.838 . . . . 0.0 109.752 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.94 109.48 21.84 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.58 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.537 0.684 . . . . 0.0 110.507 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.0 145.52 52.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.68 115.95 6.19 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.01 -1.994 . . . . 0.0 114.587 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.53 127.39 4.38 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 CA-C-N 122.294 3.047 . . . . 0.0 113.82 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -82.03 107.54 14.82 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.36 0.6 . . . . 0.0 110.465 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.255 6.4 mp 71.82 95.85 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.914 1.286 . . . . 0.0 109.988 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.495 1.81 0 C-N-CA 124.535 1.134 . . . . 0.0 112.55 179.75 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 CA--C 1.556 1.175 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -117.91 -99.29 0.44 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.016 -0.992 . . . . 0.0 108.966 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.329 27.8 tt0 62.27 -96.87 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 168.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -123.02 106.96 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.47 108.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.69 122.01 23.36 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.554 1.169 . . . . 0.0 114.028 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.43 74.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.078 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.44 -64.73 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.87 0.868 . . . . 0.0 109.514 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.85 -81.52 0.19 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -160.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -76.22 -76.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.036 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.02 79.94 0.03 OUTLIER Glycine 0 N--CA 1.478 1.44 0 CA-C-N 118.874 0.761 . . . . 0.0 112.087 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.65 -58.91 1.03 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.435 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.1 tp -81.17 123.15 28.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.087 1.312 . . . . 0.0 108.606 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -142.71 131.97 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 123.387 0.675 . . . . 0.0 111.864 -167.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -122.4 132.19 54.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 0.0 113.392 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -110.61 125.34 53.3 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.593 -0.692 . . . . 0.0 109.642 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -81.04 124.41 29.16 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.311 0.505 . . . . 0.0 111.078 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HB2' ' HZ3' ' A' ' 48' ' ' LYS . 13.8 tp -87.32 -71.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.509 0.724 . . . . 0.0 110.058 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.89 100.65 53.83 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.14 160.67 42.23 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.741 2.294 . . . . 0.0 113.842 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.22 151.26 52.09 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.987 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.56 165.07 28.58 Favored 'Trans proline' 0 CA--C 1.572 2.382 0 C-N-CA 123.132 2.555 . . . . 0.0 115.852 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 115.49 3.93 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 123.139 2.56 . . . . 0.0 112.68 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.11 -103.97 1.04 Allowed Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -167.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.4 m 59.34 100.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.4 m -80.66 128.63 33.84 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.151 0.501 . . . . 0.0 110.126 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -93.12 113.73 60.76 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.808 -1.092 . . . . 0.0 110.495 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.81 150.88 68.47 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.972 2.448 . . . . 0.0 115.274 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.8 166.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.857 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -73.09 99.75 2.86 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.762 0.825 . . . . 0.0 110.656 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.03 -52.36 0.56 Allowed Glycine 0 CA--C 1.549 2.176 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.333 -155.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -73.76 140.16 45.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.764 0.825 . . . . 0.0 112.201 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.7 t -90.17 112.62 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.63 142.88 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.52 1.152 . . . . 0.0 110.481 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -106.43 116.32 31.73 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.37 126.61 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 122.72 0.408 . . . . 0.0 110.21 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -73.62 103.77 4.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 161.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 tp -102.14 100.3 10.51 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -93.62 90.28 6.57 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -90.57 121.68 32.71 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -167.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -124.11 175.88 6.73 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.312 1.045 . . . . 0.0 110.843 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -80.31 -83.54 0.1 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.661 0.784 . . . . 0.0 109.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.05 -69.94 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.602 0.761 . . . . 0.0 109.366 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.16 66.63 1.82 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.399 0.619 . . . . 0.0 110.901 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.22 65.28 3.47 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -132.45 104.35 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.63 107.11 3.76 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.6 0.714 . . . . 0.0 112.514 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.25 18.9 m -87.11 -52.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.856 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.66 82.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.16 114.12 14.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.379 0.609 . . . . 0.0 112.452 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -125.63 97.22 36.72 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.765 -158.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.4 109.01 2.24 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 123.804 3.003 . . . . 0.0 111.037 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' CD ' ' HZ3' ' A' ' 144' ' ' LYS 0.574 1.2 pm0 67.51 81.03 0.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.59 103.32 6.51 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 156.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.1 t -96.87 121.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 148.67 28.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.719 -168.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.5 m -66.8 124.8 23.93 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.06 103.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.358 1.063 . . . . 0.0 112.952 -163.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.04 -42.89 2.91 Favored Glycine 0 CA--C 1.549 2.162 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -55.62 5.98 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.09 108.32 15.47 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.468 0.576 . . . . 0.0 111.675 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.294 2.7 t70 81.01 -51.6 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 170.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.78 158.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -150.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 168.9 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 113.528 -1.669 . . . . 0.0 113.977 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -61.03 -26.8 67.87 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.81 75.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 168.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.68 -49.74 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -56.98 -44.6 82.84 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.6 mt -71.4 -50.77 28.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.6 p -71.91 -45.08 62.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -175.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.46 -39.68 51.3 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 114.919 -2.467 . . . . 0.0 115.462 -169.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.05 -33.09 92.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 126.412 3.326 . . . . 0.0 116.573 168.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.64 -26.49 64.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 69.2 mmm -71.31 129.87 39.95 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 120.003 1.274 . . . . 0.0 111.393 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.44 158.57 33.62 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 122.752 1.263 . . . . 0.0 113.614 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.74 108.22 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.019 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.35 23.62 23.86 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 117.476 1.751 . . . . 0.0 117.476 -163.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -98.05 129.59 44.89 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.812 1.806 . . . . 0.0 111.184 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.6 m -107.33 123.03 47.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.49 131.53 9.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 0.0 110.736 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.91 104.68 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.415 0.686 . . . . 0.0 109.369 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.1 t -93.62 96.27 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 79.5 p -90.16 102.26 14.98 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 124.35 38.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.972 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -63.61 164.78 9.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.1 p -74.83 74.16 2.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.525 1.155 . . . . 0.0 113.004 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp 176.96 -65.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.508 1.523 . . . . 0.0 107.113 -158.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -75.18 -34.11 61.53 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.284 1.434 . . . . 0.0 114.031 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' A' ' 137' ' ' LEU . 34.7 t -68.42 -76.94 0.08 Allowed 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.381 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -133.93 -80.74 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.25 -105.13 0.26 Allowed Glycine 0 CA--C 1.547 2.062 0 CA-C-O 116.881 -2.066 . . . . 0.0 111.427 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.0 -47.7 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 122.266 3.033 . . . . 0.0 116.399 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -148.33 117.26 6.74 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 133' ' ' PRO . . . -92.46 -120.07 2.7 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 123.205 0.431 . . . . 0.0 112.312 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -128.73 72.01 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.359 0.664 . . . . 0.0 110.103 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 t -73.85 135.35 77.58 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.783 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.06 -22.18 15.63 Favored 'Cis proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.294 2.767 . . . . 0.0 119.294 9.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -56.06 -41.66 75.41 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 104.39 50.67 Favored Pre-proline 0 CA--C 1.574 1.881 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.83 157.07 58.38 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 C-N-CA 123.038 2.492 . . . . 0.0 114.726 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.476 ' HA ' ' H ' ' A' ' 126' ' ' GLY . 47.7 Cg_endo -70.88 -68.93 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.613 2.209 . . . . 0.0 116.623 -157.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -121.77 76.66 1.29 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.28 154.07 48.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.345 1.058 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.3 8.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.43 HD23 ' SG ' ' A' ' 121' ' ' CYS . 9.0 mp -69.05 134.79 49.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.726 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 77.5 m -104.25 99.67 9.39 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.16 106.85 10.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.557 0.743 . . . . 0.0 109.713 -167.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.15 117.52 24.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.803 0.811 . . . . 0.0 112.162 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.3 t -88.52 108.02 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.0 m -115.82 108.28 16.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.48 106.87 5.45 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.064 0.546 . . . . 0.0 110.4 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' HZ3' ' CD ' ' A' ' 85' ' ' GLU . 44.3 mtmt -87.53 -53.01 5.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.168 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.4 p -145.82 131.97 19.4 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.21 0.914 . . . . 0.0 108.936 173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.12 118.64 37.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.187 0.595 . . . . 0.0 109.453 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.26 165.46 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.225 1.012 . . . . 0.0 109.687 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.35 -179.11 4.32 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.36 99.79 1.72 Allowed Glycine 0 CA--C 1.55 2.219 0 CA-C-O 116.939 -2.034 . . . . 0.0 110.797 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.67 127.32 6.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 CA-C-N 122.503 3.151 . . . . 0.0 113.722 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.01 118.83 23.21 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.754 0.822 . . . . 0.0 108.86 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.257 7.6 mp 73.45 118.68 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.966 1.306 . . . . 0.0 111.346 -176.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 123.284 1.516 . . . . 0.0 111.42 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 CA--C 1.554 1.122 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -147.47 113.63 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.51 114.71 12.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.587 -0.695 . . . . 0.0 111.516 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.264 17.1 m0 84.46 120.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.287 1.435 . . . . 0.0 109.504 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.21 117.42 28.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.098 0.475 . . . . 0.0 110.779 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.25 150.75 25.98 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.47 -54.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.488 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.05 -63.2 1.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.82 0.78 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -127.63 -82.67 0.6 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.844 1.822 . . . . 0.0 106.195 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.08 76.78 0.05 OUTLIER Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.446 0.566 . . . . 0.0 111.869 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.88 -67.21 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 tp -85.83 112.31 21.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.739 0.815 . . . . 0.0 108.818 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -134.9 112.91 11.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.202 0.525 . . . . 0.0 111.386 -170.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -91.79 100.95 13.55 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 111.687 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -94.45 120.07 34.13 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.38 0.672 . . . . 0.0 109.791 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.4 m -80.14 114.96 19.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.298 0.57 . . . . 0.0 110.126 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.56 -71.87 0.5 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.124 0.97 . . . . 0.0 109.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.51 126.09 61.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.3 162.15 43.42 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.066 2.511 . . . . 0.0 114.817 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.85 122.83 7.2 Favored Glycine 0 CA--C 1.555 2.542 0 CA-C-O 116.964 -2.02 . . . . 0.0 112.941 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.57 165.89 21.51 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 CA-C-N 122.541 3.171 . . . . 0.0 115.51 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.31 120.95 8.42 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.179 2.586 . . . . 0.0 114.002 -170.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.91 -111.65 3.83 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m 58.99 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 m -117.72 125.76 51.25 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.379 1.085 . . . . 0.0 109.979 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -68.17 136.47 91.54 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 114.287 171.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.16 179.56 4.85 Favored 'Trans proline' 0 CA--C 1.568 2.187 0 C-N-CA 122.947 2.431 . . . . 0.0 115.449 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.0 m -93.65 175.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 124.19 0.996 . . . . 0.0 112.325 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 59.4 tttp -63.28 128.08 34.19 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.563 0.745 . . . . 0.0 112.856 168.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.96 4.5 Favored Glycine 0 CA--C 1.548 2.156 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.793 -167.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -148.22 138.81 22.9 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.51 118.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -172.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.04 134.09 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.812 0.845 . . . . 0.0 109.351 170.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -99.44 118.21 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.6 130.95 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -91.64 100.5 13.22 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.657 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -96.51 131.99 42.54 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.196 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -127.57 104.88 8.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -82.23 132.8 35.23 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.049 -169.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -131.03 116.13 17.38 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.21 94.51 9.68 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 12.1 pt-20 -70.39 -26.34 63.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.07 -41.43 96.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 160.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.33 -104.53 2.89 Favored Glycine 0 CA--C 1.544 1.852 0 CA-C-N 119.398 0.999 . . . . 0.0 112.159 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.3 m -131.31 146.4 52.28 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.019 0.928 . . . . 0.0 108.92 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -62.8 118.46 7.74 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.89 -45.67 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.272 13.8 mm100 75.3 92.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.879 1.671 . . . . 0.0 110.442 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.45 159.5 16.11 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-O 122.518 1.152 . . . . 0.0 112.703 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.2 139.69 95.17 Favored Pre-proline 0 CA--C 1.58 2.11 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -167.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.34 -13.04 16.98 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 119.862 2.985 . . . . 0.0 119.862 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.13 75.43 1.59 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.908 1.685 . . . . 0.0 110.682 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.34 106.31 18.33 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.05 135.56 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.192 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -159.76 157.85 30.12 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -91.3 131.48 36.78 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.112 0.965 . . . . 0.0 109.729 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.55 142.29 58.48 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.618 0.767 . . . . 0.0 113.061 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.66 -60.15 4.84 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 114.354 0.502 . . . . 0.0 114.354 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.41 ' CG ' ' HZ3' ' A' ' 62' ' ' LYS . 8.6 m-20 -67.79 115.46 7.36 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.748 1.219 . . . . 0.0 111.407 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.7 77.62 6.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.698 1.237 . . . . 0.0 113.492 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.72 -50.46 17.4 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.882 162.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.4 m -82.29 -178.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 C-N-CA 124.815 1.246 . . . . 0.0 113.254 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -60.87 161.04 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 124.713 1.205 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -61.0 -36.63 79.98 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -44.64 97.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 169.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.3 mt -65.3 -55.8 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 117.741 -1.124 . . . . 0.0 113.496 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -50.67 -48.81 58.29 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.28 -32.54 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.1 p -80.13 1.96 25.98 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 166.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.17 -52.49 74.23 Favored Pre-proline 0 N--CA 1.499 2.002 0 CA-C-O 115.044 -2.408 . . . . 0.0 112.683 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.37 39.35 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.517 0 CA-C-N 124.848 2.767 . . . . 0.0 116.827 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.2 mt -144.99 -46.04 0.23 Allowed 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 125.618 1.567 . . . . 0.0 110.631 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -76.41 113.44 14.0 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.804 1.184 . . . . 0.0 112.35 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.9 163.89 12.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.76 1.267 . . . . 0.0 111.882 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.49 115.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.294 -0.879 . . . . 0.0 112.155 -166.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.82 -40.19 2.4 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 117.091 1.596 . . . . 0.0 117.091 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.47 134.9 46.88 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.58 1.69 . . . . 0.0 115.459 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -90.98 125.29 35.74 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 154.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.61 121.89 13.06 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.4 ptp -75.8 125.88 29.92 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.404 1.097 . . . . 0.0 110.706 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.9 t -102.08 95.2 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.8 p -89.62 102.87 15.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.5 143.9 49.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.128 -161.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.82 162.37 4.12 Favored 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.1 p -54.02 -34.89 61.14 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 160.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.12 -43.91 82.76 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 161.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -86.56 63.91 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.899 0.772 . . . . 0.0 110.664 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.6 t -171.5 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -137.8 5.47 2.62 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.74 145.79 19.26 Favored Glycine 0 CA--C 1.56 2.885 0 CA-C-N 120.867 1.667 . . . . 0.0 111.892 -160.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.0 80.21 2.73 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 CA-C-N 122.558 3.179 . . . . 0.0 112.279 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -138.21 -74.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.16 0.584 . . . . 0.0 110.022 -164.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.42 96.48 0.12 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 140.75 49.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.287 0.635 . . . . 0.0 110.821 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.2 p -66.86 138.87 95.42 Favored Pre-proline 0 CA--C 1.573 1.831 0 CA-C-O 117.678 -1.153 . . . . 0.0 113.662 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.35 -44.82 0.45 Allowed 'Cis proline' 0 CA--C 1.563 1.934 0 N-CA-C 117.106 1.926 . . . . 0.0 117.106 8.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -155.18 88.73 1.17 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 83.4 mt -121.92 86.36 46.1 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.66 163.47 31.63 Favored 'Trans proline' 0 CA--C 1.572 2.421 0 C-N-CA 122.68 2.253 . . . . 0.0 115.424 -171.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.84 119.87 6.49 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.162 2.574 . . . . 0.0 113.232 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.258 96.1 m-70 66.8 76.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.796 1.239 . . . . 0.0 111.49 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.49 116.78 2.99 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.28 127.48 33.68 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.967 0.889 . . . . 0.0 112.844 -171.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.49 129.76 49.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.264 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.72 94.7 5.34 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.271 0.629 . . . . 0.0 109.372 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.37 121.64 45.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.445 0.698 . . . . 0.0 110.441 -170.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.9 100.41 6.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.011 0.524 . . . . 0.0 111.586 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.44 109.0 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.9 m -113.86 121.65 44.63 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.66 102.03 10.43 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -84.05 -59.55 2.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 60.1 p -122.46 149.5 43.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.658 0.783 . . . . 0.0 109.749 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.51 107.93 8.32 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.79 170.24 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.24 1.016 . . . . 0.0 110.096 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.56 -161.46 0.19 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.86 111.09 3.9 Favored Glycine 0 CA--C 1.555 2.538 0 CA-C-O 116.728 -2.151 . . . . 0.0 112.701 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.94 124.06 3.78 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 122.712 3.256 . . . . 0.0 113.301 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -92.56 119.3 31.89 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 123.105 0.562 . . . . 0.0 110.083 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.91 -64.13 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.326 0.651 . . . . 0.0 111.144 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 123.432 0.693 . . . . 0.0 109.885 -177.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -113.61 -48.55 2.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -77.38 123.98 27.26 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -160.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 91.6 m95 76.09 94.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.692 1.197 . . . . 0.0 111.564 168.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.87 113.2 26.55 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.93 110.45 5.04 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.016 0.912 . . . . 0.0 113.348 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.17 -42.11 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.806 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -73.95 -63.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.501 1.046 . . . . 0.0 111.274 165.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.5 -89.64 0.15 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -83.57 -40.53 18.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.04 82.12 1.49 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.093 0.861 . . . . 0.0 115.25 -163.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp 40.55 63.31 1.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 162.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 tp -162.29 92.74 0.83 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -117.16 117.78 30.54 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.509 0.724 . . . . 0.0 109.247 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.79 105.83 17.18 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.51 -0.744 . . . . 0.0 111.331 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 101.48 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 166.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.5 p -84.45 110.48 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.56 -59.51 2.72 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.601 0.76 . . . . 0.0 111.827 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.34 103.44 54.99 Favored Pre-proline 0 CA--C 1.57 1.729 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.65 87.07 1.55 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.989 2.459 . . . . 0.0 112.963 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.04 88.41 0.11 Allowed Glycine 0 CA--C 1.553 2.451 0 CA-C-O 116.339 -2.367 . . . . 0.0 113.286 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.82 167.84 16.63 Favored 'Trans proline' 0 CA--C 1.576 2.607 0 CA-C-N 123.154 3.477 . . . . 0.0 115.336 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.46 127.68 21.53 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 123.211 2.608 . . . . 0.0 114.86 -168.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.58 -123.12 6.63 Favored Glycine 0 CA--C 1.546 1.988 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -160.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m 59.43 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 164.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -123.4 127.28 48.22 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.705 1.241 . . . . 0.0 110.12 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -69.93 122.32 85.64 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 113.1 -1.864 . . . . 0.0 113.225 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.45 171.82 16.29 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.795 2.33 . . . . 0.0 115.352 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.95 174.65 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -60.57 133.09 55.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.13 51.1 4.57 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.284 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -146.63 131.87 18.45 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.76 113.45 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.67 124.77 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 ' HB ' ' HG1' ' A' ' 145' ' ' THR . 59.9 m -92.97 133.55 36.01 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 m -127.92 145.37 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.629 0.728 . . . . 0.0 110.16 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.73 98.28 8.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 165.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.51 125.72 31.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -103.98 73.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' HG1' ' HB3' ' A' ' 139' ' ' LEU . 18.8 m -79.46 119.45 22.48 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.9 m -146.91 133.9 20.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 tp -67.18 151.91 46.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.662 0.785 . . . . 0.0 113.001 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.14 12.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -77.65 -63.82 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.587 1.085 . . . . 0.0 112.529 168.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.07 76.38 0.02 OUTLIER Glycine 0 N--CA 1.48 1.583 0 CA-C-N 118.786 0.721 . . . . 0.0 111.533 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -149.39 113.91 5.29 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -74.6 104.23 5.21 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.248 0.477 . . . . 0.0 111.633 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.58 -61.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.003 -165.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.85 85.81 1.43 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -100.03 91.56 4.85 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.845 0.458 . . . . 0.0 110.231 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -98.97 116.33 65.31 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.087 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.73 -53.36 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.875 2.384 . . . . 0.0 115.079 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -98.73 81.25 2.64 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.252 0.933 . . . . 0.0 111.192 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.72 98.79 11.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.73 109.93 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -165.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -137.46 151.73 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -88.08 118.98 28.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.86 145.56 32.67 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.77 -50.0 4.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.71 -2.81 0.89 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 58.2 m 75.41 90.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.985 1.314 . . . . 0.0 111.46 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.76 -63.01 1.1 Allowed 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.297 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.88 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 124.28 1.032 . . . . 0.0 113.396 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 pt -56.57 148.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 125.06 1.344 . . . . 0.0 113.171 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -61.7 -26.69 68.2 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.45 69.84 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 120.29 1.405 . . . . 0.0 114.74 165.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -44.17 93.3 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.34 -40.35 95.7 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.91 -30.97 72.0 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 167.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -77.62 -0.17 25.53 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.64 -55.41 45.25 Favored Pre-proline 0 N--CA 1.502 2.125 0 CA-C-O 115.329 -2.272 . . . . 0.0 112.708 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.36 24.57 0.23 Allowed 'Trans proline' 0 CA--C 1.574 2.483 0 CA-C-N 124.683 2.708 . . . . 0.0 118.249 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.92 -39.14 1.23 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.97 1.308 . . . . 0.0 111.825 168.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -75.45 123.42 25.39 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.883 1.219 . . . . 0.0 113.566 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.92 170.27 8.18 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.76 1.267 . . . . 0.0 111.771 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.29 111.99 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.313 -0.867 . . . . 0.0 110.112 -157.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.89 2.14 57.22 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 -166.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -75.32 123.42 25.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 121.27 2.535 . . . . 0.0 111.961 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.8 m -103.82 116.73 32.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.53 128.16 10.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.4 tpp -80.79 113.71 19.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.756 0.823 . . . . 0.0 109.569 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.13 93.3 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -91.28 109.53 20.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.96 147.04 30.33 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -48.15 150.79 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 t -70.52 78.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.627 1.203 . . . . 0.0 111.491 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -179.76 -67.34 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.455 -1.702 . . . . 0.0 106.639 -156.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -65.87 -55.47 16.84 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.95 0.9 . . . . 0.0 111.718 159.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 71.6 m -73.21 111.5 8.39 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.768 0.713 . . . . 0.0 110.367 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.323 75.7 m-85 80.08 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.242 1.017 . . . . 0.0 112.036 170.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.45 162.99 26.33 Favored Glycine 0 CA--C 1.557 2.687 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.085 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.21 -22.16 47.17 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 123.183 2.589 . . . . 0.0 118.411 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -80.54 -45.04 18.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.92 97.98 1.37 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -171.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -84.14 178.66 7.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.366 1.079 . . . . 0.0 112.757 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -75.03 138.1 72.65 Favored Pre-proline 0 CA--C 1.57 1.745 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.643 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.67 -56.36 0.14 OUTLIER 'Cis proline' 0 CA--C 1.562 1.891 0 CA-C-N 122.316 1.863 . . . . 0.0 115.704 6.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -145.96 70.82 1.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.14 0.882 . . . . 0.0 109.386 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.7 mm -90.6 119.06 69.1 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.423 -1.275 . . . . 0.0 107.933 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.65 121.41 5.94 Favored 'Trans proline' 0 CA--C 1.571 2.36 0 C-N-CA 122.716 2.277 . . . . 0.0 112.253 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.64 132.73 20.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 123.012 2.475 . . . . 0.0 112.704 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.273 14.9 m170 78.86 148.28 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 124.61 1.164 . . . . 0.0 110.748 -166.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.26 . . 78.93 136.26 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.841 1.257 . . . . 0.0 112.514 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.32 136.49 33.88 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.54 136.15 37.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.816 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.9 m -101.11 102.91 13.96 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.441 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 0.7 OUTLIER -113.01 109.36 18.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.289 0.636 . . . . 0.0 111.22 -175.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.32 98.74 9.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.486 0.66 . . . . 0.0 110.377 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.82 111.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.8 m -110.77 114.32 27.58 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.56 120.18 18.81 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.057 0.543 . . . . 0.0 111.014 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.11 -65.41 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.488 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.471 ' HG1' ' HB ' ' A' ' 67' ' ' THR . 46.6 p -124.77 150.59 46.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.852 0.834 . . . . 0.0 109.847 -166.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.79 98.67 4.24 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.24 164.59 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.934 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.65 -160.58 0.19 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -108.68 93.25 0.77 Allowed Glycine 0 CA--C 1.549 2.195 0 CA-C-O 117.075 -1.959 . . . . 0.0 110.824 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.46 137.11 12.9 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 CA-C-N 122.174 2.987 . . . . 0.0 113.244 -173.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.08 101.51 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 122.097 0.951 . . . . 0.0 113.083 -175.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.44 94.72 5.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.878 0.847 . . . . 0.0 110.1 -179.663 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 68.23 132.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.15 -67.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -156.4 146.59 21.35 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.625 1.17 . . . . 0.0 109.371 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 tp -74.31 136.15 42.58 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.259 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -83.47 -178.27 7.0 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-O 123.452 1.596 . . . . 0.0 114.928 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 -74.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.36 -39.9 58.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.39 67.94 0.57 Allowed Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -146.94 -65.54 0.28 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.71 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.43 -50.32 0.83 Allowed Glycine 0 CA--C 1.545 1.957 0 CA-C-N 118.907 0.776 . . . . 0.0 114.074 -164.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.69 -56.74 8.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.68 112.83 24.9 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.861 0.755 . . . . 0.0 109.076 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -133.73 148.65 51.45 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.127 0.971 . . . . 0.0 111.444 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -108.55 127.16 53.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.647 -0.658 . . . . 0.0 111.511 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.92 -43.1 95.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.269 19.5 m 73.5 95.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 174.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.78 -65.62 0.99 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.889 . . . . 0.0 110.166 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.46 113.01 33.85 Favored Pre-proline 0 CA--C 1.569 1.689 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.3 78.99 3.01 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.87 2.38 . . . . 0.0 113.095 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.34 160.95 17.09 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.14 170.2 20.08 Favored 'Trans proline' 0 CA--C 1.574 2.499 0 C-N-CA 123.266 2.644 . . . . 0.0 114.39 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.35 108.28 1.97 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.031 2.487 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.06 83.34 0.96 Allowed Glycine 0 CA--C 1.544 1.88 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -159.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -100.51 123.63 44.98 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.884 0.474 . . . . 0.0 111.961 -166.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -92.33 138.85 31.17 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.335 0.654 . . . . 0.0 112.218 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -113.12 107.19 54.3 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.4 148.22 29.77 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.022 2.482 . . . . 0.0 114.53 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.39 147.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.0 0.92 . . . . 0.0 112.576 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 86.3 2.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.74 62.79 0.01 OUTLIER Glycine 0 CA--C 1.54 1.634 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.158 172.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.07 0.938 . . . . 0.0 110.596 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.45 109.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.77 112.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.455 ' HG1' HG21 ' A' ' 87' ' ' VAL . 70.8 m -93.1 106.84 18.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 173.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.35 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -171.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -74.41 112.45 10.6 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 165.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.69 105.8 7.74 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -167.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.29 100.66 11.97 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -79.47 112.48 16.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.3 t -135.88 149.13 48.89 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.094 0.949 . . . . 0.0 110.306 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.94 142.32 51.25 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.269 1.028 . . . . 0.0 112.218 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.29 -38.7 28.2 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -66.21 -66.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.598 0.759 . . . . 0.0 111.959 168.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.64 79.61 0.03 OUTLIER Glycine 0 N--CA 1.479 1.536 0 CA-C-N 119.012 0.824 . . . . 0.0 112.005 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.2 m -151.04 112.96 4.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 102.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.64 -45.83 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -145.08 105.91 4.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.26 124.54 31.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.431 0.634 . . . . 0.0 109.681 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -130.58 78.43 74.03 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -170.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.81 -44.3 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.095 2.53 . . . . 0.0 116.443 -171.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.12 83.15 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.197 0.908 . . . . 0.0 109.803 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.4 tp -101.05 98.51 8.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG21 ' HG1' ' A' ' 67' ' ' THR . 58.1 t -103.76 111.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -165.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.8 166.14 33.84 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.755 -175.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -82.06 136.02 35.26 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.234 0.613 . . . . 0.0 110.398 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 tt -68.37 114.13 6.55 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.222 1.009 . . . . 0.0 112.828 -164.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.92 34.8 77.75 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 118.0 1.96 . . . . 0.0 118.0 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.44 169.11 14.7 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.44 1.114 . . . . 0.0 110.028 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.77 89.91 2.87 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.603 1.192 . . . . 0.0 113.205 -167.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.44 -67.55 0.21 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.846 -1.524 . . . . 0.0 107.998 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.85 165.29 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 124.605 1.162 . . . . 0.0 112.988 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 159.92 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -30.18 63.77 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.82 80.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 170.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.3 -38.4 65.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -43.29 -48.48 6.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.72 -45.46 58.63 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.6 p -90.27 45.94 1.31 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.67 -55.95 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.913 0 CA-C-O 115.013 -2.423 . . . . 0.0 107.235 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.73 83.32 1.95 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 CA-C-N 125.421 2.972 . . . . 0.0 112.802 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.317 4.4 pp 163.0 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 127.194 2.197 . . . . 0.0 111.821 -167.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.23 140.73 38.9 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.98 1.264 . . . . 0.0 112.04 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.27 159.81 33.93 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.618 163.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.68 97.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 143' ' ' LEU . . . 99.06 39.17 3.61 Favored Glycine 0 CA--C 1.552 2.379 0 CA-C-O 118.494 -1.17 . . . . 0.0 115.981 -162.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.42 99.91 11.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.064 1.432 . . . . 0.0 109.076 173.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.9 m -83.69 118.05 23.61 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 128.31 6.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.768 0.427 . . . . 0.0 110.223 -173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.4 tpp -85.51 107.16 17.32 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.75 99.05 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -91.5 104.26 16.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.15 160.64 15.46 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.164 0.983 . . . . 0.0 113.303 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 159.04 22.19 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.663 164.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.3 p -73.95 68.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -175.9 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.452 1.501 . . . . 0.0 108.405 -168.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -59.62 -51.03 71.56 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.651 1.18 . . . . 0.0 114.113 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.5 m -66.11 -70.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.821 0.737 . . . . 0.0 112.582 170.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -144.48 -65.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.938 0.79 . . . . 0.0 109.39 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.64 -167.93 30.16 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.14 102.47 1.6 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.081 2.521 . . . . 0.0 112.441 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -152.95 -69.45 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.716 -169.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.72 95.29 1.23 Allowed Glycine 0 CA--C 1.541 1.683 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -167.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -132.82 148.65 52.31 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.201 1.0 . . . . 0.0 110.667 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.4 m -76.8 140.85 67.7 Favored Pre-proline 0 CA--C 1.57 1.74 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.22 173.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.02 -47.35 0.26 Allowed 'Cis proline' 0 CA--C 1.563 1.939 0 CA-C-N 122.377 1.885 . . . . 0.0 116.909 9.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.33 77.16 1.43 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.76 117.37 46.64 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.8 151.33 27.97 Favored 'Trans proline' 0 CA--C 1.571 2.358 0 C-N-CA 122.813 2.342 . . . . 0.0 114.417 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.15 119.59 6.55 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.128 2.552 . . . . 0.0 111.931 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 93.9 m-70 76.8 101.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.222 1.409 . . . . 0.0 109.478 -165.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.83 88.86 3.0 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.171 0.588 . . . . 0.0 109.634 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.6 76.15 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 153.33 20.59 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.443 1.115 . . . . 0.0 112.243 -165.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -91.75 109.6 20.92 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.661 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.37 117.79 32.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.304 1.042 . . . . 0.0 108.217 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.16 99.2 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.398 -0.814 . . . . 0.0 110.196 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.06 125.6 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.5 m -142.14 124.33 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' HB2' ' H ' ' A' ' 109' ' ' GLY . 3.2 mm? -76.47 111.32 11.81 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.384 0.674 . . . . 0.0 110.021 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -84.01 -55.95 3.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 118.659 -0.686 . . . . 0.0 112.745 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 69.7 p -135.94 133.61 37.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -117.68 106.96 13.63 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 167.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.93 133.48 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 123.439 0.696 . . . . 0.0 110.078 -170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -86.17 103.96 15.29 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 168.47 93.74 0.09 OUTLIER Glycine 0 CA--C 1.545 1.964 0 CA-C-O 116.801 -2.111 . . . . 0.0 112.08 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.92 131.87 12.48 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 CA-C-N 122.283 3.042 . . . . 0.0 112.62 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 61.17 90.41 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.477 1.111 . . . . 0.0 112.648 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.61 -63.29 1.42 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -165.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.722 0.772 . . . . 0.0 110.989 -176.513 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 53.17 61.39 3.18 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.11 169.9 20.18 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.693 1.235 . . . . 0.0 113.568 -163.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -79.41 115.44 19.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 153.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.46 103.61 15.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -163.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.97 103.04 12.13 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.072 0.939 . . . . 0.0 112.331 -176.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 pt -84.23 -176.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.648 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.357 2.6 tt 90.46 -75.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.343 1.457 . . . . 0.0 110.624 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.98 -72.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.377 0.535 . . . . 0.0 112.708 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.74 -75.36 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.179 0.592 . . . . 0.0 111.462 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.94 73.54 0.04 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 mt -141.73 -62.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.092 0.957 . . . . 0.0 108.753 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.77 130.51 38.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.101 0.96 . . . . 0.0 110.753 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -133.41 74.95 1.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -159.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -92.17 86.58 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.037 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -75.51 116.88 16.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 111.071 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 m -74.89 104.62 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.209 0.603 . . . . 0.0 109.404 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.79 -79.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.644 0.777 . . . . 0.0 110.077 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.93 113.38 63.67 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 169.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.17 175.63 8.97 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.873 2.382 . . . . 0.0 114.889 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 119.37 10.85 Favored Glycine 0 CA--C 1.558 2.738 0 CA-C-O 116.948 -2.029 . . . . 0.0 112.62 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.65 161.91 36.7 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 CA-C-N 122.498 3.149 . . . . 0.0 115.327 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.84 113.64 2.07 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.175 2.584 . . . . 0.0 113.562 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.4 71.67 1.09 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.711 -159.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -157.86 114.52 2.89 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 m -126.06 117.74 23.84 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 122.273 1.035 . . . . 0.0 110.086 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -59.4 134.06 88.46 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.01 144.89 43.71 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.783 2.322 . . . . 0.0 116.568 -158.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -72.16 155.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.002 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -70.17 110.99 5.49 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.72 65.08 0.47 Allowed Glycine 0 CA--C 1.544 1.863 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.548 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -150.01 140.74 22.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.19 108.04 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 m -117.87 121.6 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -109.75 134.46 51.98 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.63 153.15 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.254 1.026 . . . . 0.0 110.278 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -102.44 91.58 4.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.343 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.406 HD11 ' HG1' ' A' ' 72' ' ' THR . 2.1 pp -86.94 147.38 25.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.311 0.576 . . . . 0.0 110.383 163.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.01 92.5 2.88 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.406 ' HG1' HD11 ' A' ' 70' ' ' LEU . 36.8 m -83.11 122.11 27.93 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.661 0.743 . . . . 0.0 109.889 -175.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 m -140.93 136.62 32.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.529 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.19 131.81 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -52.23 -46.82 65.87 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.37 -44.26 12.95 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.81 80.78 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 120.783 3.073 . . . . 0.0 120.783 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.0 m 77.65 117.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.143 1.972 . . . . 0.0 112.839 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.252 7.3 ttt85 38.86 53.91 2.01 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 160.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 21.1 m -74.77 -40.96 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -159.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -146.96 76.3 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.561 1.073 . . . . 0.0 109.055 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -73.39 111.05 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.609 0.719 . . . . 0.0 111.56 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -130.94 84.06 59.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.91 -46.58 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.906 2.404 . . . . 0.0 117.248 -164.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.95 92.95 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.876 1.216 . . . . 0.0 110.702 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 tp -111.57 81.13 1.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.53 -172.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -89.84 136.44 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.406 0.682 . . . . 0.0 110.884 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -162.81 150.48 13.62 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.947 0.899 . . . . 0.0 110.345 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -80.77 140.97 35.21 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.94 104.81 5.68 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.38 70.83 0.85 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.032 -159.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -156.63 -66.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.734 0.814 . . . . 0.0 110.478 -176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.351 4.8 t 65.94 40.87 3.94 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.59 -47.68 80.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.878 -1.139 . . . . 0.0 113.217 152.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -55.04 166.85 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 125.282 1.433 . . . . 0.0 114.321 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.462 HG13 ' H ' ' A' ' 99' ' ' LEU . 46.4 pt -60.34 151.19 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -35.99 65.93 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.35 94.54 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 117.176 2.288 . . . . 0.0 117.176 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' H ' HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -63.89 -56.54 14.57 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.907 -1.044 . . . . 0.0 113.138 178.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -49.98 -43.24 50.17 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.38 -39.87 94.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.1 p -77.91 -4.11 45.16 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.79 -53.05 68.03 Favored Pre-proline 0 N--CA 1.502 2.138 0 CA-C-O 115.388 -2.244 . . . . 0.0 112.62 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.48 0.34 1.47 Allowed 'Trans proline' 0 CA--C 1.569 2.254 0 N-CA-C 119.483 2.839 . . . . 0.0 119.483 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 99.4 mt -128.57 73.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 119.993 1.27 . . . . 0.0 107.982 158.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 38.9 ttm -164.29 96.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.06 167.64 17.68 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.322 1.058 . . . . 0.0 113.282 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -70.41 108.29 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.578 0.751 . . . . 0.0 109.691 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.78 20.2 41.0 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 117.912 1.925 . . . . 0.0 117.912 -167.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 107.59 18.66 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 120.387 2.093 . . . . 0.0 110.476 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.4 m -78.75 113.07 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 163.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.79 121.49 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 ttt -83.68 108.12 16.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.024 0.529 . . . . 0.0 110.239 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.34 118.38 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 t -129.07 77.04 1.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.61 145.92 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.715 0.769 . . . . 0.0 112.044 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.86 164.65 0.36 Allowed 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -69.54 81.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.832 1.301 . . . . 0.0 111.595 172.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.888 -147.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -120.11 57.99 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.399 0.68 . . . . 0.0 111.938 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -110.37 -100.38 0.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -136.14 63.13 1.6 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 119.047 0.84 . . . . 0.0 109.414 168.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.24 -156.12 30.42 Favored Glycine 0 CA--C 1.562 2.977 0 N-CA-C 116.671 1.428 . . . . 0.0 116.671 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.25 102.64 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.95 2.433 . . . . 0.0 110.783 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.272 58.7 tp60 73.24 120.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.088 1.355 . . . . 0.0 111.16 -168.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.24 -139.95 10.54 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.8 158.85 15.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.293 1.044 . . . . 0.0 111.856 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.8 m -64.52 137.32 97.1 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 117.789 -1.1 . . . . 0.0 112.756 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.78 -42.56 0.68 Allowed 'Cis proline' 0 CA--C 1.563 1.96 0 N-CA-C 117.661 2.139 . . . . 0.0 117.661 10.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -168.21 100.69 0.44 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.43 105.63 56.86 Favored Pre-proline 0 CA--C 1.571 1.77 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.86 146.72 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.667 2.244 . . . . 0.0 114.747 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.61 -54.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.292 2.661 . . . . 0.0 115.272 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -65.24 145.61 56.01 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.521 1.128 . . . . 0.0 112.915 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.18 128.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.796 1.238 . . . . 0.0 111.886 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.72 114.08 8.44 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.603 0.761 . . . . 0.0 111.988 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.85 125.49 29.77 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 120.967 0.413 . . . . 0.0 111.301 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.55 118.29 31.98 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.097 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.53 121.72 27.76 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.402 0.681 . . . . 0.0 109.677 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -87.6 98.33 11.35 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.2 0.6 . . . . 0.0 110.768 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.82 126.08 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -133.31 125.32 28.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.59 111.16 5.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.57 0.748 . . . . 0.0 111.184 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -77.37 -66.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -132.81 143.22 49.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.619 0.723 . . . . 0.0 109.321 -168.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.54 96.95 4.25 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.72 129.06 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -170.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.2 111.48 22.67 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.277 0.56 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 172.0 97.04 0.1 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-O 116.764 -2.131 . . . . 0.0 110.633 -175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.8 151.37 31.59 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 CA-C-N 122.359 3.079 . . . . 0.0 114.368 -172.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . 0.259 18.8 t0 68.51 98.85 0.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 124.616 1.166 . . . . 0.0 112.43 -175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.63 121.5 43.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.638 0.775 . . . . 0.0 109.039 -170.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.488 1.462 0 C-N-CA 123.238 0.615 . . . . 0.0 110.954 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 104.9 4.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -58.57 168.45 1.16 Allowed 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -48.79 120.57 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.447 1.099 . . . . 0.0 113.778 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.6 tp -80.36 109.81 15.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.439 0.696 . . . . 0.0 110.99 -164.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.56 101.78 13.52 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.355 1.074 . . . . 0.0 112.634 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -29.84 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 170.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.23 -48.95 71.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.159 1.345 . . . . 0.0 113.68 158.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 -36.12 4.44 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -73.1 -71.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.397 1.099 . . . . 0.0 111.961 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.11 61.27 0.03 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 mt -143.83 -76.2 0.24 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.4 tp -88.15 119.69 28.78 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.65 0.78 . . . . 0.0 109.203 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -137.79 121.63 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.644 0.778 . . . . 0.0 109.681 -172.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 110.5 16.09 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 110.485 -164.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -116.94 130.85 56.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.214 . . . . 0.0 110.009 172.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.9 m -93.2 119.25 32.17 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.858 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.86 -68.32 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.517 0.727 . . . . 0.0 110.117 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.4 t -85.08 122.79 74.05 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 156.56 42.42 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 122.925 2.417 . . . . 0.0 114.699 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 121.14 5.32 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-O 116.924 -2.042 . . . . 0.0 113.071 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.22 144.64 52.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.597 3.199 . . . . 0.0 115.0 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.43 119.01 5.74 Favored 'Trans proline' 0 CA--C 1.558 1.693 0 C-N-CA 123.241 2.627 . . . . 0.0 112.643 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.28 -81.88 0.22 Allowed Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -88.71 98.64 11.8 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 m -148.86 133.23 17.52 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.763 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.273 19.2 mtm180 42.44 74.68 0.72 Allowed Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.97 161.49 32.9 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.726 2.284 . . . . 0.0 114.251 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.19 170.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.283 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 69.2 tttt -71.26 115.9 10.95 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.881 0.848 . . . . 0.0 111.902 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.64 -63.4 0.44 Allowed Glycine 0 CA--C 1.54 1.649 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -155.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -70.67 114.99 9.31 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.433 0.693 . . . . 0.0 110.028 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.34 114.04 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 m -92.52 135.74 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.444 -169.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -120.06 126.11 49.97 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.45 141.43 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.696 0.76 . . . . 0.0 110.98 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -89.92 93.67 9.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 161.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.34 143.19 28.34 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.782 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -126.93 90.41 3.15 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -74.53 115.55 14.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -140.92 119.15 12.06 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -162.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.08 137.13 45.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.669 0.387 . . . . 0.0 110.573 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.63 87.41 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.619 1.199 . . . . 0.0 112.608 -170.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -171.25 -75.59 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -170.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.14 71.0 0.05 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.2 t -162.75 141.34 8.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.26 0.624 . . . . 0.0 110.05 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 113.63 25.24 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.264 23.5 m -78.25 -51.18 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -141.02 81.22 1.78 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 119.226 0.921 . . . . 0.0 109.198 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.76 119.39 30.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.66 94.34 47.65 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.095 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.64 -44.82 0.63 Allowed 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.084 2.523 . . . . 0.0 117.202 -172.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.8 76.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.783 1.174 . . . . 0.0 110.238 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -99.68 92.67 5.45 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.22 132.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.737 0.78 . . . . 0.0 109.24 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -155.62 142.99 19.42 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.954 -174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.5 m -74.17 133.51 42.75 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.917 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -70.83 109.05 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.336 -165.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.27 67.79 1.48 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.493 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 62' ' ' LYS . 16.1 m-20 -148.72 145.16 27.53 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.239 1.018 . . . . 0.0 109.739 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 75.8 m -75.72 76.72 2.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.647 1.213 . . . . 0.0 111.829 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -129.69 -63.44 0.92 Allowed 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.657 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.16 176.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.005 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.71 140.9 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.052 0.941 . . . . 0.0 112.443 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -61.47 -33.72 74.23 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.07 -40.93 70.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 167.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -56.69 10.65 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.931 0.892 . . . . 0.0 113.037 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.57 -39.72 94.59 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.5 mt -61.09 -34.8 75.52 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.1 p -74.35 -11.94 60.39 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 167.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -56.01 -50.45 87.25 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 115.292 -2.29 . . . . 0.0 115.092 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -53.32 -26.57 35.27 Favored 'Trans proline' 0 CA--C 1.567 2.165 0 CA-C-N 125.659 3.057 . . . . 0.0 118.549 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -110.09 73.21 0.83 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.087 0.955 . . . . 0.0 109.709 164.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 53.0 tpp -149.61 107.45 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.39 161.85 15.39 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.681 1.229 . . . . 0.0 113.066 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 t -81.96 103.15 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 59.17 1.31 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.932 -170.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -126.06 123.76 39.11 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.57 0.748 . . . . 0.0 109.829 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -91.49 103.54 16.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.1 120.74 14.27 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.976 0.417 . . . . 0.0 110.433 -164.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.4 ttm -83.6 141.25 31.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.99 0.9 . . . . 0.0 110.802 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.27 96.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.6 p -81.72 104.87 12.42 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -135.68 139.23 43.53 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.511 0.724 . . . . 0.0 111.024 -168.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -63.23 149.49 45.38 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.8 m -71.32 81.73 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 123.273 1.511 . . . . 0.0 110.8 167.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -172.78 -68.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.961 -1.927 . . . . 0.0 106.446 -159.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -73.85 -45.61 50.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.638 0.775 . . . . 0.0 112.477 161.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.1 m -58.98 -56.55 20.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.2 -84.41 0.23 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.465 1.029 . . . . 0.0 108.713 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.82 -175.35 28.99 Favored Glycine 0 CA--C 1.557 2.718 0 CA-C-N 119.014 0.824 . . . . 0.0 114.651 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.53 105.13 1.83 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.483 2.788 . . . . 0.0 112.591 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' H ' ' HA ' ' A' ' 133' ' ' PRO . 2.5 tm0? 57.84 85.57 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.202 1.401 . . . . 0.0 112.908 -172.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.66 -88.53 1.54 Allowed Glycine 0 CA--C 1.539 1.59 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -122.35 81.66 1.87 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.667 0.787 . . . . 0.0 109.96 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.1 p -73.44 145.29 84.97 Favored Pre-proline 0 CA--C 1.571 1.78 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.995 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.8 -16.38 30.09 Favored 'Cis proline' 0 CA--C 1.564 1.984 0 N-CA-C 119.437 2.822 . . . . 0.0 119.437 9.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -64.21 -42.69 96.5 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.73 118.43 68.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.32 163.51 27.41 Favored 'Trans proline' 0 CA--C 1.576 2.62 0 C-N-CA 122.84 2.36 . . . . 0.0 114.082 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 125' ' ' GLN . 56.2 Cg_endo -69.09 -64.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.107 2.538 . . . . 0.0 115.488 -177.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -136.03 94.05 3.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.24 125.69 8.81 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.95 108.31 14.51 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.566 0.698 . . . . 0.0 112.385 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 157.84 16.16 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.736 176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.52 104.73 16.78 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.092 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -104.57 118.7 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.42 148.5 51.78 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.293 0.568 . . . . 0.0 112.383 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.96 99.96 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.5 m -102.44 109.39 21.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 104.15 8.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -80.88 -58.47 3.07 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 70.7 p -137.46 134.17 35.51 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.287 0.635 . . . . 0.0 109.64 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.16 94.94 4.86 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -166.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.08 115.31 22.81 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.412 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.82 -173.68 38.81 Favored Glycine 0 CA--C 1.557 2.7 0 CA-C-O 119.325 -0.708 . . . . 0.0 114.528 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.13 95.02 0.89 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.754 2.303 . . . . 0.0 113.327 -173.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -147.13 113.12 5.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.4 tp 70.79 106.86 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.986 1.314 . . . . 0.0 111.702 -173.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.253 0.549 . . . . 0.0 110.198 -178.807 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 62.3 mtp . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.342 19.2 mmt-85 65.73 134.99 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -172.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -89.03 131.03 35.38 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -149.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -99.78 133.59 43.91 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.618 161.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER 68.25 163.13 0.21 Allowed 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 171.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.268 14.2 t0 73.19 111.7 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -127.29 -59.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -60.59 -37.46 81.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.78 51.85 0.22 Allowed Glycine 0 CA--C 1.548 2.129 0 C-N-CA 124.621 1.105 . . . . 0.0 113.116 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -166.83 -71.84 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.24 61.67 0.07 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.317 0.961 . . . . 0.0 111.36 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.0 mt -142.48 -53.87 0.41 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.841 0.856 . . . . 0.0 109.593 -163.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.0 115.28 20.4 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 154.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -122.61 70.45 1.0 Allowed 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -162.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -88.77 120.08 29.85 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.636 -1.29 . . . . 0.0 113.06 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.15 114.57 24.66 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 161.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 m -75.57 121.2 22.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.65 -69.18 0.34 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.771 0.828 . . . . 0.0 111.791 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.07 121.89 26.24 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.42 169.02 23.45 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.811 2.341 . . . . 0.0 113.682 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.02 176.42 40.44 Favored Glycine 0 CA--C 1.562 3.018 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.73 163.45 35.21 Favored 'Trans proline' 0 CA--C 1.573 2.437 0 C-N-CA 123.047 2.498 . . . . 0.0 115.36 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.46 107.81 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.219 2.613 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.98 89.85 1.55 Allowed Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -164.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -133.08 109.48 9.54 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.7 p -77.99 129.76 35.68 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.176 0.512 . . . . 0.0 112.134 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -92.14 113.0 57.77 Favored Pre-proline 0 CA--C 1.577 2.002 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.818 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -68.67 155.02 70.24 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 122.956 2.437 . . . . 0.0 117.511 -161.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.66 165.31 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.897 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.55 105.23 5.57 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.737 0.779 . . . . 0.0 111.534 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.73 48.6 0.84 Allowed Glycine 0 CA--C 1.55 2.235 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.391 -164.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -154.84 110.95 3.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.03 115.16 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.429 0.691 . . . . 0.0 109.826 -163.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.89 129.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.528 0.731 . . . . 0.0 110.863 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.429 ' HG1' HG21 ' A' ' 87' ' ' VAL . 33.9 m -89.73 129.76 36.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 168.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -144.9 129.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -170.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -99.01 101.76 13.25 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.21 1.004 . . . . 0.0 108.463 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.32 127.54 55.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.149 0.58 . . . . 0.0 109.742 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -108.97 80.87 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.908 0.483 . . . . 0.0 110.214 -166.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.531 ' HG1' ' HB3' ' A' ' 139' ' ' LEU . 11.8 m -78.83 127.45 32.05 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.437 0.637 . . . . 0.0 110.49 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -148.87 151.18 34.26 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.287 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.32 145.01 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.57 76.78 8.48 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 122.414 1.102 . . . . 0.0 110.277 168.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -172.22 -63.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.197 1.399 . . . . 0.0 107.27 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.62 -62.59 0.16 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 119.516 -0.602 . . . . 0.0 113.193 -173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 133.98 33.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 117.502 0.651 . . . . 0.0 110.149 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 142.68 46.39 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.88 -74.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -145.12 118.66 9.1 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -97.86 93.0 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 109.948 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mp0 -72.92 113.59 23.01 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.818 -172.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -53.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.991 2.46 . . . . 0.0 116.111 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 144' ' ' LYS . 3.2 tp10 -125.82 70.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 118.947 0.794 . . . . 0.0 110.705 -172.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.92 113.83 26.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG21 ' HG1' ' A' ' 67' ' ' THR . 96.6 t -106.76 100.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -174.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -113.06 146.57 38.9 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.042 0.537 . . . . 0.0 111.08 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.1 m -80.08 128.15 33.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.72 110.33 8.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.47 -67.1 0.25 Allowed Glycine 0 N--CA 1.48 1.583 0 CA-C-O 119.406 -0.663 . . . . 0.0 112.955 -167.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.42 85.94 7.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.523 0.678 . . . . 0.0 109.961 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 83.9 m -95.38 115.31 27.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.432 0.634 . . . . 0.0 112.373 -158.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -58.73 -38.41 78.31 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 159.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.3 m -71.13 164.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.639 1.209 . . . . 0.0 114.157 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.39 171.6 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.569 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -57.16 -40.06 76.49 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.85 -43.63 86.02 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.92 -49.07 61.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.559 -1.21 . . . . 0.0 114.111 170.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -49.54 -49.84 44.47 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.0 -44.31 94.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.1 p -87.23 49.41 1.81 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.3 t -96.56 -57.41 0.19 Allowed Pre-proline 0 CA--C 1.572 1.827 0 CA-C-O 115.226 -2.321 . . . . 0.0 109.195 163.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.85 -7.7 11.91 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.497 2.999 . . . . 0.0 118.776 174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.88 -34.84 15.09 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.77 1.168 . . . . 0.0 113.728 162.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.86 116.51 7.81 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.216 1.371 . . . . 0.0 112.806 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -85.73 149.46 25.27 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.129 0.966 . . . . 0.0 112.009 167.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.73 105.32 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.84 -33.4 2.84 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.763 -164.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.31 132.37 43.01 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 120.818 2.309 . . . . 0.0 115.047 -170.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -96.86 122.96 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 162.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.42 122.33 9.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 120.892 0.377 . . . . 0.0 111.415 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.5 ttt -82.83 105.79 14.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.327 0.651 . . . . 0.0 109.834 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.14 119.51 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.5 p -94.35 78.22 3.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.41 144.3 49.83 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 152.48 45.34 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.2 t -76.89 69.15 3.18 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.672 1.225 . . . . 0.0 111.689 167.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -176.45 -64.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.477 1.511 . . . . 0.0 108.001 -164.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -79.27 -31.56 43.44 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.5 t -69.0 -75.98 0.1 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.166 1.348 . . . . 0.0 112.064 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.97 43.7 2.93 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.281 1.4 . . . . 0.0 112.55 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.09 176.25 6.69 Favored Glycine 0 CA--C 1.56 2.86 0 N-CA-C 116.467 1.347 . . . . 0.0 116.467 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.6 67.59 8.55 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 CA-C-N 120.979 2.389 . . . . 0.0 111.709 160.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -158.7 -66.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.498 1.119 . . . . 0.0 108.072 -169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.17 120.19 2.91 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 118.775 0.716 . . . . 0.0 111.776 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.04 67.42 1.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m 67.39 143.53 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 166.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.81 -42.62 0.78 Allowed 'Cis proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.804 2.037 . . . . 0.0 117.111 -1.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -138.15 68.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.42 1.009 . . . . 0.0 109.913 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.81 117.07 44.81 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 172.57 13.78 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 C-N-CA 123.006 2.471 . . . . 0.0 114.075 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.0 2.35 2.7 Favored 'Trans proline' 0 CA--C 1.567 2.126 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -148.56 90.24 1.77 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.27 114.28 3.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.99 107.57 13.92 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.2 125.04 35.85 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.015 0.912 . . . . 0.0 110.703 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 29.4 m -97.81 95.4 7.51 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.927 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.531 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -99.7 119.01 37.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.196 0.599 . . . . 0.0 110.091 174.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -88.49 103.61 16.04 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.275 1.036 . . . . 0.0 109.841 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.38 103.63 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.295 -1.32 . . . . 0.0 107.653 -170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -94.06 108.52 20.34 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.02 105.88 12.59 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 85' ' ' GLU . 62.3 mttt -77.88 -72.27 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -144.77 135.84 25.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 118.8 0.727 . . . . 0.0 109.886 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.64 111.12 23.31 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.96 138.77 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.05 148.5 50.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -96.3 115.98 5.33 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.151 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.66 155.51 31.36 Favored 'Trans proline' 0 CA--C 1.562 1.924 0 CA-C-N 122.445 3.122 . . . . 0.0 113.821 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.13 -83.64 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -172.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 62.76 71.03 0.53 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.687 1.195 . . . . 0.0 113.184 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.327 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -146.4 93.78 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.788 0.435 . . . . 0.0 109.995 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.23 133.38 35.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.136 0.574 . . . . 0.0 111.255 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.25 82.2 m95 75.51 103.11 0.07 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.924 1.289 . . . . 0.0 110.099 -176.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.1 97.48 9.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.27 129.79 37.19 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.593 1.187 . . . . 0.0 113.365 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 pt -103.42 66.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.867 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 tp -163.0 -60.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.399 0.68 . . . . 0.0 110.187 -164.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.4 44.49 3.72 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -161.05 -80.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.65 58.01 0.01 OUTLIER Glycine 0 CA--C 1.543 1.808 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.248 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 mt -131.06 -54.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.843 0.857 . . . . 0.0 110.978 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.9 tp -87.01 102.35 14.32 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 108.991 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.73 90.06 3.18 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 122.885 0.474 . . . . 0.0 111.375 -161.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.04 93.79 8.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.814 -1.179 . . . . 0.0 111.106 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -99.32 122.91 43.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.356 0.662 . . . . 0.0 109.251 168.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.9 m -80.58 117.03 20.93 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.131 0.572 . . . . 0.0 109.916 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -79.87 -71.68 0.44 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.957 0.903 . . . . 0.0 110.512 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.14 123.18 45.87 Favored Pre-proline 0 CA--C 1.573 1.845 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.74 157.59 51.77 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.921 2.414 . . . . 0.0 114.85 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.37 116.56 4.25 Favored Glycine 0 CA--C 1.55 2.233 0 CA-C-O 116.807 -2.107 . . . . 0.0 112.9 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.11 142.02 37.34 Favored 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 122.658 3.229 . . . . 0.0 114.315 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 113.19 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.045 2.497 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.81 -85.92 0.11 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 t -85.12 109.21 18.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.1 p -111.17 172.11 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.085 0.945 . . . . 0.0 112.907 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -50.64 122.7 16.62 Favored Pre-proline 0 CA--C 1.582 2.182 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.02 162.09 37.66 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.089 2.526 . . . . 0.0 115.799 -171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 167.56 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.465 1.126 . . . . 0.0 112.22 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -64.57 126.72 28.77 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.729 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.31 59.79 1.08 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.251 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -146.27 139.69 25.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.38 102.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.65 120.6 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.505 ' HB ' ' HG1' ' A' ' 145' ' ' THR . 10.0 m -100.03 142.62 31.27 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.39 0.676 . . . . 0.0 109.444 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.98 141.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.589 0.756 . . . . 0.0 109.638 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -83.16 109.67 17.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 160.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -95.62 113.18 24.8 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -94.02 91.27 6.78 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 m -82.94 116.94 22.44 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HG ' ' HA ' ' A' ' 79' ' ' ARG . 70.8 m -145.19 171.59 14.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.303 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.21 130.94 55.75 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.61 -38.92 79.04 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -65.29 -48.18 74.04 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 163.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.89 -116.51 4.14 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 119.245 0.929 . . . . 0.0 112.564 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.584 ' HG1' ' H ' ' A' ' 79' ' ' ARG . 5.5 t -153.69 -176.39 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.77 0.795 . . . . 0.0 111.909 -168.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.584 ' H ' ' HG1' ' A' ' 78' ' ' THR . 35.8 ptt180 -61.53 122.69 15.86 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.49 -49.88 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.45 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -146.59 103.42 3.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -84.88 82.04 8.62 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.346 1.069 . . . . 0.0 111.459 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.49 112.02 58.75 Favored Pre-proline 0 CA--C 1.576 1.947 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.533 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.33 -61.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.181 2.588 . . . . 0.0 116.364 -169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -97.82 74.08 2.33 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.222 1.374 . . . . 0.0 111.18 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.23 92.39 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.16 139.07 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.048 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.45 155.39 33.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.59 -172.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.7 m -77.97 131.22 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.42 116.27 4.17 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.825 0.85 . . . . 0.0 112.467 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.6 55.26 8.73 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -152.28 150.82 30.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.261 1.029 . . . . 0.0 110.081 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -74.89 81.96 2.16 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 122.824 1.297 . . . . 0.0 114.033 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -130.92 -60.48 0.97 Allowed 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.222 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.52 172.21 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.513 1.125 . . . . 0.0 113.138 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.67 161.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.28 -45.56 90.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.67 77.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -54.53 17.83 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.998 0.919 . . . . 0.0 112.863 172.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -49.28 -50.92 36.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.5 -39.98 77.69 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.2 p -84.22 22.91 1.14 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -74.0 -54.84 3.37 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.382 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.05 61.4 8.19 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 CA-C-N 125.39 2.961 . . . . 0.0 114.642 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.6 mt -155.96 -48.31 0.08 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.628 1.571 . . . . 0.0 109.66 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -76.54 107.12 8.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.523 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.79 169.88 17.28 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.961 167.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.05 106.88 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.884 -1.135 . . . . 0.0 108.413 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 10.34 46.19 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -163.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.98 93.99 6.05 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.504 2.152 . . . . 0.0 109.812 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.3 m -88.54 136.38 33.02 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.168 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.75 138.19 8.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.936 0.494 . . . . 0.0 110.112 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.1 ptm -83.04 124.77 30.75 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.03 71.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -84.93 113.76 21.64 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.6 -0.687 . . . . 0.0 109.414 -164.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.11 154.23 26.94 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.855 0.862 . . . . 0.0 112.051 -167.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -52.33 147.98 7.25 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 168.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.0 p -68.89 78.14 0.31 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.84 1.305 . . . . 0.0 112.619 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -176.12 -60.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.797 -151.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.02 -51.81 23.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.9 m -67.35 -80.34 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -158.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.12 72.3 1.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.32 -142.87 47.75 Favored Glycine 0 CA--C 1.562 3.01 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.78 -164.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.78 50.58 1.91 Allowed 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 122.892 2.395 . . . . 0.0 113.661 165.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 56.0 85.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.905 1.282 . . . . 0.0 113.769 -168.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 162.0 74.06 0.02 OUTLIER Glycine 0 N--CA 1.481 1.687 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.544 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 69.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.7 m 68.53 127.9 0.03 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 166.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.82 -44.8 0.36 Allowed 'Cis proline' 0 CA--C 1.565 2.029 0 CA-C-N 123.009 2.11 . . . . 0.0 116.39 2.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.29 82.35 1.42 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.57 99.08 46.36 Favored Pre-proline 0 CA--C 1.57 1.745 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.34 134.08 12.42 Favored 'Trans proline' 0 CA--C 1.567 2.175 0 C-N-CA 122.828 2.352 . . . . 0.0 113.799 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.66 154.31 64.26 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.137 2.558 . . . . 0.0 115.297 -172.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.256 15.5 m170 82.2 137.61 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.41 1.084 . . . . 0.0 112.069 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.258 . . 73.29 136.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.843 1.257 . . . . 0.0 113.236 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.88 169.73 11.01 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -158.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tt -115.3 125.6 53.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.349 1.06 . . . . 0.0 110.33 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -87.3 118.45 26.74 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.105 0.962 . . . . 0.0 110.971 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.22 111.88 11.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.73 103.67 15.59 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.119 0.485 . . . . 0.0 110.726 -169.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.25 101.18 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.0 m -109.19 121.89 46.14 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.23 105.59 11.6 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.626 0.37 . . . . 0.0 110.162 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -78.61 -69.73 0.54 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.505 ' HG1' ' HB ' ' A' ' 67' ' ' THR . 29.8 p -132.37 143.57 49.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.334 0.588 . . . . 0.0 109.59 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.32 100.13 5.27 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.44 149.66 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.963 0.905 . . . . 0.0 109.002 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -65.59 163.56 15.96 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -117.99 86.43 0.41 Allowed Glycine 0 CA--C 1.548 2.102 0 CA-C-O 117.225 -1.875 . . . . 0.0 113.529 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.49 119.03 3.65 Favored 'Trans proline' 0 CA--C 1.558 1.69 0 CA-C-N 121.702 2.751 . . . . 0.0 111.571 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.98 112.44 10.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.693 0.758 . . . . 0.0 112.873 -168.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.6 128.58 44.96 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.996 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 123.162 1.458 . . . . 0.0 111.639 175.834 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.55 0.947 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -143.24 95.92 2.84 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.041 0.536 . . . . 0.0 110.714 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.268 14.7 tp10 68.06 157.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 160.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -69.76 151.76 45.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.913 167.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.34 98.81 9.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.037 0.535 . . . . 0.0 109.992 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.06 120.89 20.27 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 122.058 0.933 . . . . 0.0 112.146 171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.21 -80.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -165.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.64 120.9 23.45 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.85 2.74 0.07 OUTLIER Glycine 0 CA--C 1.543 1.81 0 CA-C-O 117.51 -1.717 . . . . 0.0 116.701 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.364 12.5 p30 49.01 56.86 7.13 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 120.281 2.04 . . . . 0.0 114.727 -165.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 54.61 6.57 Favored Glycine 0 CA--C 1.546 1.991 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 99.4 mt -126.21 -66.47 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.478 1.139 . . . . 0.0 110.299 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 tp -82.86 111.44 18.76 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.444 1.02 . . . . 0.0 109.921 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -115.81 144.27 44.23 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.502 0.721 . . . . 0.0 112.606 -173.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HZ2' ' HA ' ' A' ' 102' ' ' SER . 0.9 OUTLIER -131.02 136.07 48.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 0.0 112.095 176.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.8 121.14 40.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 158.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.2 m -75.63 109.16 8.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.19 -61.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.736 0.815 . . . . 0.0 112.592 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.68 108.02 56.41 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.66 148.44 17.95 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.952 2.435 . . . . 0.0 113.989 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.49 118.76 7.37 Favored Glycine 0 CA--C 1.555 2.562 0 CA-C-O 116.986 -2.008 . . . . 0.0 114.882 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.33 168.35 23.69 Favored 'Trans proline' 0 CA--C 1.573 2.472 0 CA-C-N 122.306 3.053 . . . . 0.0 115.452 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.7 116.72 4.1 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 123.195 2.597 . . . . 0.0 113.021 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.27 69.75 1.18 Allowed Glycine 0 CA--C 1.545 1.91 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.319 -163.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -150.9 117.51 5.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -70.53 140.31 51.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -117.64 121.27 32.08 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-O 117.73 -1.129 . . . . 0.0 109.389 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.0 145.92 40.69 Favored 'Trans proline' 0 CA--C 1.558 1.689 0 C-N-CA 122.606 2.204 . . . . 0.0 114.657 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.28 154.68 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.63 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.24 107.89 1.16 Allowed 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.898 0.879 . . . . 0.0 112.425 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.37 69.12 0.87 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.391 -158.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -153.75 127.29 8.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -77.61 100.12 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.43 140.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.945 0.898 . . . . 0.0 109.437 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.43 ' HB ' ' HG1' ' A' ' 145' ' ' THR . 61.9 m -89.22 127.26 35.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 164.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.41 130.3 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.151 0.977 . . . . 0.0 109.244 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -98.12 95.25 7.31 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.7 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.59 131.45 55.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.547 0.739 . . . . 0.0 109.297 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' HA ' ' H ' ' A' ' 82' ' ' GLU . 13.3 mm-40 -139.08 116.09 10.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.8 m -88.06 119.08 28.09 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.296 -168.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -88.95 129.16 35.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.711 0.804 . . . . 0.0 110.599 170.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.76 140.82 37.09 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.444 0.64 . . . . 0.0 109.854 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -52.79 -45.92 67.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -93.16 90.89 7.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.06 69.12 1.4 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 117.411 1.724 . . . . 0.0 117.411 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.409 1.7 t 53.51 -168.09 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 158.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.364 9.2 ptp180 -77.14 104.9 7.9 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -170.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.79 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-N 112.214 -2.266 . . . . 0.0 116.086 165.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 80.02 112.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' H ' ' HA ' ' A' ' 71' ' ' GLN . 5.3 mm-40 -116.92 69.03 0.75 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 72.43 96.57 0.04 OUTLIER Pre-proline 0 CA--C 1.578 2.054 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 167.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.13 -19.09 39.61 Favored 'Trans proline' 0 CA--C 1.56 1.819 0 N-CA-C 119.047 2.672 . . . . 0.0 119.047 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.02 86.03 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.297 1.408 . . . . 0.0 109.259 164.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -87.53 116.68 25.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.1 133.53 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 123.434 0.694 . . . . 0.0 109.404 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.93 148.93 19.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.119 0.568 . . . . 0.0 111.185 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -70.42 130.35 41.69 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.39 0.676 . . . . 0.0 109.563 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 tp -51.27 -36.93 44.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -161.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.69 -102.65 0.55 Allowed Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.472 162.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.42 0.5 OUTLIER 62.2 169.48 0.12 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.16 17.89 23.27 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.37 -51.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 120.288 1.404 . . . . 0.0 113.318 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.0 167.06 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.412 1.101 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.0 pt -68.08 160.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.295 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.58 -36.69 76.72 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.8 73.11 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 167.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -48.98 58.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.44 -37.28 67.5 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.48 -32.66 60.65 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.4 ' HA ' ' HZ2' ' A' ' 47' ' ' LYS . 86.7 p -75.27 -11.93 60.17 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 165.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.287 1.3 t -54.66 -49.58 90.49 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 115.477 -2.202 . . . . 0.0 115.255 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.19 -13.46 32.21 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 125.127 2.867 . . . . 0.0 119.514 175.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.12 77.96 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.523 1.51 . . . . 0.0 108.886 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -162.45 109.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -88.69 168.36 12.57 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.166 0.984 . . . . 0.0 112.283 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.49 124.86 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.13 88.4 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -110.39 130.04 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.833 2.316 . . . . 0.0 113.244 -159.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 m -78.05 133.5 37.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.009 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.7 tpt -80.53 106.63 12.69 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.9 115.24 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 p -94.58 100.9 12.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.01 125.84 36.86 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.89 -172.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.79 165.24 17.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.4 p -53.12 -42.77 66.34 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 162.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.75 -43.87 87.62 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 164.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -103.36 67.34 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.398 0.679 . . . . 0.0 110.175 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.8 t -148.15 -93.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.59 42.21 3.32 Favored 'General case' 0 CA--C 1.574 1.879 0 CA-C-N 119.758 1.163 . . . . 0.0 111.527 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 56.98 -109.17 1.52 Allowed Glycine 0 CA--C 1.557 2.71 0 CA-C-O 117.454 -1.748 . . . . 0.0 115.109 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.34 -50.46 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 CA-C-N 121.439 2.619 . . . . 0.0 115.782 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -152.05 133.2 14.36 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.162 0.985 . . . . 0.0 108.54 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.15 -124.6 5.21 Favored Glycine 0 N--CA 1.481 1.643 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.865 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -88.02 68.08 9.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.43 0.692 . . . . 0.0 111.775 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -75.4 137.11 71.42 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.116 -172.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.04 -6.15 53.88 Favored 'Cis proline' 0 CA--C 1.568 2.216 0 N-CA-C 119.494 2.844 . . . . 0.0 119.494 9.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -57.94 -51.83 68.02 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.45 98.71 11.27 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 167.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.25 164.06 37.04 Favored 'Trans proline' 0 CA--C 1.572 2.389 0 C-N-CA 122.703 2.269 . . . . 0.0 114.137 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.47 111.25 2.27 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 123.072 2.515 . . . . 0.0 113.375 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 70.71 99.29 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.656 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.6 132.77 16.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.252 0.621 . . . . 0.0 110.364 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.89 85.11 4.68 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 109.908 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.11 147.5 41.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.014 0.911 . . . . 0.0 112.642 -161.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.2 m -76.55 152.2 36.06 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.84 129.72 4.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.809 0.843 . . . . 0.0 110.218 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.67 98.74 11.6 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.588 . . . . 0.0 110.852 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.4 100.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.1 m -109.17 123.98 50.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.97 117.37 17.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -82.63 -66.19 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.43 ' HG1' ' HB ' ' A' ' 67' ' ' THR . 44.3 p -131.26 147.57 52.6 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 -169.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.18 107.72 11.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 167.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.58 147.31 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.474 -170.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.62 144.39 49.47 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -75.82 120.69 6.06 Favored Glycine 0 CA--C 1.556 2.6 0 CA-C-O 116.923 -2.043 . . . . 0.0 114.671 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.77 112.16 2.86 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 CA-C-N 122.466 3.133 . . . . 0.0 112.54 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.51 124.61 34.17 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 121.314 0.578 . . . . 0.0 111.476 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 tt 71.99 91.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.903 1.281 . . . . 0.0 111.085 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.222 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 CA--C 1.551 1.007 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -150.83 136.69 18.2 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.687 0.756 . . . . 0.0 110.887 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 116.29 7.5 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.012 0.925 . . . . 0.0 111.98 173.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' HB2' ' HE ' ' A' ' 46' ' ' ARG . 50.2 m95 73.11 134.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.383 1.073 . . . . 0.0 111.516 -175.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.612 0.765 . . . . 0.0 109.724 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.92 104.46 8.49 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.083 0.953 . . . . 0.0 111.927 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -98.52 130.41 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.436 0.6 OUTLIER 101.15 -66.5 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.231 1.812 . . . . 0.0 111.641 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.57 -70.62 0.08 OUTLIER Glycine 0 N--CA 1.484 1.835 0 CA-C-N 120.034 1.288 . . . . 0.0 114.33 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -73.26 -71.0 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.65 0.78 . . . . 0.0 111.341 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.89 61.28 0.05 OUTLIER Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.31 -0.717 . . . . 0.0 112.321 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.2 -58.72 2.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.638 0.719 . . . . 0.0 110.924 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.51 114.79 29.18 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 36' ' ' TRP . 22.7 mtp85 -115.03 108.87 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.84 0.456 . . . . 0.0 111.197 -168.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -99.48 116.0 30.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.992 -1.067 . . . . 0.0 111.987 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -85.77 119.69 26.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.01 -1.057 . . . . 0.0 108.681 158.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.7 m -90.46 108.66 19.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -71.61 -65.45 0.76 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.166 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.46 136.4 21.47 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.166 164.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.17 176.91 9.4 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 123.0 2.467 . . . . 0.0 114.605 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.9 116.16 5.86 Favored Glycine 0 CA--C 1.558 2.729 0 CA-C-O 117.061 -1.966 . . . . 0.0 111.335 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.64 167.12 27.37 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 CA-C-N 122.55 3.175 . . . . 0.0 115.626 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.98 111.96 2.35 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.072 2.515 . . . . 0.0 112.334 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.54 76.3 1.32 Allowed Glycine 0 CA--C 1.544 1.868 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.661 -161.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.1 p -155.28 131.42 10.19 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.423 0.689 . . . . 0.0 109.744 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -117.27 119.93 36.69 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.457 1.123 . . . . 0.0 112.327 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -73.92 116.67 54.46 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.143 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.03 162.63 40.92 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 122.867 2.378 . . . . 0.0 116.047 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.01 158.7 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.213 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.63 77.74 9.8 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.13 0.966 . . . . 0.0 113.356 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.32 47.07 0.01 OUTLIER Glycine 0 CA--C 1.551 2.315 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.053 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.43 25.4 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.581 1.19 . . . . 0.0 109.269 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.86 103.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.691 0.796 . . . . 0.0 109.858 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.53 113.26 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.9 m -88.48 105.33 17.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.77 141.86 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.64 108.25 3.78 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 109.346 165.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.76 92.57 3.84 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 HE22 ' HG ' ' A' ' 73' ' ' SER . 1.5 tm0? -94.39 105.8 17.77 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -172.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -85.26 101.96 12.95 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.162 0.506 . . . . 0.0 109.743 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.475 ' HG ' HE22 ' A' ' 71' ' ' GLN . 36.8 m -121.65 157.07 31.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.381 1.073 . . . . 0.0 109.818 171.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.89 103.8 15.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.601 -0.687 . . . . 0.0 109.962 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.396 26.3 tt0 68.27 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 169.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.53 61.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.291 0.636 . . . . 0.0 111.482 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.43 66.29 2.46 Favored Glycine 0 CA--C 1.543 1.804 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -126.02 96.9 4.9 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 173.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -78.38 96.46 5.34 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -165.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 m -81.99 -50.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -152.75 134.73 14.8 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.909 0.861 . . . . 0.0 109.169 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.09 112.79 24.85 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.687 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.33 69.06 3.88 Favored Pre-proline 0 CA--C 1.585 2.289 0 O-C-N 121.446 -0.784 . . . . 0.0 110.953 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.96 -54.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.255 2.637 . . . . 0.0 115.487 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.83 76.61 6.51 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 121.4 1.909 . . . . 0.0 112.536 164.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.58 97.83 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.59 109.01 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -136.05 139.64 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 m -69.28 132.6 46.71 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 tt -69.57 109.68 4.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 80.24 0.98 Allowed Glycine 0 CA--C 1.54 1.644 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.552 -162.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -149.34 160.7 43.19 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.275 1.036 . . . . 0.0 110.793 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.6 p -79.93 71.0 6.6 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.268 1.032 . . . . 0.0 113.433 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -150.58 -62.91 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.479 1.111 . . . . 0.0 110.092 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.84 158.9 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 CA-C-O 123.173 1.463 . . . . 0.0 112.216 -161.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -66.3 152.99 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.726 177.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -57.89 -33.55 68.84 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.51 -46.76 57.42 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -57.65 5.54 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 112.473 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -58.52 -34.24 70.75 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.37 -38.0 77.84 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 167.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -70.49 -20.49 62.85 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.258 54.7 t -62.73 -52.45 64.46 Favored Pre-proline 0 CA--C 1.577 1.995 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.629 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.41 10.47 0.44 Allowed 'Trans proline' 0 CA--C 1.572 2.393 0 CA-C-N 124.703 2.715 . . . . 0.0 118.521 171.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.06 -46.28 5.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.245 1.018 . . . . 0.0 111.59 158.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.0 128.92 35.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.637 1.108 . . . . 0.0 113.013 -173.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -94.97 -147.71 0.28 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 123.153 0.581 . . . . 0.0 111.187 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.97 123.79 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.629 -1.294 . . . . 0.0 110.363 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.77 -103.07 2.97 Favored Glycine 0 CA--C 1.54 1.608 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -168.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 32.57 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -168.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.598 ' HA ' ' HG1' ' A' ' 142' ' ' THR . 30.5 m -82.06 115.71 21.32 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.58 123.35 11.91 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.324 0.583 . . . . 0.0 110.01 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.9 ttp -76.98 104.97 7.77 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.705 0.802 . . . . 0.0 110.544 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.91 97.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.3 m -99.37 104.22 16.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.18 37.26 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.794 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -48.91 134.24 17.0 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 165.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -51.04 -39.01 54.92 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.254 14.5 pttp -58.69 -41.26 85.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -66.9 -49.79 64.48 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 171.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.03 -160.71 0.34 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.822 0.849 . . . . 0.0 112.295 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -85.73 101.52 12.84 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.91 -91.6 1.78 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 116.866 -2.075 . . . . 0.0 109.66 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.59 -46.53 3.69 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 122.073 2.936 . . . . 0.0 116.253 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -91.3 98.64 11.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -90.42 134.43 12.34 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 115.336 -0.847 . . . . 0.0 115.117 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -113.51 91.44 3.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.889 0.476 . . . . 0.0 109.848 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.4 m 72.68 103.58 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.763 0 CA-C-O 117.476 -1.249 . . . . 0.0 112.003 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.63 -70.07 0.01 OUTLIER 'Cis proline' 0 CA--C 1.565 2.061 0 CA-C-N 122.923 2.08 . . . . 0.0 112.032 8.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.02 78.69 1.62 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 168.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.2 mt -67.29 121.96 80.87 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 -162.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.13 155.17 29.42 Favored 'Trans proline' 0 CA--C 1.569 2.267 0 C-N-CA 122.762 2.308 . . . . 0.0 115.214 -170.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.55 146.6 44.37 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.238 2.626 . . . . 0.0 113.459 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.267 22.4 m170 77.09 157.7 0.19 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.458 1.103 . . . . 0.0 112.245 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.12 127.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.984 1.314 . . . . 0.0 111.705 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.14 114.93 15.35 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.684 0.394 . . . . 0.0 112.038 -174.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.14 130.23 34.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.523 0.729 . . . . 0.0 110.895 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.6 p -85.66 93.33 8.81 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.564 0.746 . . . . 0.0 112.444 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.13 107.91 19.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.743 0.817 . . . . 0.0 109.01 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -85.36 105.99 16.41 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.663 0.744 . . . . 0.0 111.184 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.5 t -90.74 123.44 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.521 1.128 . . . . 0.0 107.969 -173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.598 ' HG1' ' HA ' ' A' ' 111' ' ' THR . 7.9 m -135.94 126.6 27.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 tp -75.45 109.89 9.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.913 -0.492 . . . . 0.0 110.229 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -81.18 -59.54 2.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.382 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.0 p -140.28 132.35 27.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.366 0.667 . . . . 0.0 109.388 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -105.52 112.61 25.77 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.48 138.13 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.516 0.674 . . . . 0.0 109.608 -170.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.52 155.95 35.61 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.195 0.997 . . . . 0.0 113.643 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.92 120.81 17.46 Favored Glycine 0 CA--C 1.559 2.795 0 CA-C-O 116.963 -2.021 . . . . 0.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.47 121.77 5.76 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 CA-C-N 122.494 3.147 . . . . 0.0 113.717 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.35 -60.17 2.3 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.57 123.28 29.6 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.377 0.671 . . . . 0.0 110.648 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.486 1.363 0 C-N-CA 123.142 0.577 . . . . 0.0 109.747 177.178 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.407 1.1 mm-40 . . . . . 0 CA--C 1.576 1.979 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -104.37 162.96 12.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.997 1.319 . . . . 0.0 110.052 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.59 107.55 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 109.488 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.09 129.7 54.79 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 121.644 0.735 . . . . 0.0 111.744 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.64 -48.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.003 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.22 -70.3 0.25 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 120.111 1.323 . . . . 0.0 113.982 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.79 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.28 -52.19 13.03 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.6 -124.03 0.7 Allowed Glycine 0 CA--C 1.54 1.599 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . 0.377 5.3 mp 72.93 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.115 1.366 . . . . 0.0 112.481 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.98 95.72 10.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -109.38 90.13 3.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -97.37 96.82 8.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.587 -0.696 . . . . 0.0 110.572 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.61 103.11 7.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.488 -0.758 . . . . 0.0 110.415 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.4 m -83.21 100.74 10.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.37 -65.36 1.02 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.616 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -84.2 128.28 62.96 Favored Pre-proline 0 CA--C 1.575 1.931 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 167.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.77 -56.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.953 2.435 . . . . 0.0 116.26 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.72 101.29 0.89 Allowed Glycine 0 CA--C 1.547 2.034 0 CA-C-O 116.71 -2.161 . . . . 0.0 107.887 -162.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.21 162.75 40.53 Favored 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 122.631 3.215 . . . . 0.0 116.42 -164.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.36 130.64 22.91 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.243 2.629 . . . . 0.0 113.701 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.79 -69.16 0.21 Allowed Glycine 0 CA--C 1.542 1.744 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -160.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -82.05 94.16 7.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.397 0.679 . . . . 0.0 111.165 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.0 m -128.09 166.49 18.35 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.983 0.897 . . . . 0.0 111.813 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 134.87 33.73 Favored Pre-proline 0 CA--C 1.577 2.0 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -165.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.33 144.84 11.78 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.133 2.556 . . . . 0.0 114.765 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.4 156.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 124.019 0.927 . . . . 0.0 109.32 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.83 89.09 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -160.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.11 61.15 0.01 OUTLIER Glycine 0 CA--C 1.546 1.988 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.989 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -151.16 144.43 24.76 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.08 94.19 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.78 141.66 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.603 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -124.09 128.21 48.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.579 -167.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.67 150.42 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.3 1.047 . . . . 0.0 110.5 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -96.63 107.55 20.01 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 tt -112.25 106.24 14.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -104.77 120.08 40.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -91.58 126.31 36.61 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -124.3 162.77 23.06 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.132 0.968 . . . . 0.0 110.563 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -83.58 153.27 24.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.326 -0.858 . . . . 0.0 111.815 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -50.86 -45.17 59.76 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 163.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -124.62 63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.44 0.564 . . . . 0.0 110.348 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.39 -116.52 0.59 Allowed Glycine 0 CA--C 1.538 1.485 0 O-C-N 121.178 -0.951 . . . . 0.0 112.128 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.6 t -158.01 -169.38 2.79 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.713 0.805 . . . . 0.0 111.168 -164.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.4 111.67 1.17 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.09 -52.13 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.009 1.324 . . . . 0.0 111.34 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -150.52 107.59 3.58 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -97.45 100.7 12.13 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.523 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.31 90.4 42.05 Favored Pre-proline 0 CA--C 1.572 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.77 -6.16 15.07 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 N-CA-C 120.055 3.06 . . . . 0.0 120.055 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -127.64 102.84 7.01 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.45 1.477 . . . . 0.0 110.071 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -126.8 97.65 5.07 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.69 136.58 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.924 0.889 . . . . 0.0 109.308 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -164.87 154.32 13.12 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.607 0.763 . . . . 0.0 111.032 -169.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.8 m -76.75 137.97 39.64 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.393 0.616 . . . . 0.0 110.398 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.04 115.93 11.85 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.974 0.909 . . . . 0.0 109.98 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.54 73.01 0.97 Allowed Glycine 0 N--CA 1.481 1.639 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.724 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.99 149.5 19.68 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.873 0.844 . . . . 0.0 110.624 -168.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 76.9 m -77.49 80.71 3.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.58 1.181 . . . . 0.0 112.113 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.49 -65.27 0.24 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.856 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -81.08 164.73 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-O 122.437 1.113 . . . . 0.0 112.397 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.84 159.35 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.514 1.126 . . . . 0.0 113.983 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -55.52 -40.23 71.52 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -44.48 71.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.96 -67.67 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 117.199 -1.382 . . . . 0.0 111.616 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -46.48 -42.43 15.52 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.86 -51.51 66.71 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.3 p -77.48 -4.51 45.88 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.304 1.6 t -68.26 -45.64 38.8 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 114.892 -2.48 . . . . 0.0 114.976 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.93 -30.14 91.06 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 CA-C-N 126.77 3.454 . . . . 0.0 117.489 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -100.49 70.66 1.48 Allowed 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.213 1.005 . . . . 0.0 111.146 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -136.32 107.65 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.26 136.52 37.07 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.997 0.903 . . . . 0.0 111.63 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.93 114.17 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.883 -158.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.29 44.75 2.5 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.571 -1.195 . . . . 0.0 115.496 -166.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.39 167.28 12.39 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 118.837 1.318 . . . . 0.0 113.713 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 95.3 m -143.31 108.38 4.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.94 121.34 15.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.315 0.246 . . . . 0.0 110.751 -166.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 ttt -81.57 115.99 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.853 0.461 . . . . 0.0 110.168 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.99 100.61 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.0 p -84.41 97.65 9.62 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.35 32.05 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.343 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.67 144.91 53.81 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t -58.56 -38.63 78.24 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -69.71 -37.46 76.57 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.23 -44.15 92.76 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 169.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.9 t -91.24 -179.66 5.48 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 123.062 1.41 . . . . 0.0 111.49 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.25 113.79 3.41 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.022 158.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.41 -89.38 0.08 OUTLIER Glycine 0 CA--C 1.546 1.986 0 CA-C-O 116.792 -2.115 . . . . 0.0 109.077 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.15 -57.14 0.13 Allowed 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 122.307 3.053 . . . . 0.0 114.295 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -89.13 103.21 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.57 -118.75 0.47 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.051 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -141.9 60.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.875 0.845 . . . . 0.0 111.877 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.9 p -87.85 150.64 48.42 Favored Pre-proline 0 CA--C 1.572 1.808 0 C-N-CA 124.214 1.005 . . . . 0.0 113.129 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.12 -7.33 46.59 Favored 'Cis proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.552 2.866 . . . . 0.0 119.552 11.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.83 -57.71 9.93 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 120.278 1.399 . . . . 0.0 113.854 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.1 mt -90.28 117.84 68.34 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.47 161.4 9.57 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.875 2.383 . . . . 0.0 116.095 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 131.83 21.4 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.138 2.559 . . . . 0.0 112.62 168.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.29 92.0 m-70 71.13 174.65 0.3 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 123.729 0.812 . . . . 0.0 112.306 -170.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.72 118.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.054 1.342 . . . . 0.0 111.964 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.51 97.9 8.67 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.43 149.12 21.85 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.526 0.679 . . . . 0.0 112.749 -171.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -87.77 147.05 25.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.371 0.668 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.58 109.31 3.25 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.59 120.65 26.6 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.797 0.808 . . . . 0.0 111.917 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.6 t -103.3 109.23 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.6 m -116.17 104.48 11.57 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.1 113.87 7.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.398 0.679 . . . . 0.0 110.664 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -85.16 -61.07 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.1 p -142.8 133.27 24.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.21 100.94 10.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.94 132.38 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.119 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.94 73.22 10.36 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.27 1.033 . . . . 0.0 113.766 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.344 0 CA-C-O 116.787 -2.119 . . . . 0.0 114.472 177.981 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 87.8 m95 72.57 134.05 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.504 1.122 . . . . 0.0 113.526 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.53 93.98 7.1 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.17 112.63 17.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.483 0.713 . . . . 0.0 111.265 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -64.03 -49.88 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.746 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.1 -61.07 2.91 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.8 -71.41 0.26 Allowed Glycine 0 N--CA 1.48 1.576 0 CA-C-N 118.632 0.651 . . . . 0.0 111.763 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -66.62 -72.7 0.15 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.785 0.834 . . . . 0.0 112.025 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.78 72.64 0.03 OUTLIER Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.517 0.599 . . . . 0.0 112.684 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.82 -72.98 0.66 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.31 143.71 31.09 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.999 0.92 . . . . 0.0 110.614 172.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -141.19 161.84 36.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.002 0.921 . . . . 0.0 112.473 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.87 37.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 112.182 164.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -173.48 2.34 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 122.009 0.909 . . . . 0.0 111.591 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -140.8 97.19 3.14 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 164.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.15 -69.09 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.609 0.764 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -101.78 131.63 22.62 Favored Pre-proline 0 CA--C 1.573 1.836 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 160.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 175.17 11.7 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.106 2.538 . . . . 0.0 114.53 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.73 115.34 4.96 Favored Glycine 0 CA--C 1.556 2.64 0 CA-C-O 116.879 -2.067 . . . . 0.0 112.066 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.27 169.36 15.52 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 CA-C-N 122.602 3.201 . . . . 0.0 115.597 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.68 -38.6 76.87 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 123.326 2.684 . . . . 0.0 118.182 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.7 87.61 0.94 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 118.968 0.804 . . . . 0.0 111.597 163.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.7 p -144.4 95.53 2.73 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 p -91.66 108.62 20.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.944 0.878 . . . . 0.0 110.598 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -76.41 126.67 86.02 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.59 -172.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.44 149.62 56.65 Favored 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 115.55 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.85 166.87 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.127 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -62.52 118.77 8.02 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.118 0.567 . . . . 0.0 112.438 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.58 58.41 1.13 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.287 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -143.89 135.65 26.22 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.28 101.8 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 m -122.68 128.24 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.789 0.804 . . . . 0.0 109.249 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -95.13 137.42 34.2 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.913 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 144.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.831 0.824 . . . . 0.0 109.461 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -92.05 100.66 13.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 163.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 tp -86.38 107.05 17.84 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.001 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -102.83 80.25 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 109.519 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.9 m -75.83 129.34 36.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.792 0.837 . . . . 0.0 109.991 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -139.86 164.87 28.82 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.473 1.13 . . . . 0.0 111.621 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.1 tp -78.9 161.68 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.985 0.914 . . . . 0.0 111.992 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -49.37 -42.08 41.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.61 -68.47 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.596 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.83 83.35 0.05 OUTLIER Glycine 0 N--CA 1.479 1.53 0 CA-C-N 119.117 0.871 . . . . 0.0 112.03 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -159.44 122.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.52 115.02 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.29 -45.89 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -145.43 109.16 4.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -94.33 101.64 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.458 0.647 . . . . 0.0 110.113 164.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -92.65 109.29 37.74 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.645 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.14 -51.45 0.6 Allowed 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.026 2.484 . . . . 0.0 117.308 -165.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -121.57 94.91 4.47 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.983 0.896 . . . . 0.0 111.551 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -97.23 102.98 14.87 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.15 123.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -149.7 149.21 30.26 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -170.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -75.77 124.27 27.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.34 114.89 8.0 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.536 0.734 . . . . 0.0 111.004 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.11 18.44 77.9 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 119.64 2.616 . . . . 0.0 119.64 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -132.85 66.25 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.661 1.73 . . . . 0.0 111.587 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.6 t 58.9 78.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -149.78 -66.71 0.21 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 m -97.58 167.27 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.733 1.254 . . . . 0.0 112.256 -166.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -61.09 159.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.946 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.46 -41.34 89.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.86 -46.21 71.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 168.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.7 -57.53 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.345 168.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -46.58 -58.05 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.35 -32.82 74.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.5 p -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.264 1.7 t -64.22 -49.19 74.35 Favored Pre-proline 0 N--CA 1.505 2.295 0 CA-C-N 122.391 2.36 . . . . 0.0 113.71 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.99 1.08 3.65 Favored 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 125.119 2.864 . . . . 0.0 118.61 169.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -97.27 -25.78 15.14 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 156.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 12.0 tpp -81.9 105.38 12.97 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.851 1.205 . . . . 0.0 110.441 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.34 167.48 20.83 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 122.146 0.974 . . . . 0.0 112.095 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.96 107.36 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 108.746 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 14.01 52.14 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.148 2.019 . . . . 0.0 118.148 -166.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.27 110.15 22.12 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 119.971 1.885 . . . . 0.0 109.561 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.9 m -94.29 120.36 34.41 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.22 135.31 49.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.553 0.741 . . . . 0.0 109.535 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 tpt -80.86 103.72 10.88 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.8 t -90.96 94.03 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.5 p -89.14 91.43 8.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.822 0.82 . . . . 0.0 109.487 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.71 134.87 41.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.843 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.9 132.57 47.59 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.908 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.476 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . 26.7 t -74.32 75.09 1.86 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 123.26 1.505 . . . . 0.0 112.723 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -172.17 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.481 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -87.87 -56.94 3.13 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.614 1.166 . . . . 0.0 110.179 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 118' ' ' SER . 20.1 p -46.28 -57.18 4.81 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 168.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -124.94 -46.16 1.85 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.609 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.97 144.46 17.21 Favored Glycine 0 CA--C 1.555 2.541 0 CA-C-O 117.677 -1.624 . . . . 0.0 112.255 -168.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.88 87.91 1.36 Allowed 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 122.184 2.992 . . . . 0.0 113.05 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -144.67 -66.92 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.75 86.0 1.84 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.604 0.621 . . . . 0.0 111.594 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -91.96 152.47 20.01 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.2 m -68.03 140.16 93.38 Favored Pre-proline 0 CA--C 1.573 1.83 0 CA-C-O 117.707 -1.139 . . . . 0.0 112.729 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.71 -50.25 0.2 OUTLIER 'Cis proline' 0 CA--C 1.562 1.923 0 N-CA-C 117.238 1.976 . . . . 0.0 117.238 11.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -149.92 76.47 1.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 119.506 1.048 . . . . 0.0 109.208 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.77 118.11 49.15 Favored Pre-proline 0 CA--C 1.57 1.73 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.59 142.03 12.71 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 122.877 2.385 . . . . 0.0 114.303 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 125.33 10.66 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.131 2.554 . . . . 0.0 112.103 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.278 97.6 m-70 70.0 172.18 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.708 0.803 . . . . 0.0 112.883 -171.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.18 111.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.999 1.32 . . . . 0.0 111.15 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.23 117.25 8.26 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.43 128.11 33.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.819 0.448 . . . . 0.0 109.8 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.11 98.45 8.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.601 0.761 . . . . 0.0 109.355 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 107.0 18.03 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.572 0.749 . . . . 0.0 110.575 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.4 107.9 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.126 0.965 . . . . 0.0 111.276 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.84 105.97 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.9 m -101.34 122.39 43.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -73.07 -74.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.1 p -147.45 131.9 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.776 0.716 . . . . 0.0 109.113 -169.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.47 112.51 25.55 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.209 0.604 . . . . 0.0 109.579 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.2 143.4 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.624 0.77 . . . . 0.0 110.109 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.67 79.43 4.26 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.074 0.94 . . . . 0.0 113.124 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 2.937 0 N-CA-C 116.568 1.387 . . . . 0.0 116.568 173.647 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 122.088 0.947 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.322 14.9 m0 68.92 -135.94 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.362 1.065 . . . . 0.0 111.581 168.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 tt -138.25 119.31 14.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.64 108.81 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.39 0.676 . . . . 0.0 112.207 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.29 45.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -58.45 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 125.272 1.429 . . . . 0.0 110.213 172.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.52 -91.3 0.51 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.95 -36.32 64.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.08 1.35 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -167.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mp 15.82 63.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 165.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 tp -157.99 117.37 3.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -148.76 115.22 5.89 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 -161.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -117.03 133.64 55.75 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -171.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -73.7 143.74 46.07 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.978 0.911 . . . . 0.0 111.661 159.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.5 m -93.45 92.13 7.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 159.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.73 -60.98 2.11 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.774 0.829 . . . . 0.0 113.044 -167.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -113.82 130.2 24.04 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 157.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.84 170.03 21.27 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.088 2.526 . . . . 0.0 114.97 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 152.39 49.65 Favored Glycine 0 CA--C 1.561 2.925 0 CA-C-O 118.376 -1.236 . . . . 0.0 115.345 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.95 164.58 31.24 Favored 'Trans proline' 0 CA--C 1.574 2.486 0 CA-C-N 121.433 2.616 . . . . 0.0 115.556 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.14 113.58 2.68 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 123.201 2.601 . . . . 0.0 113.038 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.6 -96.27 0.94 Allowed Glycine 0 CA--C 1.539 1.557 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -163.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.268 82.9 p 53.96 85.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -79.9 120.62 24.36 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.424 0.63 . . . . 0.0 111.534 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -81.61 124.01 80.25 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.746 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.52 147.9 65.45 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.1 2.533 . . . . 0.0 115.567 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.16 152.74 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.059 0.944 . . . . 0.0 111.842 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.81 118.42 8.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.06 60.48 0.55 Allowed Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.71 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -146.86 146.0 30.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.364 1.078 . . . . 0.0 108.559 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.3 101.39 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.81 125.49 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -107.4 140.29 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.371 0.668 . . . . 0.0 109.308 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.27 141.32 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.801 0.841 . . . . 0.0 109.023 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -83.82 101.32 11.54 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 158.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.6 tp -86.26 100.56 12.35 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -93.68 101.38 13.52 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -81.03 117.51 21.69 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -142.58 154.36 44.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.656 0.783 . . . . 0.0 109.566 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.21 141.54 49.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.858 0.837 . . . . 0.0 111.206 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -57.63 -45.63 85.17 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 157.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.18 -58.01 3.96 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.83 54.13 0.75 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.472 2.5 t 50.92 -157.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 163.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -79.97 107.37 12.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.211 1.004 . . . . 0.0 111.973 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.2 -71.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.378 0.671 . . . . 0.0 111.26 -165.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.92 111.18 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -163.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.25 113.11 25.23 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.133 0.573 . . . . 0.0 110.739 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.92 91.89 16.48 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.498 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.08 -61.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.36 2.707 . . . . 0.0 116.047 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 86.33 5.66 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.663 1.12 . . . . 0.0 110.625 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.8 tp -106.88 92.6 4.16 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 165.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.2 139.44 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.533 0.733 . . . . 0.0 110.395 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -159.6 154.65 24.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.516 0.674 . . . . 0.0 111.748 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -74.87 133.1 41.9 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 171.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.18 111.3 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.129 0.972 . . . . 0.0 111.409 -172.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.35 77.96 0.33 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.015 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.84 157.7 27.12 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.28 1.038 . . . . 0.0 111.228 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.47 83.56 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.274 1.035 . . . . 0.0 112.253 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -151.39 -66.44 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.32 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.61 169.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.702 1.239 . . . . 0.0 113.44 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 pt -52.27 151.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 114.131 -1.395 . . . . 0.0 114.053 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -60.73 -36.78 79.74 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.14 83.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.32 -57.78 7.54 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 117.406 -1.283 . . . . 0.0 113.289 165.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -52.49 -39.9 61.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.6 p -104.54 61.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.96 -61.02 0.17 Allowed Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 115.543 -2.17 . . . . 0.0 108.987 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.97 -25.08 59.67 Favored 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 124.986 2.816 . . . . 0.0 117.542 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -6.27 5.72 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 167.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.2 mtt -114.44 119.8 38.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.935 1.243 . . . . 0.0 109.017 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -64.45 163.3 13.57 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.62 99.72 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 49.28 3.09 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 118.352 1.076 . . . . 0.0 110.741 163.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.3 m -93.5 142.28 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.29 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.83 123.17 13.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.727 0.411 . . . . 0.0 110.705 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.3 tpt -84.02 101.78 12.01 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.47 125.63 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 p -106.35 96.42 6.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.843 0.83 . . . . 0.0 109.219 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.19 167.69 15.46 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.965 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.45 42.91 1.12 Allowed 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.7 p 35.34 54.79 0.81 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -151.86 -58.86 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.821 -159.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.9 -45.61 92.98 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 157.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.6 t -90.78 113.6 25.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.821 0.848 . . . . 0.0 111.173 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.287 81.0 m-85 65.2 14.46 9.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.17 179.1 25.31 Favored Glycine 0 CA--C 1.559 2.824 0 N-CA-C 116.523 1.369 . . . . 0.0 116.523 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -83.46 62.56 7.34 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 122.921 2.414 . . . . 0.0 113.407 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.54 -70.69 0.07 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.84 132.82 7.67 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 118.22 0.464 . . . . 0.0 112.038 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -111.34 52.42 0.75 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.9 m 65.46 143.77 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 170.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.03 -40.39 0.85 Allowed 'Cis proline' 0 CA--C 1.563 1.932 0 CA-C-N 122.687 1.996 . . . . 0.0 116.472 -1.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -132.81 67.33 1.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.2 mt -115.77 119.64 37.13 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -85.54 159.81 10.87 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 C-N-CA 123.157 2.571 . . . . 0.0 115.196 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.08 -39.51 0.87 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 122.959 2.44 . . . . 0.0 117.291 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.87 72.34 1.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.021 0.828 . . . . 0.0 109.04 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.19 21.3 0.25 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 72.68 134.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 tt -138.75 123.48 18.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -99.48 97.3 8.32 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.877 0.846 . . . . 0.0 110.138 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.66 125.59 39.41 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.284 1.034 . . . . 0.0 109.602 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -98.54 103.48 15.43 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.878 0.847 . . . . 0.0 110.298 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.23 109.17 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.7 m -105.26 121.61 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.09 105.83 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.91 -66.9 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.5 p -135.06 135.41 41.26 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.44 0.696 . . . . 0.0 109.219 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.86 104.07 11.82 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.03 154.48 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.742 0.782 . . . . 0.0 109.915 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.19 -170.05 0.89 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.614 0 CA-C-O 116.874 -2.07 . . . . 0.0 115.021 -173.249 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.317 98.5 m95 86.54 106.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.709 1.204 . . . . 0.0 109.596 -161.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.27 107.33 19.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -83.48 116.03 22.35 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.527 0.679 . . . . 0.0 112.193 -165.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.46 -48.83 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 123.909 0.884 . . . . 0.0 111.413 170.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.38 -60.3 3.75 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.413 1.006 . . . . 0.0 113.143 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.78 -72.63 0.29 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-N 118.912 0.778 . . . . 0.0 112.446 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -69.56 -70.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.687 0.795 . . . . 0.0 112.353 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.82 64.06 0.09 OUTLIER Glycine 0 N--CA 1.481 1.644 0 CA-C-N 118.393 0.542 . . . . 0.0 111.863 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.1 mt -137.04 -78.74 0.4 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.894 -163.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 tp -88.27 124.72 34.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 121.022 1.737 . . . . 0.0 107.988 166.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -154.95 113.19 3.49 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.477 -164.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -119.2 115.99 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.339 1.056 . . . . 0.0 109.127 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -103.8 141.18 36.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.819 -0.551 . . . . 0.0 111.081 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.9 m -80.18 115.35 19.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.9 -69.08 0.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.539 0.736 . . . . 0.0 109.293 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.6 134.09 24.72 Favored Pre-proline 0 CA--C 1.578 2.035 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.021 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.04 149.83 29.08 Favored 'Trans proline' 0 CA--C 1.558 1.686 0 C-N-CA 122.851 2.368 . . . . 0.0 114.11 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 114.49 4.0 Favored Glycine 0 CA--C 1.555 2.578 0 CA-C-O 116.872 -2.071 . . . . 0.0 113.127 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.83 164.17 36.53 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 CA-C-N 122.775 3.287 . . . . 0.0 116.0 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.09 109.56 2.6 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.272 2.648 . . . . 0.0 111.74 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.81 -66.0 0.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.026 -158.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -65.49 135.03 54.65 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -138.67 146.66 41.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.702 0.763 . . . . 0.0 110.004 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.59 112.46 6.63 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-O 117.998 -1.001 . . . . 0.0 113.362 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.42 166.25 29.88 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.499 2.133 . . . . 0.0 115.942 -161.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.66 162.82 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.22 -168.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 107.52 4.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.391 0.676 . . . . 0.0 110.223 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.45 -47.84 0.8 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 115.415 -0.811 . . . . 0.0 113.919 -163.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -63.36 124.05 20.28 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.708 0.803 . . . . 0.0 111.739 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.49 99.25 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.49 140.35 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.863 0.839 . . . . 0.0 110.557 -172.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 m -114.41 124.04 50.95 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.15 142.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.794 0.837 . . . . 0.0 110.288 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -94.67 99.52 11.62 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 165.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.25 106.01 18.1 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.9 87.92 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.6 m -71.48 125.07 26.08 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.149 0.58 . . . . 0.0 110.562 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 t -131.38 155.34 47.44 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.098 0.952 . . . . 0.0 110.329 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.1 146.93 30.34 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.612 165.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.59 -33.33 60.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -68.16 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.96 0.8 . . . . 0.0 112.059 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.5 77.27 0.03 OUTLIER Glycine 0 N--CA 1.479 1.502 0 CA-C-N 119.117 0.871 . . . . 0.0 113.147 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 m -149.34 106.61 3.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -82.65 105.96 14.12 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.1 m -96.79 -45.3 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -165.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -136.1 87.99 2.35 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.847 1.203 . . . . 0.0 110.101 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.38 115.07 26.85 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.322 0.582 . . . . 0.0 111.671 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.13 102.41 48.84 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.726 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -87.22 77.17 2.02 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.633 2.222 . . . . 0.0 114.073 -166.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.461 8.7 pt-20 133.36 94.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 127.401 2.281 . . . . 0.0 110.047 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.33 99.56 7.1 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.31 138.22 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.693 -169.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -164.54 149.88 10.1 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.253 0.621 . . . . 0.0 110.683 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -79.46 128.62 33.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.64 135.1 52.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.563 0.745 . . . . 0.0 112.115 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 52.38 18.4 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.32 -16.71 0.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.255 17.0 t 76.2 86.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.44 1.496 . . . . 0.0 110.558 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -132.84 -70.63 0.54 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.062 0.545 . . . . 0.0 110.541 -174.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.68 178.81 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 123.795 0.838 . . . . 0.0 112.521 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -54.76 144.2 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.361 1.064 . . . . 0.0 113.671 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -57.32 -27.88 62.59 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.37 -47.58 85.19 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -62.59 1.33 Allowed 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.853 170.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.15 -51.5 42.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.66 -36.14 81.89 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.6 p -74.48 -10.15 59.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.556 2.799 . . . . 0.0 118.556 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -59.88 -50.29 87.28 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 115.391 -2.243 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.16 -30.59 61.64 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 CA-C-N 125.362 2.951 . . . . 0.0 118.283 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.28 65.54 1.43 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 119.057 0.844 . . . . 0.0 111.176 163.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.0 ttm -160.23 109.65 1.76 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 157.71 20.44 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.071 0.938 . . . . 0.0 112.566 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.14 121.62 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.354 -0.841 . . . . 0.0 111.405 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.433 ' H ' HD12 ' A' ' 143' ' ' LEU . . . 89.72 -3.69 83.32 Favored Glycine 0 CA--C 1.552 2.364 0 N-CA-C 118.49 2.156 . . . . 0.0 118.49 -167.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.5 114.26 12.69 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 121.25 2.525 . . . . 0.0 112.147 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.5 m -84.14 124.24 30.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 133.19 21.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.421 0.689 . . . . 0.0 109.579 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.438 ' SD ' ' SG ' ' A' ' 138' ' ' CYS . 26.9 tpp -83.75 137.9 33.52 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.86 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.8 t -128.48 125.22 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.5 p -102.74 95.49 6.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.81 127.25 32.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.297 172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.73 59.46 4.66 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.8 p 33.35 64.09 0.32 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -173.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -176.6 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.899 -155.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -79.64 -38.76 33.02 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.288 1.435 . . . . 0.0 112.745 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.8 t -62.3 -63.92 1.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 163.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -137.16 -69.41 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.87 0.868 . . . . 0.0 109.665 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 119.63 -166.15 13.37 Favored Glycine 0 CA--C 1.555 2.549 0 CA-C-N 118.938 0.79 . . . . 0.0 113.17 -167.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -64.38 -10.46 24.05 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 N-CA-C 118.573 2.49 . . . . 0.0 118.573 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -105.47 103.27 12.76 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -122.7 157.63 17.3 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 123.685 0.66 . . . . 0.0 112.356 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -87.75 78.21 8.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.1 p -75.69 142.59 73.91 Favored Pre-proline 0 CA--C 1.568 1.668 0 CA-C-O 117.819 -1.086 . . . . 0.0 113.096 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.31 -15.29 32.51 Favored 'Cis proline' 0 CA--C 1.565 2.027 0 N-CA-C 119.397 2.807 . . . . 0.0 119.397 10.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -64.22 -47.86 78.09 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.25 101.01 53.92 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 171.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.34 145.82 66.92 Favored 'Trans proline' 0 CA--C 1.572 2.387 0 C-N-CA 122.525 2.15 . . . . 0.0 113.387 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.69 -34.55 62.19 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 123.196 2.597 . . . . 0.0 118.343 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -125.36 157.04 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.85 0.86 . . . . 0.0 109.905 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.262 . . 81.05 128.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.151 1.38 . . . . 0.0 111.569 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.99 153.44 33.8 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.374 1.991 . . . . 0.0 116.374 -169.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.77 134.62 54.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.69 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 113' ' ' MET . 42.3 t -90.92 91.93 8.55 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.988 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 139' ' ' LEU . 1.7 pt? -79.66 121.12 24.9 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.049 0.928 . . . . 0.0 110.443 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -99.46 88.35 3.85 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.839 1.255 . . . . 0.0 109.053 -170.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.0 t -84.14 126.25 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -166.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -115.33 118.21 32.62 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -78.56 108.83 12.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -81.69 -70.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -145.28 135.65 24.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -167.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.87 95.57 5.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.512 0.673 . . . . 0.0 109.301 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.53 158.14 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 124.013 0.925 . . . . 0.0 109.785 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.04 -177.7 3.01 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.651 0 CA-C-O 116.906 -2.052 . . . . 0.0 113.502 179.503 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -109.79 136.43 49.13 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.158 0.983 . . . . 0.0 109.774 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 tp -145.64 113.44 6.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.98 161.37 27.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.9 mm -90.16 -67.74 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.427 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.255 2.4 pt? -70.28 -52.96 19.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -171.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.77 56.64 0.05 OUTLIER Glycine 0 N--CA 1.483 1.824 0 C-N-CA 123.73 0.681 . . . . 0.0 113.232 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -150.51 -55.84 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.973 0.909 . . . . 0.0 110.706 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.32 57.77 0.38 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 124.24 0.924 . . . . 0.0 111.693 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.7 mt -141.18 -59.75 0.49 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.081 0.953 . . . . 0.0 108.896 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.9 tp -92.07 89.13 6.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.222 0.919 . . . . 0.0 108.553 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -101.13 96.93 7.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.565 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -91.77 99.72 12.55 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.61 0.764 . . . . 0.0 112.185 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -86.37 127.34 34.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.474 -0.766 . . . . 0.0 109.806 164.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.2 m -87.47 112.89 22.67 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.67 -68.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.82 0.848 . . . . 0.0 110.242 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.03 117.88 66.04 Favored Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.89 167.58 16.29 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.956 2.438 . . . . 0.0 114.937 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.45 170.47 50.58 Favored Glycine 0 CA--C 1.564 3.109 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 170.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.38 169.19 17.56 Favored 'Trans proline' 0 CA--C 1.575 2.549 0 C-N-CA 122.972 2.448 . . . . 0.0 115.844 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.86 113.42 3.22 Favored 'Trans proline' 0 CA--C 1.558 1.723 0 C-N-CA 123.039 2.493 . . . . 0.0 112.326 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.35 -86.1 0.44 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -164.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.285 81.7 p 63.05 113.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.6 m -92.22 135.93 33.6 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.135 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 143.06 26.01 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.04 145.96 22.55 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.525 2.15 . . . . 0.0 115.764 -162.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 62' ' ' LYS . 8.3 p -95.71 -179.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 124.578 1.151 . . . . 0.0 111.759 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 61' ' ' VAL . 25.6 tttm -63.66 119.95 10.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.73 47.05 2.0 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.88 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.45 124.83 26.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.54 99.87 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -103.72 126.54 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.747 0.819 . . . . 0.0 109.17 -171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -100.86 113.4 26.31 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.69 140.76 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.821 0.848 . . . . 0.0 109.014 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -92.56 100.52 13.03 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.68 106.31 17.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.78 99.82 11.39 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -78.22 119.26 21.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -132.24 145.73 51.52 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.753 0.787 . . . . 0.0 109.945 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.96 148.78 48.49 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.704 172.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -55.15 -31.34 61.25 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -63.6 -68.04 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.97 0.805 . . . . 0.0 111.682 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.02 77.04 0.02 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -147.57 117.9 7.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -74.1 95.74 2.6 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 122.624 1.202 . . . . 0.0 112.903 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.04 -45.39 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -125.11 150.27 47.02 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.313 1.054 . . . . 0.0 109.822 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -147.35 79.26 1.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.566 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.89 98.43 5.39 Favored Pre-proline 0 CA--C 1.579 2.069 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.28 -43.92 1.98 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.176 2.584 . . . . 0.0 115.865 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.9 77.27 8.53 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.312 1.053 . . . . 0.0 110.067 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.0 tp -100.33 98.01 8.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.92 135.56 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -158.56 142.24 15.26 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.459 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 m -80.24 133.3 35.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.46 138.6 57.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.967 0.507 . . . . 0.0 111.97 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.2 -66.01 0.25 Allowed Glycine 0 N--CA 1.478 1.484 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.65 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 104.48 5.68 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.312 0.577 . . . . 0.0 110.037 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.82 82.84 6.18 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.797 0.808 . . . . 0.0 112.803 -161.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.89 -50.8 14.0 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.122 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.64 161.05 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.1 pt -54.59 151.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 124.829 1.252 . . . . 0.0 114.222 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -65.41 -17.12 64.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -36.98 85.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.98 -71.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.378 -1.296 . . . . 0.0 111.641 159.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.74 -44.34 27.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 -168.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.26 -50.18 72.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -75.49 -12.0 60.15 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.272 5.7 t -67.79 -46.48 44.5 Favored Pre-proline 0 N--CA 1.497 1.923 0 CA-C-O 115.214 -2.327 . . . . 0.0 114.023 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.22 35.14 0.38 Allowed 'Trans proline' 0 CA--C 1.579 2.74 0 CA-C-N 125.415 2.969 . . . . 0.0 116.672 165.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.3 mt -138.89 -38.75 0.5 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 126.525 1.93 . . . . 0.0 110.495 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 42.3 mtt -63.65 123.82 19.82 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.814 1.246 . . . . 0.0 112.768 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.67 159.96 23.83 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.661 1.22 . . . . 0.0 112.836 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.57 105.15 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.6 62.42 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.685 -1.064 . . . . 0.0 114.296 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.27 129.04 23.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.477 1.138 . . . . 0.0 112.194 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.9 m -85.62 130.14 34.65 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.98 127.75 14.34 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.643 0.259 . . . . 0.0 111.284 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.4 tpp -84.06 108.92 17.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.02 106.58 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 66.0 p -94.69 93.51 7.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.42 18.06 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -74.46 153.9 38.96 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.688 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.3 t -75.12 83.82 2.33 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.782 1.277 . . . . 0.0 110.623 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -178.02 -61.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.047 -155.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -77.69 -53.2 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.582 1.153 . . . . 0.0 111.793 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m -81.76 107.75 14.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.86 0.864 . . . . 0.0 110.243 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.305 23.8 m-85 70.12 -0.04 2.94 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.27 -179.91 48.24 Favored Glycine 0 CA--C 1.559 2.823 0 CA-C-N 120.26 1.391 . . . . 0.0 115.649 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.95 -46.05 9.24 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.286 2.657 . . . . 0.0 116.325 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -95.43 102.52 14.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.71 -152.9 11.75 Favored Glycine 0 CA--C 1.548 2.11 0 N-CA-C 116.713 1.445 . . . . 0.0 116.713 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -82.75 66.11 8.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 124.114 0.966 . . . . 0.0 112.182 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.5 p -80.21 146.97 63.79 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.384 -175.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.1 -11.98 29.93 Favored 'Cis proline' 0 CA--C 1.565 2.073 0 N-CA-C 119.637 2.899 . . . . 0.0 119.637 7.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -60.55 -58.02 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -96.5 105.03 20.0 Favored Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.29 160.8 48.3 Favored 'Trans proline' 0 CA--C 1.573 2.432 0 C-N-CA 122.711 2.274 . . . . 0.0 113.986 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.98 112.61 2.76 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 123.031 2.488 . . . . 0.0 112.965 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 88.6 m-70 72.92 86.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.71 1.204 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.88 121.74 4.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.65 122.98 25.44 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.015 0.526 . . . . 0.0 111.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 mt -97.84 139.95 32.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.696 0.76 . . . . 0.0 111.92 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -102.2 90.74 4.02 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.832 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.86 118.81 37.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.706 0.802 . . . . 0.0 110.227 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.5 107.43 19.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.041 0.924 . . . . 0.0 110.901 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.23 111.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -108.98 117.11 33.35 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.07 108.81 10.41 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.45 -59.72 2.14 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.254 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 76.1 p -132.93 139.3 47.27 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.654 0.781 . . . . 0.0 109.114 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.67 112.75 17.13 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -128.46 132.16 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.49 119.44 23.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.125 0.488 . . . . 0.0 111.619 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.673 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.895 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.75 0.786 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 m0 67.91 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.425 1.49 . . . . 0.0 112.928 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.426 HD13 ' H ' ' A' ' 37' ' ' LEU 0.25 0.0 OUTLIER -80.22 128.23 33.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.466 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -109.73 148.35 31.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.132 0.973 . . . . 0.0 113.589 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.53 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 tp -166.07 -70.73 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.29 -75.01 0.27 Allowed Glycine 0 CA--C 1.54 1.594 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -164.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.6 -84.75 0.08 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.464 0.706 . . . . 0.0 110.694 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.21 84.53 0.05 OUTLIER Glycine 0 N--CA 1.476 1.363 0 CA-C-N 118.825 0.739 . . . . 0.0 111.68 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.08 -58.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.803 0.841 . . . . 0.0 109.61 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.5 96.0 7.89 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.142 0.883 . . . . 0.0 108.895 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -118.1 90.04 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.075 0.95 . . . . 0.0 109.071 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.263 17.1 ptmt -83.49 123.8 30.08 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.78 138.35 32.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 161.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 m -98.62 109.06 21.88 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.52 -77.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.92 125.44 34.56 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.78 -168.49 0.59 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 123.54 2.827 . . . . 0.0 113.312 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.62 Favored Glycine 0 CA--C 1.563 3.089 0 CA-C-O 118.959 -0.911 . . . . 0.0 115.103 163.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.35 167.28 22.71 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 C-N-CA 123.085 2.523 . . . . 0.0 114.931 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.8 109.6 1.5 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.125 2.55 . . . . 0.0 111.854 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.07 81.56 1.49 Allowed Glycine 0 CA--C 1.543 1.782 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.992 -157.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.2 p -141.05 116.05 9.82 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 144.53 31.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.462 0.705 . . . . 0.0 112.053 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -93.27 111.81 53.59 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.384 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.4 169.31 22.01 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 123.196 2.597 . . . . 0.0 115.938 -165.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.6 160.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 123.808 0.843 . . . . 0.0 112.429 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -69.5 110.37 4.73 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 122.938 0.495 . . . . 0.0 109.995 162.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.51 -60.36 0.64 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.887 -157.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.87 119.84 17.67 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.233 0.613 . . . . 0.0 110.874 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.01 112.53 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.83 139.51 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.295 0.569 . . . . 0.0 110.985 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -101.52 131.41 47.69 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.9 138.92 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.032 0.533 . . . . 0.0 111.345 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.72 98.7 9.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.55 127.74 33.63 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 164.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -116.5 87.36 2.67 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 m -85.75 116.44 24.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.7 m -138.61 33.62 2.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.258 10.3 mt 55.59 167.05 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.91 -43.91 97.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.35 -60.72 2.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.99 73.94 0.03 OUTLIER Glycine 0 CA--C 1.543 1.783 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -174.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 m -152.87 117.03 4.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -76.58 111.01 11.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -83.69 -63.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 124.034 0.934 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -146.94 103.13 3.59 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -91.96 90.34 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.706 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -100.08 107.12 45.51 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.892 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.0 -49.84 0.12 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.277 2.652 . . . . 0.0 117.041 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.56 84.16 1.92 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.371 0.669 . . . . 0.0 110.316 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.9 tp -103.09 92.19 4.43 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.79 128.71 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -157.9 149.09 21.25 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.213 0.605 . . . . 0.0 111.057 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -73.28 126.82 30.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.2 tp -59.67 117.0 4.43 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -159.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.61 40.27 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.08 178.51 6.97 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.726 1.251 . . . . 0.0 111.483 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 77.4 m -78.19 68.11 4.15 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -167.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.89 -54.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.676 1.59 . . . . 0.0 109.278 172.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.09 164.65 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 122.545 1.164 . . . . 0.0 112.917 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.9 pt -62.69 154.77 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.824 1.25 . . . . 0.0 113.276 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.39 -32.53 71.4 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.2 74.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 168.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.34 -50.97 63.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 169.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -51.66 -45.83 63.55 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.26 -36.36 79.31 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -72.65 -19.07 61.5 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.27 2.1 t -52.35 -51.33 73.41 Favored Pre-proline 0 CA--C 1.578 2.044 0 CA-C-O 115.125 -2.369 . . . . 0.0 116.627 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.08 -41.84 68.95 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 125.216 2.898 . . . . 0.0 118.066 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -89.81 16.24 8.4 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.9 mtm -81.47 102.45 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 121.023 1.738 . . . . 0.0 110.314 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.96 152.8 35.12 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.044 0.926 . . . . 0.0 111.814 167.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -67.04 111.36 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.5 12.68 55.62 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 116.69 17.03 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.709 2.755 . . . . 0.0 112.519 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.0 m -100.23 102.78 14.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 125.19 22.88 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 -166.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.6 tpp -68.14 102.6 1.37 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.773 0.829 . . . . 0.0 111.698 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.72 96.16 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.5 t -114.65 116.08 28.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.538 0.735 . . . . 0.0 109.045 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.33 155.35 21.29 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.509 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -58.19 152.8 16.29 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.235 150.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 78.6 p -70.04 77.23 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.326 1.06 . . . . 0.0 112.493 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -52.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.638 -165.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.27 -51.38 8.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.063 1.345 . . . . 0.0 111.328 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -64.01 -62.9 1.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -133.31 -58.32 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.52 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.66 179.05 47.89 Favored Glycine 0 CA--C 1.558 2.721 0 CA-C-N 119.319 0.963 . . . . 0.0 114.955 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.45 100.97 0.82 Allowed 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 123.138 2.559 . . . . 0.0 112.57 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -158.08 -71.26 0.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.621 -165.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.94 83.74 1.08 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 118.601 0.637 . . . . 0.0 112.13 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -89.95 152.48 21.2 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-O 121.919 0.866 . . . . 0.0 111.696 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -75.36 140.67 72.73 Favored Pre-proline 0 CA--C 1.571 1.761 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.892 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.54 -58.68 0.07 OUTLIER 'Cis proline' 0 CA--C 1.563 1.935 0 CA-C-N 122.85 2.053 . . . . 0.0 116.156 10.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -137.44 67.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mt -103.49 114.08 65.14 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.21 137.93 24.37 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.403 2.068 . . . . 0.0 114.694 -166.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.58 -45.88 8.14 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 123.207 2.605 . . . . 0.0 116.343 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -128.22 85.78 2.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.697 0.799 . . . . 0.0 109.85 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.77 125.19 3.15 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.66 101.66 5.84 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.067 0.547 . . . . 0.0 111.392 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -103.3 143.92 32.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.2 m -92.89 136.21 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.637 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.83 106.92 3.58 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.067 0.547 . . . . 0.0 110.478 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -87.31 117.63 26.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.486 1.136 . . . . 0.0 113.806 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.78 114.99 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -169.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -96.26 121.9 38.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.26 104.8 11.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -81.4 -63.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 -171.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 58.5 p -144.25 132.24 21.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.21 103.63 15.59 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 168.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.53 123.24 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -171.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.75 124.4 28.16 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 112.464 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.796 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.173 -169.084 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 CA--C 1.572 1.816 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -55.08 121.26 8.36 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -167.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 tp -175.01 154.43 1.82 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.037 -159.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.6 t0 68.78 119.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 149.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 mm -118.02 -54.66 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.072 0.949 . . . . 0.0 109.23 167.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.14 -63.77 1.11 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.48 -61.7 0.01 OUTLIER Glycine 0 N--CA 1.483 1.809 0 CA-C-N 119.448 1.022 . . . . 0.0 115.259 -171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -90.23 -78.58 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 117.734 0.767 . . . . 0.0 110.777 -172.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 177.0 72.24 0.06 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 mt -122.11 -66.32 1.04 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -163.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -80.06 98.54 7.29 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.19 96.46 7.49 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.946 0.498 . . . . 0.0 110.017 -164.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -105.47 132.93 51.02 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -113.36 145.61 40.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.806 -0.559 . . . . 0.0 110.249 152.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.9 m -88.74 108.45 19.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.29 -67.96 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.586 0.755 . . . . 0.0 111.45 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.05 122.29 62.14 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 167.83 19.41 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 114.586 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.66 123.42 6.68 Favored Glycine 0 CA--C 1.556 2.643 0 CA-C-O 117.049 -1.973 . . . . 0.0 113.351 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.45 167.92 22.64 Favored 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 122.53 3.165 . . . . 0.0 115.607 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.05 112.96 3.1 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.105 2.537 . . . . 0.0 111.869 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 76.81 1.34 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.473 -160.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 t -159.4 108.45 1.85 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 m -128.71 118.29 22.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.41 1.1 . . . . 0.0 110.368 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -64.13 132.94 95.45 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.86 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 164.09 35.25 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.91 2.407 . . . . 0.0 116.31 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.9 t -82.24 150.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.947 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -59.09 104.12 0.22 Allowed 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.971 1.308 . . . . 0.0 113.31 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.29 62.54 0.34 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.032 -165.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -155.44 138.66 15.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.48 106.89 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.329 -0.857 . . . . 0.0 109.671 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.16 118.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 124.128 0.971 . . . . 0.0 108.765 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.5 m -100.31 124.2 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.57 137.29 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.208 0.528 . . . . 0.0 110.459 -173.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -88.71 106.98 18.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 165.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.6 pt? -103.52 121.67 43.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.161 0.585 . . . . 0.0 110.094 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -103.44 99.17 8.99 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -93.64 99.44 11.87 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.037 0.535 . . . . 0.0 110.7 -165.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -104.57 -169.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.3 0.64 . . . . 0.0 111.359 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 tp -114.88 147.82 39.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.705 1.202 . . . . 0.0 109.513 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.322 4.2 pt-20 -60.44 -29.99 69.37 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 117.527 2.418 . . . . 0.0 117.527 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -64.64 -68.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.896 161.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.08 0.05 OUTLIER Glycine 0 N--CA 1.482 1.756 0 CA-C-N 119.53 1.059 . . . . 0.0 113.107 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.3 m -153.33 122.58 6.6 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -76.52 97.15 4.26 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.041 0.924 . . . . 0.0 111.301 171.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -84.99 -47.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.138 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -125.04 156.78 37.64 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.842 1.306 . . . . 0.0 110.503 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.86 93.0 2.87 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 161.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -85.24 116.7 66.61 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.622 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.86 -49.46 0.15 Allowed 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.938 2.426 . . . . 0.0 116.56 -168.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -137.84 93.66 2.8 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.134 0.879 . . . . 0.0 109.423 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 tp -85.4 104.42 15.19 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.74 96.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -125.42 147.57 49.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.598 0.759 . . . . 0.0 109.32 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.0 m -100.38 66.51 1.28 Allowed 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 123.012 0.525 . . . . 0.0 110.019 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . 0.401 7.6 mp 61.17 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.25 -94.4 0.18 Allowed Glycine 0 N--CA 1.483 1.816 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.448 165.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 68.1 150.11 0.07 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.2 t -82.26 72.73 9.32 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.58 1.181 . . . . 0.0 113.445 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.74 -61.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.251 1.42 . . . . 0.0 108.982 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.6 152.98 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.829 1.3 . . . . 0.0 113.147 -151.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.1 pt -68.94 165.7 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.876 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -57.97 -34.65 70.17 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 171.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.21 86.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.15 -45.77 62.84 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -66.79 -32.36 73.6 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.11 -15.09 57.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.3 p -71.05 -36.39 72.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.233 1.833 . . . . 0.0 115.37 164.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.0 -53.33 39.21 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 115.897 -2.001 . . . . 0.0 115.027 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.44 -15.0 42.54 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 123.644 2.896 . . . . 0.0 119.104 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.33 48.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 120.341 1.428 . . . . 0.0 112.869 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.8 mtp -143.12 100.15 3.58 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.38 176.05 8.09 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.244 1.021 . . . . 0.0 110.829 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.84 105.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.798 -1.189 . . . . 0.0 109.874 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.14 61.16 0.86 Allowed Glycine 0 CA--C 1.546 1.978 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.737 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -140.49 122.19 15.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.656 0.782 . . . . 0.0 110.08 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.1 m -94.6 136.24 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 160.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.08 113.73 9.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 53.3 ttm -84.84 115.01 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.88 128.14 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.0 p -94.64 87.53 5.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.09 19.16 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.222 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.85 144.74 8.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.6 p -54.87 -19.28 6.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -59.24 -51.3 70.55 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 161.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -77.89 -48.84 15.45 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.83 1.252 . . . . 0.0 113.511 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.46 174.56 7.48 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.092 1.357 . . . . 0.0 112.94 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -73.69 100.89 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.593 0.757 . . . . 0.0 110.711 166.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.93 -87.78 1.96 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 116.147 -2.474 . . . . 0.0 108.317 163.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.54 52.61 4.15 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 122.675 3.237 . . . . 0.0 114.722 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -132.41 -77.81 0.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.55 112.1 2.02 Favored Glycine 0 N--CA 1.48 1.617 0 CA-C-N 119.685 1.13 . . . . 0.0 113.507 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -104.08 127.49 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 157.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 145.64 89.84 Favored Pre-proline 0 CA--C 1.571 1.767 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -91.23 -64.99 0.03 OUTLIER 'Cis proline' 0 CA--C 1.565 2.047 0 CA-C-N 122.689 1.996 . . . . 0.0 116.701 8.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -115.48 43.95 1.95 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -165.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.2 mt -80.31 118.21 71.35 Favored Pre-proline 0 CA--C 1.58 2.121 0 O-C-N 120.643 -1.286 . . . . 0.0 108.113 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.28 160.65 26.11 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 122.933 2.422 . . . . 0.0 116.242 -166.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.1 136.23 24.29 Favored 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 123.292 2.662 . . . . 0.0 114.251 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.285 97.1 m-70 73.65 162.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.688 1.195 . . . . 0.0 113.828 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 77.24 148.07 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.075 1.35 . . . . 0.0 113.436 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.53 148.02 47.14 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.4 mt -100.65 123.38 44.78 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.017 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.5 84.48 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.335 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.65 120.86 43.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.389 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.69 147.81 50.08 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.343 160.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 t -134.21 100.12 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -95.69 123.3 39.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.31 104.62 13.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -88.61 -56.81 3.15 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.781 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.1 p -140.15 134.69 31.58 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.381 0.673 . . . . 0.0 109.558 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.82 105.3 12.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.5 m -136.5 131.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.422 0.689 . . . . 0.0 109.249 -166.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.88 118.6 30.88 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.046 0.538 . . . . 0.0 110.297 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.087 0 CA-C-O 117.091 -1.95 . . . . 0.0 111.88 177.488 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.26 7.5 tp10 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 m95 73.36 99.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.901 1.281 . . . . 0.0 110.111 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -83.86 114.07 21.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.76 101.33 6.64 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.866 0.841 . . . . 0.0 111.066 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.46 -51.89 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 123.982 0.913 . . . . 0.0 111.407 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -66.11 -63.96 0.97 Allowed 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.24 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.479 1.561 0 CA-C-N 118.96 0.8 . . . . 0.0 112.102 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.37 -66.22 0.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.178 0.591 . . . . 0.0 112.539 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.7 70.15 0.04 OUTLIER Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.401 0.546 . . . . 0.0 112.601 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -124.71 -70.32 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -81.91 120.18 24.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 118.822 0.737 . . . . 0.0 109.762 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.17 152.37 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.322 1.049 . . . . 0.0 111.443 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.37 117.74 14.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 0.0 112.504 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.83 121.14 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.993 . . . . 0.0 108.776 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -86.85 115.79 24.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.77 -65.56 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.777 0.831 . . . . 0.0 110.638 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -116.37 140.44 26.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 119.12 0.873 . . . . 0.0 109.27 165.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.98 171.73 16.73 Favored 'Trans proline' 0 CA--C 1.563 1.958 0 C-N-CA 123.072 2.515 . . . . 0.0 114.443 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.3 103.41 3.04 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-O 116.787 -2.118 . . . . 0.0 109.835 164.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 163.48 35.42 Favored 'Trans proline' 0 CA--C 1.571 2.355 0 CA-C-N 122.734 3.267 . . . . 0.0 116.252 -164.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.41 127.27 15.42 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.273 2.649 . . . . 0.0 113.156 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 -71.36 0.39 Allowed Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -159.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.1 p -75.24 102.46 5.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.402 0.681 . . . . 0.0 111.183 168.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -113.09 147.46 37.25 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.969 0.89 . . . . 0.0 111.287 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -60.34 128.6 88.06 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.56 160.14 47.29 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.041 2.494 . . . . 0.0 115.022 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.4 m -85.23 166.43 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.451 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -53.2 131.13 36.54 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.66 46.76 2.06 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 114.123 -1.398 . . . . 0.0 114.716 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.58 136.23 32.6 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.82 100.74 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 m -92.47 110.02 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -92.47 112.55 24.54 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.36 142.08 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.69 0.757 . . . . 0.0 110.44 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.05 107.26 11.68 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 162.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.45 107.19 17.95 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -103.61 111.89 24.57 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.98 117.44 28.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 t -133.98 152.66 51.94 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.064 0.935 . . . . 0.0 110.048 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.62 139.79 49.47 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.563 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.83 -37.95 77.58 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.99 -53.05 56.12 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 167.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.743 1.156 . . . . 0.0 114.881 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -63.87 137.75 58.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -160.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -61.56 117.01 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.28 35.6 m -81.59 -47.71 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.672 176.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -145.23 119.79 9.74 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 165.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -106.96 83.6 1.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.542 0.686 . . . . 0.0 110.105 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.57 101.84 51.92 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.651 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.64 50.27 3.5 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.644 2.23 . . . . 0.0 115.905 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -161.51 117.05 2.08 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.809 0.844 . . . . 0.0 109.281 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.49 103.91 3.17 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.54 114.26 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.6 142.11 32.08 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -78.46 121.26 24.32 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.29 133.59 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.32 0.509 . . . . 0.0 112.31 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.37 -70.34 0.74 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.925 -167.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -90.71 77.95 6.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.77 0.795 . . . . 0.0 110.215 172.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.36 126.64 53.02 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.628 -163.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -97.72 70.29 2.19 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.477 1.132 . . . . 0.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.03 177.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.411 1.1 . . . . 0.0 110.331 -163.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.59 150.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.833 0.853 . . . . 0.0 112.441 170.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.35 -29.76 71.01 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.09 81.87 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.93 -54.62 35.78 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.436 -1.269 . . . . 0.0 113.96 167.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -53.31 -49.0 67.93 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.6 p -79.3 -8.85 59.37 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 117.684 2.476 . . . . 0.0 117.684 168.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.263 12.8 t -52.44 -48.79 88.67 Favored Pre-proline 0 N--CA 1.501 2.094 0 CA-C-O 115.264 -2.303 . . . . 0.0 114.449 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.74 0.59 1.44 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 CA-C-N 125.114 2.862 . . . . 0.0 119.314 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.253 2.0 pt? -149.21 65.81 1.02 Allowed 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.079 1.309 . . . . 0.0 111.581 167.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.2 mmt -138.35 99.96 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.39 164.04 12.81 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.146 0.974 . . . . 0.0 113.101 -168.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.27 114.73 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.63 -6.78 45.23 Favored Glycine 0 CA--C 1.552 2.381 0 N-CA-C 117.905 1.922 . . . . 0.0 117.905 -167.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.41 126.27 33.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 121.132 2.466 . . . . 0.0 113.396 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.9 m -100.45 127.98 46.64 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 158.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.94 124.08 6.3 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.577 0.351 . . . . 0.0 110.165 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.9 ptm -77.8 131.94 37.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.124 0.57 . . . . 0.0 110.791 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.8 t -113.23 96.2 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.3 p -85.65 102.21 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.2 138.7 54.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.106 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.61 153.24 0.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.9 p -70.67 76.51 0.6 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.921 1.344 . . . . 0.0 112.153 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -179.03 -61.54 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.867 -152.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.17 -50.71 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.443 1.097 . . . . 0.0 112.674 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.24 -68.33 0.4 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -138.82 -66.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.798 0.726 . . . . 0.0 109.31 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.4 -147.93 19.78 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.391 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -72.72 112.71 3.55 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.253 51.3 mt-30 69.37 92.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.891 1.276 . . . . 0.0 110.271 -164.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.81 54.8 Favored Glycine 0 CA--C 1.547 2.049 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -101.39 60.09 0.9 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -163.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 40.7 m 66.95 141.78 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 167.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.45 -45.85 0.4 Allowed 'Cis proline' 0 CA--C 1.564 1.992 0 CA-C-N 122.627 1.974 . . . . 0.0 115.705 -3.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -134.42 63.26 1.63 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.703 0.801 . . . . 0.0 110.489 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.1 mt -91.32 121.35 67.72 Favored Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.47 162.4 35.98 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.918 2.412 . . . . 0.0 116.303 -170.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.85 -46.3 6.78 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 123.215 2.61 . . . . 0.0 116.598 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -97.39 -166.73 1.43 Allowed 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 124.498 1.119 . . . . 0.0 111.689 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.28 128.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.248 1.419 . . . . 0.0 113.106 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.25 101.91 12.91 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.137 0.575 . . . . 0.0 110.921 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.87 143.11 44.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -164.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.7 m -84.7 115.5 22.71 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.002 0.921 . . . . 0.0 110.706 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.19 98.86 6.37 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -82.94 107.36 15.49 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.238 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.7 93.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.4 m -99.99 112.42 24.71 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.53 102.91 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -73.86 -65.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.155 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.0 p -144.72 130.61 19.25 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.37 103.35 15.28 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.11 153.27 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.543 0.737 . . . . 0.0 110.13 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.39 145.73 55.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.097 0 CA-C-O 117.178 -1.901 . . . . 0.0 111.981 -174.625 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.569 1.693 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -76.76 128.42 34.61 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.515 0.726 . . . . 0.0 109.809 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.89 114.2 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.332 0.653 . . . . 0.0 110.692 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.69 127.13 44.52 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.084 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.37 74.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.281 0.632 . . . . 0.0 109.679 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -157.58 -72.75 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.66 0.784 . . . . 0.0 109.018 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.77 -83.34 0.11 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -164.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.55 -70.26 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.239 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.52 85.02 0.05 OUTLIER Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.966 0.803 . . . . 0.0 112.971 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.55 -59.34 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -74.17 114.26 12.3 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.15 0.886 . . . . 0.0 110.489 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -143.46 105.54 4.38 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.716 0.807 . . . . 0.0 109.782 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -101.93 101.42 11.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 112.316 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.26 120.0 23.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.852 -1.155 . . . . 0.0 109.515 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.4 m -78.9 115.66 18.73 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.358 0.599 . . . . 0.0 110.141 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.03 -69.0 0.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.733 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.48 106.82 52.03 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.45 175.14 11.67 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 122.651 2.234 . . . . 0.0 114.655 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.94 123.46 24.14 Favored Glycine 0 CA--C 1.558 2.74 0 CA-C-O 117.133 -1.926 . . . . 0.0 112.466 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.4 161.19 44.33 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 CA-C-N 122.321 3.06 . . . . 0.0 115.29 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 106.74 1.22 Allowed 'Trans proline' 0 CA--C 1.558 1.722 0 C-N-CA 123.181 2.588 . . . . 0.0 112.171 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.72 76.29 1.32 Allowed Glycine 0 CA--C 1.545 1.95 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.591 -159.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -147.96 117.24 6.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -79.71 142.37 35.53 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.056 0.542 . . . . 0.0 112.261 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -91.4 116.3 66.16 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.186 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.93 144.86 31.0 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.703 2.269 . . . . 0.0 114.665 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.18 169.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.196 0.999 . . . . 0.0 112.645 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -64.54 120.32 12.12 Favored 'General case' 0 CA--C 1.568 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 112.084 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.0 40.67 3.72 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -138.26 115.55 11.09 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -72.26 109.46 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 123.285 0.634 . . . . 0.0 110.099 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.5 123.98 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.616 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.7 m -102.61 121.32 42.16 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.94 142.46 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.389 0.675 . . . . 0.0 110.783 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -82.72 104.59 13.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 161.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.35 125.43 47.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -133.3 122.15 23.45 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.489 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.8 p -93.0 131.37 38.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.08 0.952 . . . . 0.0 111.558 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.9 m -155.57 131.5 9.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.579 0.751 . . . . 0.0 109.708 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.03 157.28 19.15 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -52.7 -40.56 63.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -73.36 -64.73 0.92 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.537 0.735 . . . . 0.0 111.142 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.35 0.05 OUTLIER Glycine 0 N--CA 1.478 1.466 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.2 m -146.15 120.82 9.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -80.14 119.4 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.864 0.866 . . . . 0.0 111.974 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.0 t -97.41 -69.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.585 -166.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -143.83 122.11 12.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -167.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -85.52 94.68 9.08 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.456 0.702 . . . . 0.0 110.591 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.12 68.32 46.58 Favored Pre-proline 0 CA--C 1.579 2.068 0 O-C-N 121.384 -0.823 . . . . 0.0 113.163 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 -39.65 3.05 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.355 2.703 . . . . 0.0 117.58 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 76.73 1.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.575 1.079 . . . . 0.0 110.391 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.18 95.96 7.44 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.5 t -101.89 114.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.27 152.51 40.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 111.323 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -75.29 128.32 35.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.94 124.89 21.6 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.032 0.933 . . . . 0.0 111.979 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.64 -41.24 3.06 Favored Glycine 0 CA--C 1.547 2.079 0 N-CA-C 117.505 1.762 . . . . 0.0 117.505 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.91 107.77 18.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.012 1.406 . . . . 0.0 109.562 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -85.98 81.42 8.51 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -150.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.98 -47.37 52.58 Favored 'General case' 0 CA--C 1.574 1.899 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.105 156.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.08 179.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.602 1.161 . . . . 0.0 114.108 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.01 152.09 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.648 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -64.19 -33.46 75.84 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.31 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 167.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -53.09 38.64 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.23 -42.63 86.71 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.86 -34.31 77.66 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -72.82 -22.99 60.72 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.2 t -57.38 -49.94 90.99 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 114.871 -2.49 . . . . 0.0 115.996 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -53.28 -34.58 70.71 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 126.12 3.221 . . . . 0.0 118.424 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.3 pt? -101.01 63.74 1.02 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.598 0.759 . . . . 0.0 111.579 168.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.28 113.32 6.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -97.02 168.12 10.65 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.878 0.847 . . . . 0.0 111.915 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.76 118.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.852 -1.155 . . . . 0.0 108.403 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.09 6.04 72.28 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.144 2.018 . . . . 0.0 118.144 -165.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.12 108.4 19.84 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 120.5 2.15 . . . . 0.0 109.625 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -109.19 119.71 40.34 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.06 136.93 34.14 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.776 0.798 . . . . 0.0 111.075 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.9 ttm -84.0 103.14 13.0 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.062 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.95 92.6 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.9 p -81.41 126.55 31.77 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.282 0.633 . . . . 0.0 109.769 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.1 136.88 17.08 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.316 -175.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -46.02 133.33 8.96 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 124.785 1.234 . . . . 0.0 113.983 168.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.4 m -74.55 84.83 2.05 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.279 1.038 . . . . 0.0 110.983 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -179.55 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -142.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -68.62 -36.52 78.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 162.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.1 m -72.22 -75.12 0.14 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.17 0.895 . . . . 0.0 111.179 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.92 -67.71 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.263 0.938 . . . . 0.0 110.774 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.7 170.72 27.94 Favored Glycine 0 CA--C 1.553 2.45 0 CA-C-N 119.036 0.834 . . . . 0.0 115.088 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.22 10.03 0.35 Allowed 'Trans proline' 0 CA--C 1.571 2.348 0 N-CA-C 119.375 2.798 . . . . 0.0 119.375 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -131.53 -76.65 0.52 Allowed 'General case' 0 CA--C 1.561 1.376 0 CA-C-N 119.527 1.058 . . . . 0.0 108.258 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.56 124.08 1.11 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 119.69 1.132 . . . . 0.0 112.545 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -93.05 39.09 1.04 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.6 m 66.72 139.25 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.79 -50.46 0.17 OUTLIER 'Cis proline' 0 CA--C 1.563 1.964 0 CA-C-N 123.097 2.142 . . . . 0.0 115.896 4.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -132.4 71.76 1.48 Allowed 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.891 0.877 . . . . 0.0 108.855 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.6 mm -99.72 134.55 20.98 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.927 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.32 162.31 33.88 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.203 2.602 . . . . 0.0 116.215 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.77 -94.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 123.358 2.706 . . . . 0.0 113.094 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -136.51 80.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.109 1.322 . . . . 0.0 109.542 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.75 38.55 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 60.14 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tt -96.58 130.04 43.85 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.8 t -100.37 113.36 26.03 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.872 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.15 108.69 20.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.32 97.38 9.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.003 -0.436 . . . . 0.0 110.189 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.79 111.43 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -168.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.1 m -113.79 113.28 24.72 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.04 103.51 9.97 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 120.942 0.401 . . . . 0.0 110.052 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -80.88 -64.46 1.18 Allowed 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -141.78 137.33 31.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.725 0.81 . . . . 0.0 109.008 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.56 107.95 18.65 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.11 125.43 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -81.39 91.04 6.21 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.203 1.001 . . . . 0.0 112.957 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.344 0 CA-C-O 116.876 -2.069 . . . . 0.0 113.851 179.07 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.505 2.286 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -141.4 117.43 10.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -100.03 107.82 19.85 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.57 123.94 30.27 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.448 0.642 . . . . 0.0 111.676 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.44 -58.84 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.664 0.786 . . . . 0.0 110.735 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.258 3.7 pp -66.48 -17.63 64.91 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.45 55.86 4.49 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 119.948 1.249 . . . . 0.0 116.034 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -156.13 -81.18 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.33 59.62 0.03 OUTLIER Glycine 0 CA--C 1.541 1.689 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.172 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.76 -70.98 0.45 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.0 tp -88.29 102.81 15.2 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.495 1.043 . . . . 0.0 108.84 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.0 117.58 31.01 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.363 0.665 . . . . 0.0 110.004 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -122.36 103.62 8.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 0.0 110.266 -168.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -81.02 141.22 34.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.461 -0.775 . . . . 0.0 109.729 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -81.65 96.48 7.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 159.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 112' ' ' ALA . 32.1 tp -64.39 -63.08 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.824 1.25 . . . . 0.0 113.218 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.97 123.89 23.75 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 162.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.61 165.42 24.96 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 C-N-CA 123.117 2.545 . . . . 0.0 114.844 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.3 171.3 55.17 Favored Glycine 0 CA--C 1.562 2.98 0 N-CA-C 115.35 0.9 . . . . 0.0 115.35 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.41 162.72 39.42 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 123.257 2.638 . . . . 0.0 115.827 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.78 -42.2 48.08 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 123.423 2.749 . . . . 0.0 116.743 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.97 -176.21 50.58 Favored Glycine 0 CA--C 1.552 2.365 0 CA-C-N 119.04 0.836 . . . . 0.0 113.711 161.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m 62.36 86.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.376 1.071 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.0 p -98.71 153.67 18.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -165.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -45.13 128.39 5.65 Favored Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.38 165.88 28.48 Favored 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 122.948 2.432 . . . . 0.0 115.843 -173.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -102.63 159.06 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.444 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -63.77 132.79 52.03 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 113.588 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.34 14.28 9.92 Favored Glycine 0 CA--C 1.557 2.717 0 CA-C-N 113.82 -1.536 . . . . 0.0 115.564 -153.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -138.65 114.87 10.29 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.88 109.55 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.75 134.88 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.594 0.758 . . . . 0.0 110.737 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -92.71 127.98 38.41 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.2 126.15 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -71.55 107.0 4.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.879 0.872 . . . . 0.0 110.38 171.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.35 131.72 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.055 0.931 . . . . 0.0 108.975 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -137.66 91.8 2.63 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -87.2 123.76 32.57 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -132.63 179.24 6.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.144 0.978 . . . . 0.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.0 tp -94.37 149.27 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.099 -1.001 . . . . 0.0 110.074 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.48 -20.87 61.48 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.04 -71.79 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.223 0.92 . . . . 0.0 110.494 161.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.28 81.75 0.04 OUTLIER Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.494 1.043 . . . . 0.0 112.917 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.3 m -152.9 114.32 4.24 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.298 19.8 ptp180 -78.08 105.54 9.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -81.14 -48.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -137.79 89.88 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.14 96.93 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.817 0.818 . . . . 0.0 110.192 168.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.14 89.72 17.94 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.88 2.59 6.4 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 N-CA-C 120.139 3.092 . . . . 0.0 120.139 -159.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.301 9.2 pt-20 -151.84 148.75 28.2 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.824 2.102 . . . . 0.0 113.214 154.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.7 tp -142.1 106.44 4.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -165.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.3 t -98.56 106.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -137.55 155.77 48.85 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.4 m -80.75 130.29 35.0 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.366 0.667 . . . . 0.0 109.659 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.61 119.23 10.1 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 62.25 3.49 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -152.52 144.46 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.148 0.979 . . . . 0.0 110.261 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.15 74.8 2.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -126.61 -59.44 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.093 1.357 . . . . 0.0 109.858 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.16 178.14 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.593 1.157 . . . . 0.0 113.074 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.54 137.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.757 0.823 . . . . 0.0 112.011 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -62.07 -29.23 70.16 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.11 84.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 165.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -53.48 57.33 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -66.31 -33.92 76.83 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.37 -34.92 79.04 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 165.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 p -79.82 2.01 24.72 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 167.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.262 2.5 t -53.08 -48.83 90.54 Favored Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 115.262 -2.304 . . . . 0.0 114.787 170.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.04 -18.33 22.48 Favored 'Trans proline' 0 CA--C 1.566 2.121 0 CA-C-N 125.38 2.957 . . . . 0.0 119.012 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.84 70.78 0.74 Allowed 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.295 0.952 . . . . 0.0 108.741 166.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.1 mmt -149.44 90.35 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.36 161.07 18.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.294 1.045 . . . . 0.0 111.994 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.83 104.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.706 . . . . 0.0 109.098 -165.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.75 29.78 Favored Glycine 0 CA--C 1.556 2.63 0 CA-C-O 117.002 -1.999 . . . . 0.0 117.952 -164.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.64 113.72 14.59 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 121.39 2.595 . . . . 0.0 112.761 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -88.73 117.81 27.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.408 ' HA ' ' H ' ' A' ' 50' ' ' LEU . . . -140.28 132.88 28.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.416 0.286 . . . . 0.0 111.465 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.3 tpp -82.19 106.83 14.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.53 87.55 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -106.06 108.8 20.5 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.2 176.74 4.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.36 1.076 . . . . 0.0 112.167 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.13 157.94 29.9 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.9 t -75.36 78.5 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.631 1.205 . . . . 0.0 110.991 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 179.95 -67.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.555 -1.657 . . . . 0.0 106.964 -152.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.65 -41.89 36.71 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.249 1.02 . . . . 0.0 113.082 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 66.7 m -58.55 -63.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.596 1.089 . . . . 0.0 113.011 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.71 -76.05 0.32 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.413 1.006 . . . . 0.0 108.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.47 162.96 21.61 Favored Glycine 0 CA--C 1.557 2.714 0 CA-C-O 118.918 -0.935 . . . . 0.0 113.148 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.26 60.83 5.58 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 CA-C-N 121.151 2.475 . . . . 0.0 114.964 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -158.46 -77.14 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.0 95.76 0.27 Allowed Glycine 0 CA--C 1.536 1.396 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.64 48.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m 65.68 135.24 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.22 -51.05 0.16 OUTLIER 'Cis proline' 0 CA--C 1.562 1.92 0 CA-C-N 123.001 2.107 . . . . 0.0 116.271 3.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -141.66 77.87 1.61 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.335 1.064 . . . . 0.0 108.481 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mt -99.57 120.69 56.98 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 144.09 34.09 Favored 'Trans proline' 0 CA--C 1.571 2.357 0 C-N-CA 122.729 2.286 . . . . 0.0 114.349 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 122.31 8.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.078 2.519 . . . . 0.0 113.026 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.36 32.1 p80 51.86 67.84 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.08 108.27 3.59 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.66 126.75 28.4 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -167.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 tp -111.45 127.27 55.63 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.3 -155.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.1 m -74.75 152.2 39.08 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.12 113.55 3.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.08 0.552 . . . . 0.0 109.866 167.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.53 112.13 20.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.153 0.977 . . . . 0.0 111.374 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.62 107.7 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.3 m -106.53 117.65 34.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.31 109.87 6.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.176 0.591 . . . . 0.0 110.291 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -78.52 -68.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.457 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.1 p -141.8 131.69 24.41 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.044 0.838 . . . . 0.0 109.752 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.94 109.48 21.84 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.58 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.537 0.684 . . . . 0.0 110.507 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.0 145.52 52.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.665 0 CA-C-O 117.01 -1.994 . . . . 0.0 114.587 -176.236 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.329 27.8 tt0 . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -123.02 106.96 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.47 108.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.69 122.01 23.36 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.554 1.169 . . . . 0.0 114.028 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.43 74.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.078 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.44 -64.73 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.87 0.868 . . . . 0.0 109.514 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.85 -81.52 0.19 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -160.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -76.22 -76.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.036 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.02 79.94 0.03 OUTLIER Glycine 0 N--CA 1.478 1.44 0 CA-C-N 118.874 0.761 . . . . 0.0 112.087 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.65 -58.91 1.03 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.435 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.1 tp -81.17 123.15 28.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.087 1.312 . . . . 0.0 108.606 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -142.71 131.97 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 123.387 0.675 . . . . 0.0 111.864 -167.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -122.4 132.19 54.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 0.0 113.392 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HZ3' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -110.61 125.34 53.3 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.593 -0.692 . . . . 0.0 109.642 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -81.04 124.41 29.16 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.311 0.505 . . . . 0.0 111.078 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 48' ' ' LYS . 13.8 tp -87.32 -71.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.509 0.724 . . . . 0.0 110.058 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.89 100.65 53.83 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.14 160.67 42.23 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.741 2.294 . . . . 0.0 113.842 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.22 151.26 52.09 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.987 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.56 165.07 28.58 Favored 'Trans proline' 0 CA--C 1.572 2.382 0 C-N-CA 123.132 2.555 . . . . 0.0 115.852 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 115.49 3.93 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 123.139 2.56 . . . . 0.0 112.68 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.11 -103.97 1.04 Allowed Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -167.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.4 m 59.34 100.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.4 m -80.66 128.63 33.84 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.151 0.501 . . . . 0.0 110.126 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -93.12 113.73 60.76 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.808 -1.092 . . . . 0.0 110.495 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.81 150.88 68.47 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.972 2.448 . . . . 0.0 115.274 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.8 166.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.857 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -73.09 99.75 2.86 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.762 0.825 . . . . 0.0 110.656 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.03 -52.36 0.56 Allowed Glycine 0 CA--C 1.549 2.176 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.333 -155.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -73.76 140.16 45.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.764 0.825 . . . . 0.0 112.201 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.7 t -90.17 112.62 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.63 142.88 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.52 1.152 . . . . 0.0 110.481 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -106.43 116.32 31.73 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.37 126.61 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 122.72 0.408 . . . . 0.0 110.21 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -73.62 103.77 4.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 161.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 tp -102.14 100.3 10.51 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -93.62 90.28 6.57 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -90.57 121.68 32.71 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -167.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -124.11 175.88 6.73 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.312 1.045 . . . . 0.0 110.843 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -80.31 -83.54 0.1 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.661 0.784 . . . . 0.0 109.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.05 -69.94 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.602 0.761 . . . . 0.0 109.366 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.16 66.63 1.82 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.399 0.619 . . . . 0.0 110.901 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.22 65.28 3.47 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -132.45 104.35 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.63 107.11 3.76 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.6 0.714 . . . . 0.0 112.514 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.25 18.9 m -87.11 -52.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.856 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.66 82.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.16 114.12 14.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.379 0.609 . . . . 0.0 112.452 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -125.63 97.22 36.72 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.765 -158.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.4 109.01 2.24 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 123.804 3.003 . . . . 0.0 111.037 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.574 1.2 pm0 67.51 81.03 0.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.59 103.32 6.51 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 156.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.1 t -96.87 121.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 148.67 28.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.719 -168.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.5 m -66.8 124.8 23.93 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.06 103.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.358 1.063 . . . . 0.0 112.952 -163.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.04 -42.89 2.91 Favored Glycine 0 CA--C 1.549 2.162 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -55.62 5.98 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.09 108.32 15.47 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.468 0.576 . . . . 0.0 111.675 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.294 2.7 t70 81.01 -51.6 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 170.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.78 158.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -150.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 168.9 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 113.528 -1.669 . . . . 0.0 113.977 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -61.03 -26.8 67.87 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.81 75.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 168.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.68 -49.74 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -56.98 -44.6 82.84 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.6 mt -71.4 -50.77 28.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.6 p -71.91 -45.08 62.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -175.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.46 -39.68 51.3 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 114.919 -2.467 . . . . 0.0 115.462 -169.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.05 -33.09 92.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 126.412 3.326 . . . . 0.0 116.573 168.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.64 -26.49 64.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 69.2 mmm -71.31 129.87 39.95 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 120.003 1.274 . . . . 0.0 111.393 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.44 158.57 33.62 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 122.752 1.263 . . . . 0.0 113.614 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.74 108.22 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.019 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.35 23.62 23.86 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 117.476 1.751 . . . . 0.0 117.476 -163.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -98.05 129.59 44.89 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.812 1.806 . . . . 0.0 111.184 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.6 m -107.33 123.03 47.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.49 131.53 9.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 0.0 110.736 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.91 104.68 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.415 0.686 . . . . 0.0 109.369 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.1 t -93.62 96.27 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 79.5 p -90.16 102.26 14.98 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 124.35 38.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.972 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -63.61 164.78 9.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.1 p -74.83 74.16 2.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.525 1.155 . . . . 0.0 113.004 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp 176.96 -65.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.508 1.523 . . . . 0.0 107.113 -158.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -75.18 -34.11 61.53 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.284 1.434 . . . . 0.0 114.031 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 137' ' ' LEU . 34.7 t -68.42 -76.94 0.08 Allowed 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.381 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -133.93 -80.74 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.25 -105.13 0.26 Allowed Glycine 0 CA--C 1.547 2.062 0 CA-C-O 116.881 -2.066 . . . . 0.0 111.427 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.0 -47.7 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 122.266 3.033 . . . . 0.0 116.399 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -148.33 117.26 6.74 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 133' ' ' PRO . . . -92.46 -120.07 2.7 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 123.205 0.431 . . . . 0.0 112.312 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -128.73 72.01 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.359 0.664 . . . . 0.0 110.103 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 t -73.85 135.35 77.58 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.783 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.06 -22.18 15.63 Favored 'Cis proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.294 2.767 . . . . 0.0 119.294 9.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -56.06 -41.66 75.41 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 104.39 50.67 Favored Pre-proline 0 CA--C 1.574 1.881 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.83 157.07 58.38 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 C-N-CA 123.038 2.492 . . . . 0.0 114.726 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 126' ' ' GLY . 47.7 Cg_endo -70.88 -68.93 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.613 2.209 . . . . 0.0 116.623 -157.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -121.77 76.66 1.29 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.28 154.07 48.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.345 1.058 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.3 8.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 121' ' ' CYS . 9.0 mp -69.05 134.79 49.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.726 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 77.5 m -104.25 99.67 9.39 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.16 106.85 10.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.557 0.743 . . . . 0.0 109.713 -167.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.15 117.52 24.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.803 0.811 . . . . 0.0 112.162 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.3 t -88.52 108.02 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.0 m -115.82 108.28 16.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.48 106.87 5.45 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.064 0.546 . . . . 0.0 110.4 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -87.53 -53.01 5.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.168 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.4 p -145.82 131.97 19.4 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.21 0.914 . . . . 0.0 108.936 173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.12 118.64 37.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.187 0.595 . . . . 0.0 109.453 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.26 165.46 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.225 1.012 . . . . 0.0 109.687 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.35 -179.11 4.32 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.219 0 CA-C-O 116.939 -2.034 . . . . 0.0 110.797 172.161 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.661 0.267 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.264 17.1 m0 84.46 120.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.287 1.435 . . . . 0.0 109.504 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.21 117.42 28.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.098 0.475 . . . . 0.0 110.779 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.25 150.75 25.98 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.47 -54.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.488 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.05 -63.2 1.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.82 0.78 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -127.63 -82.67 0.6 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.844 1.822 . . . . 0.0 106.195 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.08 76.78 0.05 OUTLIER Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.446 0.566 . . . . 0.0 111.869 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.88 -67.21 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 tp -85.83 112.31 21.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.739 0.815 . . . . 0.0 108.818 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -134.9 112.91 11.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.202 0.525 . . . . 0.0 111.386 -170.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -91.79 100.95 13.55 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 111.687 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -94.45 120.07 34.13 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.38 0.672 . . . . 0.0 109.791 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.4 m -80.14 114.96 19.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.298 0.57 . . . . 0.0 110.126 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.56 -71.87 0.5 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.124 0.97 . . . . 0.0 109.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.51 126.09 61.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.3 162.15 43.42 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.066 2.511 . . . . 0.0 114.817 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.85 122.83 7.2 Favored Glycine 0 CA--C 1.555 2.542 0 CA-C-O 116.964 -2.02 . . . . 0.0 112.941 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.57 165.89 21.51 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 CA-C-N 122.541 3.171 . . . . 0.0 115.51 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.31 120.95 8.42 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.179 2.586 . . . . 0.0 114.002 -170.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.91 -111.65 3.83 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m 58.99 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 m -117.72 125.76 51.25 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.379 1.085 . . . . 0.0 109.979 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -68.17 136.47 91.54 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 114.287 171.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.16 179.56 4.85 Favored 'Trans proline' 0 CA--C 1.568 2.187 0 C-N-CA 122.947 2.431 . . . . 0.0 115.449 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.0 m -93.65 175.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 124.19 0.996 . . . . 0.0 112.325 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -63.28 128.08 34.19 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.563 0.745 . . . . 0.0 112.856 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.96 4.5 Favored Glycine 0 CA--C 1.548 2.156 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.793 -167.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -148.22 138.81 22.9 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.51 118.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -172.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.04 134.09 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.812 0.845 . . . . 0.0 109.351 170.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -99.44 118.21 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.6 130.95 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -91.64 100.5 13.22 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.657 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -96.51 131.99 42.54 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.196 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -127.57 104.88 8.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -82.23 132.8 35.23 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.049 -169.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -131.03 116.13 17.38 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.21 94.51 9.68 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 12.1 pt-20 -70.39 -26.34 63.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.07 -41.43 96.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 160.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.33 -104.53 2.89 Favored Glycine 0 CA--C 1.544 1.852 0 CA-C-N 119.398 0.999 . . . . 0.0 112.159 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.3 m -131.31 146.4 52.28 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.019 0.928 . . . . 0.0 108.92 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -62.8 118.46 7.74 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.89 -45.67 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.272 13.8 mm100 75.3 92.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.879 1.671 . . . . 0.0 110.442 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.45 159.5 16.11 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-O 122.518 1.152 . . . . 0.0 112.703 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.2 139.69 95.17 Favored Pre-proline 0 CA--C 1.58 2.11 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -167.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.34 -13.04 16.98 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 119.862 2.985 . . . . 0.0 119.862 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.13 75.43 1.59 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.908 1.685 . . . . 0.0 110.682 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.34 106.31 18.33 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.05 135.56 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.192 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -159.76 157.85 30.12 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -91.3 131.48 36.78 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.112 0.965 . . . . 0.0 109.729 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.55 142.29 58.48 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.618 0.767 . . . . 0.0 113.061 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.66 -60.15 4.84 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 114.354 0.502 . . . . 0.0 114.354 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.79 115.46 7.36 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.748 1.219 . . . . 0.0 111.407 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.7 77.62 6.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.698 1.237 . . . . 0.0 113.492 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.72 -50.46 17.4 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.882 162.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.4 m -82.29 -178.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 C-N-CA 124.815 1.246 . . . . 0.0 113.254 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -60.87 161.04 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 124.713 1.205 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -61.0 -36.63 79.98 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -44.64 97.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 169.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.3 mt -65.3 -55.8 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 117.741 -1.124 . . . . 0.0 113.496 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -50.67 -48.81 58.29 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.28 -32.54 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.1 p -80.13 1.96 25.98 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 166.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.17 -52.49 74.23 Favored Pre-proline 0 N--CA 1.499 2.002 0 CA-C-O 115.044 -2.408 . . . . 0.0 112.683 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.37 39.35 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.517 0 CA-C-N 124.848 2.767 . . . . 0.0 116.827 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.2 mt -144.99 -46.04 0.23 Allowed 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 125.618 1.567 . . . . 0.0 110.631 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -76.41 113.44 14.0 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.804 1.184 . . . . 0.0 112.35 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.9 163.89 12.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.76 1.267 . . . . 0.0 111.882 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.49 115.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.294 -0.879 . . . . 0.0 112.155 -166.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.82 -40.19 2.4 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 117.091 1.596 . . . . 0.0 117.091 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.47 134.9 46.88 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.58 1.69 . . . . 0.0 115.459 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -90.98 125.29 35.74 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 154.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.61 121.89 13.06 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.4 ptp -75.8 125.88 29.92 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.404 1.097 . . . . 0.0 110.706 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.9 t -102.08 95.2 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.8 p -89.62 102.87 15.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.5 143.9 49.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.128 -161.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.82 162.37 4.12 Favored 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.1 p -54.02 -34.89 61.14 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 160.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.12 -43.91 82.76 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 161.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -86.56 63.91 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.899 0.772 . . . . 0.0 110.664 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.6 t -171.5 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -137.8 5.47 2.62 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.74 145.79 19.26 Favored Glycine 0 CA--C 1.56 2.885 0 CA-C-N 120.867 1.667 . . . . 0.0 111.892 -160.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.0 80.21 2.73 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 CA-C-N 122.558 3.179 . . . . 0.0 112.279 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -138.21 -74.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.16 0.584 . . . . 0.0 110.022 -164.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.42 96.48 0.12 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 140.75 49.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.287 0.635 . . . . 0.0 110.821 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.2 p -66.86 138.87 95.42 Favored Pre-proline 0 CA--C 1.573 1.831 0 CA-C-O 117.678 -1.153 . . . . 0.0 113.662 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.35 -44.82 0.45 Allowed 'Cis proline' 0 CA--C 1.563 1.934 0 N-CA-C 117.106 1.926 . . . . 0.0 117.106 8.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -155.18 88.73 1.17 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 83.4 mt -121.92 86.36 46.1 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.66 163.47 31.63 Favored 'Trans proline' 0 CA--C 1.572 2.421 0 C-N-CA 122.68 2.253 . . . . 0.0 115.424 -171.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.84 119.87 6.49 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.162 2.574 . . . . 0.0 113.232 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.258 96.1 m-70 66.8 76.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.796 1.239 . . . . 0.0 111.49 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.49 116.78 2.99 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.28 127.48 33.68 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.967 0.889 . . . . 0.0 112.844 -171.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.49 129.76 49.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.264 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.72 94.7 5.34 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.271 0.629 . . . . 0.0 109.372 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.37 121.64 45.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.445 0.698 . . . . 0.0 110.441 -170.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.9 100.41 6.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.011 0.524 . . . . 0.0 111.586 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.44 109.0 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.9 m -113.86 121.65 44.63 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.66 102.03 10.43 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -84.05 -59.55 2.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 60.1 p -122.46 149.5 43.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.658 0.783 . . . . 0.0 109.749 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.51 107.93 8.32 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.79 170.24 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.24 1.016 . . . . 0.0 110.096 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.56 -161.46 0.19 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.538 0 CA-C-O 116.728 -2.151 . . . . 0.0 112.701 178.735 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 . . . . . 0 CA--C 1.561 1.38 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 91.6 m95 76.09 94.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.692 1.197 . . . . 0.0 111.564 168.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.87 113.2 26.55 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.93 110.45 5.04 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.016 0.912 . . . . 0.0 113.348 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.17 -42.11 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.806 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -73.95 -63.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.501 1.046 . . . . 0.0 111.274 165.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.5 -89.64 0.15 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -83.57 -40.53 18.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.04 82.12 1.49 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.093 0.861 . . . . 0.0 115.25 -163.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp 40.55 63.31 1.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 162.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 tp -162.29 92.74 0.83 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -117.16 117.78 30.54 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.509 0.724 . . . . 0.0 109.247 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.79 105.83 17.18 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.51 -0.744 . . . . 0.0 111.331 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 101.48 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 166.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.5 p -84.45 110.48 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.56 -59.51 2.72 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.601 0.76 . . . . 0.0 111.827 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.34 103.44 54.99 Favored Pre-proline 0 CA--C 1.57 1.729 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.65 87.07 1.55 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.989 2.459 . . . . 0.0 112.963 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.04 88.41 0.11 Allowed Glycine 0 CA--C 1.553 2.451 0 CA-C-O 116.339 -2.367 . . . . 0.0 113.286 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.82 167.84 16.63 Favored 'Trans proline' 0 CA--C 1.576 2.607 0 CA-C-N 123.154 3.477 . . . . 0.0 115.336 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.46 127.68 21.53 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 123.211 2.608 . . . . 0.0 114.86 -168.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.58 -123.12 6.63 Favored Glycine 0 CA--C 1.546 1.988 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -160.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m 59.43 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 164.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -123.4 127.28 48.22 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.705 1.241 . . . . 0.0 110.12 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -69.93 122.32 85.64 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 113.1 -1.864 . . . . 0.0 113.225 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.45 171.82 16.29 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.795 2.33 . . . . 0.0 115.352 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.95 174.65 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -60.57 133.09 55.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.13 51.1 4.57 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.284 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -146.63 131.87 18.45 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.76 113.45 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.67 124.77 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -92.97 133.55 36.01 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 m -127.92 145.37 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.629 0.728 . . . . 0.0 110.16 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.73 98.28 8.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 165.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.51 125.72 31.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -103.98 73.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -79.46 119.45 22.48 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.9 m -146.91 133.9 20.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 tp -67.18 151.91 46.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.662 0.785 . . . . 0.0 113.001 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.14 12.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -77.65 -63.82 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.587 1.085 . . . . 0.0 112.529 168.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.07 76.38 0.02 OUTLIER Glycine 0 N--CA 1.48 1.583 0 CA-C-N 118.786 0.721 . . . . 0.0 111.533 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -149.39 113.91 5.29 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -74.6 104.23 5.21 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.248 0.477 . . . . 0.0 111.633 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.58 -61.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.003 -165.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.85 85.81 1.43 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -100.03 91.56 4.85 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.845 0.458 . . . . 0.0 110.231 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -98.97 116.33 65.31 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.087 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.73 -53.36 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.875 2.384 . . . . 0.0 115.079 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -98.73 81.25 2.64 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.252 0.933 . . . . 0.0 111.192 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.72 98.79 11.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.73 109.93 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -165.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -137.46 151.73 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -88.08 118.98 28.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.86 145.56 32.67 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.77 -50.0 4.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.71 -2.81 0.89 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 58.2 m 75.41 90.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.985 1.314 . . . . 0.0 111.46 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.76 -63.01 1.1 Allowed 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.297 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.88 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 124.28 1.032 . . . . 0.0 113.396 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 pt -56.57 148.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 125.06 1.344 . . . . 0.0 113.171 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -61.7 -26.69 68.2 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.45 69.84 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 120.29 1.405 . . . . 0.0 114.74 165.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -44.17 93.3 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.34 -40.35 95.7 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.91 -30.97 72.0 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 167.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -77.62 -0.17 25.53 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.64 -55.41 45.25 Favored Pre-proline 0 N--CA 1.502 2.125 0 CA-C-O 115.329 -2.272 . . . . 0.0 112.708 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.36 24.57 0.23 Allowed 'Trans proline' 0 CA--C 1.574 2.483 0 CA-C-N 124.683 2.708 . . . . 0.0 118.249 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.92 -39.14 1.23 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.97 1.308 . . . . 0.0 111.825 168.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -75.45 123.42 25.39 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.883 1.219 . . . . 0.0 113.566 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.92 170.27 8.18 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.76 1.267 . . . . 0.0 111.771 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.29 111.99 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.313 -0.867 . . . . 0.0 110.112 -157.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.89 2.14 57.22 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 -166.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -75.32 123.42 25.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 121.27 2.535 . . . . 0.0 111.961 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.8 m -103.82 116.73 32.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.53 128.16 10.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.4 tpp -80.79 113.71 19.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.756 0.823 . . . . 0.0 109.569 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.13 93.3 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -91.28 109.53 20.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.96 147.04 30.33 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -48.15 150.79 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 t -70.52 78.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.627 1.203 . . . . 0.0 111.491 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -179.76 -67.34 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.455 -1.702 . . . . 0.0 106.639 -156.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -65.87 -55.47 16.84 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.95 0.9 . . . . 0.0 111.718 159.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 71.6 m -73.21 111.5 8.39 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.768 0.713 . . . . 0.0 110.367 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.323 75.7 m-85 80.08 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.242 1.017 . . . . 0.0 112.036 170.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.45 162.99 26.33 Favored Glycine 0 CA--C 1.557 2.687 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.085 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.21 -22.16 47.17 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 123.183 2.589 . . . . 0.0 118.411 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -80.54 -45.04 18.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.92 97.98 1.37 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -171.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -84.14 178.66 7.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.366 1.079 . . . . 0.0 112.757 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -75.03 138.1 72.65 Favored Pre-proline 0 CA--C 1.57 1.745 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.643 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.67 -56.36 0.14 OUTLIER 'Cis proline' 0 CA--C 1.562 1.891 0 CA-C-N 122.316 1.863 . . . . 0.0 115.704 6.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -145.96 70.82 1.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.14 0.882 . . . . 0.0 109.386 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.7 mm -90.6 119.06 69.1 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.423 -1.275 . . . . 0.0 107.933 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.65 121.41 5.94 Favored 'Trans proline' 0 CA--C 1.571 2.36 0 C-N-CA 122.716 2.277 . . . . 0.0 112.253 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.64 132.73 20.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 123.012 2.475 . . . . 0.0 112.704 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.273 14.9 m170 78.86 148.28 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 124.61 1.164 . . . . 0.0 110.748 -166.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.26 . . 78.93 136.26 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.841 1.257 . . . . 0.0 112.514 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.32 136.49 33.88 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.54 136.15 37.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.816 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.9 m -101.11 102.91 13.96 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 109.36 18.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.289 0.636 . . . . 0.0 111.22 -175.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.32 98.74 9.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.486 0.66 . . . . 0.0 110.377 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.82 111.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.8 m -110.77 114.32 27.58 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.56 120.18 18.81 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.057 0.543 . . . . 0.0 111.014 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.11 -65.41 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.488 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 46.6 p -124.77 150.59 46.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.852 0.834 . . . . 0.0 109.847 -166.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.79 98.67 4.24 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.24 164.59 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.934 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.65 -160.58 0.19 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.195 0 CA-C-O 117.075 -1.959 . . . . 0.0 110.824 172.413 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -156.4 146.59 21.35 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.625 1.17 . . . . 0.0 109.371 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 tp -74.31 136.15 42.58 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.259 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -83.47 -178.27 7.0 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-O 123.452 1.596 . . . . 0.0 114.928 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 -74.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.36 -39.9 58.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.39 67.94 0.57 Allowed Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -146.94 -65.54 0.28 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.71 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.43 -50.32 0.83 Allowed Glycine 0 CA--C 1.545 1.957 0 CA-C-N 118.907 0.776 . . . . 0.0 114.074 -164.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.69 -56.74 8.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.68 112.83 24.9 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.861 0.755 . . . . 0.0 109.076 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -133.73 148.65 51.45 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.127 0.971 . . . . 0.0 111.444 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -108.55 127.16 53.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.647 -0.658 . . . . 0.0 111.511 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.92 -43.1 95.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.269 19.5 m 73.5 95.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 174.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.78 -65.62 0.99 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.889 . . . . 0.0 110.166 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.46 113.01 33.85 Favored Pre-proline 0 CA--C 1.569 1.689 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.3 78.99 3.01 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.87 2.38 . . . . 0.0 113.095 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.34 160.95 17.09 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.14 170.2 20.08 Favored 'Trans proline' 0 CA--C 1.574 2.499 0 C-N-CA 123.266 2.644 . . . . 0.0 114.39 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.35 108.28 1.97 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.031 2.487 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.06 83.34 0.96 Allowed Glycine 0 CA--C 1.544 1.88 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -159.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -100.51 123.63 44.98 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.884 0.474 . . . . 0.0 111.961 -166.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -92.33 138.85 31.17 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.335 0.654 . . . . 0.0 112.218 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -113.12 107.19 54.3 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.4 148.22 29.77 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.022 2.482 . . . . 0.0 114.53 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.39 147.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.0 0.92 . . . . 0.0 112.576 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 86.3 2.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.74 62.79 0.01 OUTLIER Glycine 0 CA--C 1.54 1.634 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.158 172.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.07 0.938 . . . . 0.0 110.596 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.45 109.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.77 112.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 m -93.1 106.84 18.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.35 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -171.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -74.41 112.45 10.6 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 165.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.69 105.8 7.74 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -167.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.29 100.66 11.97 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -79.47 112.48 16.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.3 t -135.88 149.13 48.89 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.094 0.949 . . . . 0.0 110.306 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.94 142.32 51.25 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.269 1.028 . . . . 0.0 112.218 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.29 -38.7 28.2 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -66.21 -66.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.598 0.759 . . . . 0.0 111.959 168.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.64 79.61 0.03 OUTLIER Glycine 0 N--CA 1.479 1.536 0 CA-C-N 119.012 0.824 . . . . 0.0 112.005 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.2 m -151.04 112.96 4.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 102.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.64 -45.83 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -145.08 105.91 4.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.26 124.54 31.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.431 0.634 . . . . 0.0 109.681 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -130.58 78.43 74.03 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -170.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.81 -44.3 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.095 2.53 . . . . 0.0 116.443 -171.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.12 83.15 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.197 0.908 . . . . 0.0 109.803 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.4 tp -101.05 98.51 8.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.76 111.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -165.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.8 166.14 33.84 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.755 -175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -82.06 136.02 35.26 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.234 0.613 . . . . 0.0 110.398 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 tt -68.37 114.13 6.55 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.222 1.009 . . . . 0.0 112.828 -164.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.92 34.8 77.75 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 118.0 1.96 . . . . 0.0 118.0 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.44 169.11 14.7 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.44 1.114 . . . . 0.0 110.028 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.77 89.91 2.87 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.603 1.192 . . . . 0.0 113.205 -167.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.44 -67.55 0.21 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.846 -1.524 . . . . 0.0 107.998 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.85 165.29 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 124.605 1.162 . . . . 0.0 112.988 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 159.92 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -30.18 63.77 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.82 80.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 170.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.3 -38.4 65.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -43.29 -48.48 6.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.72 -45.46 58.63 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.6 p -90.27 45.94 1.31 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.67 -55.95 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.913 0 CA-C-O 115.013 -2.423 . . . . 0.0 107.235 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.73 83.32 1.95 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 CA-C-N 125.421 2.972 . . . . 0.0 112.802 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.317 4.4 pp 163.0 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 127.194 2.197 . . . . 0.0 111.821 -167.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.23 140.73 38.9 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.98 1.264 . . . . 0.0 112.04 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.27 159.81 33.93 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.618 163.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.68 97.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 143' ' ' LEU . . . 99.06 39.17 3.61 Favored Glycine 0 CA--C 1.552 2.379 0 CA-C-O 118.494 -1.17 . . . . 0.0 115.981 -162.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.42 99.91 11.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.064 1.432 . . . . 0.0 109.076 173.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.9 m -83.69 118.05 23.61 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 128.31 6.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.768 0.427 . . . . 0.0 110.223 -173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.4 tpp -85.51 107.16 17.32 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.75 99.05 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -91.5 104.26 16.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.15 160.64 15.46 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.164 0.983 . . . . 0.0 113.303 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 159.04 22.19 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.663 164.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.3 p -73.95 68.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -175.9 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.452 1.501 . . . . 0.0 108.405 -168.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -59.62 -51.03 71.56 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.651 1.18 . . . . 0.0 114.113 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.5 m -66.11 -70.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.821 0.737 . . . . 0.0 112.582 170.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -144.48 -65.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.938 0.79 . . . . 0.0 109.39 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.64 -167.93 30.16 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.14 102.47 1.6 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.081 2.521 . . . . 0.0 112.441 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -152.95 -69.45 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.716 -169.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.72 95.29 1.23 Allowed Glycine 0 CA--C 1.541 1.683 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -167.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -132.82 148.65 52.31 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.201 1.0 . . . . 0.0 110.667 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.4 m -76.8 140.85 67.7 Favored Pre-proline 0 CA--C 1.57 1.74 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.22 173.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.02 -47.35 0.26 Allowed 'Cis proline' 0 CA--C 1.563 1.939 0 CA-C-N 122.377 1.885 . . . . 0.0 116.909 9.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.33 77.16 1.43 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.76 117.37 46.64 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.8 151.33 27.97 Favored 'Trans proline' 0 CA--C 1.571 2.358 0 C-N-CA 122.813 2.342 . . . . 0.0 114.417 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.15 119.59 6.55 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.128 2.552 . . . . 0.0 111.931 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 93.9 m-70 76.8 101.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.222 1.409 . . . . 0.0 109.478 -165.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.83 88.86 3.0 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.171 0.588 . . . . 0.0 109.634 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.6 76.15 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 153.33 20.59 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.443 1.115 . . . . 0.0 112.243 -165.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -91.75 109.6 20.92 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.661 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.37 117.79 32.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.304 1.042 . . . . 0.0 108.217 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.16 99.2 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.398 -0.814 . . . . 0.0 110.196 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.06 125.6 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.5 m -142.14 124.33 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' HB2' ' H ' ' A' ' 109' ' ' GLY . 3.2 mm? -76.47 111.32 11.81 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.384 0.674 . . . . 0.0 110.021 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -84.01 -55.95 3.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 118.659 -0.686 . . . . 0.0 112.745 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 69.7 p -135.94 133.61 37.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -117.68 106.96 13.63 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 167.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.93 133.48 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 123.439 0.696 . . . . 0.0 110.078 -170.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -86.17 103.96 15.29 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.964 0 CA-C-O 116.801 -2.111 . . . . 0.0 112.08 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 122.693 1.235 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -79.41 115.44 19.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 153.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.46 103.61 15.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -163.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.97 103.04 12.13 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.072 0.939 . . . . 0.0 112.331 -176.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 pt -84.23 -176.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.648 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.357 2.6 tt 90.46 -75.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.343 1.457 . . . . 0.0 110.624 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.98 -72.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.377 0.535 . . . . 0.0 112.708 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.74 -75.36 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.179 0.592 . . . . 0.0 111.462 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.94 73.54 0.04 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 mt -141.73 -62.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.092 0.957 . . . . 0.0 108.753 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.77 130.51 38.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.101 0.96 . . . . 0.0 110.753 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -133.41 74.95 1.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -159.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -92.17 86.58 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.037 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -75.51 116.88 16.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 111.071 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 m -74.89 104.62 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.209 0.603 . . . . 0.0 109.404 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.79 -79.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.644 0.777 . . . . 0.0 110.077 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.93 113.38 63.67 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 169.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.17 175.63 8.97 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.873 2.382 . . . . 0.0 114.889 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 119.37 10.85 Favored Glycine 0 CA--C 1.558 2.738 0 CA-C-O 116.948 -2.029 . . . . 0.0 112.62 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.65 161.91 36.7 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 CA-C-N 122.498 3.149 . . . . 0.0 115.327 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.84 113.64 2.07 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.175 2.584 . . . . 0.0 113.562 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.4 71.67 1.09 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.711 -159.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -157.86 114.52 2.89 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 m -126.06 117.74 23.84 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 122.273 1.035 . . . . 0.0 110.086 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -59.4 134.06 88.46 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.01 144.89 43.71 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.783 2.322 . . . . 0.0 116.568 -158.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -72.16 155.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.002 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -70.17 110.99 5.49 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.72 65.08 0.47 Allowed Glycine 0 CA--C 1.544 1.863 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.548 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -150.01 140.74 22.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.19 108.04 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 m -117.87 121.6 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -109.75 134.46 51.98 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.63 153.15 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.254 1.026 . . . . 0.0 110.278 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -102.44 91.58 4.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.343 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.94 147.38 25.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.311 0.576 . . . . 0.0 110.383 163.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.01 92.5 2.88 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 m -83.11 122.11 27.93 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.661 0.743 . . . . 0.0 109.889 -175.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 m -140.93 136.62 32.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.529 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.19 131.81 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -52.23 -46.82 65.87 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.37 -44.26 12.95 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.81 80.78 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 120.783 3.073 . . . . 0.0 120.783 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.0 m 77.65 117.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.143 1.972 . . . . 0.0 112.839 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.252 7.3 ttt85 38.86 53.91 2.01 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 160.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 21.1 m -74.77 -40.96 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -159.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -146.96 76.3 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.561 1.073 . . . . 0.0 109.055 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -73.39 111.05 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.609 0.719 . . . . 0.0 111.56 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -130.94 84.06 59.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.91 -46.58 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.906 2.404 . . . . 0.0 117.248 -164.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.95 92.95 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.876 1.216 . . . . 0.0 110.702 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 tp -111.57 81.13 1.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.53 -172.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -89.84 136.44 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.406 0.682 . . . . 0.0 110.884 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -162.81 150.48 13.62 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.947 0.899 . . . . 0.0 110.345 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -80.77 140.97 35.21 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.94 104.81 5.68 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.38 70.83 0.85 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.032 -159.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -156.63 -66.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.734 0.814 . . . . 0.0 110.478 -176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.351 4.8 t 65.94 40.87 3.94 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.59 -47.68 80.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.878 -1.139 . . . . 0.0 113.217 152.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -55.04 166.85 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 125.282 1.433 . . . . 0.0 114.321 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 99' ' ' LEU . 46.4 pt -60.34 151.19 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -35.99 65.93 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.35 94.54 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 117.176 2.288 . . . . 0.0 117.176 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.459 ' H ' HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -63.89 -56.54 14.57 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.907 -1.044 . . . . 0.0 113.138 178.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -49.98 -43.24 50.17 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.38 -39.87 94.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.1 p -77.91 -4.11 45.16 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.79 -53.05 68.03 Favored Pre-proline 0 N--CA 1.502 2.138 0 CA-C-O 115.388 -2.244 . . . . 0.0 112.62 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.48 0.34 1.47 Allowed 'Trans proline' 0 CA--C 1.569 2.254 0 N-CA-C 119.483 2.839 . . . . 0.0 119.483 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 99.4 mt -128.57 73.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 119.993 1.27 . . . . 0.0 107.982 158.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 38.9 ttm -164.29 96.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.06 167.64 17.68 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.322 1.058 . . . . 0.0 113.282 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -70.41 108.29 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.578 0.751 . . . . 0.0 109.691 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.78 20.2 41.0 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 117.912 1.925 . . . . 0.0 117.912 -167.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 107.59 18.66 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 120.387 2.093 . . . . 0.0 110.476 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.4 m -78.75 113.07 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 163.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.79 121.49 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 ttt -83.68 108.12 16.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.024 0.529 . . . . 0.0 110.239 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.34 118.38 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 t -129.07 77.04 1.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.61 145.92 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.715 0.769 . . . . 0.0 112.044 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.86 164.65 0.36 Allowed 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -69.54 81.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.832 1.301 . . . . 0.0 111.595 172.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.888 -147.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -120.11 57.99 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.399 0.68 . . . . 0.0 111.938 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -110.37 -100.38 0.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -136.14 63.13 1.6 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 119.047 0.84 . . . . 0.0 109.414 168.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.24 -156.12 30.42 Favored Glycine 0 CA--C 1.562 2.977 0 N-CA-C 116.671 1.428 . . . . 0.0 116.671 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.25 102.64 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.95 2.433 . . . . 0.0 110.783 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.272 58.7 tp60 73.24 120.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.088 1.355 . . . . 0.0 111.16 -168.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.24 -139.95 10.54 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.8 158.85 15.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.293 1.044 . . . . 0.0 111.856 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.8 m -64.52 137.32 97.1 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 117.789 -1.1 . . . . 0.0 112.756 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.78 -42.56 0.68 Allowed 'Cis proline' 0 CA--C 1.563 1.96 0 N-CA-C 117.661 2.139 . . . . 0.0 117.661 10.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -168.21 100.69 0.44 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.43 105.63 56.86 Favored Pre-proline 0 CA--C 1.571 1.77 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.86 146.72 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.667 2.244 . . . . 0.0 114.747 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.61 -54.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.292 2.661 . . . . 0.0 115.272 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -65.24 145.61 56.01 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.521 1.128 . . . . 0.0 112.915 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.18 128.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.796 1.238 . . . . 0.0 111.886 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.72 114.08 8.44 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.603 0.761 . . . . 0.0 111.988 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.85 125.49 29.77 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 120.967 0.413 . . . . 0.0 111.301 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.55 118.29 31.98 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.097 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.53 121.72 27.76 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.402 0.681 . . . . 0.0 109.677 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -87.6 98.33 11.35 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.2 0.6 . . . . 0.0 110.768 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.82 126.08 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -133.31 125.32 28.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.59 111.16 5.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.57 0.748 . . . . 0.0 111.184 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -77.37 -66.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -132.81 143.22 49.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.619 0.723 . . . . 0.0 109.321 -168.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.54 96.95 4.25 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.72 129.06 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -170.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.2 111.48 22.67 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.277 0.56 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.104 0 CA-C-O 116.764 -2.131 . . . . 0.0 110.633 -175.392 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 . . . . . 0 CA--C 1.574 1.868 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -48.79 120.57 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.447 1.099 . . . . 0.0 113.778 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.6 tp -80.36 109.81 15.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.439 0.696 . . . . 0.0 110.99 -164.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.56 101.78 13.52 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.355 1.074 . . . . 0.0 112.634 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -71.32 -29.84 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 170.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.23 -48.95 71.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.159 1.345 . . . . 0.0 113.68 158.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 -36.12 4.44 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -73.1 -71.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.397 1.099 . . . . 0.0 111.961 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.11 61.27 0.03 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 mt -143.83 -76.2 0.24 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.4 tp -88.15 119.69 28.78 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.65 0.78 . . . . 0.0 109.203 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -137.79 121.63 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.644 0.778 . . . . 0.0 109.681 -172.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 110.5 16.09 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 110.485 -164.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -116.94 130.85 56.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.214 . . . . 0.0 110.009 172.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.9 m -93.2 119.25 32.17 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.858 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.86 -68.32 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.517 0.727 . . . . 0.0 110.117 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.4 t -85.08 122.79 74.05 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 156.56 42.42 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 122.925 2.417 . . . . 0.0 114.699 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 121.14 5.32 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-O 116.924 -2.042 . . . . 0.0 113.071 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.22 144.64 52.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.597 3.199 . . . . 0.0 115.0 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.43 119.01 5.74 Favored 'Trans proline' 0 CA--C 1.558 1.693 0 C-N-CA 123.241 2.627 . . . . 0.0 112.643 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.28 -81.88 0.22 Allowed Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -88.71 98.64 11.8 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 m -148.86 133.23 17.52 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.763 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.273 19.2 mtm180 42.44 74.68 0.72 Allowed Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.97 161.49 32.9 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.726 2.284 . . . . 0.0 114.251 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.19 170.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.283 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -71.26 115.9 10.95 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.881 0.848 . . . . 0.0 111.902 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.64 -63.4 0.44 Allowed Glycine 0 CA--C 1.54 1.649 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -155.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -70.67 114.99 9.31 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.433 0.693 . . . . 0.0 110.028 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.34 114.04 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 m -92.52 135.74 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.444 -169.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -120.06 126.11 49.97 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.45 141.43 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.696 0.76 . . . . 0.0 110.98 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -89.92 93.67 9.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 161.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.34 143.19 28.34 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.782 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -126.93 90.41 3.15 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -74.53 115.55 14.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -140.92 119.15 12.06 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -162.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.08 137.13 45.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.669 0.387 . . . . 0.0 110.573 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.63 87.41 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.619 1.199 . . . . 0.0 112.608 -170.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -171.25 -75.59 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -170.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.14 71.0 0.05 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.2 t -162.75 141.34 8.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.26 0.624 . . . . 0.0 110.05 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 113.63 25.24 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.264 23.5 m -78.25 -51.18 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -141.02 81.22 1.78 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 119.226 0.921 . . . . 0.0 109.198 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.76 119.39 30.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.66 94.34 47.65 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.095 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.64 -44.82 0.63 Allowed 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.084 2.523 . . . . 0.0 117.202 -172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.8 76.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.783 1.174 . . . . 0.0 110.238 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -99.68 92.67 5.45 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.22 132.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.737 0.78 . . . . 0.0 109.24 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -155.62 142.99 19.42 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.954 -174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.5 m -74.17 133.51 42.75 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.917 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -70.83 109.05 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.336 -165.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.27 67.79 1.48 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.493 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.72 145.16 27.53 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.239 1.018 . . . . 0.0 109.739 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 75.8 m -75.72 76.72 2.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.647 1.213 . . . . 0.0 111.829 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -129.69 -63.44 0.92 Allowed 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.657 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.16 176.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.005 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.71 140.9 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.052 0.941 . . . . 0.0 112.443 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -61.47 -33.72 74.23 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.07 -40.93 70.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 167.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -56.69 10.65 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.931 0.892 . . . . 0.0 113.037 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.57 -39.72 94.59 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.5 mt -61.09 -34.8 75.52 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.1 p -74.35 -11.94 60.39 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 167.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -56.01 -50.45 87.25 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 115.292 -2.29 . . . . 0.0 115.092 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -53.32 -26.57 35.27 Favored 'Trans proline' 0 CA--C 1.567 2.165 0 CA-C-N 125.659 3.057 . . . . 0.0 118.549 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -110.09 73.21 0.83 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.087 0.955 . . . . 0.0 109.709 164.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 53.0 tpp -149.61 107.45 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.39 161.85 15.39 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.681 1.229 . . . . 0.0 113.066 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 t -81.96 103.15 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 59.17 1.31 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.932 -170.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -126.06 123.76 39.11 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.57 0.748 . . . . 0.0 109.829 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -91.49 103.54 16.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.1 120.74 14.27 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.976 0.417 . . . . 0.0 110.433 -164.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.4 ttm -83.6 141.25 31.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.99 0.9 . . . . 0.0 110.802 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.27 96.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.6 p -81.72 104.87 12.42 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -135.68 139.23 43.53 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.511 0.724 . . . . 0.0 111.024 -168.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -63.23 149.49 45.38 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.8 m -71.32 81.73 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 123.273 1.511 . . . . 0.0 110.8 167.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -172.78 -68.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.961 -1.927 . . . . 0.0 106.446 -159.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -73.85 -45.61 50.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.638 0.775 . . . . 0.0 112.477 161.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.1 m -58.98 -56.55 20.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.2 -84.41 0.23 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.465 1.029 . . . . 0.0 108.713 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.82 -175.35 28.99 Favored Glycine 0 CA--C 1.557 2.718 0 CA-C-N 119.014 0.824 . . . . 0.0 114.651 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.53 105.13 1.83 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.483 2.788 . . . . 0.0 112.591 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 57.84 85.57 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.202 1.401 . . . . 0.0 112.908 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.66 -88.53 1.54 Allowed Glycine 0 CA--C 1.539 1.59 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -122.35 81.66 1.87 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.667 0.787 . . . . 0.0 109.96 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.1 p -73.44 145.29 84.97 Favored Pre-proline 0 CA--C 1.571 1.78 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.995 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.8 -16.38 30.09 Favored 'Cis proline' 0 CA--C 1.564 1.984 0 N-CA-C 119.437 2.822 . . . . 0.0 119.437 9.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -64.21 -42.69 96.5 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.73 118.43 68.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.32 163.51 27.41 Favored 'Trans proline' 0 CA--C 1.576 2.62 0 C-N-CA 122.84 2.36 . . . . 0.0 114.082 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -64.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.107 2.538 . . . . 0.0 115.488 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -136.03 94.05 3.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.24 125.69 8.81 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.95 108.31 14.51 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.566 0.698 . . . . 0.0 112.385 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -92.88 157.84 16.16 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.736 176.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.52 104.73 16.78 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.092 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -104.57 118.7 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.42 148.5 51.78 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.293 0.568 . . . . 0.0 112.383 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.96 99.96 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.5 m -102.44 109.39 21.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 104.15 8.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -80.88 -58.47 3.07 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 70.7 p -137.46 134.17 35.51 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.287 0.635 . . . . 0.0 109.64 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.16 94.94 4.86 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -166.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.08 115.31 22.81 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.412 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.7 0 CA-C-O 119.325 -0.708 . . . . 0.0 114.528 -178.076 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 . . . . . 0 CA--C 1.561 1.371 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -99.78 133.59 43.91 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.618 161.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER 68.25 163.13 0.21 Allowed 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 171.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.268 14.2 t0 73.19 111.7 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -127.29 -59.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -60.59 -37.46 81.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.78 51.85 0.22 Allowed Glycine 0 CA--C 1.548 2.129 0 C-N-CA 124.621 1.105 . . . . 0.0 113.116 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -166.83 -71.84 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.24 61.67 0.07 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.317 0.961 . . . . 0.0 111.36 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.0 mt -142.48 -53.87 0.41 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.841 0.856 . . . . 0.0 109.593 -163.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.0 115.28 20.4 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 154.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -122.61 70.45 1.0 Allowed 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -162.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -88.77 120.08 29.85 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.636 -1.29 . . . . 0.0 113.06 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.15 114.57 24.66 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 161.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 m -75.57 121.2 22.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.65 -69.18 0.34 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.771 0.828 . . . . 0.0 111.791 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.07 121.89 26.24 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.42 169.02 23.45 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.811 2.341 . . . . 0.0 113.682 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.02 176.42 40.44 Favored Glycine 0 CA--C 1.562 3.018 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.73 163.45 35.21 Favored 'Trans proline' 0 CA--C 1.573 2.437 0 C-N-CA 123.047 2.498 . . . . 0.0 115.36 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.46 107.81 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.219 2.613 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.98 89.85 1.55 Allowed Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -164.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -133.08 109.48 9.54 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.7 p -77.99 129.76 35.68 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.176 0.512 . . . . 0.0 112.134 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -92.14 113.0 57.77 Favored Pre-proline 0 CA--C 1.577 2.002 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.818 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -68.67 155.02 70.24 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 122.956 2.437 . . . . 0.0 117.511 -161.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.66 165.31 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.897 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.55 105.23 5.57 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.737 0.779 . . . . 0.0 111.534 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.73 48.6 0.84 Allowed Glycine 0 CA--C 1.55 2.235 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.391 -164.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -154.84 110.95 3.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.03 115.16 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.429 0.691 . . . . 0.0 109.826 -163.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.89 129.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.528 0.731 . . . . 0.0 110.863 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -89.73 129.76 36.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 168.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -144.9 129.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -170.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -99.01 101.76 13.25 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.21 1.004 . . . . 0.0 108.463 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.32 127.54 55.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.149 0.58 . . . . 0.0 109.742 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -108.97 80.87 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.908 0.483 . . . . 0.0 110.214 -166.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.83 127.45 32.05 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.437 0.637 . . . . 0.0 110.49 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -148.87 151.18 34.26 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.287 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.32 145.01 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.57 76.78 8.48 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 122.414 1.102 . . . . 0.0 110.277 168.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -172.22 -63.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.197 1.399 . . . . 0.0 107.27 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.62 -62.59 0.16 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 119.516 -0.602 . . . . 0.0 113.193 -173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 133.98 33.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 117.502 0.651 . . . . 0.0 110.149 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 142.68 46.39 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.88 -74.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -145.12 118.66 9.1 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -97.86 93.0 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 109.948 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mp0 -72.92 113.59 23.01 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.818 -172.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -53.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.991 2.46 . . . . 0.0 116.111 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -125.82 70.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 118.947 0.794 . . . . 0.0 110.705 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.92 113.83 26.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.6 t -106.76 100.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -113.06 146.57 38.9 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.042 0.537 . . . . 0.0 111.08 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.1 m -80.08 128.15 33.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.72 110.33 8.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.47 -67.1 0.25 Allowed Glycine 0 N--CA 1.48 1.583 0 CA-C-O 119.406 -0.663 . . . . 0.0 112.955 -167.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.42 85.94 7.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.523 0.678 . . . . 0.0 109.961 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 83.9 m -95.38 115.31 27.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.432 0.634 . . . . 0.0 112.373 -158.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -58.73 -38.41 78.31 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 159.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.3 m -71.13 164.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.639 1.209 . . . . 0.0 114.157 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.39 171.6 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.569 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -57.16 -40.06 76.49 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.85 -43.63 86.02 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.92 -49.07 61.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.559 -1.21 . . . . 0.0 114.111 170.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -49.54 -49.84 44.47 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.0 -44.31 94.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.1 p -87.23 49.41 1.81 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.3 t -96.56 -57.41 0.19 Allowed Pre-proline 0 CA--C 1.572 1.827 0 CA-C-O 115.226 -2.321 . . . . 0.0 109.195 163.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.85 -7.7 11.91 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.497 2.999 . . . . 0.0 118.776 174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.88 -34.84 15.09 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.77 1.168 . . . . 0.0 113.728 162.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.86 116.51 7.81 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.216 1.371 . . . . 0.0 112.806 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -85.73 149.46 25.27 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.129 0.966 . . . . 0.0 112.009 167.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.73 105.32 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.84 -33.4 2.84 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.763 -164.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.31 132.37 43.01 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 120.818 2.309 . . . . 0.0 115.047 -170.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -96.86 122.96 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 162.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.42 122.33 9.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 120.892 0.377 . . . . 0.0 111.415 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.5 ttt -82.83 105.79 14.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.327 0.651 . . . . 0.0 109.834 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.14 119.51 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.5 p -94.35 78.22 3.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.41 144.3 49.83 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 152.48 45.34 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.2 t -76.89 69.15 3.18 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.672 1.225 . . . . 0.0 111.689 167.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -176.45 -64.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.477 1.511 . . . . 0.0 108.001 -164.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -79.27 -31.56 43.44 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.5 t -69.0 -75.98 0.1 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.166 1.348 . . . . 0.0 112.064 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.97 43.7 2.93 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.281 1.4 . . . . 0.0 112.55 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.09 176.25 6.69 Favored Glycine 0 CA--C 1.56 2.86 0 N-CA-C 116.467 1.347 . . . . 0.0 116.467 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.6 67.59 8.55 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 CA-C-N 120.979 2.389 . . . . 0.0 111.709 160.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -158.7 -66.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.498 1.119 . . . . 0.0 108.072 -169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.17 120.19 2.91 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 118.775 0.716 . . . . 0.0 111.776 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.04 67.42 1.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m 67.39 143.53 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 166.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.81 -42.62 0.78 Allowed 'Cis proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.804 2.037 . . . . 0.0 117.111 -1.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -138.15 68.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.42 1.009 . . . . 0.0 109.913 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.81 117.07 44.81 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 172.57 13.78 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 C-N-CA 123.006 2.471 . . . . 0.0 114.075 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.0 2.35 2.7 Favored 'Trans proline' 0 CA--C 1.567 2.126 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -148.56 90.24 1.77 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.27 114.28 3.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.99 107.57 13.92 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.2 125.04 35.85 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.015 0.912 . . . . 0.0 110.703 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 29.4 m -97.81 95.4 7.51 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.927 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.7 119.01 37.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.196 0.599 . . . . 0.0 110.091 174.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -88.49 103.61 16.04 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.275 1.036 . . . . 0.0 109.841 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.38 103.63 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.295 -1.32 . . . . 0.0 107.653 -170.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -94.06 108.52 20.34 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.02 105.88 12.59 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -77.88 -72.27 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -144.77 135.84 25.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 118.8 0.727 . . . . 0.0 109.886 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.64 111.12 23.31 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.96 138.77 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.05 148.5 50.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.302 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.151 -174.516 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.723 0.296 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.25 82.2 m95 75.51 103.11 0.07 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.924 1.289 . . . . 0.0 110.099 -176.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.1 97.48 9.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.27 129.79 37.19 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.593 1.187 . . . . 0.0 113.365 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 pt -103.42 66.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.867 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 tp -163.0 -60.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.399 0.68 . . . . 0.0 110.187 -164.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.4 44.49 3.72 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -161.05 -80.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.65 58.01 0.01 OUTLIER Glycine 0 CA--C 1.543 1.808 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.248 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 mt -131.06 -54.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.843 0.857 . . . . 0.0 110.978 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.9 tp -87.01 102.35 14.32 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 108.991 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.73 90.06 3.18 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 122.885 0.474 . . . . 0.0 111.375 -161.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.04 93.79 8.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.814 -1.179 . . . . 0.0 111.106 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -99.32 122.91 43.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.356 0.662 . . . . 0.0 109.251 168.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.9 m -80.58 117.03 20.93 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.131 0.572 . . . . 0.0 109.916 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -79.87 -71.68 0.44 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.957 0.903 . . . . 0.0 110.512 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.14 123.18 45.87 Favored Pre-proline 0 CA--C 1.573 1.845 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.74 157.59 51.77 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.921 2.414 . . . . 0.0 114.85 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.37 116.56 4.25 Favored Glycine 0 CA--C 1.55 2.233 0 CA-C-O 116.807 -2.107 . . . . 0.0 112.9 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.11 142.02 37.34 Favored 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 122.658 3.229 . . . . 0.0 114.315 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 113.19 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.045 2.497 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.81 -85.92 0.11 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 t -85.12 109.21 18.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.1 p -111.17 172.11 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.085 0.945 . . . . 0.0 112.907 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -50.64 122.7 16.62 Favored Pre-proline 0 CA--C 1.582 2.182 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.02 162.09 37.66 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.089 2.526 . . . . 0.0 115.799 -171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 167.56 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.465 1.126 . . . . 0.0 112.22 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -64.57 126.72 28.77 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.729 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.31 59.79 1.08 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.251 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -146.27 139.69 25.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.38 102.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.65 120.6 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -100.03 142.62 31.27 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.39 0.676 . . . . 0.0 109.444 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.98 141.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.589 0.756 . . . . 0.0 109.638 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -83.16 109.67 17.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 160.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -95.62 113.18 24.8 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.02 91.27 6.78 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 m -82.94 116.94 22.44 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -145.19 171.59 14.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.303 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.21 130.94 55.75 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.61 -38.92 79.04 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -65.29 -48.18 74.04 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 163.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.89 -116.51 4.14 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 119.245 0.929 . . . . 0.0 112.564 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.5 t -153.69 -176.39 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.77 0.795 . . . . 0.0 111.909 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -61.53 122.69 15.86 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.49 -49.88 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.45 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -146.59 103.42 3.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -84.88 82.04 8.62 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.346 1.069 . . . . 0.0 111.459 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.49 112.02 58.75 Favored Pre-proline 0 CA--C 1.576 1.947 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.533 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.33 -61.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.181 2.588 . . . . 0.0 116.364 -169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -97.82 74.08 2.33 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.222 1.374 . . . . 0.0 111.18 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.23 92.39 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.16 139.07 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.048 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.45 155.39 33.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.59 -172.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.7 m -77.97 131.22 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.42 116.27 4.17 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.825 0.85 . . . . 0.0 112.467 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.6 55.26 8.73 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -152.28 150.82 30.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.261 1.029 . . . . 0.0 110.081 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -74.89 81.96 2.16 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 122.824 1.297 . . . . 0.0 114.033 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -130.92 -60.48 0.97 Allowed 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.222 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.52 172.21 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.513 1.125 . . . . 0.0 113.138 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.67 161.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.28 -45.56 90.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.67 77.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -54.53 17.83 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.998 0.919 . . . . 0.0 112.863 172.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -49.28 -50.92 36.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.5 -39.98 77.69 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.2 p -84.22 22.91 1.14 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -74.0 -54.84 3.37 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.382 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.05 61.4 8.19 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 CA-C-N 125.39 2.961 . . . . 0.0 114.642 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.6 mt -155.96 -48.31 0.08 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.628 1.571 . . . . 0.0 109.66 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -76.54 107.12 8.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.523 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.79 169.88 17.28 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.961 167.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.05 106.88 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.884 -1.135 . . . . 0.0 108.413 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 10.34 46.19 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -163.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.98 93.99 6.05 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.504 2.152 . . . . 0.0 109.812 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.3 m -88.54 136.38 33.02 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.168 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.75 138.19 8.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.936 0.494 . . . . 0.0 110.112 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.1 ptm -83.04 124.77 30.75 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.03 71.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -84.93 113.76 21.64 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.6 -0.687 . . . . 0.0 109.414 -164.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.11 154.23 26.94 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.855 0.862 . . . . 0.0 112.051 -167.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -52.33 147.98 7.25 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 168.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.0 p -68.89 78.14 0.31 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.84 1.305 . . . . 0.0 112.619 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -176.12 -60.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.797 -151.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.02 -51.81 23.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.9 m -67.35 -80.34 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -158.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.12 72.3 1.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.32 -142.87 47.75 Favored Glycine 0 CA--C 1.562 3.01 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.78 -164.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.78 50.58 1.91 Allowed 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 122.892 2.395 . . . . 0.0 113.661 165.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 56.0 85.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.905 1.282 . . . . 0.0 113.769 -168.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 162.0 74.06 0.02 OUTLIER Glycine 0 N--CA 1.481 1.687 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.544 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 69.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.7 m 68.53 127.9 0.03 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 166.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.82 -44.8 0.36 Allowed 'Cis proline' 0 CA--C 1.565 2.029 0 CA-C-N 123.009 2.11 . . . . 0.0 116.39 2.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.29 82.35 1.42 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.57 99.08 46.36 Favored Pre-proline 0 CA--C 1.57 1.745 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.34 134.08 12.42 Favored 'Trans proline' 0 CA--C 1.567 2.175 0 C-N-CA 122.828 2.352 . . . . 0.0 113.799 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.66 154.31 64.26 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.137 2.558 . . . . 0.0 115.297 -172.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.256 15.5 m170 82.2 137.61 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.41 1.084 . . . . 0.0 112.069 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.258 . . 73.29 136.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.843 1.257 . . . . 0.0 113.236 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.88 169.73 11.01 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -158.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tt -115.3 125.6 53.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.349 1.06 . . . . 0.0 110.33 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -87.3 118.45 26.74 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.105 0.962 . . . . 0.0 110.971 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.22 111.88 11.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.73 103.67 15.59 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.119 0.485 . . . . 0.0 110.726 -169.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.25 101.18 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.0 m -109.19 121.89 46.14 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.23 105.59 11.6 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.626 0.37 . . . . 0.0 110.162 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -78.61 -69.73 0.54 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.8 p -132.37 143.57 49.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.334 0.588 . . . . 0.0 109.59 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.32 100.13 5.27 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.44 149.66 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.963 0.905 . . . . 0.0 109.002 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -65.59 163.56 15.96 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 CA-C-O 117.225 -1.875 . . . . 0.0 113.529 -175.611 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.268 14.7 tp10 . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -69.76 151.76 45.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.913 167.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.34 98.81 9.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.037 0.535 . . . . 0.0 109.992 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.06 120.89 20.27 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 122.058 0.933 . . . . 0.0 112.146 171.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.21 -80.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -165.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.64 120.9 23.45 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.85 2.74 0.07 OUTLIER Glycine 0 CA--C 1.543 1.81 0 CA-C-O 117.51 -1.717 . . . . 0.0 116.701 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.364 12.5 p30 49.01 56.86 7.13 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 120.281 2.04 . . . . 0.0 114.727 -165.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 54.61 6.57 Favored Glycine 0 CA--C 1.546 1.991 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 99.4 mt -126.21 -66.47 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.478 1.139 . . . . 0.0 110.299 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 tp -82.86 111.44 18.76 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.444 1.02 . . . . 0.0 109.921 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -115.81 144.27 44.23 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.502 0.721 . . . . 0.0 112.606 -173.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.02 136.07 48.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 0.0 112.095 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.8 121.14 40.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 158.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.2 m -75.63 109.16 8.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.19 -61.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.736 0.815 . . . . 0.0 112.592 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.68 108.02 56.41 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.66 148.44 17.95 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.952 2.435 . . . . 0.0 113.989 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.49 118.76 7.37 Favored Glycine 0 CA--C 1.555 2.562 0 CA-C-O 116.986 -2.008 . . . . 0.0 114.882 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.33 168.35 23.69 Favored 'Trans proline' 0 CA--C 1.573 2.472 0 CA-C-N 122.306 3.053 . . . . 0.0 115.452 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.7 116.72 4.1 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 123.195 2.597 . . . . 0.0 113.021 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.27 69.75 1.18 Allowed Glycine 0 CA--C 1.545 1.91 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.319 -163.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -150.9 117.51 5.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -70.53 140.31 51.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -117.64 121.27 32.08 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-O 117.73 -1.129 . . . . 0.0 109.389 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.0 145.92 40.69 Favored 'Trans proline' 0 CA--C 1.558 1.689 0 C-N-CA 122.606 2.204 . . . . 0.0 114.657 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.28 154.68 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.63 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.24 107.89 1.16 Allowed 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.898 0.879 . . . . 0.0 112.425 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.37 69.12 0.87 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.391 -158.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -153.75 127.29 8.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -77.61 100.12 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.43 140.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.945 0.898 . . . . 0.0 109.437 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -89.22 127.26 35.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 164.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.41 130.3 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.151 0.977 . . . . 0.0 109.244 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -98.12 95.25 7.31 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.7 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.59 131.45 55.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.547 0.739 . . . . 0.0 109.297 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -139.08 116.09 10.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.8 m -88.06 119.08 28.09 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.296 -168.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -88.95 129.16 35.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.711 0.804 . . . . 0.0 110.599 170.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.76 140.82 37.09 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.444 0.64 . . . . 0.0 109.854 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -52.79 -45.92 67.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -93.16 90.89 7.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.06 69.12 1.4 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 117.411 1.724 . . . . 0.0 117.411 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.409 1.7 t 53.51 -168.09 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 158.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.364 9.2 ptp180 -77.14 104.9 7.9 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -170.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.79 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-N 112.214 -2.266 . . . . 0.0 116.086 165.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 80.02 112.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -116.92 69.03 0.75 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 72.43 96.57 0.04 OUTLIER Pre-proline 0 CA--C 1.578 2.054 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 167.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.13 -19.09 39.61 Favored 'Trans proline' 0 CA--C 1.56 1.819 0 N-CA-C 119.047 2.672 . . . . 0.0 119.047 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.02 86.03 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.297 1.408 . . . . 0.0 109.259 164.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -87.53 116.68 25.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.1 133.53 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 123.434 0.694 . . . . 0.0 109.404 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.93 148.93 19.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.119 0.568 . . . . 0.0 111.185 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -70.42 130.35 41.69 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.39 0.676 . . . . 0.0 109.563 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 tp -51.27 -36.93 44.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -161.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.69 -102.65 0.55 Allowed Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.472 162.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.42 0.5 OUTLIER 62.2 169.48 0.12 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.16 17.89 23.27 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.37 -51.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 120.288 1.404 . . . . 0.0 113.318 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.0 167.06 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.412 1.101 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.0 pt -68.08 160.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.295 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.58 -36.69 76.72 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.8 73.11 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 167.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -48.98 58.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.44 -37.28 67.5 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.48 -32.66 60.65 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.7 p -75.27 -11.93 60.17 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 165.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.287 1.3 t -54.66 -49.58 90.49 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 115.477 -2.202 . . . . 0.0 115.255 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.19 -13.46 32.21 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 125.127 2.867 . . . . 0.0 119.514 175.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.12 77.96 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.523 1.51 . . . . 0.0 108.886 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -162.45 109.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -88.69 168.36 12.57 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.166 0.984 . . . . 0.0 112.283 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.49 124.86 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.13 88.4 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -110.39 130.04 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.833 2.316 . . . . 0.0 113.244 -159.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 m -78.05 133.5 37.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.009 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.7 tpt -80.53 106.63 12.69 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.9 115.24 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 p -94.58 100.9 12.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.01 125.84 36.86 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.89 -172.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.79 165.24 17.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.4 p -53.12 -42.77 66.34 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 162.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.75 -43.87 87.62 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 164.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -103.36 67.34 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.398 0.679 . . . . 0.0 110.175 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.8 t -148.15 -93.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.59 42.21 3.32 Favored 'General case' 0 CA--C 1.574 1.879 0 CA-C-N 119.758 1.163 . . . . 0.0 111.527 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 56.98 -109.17 1.52 Allowed Glycine 0 CA--C 1.557 2.71 0 CA-C-O 117.454 -1.748 . . . . 0.0 115.109 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.34 -50.46 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 CA-C-N 121.439 2.619 . . . . 0.0 115.782 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -152.05 133.2 14.36 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.162 0.985 . . . . 0.0 108.54 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.15 -124.6 5.21 Favored Glycine 0 N--CA 1.481 1.643 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.865 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -88.02 68.08 9.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.43 0.692 . . . . 0.0 111.775 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -75.4 137.11 71.42 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.116 -172.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.04 -6.15 53.88 Favored 'Cis proline' 0 CA--C 1.568 2.216 0 N-CA-C 119.494 2.844 . . . . 0.0 119.494 9.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -57.94 -51.83 68.02 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.45 98.71 11.27 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 167.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.25 164.06 37.04 Favored 'Trans proline' 0 CA--C 1.572 2.389 0 C-N-CA 122.703 2.269 . . . . 0.0 114.137 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.47 111.25 2.27 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 123.072 2.515 . . . . 0.0 113.375 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 70.71 99.29 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.656 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.6 132.77 16.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.252 0.621 . . . . 0.0 110.364 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.89 85.11 4.68 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 109.908 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.11 147.5 41.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.014 0.911 . . . . 0.0 112.642 -161.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.2 m -76.55 152.2 36.06 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.84 129.72 4.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.809 0.843 . . . . 0.0 110.218 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.67 98.74 11.6 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.588 . . . . 0.0 110.852 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.4 100.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.1 m -109.17 123.98 50.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.97 117.37 17.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -82.63 -66.19 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -131.26 147.57 52.6 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 -169.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.18 107.72 11.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 167.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.58 147.31 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.474 -170.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.62 144.39 49.47 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.6 0 CA-C-O 116.923 -2.043 . . . . 0.0 114.671 -173.898 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 CA--C 1.564 1.514 0 CA-C-O 121.643 0.735 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 m95 73.11 134.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.383 1.073 . . . . 0.0 111.516 -175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.612 0.765 . . . . 0.0 109.724 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.92 104.46 8.49 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.083 0.953 . . . . 0.0 111.927 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -98.52 130.41 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.436 0.6 OUTLIER 101.15 -66.5 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.231 1.812 . . . . 0.0 111.641 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.57 -70.62 0.08 OUTLIER Glycine 0 N--CA 1.484 1.835 0 CA-C-N 120.034 1.288 . . . . 0.0 114.33 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -73.26 -71.0 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.65 0.78 . . . . 0.0 111.341 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.89 61.28 0.05 OUTLIER Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.31 -0.717 . . . . 0.0 112.321 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.2 -58.72 2.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.638 0.719 . . . . 0.0 110.924 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.51 114.79 29.18 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -115.03 108.87 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.84 0.456 . . . . 0.0 111.197 -168.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -99.48 116.0 30.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.992 -1.067 . . . . 0.0 111.987 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -85.77 119.69 26.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.01 -1.057 . . . . 0.0 108.681 158.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.7 m -90.46 108.66 19.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -71.61 -65.45 0.76 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.166 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.46 136.4 21.47 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.166 164.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.17 176.91 9.4 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 123.0 2.467 . . . . 0.0 114.605 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.9 116.16 5.86 Favored Glycine 0 CA--C 1.558 2.729 0 CA-C-O 117.061 -1.966 . . . . 0.0 111.335 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.64 167.12 27.37 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 CA-C-N 122.55 3.175 . . . . 0.0 115.626 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.98 111.96 2.35 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.072 2.515 . . . . 0.0 112.334 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.54 76.3 1.32 Allowed Glycine 0 CA--C 1.544 1.868 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.661 -161.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.1 p -155.28 131.42 10.19 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.423 0.689 . . . . 0.0 109.744 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -117.27 119.93 36.69 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.457 1.123 . . . . 0.0 112.327 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -73.92 116.67 54.46 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.143 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.03 162.63 40.92 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 122.867 2.378 . . . . 0.0 116.047 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.01 158.7 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.213 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.63 77.74 9.8 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.13 0.966 . . . . 0.0 113.356 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.32 47.07 0.01 OUTLIER Glycine 0 CA--C 1.551 2.315 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.053 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.43 25.4 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.581 1.19 . . . . 0.0 109.269 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.86 103.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.691 0.796 . . . . 0.0 109.858 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.53 113.26 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.9 m -88.48 105.33 17.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.77 141.86 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.64 108.25 3.78 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 109.346 165.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.76 92.57 3.84 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.39 105.8 17.77 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -85.26 101.96 12.95 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.162 0.506 . . . . 0.0 109.743 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -121.65 157.07 31.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.381 1.073 . . . . 0.0 109.818 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.89 103.8 15.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.601 -0.687 . . . . 0.0 109.962 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.396 26.3 tt0 68.27 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 169.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.53 61.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.291 0.636 . . . . 0.0 111.482 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.43 66.29 2.46 Favored Glycine 0 CA--C 1.543 1.804 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -126.02 96.9 4.9 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 173.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -78.38 96.46 5.34 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -165.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 m -81.99 -50.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -152.75 134.73 14.8 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.909 0.861 . . . . 0.0 109.169 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.09 112.79 24.85 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.687 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.33 69.06 3.88 Favored Pre-proline 0 CA--C 1.585 2.289 0 O-C-N 121.446 -0.784 . . . . 0.0 110.953 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.96 -54.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.255 2.637 . . . . 0.0 115.487 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.83 76.61 6.51 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 121.4 1.909 . . . . 0.0 112.536 164.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.58 97.83 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.59 109.01 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -136.05 139.64 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 m -69.28 132.6 46.71 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 tt -69.57 109.68 4.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 80.24 0.98 Allowed Glycine 0 CA--C 1.54 1.644 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.552 -162.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -149.34 160.7 43.19 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.275 1.036 . . . . 0.0 110.793 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.6 p -79.93 71.0 6.6 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.268 1.032 . . . . 0.0 113.433 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -150.58 -62.91 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.479 1.111 . . . . 0.0 110.092 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.84 158.9 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 CA-C-O 123.173 1.463 . . . . 0.0 112.216 -161.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -66.3 152.99 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.726 177.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -57.89 -33.55 68.84 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.51 -46.76 57.42 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -57.65 5.54 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 112.473 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -58.52 -34.24 70.75 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.37 -38.0 77.84 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 167.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -70.49 -20.49 62.85 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.258 54.7 t -62.73 -52.45 64.46 Favored Pre-proline 0 CA--C 1.577 1.995 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.629 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.41 10.47 0.44 Allowed 'Trans proline' 0 CA--C 1.572 2.393 0 CA-C-N 124.703 2.715 . . . . 0.0 118.521 171.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.06 -46.28 5.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.245 1.018 . . . . 0.0 111.59 158.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.0 128.92 35.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.637 1.108 . . . . 0.0 113.013 -173.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -94.97 -147.71 0.28 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 123.153 0.581 . . . . 0.0 111.187 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.97 123.79 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.629 -1.294 . . . . 0.0 110.363 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.77 -103.07 2.97 Favored Glycine 0 CA--C 1.54 1.608 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -168.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 32.57 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -168.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 m -82.06 115.71 21.32 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.58 123.35 11.91 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.324 0.583 . . . . 0.0 110.01 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.9 ttp -76.98 104.97 7.77 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.705 0.802 . . . . 0.0 110.544 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.91 97.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.3 m -99.37 104.22 16.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.18 37.26 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.794 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -48.91 134.24 17.0 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 165.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -51.04 -39.01 54.92 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.254 14.5 pttp -58.69 -41.26 85.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -66.9 -49.79 64.48 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 171.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.03 -160.71 0.34 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.822 0.849 . . . . 0.0 112.295 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -85.73 101.52 12.84 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.91 -91.6 1.78 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 116.866 -2.075 . . . . 0.0 109.66 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.59 -46.53 3.69 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 122.073 2.936 . . . . 0.0 116.253 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -91.3 98.64 11.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -90.42 134.43 12.34 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 115.336 -0.847 . . . . 0.0 115.117 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -113.51 91.44 3.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.889 0.476 . . . . 0.0 109.848 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.4 m 72.68 103.58 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.763 0 CA-C-O 117.476 -1.249 . . . . 0.0 112.003 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.63 -70.07 0.01 OUTLIER 'Cis proline' 0 CA--C 1.565 2.061 0 CA-C-N 122.923 2.08 . . . . 0.0 112.032 8.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.02 78.69 1.62 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 168.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.2 mt -67.29 121.96 80.87 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 -162.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.13 155.17 29.42 Favored 'Trans proline' 0 CA--C 1.569 2.267 0 C-N-CA 122.762 2.308 . . . . 0.0 115.214 -170.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.55 146.6 44.37 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.238 2.626 . . . . 0.0 113.459 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.267 22.4 m170 77.09 157.7 0.19 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.458 1.103 . . . . 0.0 112.245 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.12 127.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.984 1.314 . . . . 0.0 111.705 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.14 114.93 15.35 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.684 0.394 . . . . 0.0 112.038 -174.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.14 130.23 34.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.523 0.729 . . . . 0.0 110.895 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.6 p -85.66 93.33 8.81 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.564 0.746 . . . . 0.0 112.444 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.13 107.91 19.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.743 0.817 . . . . 0.0 109.01 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -85.36 105.99 16.41 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.663 0.744 . . . . 0.0 111.184 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.5 t -90.74 123.44 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.521 1.128 . . . . 0.0 107.969 -173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.9 m -135.94 126.6 27.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 tp -75.45 109.89 9.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.913 -0.492 . . . . 0.0 110.229 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -81.18 -59.54 2.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.382 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.0 p -140.28 132.35 27.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.366 0.667 . . . . 0.0 109.388 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -105.52 112.61 25.77 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.48 138.13 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.516 0.674 . . . . 0.0 109.608 -170.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.52 155.95 35.61 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.195 0.997 . . . . 0.0 113.643 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.795 0 CA-C-O 116.963 -2.021 . . . . 0.0 114.189 -179.4 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.55 0.975 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 11.0 mpt_? 64.71 61.9 0.79 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.407 1.1 mm-40 64.49 -173.24 0.17 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 172.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -104.37 162.96 12.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.997 1.319 . . . . 0.0 110.052 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.59 107.55 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 109.488 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.09 129.7 54.79 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 121.644 0.735 . . . . 0.0 111.744 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.64 -48.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.003 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.22 -70.3 0.25 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 120.111 1.323 . . . . 0.0 113.982 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.79 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.28 -52.19 13.03 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.6 -124.03 0.7 Allowed Glycine 0 CA--C 1.54 1.599 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . 0.377 5.3 mp 72.93 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.115 1.366 . . . . 0.0 112.481 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.98 95.72 10.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -109.38 90.13 3.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -97.37 96.82 8.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.587 -0.696 . . . . 0.0 110.572 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.61 103.11 7.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.488 -0.758 . . . . 0.0 110.415 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.4 m -83.21 100.74 10.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.37 -65.36 1.02 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.616 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -84.2 128.28 62.96 Favored Pre-proline 0 CA--C 1.575 1.931 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 167.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.77 -56.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.953 2.435 . . . . 0.0 116.26 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.72 101.29 0.89 Allowed Glycine 0 CA--C 1.547 2.034 0 CA-C-O 116.71 -2.161 . . . . 0.0 107.887 -162.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.21 162.75 40.53 Favored 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 122.631 3.215 . . . . 0.0 116.42 -164.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.36 130.64 22.91 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.243 2.629 . . . . 0.0 113.701 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.79 -69.16 0.21 Allowed Glycine 0 CA--C 1.542 1.744 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -160.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -82.05 94.16 7.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.397 0.679 . . . . 0.0 111.165 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.0 m -128.09 166.49 18.35 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.983 0.897 . . . . 0.0 111.813 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 134.87 33.73 Favored Pre-proline 0 CA--C 1.577 2.0 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -165.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.33 144.84 11.78 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.133 2.556 . . . . 0.0 114.765 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.4 156.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 124.019 0.927 . . . . 0.0 109.32 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.83 89.09 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -160.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.11 61.15 0.01 OUTLIER Glycine 0 CA--C 1.546 1.988 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.989 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -151.16 144.43 24.76 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.08 94.19 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.78 141.66 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.603 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -124.09 128.21 48.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.579 -167.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.67 150.42 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.3 1.047 . . . . 0.0 110.5 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -96.63 107.55 20.01 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 tt -112.25 106.24 14.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -104.77 120.08 40.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -91.58 126.31 36.61 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -124.3 162.77 23.06 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.132 0.968 . . . . 0.0 110.563 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -83.58 153.27 24.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.326 -0.858 . . . . 0.0 111.815 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -50.86 -45.17 59.76 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 163.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -124.62 63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.44 0.564 . . . . 0.0 110.348 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.39 -116.52 0.59 Allowed Glycine 0 CA--C 1.538 1.485 0 O-C-N 121.178 -0.951 . . . . 0.0 112.128 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.6 t -158.01 -169.38 2.79 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.713 0.805 . . . . 0.0 111.168 -164.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.4 111.67 1.17 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.09 -52.13 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.009 1.324 . . . . 0.0 111.34 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -150.52 107.59 3.58 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -97.45 100.7 12.13 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.523 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.31 90.4 42.05 Favored Pre-proline 0 CA--C 1.572 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.77 -6.16 15.07 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 N-CA-C 120.055 3.06 . . . . 0.0 120.055 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -127.64 102.84 7.01 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.45 1.477 . . . . 0.0 110.071 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -126.8 97.65 5.07 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.69 136.58 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.924 0.889 . . . . 0.0 109.308 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -164.87 154.32 13.12 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.607 0.763 . . . . 0.0 111.032 -169.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.8 m -76.75 137.97 39.64 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.393 0.616 . . . . 0.0 110.398 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.04 115.93 11.85 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.974 0.909 . . . . 0.0 109.98 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.54 73.01 0.97 Allowed Glycine 0 N--CA 1.481 1.639 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.724 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.99 149.5 19.68 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.873 0.844 . . . . 0.0 110.624 -168.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 76.9 m -77.49 80.71 3.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.58 1.181 . . . . 0.0 112.113 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.49 -65.27 0.24 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.856 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -81.08 164.73 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-O 122.437 1.113 . . . . 0.0 112.397 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.84 159.35 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.514 1.126 . . . . 0.0 113.983 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -55.52 -40.23 71.52 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -44.48 71.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.96 -67.67 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 117.199 -1.382 . . . . 0.0 111.616 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -46.48 -42.43 15.52 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.86 -51.51 66.71 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.3 p -77.48 -4.51 45.88 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.304 1.6 t -68.26 -45.64 38.8 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 114.892 -2.48 . . . . 0.0 114.976 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.93 -30.14 91.06 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 CA-C-N 126.77 3.454 . . . . 0.0 117.489 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -100.49 70.66 1.48 Allowed 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.213 1.005 . . . . 0.0 111.146 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -136.32 107.65 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.26 136.52 37.07 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.997 0.903 . . . . 0.0 111.63 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.93 114.17 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.883 -158.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.29 44.75 2.5 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.571 -1.195 . . . . 0.0 115.496 -166.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.39 167.28 12.39 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 118.837 1.318 . . . . 0.0 113.713 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 95.3 m -143.31 108.38 4.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.94 121.34 15.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.315 0.246 . . . . 0.0 110.751 -166.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 ttt -81.57 115.99 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.853 0.461 . . . . 0.0 110.168 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.99 100.61 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.0 p -84.41 97.65 9.62 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.35 32.05 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.343 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.67 144.91 53.81 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t -58.56 -38.63 78.24 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -69.71 -37.46 76.57 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.23 -44.15 92.76 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 169.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.9 t -91.24 -179.66 5.48 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 123.062 1.41 . . . . 0.0 111.49 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.25 113.79 3.41 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.022 158.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.41 -89.38 0.08 OUTLIER Glycine 0 CA--C 1.546 1.986 0 CA-C-O 116.792 -2.115 . . . . 0.0 109.077 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.15 -57.14 0.13 Allowed 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 122.307 3.053 . . . . 0.0 114.295 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -89.13 103.21 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.57 -118.75 0.47 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.051 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -141.9 60.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.875 0.845 . . . . 0.0 111.877 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.9 p -87.85 150.64 48.42 Favored Pre-proline 0 CA--C 1.572 1.808 0 C-N-CA 124.214 1.005 . . . . 0.0 113.129 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.12 -7.33 46.59 Favored 'Cis proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.552 2.866 . . . . 0.0 119.552 11.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.83 -57.71 9.93 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 120.278 1.399 . . . . 0.0 113.854 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.1 mt -90.28 117.84 68.34 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.47 161.4 9.57 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.875 2.383 . . . . 0.0 116.095 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 131.83 21.4 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.138 2.559 . . . . 0.0 112.62 168.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.29 92.0 m-70 71.13 174.65 0.3 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 123.729 0.812 . . . . 0.0 112.306 -170.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.72 118.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.054 1.342 . . . . 0.0 111.964 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.51 97.9 8.67 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.43 149.12 21.85 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.526 0.679 . . . . 0.0 112.749 -171.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -87.77 147.05 25.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.371 0.668 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.58 109.31 3.25 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.59 120.65 26.6 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.797 0.808 . . . . 0.0 111.917 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.6 t -103.3 109.23 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.6 m -116.17 104.48 11.57 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.1 113.87 7.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.398 0.679 . . . . 0.0 110.664 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -85.16 -61.07 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.1 p -142.8 133.27 24.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.21 100.94 10.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.94 132.38 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.119 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.94 73.22 10.36 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.27 1.033 . . . . 0.0 113.766 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.5 83.35 0.55 Allowed Glycine 0 CA--C 1.552 2.344 0 CA-C-O 116.787 -2.119 . . . . 0.0 114.472 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.76 106.83 1.5 Allowed 'Trans proline' 0 CA--C 1.56 1.793 0 CA-C-N 122.259 3.029 . . . . 0.0 112.017 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.91 119.52 31.18 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.168 0.587 . . . . 0.0 111.202 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.69 110.17 4.23 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 123.229 1.49 . . . . 0.0 111.013 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 118.845 -0.597 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -77.3 -73.55 0.29 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.964 0.802 . . . . 0.0 111.538 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.31 116.92 6.18 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 87.8 m95 72.57 134.05 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.504 1.122 . . . . 0.0 113.526 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.53 93.98 7.1 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.17 112.63 17.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.483 0.713 . . . . 0.0 111.265 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -64.03 -49.88 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.746 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.1 -61.07 2.91 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.8 -71.41 0.26 Allowed Glycine 0 N--CA 1.48 1.576 0 CA-C-N 118.632 0.651 . . . . 0.0 111.763 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -66.62 -72.7 0.15 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.785 0.834 . . . . 0.0 112.025 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.78 72.64 0.03 OUTLIER Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.517 0.599 . . . . 0.0 112.684 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.82 -72.98 0.66 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.31 143.71 31.09 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.999 0.92 . . . . 0.0 110.614 172.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -141.19 161.84 36.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.002 0.921 . . . . 0.0 112.473 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.87 37.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 112.182 164.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -173.48 2.34 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 122.009 0.909 . . . . 0.0 111.591 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -140.8 97.19 3.14 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 164.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.15 -69.09 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.609 0.764 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -101.78 131.63 22.62 Favored Pre-proline 0 CA--C 1.573 1.836 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 160.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 175.17 11.7 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.106 2.538 . . . . 0.0 114.53 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.73 115.34 4.96 Favored Glycine 0 CA--C 1.556 2.64 0 CA-C-O 116.879 -2.067 . . . . 0.0 112.066 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.27 169.36 15.52 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 CA-C-N 122.602 3.201 . . . . 0.0 115.597 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.68 -38.6 76.87 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 123.326 2.684 . . . . 0.0 118.182 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.7 87.61 0.94 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 118.968 0.804 . . . . 0.0 111.597 163.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.7 p -144.4 95.53 2.73 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 p -91.66 108.62 20.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.944 0.878 . . . . 0.0 110.598 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -76.41 126.67 86.02 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.59 -172.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.44 149.62 56.65 Favored 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 115.55 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.85 166.87 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.127 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -62.52 118.77 8.02 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.118 0.567 . . . . 0.0 112.438 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.58 58.41 1.13 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.287 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -143.89 135.65 26.22 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.28 101.8 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 m -122.68 128.24 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.789 0.804 . . . . 0.0 109.249 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -95.13 137.42 34.2 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.913 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 144.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.831 0.824 . . . . 0.0 109.461 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -92.05 100.66 13.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 163.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 tp -86.38 107.05 17.84 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.001 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -102.83 80.25 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 109.519 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.9 m -75.83 129.34 36.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.792 0.837 . . . . 0.0 109.991 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -139.86 164.87 28.82 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.473 1.13 . . . . 0.0 111.621 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.1 tp -78.9 161.68 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.985 0.914 . . . . 0.0 111.992 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -49.37 -42.08 41.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.61 -68.47 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.596 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.83 83.35 0.05 OUTLIER Glycine 0 N--CA 1.479 1.53 0 CA-C-N 119.117 0.871 . . . . 0.0 112.03 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -159.44 122.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.52 115.02 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.29 -45.89 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -145.43 109.16 4.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -94.33 101.64 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.458 0.647 . . . . 0.0 110.113 164.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -92.65 109.29 37.74 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.645 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.14 -51.45 0.6 Allowed 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.026 2.484 . . . . 0.0 117.308 -165.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -121.57 94.91 4.47 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.983 0.896 . . . . 0.0 111.551 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -97.23 102.98 14.87 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.15 123.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -149.7 149.21 30.26 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -170.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -75.77 124.27 27.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.34 114.89 8.0 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.536 0.734 . . . . 0.0 111.004 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.11 18.44 77.9 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 119.64 2.616 . . . . 0.0 119.64 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -132.85 66.25 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.661 1.73 . . . . 0.0 111.587 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.6 t 58.9 78.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -149.78 -66.71 0.21 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 m -97.58 167.27 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.733 1.254 . . . . 0.0 112.256 -166.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -61.09 159.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.946 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.46 -41.34 89.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.86 -46.21 71.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 168.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.7 -57.53 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.345 168.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -46.58 -58.05 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.35 -32.82 74.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.5 p -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.264 1.7 t -64.22 -49.19 74.35 Favored Pre-proline 0 N--CA 1.505 2.295 0 CA-C-N 122.391 2.36 . . . . 0.0 113.71 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.99 1.08 3.65 Favored 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 125.119 2.864 . . . . 0.0 118.61 169.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -97.27 -25.78 15.14 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 156.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 12.0 tpp -81.9 105.38 12.97 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.851 1.205 . . . . 0.0 110.441 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.34 167.48 20.83 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 122.146 0.974 . . . . 0.0 112.095 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.96 107.36 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 108.746 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 14.01 52.14 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.148 2.019 . . . . 0.0 118.148 -166.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.27 110.15 22.12 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 119.971 1.885 . . . . 0.0 109.561 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.9 m -94.29 120.36 34.41 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.22 135.31 49.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.553 0.741 . . . . 0.0 109.535 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 tpt -80.86 103.72 10.88 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.8 t -90.96 94.03 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.5 p -89.14 91.43 8.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.822 0.82 . . . . 0.0 109.487 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.71 134.87 41.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.843 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.9 132.57 47.59 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.908 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.476 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . 26.7 t -74.32 75.09 1.86 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 123.26 1.505 . . . . 0.0 112.723 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -172.17 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.481 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -87.87 -56.94 3.13 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.614 1.166 . . . . 0.0 110.179 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 118' ' ' SER . 20.1 p -46.28 -57.18 4.81 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 168.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -124.94 -46.16 1.85 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.609 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.97 144.46 17.21 Favored Glycine 0 CA--C 1.555 2.541 0 CA-C-O 117.677 -1.624 . . . . 0.0 112.255 -168.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.88 87.91 1.36 Allowed 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 122.184 2.992 . . . . 0.0 113.05 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -144.67 -66.92 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.75 86.0 1.84 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.604 0.621 . . . . 0.0 111.594 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -91.96 152.47 20.01 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.2 m -68.03 140.16 93.38 Favored Pre-proline 0 CA--C 1.573 1.83 0 CA-C-O 117.707 -1.139 . . . . 0.0 112.729 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.71 -50.25 0.2 OUTLIER 'Cis proline' 0 CA--C 1.562 1.923 0 N-CA-C 117.238 1.976 . . . . 0.0 117.238 11.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -149.92 76.47 1.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 119.506 1.048 . . . . 0.0 109.208 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.77 118.11 49.15 Favored Pre-proline 0 CA--C 1.57 1.73 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.59 142.03 12.71 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 122.877 2.385 . . . . 0.0 114.303 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 125.33 10.66 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.131 2.554 . . . . 0.0 112.103 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.278 97.6 m-70 70.0 172.18 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.708 0.803 . . . . 0.0 112.883 -171.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.18 111.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.999 1.32 . . . . 0.0 111.15 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.23 117.25 8.26 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.43 128.11 33.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.819 0.448 . . . . 0.0 109.8 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.11 98.45 8.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.601 0.761 . . . . 0.0 109.355 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 107.0 18.03 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.572 0.749 . . . . 0.0 110.575 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.4 107.9 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.126 0.965 . . . . 0.0 111.276 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.84 105.97 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.9 m -101.34 122.39 43.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -73.07 -74.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.1 p -147.45 131.9 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.776 0.716 . . . . 0.0 109.113 -169.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.47 112.51 25.55 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.209 0.604 . . . . 0.0 109.579 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.2 143.4 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.624 0.77 . . . . 0.0 110.109 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.67 79.43 4.26 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.074 0.94 . . . . 0.0 113.124 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.15 159.26 27.2 Favored Glycine 0 CA--C 1.561 2.937 0 N-CA-C 116.568 1.387 . . . . 0.0 116.568 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.11 164.91 21.96 Favored 'Trans proline' 0 CA--C 1.563 1.941 0 C-N-CA 123.178 2.585 . . . . 0.0 114.335 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.24 96.9 8.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.54 0.686 . . . . 0.0 109.994 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -158.01 113.35 2.7 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.32 10.1 pt-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -132.12 -76.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.447 175.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -145.96 95.27 2.6 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.747 1.158 . . . . 0.0 111.766 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.322 14.9 m0 68.92 -135.94 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.362 1.065 . . . . 0.0 111.581 168.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 tt -138.25 119.31 14.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.64 108.81 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.39 0.676 . . . . 0.0 112.207 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.29 45.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -58.45 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 125.272 1.429 . . . . 0.0 110.213 172.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.52 -91.3 0.51 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.95 -36.32 64.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.08 1.35 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -167.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mp 15.82 63.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 165.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 tp -157.99 117.37 3.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -148.76 115.22 5.89 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 -161.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -117.03 133.64 55.75 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -171.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -73.7 143.74 46.07 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.978 0.911 . . . . 0.0 111.661 159.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.5 m -93.45 92.13 7.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 159.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.73 -60.98 2.11 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.774 0.829 . . . . 0.0 113.044 -167.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -113.82 130.2 24.04 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 157.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.84 170.03 21.27 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.088 2.526 . . . . 0.0 114.97 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 152.39 49.65 Favored Glycine 0 CA--C 1.561 2.925 0 CA-C-O 118.376 -1.236 . . . . 0.0 115.345 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.95 164.58 31.24 Favored 'Trans proline' 0 CA--C 1.574 2.486 0 CA-C-N 121.433 2.616 . . . . 0.0 115.556 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.14 113.58 2.68 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 123.201 2.601 . . . . 0.0 113.038 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.6 -96.27 0.94 Allowed Glycine 0 CA--C 1.539 1.557 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -163.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.268 82.9 p 53.96 85.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -79.9 120.62 24.36 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.424 0.63 . . . . 0.0 111.534 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -81.61 124.01 80.25 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.746 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.52 147.9 65.45 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.1 2.533 . . . . 0.0 115.567 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.16 152.74 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.059 0.944 . . . . 0.0 111.842 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.81 118.42 8.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.06 60.48 0.55 Allowed Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.71 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -146.86 146.0 30.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.364 1.078 . . . . 0.0 108.559 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.3 101.39 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.81 125.49 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -107.4 140.29 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.371 0.668 . . . . 0.0 109.308 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.27 141.32 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.801 0.841 . . . . 0.0 109.023 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -83.82 101.32 11.54 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 158.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.6 tp -86.26 100.56 12.35 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -93.68 101.38 13.52 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -81.03 117.51 21.69 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -142.58 154.36 44.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.656 0.783 . . . . 0.0 109.566 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.21 141.54 49.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.858 0.837 . . . . 0.0 111.206 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -57.63 -45.63 85.17 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 157.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.18 -58.01 3.96 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.83 54.13 0.75 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.472 2.5 t 50.92 -157.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 163.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -79.97 107.37 12.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.211 1.004 . . . . 0.0 111.973 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.2 -71.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.378 0.671 . . . . 0.0 111.26 -165.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.92 111.18 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -163.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.25 113.11 25.23 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.133 0.573 . . . . 0.0 110.739 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.92 91.89 16.48 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.498 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.08 -61.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.36 2.707 . . . . 0.0 116.047 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 86.33 5.66 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.663 1.12 . . . . 0.0 110.625 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.8 tp -106.88 92.6 4.16 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 165.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.2 139.44 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.533 0.733 . . . . 0.0 110.395 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -159.6 154.65 24.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.516 0.674 . . . . 0.0 111.748 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -74.87 133.1 41.9 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 171.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.18 111.3 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.129 0.972 . . . . 0.0 111.409 -172.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.35 77.96 0.33 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.015 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.84 157.7 27.12 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.28 1.038 . . . . 0.0 111.228 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.47 83.56 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.274 1.035 . . . . 0.0 112.253 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -151.39 -66.44 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.32 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.61 169.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.702 1.239 . . . . 0.0 113.44 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 pt -52.27 151.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 114.131 -1.395 . . . . 0.0 114.053 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -60.73 -36.78 79.74 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.14 83.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.32 -57.78 7.54 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 117.406 -1.283 . . . . 0.0 113.289 165.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -52.49 -39.9 61.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.6 p -104.54 61.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.96 -61.02 0.17 Allowed Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 115.543 -2.17 . . . . 0.0 108.987 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.97 -25.08 59.67 Favored 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 124.986 2.816 . . . . 0.0 117.542 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -6.27 5.72 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 167.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.2 mtt -114.44 119.8 38.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.935 1.243 . . . . 0.0 109.017 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -64.45 163.3 13.57 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.62 99.72 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 49.28 3.09 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 118.352 1.076 . . . . 0.0 110.741 163.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.3 m -93.5 142.28 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.29 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.83 123.17 13.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.727 0.411 . . . . 0.0 110.705 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.3 tpt -84.02 101.78 12.01 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.47 125.63 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 p -106.35 96.42 6.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.843 0.83 . . . . 0.0 109.219 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.19 167.69 15.46 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.965 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.45 42.91 1.12 Allowed 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.7 p 35.34 54.79 0.81 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -151.86 -58.86 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.821 -159.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.9 -45.61 92.98 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 157.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.6 t -90.78 113.6 25.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.821 0.848 . . . . 0.0 111.173 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.287 81.0 m-85 65.2 14.46 9.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.17 179.1 25.31 Favored Glycine 0 CA--C 1.559 2.824 0 N-CA-C 116.523 1.369 . . . . 0.0 116.523 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -83.46 62.56 7.34 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 122.921 2.414 . . . . 0.0 113.407 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.54 -70.69 0.07 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.84 132.82 7.67 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 118.22 0.464 . . . . 0.0 112.038 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -111.34 52.42 0.75 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.9 m 65.46 143.77 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 170.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.03 -40.39 0.85 Allowed 'Cis proline' 0 CA--C 1.563 1.932 0 CA-C-N 122.687 1.996 . . . . 0.0 116.472 -1.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -132.81 67.33 1.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.2 mt -115.77 119.64 37.13 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -85.54 159.81 10.87 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 C-N-CA 123.157 2.571 . . . . 0.0 115.196 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.08 -39.51 0.87 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 122.959 2.44 . . . . 0.0 117.291 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.87 72.34 1.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.021 0.828 . . . . 0.0 109.04 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.19 21.3 0.25 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 72.68 134.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 tt -138.75 123.48 18.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -99.48 97.3 8.32 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.877 0.846 . . . . 0.0 110.138 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.66 125.59 39.41 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.284 1.034 . . . . 0.0 109.602 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -98.54 103.48 15.43 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.878 0.847 . . . . 0.0 110.298 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.23 109.17 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.7 m -105.26 121.61 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.09 105.83 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.91 -66.9 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.5 p -135.06 135.41 41.26 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.44 0.696 . . . . 0.0 109.219 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.86 104.07 11.82 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.03 154.48 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.742 0.782 . . . . 0.0 109.915 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.19 -170.05 0.89 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -80.85 117.38 4.41 Favored Glycine 0 CA--C 1.556 2.614 0 CA-C-O 116.874 -2.07 . . . . 0.0 115.021 -173.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.73 147.22 19.33 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 CA-C-N 122.58 3.19 . . . . 0.0 113.774 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.03 168.47 19.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.54 159.19 22.86 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.276 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 123.813 0.845 . . . . 0.0 112.146 -171.285 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.8 ttp-105 -146.84 127.69 14.43 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.162 0.585 . . . . 0.0 111.081 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.27 122.62 20.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.173 0.589 . . . . 0.0 109.746 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.317 98.5 m95 86.54 106.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.709 1.204 . . . . 0.0 109.596 -161.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.27 107.33 19.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -83.48 116.03 22.35 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.527 0.679 . . . . 0.0 112.193 -165.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.46 -48.83 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 123.909 0.884 . . . . 0.0 111.413 170.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.38 -60.3 3.75 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.413 1.006 . . . . 0.0 113.143 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.78 -72.63 0.29 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-N 118.912 0.778 . . . . 0.0 112.446 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -69.56 -70.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.687 0.795 . . . . 0.0 112.353 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.82 64.06 0.09 OUTLIER Glycine 0 N--CA 1.481 1.644 0 CA-C-N 118.393 0.542 . . . . 0.0 111.863 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.1 mt -137.04 -78.74 0.4 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.894 -163.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 tp -88.27 124.72 34.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 121.022 1.737 . . . . 0.0 107.988 166.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -154.95 113.19 3.49 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.477 -164.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -119.2 115.99 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.339 1.056 . . . . 0.0 109.127 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -103.8 141.18 36.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.819 -0.551 . . . . 0.0 111.081 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.9 m -80.18 115.35 19.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.9 -69.08 0.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.539 0.736 . . . . 0.0 109.293 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.6 134.09 24.72 Favored Pre-proline 0 CA--C 1.578 2.035 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.021 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.04 149.83 29.08 Favored 'Trans proline' 0 CA--C 1.558 1.686 0 C-N-CA 122.851 2.368 . . . . 0.0 114.11 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 114.49 4.0 Favored Glycine 0 CA--C 1.555 2.578 0 CA-C-O 116.872 -2.071 . . . . 0.0 113.127 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.83 164.17 36.53 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 CA-C-N 122.775 3.287 . . . . 0.0 116.0 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.09 109.56 2.6 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.272 2.648 . . . . 0.0 111.74 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.81 -66.0 0.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.026 -158.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -65.49 135.03 54.65 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -138.67 146.66 41.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.702 0.763 . . . . 0.0 110.004 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.59 112.46 6.63 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-O 117.998 -1.001 . . . . 0.0 113.362 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.42 166.25 29.88 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.499 2.133 . . . . 0.0 115.942 -161.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.66 162.82 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.22 -168.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 107.52 4.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.391 0.676 . . . . 0.0 110.223 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.45 -47.84 0.8 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 115.415 -0.811 . . . . 0.0 113.919 -163.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -63.36 124.05 20.28 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.708 0.803 . . . . 0.0 111.739 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.49 99.25 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.49 140.35 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.863 0.839 . . . . 0.0 110.557 -172.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 m -114.41 124.04 50.95 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.15 142.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.794 0.837 . . . . 0.0 110.288 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -94.67 99.52 11.62 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 165.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.25 106.01 18.1 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.9 87.92 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.6 m -71.48 125.07 26.08 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.149 0.58 . . . . 0.0 110.562 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 t -131.38 155.34 47.44 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.098 0.952 . . . . 0.0 110.329 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.1 146.93 30.34 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.612 165.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.59 -33.33 60.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -68.16 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.96 0.8 . . . . 0.0 112.059 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.5 77.27 0.03 OUTLIER Glycine 0 N--CA 1.479 1.502 0 CA-C-N 119.117 0.871 . . . . 0.0 113.147 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 m -149.34 106.61 3.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -82.65 105.96 14.12 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.1 m -96.79 -45.3 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -165.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -136.1 87.99 2.35 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.847 1.203 . . . . 0.0 110.101 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.38 115.07 26.85 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.322 0.582 . . . . 0.0 111.671 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.13 102.41 48.84 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.726 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -87.22 77.17 2.02 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.633 2.222 . . . . 0.0 114.073 -166.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.461 8.7 pt-20 133.36 94.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 127.401 2.281 . . . . 0.0 110.047 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.33 99.56 7.1 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.31 138.22 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.693 -169.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -164.54 149.88 10.1 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.253 0.621 . . . . 0.0 110.683 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -79.46 128.62 33.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.64 135.1 52.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.563 0.745 . . . . 0.0 112.115 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 52.38 18.4 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.32 -16.71 0.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.255 17.0 t 76.2 86.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.44 1.496 . . . . 0.0 110.558 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -132.84 -70.63 0.54 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.062 0.545 . . . . 0.0 110.541 -174.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.68 178.81 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 123.795 0.838 . . . . 0.0 112.521 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -54.76 144.2 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.361 1.064 . . . . 0.0 113.671 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -57.32 -27.88 62.59 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.37 -47.58 85.19 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -62.59 1.33 Allowed 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.853 170.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.15 -51.5 42.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.66 -36.14 81.89 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.6 p -74.48 -10.15 59.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.556 2.799 . . . . 0.0 118.556 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -59.88 -50.29 87.28 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 115.391 -2.243 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.16 -30.59 61.64 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 CA-C-N 125.362 2.951 . . . . 0.0 118.283 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.28 65.54 1.43 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 119.057 0.844 . . . . 0.0 111.176 163.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.0 ttm -160.23 109.65 1.76 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 157.71 20.44 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.071 0.938 . . . . 0.0 112.566 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.14 121.62 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.354 -0.841 . . . . 0.0 111.405 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.433 ' H ' HD12 ' A' ' 143' ' ' LEU . . . 89.72 -3.69 83.32 Favored Glycine 0 CA--C 1.552 2.364 0 N-CA-C 118.49 2.156 . . . . 0.0 118.49 -167.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.5 114.26 12.69 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 121.25 2.525 . . . . 0.0 112.147 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.5 m -84.14 124.24 30.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 133.19 21.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.421 0.689 . . . . 0.0 109.579 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.438 ' SD ' ' SG ' ' A' ' 138' ' ' CYS . 26.9 tpp -83.75 137.9 33.52 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.86 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.8 t -128.48 125.22 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.5 p -102.74 95.49 6.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.81 127.25 32.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.297 172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.73 59.46 4.66 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.8 p 33.35 64.09 0.32 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -173.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -176.6 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.899 -155.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -79.64 -38.76 33.02 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.288 1.435 . . . . 0.0 112.745 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.8 t -62.3 -63.92 1.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 163.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -137.16 -69.41 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.87 0.868 . . . . 0.0 109.665 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 119.63 -166.15 13.37 Favored Glycine 0 CA--C 1.555 2.549 0 CA-C-N 118.938 0.79 . . . . 0.0 113.17 -167.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -64.38 -10.46 24.05 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 N-CA-C 118.573 2.49 . . . . 0.0 118.573 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -105.47 103.27 12.76 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -122.7 157.63 17.3 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 123.685 0.66 . . . . 0.0 112.356 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -87.75 78.21 8.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.1 p -75.69 142.59 73.91 Favored Pre-proline 0 CA--C 1.568 1.668 0 CA-C-O 117.819 -1.086 . . . . 0.0 113.096 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.31 -15.29 32.51 Favored 'Cis proline' 0 CA--C 1.565 2.027 0 N-CA-C 119.397 2.807 . . . . 0.0 119.397 10.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -64.22 -47.86 78.09 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.25 101.01 53.92 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 171.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.34 145.82 66.92 Favored 'Trans proline' 0 CA--C 1.572 2.387 0 C-N-CA 122.525 2.15 . . . . 0.0 113.387 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.69 -34.55 62.19 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 123.196 2.597 . . . . 0.0 118.343 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -125.36 157.04 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.85 0.86 . . . . 0.0 109.905 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.262 . . 81.05 128.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.151 1.38 . . . . 0.0 111.569 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.99 153.44 33.8 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.374 1.991 . . . . 0.0 116.374 -169.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.77 134.62 54.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.69 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 113' ' ' MET . 42.3 t -90.92 91.93 8.55 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.988 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 139' ' ' LEU . 1.7 pt? -79.66 121.12 24.9 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.049 0.928 . . . . 0.0 110.443 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -99.46 88.35 3.85 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.839 1.255 . . . . 0.0 109.053 -170.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.0 t -84.14 126.25 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -166.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -115.33 118.21 32.62 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -78.56 108.83 12.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -81.69 -70.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -145.28 135.65 24.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -167.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.87 95.57 5.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.512 0.673 . . . . 0.0 109.301 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.53 158.14 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 124.013 0.925 . . . . 0.0 109.785 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.04 -177.7 3.01 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.15 120.2 5.22 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-O 116.906 -2.052 . . . . 0.0 113.502 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.46 148.63 26.61 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 CA-C-N 122.589 3.194 . . . . 0.0 114.244 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.35 -30.95 66.77 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 118.47 2.767 . . . . 0.0 118.47 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.98 121.83 25.97 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.268 0.94 . . . . 0.0 109.832 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 123.209 1.48 . . . . 0.0 111.093 179.598 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.267 80.9 mtp180 57.76 37.57 27.19 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.43 -17.84 60.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -109.79 136.43 49.13 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.158 0.983 . . . . 0.0 109.774 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 tp -145.64 113.44 6.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.98 161.37 27.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.9 mm -90.16 -67.74 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.427 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.255 2.4 pt? -70.28 -52.96 19.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -171.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.77 56.64 0.05 OUTLIER Glycine 0 N--CA 1.483 1.824 0 C-N-CA 123.73 0.681 . . . . 0.0 113.232 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -150.51 -55.84 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.973 0.909 . . . . 0.0 110.706 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.32 57.77 0.38 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 124.24 0.924 . . . . 0.0 111.693 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.7 mt -141.18 -59.75 0.49 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.081 0.953 . . . . 0.0 108.896 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.9 tp -92.07 89.13 6.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.222 0.919 . . . . 0.0 108.553 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -101.13 96.93 7.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.565 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -91.77 99.72 12.55 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.61 0.764 . . . . 0.0 112.185 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -86.37 127.34 34.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.474 -0.766 . . . . 0.0 109.806 164.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.2 m -87.47 112.89 22.67 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.67 -68.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.82 0.848 . . . . 0.0 110.242 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.03 117.88 66.04 Favored Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.89 167.58 16.29 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.956 2.438 . . . . 0.0 114.937 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.45 170.47 50.58 Favored Glycine 0 CA--C 1.564 3.109 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 170.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.38 169.19 17.56 Favored 'Trans proline' 0 CA--C 1.575 2.549 0 C-N-CA 122.972 2.448 . . . . 0.0 115.844 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.86 113.42 3.22 Favored 'Trans proline' 0 CA--C 1.558 1.723 0 C-N-CA 123.039 2.493 . . . . 0.0 112.326 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.35 -86.1 0.44 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -164.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.285 81.7 p 63.05 113.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.6 m -92.22 135.93 33.6 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.135 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 143.06 26.01 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.04 145.96 22.55 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.525 2.15 . . . . 0.0 115.764 -162.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 62' ' ' LYS . 8.3 p -95.71 -179.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 124.578 1.151 . . . . 0.0 111.759 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 61' ' ' VAL . 25.6 tttm -63.66 119.95 10.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.73 47.05 2.0 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.88 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.45 124.83 26.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.54 99.87 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -103.72 126.54 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.747 0.819 . . . . 0.0 109.17 -171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -100.86 113.4 26.31 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.69 140.76 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.821 0.848 . . . . 0.0 109.014 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -92.56 100.52 13.03 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.68 106.31 17.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.78 99.82 11.39 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -78.22 119.26 21.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -132.24 145.73 51.52 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.753 0.787 . . . . 0.0 109.945 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.96 148.78 48.49 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.704 172.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -55.15 -31.34 61.25 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -63.6 -68.04 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.97 0.805 . . . . 0.0 111.682 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.02 77.04 0.02 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -147.57 117.9 7.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -74.1 95.74 2.6 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 122.624 1.202 . . . . 0.0 112.903 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.04 -45.39 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -125.11 150.27 47.02 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.313 1.054 . . . . 0.0 109.822 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -147.35 79.26 1.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.566 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.89 98.43 5.39 Favored Pre-proline 0 CA--C 1.579 2.069 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.28 -43.92 1.98 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.176 2.584 . . . . 0.0 115.865 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.9 77.27 8.53 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.312 1.053 . . . . 0.0 110.067 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.0 tp -100.33 98.01 8.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.92 135.56 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -158.56 142.24 15.26 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.459 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 m -80.24 133.3 35.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.46 138.6 57.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.967 0.507 . . . . 0.0 111.97 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.2 -66.01 0.25 Allowed Glycine 0 N--CA 1.478 1.484 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.65 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 104.48 5.68 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.312 0.577 . . . . 0.0 110.037 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.82 82.84 6.18 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.797 0.808 . . . . 0.0 112.803 -161.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.89 -50.8 14.0 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.122 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.64 161.05 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.1 pt -54.59 151.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 124.829 1.252 . . . . 0.0 114.222 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -65.41 -17.12 64.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -36.98 85.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.98 -71.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.378 -1.296 . . . . 0.0 111.641 159.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.74 -44.34 27.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 -168.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.26 -50.18 72.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -75.49 -12.0 60.15 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.272 5.7 t -67.79 -46.48 44.5 Favored Pre-proline 0 N--CA 1.497 1.923 0 CA-C-O 115.214 -2.327 . . . . 0.0 114.023 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.22 35.14 0.38 Allowed 'Trans proline' 0 CA--C 1.579 2.74 0 CA-C-N 125.415 2.969 . . . . 0.0 116.672 165.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.3 mt -138.89 -38.75 0.5 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 126.525 1.93 . . . . 0.0 110.495 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 42.3 mtt -63.65 123.82 19.82 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.814 1.246 . . . . 0.0 112.768 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.67 159.96 23.83 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.661 1.22 . . . . 0.0 112.836 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.57 105.15 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.6 62.42 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.685 -1.064 . . . . 0.0 114.296 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.27 129.04 23.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.477 1.138 . . . . 0.0 112.194 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.9 m -85.62 130.14 34.65 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.98 127.75 14.34 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.643 0.259 . . . . 0.0 111.284 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.4 tpp -84.06 108.92 17.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.02 106.58 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 66.0 p -94.69 93.51 7.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.42 18.06 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -74.46 153.9 38.96 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.688 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.3 t -75.12 83.82 2.33 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.782 1.277 . . . . 0.0 110.623 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -178.02 -61.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.047 -155.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -77.69 -53.2 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.582 1.153 . . . . 0.0 111.793 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m -81.76 107.75 14.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.86 0.864 . . . . 0.0 110.243 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.305 23.8 m-85 70.12 -0.04 2.94 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.27 -179.91 48.24 Favored Glycine 0 CA--C 1.559 2.823 0 CA-C-N 120.26 1.391 . . . . 0.0 115.649 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.95 -46.05 9.24 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.286 2.657 . . . . 0.0 116.325 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -95.43 102.52 14.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.71 -152.9 11.75 Favored Glycine 0 CA--C 1.548 2.11 0 N-CA-C 116.713 1.445 . . . . 0.0 116.713 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -82.75 66.11 8.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 124.114 0.966 . . . . 0.0 112.182 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.5 p -80.21 146.97 63.79 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.384 -175.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.1 -11.98 29.93 Favored 'Cis proline' 0 CA--C 1.565 2.073 0 N-CA-C 119.637 2.899 . . . . 0.0 119.637 7.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -60.55 -58.02 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -96.5 105.03 20.0 Favored Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.29 160.8 48.3 Favored 'Trans proline' 0 CA--C 1.573 2.432 0 C-N-CA 122.711 2.274 . . . . 0.0 113.986 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.98 112.61 2.76 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 123.031 2.488 . . . . 0.0 112.965 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 88.6 m-70 72.92 86.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.71 1.204 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.88 121.74 4.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.65 122.98 25.44 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.015 0.526 . . . . 0.0 111.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 mt -97.84 139.95 32.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.696 0.76 . . . . 0.0 111.92 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -102.2 90.74 4.02 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.832 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.86 118.81 37.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.706 0.802 . . . . 0.0 110.227 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.5 107.43 19.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.041 0.924 . . . . 0.0 110.901 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.23 111.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -108.98 117.11 33.35 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.07 108.81 10.41 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.45 -59.72 2.14 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.254 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 76.1 p -132.93 139.3 47.27 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.654 0.781 . . . . 0.0 109.114 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.67 112.75 17.13 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -128.46 132.16 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.49 119.44 23.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.125 0.488 . . . . 0.0 111.619 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -166.88 172.45 42.02 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.4 162.61 25.05 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.151 2.567 . . . . 0.0 114.594 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.39 -57.58 11.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp 74.78 117.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.262 1.425 . . . . 0.0 113.587 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.496 1.842 0 C-N-CA 124.622 1.169 . . . . 0.0 113.883 170.661 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -151.73 116.28 5.09 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.117 0.567 . . . . 0.0 110.894 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -136.95 89.97 2.49 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.75 0.786 . . . . 0.0 109.065 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 m0 67.91 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.425 1.49 . . . . 0.0 112.928 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.426 HD13 ' H ' ' A' ' 37' ' ' LEU 0.25 0.0 OUTLIER -80.22 128.23 33.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.466 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -109.73 148.35 31.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.132 0.973 . . . . 0.0 113.589 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.53 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 tp -166.07 -70.73 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.29 -75.01 0.27 Allowed Glycine 0 CA--C 1.54 1.594 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -164.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.6 -84.75 0.08 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.464 0.706 . . . . 0.0 110.694 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.21 84.53 0.05 OUTLIER Glycine 0 N--CA 1.476 1.363 0 CA-C-N 118.825 0.739 . . . . 0.0 111.68 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.08 -58.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.803 0.841 . . . . 0.0 109.61 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.5 96.0 7.89 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.142 0.883 . . . . 0.0 108.895 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -118.1 90.04 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.075 0.95 . . . . 0.0 109.071 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.263 17.1 ptmt -83.49 123.8 30.08 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.78 138.35 32.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 161.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 m -98.62 109.06 21.88 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.52 -77.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.92 125.44 34.56 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.78 -168.49 0.59 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 123.54 2.827 . . . . 0.0 113.312 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.62 Favored Glycine 0 CA--C 1.563 3.089 0 CA-C-O 118.959 -0.911 . . . . 0.0 115.103 163.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.35 167.28 22.71 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 C-N-CA 123.085 2.523 . . . . 0.0 114.931 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.8 109.6 1.5 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.125 2.55 . . . . 0.0 111.854 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.07 81.56 1.49 Allowed Glycine 0 CA--C 1.543 1.782 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.992 -157.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.2 p -141.05 116.05 9.82 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 144.53 31.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.462 0.705 . . . . 0.0 112.053 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -93.27 111.81 53.59 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.384 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.4 169.31 22.01 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 123.196 2.597 . . . . 0.0 115.938 -165.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.6 160.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 123.808 0.843 . . . . 0.0 112.429 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -69.5 110.37 4.73 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 122.938 0.495 . . . . 0.0 109.995 162.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.51 -60.36 0.64 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.887 -157.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.87 119.84 17.67 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.233 0.613 . . . . 0.0 110.874 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.01 112.53 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.83 139.51 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.295 0.569 . . . . 0.0 110.985 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -101.52 131.41 47.69 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.9 138.92 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.032 0.533 . . . . 0.0 111.345 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.72 98.7 9.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.55 127.74 33.63 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 164.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -116.5 87.36 2.67 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 m -85.75 116.44 24.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.7 m -138.61 33.62 2.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.258 10.3 mt 55.59 167.05 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.91 -43.91 97.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.35 -60.72 2.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.99 73.94 0.03 OUTLIER Glycine 0 CA--C 1.543 1.783 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -174.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 m -152.87 117.03 4.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -76.58 111.01 11.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -83.69 -63.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 124.034 0.934 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -146.94 103.13 3.59 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -91.96 90.34 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.706 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -100.08 107.12 45.51 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.892 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.0 -49.84 0.12 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.277 2.652 . . . . 0.0 117.041 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.56 84.16 1.92 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.371 0.669 . . . . 0.0 110.316 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.9 tp -103.09 92.19 4.43 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.79 128.71 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -157.9 149.09 21.25 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.213 0.605 . . . . 0.0 111.057 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -73.28 126.82 30.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.2 tp -59.67 117.0 4.43 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -159.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.61 40.27 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.08 178.51 6.97 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.726 1.251 . . . . 0.0 111.483 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 77.4 m -78.19 68.11 4.15 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -167.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.89 -54.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.676 1.59 . . . . 0.0 109.278 172.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.09 164.65 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 122.545 1.164 . . . . 0.0 112.917 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.9 pt -62.69 154.77 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.824 1.25 . . . . 0.0 113.276 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.39 -32.53 71.4 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.2 74.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 168.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.34 -50.97 63.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 169.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -51.66 -45.83 63.55 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.26 -36.36 79.31 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -72.65 -19.07 61.5 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.27 2.1 t -52.35 -51.33 73.41 Favored Pre-proline 0 CA--C 1.578 2.044 0 CA-C-O 115.125 -2.369 . . . . 0.0 116.627 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.08 -41.84 68.95 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 125.216 2.898 . . . . 0.0 118.066 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -89.81 16.24 8.4 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.9 mtm -81.47 102.45 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 121.023 1.738 . . . . 0.0 110.314 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.96 152.8 35.12 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.044 0.926 . . . . 0.0 111.814 167.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -67.04 111.36 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.5 12.68 55.62 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 116.69 17.03 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.709 2.755 . . . . 0.0 112.519 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.0 m -100.23 102.78 14.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 125.19 22.88 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 -166.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.6 tpp -68.14 102.6 1.37 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.773 0.829 . . . . 0.0 111.698 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.72 96.16 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.5 t -114.65 116.08 28.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.538 0.735 . . . . 0.0 109.045 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.33 155.35 21.29 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.509 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -58.19 152.8 16.29 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.235 150.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 78.6 p -70.04 77.23 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.326 1.06 . . . . 0.0 112.493 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -52.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.638 -165.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.27 -51.38 8.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.063 1.345 . . . . 0.0 111.328 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -64.01 -62.9 1.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -133.31 -58.32 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.52 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.66 179.05 47.89 Favored Glycine 0 CA--C 1.558 2.721 0 CA-C-N 119.319 0.963 . . . . 0.0 114.955 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.45 100.97 0.82 Allowed 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 123.138 2.559 . . . . 0.0 112.57 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -158.08 -71.26 0.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.621 -165.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.94 83.74 1.08 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 118.601 0.637 . . . . 0.0 112.13 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -89.95 152.48 21.2 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-O 121.919 0.866 . . . . 0.0 111.696 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -75.36 140.67 72.73 Favored Pre-proline 0 CA--C 1.571 1.761 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.892 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.54 -58.68 0.07 OUTLIER 'Cis proline' 0 CA--C 1.563 1.935 0 CA-C-N 122.85 2.053 . . . . 0.0 116.156 10.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -137.44 67.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mt -103.49 114.08 65.14 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.21 137.93 24.37 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.403 2.068 . . . . 0.0 114.694 -166.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.58 -45.88 8.14 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 123.207 2.605 . . . . 0.0 116.343 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -128.22 85.78 2.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.697 0.799 . . . . 0.0 109.85 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.77 125.19 3.15 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.66 101.66 5.84 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.067 0.547 . . . . 0.0 111.392 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -103.3 143.92 32.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.2 m -92.89 136.21 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.637 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.83 106.92 3.58 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.067 0.547 . . . . 0.0 110.478 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -87.31 117.63 26.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.486 1.136 . . . . 0.0 113.806 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.78 114.99 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -169.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -96.26 121.9 38.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.26 104.8 11.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -81.4 -63.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 -171.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 58.5 p -144.25 132.24 21.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.21 103.63 15.59 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 168.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.53 123.24 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -171.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.75 124.4 28.16 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 112.464 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.96 164.5 35.28 Favored Glycine 0 CA--C 1.559 2.796 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.173 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.54 115.98 4.53 Favored 'Trans proline' 0 CA--C 1.559 1.733 0 C-N-CA 123.071 2.514 . . . . 0.0 113.173 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.64 119.4 24.71 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.455 0.702 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.0 tp -137.8 -77.42 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.184 0.594 . . . . 0.0 109.693 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.95 0.881 . . . . 0.0 109.569 -174.794 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -113.2 107.97 16.64 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 168.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.64 167.38 13.21 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -55.08 121.26 8.36 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -167.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 tp -175.01 154.43 1.82 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.037 -159.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.6 t0 68.78 119.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 149.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 mm -118.02 -54.66 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.072 0.949 . . . . 0.0 109.23 167.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.14 -63.77 1.11 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.48 -61.7 0.01 OUTLIER Glycine 0 N--CA 1.483 1.809 0 CA-C-N 119.448 1.022 . . . . 0.0 115.259 -171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -90.23 -78.58 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 117.734 0.767 . . . . 0.0 110.777 -172.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 177.0 72.24 0.06 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 mt -122.11 -66.32 1.04 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -163.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -80.06 98.54 7.29 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.19 96.46 7.49 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.946 0.498 . . . . 0.0 110.017 -164.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -105.47 132.93 51.02 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -113.36 145.61 40.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.806 -0.559 . . . . 0.0 110.249 152.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.9 m -88.74 108.45 19.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.29 -67.96 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.586 0.755 . . . . 0.0 111.45 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.05 122.29 62.14 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 167.83 19.41 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 114.586 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.66 123.42 6.68 Favored Glycine 0 CA--C 1.556 2.643 0 CA-C-O 117.049 -1.973 . . . . 0.0 113.351 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.45 167.92 22.64 Favored 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 122.53 3.165 . . . . 0.0 115.607 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.05 112.96 3.1 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.105 2.537 . . . . 0.0 111.869 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 76.81 1.34 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.473 -160.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 t -159.4 108.45 1.85 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 m -128.71 118.29 22.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.41 1.1 . . . . 0.0 110.368 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -64.13 132.94 95.45 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.86 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 164.09 35.25 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.91 2.407 . . . . 0.0 116.31 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.9 t -82.24 150.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.947 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -59.09 104.12 0.22 Allowed 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.971 1.308 . . . . 0.0 113.31 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.29 62.54 0.34 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.032 -165.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -155.44 138.66 15.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.48 106.89 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.329 -0.857 . . . . 0.0 109.671 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.16 118.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 124.128 0.971 . . . . 0.0 108.765 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.5 m -100.31 124.2 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.57 137.29 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.208 0.528 . . . . 0.0 110.459 -173.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -88.71 106.98 18.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 165.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.6 pt? -103.52 121.67 43.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.161 0.585 . . . . 0.0 110.094 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -103.44 99.17 8.99 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -93.64 99.44 11.87 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.037 0.535 . . . . 0.0 110.7 -165.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -104.57 -169.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.3 0.64 . . . . 0.0 111.359 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 tp -114.88 147.82 39.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.705 1.202 . . . . 0.0 109.513 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.322 4.2 pt-20 -60.44 -29.99 69.37 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 117.527 2.418 . . . . 0.0 117.527 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -64.64 -68.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.896 161.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.08 0.05 OUTLIER Glycine 0 N--CA 1.482 1.756 0 CA-C-N 119.53 1.059 . . . . 0.0 113.107 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.3 m -153.33 122.58 6.6 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -76.52 97.15 4.26 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.041 0.924 . . . . 0.0 111.301 171.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -84.99 -47.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.138 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -125.04 156.78 37.64 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.842 1.306 . . . . 0.0 110.503 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.86 93.0 2.87 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 161.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -85.24 116.7 66.61 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.622 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.86 -49.46 0.15 Allowed 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.938 2.426 . . . . 0.0 116.56 -168.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -137.84 93.66 2.8 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.134 0.879 . . . . 0.0 109.423 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 tp -85.4 104.42 15.19 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.74 96.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -125.42 147.57 49.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.598 0.759 . . . . 0.0 109.32 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.0 m -100.38 66.51 1.28 Allowed 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 123.012 0.525 . . . . 0.0 110.019 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . 0.401 7.6 mp 61.17 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.25 -94.4 0.18 Allowed Glycine 0 N--CA 1.483 1.816 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.448 165.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 68.1 150.11 0.07 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.2 t -82.26 72.73 9.32 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.58 1.181 . . . . 0.0 113.445 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.74 -61.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.251 1.42 . . . . 0.0 108.982 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.6 152.98 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.829 1.3 . . . . 0.0 113.147 -151.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.1 pt -68.94 165.7 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.876 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -57.97 -34.65 70.17 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 171.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.21 86.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.15 -45.77 62.84 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -66.79 -32.36 73.6 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.11 -15.09 57.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.3 p -71.05 -36.39 72.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.233 1.833 . . . . 0.0 115.37 164.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.0 -53.33 39.21 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 115.897 -2.001 . . . . 0.0 115.027 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.44 -15.0 42.54 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 123.644 2.896 . . . . 0.0 119.104 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.33 48.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 120.341 1.428 . . . . 0.0 112.869 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.8 mtp -143.12 100.15 3.58 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.38 176.05 8.09 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.244 1.021 . . . . 0.0 110.829 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.84 105.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.798 -1.189 . . . . 0.0 109.874 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.14 61.16 0.86 Allowed Glycine 0 CA--C 1.546 1.978 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.737 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -140.49 122.19 15.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.656 0.782 . . . . 0.0 110.08 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.1 m -94.6 136.24 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 160.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.08 113.73 9.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 53.3 ttm -84.84 115.01 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.88 128.14 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.0 p -94.64 87.53 5.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.09 19.16 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.222 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.85 144.74 8.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.6 p -54.87 -19.28 6.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -59.24 -51.3 70.55 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 161.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -77.89 -48.84 15.45 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.83 1.252 . . . . 0.0 113.511 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.46 174.56 7.48 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.092 1.357 . . . . 0.0 112.94 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -73.69 100.89 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.593 0.757 . . . . 0.0 110.711 166.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.93 -87.78 1.96 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 116.147 -2.474 . . . . 0.0 108.317 163.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.54 52.61 4.15 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 122.675 3.237 . . . . 0.0 114.722 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -132.41 -77.81 0.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.55 112.1 2.02 Favored Glycine 0 N--CA 1.48 1.617 0 CA-C-N 119.685 1.13 . . . . 0.0 113.507 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -104.08 127.49 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 157.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 145.64 89.84 Favored Pre-proline 0 CA--C 1.571 1.767 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -91.23 -64.99 0.03 OUTLIER 'Cis proline' 0 CA--C 1.565 2.047 0 CA-C-N 122.689 1.996 . . . . 0.0 116.701 8.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -115.48 43.95 1.95 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -165.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.2 mt -80.31 118.21 71.35 Favored Pre-proline 0 CA--C 1.58 2.121 0 O-C-N 120.643 -1.286 . . . . 0.0 108.113 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.28 160.65 26.11 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 122.933 2.422 . . . . 0.0 116.242 -166.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.1 136.23 24.29 Favored 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 123.292 2.662 . . . . 0.0 114.251 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.285 97.1 m-70 73.65 162.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.688 1.195 . . . . 0.0 113.828 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 77.24 148.07 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.075 1.35 . . . . 0.0 113.436 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.53 148.02 47.14 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.4 mt -100.65 123.38 44.78 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.017 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.5 84.48 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.335 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.65 120.86 43.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.389 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.69 147.81 50.08 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.343 160.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 t -134.21 100.12 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -95.69 123.3 39.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.31 104.62 13.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -88.61 -56.81 3.15 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.781 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.1 p -140.15 134.69 31.58 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.381 0.673 . . . . 0.0 109.558 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.82 105.3 12.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.5 m -136.5 131.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.422 0.689 . . . . 0.0 109.249 -166.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.88 118.6 30.88 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.046 0.538 . . . . 0.0 110.297 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.38 82.49 0.08 OUTLIER Glycine 0 CA--C 1.547 2.087 0 CA-C-O 117.091 -1.95 . . . . 0.0 111.88 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.22 103.02 0.79 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 CA-C-N 121.796 2.798 . . . . 0.0 112.336 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -81.52 124.39 29.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.576 . . . . 0.0 111.414 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.378 6.0 mp 79.37 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.844 1.258 . . . . 0.0 110.297 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.922 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -128.61 -74.51 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.282 0.633 . . . . 0.0 109.92 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.26 7.5 tp10 55.9 84.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 m95 73.36 99.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.901 1.281 . . . . 0.0 110.111 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -83.86 114.07 21.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.76 101.33 6.64 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.866 0.841 . . . . 0.0 111.066 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.46 -51.89 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 123.982 0.913 . . . . 0.0 111.407 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -66.11 -63.96 0.97 Allowed 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.24 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.479 1.561 0 CA-C-N 118.96 0.8 . . . . 0.0 112.102 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.37 -66.22 0.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.178 0.591 . . . . 0.0 112.539 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.7 70.15 0.04 OUTLIER Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.401 0.546 . . . . 0.0 112.601 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -124.71 -70.32 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -81.91 120.18 24.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 118.822 0.737 . . . . 0.0 109.762 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.17 152.37 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.322 1.049 . . . . 0.0 111.443 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.37 117.74 14.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 0.0 112.504 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.83 121.14 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.993 . . . . 0.0 108.776 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -86.85 115.79 24.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.77 -65.56 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.777 0.831 . . . . 0.0 110.638 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -116.37 140.44 26.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 119.12 0.873 . . . . 0.0 109.27 165.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.98 171.73 16.73 Favored 'Trans proline' 0 CA--C 1.563 1.958 0 C-N-CA 123.072 2.515 . . . . 0.0 114.443 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.3 103.41 3.04 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-O 116.787 -2.118 . . . . 0.0 109.835 164.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 163.48 35.42 Favored 'Trans proline' 0 CA--C 1.571 2.355 0 CA-C-N 122.734 3.267 . . . . 0.0 116.252 -164.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.41 127.27 15.42 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.273 2.649 . . . . 0.0 113.156 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 -71.36 0.39 Allowed Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -159.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.1 p -75.24 102.46 5.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.402 0.681 . . . . 0.0 111.183 168.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -113.09 147.46 37.25 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.969 0.89 . . . . 0.0 111.287 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -60.34 128.6 88.06 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.56 160.14 47.29 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.041 2.494 . . . . 0.0 115.022 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.4 m -85.23 166.43 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.451 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -53.2 131.13 36.54 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.66 46.76 2.06 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 114.123 -1.398 . . . . 0.0 114.716 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.58 136.23 32.6 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.82 100.74 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 m -92.47 110.02 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -92.47 112.55 24.54 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.36 142.08 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.69 0.757 . . . . 0.0 110.44 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.05 107.26 11.68 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 162.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.45 107.19 17.95 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -103.61 111.89 24.57 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.98 117.44 28.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 t -133.98 152.66 51.94 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.064 0.935 . . . . 0.0 110.048 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.62 139.79 49.47 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.563 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.83 -37.95 77.58 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.99 -53.05 56.12 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 167.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.743 1.156 . . . . 0.0 114.881 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -63.87 137.75 58.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -160.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -61.56 117.01 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.28 35.6 m -81.59 -47.71 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.672 176.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -145.23 119.79 9.74 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 165.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -106.96 83.6 1.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.542 0.686 . . . . 0.0 110.105 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.57 101.84 51.92 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.651 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.64 50.27 3.5 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.644 2.23 . . . . 0.0 115.905 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -161.51 117.05 2.08 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.809 0.844 . . . . 0.0 109.281 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.49 103.91 3.17 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.54 114.26 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.6 142.11 32.08 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -78.46 121.26 24.32 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.29 133.59 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.32 0.509 . . . . 0.0 112.31 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.37 -70.34 0.74 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.925 -167.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -90.71 77.95 6.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.77 0.795 . . . . 0.0 110.215 172.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.36 126.64 53.02 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.628 -163.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -97.72 70.29 2.19 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.477 1.132 . . . . 0.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.03 177.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.411 1.1 . . . . 0.0 110.331 -163.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.59 150.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.833 0.853 . . . . 0.0 112.441 170.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.35 -29.76 71.01 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.09 81.87 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.93 -54.62 35.78 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.436 -1.269 . . . . 0.0 113.96 167.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -53.31 -49.0 67.93 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.6 p -79.3 -8.85 59.37 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 117.684 2.476 . . . . 0.0 117.684 168.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.263 12.8 t -52.44 -48.79 88.67 Favored Pre-proline 0 N--CA 1.501 2.094 0 CA-C-O 115.264 -2.303 . . . . 0.0 114.449 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.74 0.59 1.44 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 CA-C-N 125.114 2.862 . . . . 0.0 119.314 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.253 2.0 pt? -149.21 65.81 1.02 Allowed 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.079 1.309 . . . . 0.0 111.581 167.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.2 mmt -138.35 99.96 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.39 164.04 12.81 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.146 0.974 . . . . 0.0 113.101 -168.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.27 114.73 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.63 -6.78 45.23 Favored Glycine 0 CA--C 1.552 2.381 0 N-CA-C 117.905 1.922 . . . . 0.0 117.905 -167.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.41 126.27 33.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 121.132 2.466 . . . . 0.0 113.396 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.9 m -100.45 127.98 46.64 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 158.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.94 124.08 6.3 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.577 0.351 . . . . 0.0 110.165 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.9 ptm -77.8 131.94 37.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.124 0.57 . . . . 0.0 110.791 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.8 t -113.23 96.2 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.3 p -85.65 102.21 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.2 138.7 54.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.106 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.61 153.24 0.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.9 p -70.67 76.51 0.6 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.921 1.344 . . . . 0.0 112.153 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -179.03 -61.54 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.867 -152.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.17 -50.71 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.443 1.097 . . . . 0.0 112.674 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.24 -68.33 0.4 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -138.82 -66.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.798 0.726 . . . . 0.0 109.31 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.4 -147.93 19.78 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.391 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -72.72 112.71 3.55 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.253 51.3 mt-30 69.37 92.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.891 1.276 . . . . 0.0 110.271 -164.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.81 54.8 Favored Glycine 0 CA--C 1.547 2.049 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -101.39 60.09 0.9 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -163.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 40.7 m 66.95 141.78 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 167.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.45 -45.85 0.4 Allowed 'Cis proline' 0 CA--C 1.564 1.992 0 CA-C-N 122.627 1.974 . . . . 0.0 115.705 -3.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -134.42 63.26 1.63 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.703 0.801 . . . . 0.0 110.489 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.1 mt -91.32 121.35 67.72 Favored Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.47 162.4 35.98 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.918 2.412 . . . . 0.0 116.303 -170.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.85 -46.3 6.78 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 123.215 2.61 . . . . 0.0 116.598 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -97.39 -166.73 1.43 Allowed 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 124.498 1.119 . . . . 0.0 111.689 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.28 128.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.248 1.419 . . . . 0.0 113.106 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.25 101.91 12.91 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.137 0.575 . . . . 0.0 110.921 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.87 143.11 44.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -164.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.7 m -84.7 115.5 22.71 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.002 0.921 . . . . 0.0 110.706 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.19 98.86 6.37 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -82.94 107.36 15.49 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.238 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.7 93.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.4 m -99.99 112.42 24.71 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.53 102.91 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -73.86 -65.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.155 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.0 p -144.72 130.61 19.25 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.37 103.35 15.28 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.11 153.27 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.543 0.737 . . . . 0.0 110.13 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.39 145.73 55.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.72 90.0 0.43 Allowed Glycine 0 CA--C 1.548 2.097 0 CA-C-O 117.178 -1.901 . . . . 0.0 111.981 -174.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.31 160.25 17.49 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 121.657 2.729 . . . . 0.0 114.389 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.04 125.06 25.67 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.589 0.756 . . . . 0.0 112.712 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -90.69 101.84 14.58 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.384 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 N--CA 1.495 1.803 0 C-N-CA 124.622 1.169 . . . . 0.0 113.873 176.53 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.1 ttm . . . . . 0 CA--C 1.556 1.177 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -99.56 104.11 15.89 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.801 0.728 . . . . 0.0 110.532 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.89 148.93 45.62 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -76.76 128.42 34.61 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.515 0.726 . . . . 0.0 109.809 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.89 114.2 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.332 0.653 . . . . 0.0 110.692 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.69 127.13 44.52 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.084 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.37 74.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.281 0.632 . . . . 0.0 109.679 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -157.58 -72.75 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.66 0.784 . . . . 0.0 109.018 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.77 -83.34 0.11 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -164.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.55 -70.26 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.239 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.52 85.02 0.05 OUTLIER Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.966 0.803 . . . . 0.0 112.971 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.55 -59.34 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -74.17 114.26 12.3 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.15 0.886 . . . . 0.0 110.489 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -143.46 105.54 4.38 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.716 0.807 . . . . 0.0 109.782 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -101.93 101.42 11.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 112.316 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.26 120.0 23.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.852 -1.155 . . . . 0.0 109.515 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.4 m -78.9 115.66 18.73 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.358 0.599 . . . . 0.0 110.141 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.03 -69.0 0.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.733 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.48 106.82 52.03 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.45 175.14 11.67 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 122.651 2.234 . . . . 0.0 114.655 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.94 123.46 24.14 Favored Glycine 0 CA--C 1.558 2.74 0 CA-C-O 117.133 -1.926 . . . . 0.0 112.466 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.4 161.19 44.33 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 CA-C-N 122.321 3.06 . . . . 0.0 115.29 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 106.74 1.22 Allowed 'Trans proline' 0 CA--C 1.558 1.722 0 C-N-CA 123.181 2.588 . . . . 0.0 112.171 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.72 76.29 1.32 Allowed Glycine 0 CA--C 1.545 1.95 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.591 -159.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -147.96 117.24 6.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -79.71 142.37 35.53 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.056 0.542 . . . . 0.0 112.261 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -91.4 116.3 66.16 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.186 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.93 144.86 31.0 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.703 2.269 . . . . 0.0 114.665 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.18 169.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.196 0.999 . . . . 0.0 112.645 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -64.54 120.32 12.12 Favored 'General case' 0 CA--C 1.568 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 112.084 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.0 40.67 3.72 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -138.26 115.55 11.09 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -72.26 109.46 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 123.285 0.634 . . . . 0.0 110.099 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.5 123.98 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.616 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.7 m -102.61 121.32 42.16 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.94 142.46 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.389 0.675 . . . . 0.0 110.783 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -82.72 104.59 13.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 161.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.35 125.43 47.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -133.3 122.15 23.45 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.489 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.8 p -93.0 131.37 38.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.08 0.952 . . . . 0.0 111.558 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.9 m -155.57 131.5 9.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.579 0.751 . . . . 0.0 109.708 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.03 157.28 19.15 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -52.7 -40.56 63.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -73.36 -64.73 0.92 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.537 0.735 . . . . 0.0 111.142 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.35 0.05 OUTLIER Glycine 0 N--CA 1.478 1.466 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.2 m -146.15 120.82 9.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -80.14 119.4 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.864 0.866 . . . . 0.0 111.974 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.0 t -97.41 -69.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.585 -166.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -143.83 122.11 12.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -167.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -85.52 94.68 9.08 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.456 0.702 . . . . 0.0 110.591 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.12 68.32 46.58 Favored Pre-proline 0 CA--C 1.579 2.068 0 O-C-N 121.384 -0.823 . . . . 0.0 113.163 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 -39.65 3.05 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.355 2.703 . . . . 0.0 117.58 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 76.73 1.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.575 1.079 . . . . 0.0 110.391 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.18 95.96 7.44 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.5 t -101.89 114.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.27 152.51 40.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 111.323 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -75.29 128.32 35.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.94 124.89 21.6 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.032 0.933 . . . . 0.0 111.979 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.64 -41.24 3.06 Favored Glycine 0 CA--C 1.547 2.079 0 N-CA-C 117.505 1.762 . . . . 0.0 117.505 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.91 107.77 18.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.012 1.406 . . . . 0.0 109.562 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -85.98 81.42 8.51 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -150.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.98 -47.37 52.58 Favored 'General case' 0 CA--C 1.574 1.899 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.105 156.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.08 179.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.602 1.161 . . . . 0.0 114.108 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.01 152.09 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.648 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -64.19 -33.46 75.84 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.31 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 167.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -53.09 38.64 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.23 -42.63 86.71 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.86 -34.31 77.66 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -72.82 -22.99 60.72 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.2 t -57.38 -49.94 90.99 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 114.871 -2.49 . . . . 0.0 115.996 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -53.28 -34.58 70.71 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 126.12 3.221 . . . . 0.0 118.424 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.3 pt? -101.01 63.74 1.02 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.598 0.759 . . . . 0.0 111.579 168.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.28 113.32 6.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -97.02 168.12 10.65 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.878 0.847 . . . . 0.0 111.915 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.76 118.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.852 -1.155 . . . . 0.0 108.403 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.09 6.04 72.28 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.144 2.018 . . . . 0.0 118.144 -165.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.12 108.4 19.84 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 120.5 2.15 . . . . 0.0 109.625 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -109.19 119.71 40.34 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.06 136.93 34.14 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.776 0.798 . . . . 0.0 111.075 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.9 ttm -84.0 103.14 13.0 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.062 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.95 92.6 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.9 p -81.41 126.55 31.77 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.282 0.633 . . . . 0.0 109.769 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.1 136.88 17.08 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.316 -175.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -46.02 133.33 8.96 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 124.785 1.234 . . . . 0.0 113.983 168.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.4 m -74.55 84.83 2.05 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.279 1.038 . . . . 0.0 110.983 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -179.55 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -142.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -68.62 -36.52 78.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 162.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.1 m -72.22 -75.12 0.14 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.17 0.895 . . . . 0.0 111.179 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.92 -67.71 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.263 0.938 . . . . 0.0 110.774 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.7 170.72 27.94 Favored Glycine 0 CA--C 1.553 2.45 0 CA-C-N 119.036 0.834 . . . . 0.0 115.088 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.22 10.03 0.35 Allowed 'Trans proline' 0 CA--C 1.571 2.348 0 N-CA-C 119.375 2.798 . . . . 0.0 119.375 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -131.53 -76.65 0.52 Allowed 'General case' 0 CA--C 1.561 1.376 0 CA-C-N 119.527 1.058 . . . . 0.0 108.258 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.56 124.08 1.11 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 119.69 1.132 . . . . 0.0 112.545 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -93.05 39.09 1.04 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.6 m 66.72 139.25 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.79 -50.46 0.17 OUTLIER 'Cis proline' 0 CA--C 1.563 1.964 0 CA-C-N 123.097 2.142 . . . . 0.0 115.896 4.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -132.4 71.76 1.48 Allowed 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.891 0.877 . . . . 0.0 108.855 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.6 mm -99.72 134.55 20.98 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.927 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.32 162.31 33.88 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.203 2.602 . . . . 0.0 116.215 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.77 -94.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 123.358 2.706 . . . . 0.0 113.094 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -136.51 80.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.109 1.322 . . . . 0.0 109.542 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.75 38.55 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 60.14 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tt -96.58 130.04 43.85 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.8 t -100.37 113.36 26.03 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.872 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.15 108.69 20.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.32 97.38 9.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.003 -0.436 . . . . 0.0 110.189 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.79 111.43 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -168.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.1 m -113.79 113.28 24.72 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.04 103.51 9.97 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 120.942 0.401 . . . . 0.0 110.052 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -80.88 -64.46 1.18 Allowed 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -141.78 137.33 31.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.725 0.81 . . . . 0.0 109.008 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.56 107.95 18.65 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.11 125.43 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -81.39 91.04 6.21 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.203 1.001 . . . . 0.0 112.957 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.32 86.32 0.82 Allowed Glycine 0 CA--C 1.552 2.344 0 CA-C-O 116.876 -2.069 . . . . 0.0 113.851 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 130.86 8.29 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 122.224 3.012 . . . . 0.0 112.556 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.76 -77.33 0.12 Allowed 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -99.18 104.1 16.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.72 0.772 . . . . 0.0 109.333 178.876 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -81.73 -3.68 54.35 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -171.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 64.07 86.0 0.13 Allowed 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.607 2.003 . . . . 0.0 113.279 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -141.4 117.43 10.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -100.03 107.82 19.85 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.57 123.94 30.27 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.448 0.642 . . . . 0.0 111.676 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.44 -58.84 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.664 0.786 . . . . 0.0 110.735 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.258 3.7 pp -66.48 -17.63 64.91 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.45 55.86 4.49 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 119.948 1.249 . . . . 0.0 116.034 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -156.13 -81.18 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.33 59.62 0.03 OUTLIER Glycine 0 CA--C 1.541 1.689 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.172 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.76 -70.98 0.45 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.0 tp -88.29 102.81 15.2 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.495 1.043 . . . . 0.0 108.84 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.0 117.58 31.01 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.363 0.665 . . . . 0.0 110.004 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -122.36 103.62 8.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 0.0 110.266 -168.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -81.02 141.22 34.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.461 -0.775 . . . . 0.0 109.729 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -81.65 96.48 7.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 159.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 112' ' ' ALA . 32.1 tp -64.39 -63.08 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.824 1.25 . . . . 0.0 113.218 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.97 123.89 23.75 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 162.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.61 165.42 24.96 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 C-N-CA 123.117 2.545 . . . . 0.0 114.844 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.3 171.3 55.17 Favored Glycine 0 CA--C 1.562 2.98 0 N-CA-C 115.35 0.9 . . . . 0.0 115.35 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.41 162.72 39.42 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 123.257 2.638 . . . . 0.0 115.827 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.78 -42.2 48.08 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 123.423 2.749 . . . . 0.0 116.743 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.97 -176.21 50.58 Favored Glycine 0 CA--C 1.552 2.365 0 CA-C-N 119.04 0.836 . . . . 0.0 113.711 161.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m 62.36 86.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.376 1.071 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.0 p -98.71 153.67 18.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -165.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -45.13 128.39 5.65 Favored Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.38 165.88 28.48 Favored 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 122.948 2.432 . . . . 0.0 115.843 -173.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -102.63 159.06 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.444 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -63.77 132.79 52.03 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 113.588 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.34 14.28 9.92 Favored Glycine 0 CA--C 1.557 2.717 0 CA-C-N 113.82 -1.536 . . . . 0.0 115.564 -153.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -138.65 114.87 10.29 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.88 109.55 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.75 134.88 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.594 0.758 . . . . 0.0 110.737 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -92.71 127.98 38.41 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.2 126.15 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -71.55 107.0 4.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.879 0.872 . . . . 0.0 110.38 171.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.35 131.72 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.055 0.931 . . . . 0.0 108.975 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -137.66 91.8 2.63 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -87.2 123.76 32.57 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -132.63 179.24 6.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.144 0.978 . . . . 0.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.0 tp -94.37 149.27 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.099 -1.001 . . . . 0.0 110.074 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.48 -20.87 61.48 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.04 -71.79 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.223 0.92 . . . . 0.0 110.494 161.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.28 81.75 0.04 OUTLIER Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.494 1.043 . . . . 0.0 112.917 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.3 m -152.9 114.32 4.24 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.298 19.8 ptp180 -78.08 105.54 9.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -81.14 -48.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -137.79 89.88 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.14 96.93 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.817 0.818 . . . . 0.0 110.192 168.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.14 89.72 17.94 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.88 2.59 6.4 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 N-CA-C 120.139 3.092 . . . . 0.0 120.139 -159.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.301 9.2 pt-20 -151.84 148.75 28.2 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.824 2.102 . . . . 0.0 113.214 154.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.7 tp -142.1 106.44 4.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -165.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.3 t -98.56 106.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -137.55 155.77 48.85 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.4 m -80.75 130.29 35.0 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.366 0.667 . . . . 0.0 109.659 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.61 119.23 10.1 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 62.25 3.49 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -152.52 144.46 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.148 0.979 . . . . 0.0 110.261 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.15 74.8 2.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -126.61 -59.44 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.093 1.357 . . . . 0.0 109.858 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.16 178.14 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.593 1.157 . . . . 0.0 113.074 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.54 137.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.757 0.823 . . . . 0.0 112.011 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -62.07 -29.23 70.16 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.11 84.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 165.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -53.48 57.33 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -66.31 -33.92 76.83 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.37 -34.92 79.04 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 165.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 p -79.82 2.01 24.72 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 167.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.262 2.5 t -53.08 -48.83 90.54 Favored Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 115.262 -2.304 . . . . 0.0 114.787 170.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.04 -18.33 22.48 Favored 'Trans proline' 0 CA--C 1.566 2.121 0 CA-C-N 125.38 2.957 . . . . 0.0 119.012 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.84 70.78 0.74 Allowed 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.295 0.952 . . . . 0.0 108.741 166.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.1 mmt -149.44 90.35 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.36 161.07 18.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.294 1.045 . . . . 0.0 111.994 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.83 104.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.706 . . . . 0.0 109.098 -165.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.75 29.78 Favored Glycine 0 CA--C 1.556 2.63 0 CA-C-O 117.002 -1.999 . . . . 0.0 117.952 -164.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.64 113.72 14.59 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 121.39 2.595 . . . . 0.0 112.761 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -88.73 117.81 27.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' HA ' ' H ' ' A' ' 50' ' ' LEU . . . -140.28 132.88 28.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.416 0.286 . . . . 0.0 111.465 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.3 tpp -82.19 106.83 14.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.53 87.55 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -106.06 108.8 20.5 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.2 176.74 4.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.36 1.076 . . . . 0.0 112.167 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.13 157.94 29.9 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.9 t -75.36 78.5 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.631 1.205 . . . . 0.0 110.991 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 179.95 -67.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.555 -1.657 . . . . 0.0 106.964 -152.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.65 -41.89 36.71 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.249 1.02 . . . . 0.0 113.082 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 66.7 m -58.55 -63.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.596 1.089 . . . . 0.0 113.011 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.71 -76.05 0.32 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.413 1.006 . . . . 0.0 108.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.47 162.96 21.61 Favored Glycine 0 CA--C 1.557 2.714 0 CA-C-O 118.918 -0.935 . . . . 0.0 113.148 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.26 60.83 5.58 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 CA-C-N 121.151 2.475 . . . . 0.0 114.964 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -158.46 -77.14 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.0 95.76 0.27 Allowed Glycine 0 CA--C 1.536 1.396 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.64 48.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m 65.68 135.24 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.22 -51.05 0.16 OUTLIER 'Cis proline' 0 CA--C 1.562 1.92 0 CA-C-N 123.001 2.107 . . . . 0.0 116.271 3.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -141.66 77.87 1.61 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.335 1.064 . . . . 0.0 108.481 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mt -99.57 120.69 56.98 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 144.09 34.09 Favored 'Trans proline' 0 CA--C 1.571 2.357 0 C-N-CA 122.729 2.286 . . . . 0.0 114.349 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 122.31 8.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.078 2.519 . . . . 0.0 113.026 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.36 32.1 p80 51.86 67.84 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.08 108.27 3.59 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.66 126.75 28.4 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -167.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 tp -111.45 127.27 55.63 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.3 -155.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.1 m -74.75 152.2 39.08 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.12 113.55 3.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.08 0.552 . . . . 0.0 109.866 167.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.53 112.13 20.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.153 0.977 . . . . 0.0 111.374 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.62 107.7 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.3 m -106.53 117.65 34.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.31 109.87 6.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.176 0.591 . . . . 0.0 110.291 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -78.52 -68.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.457 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.1 p -141.8 131.69 24.41 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.044 0.838 . . . . 0.0 109.752 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.94 109.48 21.84 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.58 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.537 0.684 . . . . 0.0 110.507 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.0 145.52 52.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.68 115.95 6.19 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.01 -1.994 . . . . 0.0 114.587 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.53 127.39 4.38 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 CA-C-N 122.294 3.047 . . . . 0.0 113.82 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -82.03 107.54 14.82 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.36 0.6 . . . . 0.0 110.465 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.255 6.4 mp 71.82 95.85 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.914 1.286 . . . . 0.0 109.988 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.495 1.81 0 C-N-CA 124.535 1.134 . . . . 0.0 112.55 179.75 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 CA--C 1.556 1.175 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -117.91 -99.29 0.44 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.016 -0.992 . . . . 0.0 108.966 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.329 27.8 tt0 62.27 -96.87 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 168.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -123.02 106.96 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.47 108.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.69 122.01 23.36 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.554 1.169 . . . . 0.0 114.028 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.43 74.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.078 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.44 -64.73 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.87 0.868 . . . . 0.0 109.514 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.85 -81.52 0.19 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -160.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -76.22 -76.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.036 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.02 79.94 0.03 OUTLIER Glycine 0 N--CA 1.478 1.44 0 CA-C-N 118.874 0.761 . . . . 0.0 112.087 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.65 -58.91 1.03 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.435 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.1 tp -81.17 123.15 28.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.087 1.312 . . . . 0.0 108.606 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -142.71 131.97 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 123.387 0.675 . . . . 0.0 111.864 -167.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -122.4 132.19 54.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 0.0 113.392 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HZ3' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -110.61 125.34 53.3 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.593 -0.692 . . . . 0.0 109.642 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -81.04 124.41 29.16 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.311 0.505 . . . . 0.0 111.078 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 48' ' ' LYS . 13.8 tp -87.32 -71.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.509 0.724 . . . . 0.0 110.058 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.89 100.65 53.83 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.14 160.67 42.23 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.741 2.294 . . . . 0.0 113.842 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.22 151.26 52.09 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.987 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.56 165.07 28.58 Favored 'Trans proline' 0 CA--C 1.572 2.382 0 C-N-CA 123.132 2.555 . . . . 0.0 115.852 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 115.49 3.93 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 123.139 2.56 . . . . 0.0 112.68 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.11 -103.97 1.04 Allowed Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -167.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.4 m 59.34 100.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.4 m -80.66 128.63 33.84 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.151 0.501 . . . . 0.0 110.126 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -93.12 113.73 60.76 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.808 -1.092 . . . . 0.0 110.495 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.81 150.88 68.47 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.972 2.448 . . . . 0.0 115.274 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.8 166.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.857 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -73.09 99.75 2.86 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.762 0.825 . . . . 0.0 110.656 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.03 -52.36 0.56 Allowed Glycine 0 CA--C 1.549 2.176 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.333 -155.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -73.76 140.16 45.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.764 0.825 . . . . 0.0 112.201 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.7 t -90.17 112.62 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.63 142.88 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.52 1.152 . . . . 0.0 110.481 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -106.43 116.32 31.73 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.37 126.61 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 122.72 0.408 . . . . 0.0 110.21 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -73.62 103.77 4.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 161.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 tp -102.14 100.3 10.51 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -93.62 90.28 6.57 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -90.57 121.68 32.71 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -167.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -124.11 175.88 6.73 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.312 1.045 . . . . 0.0 110.843 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -80.31 -83.54 0.1 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.661 0.784 . . . . 0.0 109.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.05 -69.94 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.602 0.761 . . . . 0.0 109.366 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.16 66.63 1.82 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.399 0.619 . . . . 0.0 110.901 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.22 65.28 3.47 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -132.45 104.35 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.63 107.11 3.76 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.6 0.714 . . . . 0.0 112.514 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.25 18.9 m -87.11 -52.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.856 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.66 82.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.16 114.12 14.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.379 0.609 . . . . 0.0 112.452 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -125.63 97.22 36.72 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.765 -158.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.4 109.01 2.24 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 123.804 3.003 . . . . 0.0 111.037 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.574 1.2 pm0 67.51 81.03 0.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.59 103.32 6.51 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 156.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.1 t -96.87 121.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 148.67 28.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.719 -168.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.5 m -66.8 124.8 23.93 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.06 103.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.358 1.063 . . . . 0.0 112.952 -163.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.04 -42.89 2.91 Favored Glycine 0 CA--C 1.549 2.162 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -55.62 5.98 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.09 108.32 15.47 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.468 0.576 . . . . 0.0 111.675 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.294 2.7 t70 81.01 -51.6 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 170.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.78 158.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -150.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 168.9 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 113.528 -1.669 . . . . 0.0 113.977 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -61.03 -26.8 67.87 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.81 75.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 168.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.68 -49.74 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -56.98 -44.6 82.84 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.6 mt -71.4 -50.77 28.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.6 p -71.91 -45.08 62.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -175.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.46 -39.68 51.3 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 114.919 -2.467 . . . . 0.0 115.462 -169.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.05 -33.09 92.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 126.412 3.326 . . . . 0.0 116.573 168.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.64 -26.49 64.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 69.2 mmm -71.31 129.87 39.95 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 120.003 1.274 . . . . 0.0 111.393 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.44 158.57 33.62 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 122.752 1.263 . . . . 0.0 113.614 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.74 108.22 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.019 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.35 23.62 23.86 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 117.476 1.751 . . . . 0.0 117.476 -163.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -98.05 129.59 44.89 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.812 1.806 . . . . 0.0 111.184 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.6 m -107.33 123.03 47.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.49 131.53 9.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 0.0 110.736 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.91 104.68 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.415 0.686 . . . . 0.0 109.369 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.1 t -93.62 96.27 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 79.5 p -90.16 102.26 14.98 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 124.35 38.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.972 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -63.61 164.78 9.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.1 p -74.83 74.16 2.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.525 1.155 . . . . 0.0 113.004 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp 176.96 -65.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.508 1.523 . . . . 0.0 107.113 -158.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -75.18 -34.11 61.53 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.284 1.434 . . . . 0.0 114.031 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 137' ' ' LEU . 34.7 t -68.42 -76.94 0.08 Allowed 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.381 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -133.93 -80.74 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.25 -105.13 0.26 Allowed Glycine 0 CA--C 1.547 2.062 0 CA-C-O 116.881 -2.066 . . . . 0.0 111.427 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.0 -47.7 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 122.266 3.033 . . . . 0.0 116.399 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -148.33 117.26 6.74 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 133' ' ' PRO . . . -92.46 -120.07 2.7 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 123.205 0.431 . . . . 0.0 112.312 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -128.73 72.01 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.359 0.664 . . . . 0.0 110.103 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 t -73.85 135.35 77.58 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.783 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.06 -22.18 15.63 Favored 'Cis proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.294 2.767 . . . . 0.0 119.294 9.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -56.06 -41.66 75.41 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 104.39 50.67 Favored Pre-proline 0 CA--C 1.574 1.881 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.83 157.07 58.38 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 C-N-CA 123.038 2.492 . . . . 0.0 114.726 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 126' ' ' GLY . 47.7 Cg_endo -70.88 -68.93 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.613 2.209 . . . . 0.0 116.623 -157.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -121.77 76.66 1.29 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.28 154.07 48.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.345 1.058 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.3 8.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 121' ' ' CYS . 9.0 mp -69.05 134.79 49.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.726 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 77.5 m -104.25 99.67 9.39 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.16 106.85 10.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.557 0.743 . . . . 0.0 109.713 -167.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.15 117.52 24.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.803 0.811 . . . . 0.0 112.162 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.3 t -88.52 108.02 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.0 m -115.82 108.28 16.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.48 106.87 5.45 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.064 0.546 . . . . 0.0 110.4 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -87.53 -53.01 5.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.168 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.4 p -145.82 131.97 19.4 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.21 0.914 . . . . 0.0 108.936 173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.12 118.64 37.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.187 0.595 . . . . 0.0 109.453 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.26 165.46 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.225 1.012 . . . . 0.0 109.687 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.35 -179.11 4.32 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.36 99.79 1.72 Allowed Glycine 0 CA--C 1.55 2.219 0 CA-C-O 116.939 -2.034 . . . . 0.0 110.797 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.67 127.32 6.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 CA-C-N 122.503 3.151 . . . . 0.0 113.722 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.01 118.83 23.21 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.754 0.822 . . . . 0.0 108.86 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.257 7.6 mp 73.45 118.68 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.966 1.306 . . . . 0.0 111.346 -176.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 123.284 1.516 . . . . 0.0 111.42 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 CA--C 1.554 1.122 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -147.47 113.63 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.51 114.71 12.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.587 -0.695 . . . . 0.0 111.516 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.264 17.1 m0 84.46 120.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.287 1.435 . . . . 0.0 109.504 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.21 117.42 28.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.098 0.475 . . . . 0.0 110.779 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.25 150.75 25.98 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.47 -54.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.488 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.05 -63.2 1.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.82 0.78 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -127.63 -82.67 0.6 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.844 1.822 . . . . 0.0 106.195 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.08 76.78 0.05 OUTLIER Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.446 0.566 . . . . 0.0 111.869 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.88 -67.21 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 tp -85.83 112.31 21.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.739 0.815 . . . . 0.0 108.818 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -134.9 112.91 11.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.202 0.525 . . . . 0.0 111.386 -170.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -91.79 100.95 13.55 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 111.687 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -94.45 120.07 34.13 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.38 0.672 . . . . 0.0 109.791 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.4 m -80.14 114.96 19.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.298 0.57 . . . . 0.0 110.126 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.56 -71.87 0.5 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.124 0.97 . . . . 0.0 109.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.51 126.09 61.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.3 162.15 43.42 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.066 2.511 . . . . 0.0 114.817 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.85 122.83 7.2 Favored Glycine 0 CA--C 1.555 2.542 0 CA-C-O 116.964 -2.02 . . . . 0.0 112.941 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.57 165.89 21.51 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 CA-C-N 122.541 3.171 . . . . 0.0 115.51 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.31 120.95 8.42 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.179 2.586 . . . . 0.0 114.002 -170.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.91 -111.65 3.83 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m 58.99 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 m -117.72 125.76 51.25 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.379 1.085 . . . . 0.0 109.979 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -68.17 136.47 91.54 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 114.287 171.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.16 179.56 4.85 Favored 'Trans proline' 0 CA--C 1.568 2.187 0 C-N-CA 122.947 2.431 . . . . 0.0 115.449 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.0 m -93.65 175.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 124.19 0.996 . . . . 0.0 112.325 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -63.28 128.08 34.19 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.563 0.745 . . . . 0.0 112.856 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.96 4.5 Favored Glycine 0 CA--C 1.548 2.156 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.793 -167.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -148.22 138.81 22.9 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.51 118.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -172.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.04 134.09 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.812 0.845 . . . . 0.0 109.351 170.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -99.44 118.21 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.6 130.95 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -91.64 100.5 13.22 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.657 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -96.51 131.99 42.54 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.196 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -127.57 104.88 8.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -82.23 132.8 35.23 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.049 -169.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -131.03 116.13 17.38 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.21 94.51 9.68 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 12.1 pt-20 -70.39 -26.34 63.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.07 -41.43 96.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 160.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.33 -104.53 2.89 Favored Glycine 0 CA--C 1.544 1.852 0 CA-C-N 119.398 0.999 . . . . 0.0 112.159 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.3 m -131.31 146.4 52.28 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.019 0.928 . . . . 0.0 108.92 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -62.8 118.46 7.74 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.89 -45.67 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.272 13.8 mm100 75.3 92.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.879 1.671 . . . . 0.0 110.442 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.45 159.5 16.11 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-O 122.518 1.152 . . . . 0.0 112.703 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.2 139.69 95.17 Favored Pre-proline 0 CA--C 1.58 2.11 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -167.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.34 -13.04 16.98 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 119.862 2.985 . . . . 0.0 119.862 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.13 75.43 1.59 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.908 1.685 . . . . 0.0 110.682 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.34 106.31 18.33 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.05 135.56 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.192 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -159.76 157.85 30.12 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -91.3 131.48 36.78 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.112 0.965 . . . . 0.0 109.729 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.55 142.29 58.48 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.618 0.767 . . . . 0.0 113.061 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.66 -60.15 4.84 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 114.354 0.502 . . . . 0.0 114.354 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.79 115.46 7.36 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.748 1.219 . . . . 0.0 111.407 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.7 77.62 6.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.698 1.237 . . . . 0.0 113.492 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.72 -50.46 17.4 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.882 162.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.4 m -82.29 -178.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 C-N-CA 124.815 1.246 . . . . 0.0 113.254 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -60.87 161.04 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 124.713 1.205 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -61.0 -36.63 79.98 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -44.64 97.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 169.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.3 mt -65.3 -55.8 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 117.741 -1.124 . . . . 0.0 113.496 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -50.67 -48.81 58.29 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.28 -32.54 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.1 p -80.13 1.96 25.98 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 166.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.17 -52.49 74.23 Favored Pre-proline 0 N--CA 1.499 2.002 0 CA-C-O 115.044 -2.408 . . . . 0.0 112.683 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.37 39.35 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.517 0 CA-C-N 124.848 2.767 . . . . 0.0 116.827 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.2 mt -144.99 -46.04 0.23 Allowed 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 125.618 1.567 . . . . 0.0 110.631 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -76.41 113.44 14.0 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.804 1.184 . . . . 0.0 112.35 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.9 163.89 12.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.76 1.267 . . . . 0.0 111.882 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.49 115.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.294 -0.879 . . . . 0.0 112.155 -166.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.82 -40.19 2.4 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 117.091 1.596 . . . . 0.0 117.091 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.47 134.9 46.88 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.58 1.69 . . . . 0.0 115.459 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -90.98 125.29 35.74 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 154.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.61 121.89 13.06 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.4 ptp -75.8 125.88 29.92 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.404 1.097 . . . . 0.0 110.706 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.9 t -102.08 95.2 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.8 p -89.62 102.87 15.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.5 143.9 49.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.128 -161.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.82 162.37 4.12 Favored 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.1 p -54.02 -34.89 61.14 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 160.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.12 -43.91 82.76 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 161.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -86.56 63.91 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.899 0.772 . . . . 0.0 110.664 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.6 t -171.5 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -137.8 5.47 2.62 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.74 145.79 19.26 Favored Glycine 0 CA--C 1.56 2.885 0 CA-C-N 120.867 1.667 . . . . 0.0 111.892 -160.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.0 80.21 2.73 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 CA-C-N 122.558 3.179 . . . . 0.0 112.279 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -138.21 -74.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.16 0.584 . . . . 0.0 110.022 -164.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.42 96.48 0.12 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 140.75 49.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.287 0.635 . . . . 0.0 110.821 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.2 p -66.86 138.87 95.42 Favored Pre-proline 0 CA--C 1.573 1.831 0 CA-C-O 117.678 -1.153 . . . . 0.0 113.662 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.35 -44.82 0.45 Allowed 'Cis proline' 0 CA--C 1.563 1.934 0 N-CA-C 117.106 1.926 . . . . 0.0 117.106 8.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -155.18 88.73 1.17 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 83.4 mt -121.92 86.36 46.1 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.66 163.47 31.63 Favored 'Trans proline' 0 CA--C 1.572 2.421 0 C-N-CA 122.68 2.253 . . . . 0.0 115.424 -171.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.84 119.87 6.49 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.162 2.574 . . . . 0.0 113.232 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.258 96.1 m-70 66.8 76.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.796 1.239 . . . . 0.0 111.49 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.49 116.78 2.99 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.28 127.48 33.68 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.967 0.889 . . . . 0.0 112.844 -171.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.49 129.76 49.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.264 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.72 94.7 5.34 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.271 0.629 . . . . 0.0 109.372 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.37 121.64 45.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.445 0.698 . . . . 0.0 110.441 -170.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.9 100.41 6.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.011 0.524 . . . . 0.0 111.586 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.44 109.0 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.9 m -113.86 121.65 44.63 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.66 102.03 10.43 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -84.05 -59.55 2.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 60.1 p -122.46 149.5 43.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.658 0.783 . . . . 0.0 109.749 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.51 107.93 8.32 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.79 170.24 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.24 1.016 . . . . 0.0 110.096 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.56 -161.46 0.19 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.86 111.09 3.9 Favored Glycine 0 CA--C 1.555 2.538 0 CA-C-O 116.728 -2.151 . . . . 0.0 112.701 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.94 124.06 3.78 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 122.712 3.256 . . . . 0.0 113.301 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -92.56 119.3 31.89 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 123.105 0.562 . . . . 0.0 110.083 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.91 -64.13 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.326 0.651 . . . . 0.0 111.144 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 123.432 0.693 . . . . 0.0 109.885 -177.918 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -113.61 -48.55 2.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -77.38 123.98 27.26 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -160.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 91.6 m95 76.09 94.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.692 1.197 . . . . 0.0 111.564 168.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.87 113.2 26.55 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.93 110.45 5.04 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.016 0.912 . . . . 0.0 113.348 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.17 -42.11 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.806 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -73.95 -63.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.501 1.046 . . . . 0.0 111.274 165.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.5 -89.64 0.15 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -83.57 -40.53 18.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.04 82.12 1.49 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.093 0.861 . . . . 0.0 115.25 -163.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp 40.55 63.31 1.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 162.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 tp -162.29 92.74 0.83 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -117.16 117.78 30.54 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.509 0.724 . . . . 0.0 109.247 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.79 105.83 17.18 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.51 -0.744 . . . . 0.0 111.331 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 101.48 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 166.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.5 p -84.45 110.48 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.56 -59.51 2.72 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.601 0.76 . . . . 0.0 111.827 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.34 103.44 54.99 Favored Pre-proline 0 CA--C 1.57 1.729 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.65 87.07 1.55 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.989 2.459 . . . . 0.0 112.963 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.04 88.41 0.11 Allowed Glycine 0 CA--C 1.553 2.451 0 CA-C-O 116.339 -2.367 . . . . 0.0 113.286 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.82 167.84 16.63 Favored 'Trans proline' 0 CA--C 1.576 2.607 0 CA-C-N 123.154 3.477 . . . . 0.0 115.336 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.46 127.68 21.53 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 123.211 2.608 . . . . 0.0 114.86 -168.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.58 -123.12 6.63 Favored Glycine 0 CA--C 1.546 1.988 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -160.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m 59.43 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 164.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -123.4 127.28 48.22 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.705 1.241 . . . . 0.0 110.12 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -69.93 122.32 85.64 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 113.1 -1.864 . . . . 0.0 113.225 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.45 171.82 16.29 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.795 2.33 . . . . 0.0 115.352 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.95 174.65 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -60.57 133.09 55.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.13 51.1 4.57 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.284 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -146.63 131.87 18.45 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.76 113.45 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.67 124.77 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -92.97 133.55 36.01 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 m -127.92 145.37 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.629 0.728 . . . . 0.0 110.16 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.73 98.28 8.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 165.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.51 125.72 31.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -103.98 73.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -79.46 119.45 22.48 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.9 m -146.91 133.9 20.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 tp -67.18 151.91 46.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.662 0.785 . . . . 0.0 113.001 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.14 12.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -77.65 -63.82 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.587 1.085 . . . . 0.0 112.529 168.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.07 76.38 0.02 OUTLIER Glycine 0 N--CA 1.48 1.583 0 CA-C-N 118.786 0.721 . . . . 0.0 111.533 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -149.39 113.91 5.29 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -74.6 104.23 5.21 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.248 0.477 . . . . 0.0 111.633 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.58 -61.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.003 -165.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.85 85.81 1.43 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -100.03 91.56 4.85 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.845 0.458 . . . . 0.0 110.231 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -98.97 116.33 65.31 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.087 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.73 -53.36 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.875 2.384 . . . . 0.0 115.079 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -98.73 81.25 2.64 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.252 0.933 . . . . 0.0 111.192 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.72 98.79 11.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.73 109.93 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -165.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -137.46 151.73 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -88.08 118.98 28.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.86 145.56 32.67 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.77 -50.0 4.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.71 -2.81 0.89 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 58.2 m 75.41 90.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.985 1.314 . . . . 0.0 111.46 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.76 -63.01 1.1 Allowed 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.297 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.88 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 124.28 1.032 . . . . 0.0 113.396 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 pt -56.57 148.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 125.06 1.344 . . . . 0.0 113.171 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -61.7 -26.69 68.2 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.45 69.84 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 120.29 1.405 . . . . 0.0 114.74 165.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -44.17 93.3 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.34 -40.35 95.7 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.91 -30.97 72.0 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 167.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -77.62 -0.17 25.53 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.64 -55.41 45.25 Favored Pre-proline 0 N--CA 1.502 2.125 0 CA-C-O 115.329 -2.272 . . . . 0.0 112.708 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.36 24.57 0.23 Allowed 'Trans proline' 0 CA--C 1.574 2.483 0 CA-C-N 124.683 2.708 . . . . 0.0 118.249 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.92 -39.14 1.23 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.97 1.308 . . . . 0.0 111.825 168.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -75.45 123.42 25.39 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.883 1.219 . . . . 0.0 113.566 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.92 170.27 8.18 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.76 1.267 . . . . 0.0 111.771 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.29 111.99 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.313 -0.867 . . . . 0.0 110.112 -157.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.89 2.14 57.22 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 -166.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -75.32 123.42 25.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 121.27 2.535 . . . . 0.0 111.961 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.8 m -103.82 116.73 32.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.53 128.16 10.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.4 tpp -80.79 113.71 19.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.756 0.823 . . . . 0.0 109.569 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.13 93.3 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -91.28 109.53 20.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.96 147.04 30.33 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -48.15 150.79 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 t -70.52 78.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.627 1.203 . . . . 0.0 111.491 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -179.76 -67.34 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.455 -1.702 . . . . 0.0 106.639 -156.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -65.87 -55.47 16.84 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.95 0.9 . . . . 0.0 111.718 159.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 71.6 m -73.21 111.5 8.39 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.768 0.713 . . . . 0.0 110.367 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.323 75.7 m-85 80.08 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.242 1.017 . . . . 0.0 112.036 170.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.45 162.99 26.33 Favored Glycine 0 CA--C 1.557 2.687 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.085 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.21 -22.16 47.17 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 123.183 2.589 . . . . 0.0 118.411 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -80.54 -45.04 18.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.92 97.98 1.37 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -171.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -84.14 178.66 7.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.366 1.079 . . . . 0.0 112.757 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -75.03 138.1 72.65 Favored Pre-proline 0 CA--C 1.57 1.745 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.643 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.67 -56.36 0.14 OUTLIER 'Cis proline' 0 CA--C 1.562 1.891 0 CA-C-N 122.316 1.863 . . . . 0.0 115.704 6.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -145.96 70.82 1.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.14 0.882 . . . . 0.0 109.386 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.7 mm -90.6 119.06 69.1 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.423 -1.275 . . . . 0.0 107.933 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.65 121.41 5.94 Favored 'Trans proline' 0 CA--C 1.571 2.36 0 C-N-CA 122.716 2.277 . . . . 0.0 112.253 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.64 132.73 20.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 123.012 2.475 . . . . 0.0 112.704 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.273 14.9 m170 78.86 148.28 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 124.61 1.164 . . . . 0.0 110.748 -166.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.26 . . 78.93 136.26 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.841 1.257 . . . . 0.0 112.514 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.32 136.49 33.88 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.54 136.15 37.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.816 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.9 m -101.11 102.91 13.96 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 109.36 18.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.289 0.636 . . . . 0.0 111.22 -175.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.32 98.74 9.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.486 0.66 . . . . 0.0 110.377 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.82 111.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.8 m -110.77 114.32 27.58 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.56 120.18 18.81 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.057 0.543 . . . . 0.0 111.014 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.11 -65.41 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.488 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 46.6 p -124.77 150.59 46.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.852 0.834 . . . . 0.0 109.847 -166.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.79 98.67 4.24 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.24 164.59 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.934 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.65 -160.58 0.19 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -108.68 93.25 0.77 Allowed Glycine 0 CA--C 1.549 2.195 0 CA-C-O 117.075 -1.959 . . . . 0.0 110.824 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.46 137.11 12.9 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 CA-C-N 122.174 2.987 . . . . 0.0 113.244 -173.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.08 101.51 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 122.097 0.951 . . . . 0.0 113.083 -175.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.44 94.72 5.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.878 0.847 . . . . 0.0 110.1 -179.663 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 68.23 132.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.15 -67.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -156.4 146.59 21.35 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.625 1.17 . . . . 0.0 109.371 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 tp -74.31 136.15 42.58 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.259 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -83.47 -178.27 7.0 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-O 123.452 1.596 . . . . 0.0 114.928 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 -74.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.36 -39.9 58.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.39 67.94 0.57 Allowed Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -146.94 -65.54 0.28 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.71 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.43 -50.32 0.83 Allowed Glycine 0 CA--C 1.545 1.957 0 CA-C-N 118.907 0.776 . . . . 0.0 114.074 -164.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.69 -56.74 8.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.68 112.83 24.9 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.861 0.755 . . . . 0.0 109.076 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -133.73 148.65 51.45 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.127 0.971 . . . . 0.0 111.444 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -108.55 127.16 53.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.647 -0.658 . . . . 0.0 111.511 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.92 -43.1 95.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.269 19.5 m 73.5 95.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 174.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.78 -65.62 0.99 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.889 . . . . 0.0 110.166 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.46 113.01 33.85 Favored Pre-proline 0 CA--C 1.569 1.689 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.3 78.99 3.01 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.87 2.38 . . . . 0.0 113.095 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.34 160.95 17.09 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.14 170.2 20.08 Favored 'Trans proline' 0 CA--C 1.574 2.499 0 C-N-CA 123.266 2.644 . . . . 0.0 114.39 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.35 108.28 1.97 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.031 2.487 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.06 83.34 0.96 Allowed Glycine 0 CA--C 1.544 1.88 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -159.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -100.51 123.63 44.98 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.884 0.474 . . . . 0.0 111.961 -166.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -92.33 138.85 31.17 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.335 0.654 . . . . 0.0 112.218 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -113.12 107.19 54.3 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.4 148.22 29.77 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.022 2.482 . . . . 0.0 114.53 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.39 147.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.0 0.92 . . . . 0.0 112.576 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 86.3 2.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.74 62.79 0.01 OUTLIER Glycine 0 CA--C 1.54 1.634 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.158 172.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.07 0.938 . . . . 0.0 110.596 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.45 109.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.77 112.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 m -93.1 106.84 18.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.35 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -171.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -74.41 112.45 10.6 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 165.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.69 105.8 7.74 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -167.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.29 100.66 11.97 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -79.47 112.48 16.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.3 t -135.88 149.13 48.89 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.094 0.949 . . . . 0.0 110.306 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.94 142.32 51.25 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.269 1.028 . . . . 0.0 112.218 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.29 -38.7 28.2 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -66.21 -66.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.598 0.759 . . . . 0.0 111.959 168.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.64 79.61 0.03 OUTLIER Glycine 0 N--CA 1.479 1.536 0 CA-C-N 119.012 0.824 . . . . 0.0 112.005 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.2 m -151.04 112.96 4.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 102.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.64 -45.83 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -145.08 105.91 4.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.26 124.54 31.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.431 0.634 . . . . 0.0 109.681 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -130.58 78.43 74.03 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -170.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.81 -44.3 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.095 2.53 . . . . 0.0 116.443 -171.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.12 83.15 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.197 0.908 . . . . 0.0 109.803 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.4 tp -101.05 98.51 8.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.76 111.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -165.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.8 166.14 33.84 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.755 -175.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -82.06 136.02 35.26 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.234 0.613 . . . . 0.0 110.398 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 tt -68.37 114.13 6.55 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.222 1.009 . . . . 0.0 112.828 -164.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.92 34.8 77.75 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 118.0 1.96 . . . . 0.0 118.0 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.44 169.11 14.7 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.44 1.114 . . . . 0.0 110.028 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.77 89.91 2.87 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.603 1.192 . . . . 0.0 113.205 -167.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.44 -67.55 0.21 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.846 -1.524 . . . . 0.0 107.998 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.85 165.29 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 124.605 1.162 . . . . 0.0 112.988 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 159.92 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -30.18 63.77 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.82 80.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 170.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.3 -38.4 65.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -43.29 -48.48 6.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.72 -45.46 58.63 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.6 p -90.27 45.94 1.31 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.67 -55.95 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.913 0 CA-C-O 115.013 -2.423 . . . . 0.0 107.235 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.73 83.32 1.95 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 CA-C-N 125.421 2.972 . . . . 0.0 112.802 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.317 4.4 pp 163.0 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 127.194 2.197 . . . . 0.0 111.821 -167.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.23 140.73 38.9 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.98 1.264 . . . . 0.0 112.04 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.27 159.81 33.93 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.618 163.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.68 97.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 143' ' ' LEU . . . 99.06 39.17 3.61 Favored Glycine 0 CA--C 1.552 2.379 0 CA-C-O 118.494 -1.17 . . . . 0.0 115.981 -162.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.42 99.91 11.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.064 1.432 . . . . 0.0 109.076 173.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.9 m -83.69 118.05 23.61 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 128.31 6.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.768 0.427 . . . . 0.0 110.223 -173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.4 tpp -85.51 107.16 17.32 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.75 99.05 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -91.5 104.26 16.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.15 160.64 15.46 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.164 0.983 . . . . 0.0 113.303 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 159.04 22.19 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.663 164.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.3 p -73.95 68.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -175.9 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.452 1.501 . . . . 0.0 108.405 -168.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -59.62 -51.03 71.56 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.651 1.18 . . . . 0.0 114.113 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.5 m -66.11 -70.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.821 0.737 . . . . 0.0 112.582 170.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -144.48 -65.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.938 0.79 . . . . 0.0 109.39 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.64 -167.93 30.16 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.14 102.47 1.6 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.081 2.521 . . . . 0.0 112.441 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -152.95 -69.45 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.716 -169.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.72 95.29 1.23 Allowed Glycine 0 CA--C 1.541 1.683 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -167.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -132.82 148.65 52.31 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.201 1.0 . . . . 0.0 110.667 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.4 m -76.8 140.85 67.7 Favored Pre-proline 0 CA--C 1.57 1.74 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.22 173.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.02 -47.35 0.26 Allowed 'Cis proline' 0 CA--C 1.563 1.939 0 CA-C-N 122.377 1.885 . . . . 0.0 116.909 9.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.33 77.16 1.43 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.76 117.37 46.64 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.8 151.33 27.97 Favored 'Trans proline' 0 CA--C 1.571 2.358 0 C-N-CA 122.813 2.342 . . . . 0.0 114.417 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.15 119.59 6.55 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.128 2.552 . . . . 0.0 111.931 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 93.9 m-70 76.8 101.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.222 1.409 . . . . 0.0 109.478 -165.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.83 88.86 3.0 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.171 0.588 . . . . 0.0 109.634 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.6 76.15 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 153.33 20.59 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.443 1.115 . . . . 0.0 112.243 -165.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -91.75 109.6 20.92 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.661 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.37 117.79 32.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.304 1.042 . . . . 0.0 108.217 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.16 99.2 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.398 -0.814 . . . . 0.0 110.196 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.06 125.6 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.5 m -142.14 124.33 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' HB2' ' H ' ' A' ' 109' ' ' GLY . 3.2 mm? -76.47 111.32 11.81 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.384 0.674 . . . . 0.0 110.021 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -84.01 -55.95 3.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 118.659 -0.686 . . . . 0.0 112.745 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 69.7 p -135.94 133.61 37.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -117.68 106.96 13.63 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 167.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.93 133.48 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 123.439 0.696 . . . . 0.0 110.078 -170.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -86.17 103.96 15.29 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 168.47 93.74 0.09 OUTLIER Glycine 0 CA--C 1.545 1.964 0 CA-C-O 116.801 -2.111 . . . . 0.0 112.08 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.92 131.87 12.48 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 CA-C-N 122.283 3.042 . . . . 0.0 112.62 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 61.17 90.41 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.477 1.111 . . . . 0.0 112.648 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.61 -63.29 1.42 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -165.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.722 0.772 . . . . 0.0 110.989 -176.513 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 53.17 61.39 3.18 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.11 169.9 20.18 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.693 1.235 . . . . 0.0 113.568 -163.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -79.41 115.44 19.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 153.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.46 103.61 15.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -163.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.97 103.04 12.13 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.072 0.939 . . . . 0.0 112.331 -176.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 pt -84.23 -176.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.648 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.357 2.6 tt 90.46 -75.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.343 1.457 . . . . 0.0 110.624 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.98 -72.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.377 0.535 . . . . 0.0 112.708 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.74 -75.36 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.179 0.592 . . . . 0.0 111.462 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.94 73.54 0.04 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 mt -141.73 -62.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.092 0.957 . . . . 0.0 108.753 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.77 130.51 38.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.101 0.96 . . . . 0.0 110.753 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -133.41 74.95 1.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -159.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -92.17 86.58 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.037 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -75.51 116.88 16.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 111.071 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 m -74.89 104.62 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.209 0.603 . . . . 0.0 109.404 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.79 -79.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.644 0.777 . . . . 0.0 110.077 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.93 113.38 63.67 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 169.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.17 175.63 8.97 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.873 2.382 . . . . 0.0 114.889 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 119.37 10.85 Favored Glycine 0 CA--C 1.558 2.738 0 CA-C-O 116.948 -2.029 . . . . 0.0 112.62 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.65 161.91 36.7 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 CA-C-N 122.498 3.149 . . . . 0.0 115.327 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.84 113.64 2.07 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.175 2.584 . . . . 0.0 113.562 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.4 71.67 1.09 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.711 -159.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -157.86 114.52 2.89 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 m -126.06 117.74 23.84 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 122.273 1.035 . . . . 0.0 110.086 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -59.4 134.06 88.46 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.01 144.89 43.71 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.783 2.322 . . . . 0.0 116.568 -158.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -72.16 155.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.002 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -70.17 110.99 5.49 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.72 65.08 0.47 Allowed Glycine 0 CA--C 1.544 1.863 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.548 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -150.01 140.74 22.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.19 108.04 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 m -117.87 121.6 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -109.75 134.46 51.98 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.63 153.15 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.254 1.026 . . . . 0.0 110.278 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -102.44 91.58 4.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.343 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.94 147.38 25.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.311 0.576 . . . . 0.0 110.383 163.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.01 92.5 2.88 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 m -83.11 122.11 27.93 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.661 0.743 . . . . 0.0 109.889 -175.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 m -140.93 136.62 32.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.529 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.19 131.81 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -52.23 -46.82 65.87 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.37 -44.26 12.95 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.81 80.78 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 120.783 3.073 . . . . 0.0 120.783 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.0 m 77.65 117.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.143 1.972 . . . . 0.0 112.839 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.252 7.3 ttt85 38.86 53.91 2.01 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 160.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 21.1 m -74.77 -40.96 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -159.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -146.96 76.3 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.561 1.073 . . . . 0.0 109.055 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -73.39 111.05 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.609 0.719 . . . . 0.0 111.56 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -130.94 84.06 59.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.91 -46.58 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.906 2.404 . . . . 0.0 117.248 -164.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.95 92.95 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.876 1.216 . . . . 0.0 110.702 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 tp -111.57 81.13 1.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.53 -172.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -89.84 136.44 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.406 0.682 . . . . 0.0 110.884 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -162.81 150.48 13.62 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.947 0.899 . . . . 0.0 110.345 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -80.77 140.97 35.21 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.94 104.81 5.68 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.38 70.83 0.85 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.032 -159.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -156.63 -66.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.734 0.814 . . . . 0.0 110.478 -176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.351 4.8 t 65.94 40.87 3.94 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.59 -47.68 80.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.878 -1.139 . . . . 0.0 113.217 152.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -55.04 166.85 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 125.282 1.433 . . . . 0.0 114.321 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 99' ' ' LEU . 46.4 pt -60.34 151.19 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -35.99 65.93 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.35 94.54 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 117.176 2.288 . . . . 0.0 117.176 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.459 ' H ' HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -63.89 -56.54 14.57 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.907 -1.044 . . . . 0.0 113.138 178.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -49.98 -43.24 50.17 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.38 -39.87 94.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.1 p -77.91 -4.11 45.16 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.79 -53.05 68.03 Favored Pre-proline 0 N--CA 1.502 2.138 0 CA-C-O 115.388 -2.244 . . . . 0.0 112.62 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.48 0.34 1.47 Allowed 'Trans proline' 0 CA--C 1.569 2.254 0 N-CA-C 119.483 2.839 . . . . 0.0 119.483 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 99.4 mt -128.57 73.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 119.993 1.27 . . . . 0.0 107.982 158.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 38.9 ttm -164.29 96.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.06 167.64 17.68 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.322 1.058 . . . . 0.0 113.282 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -70.41 108.29 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.578 0.751 . . . . 0.0 109.691 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.78 20.2 41.0 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 117.912 1.925 . . . . 0.0 117.912 -167.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 107.59 18.66 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 120.387 2.093 . . . . 0.0 110.476 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.4 m -78.75 113.07 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 163.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.79 121.49 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 ttt -83.68 108.12 16.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.024 0.529 . . . . 0.0 110.239 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.34 118.38 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 t -129.07 77.04 1.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.61 145.92 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.715 0.769 . . . . 0.0 112.044 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.86 164.65 0.36 Allowed 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -69.54 81.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.832 1.301 . . . . 0.0 111.595 172.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.888 -147.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -120.11 57.99 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.399 0.68 . . . . 0.0 111.938 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -110.37 -100.38 0.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -136.14 63.13 1.6 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 119.047 0.84 . . . . 0.0 109.414 168.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.24 -156.12 30.42 Favored Glycine 0 CA--C 1.562 2.977 0 N-CA-C 116.671 1.428 . . . . 0.0 116.671 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.25 102.64 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.95 2.433 . . . . 0.0 110.783 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.272 58.7 tp60 73.24 120.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.088 1.355 . . . . 0.0 111.16 -168.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.24 -139.95 10.54 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.8 158.85 15.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.293 1.044 . . . . 0.0 111.856 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.8 m -64.52 137.32 97.1 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 117.789 -1.1 . . . . 0.0 112.756 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.78 -42.56 0.68 Allowed 'Cis proline' 0 CA--C 1.563 1.96 0 N-CA-C 117.661 2.139 . . . . 0.0 117.661 10.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -168.21 100.69 0.44 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.43 105.63 56.86 Favored Pre-proline 0 CA--C 1.571 1.77 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.86 146.72 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.667 2.244 . . . . 0.0 114.747 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.61 -54.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.292 2.661 . . . . 0.0 115.272 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -65.24 145.61 56.01 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.521 1.128 . . . . 0.0 112.915 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.18 128.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.796 1.238 . . . . 0.0 111.886 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.72 114.08 8.44 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.603 0.761 . . . . 0.0 111.988 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.85 125.49 29.77 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 120.967 0.413 . . . . 0.0 111.301 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.55 118.29 31.98 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.097 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.53 121.72 27.76 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.402 0.681 . . . . 0.0 109.677 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -87.6 98.33 11.35 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.2 0.6 . . . . 0.0 110.768 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.82 126.08 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -133.31 125.32 28.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.59 111.16 5.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.57 0.748 . . . . 0.0 111.184 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -77.37 -66.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -132.81 143.22 49.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.619 0.723 . . . . 0.0 109.321 -168.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.54 96.95 4.25 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.72 129.06 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -170.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.2 111.48 22.67 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.277 0.56 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 172.0 97.04 0.1 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-O 116.764 -2.131 . . . . 0.0 110.633 -175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.8 151.37 31.59 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 CA-C-N 122.359 3.079 . . . . 0.0 114.368 -172.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . 0.259 18.8 t0 68.51 98.85 0.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 124.616 1.166 . . . . 0.0 112.43 -175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.63 121.5 43.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.638 0.775 . . . . 0.0 109.039 -170.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.488 1.462 0 C-N-CA 123.238 0.615 . . . . 0.0 110.954 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 104.9 4.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -58.57 168.45 1.16 Allowed 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -48.79 120.57 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.447 1.099 . . . . 0.0 113.778 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.6 tp -80.36 109.81 15.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.439 0.696 . . . . 0.0 110.99 -164.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.56 101.78 13.52 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.355 1.074 . . . . 0.0 112.634 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -71.32 -29.84 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 170.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.23 -48.95 71.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.159 1.345 . . . . 0.0 113.68 158.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 -36.12 4.44 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -73.1 -71.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.397 1.099 . . . . 0.0 111.961 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.11 61.27 0.03 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 mt -143.83 -76.2 0.24 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.4 tp -88.15 119.69 28.78 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.65 0.78 . . . . 0.0 109.203 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -137.79 121.63 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.644 0.778 . . . . 0.0 109.681 -172.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 110.5 16.09 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 110.485 -164.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -116.94 130.85 56.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.214 . . . . 0.0 110.009 172.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.9 m -93.2 119.25 32.17 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.858 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.86 -68.32 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.517 0.727 . . . . 0.0 110.117 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.4 t -85.08 122.79 74.05 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 156.56 42.42 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 122.925 2.417 . . . . 0.0 114.699 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 121.14 5.32 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-O 116.924 -2.042 . . . . 0.0 113.071 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.22 144.64 52.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.597 3.199 . . . . 0.0 115.0 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.43 119.01 5.74 Favored 'Trans proline' 0 CA--C 1.558 1.693 0 C-N-CA 123.241 2.627 . . . . 0.0 112.643 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.28 -81.88 0.22 Allowed Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -88.71 98.64 11.8 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 m -148.86 133.23 17.52 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.763 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.273 19.2 mtm180 42.44 74.68 0.72 Allowed Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.97 161.49 32.9 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.726 2.284 . . . . 0.0 114.251 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.19 170.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.283 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -71.26 115.9 10.95 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.881 0.848 . . . . 0.0 111.902 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.64 -63.4 0.44 Allowed Glycine 0 CA--C 1.54 1.649 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -155.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -70.67 114.99 9.31 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.433 0.693 . . . . 0.0 110.028 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.34 114.04 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 m -92.52 135.74 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.444 -169.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -120.06 126.11 49.97 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.45 141.43 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.696 0.76 . . . . 0.0 110.98 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -89.92 93.67 9.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 161.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.34 143.19 28.34 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.782 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -126.93 90.41 3.15 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -74.53 115.55 14.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -140.92 119.15 12.06 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -162.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.08 137.13 45.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.669 0.387 . . . . 0.0 110.573 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.63 87.41 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.619 1.199 . . . . 0.0 112.608 -170.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -171.25 -75.59 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -170.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.14 71.0 0.05 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.2 t -162.75 141.34 8.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.26 0.624 . . . . 0.0 110.05 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 113.63 25.24 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.264 23.5 m -78.25 -51.18 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -141.02 81.22 1.78 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 119.226 0.921 . . . . 0.0 109.198 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.76 119.39 30.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.66 94.34 47.65 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.095 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.64 -44.82 0.63 Allowed 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.084 2.523 . . . . 0.0 117.202 -172.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.8 76.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.783 1.174 . . . . 0.0 110.238 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -99.68 92.67 5.45 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.22 132.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.737 0.78 . . . . 0.0 109.24 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -155.62 142.99 19.42 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.954 -174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.5 m -74.17 133.51 42.75 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.917 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -70.83 109.05 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.336 -165.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.27 67.79 1.48 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.493 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.72 145.16 27.53 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.239 1.018 . . . . 0.0 109.739 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 75.8 m -75.72 76.72 2.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.647 1.213 . . . . 0.0 111.829 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -129.69 -63.44 0.92 Allowed 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.657 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.16 176.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.005 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.71 140.9 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.052 0.941 . . . . 0.0 112.443 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -61.47 -33.72 74.23 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.07 -40.93 70.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 167.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -56.69 10.65 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.931 0.892 . . . . 0.0 113.037 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.57 -39.72 94.59 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.5 mt -61.09 -34.8 75.52 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.1 p -74.35 -11.94 60.39 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 167.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -56.01 -50.45 87.25 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 115.292 -2.29 . . . . 0.0 115.092 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -53.32 -26.57 35.27 Favored 'Trans proline' 0 CA--C 1.567 2.165 0 CA-C-N 125.659 3.057 . . . . 0.0 118.549 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -110.09 73.21 0.83 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.087 0.955 . . . . 0.0 109.709 164.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 53.0 tpp -149.61 107.45 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.39 161.85 15.39 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.681 1.229 . . . . 0.0 113.066 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 t -81.96 103.15 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 59.17 1.31 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.932 -170.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -126.06 123.76 39.11 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.57 0.748 . . . . 0.0 109.829 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -91.49 103.54 16.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.1 120.74 14.27 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.976 0.417 . . . . 0.0 110.433 -164.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.4 ttm -83.6 141.25 31.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.99 0.9 . . . . 0.0 110.802 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.27 96.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.6 p -81.72 104.87 12.42 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -135.68 139.23 43.53 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.511 0.724 . . . . 0.0 111.024 -168.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -63.23 149.49 45.38 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.8 m -71.32 81.73 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 123.273 1.511 . . . . 0.0 110.8 167.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -172.78 -68.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.961 -1.927 . . . . 0.0 106.446 -159.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -73.85 -45.61 50.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.638 0.775 . . . . 0.0 112.477 161.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.1 m -58.98 -56.55 20.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.2 -84.41 0.23 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.465 1.029 . . . . 0.0 108.713 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.82 -175.35 28.99 Favored Glycine 0 CA--C 1.557 2.718 0 CA-C-N 119.014 0.824 . . . . 0.0 114.651 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.53 105.13 1.83 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.483 2.788 . . . . 0.0 112.591 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 57.84 85.57 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.202 1.401 . . . . 0.0 112.908 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.66 -88.53 1.54 Allowed Glycine 0 CA--C 1.539 1.59 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -122.35 81.66 1.87 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.667 0.787 . . . . 0.0 109.96 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.1 p -73.44 145.29 84.97 Favored Pre-proline 0 CA--C 1.571 1.78 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.995 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.8 -16.38 30.09 Favored 'Cis proline' 0 CA--C 1.564 1.984 0 N-CA-C 119.437 2.822 . . . . 0.0 119.437 9.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -64.21 -42.69 96.5 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.73 118.43 68.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.32 163.51 27.41 Favored 'Trans proline' 0 CA--C 1.576 2.62 0 C-N-CA 122.84 2.36 . . . . 0.0 114.082 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -64.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.107 2.538 . . . . 0.0 115.488 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -136.03 94.05 3.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.24 125.69 8.81 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.95 108.31 14.51 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.566 0.698 . . . . 0.0 112.385 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -92.88 157.84 16.16 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.736 176.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.52 104.73 16.78 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.092 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -104.57 118.7 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.42 148.5 51.78 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.293 0.568 . . . . 0.0 112.383 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.96 99.96 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.5 m -102.44 109.39 21.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 104.15 8.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -80.88 -58.47 3.07 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 70.7 p -137.46 134.17 35.51 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.287 0.635 . . . . 0.0 109.64 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.16 94.94 4.86 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -166.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.08 115.31 22.81 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.412 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.82 -173.68 38.81 Favored Glycine 0 CA--C 1.557 2.7 0 CA-C-O 119.325 -0.708 . . . . 0.0 114.528 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.13 95.02 0.89 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.754 2.303 . . . . 0.0 113.327 -173.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -147.13 113.12 5.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.4 tp 70.79 106.86 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.986 1.314 . . . . 0.0 111.702 -173.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.253 0.549 . . . . 0.0 110.198 -178.807 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 62.3 mtp . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.342 19.2 mmt-85 65.73 134.99 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -172.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -89.03 131.03 35.38 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -149.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -99.78 133.59 43.91 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.618 161.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER 68.25 163.13 0.21 Allowed 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 171.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.268 14.2 t0 73.19 111.7 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -127.29 -59.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -60.59 -37.46 81.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.78 51.85 0.22 Allowed Glycine 0 CA--C 1.548 2.129 0 C-N-CA 124.621 1.105 . . . . 0.0 113.116 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -166.83 -71.84 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.24 61.67 0.07 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.317 0.961 . . . . 0.0 111.36 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.0 mt -142.48 -53.87 0.41 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.841 0.856 . . . . 0.0 109.593 -163.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.0 115.28 20.4 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 154.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -122.61 70.45 1.0 Allowed 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -162.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -88.77 120.08 29.85 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.636 -1.29 . . . . 0.0 113.06 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.15 114.57 24.66 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 161.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 m -75.57 121.2 22.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.65 -69.18 0.34 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.771 0.828 . . . . 0.0 111.791 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.07 121.89 26.24 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.42 169.02 23.45 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.811 2.341 . . . . 0.0 113.682 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.02 176.42 40.44 Favored Glycine 0 CA--C 1.562 3.018 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.73 163.45 35.21 Favored 'Trans proline' 0 CA--C 1.573 2.437 0 C-N-CA 123.047 2.498 . . . . 0.0 115.36 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.46 107.81 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.219 2.613 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.98 89.85 1.55 Allowed Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -164.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -133.08 109.48 9.54 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.7 p -77.99 129.76 35.68 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.176 0.512 . . . . 0.0 112.134 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -92.14 113.0 57.77 Favored Pre-proline 0 CA--C 1.577 2.002 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.818 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -68.67 155.02 70.24 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 122.956 2.437 . . . . 0.0 117.511 -161.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.66 165.31 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.897 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.55 105.23 5.57 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.737 0.779 . . . . 0.0 111.534 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.73 48.6 0.84 Allowed Glycine 0 CA--C 1.55 2.235 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.391 -164.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -154.84 110.95 3.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.03 115.16 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.429 0.691 . . . . 0.0 109.826 -163.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.89 129.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.528 0.731 . . . . 0.0 110.863 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -89.73 129.76 36.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 168.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -144.9 129.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -170.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -99.01 101.76 13.25 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.21 1.004 . . . . 0.0 108.463 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.32 127.54 55.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.149 0.58 . . . . 0.0 109.742 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -108.97 80.87 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.908 0.483 . . . . 0.0 110.214 -166.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.83 127.45 32.05 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.437 0.637 . . . . 0.0 110.49 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -148.87 151.18 34.26 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.287 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.32 145.01 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.57 76.78 8.48 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 122.414 1.102 . . . . 0.0 110.277 168.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -172.22 -63.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.197 1.399 . . . . 0.0 107.27 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.62 -62.59 0.16 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 119.516 -0.602 . . . . 0.0 113.193 -173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 133.98 33.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 117.502 0.651 . . . . 0.0 110.149 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 142.68 46.39 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.88 -74.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -145.12 118.66 9.1 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -97.86 93.0 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 109.948 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mp0 -72.92 113.59 23.01 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.818 -172.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -53.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.991 2.46 . . . . 0.0 116.111 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -125.82 70.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 118.947 0.794 . . . . 0.0 110.705 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.92 113.83 26.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.6 t -106.76 100.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -113.06 146.57 38.9 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.042 0.537 . . . . 0.0 111.08 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.1 m -80.08 128.15 33.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.72 110.33 8.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.47 -67.1 0.25 Allowed Glycine 0 N--CA 1.48 1.583 0 CA-C-O 119.406 -0.663 . . . . 0.0 112.955 -167.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.42 85.94 7.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.523 0.678 . . . . 0.0 109.961 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 83.9 m -95.38 115.31 27.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.432 0.634 . . . . 0.0 112.373 -158.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -58.73 -38.41 78.31 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 159.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.3 m -71.13 164.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.639 1.209 . . . . 0.0 114.157 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.39 171.6 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.569 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -57.16 -40.06 76.49 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.85 -43.63 86.02 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.92 -49.07 61.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.559 -1.21 . . . . 0.0 114.111 170.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -49.54 -49.84 44.47 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.0 -44.31 94.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.1 p -87.23 49.41 1.81 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.3 t -96.56 -57.41 0.19 Allowed Pre-proline 0 CA--C 1.572 1.827 0 CA-C-O 115.226 -2.321 . . . . 0.0 109.195 163.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.85 -7.7 11.91 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.497 2.999 . . . . 0.0 118.776 174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.88 -34.84 15.09 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.77 1.168 . . . . 0.0 113.728 162.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.86 116.51 7.81 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.216 1.371 . . . . 0.0 112.806 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -85.73 149.46 25.27 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.129 0.966 . . . . 0.0 112.009 167.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.73 105.32 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.84 -33.4 2.84 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.763 -164.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.31 132.37 43.01 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 120.818 2.309 . . . . 0.0 115.047 -170.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -96.86 122.96 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 162.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.42 122.33 9.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 120.892 0.377 . . . . 0.0 111.415 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.5 ttt -82.83 105.79 14.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.327 0.651 . . . . 0.0 109.834 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.14 119.51 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.5 p -94.35 78.22 3.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.41 144.3 49.83 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 152.48 45.34 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.2 t -76.89 69.15 3.18 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.672 1.225 . . . . 0.0 111.689 167.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -176.45 -64.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.477 1.511 . . . . 0.0 108.001 -164.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -79.27 -31.56 43.44 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.5 t -69.0 -75.98 0.1 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.166 1.348 . . . . 0.0 112.064 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.97 43.7 2.93 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.281 1.4 . . . . 0.0 112.55 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.09 176.25 6.69 Favored Glycine 0 CA--C 1.56 2.86 0 N-CA-C 116.467 1.347 . . . . 0.0 116.467 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.6 67.59 8.55 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 CA-C-N 120.979 2.389 . . . . 0.0 111.709 160.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -158.7 -66.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.498 1.119 . . . . 0.0 108.072 -169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.17 120.19 2.91 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 118.775 0.716 . . . . 0.0 111.776 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.04 67.42 1.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m 67.39 143.53 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 166.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.81 -42.62 0.78 Allowed 'Cis proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.804 2.037 . . . . 0.0 117.111 -1.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -138.15 68.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.42 1.009 . . . . 0.0 109.913 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.81 117.07 44.81 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 172.57 13.78 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 C-N-CA 123.006 2.471 . . . . 0.0 114.075 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.0 2.35 2.7 Favored 'Trans proline' 0 CA--C 1.567 2.126 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -148.56 90.24 1.77 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.27 114.28 3.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.99 107.57 13.92 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.2 125.04 35.85 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.015 0.912 . . . . 0.0 110.703 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 29.4 m -97.81 95.4 7.51 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.927 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.7 119.01 37.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.196 0.599 . . . . 0.0 110.091 174.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -88.49 103.61 16.04 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.275 1.036 . . . . 0.0 109.841 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.38 103.63 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.295 -1.32 . . . . 0.0 107.653 -170.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -94.06 108.52 20.34 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.02 105.88 12.59 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -77.88 -72.27 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -144.77 135.84 25.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 118.8 0.727 . . . . 0.0 109.886 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.64 111.12 23.31 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.96 138.77 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.05 148.5 50.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -96.3 115.98 5.33 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.151 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.66 155.51 31.36 Favored 'Trans proline' 0 CA--C 1.562 1.924 0 CA-C-N 122.445 3.122 . . . . 0.0 113.821 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.13 -83.64 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -172.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 62.76 71.03 0.53 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.687 1.195 . . . . 0.0 113.184 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.327 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -146.4 93.78 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.788 0.435 . . . . 0.0 109.995 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.23 133.38 35.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.136 0.574 . . . . 0.0 111.255 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.25 82.2 m95 75.51 103.11 0.07 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.924 1.289 . . . . 0.0 110.099 -176.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.1 97.48 9.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.27 129.79 37.19 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.593 1.187 . . . . 0.0 113.365 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 pt -103.42 66.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.867 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 tp -163.0 -60.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.399 0.68 . . . . 0.0 110.187 -164.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.4 44.49 3.72 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -161.05 -80.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.65 58.01 0.01 OUTLIER Glycine 0 CA--C 1.543 1.808 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.248 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 mt -131.06 -54.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.843 0.857 . . . . 0.0 110.978 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.9 tp -87.01 102.35 14.32 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 108.991 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.73 90.06 3.18 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 122.885 0.474 . . . . 0.0 111.375 -161.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.04 93.79 8.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.814 -1.179 . . . . 0.0 111.106 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -99.32 122.91 43.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.356 0.662 . . . . 0.0 109.251 168.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.9 m -80.58 117.03 20.93 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.131 0.572 . . . . 0.0 109.916 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -79.87 -71.68 0.44 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.957 0.903 . . . . 0.0 110.512 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.14 123.18 45.87 Favored Pre-proline 0 CA--C 1.573 1.845 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.74 157.59 51.77 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.921 2.414 . . . . 0.0 114.85 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.37 116.56 4.25 Favored Glycine 0 CA--C 1.55 2.233 0 CA-C-O 116.807 -2.107 . . . . 0.0 112.9 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.11 142.02 37.34 Favored 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 122.658 3.229 . . . . 0.0 114.315 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 113.19 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.045 2.497 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.81 -85.92 0.11 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 t -85.12 109.21 18.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.1 p -111.17 172.11 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.085 0.945 . . . . 0.0 112.907 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -50.64 122.7 16.62 Favored Pre-proline 0 CA--C 1.582 2.182 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.02 162.09 37.66 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.089 2.526 . . . . 0.0 115.799 -171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 167.56 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.465 1.126 . . . . 0.0 112.22 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -64.57 126.72 28.77 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.729 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.31 59.79 1.08 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.251 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -146.27 139.69 25.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.38 102.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.65 120.6 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -100.03 142.62 31.27 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.39 0.676 . . . . 0.0 109.444 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.98 141.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.589 0.756 . . . . 0.0 109.638 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -83.16 109.67 17.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 160.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -95.62 113.18 24.8 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.02 91.27 6.78 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 m -82.94 116.94 22.44 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -145.19 171.59 14.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.303 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.21 130.94 55.75 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.61 -38.92 79.04 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -65.29 -48.18 74.04 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 163.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.89 -116.51 4.14 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 119.245 0.929 . . . . 0.0 112.564 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.5 t -153.69 -176.39 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.77 0.795 . . . . 0.0 111.909 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -61.53 122.69 15.86 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.49 -49.88 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.45 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -146.59 103.42 3.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -84.88 82.04 8.62 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.346 1.069 . . . . 0.0 111.459 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.49 112.02 58.75 Favored Pre-proline 0 CA--C 1.576 1.947 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.533 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.33 -61.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.181 2.588 . . . . 0.0 116.364 -169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -97.82 74.08 2.33 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.222 1.374 . . . . 0.0 111.18 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.23 92.39 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.16 139.07 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.048 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.45 155.39 33.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.59 -172.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.7 m -77.97 131.22 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.42 116.27 4.17 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.825 0.85 . . . . 0.0 112.467 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.6 55.26 8.73 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -152.28 150.82 30.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.261 1.029 . . . . 0.0 110.081 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -74.89 81.96 2.16 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 122.824 1.297 . . . . 0.0 114.033 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -130.92 -60.48 0.97 Allowed 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.222 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.52 172.21 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.513 1.125 . . . . 0.0 113.138 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.67 161.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.28 -45.56 90.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.67 77.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -54.53 17.83 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.998 0.919 . . . . 0.0 112.863 172.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -49.28 -50.92 36.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.5 -39.98 77.69 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.2 p -84.22 22.91 1.14 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -74.0 -54.84 3.37 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.382 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.05 61.4 8.19 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 CA-C-N 125.39 2.961 . . . . 0.0 114.642 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.6 mt -155.96 -48.31 0.08 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.628 1.571 . . . . 0.0 109.66 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -76.54 107.12 8.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.523 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.79 169.88 17.28 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.961 167.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.05 106.88 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.884 -1.135 . . . . 0.0 108.413 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 10.34 46.19 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -163.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.98 93.99 6.05 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.504 2.152 . . . . 0.0 109.812 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.3 m -88.54 136.38 33.02 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.168 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.75 138.19 8.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.936 0.494 . . . . 0.0 110.112 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.1 ptm -83.04 124.77 30.75 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.03 71.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -84.93 113.76 21.64 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.6 -0.687 . . . . 0.0 109.414 -164.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.11 154.23 26.94 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.855 0.862 . . . . 0.0 112.051 -167.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -52.33 147.98 7.25 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 168.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.0 p -68.89 78.14 0.31 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.84 1.305 . . . . 0.0 112.619 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -176.12 -60.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.797 -151.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.02 -51.81 23.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.9 m -67.35 -80.34 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -158.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.12 72.3 1.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.32 -142.87 47.75 Favored Glycine 0 CA--C 1.562 3.01 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.78 -164.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.78 50.58 1.91 Allowed 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 122.892 2.395 . . . . 0.0 113.661 165.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 56.0 85.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.905 1.282 . . . . 0.0 113.769 -168.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 162.0 74.06 0.02 OUTLIER Glycine 0 N--CA 1.481 1.687 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.544 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 69.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.7 m 68.53 127.9 0.03 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 166.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.82 -44.8 0.36 Allowed 'Cis proline' 0 CA--C 1.565 2.029 0 CA-C-N 123.009 2.11 . . . . 0.0 116.39 2.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.29 82.35 1.42 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.57 99.08 46.36 Favored Pre-proline 0 CA--C 1.57 1.745 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.34 134.08 12.42 Favored 'Trans proline' 0 CA--C 1.567 2.175 0 C-N-CA 122.828 2.352 . . . . 0.0 113.799 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.66 154.31 64.26 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.137 2.558 . . . . 0.0 115.297 -172.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.256 15.5 m170 82.2 137.61 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.41 1.084 . . . . 0.0 112.069 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.258 . . 73.29 136.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.843 1.257 . . . . 0.0 113.236 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.88 169.73 11.01 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -158.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tt -115.3 125.6 53.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.349 1.06 . . . . 0.0 110.33 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -87.3 118.45 26.74 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.105 0.962 . . . . 0.0 110.971 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.22 111.88 11.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.73 103.67 15.59 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.119 0.485 . . . . 0.0 110.726 -169.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.25 101.18 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.0 m -109.19 121.89 46.14 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.23 105.59 11.6 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.626 0.37 . . . . 0.0 110.162 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -78.61 -69.73 0.54 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.8 p -132.37 143.57 49.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.334 0.588 . . . . 0.0 109.59 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.32 100.13 5.27 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.44 149.66 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.963 0.905 . . . . 0.0 109.002 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -65.59 163.56 15.96 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -117.99 86.43 0.41 Allowed Glycine 0 CA--C 1.548 2.102 0 CA-C-O 117.225 -1.875 . . . . 0.0 113.529 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.49 119.03 3.65 Favored 'Trans proline' 0 CA--C 1.558 1.69 0 CA-C-N 121.702 2.751 . . . . 0.0 111.571 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.98 112.44 10.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.693 0.758 . . . . 0.0 112.873 -168.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.6 128.58 44.96 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.996 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 123.162 1.458 . . . . 0.0 111.639 175.834 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.55 0.947 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -143.24 95.92 2.84 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.041 0.536 . . . . 0.0 110.714 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.268 14.7 tp10 68.06 157.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 160.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -69.76 151.76 45.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.913 167.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.34 98.81 9.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.037 0.535 . . . . 0.0 109.992 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.06 120.89 20.27 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 122.058 0.933 . . . . 0.0 112.146 171.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.21 -80.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -165.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.64 120.9 23.45 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.85 2.74 0.07 OUTLIER Glycine 0 CA--C 1.543 1.81 0 CA-C-O 117.51 -1.717 . . . . 0.0 116.701 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.364 12.5 p30 49.01 56.86 7.13 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 120.281 2.04 . . . . 0.0 114.727 -165.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 54.61 6.57 Favored Glycine 0 CA--C 1.546 1.991 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 99.4 mt -126.21 -66.47 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.478 1.139 . . . . 0.0 110.299 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 tp -82.86 111.44 18.76 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.444 1.02 . . . . 0.0 109.921 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -115.81 144.27 44.23 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.502 0.721 . . . . 0.0 112.606 -173.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.02 136.07 48.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 0.0 112.095 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.8 121.14 40.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 158.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.2 m -75.63 109.16 8.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.19 -61.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.736 0.815 . . . . 0.0 112.592 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.68 108.02 56.41 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.66 148.44 17.95 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.952 2.435 . . . . 0.0 113.989 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.49 118.76 7.37 Favored Glycine 0 CA--C 1.555 2.562 0 CA-C-O 116.986 -2.008 . . . . 0.0 114.882 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.33 168.35 23.69 Favored 'Trans proline' 0 CA--C 1.573 2.472 0 CA-C-N 122.306 3.053 . . . . 0.0 115.452 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.7 116.72 4.1 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 123.195 2.597 . . . . 0.0 113.021 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.27 69.75 1.18 Allowed Glycine 0 CA--C 1.545 1.91 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.319 -163.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -150.9 117.51 5.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -70.53 140.31 51.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -117.64 121.27 32.08 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-O 117.73 -1.129 . . . . 0.0 109.389 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.0 145.92 40.69 Favored 'Trans proline' 0 CA--C 1.558 1.689 0 C-N-CA 122.606 2.204 . . . . 0.0 114.657 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.28 154.68 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.63 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.24 107.89 1.16 Allowed 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.898 0.879 . . . . 0.0 112.425 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.37 69.12 0.87 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.391 -158.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -153.75 127.29 8.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -77.61 100.12 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.43 140.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.945 0.898 . . . . 0.0 109.437 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -89.22 127.26 35.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 164.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.41 130.3 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.151 0.977 . . . . 0.0 109.244 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -98.12 95.25 7.31 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.7 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.59 131.45 55.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.547 0.739 . . . . 0.0 109.297 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -139.08 116.09 10.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.8 m -88.06 119.08 28.09 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.296 -168.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -88.95 129.16 35.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.711 0.804 . . . . 0.0 110.599 170.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.76 140.82 37.09 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.444 0.64 . . . . 0.0 109.854 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -52.79 -45.92 67.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -93.16 90.89 7.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.06 69.12 1.4 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 117.411 1.724 . . . . 0.0 117.411 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.409 1.7 t 53.51 -168.09 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 158.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.364 9.2 ptp180 -77.14 104.9 7.9 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -170.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.79 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-N 112.214 -2.266 . . . . 0.0 116.086 165.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 80.02 112.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -116.92 69.03 0.75 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 72.43 96.57 0.04 OUTLIER Pre-proline 0 CA--C 1.578 2.054 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 167.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.13 -19.09 39.61 Favored 'Trans proline' 0 CA--C 1.56 1.819 0 N-CA-C 119.047 2.672 . . . . 0.0 119.047 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.02 86.03 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.297 1.408 . . . . 0.0 109.259 164.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -87.53 116.68 25.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.1 133.53 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 123.434 0.694 . . . . 0.0 109.404 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.93 148.93 19.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.119 0.568 . . . . 0.0 111.185 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -70.42 130.35 41.69 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.39 0.676 . . . . 0.0 109.563 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 tp -51.27 -36.93 44.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -161.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.69 -102.65 0.55 Allowed Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.472 162.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.42 0.5 OUTLIER 62.2 169.48 0.12 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.16 17.89 23.27 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.37 -51.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 120.288 1.404 . . . . 0.0 113.318 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.0 167.06 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.412 1.101 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.0 pt -68.08 160.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.295 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.58 -36.69 76.72 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.8 73.11 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 167.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -48.98 58.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.44 -37.28 67.5 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.48 -32.66 60.65 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.7 p -75.27 -11.93 60.17 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 165.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.287 1.3 t -54.66 -49.58 90.49 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 115.477 -2.202 . . . . 0.0 115.255 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.19 -13.46 32.21 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 125.127 2.867 . . . . 0.0 119.514 175.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.12 77.96 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.523 1.51 . . . . 0.0 108.886 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -162.45 109.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -88.69 168.36 12.57 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.166 0.984 . . . . 0.0 112.283 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.49 124.86 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.13 88.4 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -110.39 130.04 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.833 2.316 . . . . 0.0 113.244 -159.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 m -78.05 133.5 37.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.009 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.7 tpt -80.53 106.63 12.69 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.9 115.24 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 p -94.58 100.9 12.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.01 125.84 36.86 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.89 -172.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.79 165.24 17.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.4 p -53.12 -42.77 66.34 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 162.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.75 -43.87 87.62 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 164.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -103.36 67.34 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.398 0.679 . . . . 0.0 110.175 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.8 t -148.15 -93.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.59 42.21 3.32 Favored 'General case' 0 CA--C 1.574 1.879 0 CA-C-N 119.758 1.163 . . . . 0.0 111.527 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 56.98 -109.17 1.52 Allowed Glycine 0 CA--C 1.557 2.71 0 CA-C-O 117.454 -1.748 . . . . 0.0 115.109 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.34 -50.46 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 CA-C-N 121.439 2.619 . . . . 0.0 115.782 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -152.05 133.2 14.36 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.162 0.985 . . . . 0.0 108.54 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.15 -124.6 5.21 Favored Glycine 0 N--CA 1.481 1.643 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.865 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -88.02 68.08 9.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.43 0.692 . . . . 0.0 111.775 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -75.4 137.11 71.42 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.116 -172.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.04 -6.15 53.88 Favored 'Cis proline' 0 CA--C 1.568 2.216 0 N-CA-C 119.494 2.844 . . . . 0.0 119.494 9.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -57.94 -51.83 68.02 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.45 98.71 11.27 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 167.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.25 164.06 37.04 Favored 'Trans proline' 0 CA--C 1.572 2.389 0 C-N-CA 122.703 2.269 . . . . 0.0 114.137 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.47 111.25 2.27 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 123.072 2.515 . . . . 0.0 113.375 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 70.71 99.29 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.656 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.6 132.77 16.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.252 0.621 . . . . 0.0 110.364 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.89 85.11 4.68 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 109.908 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.11 147.5 41.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.014 0.911 . . . . 0.0 112.642 -161.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.2 m -76.55 152.2 36.06 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.84 129.72 4.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.809 0.843 . . . . 0.0 110.218 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.67 98.74 11.6 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.588 . . . . 0.0 110.852 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.4 100.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.1 m -109.17 123.98 50.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.97 117.37 17.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -82.63 -66.19 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -131.26 147.57 52.6 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 -169.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.18 107.72 11.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 167.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.58 147.31 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.474 -170.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.62 144.39 49.47 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -75.82 120.69 6.06 Favored Glycine 0 CA--C 1.556 2.6 0 CA-C-O 116.923 -2.043 . . . . 0.0 114.671 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.77 112.16 2.86 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 CA-C-N 122.466 3.133 . . . . 0.0 112.54 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.51 124.61 34.17 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 121.314 0.578 . . . . 0.0 111.476 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 tt 71.99 91.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.903 1.281 . . . . 0.0 111.085 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.222 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 CA--C 1.551 1.007 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -150.83 136.69 18.2 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.687 0.756 . . . . 0.0 110.887 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 116.29 7.5 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.012 0.925 . . . . 0.0 111.98 173.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 m95 73.11 134.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.383 1.073 . . . . 0.0 111.516 -175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.612 0.765 . . . . 0.0 109.724 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.92 104.46 8.49 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.083 0.953 . . . . 0.0 111.927 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -98.52 130.41 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.436 0.6 OUTLIER 101.15 -66.5 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.231 1.812 . . . . 0.0 111.641 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.57 -70.62 0.08 OUTLIER Glycine 0 N--CA 1.484 1.835 0 CA-C-N 120.034 1.288 . . . . 0.0 114.33 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -73.26 -71.0 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.65 0.78 . . . . 0.0 111.341 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.89 61.28 0.05 OUTLIER Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.31 -0.717 . . . . 0.0 112.321 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.2 -58.72 2.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.638 0.719 . . . . 0.0 110.924 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.51 114.79 29.18 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -115.03 108.87 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.84 0.456 . . . . 0.0 111.197 -168.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -99.48 116.0 30.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.992 -1.067 . . . . 0.0 111.987 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -85.77 119.69 26.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.01 -1.057 . . . . 0.0 108.681 158.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.7 m -90.46 108.66 19.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -71.61 -65.45 0.76 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.166 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.46 136.4 21.47 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.166 164.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.17 176.91 9.4 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 123.0 2.467 . . . . 0.0 114.605 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.9 116.16 5.86 Favored Glycine 0 CA--C 1.558 2.729 0 CA-C-O 117.061 -1.966 . . . . 0.0 111.335 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.64 167.12 27.37 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 CA-C-N 122.55 3.175 . . . . 0.0 115.626 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.98 111.96 2.35 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.072 2.515 . . . . 0.0 112.334 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.54 76.3 1.32 Allowed Glycine 0 CA--C 1.544 1.868 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.661 -161.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.1 p -155.28 131.42 10.19 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.423 0.689 . . . . 0.0 109.744 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -117.27 119.93 36.69 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.457 1.123 . . . . 0.0 112.327 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -73.92 116.67 54.46 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.143 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.03 162.63 40.92 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 122.867 2.378 . . . . 0.0 116.047 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.01 158.7 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.213 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.63 77.74 9.8 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.13 0.966 . . . . 0.0 113.356 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.32 47.07 0.01 OUTLIER Glycine 0 CA--C 1.551 2.315 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.053 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.43 25.4 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.581 1.19 . . . . 0.0 109.269 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.86 103.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.691 0.796 . . . . 0.0 109.858 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.53 113.26 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.9 m -88.48 105.33 17.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.77 141.86 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.64 108.25 3.78 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 109.346 165.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.76 92.57 3.84 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.39 105.8 17.77 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -85.26 101.96 12.95 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.162 0.506 . . . . 0.0 109.743 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -121.65 157.07 31.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.381 1.073 . . . . 0.0 109.818 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.89 103.8 15.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.601 -0.687 . . . . 0.0 109.962 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.396 26.3 tt0 68.27 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 169.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.53 61.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.291 0.636 . . . . 0.0 111.482 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.43 66.29 2.46 Favored Glycine 0 CA--C 1.543 1.804 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -126.02 96.9 4.9 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 173.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -78.38 96.46 5.34 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -165.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 m -81.99 -50.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -152.75 134.73 14.8 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.909 0.861 . . . . 0.0 109.169 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.09 112.79 24.85 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.687 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.33 69.06 3.88 Favored Pre-proline 0 CA--C 1.585 2.289 0 O-C-N 121.446 -0.784 . . . . 0.0 110.953 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.96 -54.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.255 2.637 . . . . 0.0 115.487 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.83 76.61 6.51 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 121.4 1.909 . . . . 0.0 112.536 164.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.58 97.83 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.59 109.01 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -136.05 139.64 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 m -69.28 132.6 46.71 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 tt -69.57 109.68 4.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 80.24 0.98 Allowed Glycine 0 CA--C 1.54 1.644 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.552 -162.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -149.34 160.7 43.19 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.275 1.036 . . . . 0.0 110.793 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.6 p -79.93 71.0 6.6 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.268 1.032 . . . . 0.0 113.433 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -150.58 -62.91 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.479 1.111 . . . . 0.0 110.092 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.84 158.9 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 CA-C-O 123.173 1.463 . . . . 0.0 112.216 -161.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -66.3 152.99 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.726 177.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -57.89 -33.55 68.84 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.51 -46.76 57.42 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -57.65 5.54 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 112.473 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -58.52 -34.24 70.75 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.37 -38.0 77.84 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 167.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -70.49 -20.49 62.85 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.258 54.7 t -62.73 -52.45 64.46 Favored Pre-proline 0 CA--C 1.577 1.995 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.629 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.41 10.47 0.44 Allowed 'Trans proline' 0 CA--C 1.572 2.393 0 CA-C-N 124.703 2.715 . . . . 0.0 118.521 171.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.06 -46.28 5.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.245 1.018 . . . . 0.0 111.59 158.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.0 128.92 35.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.637 1.108 . . . . 0.0 113.013 -173.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -94.97 -147.71 0.28 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 123.153 0.581 . . . . 0.0 111.187 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.97 123.79 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.629 -1.294 . . . . 0.0 110.363 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.77 -103.07 2.97 Favored Glycine 0 CA--C 1.54 1.608 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -168.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 32.57 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -168.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 m -82.06 115.71 21.32 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.58 123.35 11.91 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.324 0.583 . . . . 0.0 110.01 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.9 ttp -76.98 104.97 7.77 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.705 0.802 . . . . 0.0 110.544 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.91 97.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.3 m -99.37 104.22 16.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.18 37.26 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.794 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -48.91 134.24 17.0 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 165.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -51.04 -39.01 54.92 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.254 14.5 pttp -58.69 -41.26 85.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -66.9 -49.79 64.48 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 171.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.03 -160.71 0.34 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.822 0.849 . . . . 0.0 112.295 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -85.73 101.52 12.84 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.91 -91.6 1.78 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 116.866 -2.075 . . . . 0.0 109.66 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.59 -46.53 3.69 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 122.073 2.936 . . . . 0.0 116.253 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -91.3 98.64 11.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -90.42 134.43 12.34 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 115.336 -0.847 . . . . 0.0 115.117 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -113.51 91.44 3.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.889 0.476 . . . . 0.0 109.848 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.4 m 72.68 103.58 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.763 0 CA-C-O 117.476 -1.249 . . . . 0.0 112.003 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.63 -70.07 0.01 OUTLIER 'Cis proline' 0 CA--C 1.565 2.061 0 CA-C-N 122.923 2.08 . . . . 0.0 112.032 8.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.02 78.69 1.62 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 168.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.2 mt -67.29 121.96 80.87 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 -162.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.13 155.17 29.42 Favored 'Trans proline' 0 CA--C 1.569 2.267 0 C-N-CA 122.762 2.308 . . . . 0.0 115.214 -170.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.55 146.6 44.37 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.238 2.626 . . . . 0.0 113.459 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.267 22.4 m170 77.09 157.7 0.19 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.458 1.103 . . . . 0.0 112.245 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.12 127.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.984 1.314 . . . . 0.0 111.705 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.14 114.93 15.35 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.684 0.394 . . . . 0.0 112.038 -174.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.14 130.23 34.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.523 0.729 . . . . 0.0 110.895 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.6 p -85.66 93.33 8.81 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.564 0.746 . . . . 0.0 112.444 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.13 107.91 19.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.743 0.817 . . . . 0.0 109.01 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -85.36 105.99 16.41 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.663 0.744 . . . . 0.0 111.184 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.5 t -90.74 123.44 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.521 1.128 . . . . 0.0 107.969 -173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.9 m -135.94 126.6 27.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 tp -75.45 109.89 9.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.913 -0.492 . . . . 0.0 110.229 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -81.18 -59.54 2.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.382 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.0 p -140.28 132.35 27.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.366 0.667 . . . . 0.0 109.388 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -105.52 112.61 25.77 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.48 138.13 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.516 0.674 . . . . 0.0 109.608 -170.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.52 155.95 35.61 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.195 0.997 . . . . 0.0 113.643 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.92 120.81 17.46 Favored Glycine 0 CA--C 1.559 2.795 0 CA-C-O 116.963 -2.021 . . . . 0.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.47 121.77 5.76 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 CA-C-N 122.494 3.147 . . . . 0.0 113.717 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.35 -60.17 2.3 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.57 123.28 29.6 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.377 0.671 . . . . 0.0 110.648 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.486 1.363 0 C-N-CA 123.142 0.577 . . . . 0.0 109.747 177.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.407 1.1 mm-40 . . . . . 0 CA--C 1.576 1.979 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -104.37 162.96 12.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.997 1.319 . . . . 0.0 110.052 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.59 107.55 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 109.488 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.09 129.7 54.79 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 121.644 0.735 . . . . 0.0 111.744 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.64 -48.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.003 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.22 -70.3 0.25 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 120.111 1.323 . . . . 0.0 113.982 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.79 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.28 -52.19 13.03 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.6 -124.03 0.7 Allowed Glycine 0 CA--C 1.54 1.599 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . 0.377 5.3 mp 72.93 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.115 1.366 . . . . 0.0 112.481 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.98 95.72 10.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -109.38 90.13 3.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -97.37 96.82 8.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.587 -0.696 . . . . 0.0 110.572 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.61 103.11 7.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.488 -0.758 . . . . 0.0 110.415 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.4 m -83.21 100.74 10.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.37 -65.36 1.02 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.616 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -84.2 128.28 62.96 Favored Pre-proline 0 CA--C 1.575 1.931 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 167.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.77 -56.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.953 2.435 . . . . 0.0 116.26 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.72 101.29 0.89 Allowed Glycine 0 CA--C 1.547 2.034 0 CA-C-O 116.71 -2.161 . . . . 0.0 107.887 -162.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.21 162.75 40.53 Favored 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 122.631 3.215 . . . . 0.0 116.42 -164.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.36 130.64 22.91 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.243 2.629 . . . . 0.0 113.701 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.79 -69.16 0.21 Allowed Glycine 0 CA--C 1.542 1.744 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -160.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -82.05 94.16 7.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.397 0.679 . . . . 0.0 111.165 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.0 m -128.09 166.49 18.35 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.983 0.897 . . . . 0.0 111.813 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 134.87 33.73 Favored Pre-proline 0 CA--C 1.577 2.0 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -165.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.33 144.84 11.78 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.133 2.556 . . . . 0.0 114.765 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.4 156.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 124.019 0.927 . . . . 0.0 109.32 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.83 89.09 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -160.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.11 61.15 0.01 OUTLIER Glycine 0 CA--C 1.546 1.988 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.989 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -151.16 144.43 24.76 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.08 94.19 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.78 141.66 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.603 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -124.09 128.21 48.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.579 -167.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.67 150.42 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.3 1.047 . . . . 0.0 110.5 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -96.63 107.55 20.01 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 tt -112.25 106.24 14.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -104.77 120.08 40.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -91.58 126.31 36.61 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -124.3 162.77 23.06 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.132 0.968 . . . . 0.0 110.563 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -83.58 153.27 24.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.326 -0.858 . . . . 0.0 111.815 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -50.86 -45.17 59.76 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 163.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -124.62 63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.44 0.564 . . . . 0.0 110.348 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.39 -116.52 0.59 Allowed Glycine 0 CA--C 1.538 1.485 0 O-C-N 121.178 -0.951 . . . . 0.0 112.128 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.6 t -158.01 -169.38 2.79 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.713 0.805 . . . . 0.0 111.168 -164.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.4 111.67 1.17 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.09 -52.13 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.009 1.324 . . . . 0.0 111.34 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -150.52 107.59 3.58 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -97.45 100.7 12.13 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.523 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.31 90.4 42.05 Favored Pre-proline 0 CA--C 1.572 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.77 -6.16 15.07 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 N-CA-C 120.055 3.06 . . . . 0.0 120.055 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -127.64 102.84 7.01 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.45 1.477 . . . . 0.0 110.071 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -126.8 97.65 5.07 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.69 136.58 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.924 0.889 . . . . 0.0 109.308 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -164.87 154.32 13.12 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.607 0.763 . . . . 0.0 111.032 -169.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.8 m -76.75 137.97 39.64 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.393 0.616 . . . . 0.0 110.398 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.04 115.93 11.85 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.974 0.909 . . . . 0.0 109.98 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.54 73.01 0.97 Allowed Glycine 0 N--CA 1.481 1.639 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.724 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.99 149.5 19.68 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.873 0.844 . . . . 0.0 110.624 -168.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 76.9 m -77.49 80.71 3.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.58 1.181 . . . . 0.0 112.113 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.49 -65.27 0.24 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.856 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -81.08 164.73 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-O 122.437 1.113 . . . . 0.0 112.397 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.84 159.35 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.514 1.126 . . . . 0.0 113.983 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -55.52 -40.23 71.52 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -44.48 71.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.96 -67.67 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 117.199 -1.382 . . . . 0.0 111.616 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -46.48 -42.43 15.52 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.86 -51.51 66.71 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.3 p -77.48 -4.51 45.88 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.304 1.6 t -68.26 -45.64 38.8 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 114.892 -2.48 . . . . 0.0 114.976 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.93 -30.14 91.06 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 CA-C-N 126.77 3.454 . . . . 0.0 117.489 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -100.49 70.66 1.48 Allowed 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.213 1.005 . . . . 0.0 111.146 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -136.32 107.65 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.26 136.52 37.07 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.997 0.903 . . . . 0.0 111.63 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.93 114.17 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.883 -158.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.29 44.75 2.5 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.571 -1.195 . . . . 0.0 115.496 -166.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.39 167.28 12.39 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 118.837 1.318 . . . . 0.0 113.713 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 95.3 m -143.31 108.38 4.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.94 121.34 15.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.315 0.246 . . . . 0.0 110.751 -166.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 ttt -81.57 115.99 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.853 0.461 . . . . 0.0 110.168 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.99 100.61 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.0 p -84.41 97.65 9.62 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.35 32.05 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.343 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.67 144.91 53.81 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t -58.56 -38.63 78.24 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -69.71 -37.46 76.57 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.23 -44.15 92.76 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 169.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.9 t -91.24 -179.66 5.48 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 123.062 1.41 . . . . 0.0 111.49 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.25 113.79 3.41 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.022 158.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.41 -89.38 0.08 OUTLIER Glycine 0 CA--C 1.546 1.986 0 CA-C-O 116.792 -2.115 . . . . 0.0 109.077 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.15 -57.14 0.13 Allowed 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 122.307 3.053 . . . . 0.0 114.295 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -89.13 103.21 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.57 -118.75 0.47 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.051 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -141.9 60.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.875 0.845 . . . . 0.0 111.877 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.9 p -87.85 150.64 48.42 Favored Pre-proline 0 CA--C 1.572 1.808 0 C-N-CA 124.214 1.005 . . . . 0.0 113.129 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.12 -7.33 46.59 Favored 'Cis proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.552 2.866 . . . . 0.0 119.552 11.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.83 -57.71 9.93 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 120.278 1.399 . . . . 0.0 113.854 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.1 mt -90.28 117.84 68.34 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.47 161.4 9.57 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.875 2.383 . . . . 0.0 116.095 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 131.83 21.4 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.138 2.559 . . . . 0.0 112.62 168.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.29 92.0 m-70 71.13 174.65 0.3 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 123.729 0.812 . . . . 0.0 112.306 -170.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.72 118.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.054 1.342 . . . . 0.0 111.964 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.51 97.9 8.67 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.43 149.12 21.85 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.526 0.679 . . . . 0.0 112.749 -171.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -87.77 147.05 25.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.371 0.668 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.58 109.31 3.25 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.59 120.65 26.6 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.797 0.808 . . . . 0.0 111.917 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.6 t -103.3 109.23 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.6 m -116.17 104.48 11.57 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.1 113.87 7.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.398 0.679 . . . . 0.0 110.664 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -85.16 -61.07 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.1 p -142.8 133.27 24.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.21 100.94 10.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.94 132.38 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.119 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.94 73.22 10.36 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.27 1.033 . . . . 0.0 113.766 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.344 0 CA-C-O 116.787 -2.119 . . . . 0.0 114.472 177.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 87.8 m95 72.57 134.05 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.504 1.122 . . . . 0.0 113.526 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.53 93.98 7.1 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.17 112.63 17.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.483 0.713 . . . . 0.0 111.265 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -64.03 -49.88 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.746 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.1 -61.07 2.91 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.8 -71.41 0.26 Allowed Glycine 0 N--CA 1.48 1.576 0 CA-C-N 118.632 0.651 . . . . 0.0 111.763 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -66.62 -72.7 0.15 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.785 0.834 . . . . 0.0 112.025 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.78 72.64 0.03 OUTLIER Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.517 0.599 . . . . 0.0 112.684 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.82 -72.98 0.66 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.31 143.71 31.09 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.999 0.92 . . . . 0.0 110.614 172.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -141.19 161.84 36.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.002 0.921 . . . . 0.0 112.473 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.87 37.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 112.182 164.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -173.48 2.34 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 122.009 0.909 . . . . 0.0 111.591 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -140.8 97.19 3.14 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 164.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.15 -69.09 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.609 0.764 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -101.78 131.63 22.62 Favored Pre-proline 0 CA--C 1.573 1.836 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 160.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 175.17 11.7 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.106 2.538 . . . . 0.0 114.53 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.73 115.34 4.96 Favored Glycine 0 CA--C 1.556 2.64 0 CA-C-O 116.879 -2.067 . . . . 0.0 112.066 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.27 169.36 15.52 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 CA-C-N 122.602 3.201 . . . . 0.0 115.597 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.68 -38.6 76.87 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 123.326 2.684 . . . . 0.0 118.182 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.7 87.61 0.94 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 118.968 0.804 . . . . 0.0 111.597 163.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.7 p -144.4 95.53 2.73 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 p -91.66 108.62 20.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.944 0.878 . . . . 0.0 110.598 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -76.41 126.67 86.02 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.59 -172.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.44 149.62 56.65 Favored 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 115.55 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.85 166.87 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.127 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -62.52 118.77 8.02 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.118 0.567 . . . . 0.0 112.438 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.58 58.41 1.13 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.287 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -143.89 135.65 26.22 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.28 101.8 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 m -122.68 128.24 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.789 0.804 . . . . 0.0 109.249 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -95.13 137.42 34.2 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.913 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 144.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.831 0.824 . . . . 0.0 109.461 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -92.05 100.66 13.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 163.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 tp -86.38 107.05 17.84 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.001 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -102.83 80.25 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 109.519 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.9 m -75.83 129.34 36.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.792 0.837 . . . . 0.0 109.991 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -139.86 164.87 28.82 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.473 1.13 . . . . 0.0 111.621 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.1 tp -78.9 161.68 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.985 0.914 . . . . 0.0 111.992 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -49.37 -42.08 41.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.61 -68.47 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.596 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.83 83.35 0.05 OUTLIER Glycine 0 N--CA 1.479 1.53 0 CA-C-N 119.117 0.871 . . . . 0.0 112.03 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -159.44 122.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.52 115.02 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.29 -45.89 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -145.43 109.16 4.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -94.33 101.64 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.458 0.647 . . . . 0.0 110.113 164.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -92.65 109.29 37.74 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.645 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.14 -51.45 0.6 Allowed 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.026 2.484 . . . . 0.0 117.308 -165.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -121.57 94.91 4.47 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.983 0.896 . . . . 0.0 111.551 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -97.23 102.98 14.87 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.15 123.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -149.7 149.21 30.26 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -170.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -75.77 124.27 27.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.34 114.89 8.0 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.536 0.734 . . . . 0.0 111.004 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.11 18.44 77.9 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 119.64 2.616 . . . . 0.0 119.64 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -132.85 66.25 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.661 1.73 . . . . 0.0 111.587 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.6 t 58.9 78.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -149.78 -66.71 0.21 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 m -97.58 167.27 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.733 1.254 . . . . 0.0 112.256 -166.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -61.09 159.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.946 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.46 -41.34 89.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.86 -46.21 71.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 168.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.7 -57.53 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.345 168.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -46.58 -58.05 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.35 -32.82 74.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.5 p -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.264 1.7 t -64.22 -49.19 74.35 Favored Pre-proline 0 N--CA 1.505 2.295 0 CA-C-N 122.391 2.36 . . . . 0.0 113.71 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.99 1.08 3.65 Favored 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 125.119 2.864 . . . . 0.0 118.61 169.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -97.27 -25.78 15.14 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 156.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 12.0 tpp -81.9 105.38 12.97 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.851 1.205 . . . . 0.0 110.441 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.34 167.48 20.83 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 122.146 0.974 . . . . 0.0 112.095 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.96 107.36 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 108.746 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 14.01 52.14 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.148 2.019 . . . . 0.0 118.148 -166.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.27 110.15 22.12 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 119.971 1.885 . . . . 0.0 109.561 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.9 m -94.29 120.36 34.41 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.22 135.31 49.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.553 0.741 . . . . 0.0 109.535 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 tpt -80.86 103.72 10.88 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.8 t -90.96 94.03 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.5 p -89.14 91.43 8.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.822 0.82 . . . . 0.0 109.487 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.71 134.87 41.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.843 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.9 132.57 47.59 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.908 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.476 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . 26.7 t -74.32 75.09 1.86 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 123.26 1.505 . . . . 0.0 112.723 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -172.17 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.481 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -87.87 -56.94 3.13 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.614 1.166 . . . . 0.0 110.179 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 118' ' ' SER . 20.1 p -46.28 -57.18 4.81 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 168.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -124.94 -46.16 1.85 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.609 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.97 144.46 17.21 Favored Glycine 0 CA--C 1.555 2.541 0 CA-C-O 117.677 -1.624 . . . . 0.0 112.255 -168.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.88 87.91 1.36 Allowed 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 122.184 2.992 . . . . 0.0 113.05 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -144.67 -66.92 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.75 86.0 1.84 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.604 0.621 . . . . 0.0 111.594 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -91.96 152.47 20.01 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.2 m -68.03 140.16 93.38 Favored Pre-proline 0 CA--C 1.573 1.83 0 CA-C-O 117.707 -1.139 . . . . 0.0 112.729 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.71 -50.25 0.2 OUTLIER 'Cis proline' 0 CA--C 1.562 1.923 0 N-CA-C 117.238 1.976 . . . . 0.0 117.238 11.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -149.92 76.47 1.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 119.506 1.048 . . . . 0.0 109.208 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.77 118.11 49.15 Favored Pre-proline 0 CA--C 1.57 1.73 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.59 142.03 12.71 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 122.877 2.385 . . . . 0.0 114.303 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 125.33 10.66 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.131 2.554 . . . . 0.0 112.103 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.278 97.6 m-70 70.0 172.18 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.708 0.803 . . . . 0.0 112.883 -171.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.18 111.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.999 1.32 . . . . 0.0 111.15 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.23 117.25 8.26 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.43 128.11 33.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.819 0.448 . . . . 0.0 109.8 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.11 98.45 8.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.601 0.761 . . . . 0.0 109.355 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 107.0 18.03 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.572 0.749 . . . . 0.0 110.575 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.4 107.9 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.126 0.965 . . . . 0.0 111.276 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.84 105.97 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.9 m -101.34 122.39 43.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -73.07 -74.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.1 p -147.45 131.9 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.776 0.716 . . . . 0.0 109.113 -169.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.47 112.51 25.55 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.209 0.604 . . . . 0.0 109.579 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.2 143.4 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.624 0.77 . . . . 0.0 110.109 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.67 79.43 4.26 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.074 0.94 . . . . 0.0 113.124 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 2.937 0 N-CA-C 116.568 1.387 . . . . 0.0 116.568 173.647 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 122.088 0.947 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.322 14.9 m0 68.92 -135.94 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.362 1.065 . . . . 0.0 111.581 168.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 tt -138.25 119.31 14.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.64 108.81 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.39 0.676 . . . . 0.0 112.207 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.29 45.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -58.45 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 125.272 1.429 . . . . 0.0 110.213 172.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.52 -91.3 0.51 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.95 -36.32 64.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.08 1.35 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -167.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mp 15.82 63.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 165.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 tp -157.99 117.37 3.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -148.76 115.22 5.89 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 -161.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -117.03 133.64 55.75 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -171.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -73.7 143.74 46.07 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.978 0.911 . . . . 0.0 111.661 159.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.5 m -93.45 92.13 7.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 159.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.73 -60.98 2.11 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.774 0.829 . . . . 0.0 113.044 -167.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -113.82 130.2 24.04 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 157.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.84 170.03 21.27 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.088 2.526 . . . . 0.0 114.97 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 152.39 49.65 Favored Glycine 0 CA--C 1.561 2.925 0 CA-C-O 118.376 -1.236 . . . . 0.0 115.345 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.95 164.58 31.24 Favored 'Trans proline' 0 CA--C 1.574 2.486 0 CA-C-N 121.433 2.616 . . . . 0.0 115.556 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.14 113.58 2.68 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 123.201 2.601 . . . . 0.0 113.038 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.6 -96.27 0.94 Allowed Glycine 0 CA--C 1.539 1.557 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -163.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.268 82.9 p 53.96 85.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -79.9 120.62 24.36 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.424 0.63 . . . . 0.0 111.534 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -81.61 124.01 80.25 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.746 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.52 147.9 65.45 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.1 2.533 . . . . 0.0 115.567 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.16 152.74 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.059 0.944 . . . . 0.0 111.842 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.81 118.42 8.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.06 60.48 0.55 Allowed Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.71 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -146.86 146.0 30.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.364 1.078 . . . . 0.0 108.559 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.3 101.39 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.81 125.49 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -107.4 140.29 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.371 0.668 . . . . 0.0 109.308 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.27 141.32 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.801 0.841 . . . . 0.0 109.023 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -83.82 101.32 11.54 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 158.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.6 tp -86.26 100.56 12.35 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -93.68 101.38 13.52 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -81.03 117.51 21.69 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -142.58 154.36 44.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.656 0.783 . . . . 0.0 109.566 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.21 141.54 49.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.858 0.837 . . . . 0.0 111.206 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -57.63 -45.63 85.17 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 157.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.18 -58.01 3.96 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.83 54.13 0.75 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.472 2.5 t 50.92 -157.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 163.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -79.97 107.37 12.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.211 1.004 . . . . 0.0 111.973 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.2 -71.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.378 0.671 . . . . 0.0 111.26 -165.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.92 111.18 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -163.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.25 113.11 25.23 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.133 0.573 . . . . 0.0 110.739 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.92 91.89 16.48 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.498 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.08 -61.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.36 2.707 . . . . 0.0 116.047 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 86.33 5.66 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.663 1.12 . . . . 0.0 110.625 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.8 tp -106.88 92.6 4.16 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 165.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.2 139.44 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.533 0.733 . . . . 0.0 110.395 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -159.6 154.65 24.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.516 0.674 . . . . 0.0 111.748 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -74.87 133.1 41.9 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 171.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.18 111.3 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.129 0.972 . . . . 0.0 111.409 -172.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.35 77.96 0.33 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.015 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.84 157.7 27.12 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.28 1.038 . . . . 0.0 111.228 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.47 83.56 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.274 1.035 . . . . 0.0 112.253 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -151.39 -66.44 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.32 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.61 169.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.702 1.239 . . . . 0.0 113.44 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 pt -52.27 151.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 114.131 -1.395 . . . . 0.0 114.053 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -60.73 -36.78 79.74 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.14 83.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.32 -57.78 7.54 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 117.406 -1.283 . . . . 0.0 113.289 165.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -52.49 -39.9 61.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.6 p -104.54 61.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.96 -61.02 0.17 Allowed Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 115.543 -2.17 . . . . 0.0 108.987 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.97 -25.08 59.67 Favored 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 124.986 2.816 . . . . 0.0 117.542 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -6.27 5.72 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 167.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.2 mtt -114.44 119.8 38.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.935 1.243 . . . . 0.0 109.017 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -64.45 163.3 13.57 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.62 99.72 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 49.28 3.09 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 118.352 1.076 . . . . 0.0 110.741 163.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.3 m -93.5 142.28 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.29 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.83 123.17 13.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.727 0.411 . . . . 0.0 110.705 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.3 tpt -84.02 101.78 12.01 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.47 125.63 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 p -106.35 96.42 6.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.843 0.83 . . . . 0.0 109.219 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.19 167.69 15.46 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.965 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.45 42.91 1.12 Allowed 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.7 p 35.34 54.79 0.81 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -151.86 -58.86 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.821 -159.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.9 -45.61 92.98 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 157.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.6 t -90.78 113.6 25.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.821 0.848 . . . . 0.0 111.173 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.287 81.0 m-85 65.2 14.46 9.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.17 179.1 25.31 Favored Glycine 0 CA--C 1.559 2.824 0 N-CA-C 116.523 1.369 . . . . 0.0 116.523 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -83.46 62.56 7.34 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 122.921 2.414 . . . . 0.0 113.407 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.54 -70.69 0.07 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.84 132.82 7.67 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 118.22 0.464 . . . . 0.0 112.038 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -111.34 52.42 0.75 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.9 m 65.46 143.77 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 170.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.03 -40.39 0.85 Allowed 'Cis proline' 0 CA--C 1.563 1.932 0 CA-C-N 122.687 1.996 . . . . 0.0 116.472 -1.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -132.81 67.33 1.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.2 mt -115.77 119.64 37.13 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -85.54 159.81 10.87 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 C-N-CA 123.157 2.571 . . . . 0.0 115.196 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.08 -39.51 0.87 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 122.959 2.44 . . . . 0.0 117.291 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.87 72.34 1.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.021 0.828 . . . . 0.0 109.04 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.19 21.3 0.25 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 72.68 134.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 tt -138.75 123.48 18.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -99.48 97.3 8.32 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.877 0.846 . . . . 0.0 110.138 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.66 125.59 39.41 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.284 1.034 . . . . 0.0 109.602 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -98.54 103.48 15.43 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.878 0.847 . . . . 0.0 110.298 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.23 109.17 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.7 m -105.26 121.61 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.09 105.83 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.91 -66.9 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.5 p -135.06 135.41 41.26 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.44 0.696 . . . . 0.0 109.219 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.86 104.07 11.82 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.03 154.48 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.742 0.782 . . . . 0.0 109.915 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.19 -170.05 0.89 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.614 0 CA-C-O 116.874 -2.07 . . . . 0.0 115.021 -173.249 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.317 98.5 m95 86.54 106.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.709 1.204 . . . . 0.0 109.596 -161.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.27 107.33 19.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -83.48 116.03 22.35 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.527 0.679 . . . . 0.0 112.193 -165.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.46 -48.83 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 123.909 0.884 . . . . 0.0 111.413 170.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.38 -60.3 3.75 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.413 1.006 . . . . 0.0 113.143 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.78 -72.63 0.29 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-N 118.912 0.778 . . . . 0.0 112.446 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -69.56 -70.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.687 0.795 . . . . 0.0 112.353 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.82 64.06 0.09 OUTLIER Glycine 0 N--CA 1.481 1.644 0 CA-C-N 118.393 0.542 . . . . 0.0 111.863 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.1 mt -137.04 -78.74 0.4 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.894 -163.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 tp -88.27 124.72 34.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 121.022 1.737 . . . . 0.0 107.988 166.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -154.95 113.19 3.49 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.477 -164.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -119.2 115.99 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.339 1.056 . . . . 0.0 109.127 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -103.8 141.18 36.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.819 -0.551 . . . . 0.0 111.081 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.9 m -80.18 115.35 19.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.9 -69.08 0.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.539 0.736 . . . . 0.0 109.293 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.6 134.09 24.72 Favored Pre-proline 0 CA--C 1.578 2.035 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.021 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.04 149.83 29.08 Favored 'Trans proline' 0 CA--C 1.558 1.686 0 C-N-CA 122.851 2.368 . . . . 0.0 114.11 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 114.49 4.0 Favored Glycine 0 CA--C 1.555 2.578 0 CA-C-O 116.872 -2.071 . . . . 0.0 113.127 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.83 164.17 36.53 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 CA-C-N 122.775 3.287 . . . . 0.0 116.0 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.09 109.56 2.6 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.272 2.648 . . . . 0.0 111.74 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.81 -66.0 0.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.026 -158.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -65.49 135.03 54.65 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -138.67 146.66 41.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.702 0.763 . . . . 0.0 110.004 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.59 112.46 6.63 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-O 117.998 -1.001 . . . . 0.0 113.362 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.42 166.25 29.88 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.499 2.133 . . . . 0.0 115.942 -161.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.66 162.82 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.22 -168.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 107.52 4.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.391 0.676 . . . . 0.0 110.223 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.45 -47.84 0.8 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 115.415 -0.811 . . . . 0.0 113.919 -163.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -63.36 124.05 20.28 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.708 0.803 . . . . 0.0 111.739 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.49 99.25 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.49 140.35 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.863 0.839 . . . . 0.0 110.557 -172.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 m -114.41 124.04 50.95 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.15 142.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.794 0.837 . . . . 0.0 110.288 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -94.67 99.52 11.62 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 165.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.25 106.01 18.1 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.9 87.92 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.6 m -71.48 125.07 26.08 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.149 0.58 . . . . 0.0 110.562 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 t -131.38 155.34 47.44 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.098 0.952 . . . . 0.0 110.329 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.1 146.93 30.34 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.612 165.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.59 -33.33 60.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -68.16 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.96 0.8 . . . . 0.0 112.059 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.5 77.27 0.03 OUTLIER Glycine 0 N--CA 1.479 1.502 0 CA-C-N 119.117 0.871 . . . . 0.0 113.147 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 m -149.34 106.61 3.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -82.65 105.96 14.12 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.1 m -96.79 -45.3 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -165.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -136.1 87.99 2.35 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.847 1.203 . . . . 0.0 110.101 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.38 115.07 26.85 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.322 0.582 . . . . 0.0 111.671 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.13 102.41 48.84 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.726 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -87.22 77.17 2.02 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.633 2.222 . . . . 0.0 114.073 -166.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.461 8.7 pt-20 133.36 94.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 127.401 2.281 . . . . 0.0 110.047 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.33 99.56 7.1 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.31 138.22 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.693 -169.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -164.54 149.88 10.1 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.253 0.621 . . . . 0.0 110.683 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -79.46 128.62 33.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.64 135.1 52.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.563 0.745 . . . . 0.0 112.115 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 52.38 18.4 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.32 -16.71 0.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.255 17.0 t 76.2 86.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.44 1.496 . . . . 0.0 110.558 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -132.84 -70.63 0.54 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.062 0.545 . . . . 0.0 110.541 -174.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.68 178.81 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 123.795 0.838 . . . . 0.0 112.521 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -54.76 144.2 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.361 1.064 . . . . 0.0 113.671 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -57.32 -27.88 62.59 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.37 -47.58 85.19 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -62.59 1.33 Allowed 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.853 170.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.15 -51.5 42.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.66 -36.14 81.89 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.6 p -74.48 -10.15 59.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.556 2.799 . . . . 0.0 118.556 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -59.88 -50.29 87.28 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 115.391 -2.243 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.16 -30.59 61.64 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 CA-C-N 125.362 2.951 . . . . 0.0 118.283 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.28 65.54 1.43 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 119.057 0.844 . . . . 0.0 111.176 163.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.0 ttm -160.23 109.65 1.76 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 157.71 20.44 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.071 0.938 . . . . 0.0 112.566 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.14 121.62 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.354 -0.841 . . . . 0.0 111.405 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.433 ' H ' HD12 ' A' ' 143' ' ' LEU . . . 89.72 -3.69 83.32 Favored Glycine 0 CA--C 1.552 2.364 0 N-CA-C 118.49 2.156 . . . . 0.0 118.49 -167.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.5 114.26 12.69 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 121.25 2.525 . . . . 0.0 112.147 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.5 m -84.14 124.24 30.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 133.19 21.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.421 0.689 . . . . 0.0 109.579 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.438 ' SD ' ' SG ' ' A' ' 138' ' ' CYS . 26.9 tpp -83.75 137.9 33.52 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.86 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.8 t -128.48 125.22 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.5 p -102.74 95.49 6.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.81 127.25 32.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.297 172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.73 59.46 4.66 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.8 p 33.35 64.09 0.32 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -173.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -176.6 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.899 -155.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -79.64 -38.76 33.02 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.288 1.435 . . . . 0.0 112.745 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.8 t -62.3 -63.92 1.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 163.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -137.16 -69.41 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.87 0.868 . . . . 0.0 109.665 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 119.63 -166.15 13.37 Favored Glycine 0 CA--C 1.555 2.549 0 CA-C-N 118.938 0.79 . . . . 0.0 113.17 -167.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -64.38 -10.46 24.05 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 N-CA-C 118.573 2.49 . . . . 0.0 118.573 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -105.47 103.27 12.76 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -122.7 157.63 17.3 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 123.685 0.66 . . . . 0.0 112.356 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -87.75 78.21 8.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.1 p -75.69 142.59 73.91 Favored Pre-proline 0 CA--C 1.568 1.668 0 CA-C-O 117.819 -1.086 . . . . 0.0 113.096 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.31 -15.29 32.51 Favored 'Cis proline' 0 CA--C 1.565 2.027 0 N-CA-C 119.397 2.807 . . . . 0.0 119.397 10.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -64.22 -47.86 78.09 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.25 101.01 53.92 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 171.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.34 145.82 66.92 Favored 'Trans proline' 0 CA--C 1.572 2.387 0 C-N-CA 122.525 2.15 . . . . 0.0 113.387 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.69 -34.55 62.19 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 123.196 2.597 . . . . 0.0 118.343 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -125.36 157.04 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.85 0.86 . . . . 0.0 109.905 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.262 . . 81.05 128.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.151 1.38 . . . . 0.0 111.569 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.99 153.44 33.8 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.374 1.991 . . . . 0.0 116.374 -169.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.77 134.62 54.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.69 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 113' ' ' MET . 42.3 t -90.92 91.93 8.55 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.988 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 139' ' ' LEU . 1.7 pt? -79.66 121.12 24.9 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.049 0.928 . . . . 0.0 110.443 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -99.46 88.35 3.85 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.839 1.255 . . . . 0.0 109.053 -170.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.0 t -84.14 126.25 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -166.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -115.33 118.21 32.62 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -78.56 108.83 12.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -81.69 -70.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -145.28 135.65 24.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -167.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.87 95.57 5.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.512 0.673 . . . . 0.0 109.301 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.53 158.14 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 124.013 0.925 . . . . 0.0 109.785 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.04 -177.7 3.01 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.651 0 CA-C-O 116.906 -2.052 . . . . 0.0 113.502 179.503 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.496 1.858 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -109.79 136.43 49.13 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.158 0.983 . . . . 0.0 109.774 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 tp -145.64 113.44 6.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.98 161.37 27.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.9 mm -90.16 -67.74 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.427 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.255 2.4 pt? -70.28 -52.96 19.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -171.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.77 56.64 0.05 OUTLIER Glycine 0 N--CA 1.483 1.824 0 C-N-CA 123.73 0.681 . . . . 0.0 113.232 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -150.51 -55.84 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.973 0.909 . . . . 0.0 110.706 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.32 57.77 0.38 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 124.24 0.924 . . . . 0.0 111.693 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.7 mt -141.18 -59.75 0.49 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.081 0.953 . . . . 0.0 108.896 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.9 tp -92.07 89.13 6.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.222 0.919 . . . . 0.0 108.553 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -101.13 96.93 7.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.565 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -91.77 99.72 12.55 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.61 0.764 . . . . 0.0 112.185 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -86.37 127.34 34.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.474 -0.766 . . . . 0.0 109.806 164.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.2 m -87.47 112.89 22.67 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.67 -68.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.82 0.848 . . . . 0.0 110.242 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.03 117.88 66.04 Favored Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.89 167.58 16.29 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.956 2.438 . . . . 0.0 114.937 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.45 170.47 50.58 Favored Glycine 0 CA--C 1.564 3.109 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 170.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.38 169.19 17.56 Favored 'Trans proline' 0 CA--C 1.575 2.549 0 C-N-CA 122.972 2.448 . . . . 0.0 115.844 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.86 113.42 3.22 Favored 'Trans proline' 0 CA--C 1.558 1.723 0 C-N-CA 123.039 2.493 . . . . 0.0 112.326 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.35 -86.1 0.44 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -164.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.285 81.7 p 63.05 113.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.6 m -92.22 135.93 33.6 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.135 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 143.06 26.01 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.04 145.96 22.55 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.525 2.15 . . . . 0.0 115.764 -162.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 62' ' ' LYS . 8.3 p -95.71 -179.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 124.578 1.151 . . . . 0.0 111.759 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 61' ' ' VAL . 25.6 tttm -63.66 119.95 10.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.73 47.05 2.0 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.88 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.45 124.83 26.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.54 99.87 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -103.72 126.54 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.747 0.819 . . . . 0.0 109.17 -171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -100.86 113.4 26.31 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.69 140.76 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.821 0.848 . . . . 0.0 109.014 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -92.56 100.52 13.03 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.68 106.31 17.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.78 99.82 11.39 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -78.22 119.26 21.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -132.24 145.73 51.52 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.753 0.787 . . . . 0.0 109.945 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.96 148.78 48.49 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.704 172.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -55.15 -31.34 61.25 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -63.6 -68.04 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.97 0.805 . . . . 0.0 111.682 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.02 77.04 0.02 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -147.57 117.9 7.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -74.1 95.74 2.6 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 122.624 1.202 . . . . 0.0 112.903 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.04 -45.39 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -125.11 150.27 47.02 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.313 1.054 . . . . 0.0 109.822 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -147.35 79.26 1.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.566 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.89 98.43 5.39 Favored Pre-proline 0 CA--C 1.579 2.069 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.28 -43.92 1.98 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.176 2.584 . . . . 0.0 115.865 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.9 77.27 8.53 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.312 1.053 . . . . 0.0 110.067 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.0 tp -100.33 98.01 8.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.92 135.56 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -158.56 142.24 15.26 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.459 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 m -80.24 133.3 35.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.46 138.6 57.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.967 0.507 . . . . 0.0 111.97 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.2 -66.01 0.25 Allowed Glycine 0 N--CA 1.478 1.484 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.65 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 104.48 5.68 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.312 0.577 . . . . 0.0 110.037 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.82 82.84 6.18 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.797 0.808 . . . . 0.0 112.803 -161.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.89 -50.8 14.0 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.122 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.64 161.05 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.1 pt -54.59 151.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 124.829 1.252 . . . . 0.0 114.222 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -65.41 -17.12 64.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -36.98 85.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.98 -71.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.378 -1.296 . . . . 0.0 111.641 159.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.74 -44.34 27.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 -168.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.26 -50.18 72.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -75.49 -12.0 60.15 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.272 5.7 t -67.79 -46.48 44.5 Favored Pre-proline 0 N--CA 1.497 1.923 0 CA-C-O 115.214 -2.327 . . . . 0.0 114.023 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.22 35.14 0.38 Allowed 'Trans proline' 0 CA--C 1.579 2.74 0 CA-C-N 125.415 2.969 . . . . 0.0 116.672 165.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.3 mt -138.89 -38.75 0.5 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 126.525 1.93 . . . . 0.0 110.495 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 42.3 mtt -63.65 123.82 19.82 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.814 1.246 . . . . 0.0 112.768 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.67 159.96 23.83 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.661 1.22 . . . . 0.0 112.836 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.57 105.15 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.6 62.42 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.685 -1.064 . . . . 0.0 114.296 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.27 129.04 23.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.477 1.138 . . . . 0.0 112.194 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.9 m -85.62 130.14 34.65 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.98 127.75 14.34 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.643 0.259 . . . . 0.0 111.284 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.4 tpp -84.06 108.92 17.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.02 106.58 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 66.0 p -94.69 93.51 7.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.42 18.06 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -74.46 153.9 38.96 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.688 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.3 t -75.12 83.82 2.33 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.782 1.277 . . . . 0.0 110.623 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -178.02 -61.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.047 -155.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -77.69 -53.2 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.582 1.153 . . . . 0.0 111.793 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m -81.76 107.75 14.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.86 0.864 . . . . 0.0 110.243 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.305 23.8 m-85 70.12 -0.04 2.94 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.27 -179.91 48.24 Favored Glycine 0 CA--C 1.559 2.823 0 CA-C-N 120.26 1.391 . . . . 0.0 115.649 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.95 -46.05 9.24 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.286 2.657 . . . . 0.0 116.325 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -95.43 102.52 14.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.71 -152.9 11.75 Favored Glycine 0 CA--C 1.548 2.11 0 N-CA-C 116.713 1.445 . . . . 0.0 116.713 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -82.75 66.11 8.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 124.114 0.966 . . . . 0.0 112.182 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.5 p -80.21 146.97 63.79 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.384 -175.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.1 -11.98 29.93 Favored 'Cis proline' 0 CA--C 1.565 2.073 0 N-CA-C 119.637 2.899 . . . . 0.0 119.637 7.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -60.55 -58.02 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -96.5 105.03 20.0 Favored Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.29 160.8 48.3 Favored 'Trans proline' 0 CA--C 1.573 2.432 0 C-N-CA 122.711 2.274 . . . . 0.0 113.986 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.98 112.61 2.76 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 123.031 2.488 . . . . 0.0 112.965 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 88.6 m-70 72.92 86.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.71 1.204 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.88 121.74 4.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.65 122.98 25.44 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.015 0.526 . . . . 0.0 111.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 mt -97.84 139.95 32.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.696 0.76 . . . . 0.0 111.92 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -102.2 90.74 4.02 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.832 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.86 118.81 37.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.706 0.802 . . . . 0.0 110.227 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.5 107.43 19.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.041 0.924 . . . . 0.0 110.901 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.23 111.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -108.98 117.11 33.35 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.07 108.81 10.41 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.45 -59.72 2.14 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.254 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 76.1 p -132.93 139.3 47.27 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.654 0.781 . . . . 0.0 109.114 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.67 112.75 17.13 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -128.46 132.16 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.49 119.44 23.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.125 0.488 . . . . 0.0 111.619 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.673 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.75 0.786 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 m0 67.91 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.425 1.49 . . . . 0.0 112.928 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.426 ' H ' HD13 ' A' ' 37' ' ' LEU 0.25 0.0 OUTLIER -80.22 128.23 33.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.466 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -109.73 148.35 31.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.132 0.973 . . . . 0.0 113.589 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.53 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 tp -166.07 -70.73 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.29 -75.01 0.27 Allowed Glycine 0 CA--C 1.54 1.594 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -164.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.6 -84.75 0.08 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.464 0.706 . . . . 0.0 110.694 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.21 84.53 0.05 OUTLIER Glycine 0 N--CA 1.476 1.363 0 CA-C-N 118.825 0.739 . . . . 0.0 111.68 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.08 -58.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.803 0.841 . . . . 0.0 109.61 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.5 96.0 7.89 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.142 0.883 . . . . 0.0 108.895 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -118.1 90.04 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.075 0.95 . . . . 0.0 109.071 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.263 17.1 ptmt -83.49 123.8 30.08 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.78 138.35 32.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 161.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 m -98.62 109.06 21.88 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.52 -77.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.92 125.44 34.56 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.78 -168.49 0.59 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 123.54 2.827 . . . . 0.0 113.312 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.62 Favored Glycine 0 CA--C 1.563 3.089 0 CA-C-O 118.959 -0.911 . . . . 0.0 115.103 163.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.35 167.28 22.71 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 C-N-CA 123.085 2.523 . . . . 0.0 114.931 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.8 109.6 1.5 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.125 2.55 . . . . 0.0 111.854 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.07 81.56 1.49 Allowed Glycine 0 CA--C 1.543 1.782 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.992 -157.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.2 p -141.05 116.05 9.82 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 144.53 31.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.462 0.705 . . . . 0.0 112.053 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -93.27 111.81 53.59 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.384 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.4 169.31 22.01 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 123.196 2.597 . . . . 0.0 115.938 -165.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.6 160.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 123.808 0.843 . . . . 0.0 112.429 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -69.5 110.37 4.73 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 122.938 0.495 . . . . 0.0 109.995 162.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.51 -60.36 0.64 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.887 -157.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.87 119.84 17.67 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.233 0.613 . . . . 0.0 110.874 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.01 112.53 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.83 139.51 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.295 0.569 . . . . 0.0 110.985 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -101.52 131.41 47.69 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.9 138.92 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.032 0.533 . . . . 0.0 111.345 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.72 98.7 9.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.55 127.74 33.63 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 164.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -116.5 87.36 2.67 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 m -85.75 116.44 24.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.7 m -138.61 33.62 2.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.258 10.3 mt 55.59 167.05 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.91 -43.91 97.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.35 -60.72 2.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.99 73.94 0.03 OUTLIER Glycine 0 CA--C 1.543 1.783 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -174.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 m -152.87 117.03 4.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -76.58 111.01 11.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -83.69 -63.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 124.034 0.934 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -146.94 103.13 3.59 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -91.96 90.34 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.706 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -100.08 107.12 45.51 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.892 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.0 -49.84 0.12 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.277 2.652 . . . . 0.0 117.041 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.56 84.16 1.92 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.371 0.669 . . . . 0.0 110.316 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.9 tp -103.09 92.19 4.43 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.79 128.71 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -157.9 149.09 21.25 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.213 0.605 . . . . 0.0 111.057 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -73.28 126.82 30.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.2 tp -59.67 117.0 4.43 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -159.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.61 40.27 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.08 178.51 6.97 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.726 1.251 . . . . 0.0 111.483 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 77.4 m -78.19 68.11 4.15 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -167.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.89 -54.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.676 1.59 . . . . 0.0 109.278 172.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.09 164.65 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 122.545 1.164 . . . . 0.0 112.917 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.9 pt -62.69 154.77 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.824 1.25 . . . . 0.0 113.276 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.39 -32.53 71.4 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.2 74.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 168.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.34 -50.97 63.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 169.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -51.66 -45.83 63.55 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.26 -36.36 79.31 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -72.65 -19.07 61.5 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.27 2.1 t -52.35 -51.33 73.41 Favored Pre-proline 0 CA--C 1.578 2.044 0 CA-C-O 115.125 -2.369 . . . . 0.0 116.627 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.08 -41.84 68.95 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 125.216 2.898 . . . . 0.0 118.066 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -89.81 16.24 8.4 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.9 mtm -81.47 102.45 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 121.023 1.738 . . . . 0.0 110.314 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.96 152.8 35.12 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.044 0.926 . . . . 0.0 111.814 167.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -67.04 111.36 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.5 12.68 55.62 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 116.69 17.03 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.709 2.755 . . . . 0.0 112.519 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.0 m -100.23 102.78 14.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 125.19 22.88 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 -166.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.6 tpp -68.14 102.6 1.37 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.773 0.829 . . . . 0.0 111.698 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.72 96.16 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.5 t -114.65 116.08 28.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.538 0.735 . . . . 0.0 109.045 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.33 155.35 21.29 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.509 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -58.19 152.8 16.29 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.235 150.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 78.6 p -70.04 77.23 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.326 1.06 . . . . 0.0 112.493 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -52.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.638 -165.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.27 -51.38 8.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.063 1.345 . . . . 0.0 111.328 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -64.01 -62.9 1.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -133.31 -58.32 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.52 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.66 179.05 47.89 Favored Glycine 0 CA--C 1.558 2.721 0 CA-C-N 119.319 0.963 . . . . 0.0 114.955 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.45 100.97 0.82 Allowed 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 123.138 2.559 . . . . 0.0 112.57 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -158.08 -71.26 0.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.621 -165.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.94 83.74 1.08 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 118.601 0.637 . . . . 0.0 112.13 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -89.95 152.48 21.2 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-O 121.919 0.866 . . . . 0.0 111.696 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -75.36 140.67 72.73 Favored Pre-proline 0 CA--C 1.571 1.761 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.892 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.54 -58.68 0.07 OUTLIER 'Cis proline' 0 CA--C 1.563 1.935 0 CA-C-N 122.85 2.053 . . . . 0.0 116.156 10.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -137.44 67.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mt -103.49 114.08 65.14 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.21 137.93 24.37 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.403 2.068 . . . . 0.0 114.694 -166.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.58 -45.88 8.14 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 123.207 2.605 . . . . 0.0 116.343 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -128.22 85.78 2.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.697 0.799 . . . . 0.0 109.85 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.77 125.19 3.15 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.66 101.66 5.84 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.067 0.547 . . . . 0.0 111.392 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -103.3 143.92 32.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.2 m -92.89 136.21 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.637 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.83 106.92 3.58 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.067 0.547 . . . . 0.0 110.478 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -87.31 117.63 26.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.486 1.136 . . . . 0.0 113.806 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.78 114.99 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -169.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -96.26 121.9 38.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.26 104.8 11.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -81.4 -63.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 -171.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 58.5 p -144.25 132.24 21.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.21 103.63 15.59 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 168.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.53 123.24 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -171.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.75 124.4 28.16 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 112.464 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.796 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.173 -169.084 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 . . . . . 0 CA--C 1.572 1.816 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -55.08 121.26 8.36 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -167.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 tp -175.01 154.43 1.82 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.037 -159.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.6 t0 68.78 119.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 149.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 mm -118.02 -54.66 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.072 0.949 . . . . 0.0 109.23 167.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.14 -63.77 1.11 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.48 -61.7 0.01 OUTLIER Glycine 0 N--CA 1.483 1.809 0 CA-C-N 119.448 1.022 . . . . 0.0 115.259 -171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -90.23 -78.58 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 117.734 0.767 . . . . 0.0 110.777 -172.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 177.0 72.24 0.06 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 mt -122.11 -66.32 1.04 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -163.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -80.06 98.54 7.29 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.19 96.46 7.49 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.946 0.498 . . . . 0.0 110.017 -164.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -105.47 132.93 51.02 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -113.36 145.61 40.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.806 -0.559 . . . . 0.0 110.249 152.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.9 m -88.74 108.45 19.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.29 -67.96 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.586 0.755 . . . . 0.0 111.45 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.05 122.29 62.14 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 167.83 19.41 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 114.586 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.66 123.42 6.68 Favored Glycine 0 CA--C 1.556 2.643 0 CA-C-O 117.049 -1.973 . . . . 0.0 113.351 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.45 167.92 22.64 Favored 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 122.53 3.165 . . . . 0.0 115.607 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.05 112.96 3.1 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.105 2.537 . . . . 0.0 111.869 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 76.81 1.34 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.473 -160.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 t -159.4 108.45 1.85 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 m -128.71 118.29 22.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.41 1.1 . . . . 0.0 110.368 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -64.13 132.94 95.45 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.86 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 164.09 35.25 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.91 2.407 . . . . 0.0 116.31 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.9 t -82.24 150.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.947 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -59.09 104.12 0.22 Allowed 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.971 1.308 . . . . 0.0 113.31 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.29 62.54 0.34 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.032 -165.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -155.44 138.66 15.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.48 106.89 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.329 -0.857 . . . . 0.0 109.671 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.16 118.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 124.128 0.971 . . . . 0.0 108.765 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.5 m -100.31 124.2 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.57 137.29 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.208 0.528 . . . . 0.0 110.459 -173.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -88.71 106.98 18.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 165.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.6 pt? -103.52 121.67 43.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.161 0.585 . . . . 0.0 110.094 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -103.44 99.17 8.99 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -93.64 99.44 11.87 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.037 0.535 . . . . 0.0 110.7 -165.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -104.57 -169.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.3 0.64 . . . . 0.0 111.359 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 tp -114.88 147.82 39.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.705 1.202 . . . . 0.0 109.513 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.322 4.2 pt-20 -60.44 -29.99 69.37 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 117.527 2.418 . . . . 0.0 117.527 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -64.64 -68.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.896 161.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.08 0.05 OUTLIER Glycine 0 N--CA 1.482 1.756 0 CA-C-N 119.53 1.059 . . . . 0.0 113.107 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.3 m -153.33 122.58 6.6 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -76.52 97.15 4.26 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.041 0.924 . . . . 0.0 111.301 171.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -84.99 -47.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.138 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -125.04 156.78 37.64 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.842 1.306 . . . . 0.0 110.503 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.86 93.0 2.87 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 161.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -85.24 116.7 66.61 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.622 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.86 -49.46 0.15 Allowed 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.938 2.426 . . . . 0.0 116.56 -168.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -137.84 93.66 2.8 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.134 0.879 . . . . 0.0 109.423 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 tp -85.4 104.42 15.19 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.74 96.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -125.42 147.57 49.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.598 0.759 . . . . 0.0 109.32 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.0 m -100.38 66.51 1.28 Allowed 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 123.012 0.525 . . . . 0.0 110.019 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . 0.401 7.6 mp 61.17 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.25 -94.4 0.18 Allowed Glycine 0 N--CA 1.483 1.816 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.448 165.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 68.1 150.11 0.07 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.2 t -82.26 72.73 9.32 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.58 1.181 . . . . 0.0 113.445 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.74 -61.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.251 1.42 . . . . 0.0 108.982 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.6 152.98 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.829 1.3 . . . . 0.0 113.147 -151.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.1 pt -68.94 165.7 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.876 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -57.97 -34.65 70.17 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 171.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.21 86.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.15 -45.77 62.84 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -66.79 -32.36 73.6 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.11 -15.09 57.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.3 p -71.05 -36.39 72.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.233 1.833 . . . . 0.0 115.37 164.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.0 -53.33 39.21 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 115.897 -2.001 . . . . 0.0 115.027 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.44 -15.0 42.54 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 123.644 2.896 . . . . 0.0 119.104 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.33 48.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 120.341 1.428 . . . . 0.0 112.869 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.8 mtp -143.12 100.15 3.58 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.38 176.05 8.09 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.244 1.021 . . . . 0.0 110.829 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.84 105.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.798 -1.189 . . . . 0.0 109.874 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.14 61.16 0.86 Allowed Glycine 0 CA--C 1.546 1.978 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.737 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -140.49 122.19 15.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.656 0.782 . . . . 0.0 110.08 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.1 m -94.6 136.24 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 160.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.08 113.73 9.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 53.3 ttm -84.84 115.01 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.88 128.14 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.0 p -94.64 87.53 5.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.09 19.16 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.222 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.85 144.74 8.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.6 p -54.87 -19.28 6.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -59.24 -51.3 70.55 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 161.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -77.89 -48.84 15.45 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.83 1.252 . . . . 0.0 113.511 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.46 174.56 7.48 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.092 1.357 . . . . 0.0 112.94 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -73.69 100.89 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.593 0.757 . . . . 0.0 110.711 166.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.93 -87.78 1.96 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 116.147 -2.474 . . . . 0.0 108.317 163.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.54 52.61 4.15 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 122.675 3.237 . . . . 0.0 114.722 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -132.41 -77.81 0.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.55 112.1 2.02 Favored Glycine 0 N--CA 1.48 1.617 0 CA-C-N 119.685 1.13 . . . . 0.0 113.507 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -104.08 127.49 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 157.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 145.64 89.84 Favored Pre-proline 0 CA--C 1.571 1.767 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -91.23 -64.99 0.03 OUTLIER 'Cis proline' 0 CA--C 1.565 2.047 0 CA-C-N 122.689 1.996 . . . . 0.0 116.701 8.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -115.48 43.95 1.95 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -165.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.2 mt -80.31 118.21 71.35 Favored Pre-proline 0 CA--C 1.58 2.121 0 O-C-N 120.643 -1.286 . . . . 0.0 108.113 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.28 160.65 26.11 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 122.933 2.422 . . . . 0.0 116.242 -166.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.1 136.23 24.29 Favored 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 123.292 2.662 . . . . 0.0 114.251 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.285 97.1 m-70 73.65 162.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.688 1.195 . . . . 0.0 113.828 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 77.24 148.07 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.075 1.35 . . . . 0.0 113.436 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.53 148.02 47.14 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.4 mt -100.65 123.38 44.78 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.017 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.5 84.48 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.335 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.65 120.86 43.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.389 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.69 147.81 50.08 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.343 160.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 t -134.21 100.12 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -95.69 123.3 39.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.31 104.62 13.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -88.61 -56.81 3.15 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.781 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.1 p -140.15 134.69 31.58 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.381 0.673 . . . . 0.0 109.558 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.82 105.3 12.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.5 m -136.5 131.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.422 0.689 . . . . 0.0 109.249 -166.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.88 118.6 30.88 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.046 0.538 . . . . 0.0 110.297 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.087 0 CA-C-O 117.091 -1.95 . . . . 0.0 111.88 177.488 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.26 7.5 tp10 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 m95 73.36 99.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.901 1.281 . . . . 0.0 110.111 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -83.86 114.07 21.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.76 101.33 6.64 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.866 0.841 . . . . 0.0 111.066 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.46 -51.89 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 123.982 0.913 . . . . 0.0 111.407 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -66.11 -63.96 0.97 Allowed 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.24 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.479 1.561 0 CA-C-N 118.96 0.8 . . . . 0.0 112.102 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.37 -66.22 0.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.178 0.591 . . . . 0.0 112.539 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.7 70.15 0.04 OUTLIER Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.401 0.546 . . . . 0.0 112.601 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -124.71 -70.32 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -81.91 120.18 24.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 118.822 0.737 . . . . 0.0 109.762 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.17 152.37 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.322 1.049 . . . . 0.0 111.443 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.37 117.74 14.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 0.0 112.504 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.83 121.14 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.993 . . . . 0.0 108.776 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -86.85 115.79 24.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.77 -65.56 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.777 0.831 . . . . 0.0 110.638 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -116.37 140.44 26.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 119.12 0.873 . . . . 0.0 109.27 165.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.98 171.73 16.73 Favored 'Trans proline' 0 CA--C 1.563 1.958 0 C-N-CA 123.072 2.515 . . . . 0.0 114.443 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.3 103.41 3.04 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-O 116.787 -2.118 . . . . 0.0 109.835 164.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 163.48 35.42 Favored 'Trans proline' 0 CA--C 1.571 2.355 0 CA-C-N 122.734 3.267 . . . . 0.0 116.252 -164.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.41 127.27 15.42 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.273 2.649 . . . . 0.0 113.156 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 -71.36 0.39 Allowed Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -159.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.1 p -75.24 102.46 5.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.402 0.681 . . . . 0.0 111.183 168.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -113.09 147.46 37.25 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.969 0.89 . . . . 0.0 111.287 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -60.34 128.6 88.06 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.56 160.14 47.29 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.041 2.494 . . . . 0.0 115.022 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.4 m -85.23 166.43 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.451 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -53.2 131.13 36.54 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.66 46.76 2.06 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 114.123 -1.398 . . . . 0.0 114.716 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.58 136.23 32.6 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.82 100.74 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 m -92.47 110.02 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -92.47 112.55 24.54 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.36 142.08 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.69 0.757 . . . . 0.0 110.44 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.05 107.26 11.68 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 162.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.45 107.19 17.95 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -103.61 111.89 24.57 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.98 117.44 28.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 t -133.98 152.66 51.94 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.064 0.935 . . . . 0.0 110.048 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.62 139.79 49.47 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.563 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.83 -37.95 77.58 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.99 -53.05 56.12 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 167.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.743 1.156 . . . . 0.0 114.881 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -63.87 137.75 58.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -160.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -61.56 117.01 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.28 35.6 m -81.59 -47.71 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.672 176.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -145.23 119.79 9.74 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 165.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -106.96 83.6 1.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.542 0.686 . . . . 0.0 110.105 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.57 101.84 51.92 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.651 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.64 50.27 3.5 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.644 2.23 . . . . 0.0 115.905 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -161.51 117.05 2.08 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.809 0.844 . . . . 0.0 109.281 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.49 103.91 3.17 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.54 114.26 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.6 142.11 32.08 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -78.46 121.26 24.32 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.29 133.59 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.32 0.509 . . . . 0.0 112.31 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.37 -70.34 0.74 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.925 -167.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -90.71 77.95 6.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.77 0.795 . . . . 0.0 110.215 172.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.36 126.64 53.02 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.628 -163.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -97.72 70.29 2.19 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.477 1.132 . . . . 0.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.03 177.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.411 1.1 . . . . 0.0 110.331 -163.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.59 150.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.833 0.853 . . . . 0.0 112.441 170.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.35 -29.76 71.01 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.09 81.87 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.93 -54.62 35.78 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.436 -1.269 . . . . 0.0 113.96 167.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -53.31 -49.0 67.93 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.6 p -79.3 -8.85 59.37 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 117.684 2.476 . . . . 0.0 117.684 168.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.263 12.8 t -52.44 -48.79 88.67 Favored Pre-proline 0 N--CA 1.501 2.094 0 CA-C-O 115.264 -2.303 . . . . 0.0 114.449 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.74 0.59 1.44 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 CA-C-N 125.114 2.862 . . . . 0.0 119.314 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.253 2.0 pt? -149.21 65.81 1.02 Allowed 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.079 1.309 . . . . 0.0 111.581 167.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.2 mmt -138.35 99.96 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.39 164.04 12.81 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.146 0.974 . . . . 0.0 113.101 -168.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.27 114.73 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.63 -6.78 45.23 Favored Glycine 0 CA--C 1.552 2.381 0 N-CA-C 117.905 1.922 . . . . 0.0 117.905 -167.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.41 126.27 33.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 121.132 2.466 . . . . 0.0 113.396 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.9 m -100.45 127.98 46.64 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 158.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.94 124.08 6.3 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.577 0.351 . . . . 0.0 110.165 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.9 ptm -77.8 131.94 37.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.124 0.57 . . . . 0.0 110.791 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.8 t -113.23 96.2 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.3 p -85.65 102.21 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.2 138.7 54.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.106 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.61 153.24 0.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.9 p -70.67 76.51 0.6 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.921 1.344 . . . . 0.0 112.153 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -179.03 -61.54 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.867 -152.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.17 -50.71 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.443 1.097 . . . . 0.0 112.674 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.24 -68.33 0.4 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -138.82 -66.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.798 0.726 . . . . 0.0 109.31 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.4 -147.93 19.78 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.391 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -72.72 112.71 3.55 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.253 51.3 mt-30 69.37 92.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.891 1.276 . . . . 0.0 110.271 -164.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.81 54.8 Favored Glycine 0 CA--C 1.547 2.049 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -101.39 60.09 0.9 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -163.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 40.7 m 66.95 141.78 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 167.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.45 -45.85 0.4 Allowed 'Cis proline' 0 CA--C 1.564 1.992 0 CA-C-N 122.627 1.974 . . . . 0.0 115.705 -3.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -134.42 63.26 1.63 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.703 0.801 . . . . 0.0 110.489 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.1 mt -91.32 121.35 67.72 Favored Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.47 162.4 35.98 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.918 2.412 . . . . 0.0 116.303 -170.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.85 -46.3 6.78 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 123.215 2.61 . . . . 0.0 116.598 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -97.39 -166.73 1.43 Allowed 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 124.498 1.119 . . . . 0.0 111.689 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.28 128.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.248 1.419 . . . . 0.0 113.106 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.25 101.91 12.91 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.137 0.575 . . . . 0.0 110.921 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.87 143.11 44.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -164.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.7 m -84.7 115.5 22.71 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.002 0.921 . . . . 0.0 110.706 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.19 98.86 6.37 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -82.94 107.36 15.49 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.238 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.7 93.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.4 m -99.99 112.42 24.71 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.53 102.91 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -73.86 -65.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.155 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.0 p -144.72 130.61 19.25 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.37 103.35 15.28 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.11 153.27 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.543 0.737 . . . . 0.0 110.13 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.39 145.73 55.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.097 0 CA-C-O 117.178 -1.901 . . . . 0.0 111.981 -174.625 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.569 1.693 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -76.76 128.42 34.61 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.515 0.726 . . . . 0.0 109.809 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.89 114.2 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.332 0.653 . . . . 0.0 110.692 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.69 127.13 44.52 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.084 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.37 74.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.281 0.632 . . . . 0.0 109.679 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -157.58 -72.75 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.66 0.784 . . . . 0.0 109.018 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.77 -83.34 0.11 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -164.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.55 -70.26 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.239 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.52 85.02 0.05 OUTLIER Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.966 0.803 . . . . 0.0 112.971 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.55 -59.34 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -74.17 114.26 12.3 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.15 0.886 . . . . 0.0 110.489 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -143.46 105.54 4.38 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.716 0.807 . . . . 0.0 109.782 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -101.93 101.42 11.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 112.316 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.26 120.0 23.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.852 -1.155 . . . . 0.0 109.515 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.4 m -78.9 115.66 18.73 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.358 0.599 . . . . 0.0 110.141 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.03 -69.0 0.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.733 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.48 106.82 52.03 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.45 175.14 11.67 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 122.651 2.234 . . . . 0.0 114.655 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.94 123.46 24.14 Favored Glycine 0 CA--C 1.558 2.74 0 CA-C-O 117.133 -1.926 . . . . 0.0 112.466 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.4 161.19 44.33 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 CA-C-N 122.321 3.06 . . . . 0.0 115.29 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 106.74 1.22 Allowed 'Trans proline' 0 CA--C 1.558 1.722 0 C-N-CA 123.181 2.588 . . . . 0.0 112.171 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.72 76.29 1.32 Allowed Glycine 0 CA--C 1.545 1.95 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.591 -159.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -147.96 117.24 6.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -79.71 142.37 35.53 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.056 0.542 . . . . 0.0 112.261 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -91.4 116.3 66.16 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.186 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.93 144.86 31.0 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.703 2.269 . . . . 0.0 114.665 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.18 169.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.196 0.999 . . . . 0.0 112.645 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -64.54 120.32 12.12 Favored 'General case' 0 CA--C 1.568 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 112.084 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.0 40.67 3.72 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -138.26 115.55 11.09 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -72.26 109.46 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 123.285 0.634 . . . . 0.0 110.099 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.5 123.98 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.616 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.7 m -102.61 121.32 42.16 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.94 142.46 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.389 0.675 . . . . 0.0 110.783 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -82.72 104.59 13.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 161.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.35 125.43 47.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -133.3 122.15 23.45 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.489 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.8 p -93.0 131.37 38.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.08 0.952 . . . . 0.0 111.558 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.9 m -155.57 131.5 9.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.579 0.751 . . . . 0.0 109.708 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.03 157.28 19.15 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -52.7 -40.56 63.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -73.36 -64.73 0.92 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.537 0.735 . . . . 0.0 111.142 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.35 0.05 OUTLIER Glycine 0 N--CA 1.478 1.466 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.2 m -146.15 120.82 9.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -80.14 119.4 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.864 0.866 . . . . 0.0 111.974 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.0 t -97.41 -69.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.585 -166.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -143.83 122.11 12.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -167.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -85.52 94.68 9.08 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.456 0.702 . . . . 0.0 110.591 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.12 68.32 46.58 Favored Pre-proline 0 CA--C 1.579 2.068 0 O-C-N 121.384 -0.823 . . . . 0.0 113.163 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 -39.65 3.05 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.355 2.703 . . . . 0.0 117.58 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 76.73 1.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.575 1.079 . . . . 0.0 110.391 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.18 95.96 7.44 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.5 t -101.89 114.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.27 152.51 40.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 111.323 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -75.29 128.32 35.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.94 124.89 21.6 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.032 0.933 . . . . 0.0 111.979 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.64 -41.24 3.06 Favored Glycine 0 CA--C 1.547 2.079 0 N-CA-C 117.505 1.762 . . . . 0.0 117.505 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.91 107.77 18.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.012 1.406 . . . . 0.0 109.562 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -85.98 81.42 8.51 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -150.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.98 -47.37 52.58 Favored 'General case' 0 CA--C 1.574 1.899 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.105 156.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.08 179.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.602 1.161 . . . . 0.0 114.108 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.01 152.09 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.648 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -64.19 -33.46 75.84 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.31 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 167.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -53.09 38.64 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.23 -42.63 86.71 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.86 -34.31 77.66 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -72.82 -22.99 60.72 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.2 t -57.38 -49.94 90.99 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 114.871 -2.49 . . . . 0.0 115.996 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -53.28 -34.58 70.71 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 126.12 3.221 . . . . 0.0 118.424 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.3 pt? -101.01 63.74 1.02 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.598 0.759 . . . . 0.0 111.579 168.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.28 113.32 6.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -97.02 168.12 10.65 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.878 0.847 . . . . 0.0 111.915 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.76 118.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.852 -1.155 . . . . 0.0 108.403 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.09 6.04 72.28 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.144 2.018 . . . . 0.0 118.144 -165.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.12 108.4 19.84 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 120.5 2.15 . . . . 0.0 109.625 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -109.19 119.71 40.34 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.06 136.93 34.14 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.776 0.798 . . . . 0.0 111.075 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.9 ttm -84.0 103.14 13.0 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.062 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.95 92.6 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.9 p -81.41 126.55 31.77 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.282 0.633 . . . . 0.0 109.769 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.1 136.88 17.08 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.316 -175.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -46.02 133.33 8.96 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 124.785 1.234 . . . . 0.0 113.983 168.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.4 m -74.55 84.83 2.05 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.279 1.038 . . . . 0.0 110.983 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -179.55 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -142.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -68.62 -36.52 78.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 162.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.1 m -72.22 -75.12 0.14 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.17 0.895 . . . . 0.0 111.179 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.92 -67.71 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.263 0.938 . . . . 0.0 110.774 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.7 170.72 27.94 Favored Glycine 0 CA--C 1.553 2.45 0 CA-C-N 119.036 0.834 . . . . 0.0 115.088 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.22 10.03 0.35 Allowed 'Trans proline' 0 CA--C 1.571 2.348 0 N-CA-C 119.375 2.798 . . . . 0.0 119.375 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -131.53 -76.65 0.52 Allowed 'General case' 0 CA--C 1.561 1.376 0 CA-C-N 119.527 1.058 . . . . 0.0 108.258 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.56 124.08 1.11 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 119.69 1.132 . . . . 0.0 112.545 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -93.05 39.09 1.04 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.6 m 66.72 139.25 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.79 -50.46 0.17 OUTLIER 'Cis proline' 0 CA--C 1.563 1.964 0 CA-C-N 123.097 2.142 . . . . 0.0 115.896 4.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -132.4 71.76 1.48 Allowed 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.891 0.877 . . . . 0.0 108.855 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.6 mm -99.72 134.55 20.98 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.927 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.32 162.31 33.88 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.203 2.602 . . . . 0.0 116.215 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.77 -94.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 123.358 2.706 . . . . 0.0 113.094 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -136.51 80.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.109 1.322 . . . . 0.0 109.542 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.75 38.55 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 60.14 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tt -96.58 130.04 43.85 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.8 t -100.37 113.36 26.03 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.872 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.15 108.69 20.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.32 97.38 9.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.003 -0.436 . . . . 0.0 110.189 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.79 111.43 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -168.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.1 m -113.79 113.28 24.72 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.04 103.51 9.97 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 120.942 0.401 . . . . 0.0 110.052 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -80.88 -64.46 1.18 Allowed 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -141.78 137.33 31.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.725 0.81 . . . . 0.0 109.008 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.56 107.95 18.65 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.11 125.43 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -81.39 91.04 6.21 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.203 1.001 . . . . 0.0 112.957 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.344 0 CA-C-O 116.876 -2.069 . . . . 0.0 113.851 179.07 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.505 2.286 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -141.4 117.43 10.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -100.03 107.82 19.85 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.57 123.94 30.27 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.448 0.642 . . . . 0.0 111.676 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.44 -58.84 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.664 0.786 . . . . 0.0 110.735 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.258 3.7 pp -66.48 -17.63 64.91 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.45 55.86 4.49 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 119.948 1.249 . . . . 0.0 116.034 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -156.13 -81.18 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.33 59.62 0.03 OUTLIER Glycine 0 CA--C 1.541 1.689 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.172 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.76 -70.98 0.45 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.0 tp -88.29 102.81 15.2 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.495 1.043 . . . . 0.0 108.84 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.0 117.58 31.01 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.363 0.665 . . . . 0.0 110.004 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -122.36 103.62 8.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 0.0 110.266 -168.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -81.02 141.22 34.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.461 -0.775 . . . . 0.0 109.729 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -81.65 96.48 7.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 159.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 112' ' ' ALA . 32.1 tp -64.39 -63.08 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.824 1.25 . . . . 0.0 113.218 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.97 123.89 23.75 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 162.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.61 165.42 24.96 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 C-N-CA 123.117 2.545 . . . . 0.0 114.844 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.3 171.3 55.17 Favored Glycine 0 CA--C 1.562 2.98 0 N-CA-C 115.35 0.9 . . . . 0.0 115.35 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.41 162.72 39.42 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 123.257 2.638 . . . . 0.0 115.827 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.78 -42.2 48.08 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 123.423 2.749 . . . . 0.0 116.743 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.97 -176.21 50.58 Favored Glycine 0 CA--C 1.552 2.365 0 CA-C-N 119.04 0.836 . . . . 0.0 113.711 161.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m 62.36 86.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.376 1.071 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.0 p -98.71 153.67 18.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -165.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -45.13 128.39 5.65 Favored Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.38 165.88 28.48 Favored 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 122.948 2.432 . . . . 0.0 115.843 -173.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -102.63 159.06 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.444 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -63.77 132.79 52.03 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 113.588 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.34 14.28 9.92 Favored Glycine 0 CA--C 1.557 2.717 0 CA-C-N 113.82 -1.536 . . . . 0.0 115.564 -153.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -138.65 114.87 10.29 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.88 109.55 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.75 134.88 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.594 0.758 . . . . 0.0 110.737 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -92.71 127.98 38.41 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.2 126.15 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -71.55 107.0 4.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.879 0.872 . . . . 0.0 110.38 171.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.35 131.72 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.055 0.931 . . . . 0.0 108.975 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -137.66 91.8 2.63 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -87.2 123.76 32.57 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -132.63 179.24 6.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.144 0.978 . . . . 0.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.0 tp -94.37 149.27 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.099 -1.001 . . . . 0.0 110.074 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.48 -20.87 61.48 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.04 -71.79 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.223 0.92 . . . . 0.0 110.494 161.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.28 81.75 0.04 OUTLIER Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.494 1.043 . . . . 0.0 112.917 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.3 m -152.9 114.32 4.24 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.298 19.8 ptp180 -78.08 105.54 9.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -81.14 -48.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -137.79 89.88 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.14 96.93 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.817 0.818 . . . . 0.0 110.192 168.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.14 89.72 17.94 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.88 2.59 6.4 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 N-CA-C 120.139 3.092 . . . . 0.0 120.139 -159.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.301 9.2 pt-20 -151.84 148.75 28.2 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.824 2.102 . . . . 0.0 113.214 154.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.7 tp -142.1 106.44 4.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -165.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.3 t -98.56 106.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -137.55 155.77 48.85 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.4 m -80.75 130.29 35.0 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.366 0.667 . . . . 0.0 109.659 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.61 119.23 10.1 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 62.25 3.49 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -152.52 144.46 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.148 0.979 . . . . 0.0 110.261 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.15 74.8 2.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -126.61 -59.44 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.093 1.357 . . . . 0.0 109.858 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.16 178.14 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.593 1.157 . . . . 0.0 113.074 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.54 137.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.757 0.823 . . . . 0.0 112.011 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -62.07 -29.23 70.16 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.11 84.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 165.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -53.48 57.33 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -66.31 -33.92 76.83 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.37 -34.92 79.04 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 165.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 p -79.82 2.01 24.72 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 167.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.262 2.5 t -53.08 -48.83 90.54 Favored Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 115.262 -2.304 . . . . 0.0 114.787 170.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.04 -18.33 22.48 Favored 'Trans proline' 0 CA--C 1.566 2.121 0 CA-C-N 125.38 2.957 . . . . 0.0 119.012 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.84 70.78 0.74 Allowed 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.295 0.952 . . . . 0.0 108.741 166.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.1 mmt -149.44 90.35 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.36 161.07 18.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.294 1.045 . . . . 0.0 111.994 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.83 104.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.706 . . . . 0.0 109.098 -165.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.75 29.78 Favored Glycine 0 CA--C 1.556 2.63 0 CA-C-O 117.002 -1.999 . . . . 0.0 117.952 -164.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.64 113.72 14.59 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 121.39 2.595 . . . . 0.0 112.761 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -88.73 117.81 27.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.408 ' HA ' ' H ' ' A' ' 50' ' ' LEU . . . -140.28 132.88 28.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.416 0.286 . . . . 0.0 111.465 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.3 tpp -82.19 106.83 14.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.53 87.55 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -106.06 108.8 20.5 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.2 176.74 4.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.36 1.076 . . . . 0.0 112.167 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.13 157.94 29.9 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.9 t -75.36 78.5 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.631 1.205 . . . . 0.0 110.991 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 179.95 -67.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.555 -1.657 . . . . 0.0 106.964 -152.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.65 -41.89 36.71 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.249 1.02 . . . . 0.0 113.082 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 66.7 m -58.55 -63.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.596 1.089 . . . . 0.0 113.011 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.71 -76.05 0.32 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.413 1.006 . . . . 0.0 108.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.47 162.96 21.61 Favored Glycine 0 CA--C 1.557 2.714 0 CA-C-O 118.918 -0.935 . . . . 0.0 113.148 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.26 60.83 5.58 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 CA-C-N 121.151 2.475 . . . . 0.0 114.964 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -158.46 -77.14 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.0 95.76 0.27 Allowed Glycine 0 CA--C 1.536 1.396 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.64 48.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m 65.68 135.24 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.22 -51.05 0.16 OUTLIER 'Cis proline' 0 CA--C 1.562 1.92 0 CA-C-N 123.001 2.107 . . . . 0.0 116.271 3.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -141.66 77.87 1.61 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.335 1.064 . . . . 0.0 108.481 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mt -99.57 120.69 56.98 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 144.09 34.09 Favored 'Trans proline' 0 CA--C 1.571 2.357 0 C-N-CA 122.729 2.286 . . . . 0.0 114.349 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 122.31 8.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.078 2.519 . . . . 0.0 113.026 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.36 32.1 p80 51.86 67.84 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.08 108.27 3.59 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.66 126.75 28.4 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -167.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 tp -111.45 127.27 55.63 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.3 -155.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.1 m -74.75 152.2 39.08 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.12 113.55 3.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.08 0.552 . . . . 0.0 109.866 167.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.53 112.13 20.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.153 0.977 . . . . 0.0 111.374 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.62 107.7 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.3 m -106.53 117.65 34.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.31 109.87 6.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.176 0.591 . . . . 0.0 110.291 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -78.52 -68.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.457 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.1 p -141.8 131.69 24.41 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.044 0.838 . . . . 0.0 109.752 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.94 109.48 21.84 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.58 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.537 0.684 . . . . 0.0 110.507 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.0 145.52 52.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.665 0 CA-C-O 117.01 -1.994 . . . . 0.0 114.587 -176.236 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.329 27.8 tt0 . . . . . 0 N--CA 1.496 1.85 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -123.02 106.96 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.47 108.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.69 122.01 23.36 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.554 1.169 . . . . 0.0 114.028 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.43 74.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.078 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.44 -64.73 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.87 0.868 . . . . 0.0 109.514 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.85 -81.52 0.19 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -160.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -76.22 -76.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.036 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.02 79.94 0.03 OUTLIER Glycine 0 N--CA 1.478 1.44 0 CA-C-N 118.874 0.761 . . . . 0.0 112.087 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.65 -58.91 1.03 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.435 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.1 tp -81.17 123.15 28.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.087 1.312 . . . . 0.0 108.606 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -142.71 131.97 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 123.387 0.675 . . . . 0.0 111.864 -167.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -122.4 132.19 54.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 0.0 113.392 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HZ3' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -110.61 125.34 53.3 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.593 -0.692 . . . . 0.0 109.642 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -81.04 124.41 29.16 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.311 0.505 . . . . 0.0 111.078 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 48' ' ' LYS . 13.8 tp -87.32 -71.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.509 0.724 . . . . 0.0 110.058 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.89 100.65 53.83 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.14 160.67 42.23 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.741 2.294 . . . . 0.0 113.842 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.22 151.26 52.09 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.987 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.56 165.07 28.58 Favored 'Trans proline' 0 CA--C 1.572 2.382 0 C-N-CA 123.132 2.555 . . . . 0.0 115.852 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 115.49 3.93 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 123.139 2.56 . . . . 0.0 112.68 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.11 -103.97 1.04 Allowed Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -167.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.4 m 59.34 100.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.4 m -80.66 128.63 33.84 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.151 0.501 . . . . 0.0 110.126 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -93.12 113.73 60.76 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.808 -1.092 . . . . 0.0 110.495 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.81 150.88 68.47 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.972 2.448 . . . . 0.0 115.274 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.8 166.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.857 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -73.09 99.75 2.86 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.762 0.825 . . . . 0.0 110.656 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.03 -52.36 0.56 Allowed Glycine 0 CA--C 1.549 2.176 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.333 -155.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -73.76 140.16 45.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.764 0.825 . . . . 0.0 112.201 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.7 t -90.17 112.62 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.63 142.88 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.52 1.152 . . . . 0.0 110.481 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -106.43 116.32 31.73 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.37 126.61 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 122.72 0.408 . . . . 0.0 110.21 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -73.62 103.77 4.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 161.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 tp -102.14 100.3 10.51 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -93.62 90.28 6.57 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -90.57 121.68 32.71 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -167.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -124.11 175.88 6.73 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.312 1.045 . . . . 0.0 110.843 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -80.31 -83.54 0.1 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.661 0.784 . . . . 0.0 109.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.05 -69.94 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.602 0.761 . . . . 0.0 109.366 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.16 66.63 1.82 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.399 0.619 . . . . 0.0 110.901 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.22 65.28 3.47 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -132.45 104.35 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.63 107.11 3.76 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.6 0.714 . . . . 0.0 112.514 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.25 18.9 m -87.11 -52.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.856 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.66 82.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.16 114.12 14.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.379 0.609 . . . . 0.0 112.452 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -125.63 97.22 36.72 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.765 -158.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.4 109.01 2.24 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 123.804 3.003 . . . . 0.0 111.037 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.574 1.2 pm0 67.51 81.03 0.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.59 103.32 6.51 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 156.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.1 t -96.87 121.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 148.67 28.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.719 -168.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.5 m -66.8 124.8 23.93 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.06 103.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.358 1.063 . . . . 0.0 112.952 -163.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.04 -42.89 2.91 Favored Glycine 0 CA--C 1.549 2.162 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -55.62 5.98 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.09 108.32 15.47 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.468 0.576 . . . . 0.0 111.675 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.294 2.7 t70 81.01 -51.6 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 170.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.78 158.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -150.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 168.9 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 113.528 -1.669 . . . . 0.0 113.977 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -61.03 -26.8 67.87 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.81 75.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 168.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.68 -49.74 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -56.98 -44.6 82.84 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.6 mt -71.4 -50.77 28.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.6 p -71.91 -45.08 62.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -175.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.46 -39.68 51.3 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 114.919 -2.467 . . . . 0.0 115.462 -169.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.05 -33.09 92.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 126.412 3.326 . . . . 0.0 116.573 168.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.64 -26.49 64.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 69.2 mmm -71.31 129.87 39.95 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 120.003 1.274 . . . . 0.0 111.393 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.44 158.57 33.62 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 122.752 1.263 . . . . 0.0 113.614 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.74 108.22 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.019 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.35 23.62 23.86 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 117.476 1.751 . . . . 0.0 117.476 -163.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -98.05 129.59 44.89 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.812 1.806 . . . . 0.0 111.184 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.6 m -107.33 123.03 47.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.49 131.53 9.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 0.0 110.736 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.91 104.68 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.415 0.686 . . . . 0.0 109.369 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.1 t -93.62 96.27 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 79.5 p -90.16 102.26 14.98 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 124.35 38.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.972 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -63.61 164.78 9.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.1 p -74.83 74.16 2.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.525 1.155 . . . . 0.0 113.004 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp 176.96 -65.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.508 1.523 . . . . 0.0 107.113 -158.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -75.18 -34.11 61.53 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.284 1.434 . . . . 0.0 114.031 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 137' ' ' LEU . 34.7 t -68.42 -76.94 0.08 Allowed 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.381 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -133.93 -80.74 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.25 -105.13 0.26 Allowed Glycine 0 CA--C 1.547 2.062 0 CA-C-O 116.881 -2.066 . . . . 0.0 111.427 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.0 -47.7 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 122.266 3.033 . . . . 0.0 116.399 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -148.33 117.26 6.74 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 133' ' ' PRO . . . -92.46 -120.07 2.7 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 123.205 0.431 . . . . 0.0 112.312 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -128.73 72.01 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.359 0.664 . . . . 0.0 110.103 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 t -73.85 135.35 77.58 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.783 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.06 -22.18 15.63 Favored 'Cis proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.294 2.767 . . . . 0.0 119.294 9.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -56.06 -41.66 75.41 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 104.39 50.67 Favored Pre-proline 0 CA--C 1.574 1.881 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.83 157.07 58.38 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 C-N-CA 123.038 2.492 . . . . 0.0 114.726 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 126' ' ' GLY . 47.7 Cg_endo -70.88 -68.93 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.613 2.209 . . . . 0.0 116.623 -157.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -121.77 76.66 1.29 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.28 154.07 48.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.345 1.058 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.3 8.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 121' ' ' CYS . 9.0 mp -69.05 134.79 49.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.726 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 77.5 m -104.25 99.67 9.39 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.16 106.85 10.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.557 0.743 . . . . 0.0 109.713 -167.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.15 117.52 24.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.803 0.811 . . . . 0.0 112.162 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.3 t -88.52 108.02 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.0 m -115.82 108.28 16.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.48 106.87 5.45 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.064 0.546 . . . . 0.0 110.4 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -87.53 -53.01 5.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.168 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.4 p -145.82 131.97 19.4 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.21 0.914 . . . . 0.0 108.936 173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.12 118.64 37.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.187 0.595 . . . . 0.0 109.453 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.26 165.46 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.225 1.012 . . . . 0.0 109.687 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.35 -179.11 4.32 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.219 0 CA-C-O 116.939 -2.034 . . . . 0.0 110.797 172.161 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.661 0.267 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.264 17.1 m0 84.46 120.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.287 1.435 . . . . 0.0 109.504 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.21 117.42 28.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.098 0.475 . . . . 0.0 110.779 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.25 150.75 25.98 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.47 -54.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.488 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.05 -63.2 1.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.82 0.78 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -127.63 -82.67 0.6 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.844 1.822 . . . . 0.0 106.195 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.08 76.78 0.05 OUTLIER Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.446 0.566 . . . . 0.0 111.869 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.88 -67.21 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 tp -85.83 112.31 21.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.739 0.815 . . . . 0.0 108.818 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -134.9 112.91 11.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.202 0.525 . . . . 0.0 111.386 -170.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -91.79 100.95 13.55 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 111.687 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -94.45 120.07 34.13 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.38 0.672 . . . . 0.0 109.791 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.4 m -80.14 114.96 19.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.298 0.57 . . . . 0.0 110.126 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.56 -71.87 0.5 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.124 0.97 . . . . 0.0 109.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.51 126.09 61.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.3 162.15 43.42 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.066 2.511 . . . . 0.0 114.817 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.85 122.83 7.2 Favored Glycine 0 CA--C 1.555 2.542 0 CA-C-O 116.964 -2.02 . . . . 0.0 112.941 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.57 165.89 21.51 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 CA-C-N 122.541 3.171 . . . . 0.0 115.51 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.31 120.95 8.42 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.179 2.586 . . . . 0.0 114.002 -170.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.91 -111.65 3.83 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m 58.99 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 m -117.72 125.76 51.25 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.379 1.085 . . . . 0.0 109.979 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -68.17 136.47 91.54 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 114.287 171.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.16 179.56 4.85 Favored 'Trans proline' 0 CA--C 1.568 2.187 0 C-N-CA 122.947 2.431 . . . . 0.0 115.449 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.0 m -93.65 175.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 124.19 0.996 . . . . 0.0 112.325 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -63.28 128.08 34.19 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.563 0.745 . . . . 0.0 112.856 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.96 4.5 Favored Glycine 0 CA--C 1.548 2.156 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.793 -167.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -148.22 138.81 22.9 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.51 118.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -172.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.04 134.09 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.812 0.845 . . . . 0.0 109.351 170.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -99.44 118.21 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.6 130.95 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -91.64 100.5 13.22 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.657 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -96.51 131.99 42.54 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.196 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -127.57 104.88 8.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -82.23 132.8 35.23 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.049 -169.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -131.03 116.13 17.38 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.21 94.51 9.68 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 12.1 pt-20 -70.39 -26.34 63.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.07 -41.43 96.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 160.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.33 -104.53 2.89 Favored Glycine 0 CA--C 1.544 1.852 0 CA-C-N 119.398 0.999 . . . . 0.0 112.159 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.3 m -131.31 146.4 52.28 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.019 0.928 . . . . 0.0 108.92 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -62.8 118.46 7.74 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.89 -45.67 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.272 13.8 mm100 75.3 92.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.879 1.671 . . . . 0.0 110.442 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.45 159.5 16.11 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-O 122.518 1.152 . . . . 0.0 112.703 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.2 139.69 95.17 Favored Pre-proline 0 CA--C 1.58 2.11 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -167.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.34 -13.04 16.98 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 119.862 2.985 . . . . 0.0 119.862 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.13 75.43 1.59 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.908 1.685 . . . . 0.0 110.682 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.34 106.31 18.33 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.05 135.56 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.192 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -159.76 157.85 30.12 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -91.3 131.48 36.78 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.112 0.965 . . . . 0.0 109.729 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.55 142.29 58.48 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.618 0.767 . . . . 0.0 113.061 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.66 -60.15 4.84 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 114.354 0.502 . . . . 0.0 114.354 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.79 115.46 7.36 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.748 1.219 . . . . 0.0 111.407 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.7 77.62 6.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.698 1.237 . . . . 0.0 113.492 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.72 -50.46 17.4 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.882 162.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.4 m -82.29 -178.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 C-N-CA 124.815 1.246 . . . . 0.0 113.254 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -60.87 161.04 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 124.713 1.205 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -61.0 -36.63 79.98 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -44.64 97.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 169.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.3 mt -65.3 -55.8 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 117.741 -1.124 . . . . 0.0 113.496 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -50.67 -48.81 58.29 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.28 -32.54 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.1 p -80.13 1.96 25.98 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 166.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.17 -52.49 74.23 Favored Pre-proline 0 N--CA 1.499 2.002 0 CA-C-O 115.044 -2.408 . . . . 0.0 112.683 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.37 39.35 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.517 0 CA-C-N 124.848 2.767 . . . . 0.0 116.827 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.2 mt -144.99 -46.04 0.23 Allowed 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 125.618 1.567 . . . . 0.0 110.631 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -76.41 113.44 14.0 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.804 1.184 . . . . 0.0 112.35 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.9 163.89 12.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.76 1.267 . . . . 0.0 111.882 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.49 115.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.294 -0.879 . . . . 0.0 112.155 -166.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.82 -40.19 2.4 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 117.091 1.596 . . . . 0.0 117.091 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.47 134.9 46.88 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.58 1.69 . . . . 0.0 115.459 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -90.98 125.29 35.74 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 154.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.61 121.89 13.06 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.4 ptp -75.8 125.88 29.92 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.404 1.097 . . . . 0.0 110.706 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.9 t -102.08 95.2 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.8 p -89.62 102.87 15.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.5 143.9 49.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.128 -161.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.82 162.37 4.12 Favored 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.1 p -54.02 -34.89 61.14 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 160.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.12 -43.91 82.76 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 161.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -86.56 63.91 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.899 0.772 . . . . 0.0 110.664 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.6 t -171.5 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -137.8 5.47 2.62 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.74 145.79 19.26 Favored Glycine 0 CA--C 1.56 2.885 0 CA-C-N 120.867 1.667 . . . . 0.0 111.892 -160.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.0 80.21 2.73 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 CA-C-N 122.558 3.179 . . . . 0.0 112.279 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -138.21 -74.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.16 0.584 . . . . 0.0 110.022 -164.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.42 96.48 0.12 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 140.75 49.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.287 0.635 . . . . 0.0 110.821 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.2 p -66.86 138.87 95.42 Favored Pre-proline 0 CA--C 1.573 1.831 0 CA-C-O 117.678 -1.153 . . . . 0.0 113.662 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.35 -44.82 0.45 Allowed 'Cis proline' 0 CA--C 1.563 1.934 0 N-CA-C 117.106 1.926 . . . . 0.0 117.106 8.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -155.18 88.73 1.17 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 83.4 mt -121.92 86.36 46.1 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.66 163.47 31.63 Favored 'Trans proline' 0 CA--C 1.572 2.421 0 C-N-CA 122.68 2.253 . . . . 0.0 115.424 -171.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.84 119.87 6.49 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.162 2.574 . . . . 0.0 113.232 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.258 96.1 m-70 66.8 76.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.796 1.239 . . . . 0.0 111.49 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.49 116.78 2.99 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.28 127.48 33.68 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.967 0.889 . . . . 0.0 112.844 -171.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.49 129.76 49.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.264 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.72 94.7 5.34 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.271 0.629 . . . . 0.0 109.372 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.37 121.64 45.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.445 0.698 . . . . 0.0 110.441 -170.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.9 100.41 6.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.011 0.524 . . . . 0.0 111.586 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.44 109.0 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.9 m -113.86 121.65 44.63 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.66 102.03 10.43 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -84.05 -59.55 2.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 60.1 p -122.46 149.5 43.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.658 0.783 . . . . 0.0 109.749 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.51 107.93 8.32 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.79 170.24 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.24 1.016 . . . . 0.0 110.096 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.56 -161.46 0.19 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.538 0 CA-C-O 116.728 -2.151 . . . . 0.0 112.701 178.735 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 . . . . . 0 CA--C 1.561 1.38 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 91.6 m95 76.09 94.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.692 1.197 . . . . 0.0 111.564 168.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.87 113.2 26.55 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.93 110.45 5.04 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.016 0.912 . . . . 0.0 113.348 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.17 -42.11 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.806 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -73.95 -63.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.501 1.046 . . . . 0.0 111.274 165.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.5 -89.64 0.15 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -83.57 -40.53 18.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.04 82.12 1.49 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.093 0.861 . . . . 0.0 115.25 -163.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp 40.55 63.31 1.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 162.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 tp -162.29 92.74 0.83 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -117.16 117.78 30.54 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.509 0.724 . . . . 0.0 109.247 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.79 105.83 17.18 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.51 -0.744 . . . . 0.0 111.331 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 101.48 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 166.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.5 p -84.45 110.48 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.56 -59.51 2.72 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.601 0.76 . . . . 0.0 111.827 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.34 103.44 54.99 Favored Pre-proline 0 CA--C 1.57 1.729 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.65 87.07 1.55 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.989 2.459 . . . . 0.0 112.963 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.04 88.41 0.11 Allowed Glycine 0 CA--C 1.553 2.451 0 CA-C-O 116.339 -2.367 . . . . 0.0 113.286 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.82 167.84 16.63 Favored 'Trans proline' 0 CA--C 1.576 2.607 0 CA-C-N 123.154 3.477 . . . . 0.0 115.336 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.46 127.68 21.53 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 123.211 2.608 . . . . 0.0 114.86 -168.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.58 -123.12 6.63 Favored Glycine 0 CA--C 1.546 1.988 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -160.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m 59.43 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 164.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -123.4 127.28 48.22 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.705 1.241 . . . . 0.0 110.12 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -69.93 122.32 85.64 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 113.1 -1.864 . . . . 0.0 113.225 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.45 171.82 16.29 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.795 2.33 . . . . 0.0 115.352 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.95 174.65 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -60.57 133.09 55.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.13 51.1 4.57 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.284 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -146.63 131.87 18.45 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.76 113.45 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.67 124.77 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -92.97 133.55 36.01 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 m -127.92 145.37 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.629 0.728 . . . . 0.0 110.16 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.73 98.28 8.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 165.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.51 125.72 31.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -103.98 73.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -79.46 119.45 22.48 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.9 m -146.91 133.9 20.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 tp -67.18 151.91 46.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.662 0.785 . . . . 0.0 113.001 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.14 12.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -77.65 -63.82 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.587 1.085 . . . . 0.0 112.529 168.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.07 76.38 0.02 OUTLIER Glycine 0 N--CA 1.48 1.583 0 CA-C-N 118.786 0.721 . . . . 0.0 111.533 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -149.39 113.91 5.29 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -74.6 104.23 5.21 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.248 0.477 . . . . 0.0 111.633 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.58 -61.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.003 -165.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.85 85.81 1.43 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -100.03 91.56 4.85 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.845 0.458 . . . . 0.0 110.231 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -98.97 116.33 65.31 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.087 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.73 -53.36 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.875 2.384 . . . . 0.0 115.079 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -98.73 81.25 2.64 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.252 0.933 . . . . 0.0 111.192 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.72 98.79 11.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.73 109.93 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -165.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -137.46 151.73 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -88.08 118.98 28.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.86 145.56 32.67 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.77 -50.0 4.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.71 -2.81 0.89 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 58.2 m 75.41 90.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.985 1.314 . . . . 0.0 111.46 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.76 -63.01 1.1 Allowed 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.297 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.88 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 124.28 1.032 . . . . 0.0 113.396 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 pt -56.57 148.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 125.06 1.344 . . . . 0.0 113.171 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -61.7 -26.69 68.2 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.45 69.84 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 120.29 1.405 . . . . 0.0 114.74 165.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -44.17 93.3 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.34 -40.35 95.7 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.91 -30.97 72.0 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 167.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -77.62 -0.17 25.53 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.64 -55.41 45.25 Favored Pre-proline 0 N--CA 1.502 2.125 0 CA-C-O 115.329 -2.272 . . . . 0.0 112.708 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.36 24.57 0.23 Allowed 'Trans proline' 0 CA--C 1.574 2.483 0 CA-C-N 124.683 2.708 . . . . 0.0 118.249 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.92 -39.14 1.23 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.97 1.308 . . . . 0.0 111.825 168.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -75.45 123.42 25.39 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.883 1.219 . . . . 0.0 113.566 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.92 170.27 8.18 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.76 1.267 . . . . 0.0 111.771 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.29 111.99 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.313 -0.867 . . . . 0.0 110.112 -157.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.89 2.14 57.22 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 -166.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -75.32 123.42 25.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 121.27 2.535 . . . . 0.0 111.961 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.8 m -103.82 116.73 32.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.53 128.16 10.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.4 tpp -80.79 113.71 19.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.756 0.823 . . . . 0.0 109.569 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.13 93.3 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -91.28 109.53 20.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.96 147.04 30.33 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -48.15 150.79 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 t -70.52 78.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.627 1.203 . . . . 0.0 111.491 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -179.76 -67.34 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.455 -1.702 . . . . 0.0 106.639 -156.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -65.87 -55.47 16.84 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.95 0.9 . . . . 0.0 111.718 159.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 71.6 m -73.21 111.5 8.39 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.768 0.713 . . . . 0.0 110.367 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.323 75.7 m-85 80.08 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.242 1.017 . . . . 0.0 112.036 170.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.45 162.99 26.33 Favored Glycine 0 CA--C 1.557 2.687 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.085 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.21 -22.16 47.17 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 123.183 2.589 . . . . 0.0 118.411 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -80.54 -45.04 18.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.92 97.98 1.37 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -171.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -84.14 178.66 7.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.366 1.079 . . . . 0.0 112.757 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -75.03 138.1 72.65 Favored Pre-proline 0 CA--C 1.57 1.745 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.643 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.67 -56.36 0.14 OUTLIER 'Cis proline' 0 CA--C 1.562 1.891 0 CA-C-N 122.316 1.863 . . . . 0.0 115.704 6.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -145.96 70.82 1.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.14 0.882 . . . . 0.0 109.386 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.7 mm -90.6 119.06 69.1 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.423 -1.275 . . . . 0.0 107.933 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.65 121.41 5.94 Favored 'Trans proline' 0 CA--C 1.571 2.36 0 C-N-CA 122.716 2.277 . . . . 0.0 112.253 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.64 132.73 20.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 123.012 2.475 . . . . 0.0 112.704 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.273 14.9 m170 78.86 148.28 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 124.61 1.164 . . . . 0.0 110.748 -166.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.26 . . 78.93 136.26 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.841 1.257 . . . . 0.0 112.514 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.32 136.49 33.88 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.54 136.15 37.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.816 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.9 m -101.11 102.91 13.96 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 109.36 18.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.289 0.636 . . . . 0.0 111.22 -175.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.32 98.74 9.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.486 0.66 . . . . 0.0 110.377 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.82 111.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.8 m -110.77 114.32 27.58 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.56 120.18 18.81 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.057 0.543 . . . . 0.0 111.014 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.11 -65.41 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.488 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 46.6 p -124.77 150.59 46.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.852 0.834 . . . . 0.0 109.847 -166.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.79 98.67 4.24 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.24 164.59 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.934 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.65 -160.58 0.19 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.195 0 CA-C-O 117.075 -1.959 . . . . 0.0 110.824 172.413 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -156.4 146.59 21.35 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.625 1.17 . . . . 0.0 109.371 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 tp -74.31 136.15 42.58 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.259 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -83.47 -178.27 7.0 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-O 123.452 1.596 . . . . 0.0 114.928 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 -74.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.36 -39.9 58.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.39 67.94 0.57 Allowed Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -146.94 -65.54 0.28 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.71 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.43 -50.32 0.83 Allowed Glycine 0 CA--C 1.545 1.957 0 CA-C-N 118.907 0.776 . . . . 0.0 114.074 -164.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.69 -56.74 8.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.68 112.83 24.9 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.861 0.755 . . . . 0.0 109.076 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -133.73 148.65 51.45 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.127 0.971 . . . . 0.0 111.444 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -108.55 127.16 53.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.647 -0.658 . . . . 0.0 111.511 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.92 -43.1 95.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.269 19.5 m 73.5 95.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 174.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.78 -65.62 0.99 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.889 . . . . 0.0 110.166 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.46 113.01 33.85 Favored Pre-proline 0 CA--C 1.569 1.689 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.3 78.99 3.01 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.87 2.38 . . . . 0.0 113.095 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.34 160.95 17.09 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.14 170.2 20.08 Favored 'Trans proline' 0 CA--C 1.574 2.499 0 C-N-CA 123.266 2.644 . . . . 0.0 114.39 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.35 108.28 1.97 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.031 2.487 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.06 83.34 0.96 Allowed Glycine 0 CA--C 1.544 1.88 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -159.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -100.51 123.63 44.98 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.884 0.474 . . . . 0.0 111.961 -166.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -92.33 138.85 31.17 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.335 0.654 . . . . 0.0 112.218 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -113.12 107.19 54.3 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.4 148.22 29.77 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.022 2.482 . . . . 0.0 114.53 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.39 147.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.0 0.92 . . . . 0.0 112.576 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 86.3 2.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.74 62.79 0.01 OUTLIER Glycine 0 CA--C 1.54 1.634 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.158 172.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.07 0.938 . . . . 0.0 110.596 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.45 109.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.77 112.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 m -93.1 106.84 18.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.35 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -171.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -74.41 112.45 10.6 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 165.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.69 105.8 7.74 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -167.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.29 100.66 11.97 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -79.47 112.48 16.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.3 t -135.88 149.13 48.89 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.094 0.949 . . . . 0.0 110.306 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.94 142.32 51.25 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.269 1.028 . . . . 0.0 112.218 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.29 -38.7 28.2 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -66.21 -66.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.598 0.759 . . . . 0.0 111.959 168.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.64 79.61 0.03 OUTLIER Glycine 0 N--CA 1.479 1.536 0 CA-C-N 119.012 0.824 . . . . 0.0 112.005 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.2 m -151.04 112.96 4.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 102.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.64 -45.83 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -145.08 105.91 4.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.26 124.54 31.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.431 0.634 . . . . 0.0 109.681 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -130.58 78.43 74.03 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -170.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.81 -44.3 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.095 2.53 . . . . 0.0 116.443 -171.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.12 83.15 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.197 0.908 . . . . 0.0 109.803 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.4 tp -101.05 98.51 8.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.76 111.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -165.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.8 166.14 33.84 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.755 -175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -82.06 136.02 35.26 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.234 0.613 . . . . 0.0 110.398 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 tt -68.37 114.13 6.55 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.222 1.009 . . . . 0.0 112.828 -164.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.92 34.8 77.75 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 118.0 1.96 . . . . 0.0 118.0 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.44 169.11 14.7 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.44 1.114 . . . . 0.0 110.028 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.77 89.91 2.87 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.603 1.192 . . . . 0.0 113.205 -167.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.44 -67.55 0.21 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.846 -1.524 . . . . 0.0 107.998 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.85 165.29 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 124.605 1.162 . . . . 0.0 112.988 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 159.92 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -30.18 63.77 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.82 80.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 170.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.3 -38.4 65.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -43.29 -48.48 6.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.72 -45.46 58.63 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.6 p -90.27 45.94 1.31 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.67 -55.95 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.913 0 CA-C-O 115.013 -2.423 . . . . 0.0 107.235 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.73 83.32 1.95 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 CA-C-N 125.421 2.972 . . . . 0.0 112.802 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.317 4.4 pp 163.0 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 127.194 2.197 . . . . 0.0 111.821 -167.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.23 140.73 38.9 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.98 1.264 . . . . 0.0 112.04 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.27 159.81 33.93 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.618 163.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.68 97.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 143' ' ' LEU . . . 99.06 39.17 3.61 Favored Glycine 0 CA--C 1.552 2.379 0 CA-C-O 118.494 -1.17 . . . . 0.0 115.981 -162.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.42 99.91 11.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.064 1.432 . . . . 0.0 109.076 173.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.9 m -83.69 118.05 23.61 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 128.31 6.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.768 0.427 . . . . 0.0 110.223 -173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.4 tpp -85.51 107.16 17.32 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.75 99.05 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -91.5 104.26 16.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.15 160.64 15.46 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.164 0.983 . . . . 0.0 113.303 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 159.04 22.19 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.663 164.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.3 p -73.95 68.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -175.9 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.452 1.501 . . . . 0.0 108.405 -168.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -59.62 -51.03 71.56 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.651 1.18 . . . . 0.0 114.113 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.5 m -66.11 -70.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.821 0.737 . . . . 0.0 112.582 170.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -144.48 -65.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.938 0.79 . . . . 0.0 109.39 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.64 -167.93 30.16 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.14 102.47 1.6 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.081 2.521 . . . . 0.0 112.441 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -152.95 -69.45 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.716 -169.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.72 95.29 1.23 Allowed Glycine 0 CA--C 1.541 1.683 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -167.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -132.82 148.65 52.31 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.201 1.0 . . . . 0.0 110.667 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.4 m -76.8 140.85 67.7 Favored Pre-proline 0 CA--C 1.57 1.74 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.22 173.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.02 -47.35 0.26 Allowed 'Cis proline' 0 CA--C 1.563 1.939 0 CA-C-N 122.377 1.885 . . . . 0.0 116.909 9.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.33 77.16 1.43 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.76 117.37 46.64 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.8 151.33 27.97 Favored 'Trans proline' 0 CA--C 1.571 2.358 0 C-N-CA 122.813 2.342 . . . . 0.0 114.417 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.15 119.59 6.55 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.128 2.552 . . . . 0.0 111.931 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 93.9 m-70 76.8 101.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.222 1.409 . . . . 0.0 109.478 -165.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.83 88.86 3.0 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.171 0.588 . . . . 0.0 109.634 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.6 76.15 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 153.33 20.59 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.443 1.115 . . . . 0.0 112.243 -165.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -91.75 109.6 20.92 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.661 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.37 117.79 32.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.304 1.042 . . . . 0.0 108.217 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.16 99.2 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.398 -0.814 . . . . 0.0 110.196 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.06 125.6 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.5 m -142.14 124.33 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' HB2' ' H ' ' A' ' 109' ' ' GLY . 3.2 mm? -76.47 111.32 11.81 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.384 0.674 . . . . 0.0 110.021 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -84.01 -55.95 3.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 118.659 -0.686 . . . . 0.0 112.745 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 69.7 p -135.94 133.61 37.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -117.68 106.96 13.63 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 167.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.93 133.48 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 123.439 0.696 . . . . 0.0 110.078 -170.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -86.17 103.96 15.29 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.964 0 CA-C-O 116.801 -2.111 . . . . 0.0 112.08 178.394 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 122.693 1.235 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -79.41 115.44 19.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 153.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.46 103.61 15.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -163.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.97 103.04 12.13 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.072 0.939 . . . . 0.0 112.331 -176.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 pt -84.23 -176.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.648 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.357 2.6 tt 90.46 -75.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.343 1.457 . . . . 0.0 110.624 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.98 -72.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.377 0.535 . . . . 0.0 112.708 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.74 -75.36 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.179 0.592 . . . . 0.0 111.462 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.94 73.54 0.04 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 mt -141.73 -62.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.092 0.957 . . . . 0.0 108.753 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.77 130.51 38.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.101 0.96 . . . . 0.0 110.753 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -133.41 74.95 1.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -159.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -92.17 86.58 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.037 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -75.51 116.88 16.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 111.071 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 m -74.89 104.62 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.209 0.603 . . . . 0.0 109.404 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.79 -79.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.644 0.777 . . . . 0.0 110.077 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.93 113.38 63.67 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 169.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.17 175.63 8.97 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.873 2.382 . . . . 0.0 114.889 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 119.37 10.85 Favored Glycine 0 CA--C 1.558 2.738 0 CA-C-O 116.948 -2.029 . . . . 0.0 112.62 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.65 161.91 36.7 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 CA-C-N 122.498 3.149 . . . . 0.0 115.327 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.84 113.64 2.07 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.175 2.584 . . . . 0.0 113.562 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.4 71.67 1.09 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.711 -159.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -157.86 114.52 2.89 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 m -126.06 117.74 23.84 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 122.273 1.035 . . . . 0.0 110.086 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -59.4 134.06 88.46 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.01 144.89 43.71 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.783 2.322 . . . . 0.0 116.568 -158.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -72.16 155.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.002 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -70.17 110.99 5.49 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.72 65.08 0.47 Allowed Glycine 0 CA--C 1.544 1.863 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.548 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -150.01 140.74 22.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.19 108.04 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 m -117.87 121.6 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -109.75 134.46 51.98 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.63 153.15 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.254 1.026 . . . . 0.0 110.278 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -102.44 91.58 4.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.343 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.94 147.38 25.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.311 0.576 . . . . 0.0 110.383 163.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.01 92.5 2.88 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 m -83.11 122.11 27.93 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.661 0.743 . . . . 0.0 109.889 -175.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 m -140.93 136.62 32.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.529 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.19 131.81 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -52.23 -46.82 65.87 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.37 -44.26 12.95 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.81 80.78 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 120.783 3.073 . . . . 0.0 120.783 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.0 m 77.65 117.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.143 1.972 . . . . 0.0 112.839 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.252 7.3 ttt85 38.86 53.91 2.01 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 160.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 21.1 m -74.77 -40.96 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -159.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -146.96 76.3 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.561 1.073 . . . . 0.0 109.055 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -73.39 111.05 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.609 0.719 . . . . 0.0 111.56 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -130.94 84.06 59.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.91 -46.58 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.906 2.404 . . . . 0.0 117.248 -164.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.95 92.95 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.876 1.216 . . . . 0.0 110.702 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 tp -111.57 81.13 1.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.53 -172.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -89.84 136.44 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.406 0.682 . . . . 0.0 110.884 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -162.81 150.48 13.62 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.947 0.899 . . . . 0.0 110.345 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -80.77 140.97 35.21 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.94 104.81 5.68 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.38 70.83 0.85 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.032 -159.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -156.63 -66.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.734 0.814 . . . . 0.0 110.478 -176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.351 4.8 t 65.94 40.87 3.94 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.59 -47.68 80.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.878 -1.139 . . . . 0.0 113.217 152.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -55.04 166.85 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 125.282 1.433 . . . . 0.0 114.321 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 99' ' ' LEU . 46.4 pt -60.34 151.19 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -35.99 65.93 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.35 94.54 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 117.176 2.288 . . . . 0.0 117.176 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.459 ' H ' HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -63.89 -56.54 14.57 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.907 -1.044 . . . . 0.0 113.138 178.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -49.98 -43.24 50.17 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.38 -39.87 94.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.1 p -77.91 -4.11 45.16 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.79 -53.05 68.03 Favored Pre-proline 0 N--CA 1.502 2.138 0 CA-C-O 115.388 -2.244 . . . . 0.0 112.62 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.48 0.34 1.47 Allowed 'Trans proline' 0 CA--C 1.569 2.254 0 N-CA-C 119.483 2.839 . . . . 0.0 119.483 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 99.4 mt -128.57 73.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 119.993 1.27 . . . . 0.0 107.982 158.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 38.9 ttm -164.29 96.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.06 167.64 17.68 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.322 1.058 . . . . 0.0 113.282 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -70.41 108.29 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.578 0.751 . . . . 0.0 109.691 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.78 20.2 41.0 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 117.912 1.925 . . . . 0.0 117.912 -167.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 107.59 18.66 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 120.387 2.093 . . . . 0.0 110.476 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.4 m -78.75 113.07 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 163.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.79 121.49 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 ttt -83.68 108.12 16.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.024 0.529 . . . . 0.0 110.239 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.34 118.38 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 t -129.07 77.04 1.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.61 145.92 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.715 0.769 . . . . 0.0 112.044 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.86 164.65 0.36 Allowed 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -69.54 81.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.832 1.301 . . . . 0.0 111.595 172.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.888 -147.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -120.11 57.99 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.399 0.68 . . . . 0.0 111.938 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -110.37 -100.38 0.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -136.14 63.13 1.6 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 119.047 0.84 . . . . 0.0 109.414 168.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.24 -156.12 30.42 Favored Glycine 0 CA--C 1.562 2.977 0 N-CA-C 116.671 1.428 . . . . 0.0 116.671 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.25 102.64 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.95 2.433 . . . . 0.0 110.783 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.272 58.7 tp60 73.24 120.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.088 1.355 . . . . 0.0 111.16 -168.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.24 -139.95 10.54 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.8 158.85 15.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.293 1.044 . . . . 0.0 111.856 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.8 m -64.52 137.32 97.1 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 117.789 -1.1 . . . . 0.0 112.756 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.78 -42.56 0.68 Allowed 'Cis proline' 0 CA--C 1.563 1.96 0 N-CA-C 117.661 2.139 . . . . 0.0 117.661 10.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -168.21 100.69 0.44 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.43 105.63 56.86 Favored Pre-proline 0 CA--C 1.571 1.77 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.86 146.72 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.667 2.244 . . . . 0.0 114.747 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.61 -54.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.292 2.661 . . . . 0.0 115.272 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -65.24 145.61 56.01 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.521 1.128 . . . . 0.0 112.915 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.18 128.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.796 1.238 . . . . 0.0 111.886 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.72 114.08 8.44 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.603 0.761 . . . . 0.0 111.988 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.85 125.49 29.77 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 120.967 0.413 . . . . 0.0 111.301 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.55 118.29 31.98 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.097 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.53 121.72 27.76 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.402 0.681 . . . . 0.0 109.677 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -87.6 98.33 11.35 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.2 0.6 . . . . 0.0 110.768 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.82 126.08 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -133.31 125.32 28.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.59 111.16 5.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.57 0.748 . . . . 0.0 111.184 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -77.37 -66.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -132.81 143.22 49.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.619 0.723 . . . . 0.0 109.321 -168.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.54 96.95 4.25 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.72 129.06 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -170.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.2 111.48 22.67 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.277 0.56 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.104 0 CA-C-O 116.764 -2.131 . . . . 0.0 110.633 -175.392 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 . . . . . 0 CA--C 1.574 1.868 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -48.79 120.57 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.447 1.099 . . . . 0.0 113.778 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.6 tp -80.36 109.81 15.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.439 0.696 . . . . 0.0 110.99 -164.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.56 101.78 13.52 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.355 1.074 . . . . 0.0 112.634 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.555 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -71.32 -29.84 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 170.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.23 -48.95 71.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.159 1.345 . . . . 0.0 113.68 158.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 -36.12 4.44 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -73.1 -71.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.397 1.099 . . . . 0.0 111.961 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.11 61.27 0.03 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 mt -143.83 -76.2 0.24 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.4 tp -88.15 119.69 28.78 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.65 0.78 . . . . 0.0 109.203 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -137.79 121.63 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.644 0.778 . . . . 0.0 109.681 -172.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 110.5 16.09 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 110.485 -164.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -116.94 130.85 56.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.214 . . . . 0.0 110.009 172.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.9 m -93.2 119.25 32.17 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.858 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.86 -68.32 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.517 0.727 . . . . 0.0 110.117 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.4 t -85.08 122.79 74.05 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 156.56 42.42 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 122.925 2.417 . . . . 0.0 114.699 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 121.14 5.32 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-O 116.924 -2.042 . . . . 0.0 113.071 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.22 144.64 52.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.597 3.199 . . . . 0.0 115.0 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.43 119.01 5.74 Favored 'Trans proline' 0 CA--C 1.558 1.693 0 C-N-CA 123.241 2.627 . . . . 0.0 112.643 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.28 -81.88 0.22 Allowed Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -88.71 98.64 11.8 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 m -148.86 133.23 17.52 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.763 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.273 19.2 mtm180 42.44 74.68 0.72 Allowed Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.97 161.49 32.9 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.726 2.284 . . . . 0.0 114.251 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.19 170.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.283 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -71.26 115.9 10.95 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.881 0.848 . . . . 0.0 111.902 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.64 -63.4 0.44 Allowed Glycine 0 CA--C 1.54 1.649 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -155.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -70.67 114.99 9.31 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.433 0.693 . . . . 0.0 110.028 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.34 114.04 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 m -92.52 135.74 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.444 -169.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -120.06 126.11 49.97 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.45 141.43 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.696 0.76 . . . . 0.0 110.98 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -89.92 93.67 9.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 161.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.34 143.19 28.34 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.782 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -126.93 90.41 3.15 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -74.53 115.55 14.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -140.92 119.15 12.06 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -162.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.08 137.13 45.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.669 0.387 . . . . 0.0 110.573 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.63 87.41 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.619 1.199 . . . . 0.0 112.608 -170.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -171.25 -75.59 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -170.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.14 71.0 0.05 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.2 t -162.75 141.34 8.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.26 0.624 . . . . 0.0 110.05 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 113.63 25.24 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.264 23.5 m -78.25 -51.18 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -141.02 81.22 1.78 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 119.226 0.921 . . . . 0.0 109.198 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.76 119.39 30.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.66 94.34 47.65 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.095 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.64 -44.82 0.63 Allowed 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.084 2.523 . . . . 0.0 117.202 -172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.8 76.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.783 1.174 . . . . 0.0 110.238 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -99.68 92.67 5.45 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.22 132.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.737 0.78 . . . . 0.0 109.24 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -155.62 142.99 19.42 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.954 -174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.5 m -74.17 133.51 42.75 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.917 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -70.83 109.05 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.336 -165.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.27 67.79 1.48 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.493 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.72 145.16 27.53 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.239 1.018 . . . . 0.0 109.739 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 75.8 m -75.72 76.72 2.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.647 1.213 . . . . 0.0 111.829 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -129.69 -63.44 0.92 Allowed 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.657 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.16 176.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.005 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.71 140.9 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.052 0.941 . . . . 0.0 112.443 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -61.47 -33.72 74.23 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.07 -40.93 70.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 167.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -56.69 10.65 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.931 0.892 . . . . 0.0 113.037 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.57 -39.72 94.59 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.5 mt -61.09 -34.8 75.52 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.1 p -74.35 -11.94 60.39 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 167.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -56.01 -50.45 87.25 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 115.292 -2.29 . . . . 0.0 115.092 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -53.32 -26.57 35.27 Favored 'Trans proline' 0 CA--C 1.567 2.165 0 CA-C-N 125.659 3.057 . . . . 0.0 118.549 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -110.09 73.21 0.83 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.087 0.955 . . . . 0.0 109.709 164.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 53.0 tpp -149.61 107.45 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.39 161.85 15.39 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.681 1.229 . . . . 0.0 113.066 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 t -81.96 103.15 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 59.17 1.31 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.932 -170.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -126.06 123.76 39.11 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.57 0.748 . . . . 0.0 109.829 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -91.49 103.54 16.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.1 120.74 14.27 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.976 0.417 . . . . 0.0 110.433 -164.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.4 ttm -83.6 141.25 31.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.99 0.9 . . . . 0.0 110.802 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.27 96.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.6 p -81.72 104.87 12.42 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -135.68 139.23 43.53 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.511 0.724 . . . . 0.0 111.024 -168.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -63.23 149.49 45.38 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.8 m -71.32 81.73 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 123.273 1.511 . . . . 0.0 110.8 167.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -172.78 -68.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.961 -1.927 . . . . 0.0 106.446 -159.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -73.85 -45.61 50.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.638 0.775 . . . . 0.0 112.477 161.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.1 m -58.98 -56.55 20.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.2 -84.41 0.23 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.465 1.029 . . . . 0.0 108.713 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.82 -175.35 28.99 Favored Glycine 0 CA--C 1.557 2.718 0 CA-C-N 119.014 0.824 . . . . 0.0 114.651 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.53 105.13 1.83 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.483 2.788 . . . . 0.0 112.591 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 57.84 85.57 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.202 1.401 . . . . 0.0 112.908 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.66 -88.53 1.54 Allowed Glycine 0 CA--C 1.539 1.59 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -122.35 81.66 1.87 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.667 0.787 . . . . 0.0 109.96 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.1 p -73.44 145.29 84.97 Favored Pre-proline 0 CA--C 1.571 1.78 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.995 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.8 -16.38 30.09 Favored 'Cis proline' 0 CA--C 1.564 1.984 0 N-CA-C 119.437 2.822 . . . . 0.0 119.437 9.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -64.21 -42.69 96.5 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.73 118.43 68.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.32 163.51 27.41 Favored 'Trans proline' 0 CA--C 1.576 2.62 0 C-N-CA 122.84 2.36 . . . . 0.0 114.082 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -64.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.107 2.538 . . . . 0.0 115.488 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -136.03 94.05 3.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.24 125.69 8.81 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.95 108.31 14.51 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.566 0.698 . . . . 0.0 112.385 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -92.88 157.84 16.16 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.736 176.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.52 104.73 16.78 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.092 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -104.57 118.7 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.42 148.5 51.78 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.293 0.568 . . . . 0.0 112.383 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.96 99.96 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.5 m -102.44 109.39 21.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 104.15 8.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -80.88 -58.47 3.07 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 70.7 p -137.46 134.17 35.51 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.287 0.635 . . . . 0.0 109.64 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.16 94.94 4.86 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -166.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.08 115.31 22.81 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.412 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.7 0 CA-C-O 119.325 -0.708 . . . . 0.0 114.528 -178.076 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 . . . . . 0 CA--C 1.561 1.371 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -99.78 133.59 43.91 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.618 161.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER 68.25 163.13 0.21 Allowed 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 171.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.268 14.2 t0 73.19 111.7 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -127.29 -59.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -60.59 -37.46 81.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.78 51.85 0.22 Allowed Glycine 0 CA--C 1.548 2.129 0 C-N-CA 124.621 1.105 . . . . 0.0 113.116 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -166.83 -71.84 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.24 61.67 0.07 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.317 0.961 . . . . 0.0 111.36 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.0 mt -142.48 -53.87 0.41 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.841 0.856 . . . . 0.0 109.593 -163.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.0 115.28 20.4 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 154.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -122.61 70.45 1.0 Allowed 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -162.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -88.77 120.08 29.85 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.636 -1.29 . . . . 0.0 113.06 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.15 114.57 24.66 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 161.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 m -75.57 121.2 22.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.65 -69.18 0.34 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.771 0.828 . . . . 0.0 111.791 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.07 121.89 26.24 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.42 169.02 23.45 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.811 2.341 . . . . 0.0 113.682 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.02 176.42 40.44 Favored Glycine 0 CA--C 1.562 3.018 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.73 163.45 35.21 Favored 'Trans proline' 0 CA--C 1.573 2.437 0 C-N-CA 123.047 2.498 . . . . 0.0 115.36 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.46 107.81 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.219 2.613 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.98 89.85 1.55 Allowed Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -164.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -133.08 109.48 9.54 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.7 p -77.99 129.76 35.68 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.176 0.512 . . . . 0.0 112.134 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -92.14 113.0 57.77 Favored Pre-proline 0 CA--C 1.577 2.002 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.818 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -68.67 155.02 70.24 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 122.956 2.437 . . . . 0.0 117.511 -161.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.66 165.31 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.897 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.55 105.23 5.57 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.737 0.779 . . . . 0.0 111.534 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.73 48.6 0.84 Allowed Glycine 0 CA--C 1.55 2.235 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.391 -164.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -154.84 110.95 3.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.03 115.16 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.429 0.691 . . . . 0.0 109.826 -163.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.89 129.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.528 0.731 . . . . 0.0 110.863 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -89.73 129.76 36.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 168.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -144.9 129.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -170.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -99.01 101.76 13.25 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.21 1.004 . . . . 0.0 108.463 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.32 127.54 55.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.149 0.58 . . . . 0.0 109.742 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -108.97 80.87 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.908 0.483 . . . . 0.0 110.214 -166.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.83 127.45 32.05 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.437 0.637 . . . . 0.0 110.49 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -148.87 151.18 34.26 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.287 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.32 145.01 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.57 76.78 8.48 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 122.414 1.102 . . . . 0.0 110.277 168.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -172.22 -63.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.197 1.399 . . . . 0.0 107.27 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.62 -62.59 0.16 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 119.516 -0.602 . . . . 0.0 113.193 -173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 133.98 33.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 117.502 0.651 . . . . 0.0 110.149 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 142.68 46.39 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.88 -74.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -145.12 118.66 9.1 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -97.86 93.0 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 109.948 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mp0 -72.92 113.59 23.01 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.818 -172.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -53.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.991 2.46 . . . . 0.0 116.111 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -125.82 70.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 118.947 0.794 . . . . 0.0 110.705 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.92 113.83 26.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.6 t -106.76 100.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -113.06 146.57 38.9 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.042 0.537 . . . . 0.0 111.08 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.1 m -80.08 128.15 33.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.72 110.33 8.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.47 -67.1 0.25 Allowed Glycine 0 N--CA 1.48 1.583 0 CA-C-O 119.406 -0.663 . . . . 0.0 112.955 -167.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.42 85.94 7.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.523 0.678 . . . . 0.0 109.961 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 83.9 m -95.38 115.31 27.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.432 0.634 . . . . 0.0 112.373 -158.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -58.73 -38.41 78.31 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 159.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.3 m -71.13 164.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.639 1.209 . . . . 0.0 114.157 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.39 171.6 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.569 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -57.16 -40.06 76.49 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.85 -43.63 86.02 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.92 -49.07 61.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.559 -1.21 . . . . 0.0 114.111 170.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -49.54 -49.84 44.47 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.0 -44.31 94.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.1 p -87.23 49.41 1.81 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.3 t -96.56 -57.41 0.19 Allowed Pre-proline 0 CA--C 1.572 1.827 0 CA-C-O 115.226 -2.321 . . . . 0.0 109.195 163.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.85 -7.7 11.91 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.497 2.999 . . . . 0.0 118.776 174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.88 -34.84 15.09 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.77 1.168 . . . . 0.0 113.728 162.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.86 116.51 7.81 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.216 1.371 . . . . 0.0 112.806 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -85.73 149.46 25.27 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.129 0.966 . . . . 0.0 112.009 167.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.73 105.32 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.84 -33.4 2.84 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.763 -164.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.31 132.37 43.01 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 120.818 2.309 . . . . 0.0 115.047 -170.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -96.86 122.96 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 162.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.42 122.33 9.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 120.892 0.377 . . . . 0.0 111.415 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.5 ttt -82.83 105.79 14.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.327 0.651 . . . . 0.0 109.834 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.14 119.51 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.5 p -94.35 78.22 3.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.41 144.3 49.83 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 152.48 45.34 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.2 t -76.89 69.15 3.18 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.672 1.225 . . . . 0.0 111.689 167.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -176.45 -64.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.477 1.511 . . . . 0.0 108.001 -164.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -79.27 -31.56 43.44 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.5 t -69.0 -75.98 0.1 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.166 1.348 . . . . 0.0 112.064 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.97 43.7 2.93 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.281 1.4 . . . . 0.0 112.55 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.09 176.25 6.69 Favored Glycine 0 CA--C 1.56 2.86 0 N-CA-C 116.467 1.347 . . . . 0.0 116.467 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.6 67.59 8.55 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 CA-C-N 120.979 2.389 . . . . 0.0 111.709 160.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -158.7 -66.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.498 1.119 . . . . 0.0 108.072 -169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.17 120.19 2.91 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 118.775 0.716 . . . . 0.0 111.776 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.04 67.42 1.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m 67.39 143.53 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 166.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.81 -42.62 0.78 Allowed 'Cis proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.804 2.037 . . . . 0.0 117.111 -1.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -138.15 68.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.42 1.009 . . . . 0.0 109.913 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.81 117.07 44.81 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 172.57 13.78 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 C-N-CA 123.006 2.471 . . . . 0.0 114.075 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.0 2.35 2.7 Favored 'Trans proline' 0 CA--C 1.567 2.126 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -148.56 90.24 1.77 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.27 114.28 3.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.99 107.57 13.92 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.2 125.04 35.85 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.015 0.912 . . . . 0.0 110.703 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 29.4 m -97.81 95.4 7.51 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.927 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.7 119.01 37.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.196 0.599 . . . . 0.0 110.091 174.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -88.49 103.61 16.04 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.275 1.036 . . . . 0.0 109.841 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.38 103.63 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.295 -1.32 . . . . 0.0 107.653 -170.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -94.06 108.52 20.34 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.02 105.88 12.59 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -77.88 -72.27 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -144.77 135.84 25.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 118.8 0.727 . . . . 0.0 109.886 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.64 111.12 23.31 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.96 138.77 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.05 148.5 50.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.302 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.151 -174.516 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.723 0.296 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.25 82.2 m95 75.51 103.11 0.07 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.924 1.289 . . . . 0.0 110.099 -176.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.1 97.48 9.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.27 129.79 37.19 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.593 1.187 . . . . 0.0 113.365 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 pt -103.42 66.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.867 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 tp -163.0 -60.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.399 0.68 . . . . 0.0 110.187 -164.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.4 44.49 3.72 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -161.05 -80.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.65 58.01 0.01 OUTLIER Glycine 0 CA--C 1.543 1.808 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.248 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 mt -131.06 -54.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.843 0.857 . . . . 0.0 110.978 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.9 tp -87.01 102.35 14.32 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 108.991 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.73 90.06 3.18 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 122.885 0.474 . . . . 0.0 111.375 -161.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.04 93.79 8.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.814 -1.179 . . . . 0.0 111.106 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -99.32 122.91 43.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.356 0.662 . . . . 0.0 109.251 168.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.9 m -80.58 117.03 20.93 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.131 0.572 . . . . 0.0 109.916 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -79.87 -71.68 0.44 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.957 0.903 . . . . 0.0 110.512 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.14 123.18 45.87 Favored Pre-proline 0 CA--C 1.573 1.845 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.74 157.59 51.77 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.921 2.414 . . . . 0.0 114.85 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.37 116.56 4.25 Favored Glycine 0 CA--C 1.55 2.233 0 CA-C-O 116.807 -2.107 . . . . 0.0 112.9 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.11 142.02 37.34 Favored 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 122.658 3.229 . . . . 0.0 114.315 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 113.19 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.045 2.497 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.81 -85.92 0.11 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 t -85.12 109.21 18.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.1 p -111.17 172.11 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.085 0.945 . . . . 0.0 112.907 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -50.64 122.7 16.62 Favored Pre-proline 0 CA--C 1.582 2.182 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.02 162.09 37.66 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.089 2.526 . . . . 0.0 115.799 -171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 167.56 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.465 1.126 . . . . 0.0 112.22 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -64.57 126.72 28.77 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.729 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.31 59.79 1.08 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.251 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -146.27 139.69 25.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.38 102.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.65 120.6 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -100.03 142.62 31.27 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.39 0.676 . . . . 0.0 109.444 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.98 141.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.589 0.756 . . . . 0.0 109.638 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -83.16 109.67 17.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 160.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -95.62 113.18 24.8 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -94.02 91.27 6.78 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 m -82.94 116.94 22.44 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -145.19 171.59 14.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.303 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.21 130.94 55.75 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.61 -38.92 79.04 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -65.29 -48.18 74.04 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 163.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.89 -116.51 4.14 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 119.245 0.929 . . . . 0.0 112.564 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.5 t -153.69 -176.39 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.77 0.795 . . . . 0.0 111.909 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -61.53 122.69 15.86 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.49 -49.88 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.45 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -146.59 103.42 3.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -84.88 82.04 8.62 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.346 1.069 . . . . 0.0 111.459 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.49 112.02 58.75 Favored Pre-proline 0 CA--C 1.576 1.947 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.533 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.33 -61.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.181 2.588 . . . . 0.0 116.364 -169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -97.82 74.08 2.33 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.222 1.374 . . . . 0.0 111.18 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.23 92.39 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.16 139.07 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.048 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.45 155.39 33.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.59 -172.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.7 m -77.97 131.22 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.42 116.27 4.17 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.825 0.85 . . . . 0.0 112.467 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.6 55.26 8.73 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -152.28 150.82 30.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.261 1.029 . . . . 0.0 110.081 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -74.89 81.96 2.16 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 122.824 1.297 . . . . 0.0 114.033 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -130.92 -60.48 0.97 Allowed 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.222 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.52 172.21 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.513 1.125 . . . . 0.0 113.138 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.67 161.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.28 -45.56 90.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.67 77.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -54.53 17.83 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.998 0.919 . . . . 0.0 112.863 172.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -49.28 -50.92 36.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.5 -39.98 77.69 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.2 p -84.22 22.91 1.14 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -74.0 -54.84 3.37 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.382 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.05 61.4 8.19 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 CA-C-N 125.39 2.961 . . . . 0.0 114.642 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.6 mt -155.96 -48.31 0.08 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.628 1.571 . . . . 0.0 109.66 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -76.54 107.12 8.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.523 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.79 169.88 17.28 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.961 167.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.05 106.88 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.884 -1.135 . . . . 0.0 108.413 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 10.34 46.19 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -163.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.98 93.99 6.05 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.504 2.152 . . . . 0.0 109.812 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.3 m -88.54 136.38 33.02 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.168 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.75 138.19 8.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.936 0.494 . . . . 0.0 110.112 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.1 ptm -83.04 124.77 30.75 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.03 71.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -84.93 113.76 21.64 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.6 -0.687 . . . . 0.0 109.414 -164.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.11 154.23 26.94 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.855 0.862 . . . . 0.0 112.051 -167.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -52.33 147.98 7.25 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 168.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.0 p -68.89 78.14 0.31 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.84 1.305 . . . . 0.0 112.619 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -176.12 -60.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.797 -151.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.02 -51.81 23.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.9 m -67.35 -80.34 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -158.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.12 72.3 1.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.32 -142.87 47.75 Favored Glycine 0 CA--C 1.562 3.01 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.78 -164.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.78 50.58 1.91 Allowed 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 122.892 2.395 . . . . 0.0 113.661 165.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 56.0 85.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.905 1.282 . . . . 0.0 113.769 -168.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 162.0 74.06 0.02 OUTLIER Glycine 0 N--CA 1.481 1.687 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.544 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 69.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.7 m 68.53 127.9 0.03 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 166.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.82 -44.8 0.36 Allowed 'Cis proline' 0 CA--C 1.565 2.029 0 CA-C-N 123.009 2.11 . . . . 0.0 116.39 2.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.29 82.35 1.42 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.57 99.08 46.36 Favored Pre-proline 0 CA--C 1.57 1.745 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.34 134.08 12.42 Favored 'Trans proline' 0 CA--C 1.567 2.175 0 C-N-CA 122.828 2.352 . . . . 0.0 113.799 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.66 154.31 64.26 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.137 2.558 . . . . 0.0 115.297 -172.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.256 15.5 m170 82.2 137.61 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.41 1.084 . . . . 0.0 112.069 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.258 . . 73.29 136.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.843 1.257 . . . . 0.0 113.236 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.88 169.73 11.01 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -158.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tt -115.3 125.6 53.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.349 1.06 . . . . 0.0 110.33 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -87.3 118.45 26.74 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.105 0.962 . . . . 0.0 110.971 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.22 111.88 11.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.73 103.67 15.59 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.119 0.485 . . . . 0.0 110.726 -169.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.25 101.18 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.0 m -109.19 121.89 46.14 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.23 105.59 11.6 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.626 0.37 . . . . 0.0 110.162 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -78.61 -69.73 0.54 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.8 p -132.37 143.57 49.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.334 0.588 . . . . 0.0 109.59 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.32 100.13 5.27 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.44 149.66 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.963 0.905 . . . . 0.0 109.002 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -65.59 163.56 15.96 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 CA-C-O 117.225 -1.875 . . . . 0.0 113.529 -175.611 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.268 14.7 tp10 . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -69.76 151.76 45.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.913 167.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.34 98.81 9.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.037 0.535 . . . . 0.0 109.992 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.06 120.89 20.27 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 122.058 0.933 . . . . 0.0 112.146 171.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.21 -80.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -165.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.64 120.9 23.45 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.85 2.74 0.07 OUTLIER Glycine 0 CA--C 1.543 1.81 0 CA-C-O 117.51 -1.717 . . . . 0.0 116.701 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.364 12.5 p30 49.01 56.86 7.13 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 120.281 2.04 . . . . 0.0 114.727 -165.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 54.61 6.57 Favored Glycine 0 CA--C 1.546 1.991 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 99.4 mt -126.21 -66.47 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.478 1.139 . . . . 0.0 110.299 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 tp -82.86 111.44 18.76 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.444 1.02 . . . . 0.0 109.921 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -115.81 144.27 44.23 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.502 0.721 . . . . 0.0 112.606 -173.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.02 136.07 48.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 0.0 112.095 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.8 121.14 40.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 158.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.2 m -75.63 109.16 8.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.19 -61.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.736 0.815 . . . . 0.0 112.592 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.68 108.02 56.41 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.66 148.44 17.95 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.952 2.435 . . . . 0.0 113.989 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.49 118.76 7.37 Favored Glycine 0 CA--C 1.555 2.562 0 CA-C-O 116.986 -2.008 . . . . 0.0 114.882 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.33 168.35 23.69 Favored 'Trans proline' 0 CA--C 1.573 2.472 0 CA-C-N 122.306 3.053 . . . . 0.0 115.452 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.7 116.72 4.1 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 123.195 2.597 . . . . 0.0 113.021 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.27 69.75 1.18 Allowed Glycine 0 CA--C 1.545 1.91 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.319 -163.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -150.9 117.51 5.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -70.53 140.31 51.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -117.64 121.27 32.08 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-O 117.73 -1.129 . . . . 0.0 109.389 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.0 145.92 40.69 Favored 'Trans proline' 0 CA--C 1.558 1.689 0 C-N-CA 122.606 2.204 . . . . 0.0 114.657 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.28 154.68 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.63 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.24 107.89 1.16 Allowed 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.898 0.879 . . . . 0.0 112.425 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.37 69.12 0.87 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.391 -158.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -153.75 127.29 8.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -77.61 100.12 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.43 140.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.945 0.898 . . . . 0.0 109.437 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -89.22 127.26 35.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 164.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.41 130.3 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.151 0.977 . . . . 0.0 109.244 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -98.12 95.25 7.31 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.7 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.59 131.45 55.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.547 0.739 . . . . 0.0 109.297 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -139.08 116.09 10.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.8 m -88.06 119.08 28.09 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.296 -168.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -88.95 129.16 35.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.711 0.804 . . . . 0.0 110.599 170.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.76 140.82 37.09 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.444 0.64 . . . . 0.0 109.854 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -52.79 -45.92 67.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -93.16 90.89 7.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.06 69.12 1.4 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 117.411 1.724 . . . . 0.0 117.411 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.409 1.7 t 53.51 -168.09 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 158.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.364 9.2 ptp180 -77.14 104.9 7.9 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -170.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.79 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-N 112.214 -2.266 . . . . 0.0 116.086 165.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 80.02 112.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -116.92 69.03 0.75 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 72.43 96.57 0.04 OUTLIER Pre-proline 0 CA--C 1.578 2.054 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 167.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.13 -19.09 39.61 Favored 'Trans proline' 0 CA--C 1.56 1.819 0 N-CA-C 119.047 2.672 . . . . 0.0 119.047 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.02 86.03 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.297 1.408 . . . . 0.0 109.259 164.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -87.53 116.68 25.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.1 133.53 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 123.434 0.694 . . . . 0.0 109.404 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.93 148.93 19.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.119 0.568 . . . . 0.0 111.185 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -70.42 130.35 41.69 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.39 0.676 . . . . 0.0 109.563 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 tp -51.27 -36.93 44.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -161.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.69 -102.65 0.55 Allowed Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.472 162.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.42 0.5 OUTLIER 62.2 169.48 0.12 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.16 17.89 23.27 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.37 -51.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 120.288 1.404 . . . . 0.0 113.318 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.0 167.06 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.412 1.101 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.0 pt -68.08 160.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.295 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.58 -36.69 76.72 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.8 73.11 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 167.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -48.98 58.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.44 -37.28 67.5 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.48 -32.66 60.65 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.7 p -75.27 -11.93 60.17 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 165.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.287 1.3 t -54.66 -49.58 90.49 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 115.477 -2.202 . . . . 0.0 115.255 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.19 -13.46 32.21 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 125.127 2.867 . . . . 0.0 119.514 175.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.12 77.96 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.523 1.51 . . . . 0.0 108.886 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -162.45 109.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -88.69 168.36 12.57 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.166 0.984 . . . . 0.0 112.283 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.49 124.86 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.13 88.4 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -110.39 130.04 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.833 2.316 . . . . 0.0 113.244 -159.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 m -78.05 133.5 37.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.009 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.7 tpt -80.53 106.63 12.69 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.9 115.24 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 p -94.58 100.9 12.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.01 125.84 36.86 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.89 -172.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.79 165.24 17.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.4 p -53.12 -42.77 66.34 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 162.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.75 -43.87 87.62 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 164.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -103.36 67.34 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.398 0.679 . . . . 0.0 110.175 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.8 t -148.15 -93.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.59 42.21 3.32 Favored 'General case' 0 CA--C 1.574 1.879 0 CA-C-N 119.758 1.163 . . . . 0.0 111.527 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 56.98 -109.17 1.52 Allowed Glycine 0 CA--C 1.557 2.71 0 CA-C-O 117.454 -1.748 . . . . 0.0 115.109 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.34 -50.46 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 CA-C-N 121.439 2.619 . . . . 0.0 115.782 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -152.05 133.2 14.36 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.162 0.985 . . . . 0.0 108.54 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.15 -124.6 5.21 Favored Glycine 0 N--CA 1.481 1.643 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.865 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -88.02 68.08 9.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.43 0.692 . . . . 0.0 111.775 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -75.4 137.11 71.42 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.116 -172.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.04 -6.15 53.88 Favored 'Cis proline' 0 CA--C 1.568 2.216 0 N-CA-C 119.494 2.844 . . . . 0.0 119.494 9.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -57.94 -51.83 68.02 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.45 98.71 11.27 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 167.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.25 164.06 37.04 Favored 'Trans proline' 0 CA--C 1.572 2.389 0 C-N-CA 122.703 2.269 . . . . 0.0 114.137 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.47 111.25 2.27 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 123.072 2.515 . . . . 0.0 113.375 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 70.71 99.29 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.656 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.6 132.77 16.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.252 0.621 . . . . 0.0 110.364 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.89 85.11 4.68 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 109.908 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.11 147.5 41.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.014 0.911 . . . . 0.0 112.642 -161.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.2 m -76.55 152.2 36.06 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.84 129.72 4.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.809 0.843 . . . . 0.0 110.218 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.67 98.74 11.6 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.588 . . . . 0.0 110.852 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.4 100.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.1 m -109.17 123.98 50.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.97 117.37 17.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -82.63 -66.19 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -131.26 147.57 52.6 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 -169.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.18 107.72 11.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 167.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.58 147.31 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.474 -170.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.62 144.39 49.47 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.6 0 CA-C-O 116.923 -2.043 . . . . 0.0 114.671 -173.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 CA--C 1.564 1.514 0 CA-C-O 121.643 0.735 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 m95 73.11 134.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.383 1.073 . . . . 0.0 111.516 -175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.612 0.765 . . . . 0.0 109.724 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.92 104.46 8.49 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.083 0.953 . . . . 0.0 111.927 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -98.52 130.41 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.436 0.6 OUTLIER 101.15 -66.5 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.231 1.812 . . . . 0.0 111.641 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.57 -70.62 0.08 OUTLIER Glycine 0 N--CA 1.484 1.835 0 CA-C-N 120.034 1.288 . . . . 0.0 114.33 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -73.26 -71.0 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.65 0.78 . . . . 0.0 111.341 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.89 61.28 0.05 OUTLIER Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.31 -0.717 . . . . 0.0 112.321 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.2 -58.72 2.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.638 0.719 . . . . 0.0 110.924 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.51 114.79 29.18 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -115.03 108.87 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.84 0.456 . . . . 0.0 111.197 -168.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -99.48 116.0 30.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.992 -1.067 . . . . 0.0 111.987 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -85.77 119.69 26.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.01 -1.057 . . . . 0.0 108.681 158.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.7 m -90.46 108.66 19.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -71.61 -65.45 0.76 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.166 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.46 136.4 21.47 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.166 164.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.17 176.91 9.4 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 123.0 2.467 . . . . 0.0 114.605 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.9 116.16 5.86 Favored Glycine 0 CA--C 1.558 2.729 0 CA-C-O 117.061 -1.966 . . . . 0.0 111.335 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.64 167.12 27.37 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 CA-C-N 122.55 3.175 . . . . 0.0 115.626 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.98 111.96 2.35 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.072 2.515 . . . . 0.0 112.334 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.54 76.3 1.32 Allowed Glycine 0 CA--C 1.544 1.868 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.661 -161.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.1 p -155.28 131.42 10.19 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.423 0.689 . . . . 0.0 109.744 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -117.27 119.93 36.69 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.457 1.123 . . . . 0.0 112.327 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -73.92 116.67 54.46 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.143 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.03 162.63 40.92 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 122.867 2.378 . . . . 0.0 116.047 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.01 158.7 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.213 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.63 77.74 9.8 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.13 0.966 . . . . 0.0 113.356 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.32 47.07 0.01 OUTLIER Glycine 0 CA--C 1.551 2.315 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.053 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.43 25.4 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.581 1.19 . . . . 0.0 109.269 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.86 103.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.691 0.796 . . . . 0.0 109.858 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.53 113.26 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.9 m -88.48 105.33 17.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.77 141.86 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.64 108.25 3.78 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 109.346 165.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.76 92.57 3.84 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.39 105.8 17.77 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -85.26 101.96 12.95 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.162 0.506 . . . . 0.0 109.743 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -121.65 157.07 31.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.381 1.073 . . . . 0.0 109.818 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.89 103.8 15.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.601 -0.687 . . . . 0.0 109.962 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.396 26.3 tt0 68.27 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 169.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.53 61.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.291 0.636 . . . . 0.0 111.482 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.43 66.29 2.46 Favored Glycine 0 CA--C 1.543 1.804 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -126.02 96.9 4.9 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 173.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -78.38 96.46 5.34 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -165.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 m -81.99 -50.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -152.75 134.73 14.8 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.909 0.861 . . . . 0.0 109.169 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.09 112.79 24.85 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.687 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.33 69.06 3.88 Favored Pre-proline 0 CA--C 1.585 2.289 0 O-C-N 121.446 -0.784 . . . . 0.0 110.953 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.96 -54.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.255 2.637 . . . . 0.0 115.487 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.83 76.61 6.51 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 121.4 1.909 . . . . 0.0 112.536 164.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.58 97.83 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.59 109.01 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -136.05 139.64 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 m -69.28 132.6 46.71 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 tt -69.57 109.68 4.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 80.24 0.98 Allowed Glycine 0 CA--C 1.54 1.644 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.552 -162.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -149.34 160.7 43.19 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.275 1.036 . . . . 0.0 110.793 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.6 p -79.93 71.0 6.6 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.268 1.032 . . . . 0.0 113.433 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -150.58 -62.91 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.479 1.111 . . . . 0.0 110.092 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.84 158.9 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 CA-C-O 123.173 1.463 . . . . 0.0 112.216 -161.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -66.3 152.99 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.726 177.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -57.89 -33.55 68.84 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.51 -46.76 57.42 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -57.65 5.54 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 112.473 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -58.52 -34.24 70.75 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.37 -38.0 77.84 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 167.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -70.49 -20.49 62.85 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.258 54.7 t -62.73 -52.45 64.46 Favored Pre-proline 0 CA--C 1.577 1.995 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.629 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.41 10.47 0.44 Allowed 'Trans proline' 0 CA--C 1.572 2.393 0 CA-C-N 124.703 2.715 . . . . 0.0 118.521 171.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.06 -46.28 5.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.245 1.018 . . . . 0.0 111.59 158.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.0 128.92 35.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.637 1.108 . . . . 0.0 113.013 -173.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -94.97 -147.71 0.28 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 123.153 0.581 . . . . 0.0 111.187 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.97 123.79 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.629 -1.294 . . . . 0.0 110.363 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.77 -103.07 2.97 Favored Glycine 0 CA--C 1.54 1.608 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -168.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 32.57 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -168.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 m -82.06 115.71 21.32 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.58 123.35 11.91 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.324 0.583 . . . . 0.0 110.01 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.9 ttp -76.98 104.97 7.77 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.705 0.802 . . . . 0.0 110.544 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.91 97.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.3 m -99.37 104.22 16.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.18 37.26 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.794 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -48.91 134.24 17.0 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 165.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -51.04 -39.01 54.92 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.254 14.5 pttp -58.69 -41.26 85.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -66.9 -49.79 64.48 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 171.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.03 -160.71 0.34 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.822 0.849 . . . . 0.0 112.295 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -85.73 101.52 12.84 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.91 -91.6 1.78 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 116.866 -2.075 . . . . 0.0 109.66 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.59 -46.53 3.69 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 122.073 2.936 . . . . 0.0 116.253 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -91.3 98.64 11.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -90.42 134.43 12.34 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 115.336 -0.847 . . . . 0.0 115.117 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -113.51 91.44 3.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.889 0.476 . . . . 0.0 109.848 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.4 m 72.68 103.58 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.763 0 CA-C-O 117.476 -1.249 . . . . 0.0 112.003 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.63 -70.07 0.01 OUTLIER 'Cis proline' 0 CA--C 1.565 2.061 0 CA-C-N 122.923 2.08 . . . . 0.0 112.032 8.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.02 78.69 1.62 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 168.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.2 mt -67.29 121.96 80.87 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 -162.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.13 155.17 29.42 Favored 'Trans proline' 0 CA--C 1.569 2.267 0 C-N-CA 122.762 2.308 . . . . 0.0 115.214 -170.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.55 146.6 44.37 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.238 2.626 . . . . 0.0 113.459 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.267 22.4 m170 77.09 157.7 0.19 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.458 1.103 . . . . 0.0 112.245 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.12 127.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.984 1.314 . . . . 0.0 111.705 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.14 114.93 15.35 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.684 0.394 . . . . 0.0 112.038 -174.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.14 130.23 34.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.523 0.729 . . . . 0.0 110.895 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.6 p -85.66 93.33 8.81 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.564 0.746 . . . . 0.0 112.444 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.13 107.91 19.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.743 0.817 . . . . 0.0 109.01 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -85.36 105.99 16.41 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.663 0.744 . . . . 0.0 111.184 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.5 t -90.74 123.44 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.521 1.128 . . . . 0.0 107.969 -173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.9 m -135.94 126.6 27.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 tp -75.45 109.89 9.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.913 -0.492 . . . . 0.0 110.229 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -81.18 -59.54 2.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.382 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.0 p -140.28 132.35 27.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.366 0.667 . . . . 0.0 109.388 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -105.52 112.61 25.77 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.48 138.13 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.516 0.674 . . . . 0.0 109.608 -170.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.52 155.95 35.61 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.195 0.997 . . . . 0.0 113.643 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.795 0 CA-C-O 116.963 -2.021 . . . . 0.0 114.189 -179.4 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.55 0.975 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.28 11.0 mpt_? 64.71 61.9 0.79 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.407 1.1 mm-40 64.49 -173.24 0.17 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 172.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -104.37 162.96 12.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.997 1.319 . . . . 0.0 110.052 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -77.59 107.55 10.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.679 -0.638 . . . . 0.0 109.488 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.09 129.7 54.79 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 121.644 0.735 . . . . 0.0 111.744 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.64 -48.54 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 118.021 -0.99 . . . . 0.0 111.003 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.22 -70.3 0.25 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 120.111 1.323 . . . . 0.0 113.982 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.79 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -74.28 -52.19 13.03 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.6 -124.03 0.7 Allowed Glycine 0 CA--C 1.54 1.599 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . 0.377 5.3 mp 72.93 -80.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.115 1.366 . . . . 0.0 112.481 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.98 95.72 10.43 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.8 mtp-105 -109.38 90.13 3.21 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -97.37 96.82 8.63 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.587 -0.696 . . . . 0.0 110.572 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -77.61 103.11 7.35 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.488 -0.758 . . . . 0.0 110.415 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.4 m -83.21 100.74 10.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.37 -65.36 1.02 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.616 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.6 t -84.2 128.28 62.96 Favored Pre-proline 0 CA--C 1.575 1.931 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 167.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.77 -56.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.953 2.435 . . . . 0.0 116.26 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.72 101.29 0.89 Allowed Glycine 0 CA--C 1.547 2.034 0 CA-C-O 116.71 -2.161 . . . . 0.0 107.887 -162.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -69.21 162.75 40.53 Favored 'Trans proline' 0 CA--C 1.571 2.375 0 CA-C-N 122.631 3.215 . . . . 0.0 116.42 -164.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.36 130.64 22.91 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.243 2.629 . . . . 0.0 113.701 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.79 -69.16 0.21 Allowed Glycine 0 CA--C 1.542 1.744 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -160.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -82.05 94.16 7.14 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.397 0.679 . . . . 0.0 111.165 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.0 m -128.09 166.49 18.35 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.983 0.897 . . . . 0.0 111.813 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.48 134.87 33.73 Favored Pre-proline 0 CA--C 1.577 2.0 0 N-CA-C 118.484 2.772 . . . . 0.0 118.484 -165.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.33 144.84 11.78 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 123.133 2.556 . . . . 0.0 114.765 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.4 156.48 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 124.019 0.927 . . . . 0.0 109.32 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.83 89.09 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -160.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.11 61.15 0.01 OUTLIER Glycine 0 CA--C 1.546 1.988 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.989 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -151.16 144.43 24.76 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.08 94.19 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.78 141.66 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 124.466 1.106 . . . . 0.0 110.603 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.1 m -124.09 128.21 48.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.579 -167.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.67 150.42 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.3 1.047 . . . . 0.0 110.5 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -96.63 107.55 20.01 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 tt -112.25 106.24 14.76 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -104.77 120.08 40.52 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -91.58 126.31 36.61 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -124.3 162.77 23.06 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.132 0.968 . . . . 0.0 110.563 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.7 tp -83.58 153.27 24.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.326 -0.858 . . . . 0.0 111.815 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -50.86 -45.17 59.76 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 163.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -124.62 63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.44 0.564 . . . . 0.0 110.348 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.39 -116.52 0.59 Allowed Glycine 0 CA--C 1.538 1.485 0 O-C-N 121.178 -0.951 . . . . 0.0 112.128 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.6 t -158.01 -169.38 2.79 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.713 0.805 . . . . 0.0 111.168 -164.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.4 111.67 1.17 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.2 t -82.09 -52.13 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 125.009 1.324 . . . . 0.0 111.34 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -150.52 107.59 3.58 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -97.45 100.7 12.13 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.523 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -119.31 90.4 42.05 Favored Pre-proline 0 CA--C 1.572 1.822 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -168.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.77 -6.16 15.07 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 N-CA-C 120.055 3.06 . . . . 0.0 120.055 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -127.64 102.84 7.01 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.45 1.477 . . . . 0.0 110.071 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.5 tp -126.8 97.65 5.07 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.69 136.58 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.924 0.889 . . . . 0.0 109.308 173.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -164.87 154.32 13.12 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.607 0.763 . . . . 0.0 111.032 -169.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.8 m -76.75 137.97 39.64 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.393 0.616 . . . . 0.0 110.398 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 tt -72.04 115.93 11.85 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.974 0.909 . . . . 0.0 109.98 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.54 73.01 0.97 Allowed Glycine 0 N--CA 1.481 1.639 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.724 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.99 149.5 19.68 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.873 0.844 . . . . 0.0 110.624 -168.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 76.9 m -77.49 80.71 3.97 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.58 1.181 . . . . 0.0 112.113 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -148.49 -65.27 0.24 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.856 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.0 m -81.08 164.73 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-O 122.437 1.113 . . . . 0.0 112.397 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.1 pt -61.84 159.35 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.514 1.126 . . . . 0.0 113.983 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -55.52 -40.23 71.52 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.16 -44.48 71.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.96 -67.67 0.44 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 117.199 -1.382 . . . . 0.0 111.616 170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -46.48 -42.43 15.52 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.512 2.782 . . . . 0.0 118.512 -171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.86 -51.51 66.71 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.3 p -77.48 -4.51 45.88 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.304 1.6 t -68.26 -45.64 38.8 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 114.892 -2.48 . . . . 0.0 114.976 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.93 -30.14 91.06 Favored 'Trans proline' 0 CA--C 1.567 2.143 0 CA-C-N 126.77 3.454 . . . . 0.0 117.489 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.6 pt? -100.49 70.66 1.48 Allowed 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.213 1.005 . . . . 0.0 111.146 169.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -136.32 107.65 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.26 136.52 37.07 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.997 0.903 . . . . 0.0 111.63 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.93 114.17 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.883 -158.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.29 44.75 2.5 Favored Glycine 0 CA--C 1.549 2.201 0 CA-C-N 114.571 -1.195 . . . . 0.0 115.496 -166.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.39 167.28 12.39 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 118.837 1.318 . . . . 0.0 113.713 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 95.3 m -143.31 108.38 4.96 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 103.733 -2.692 . . . . 0.0 103.733 163.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.94 121.34 15.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.315 0.246 . . . . 0.0 110.751 -166.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 ttt -81.57 115.99 21.12 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.853 0.461 . . . . 0.0 110.168 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.99 100.61 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.0 p -84.41 97.65 9.62 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 166.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.45 142.35 32.05 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.343 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.67 144.91 53.81 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 169.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.3 t -58.56 -38.63 78.24 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.865 2.172 . . . . 0.0 116.865 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -69.71 -37.46 76.57 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.23 -44.15 92.76 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 169.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.9 t -91.24 -179.66 5.48 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 123.062 1.41 . . . . 0.0 111.49 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -63.25 113.79 3.41 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.022 158.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -150.41 -89.38 0.08 OUTLIER Glycine 0 CA--C 1.546 1.986 0 CA-C-O 116.792 -2.115 . . . . 0.0 109.077 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.15 -57.14 0.13 Allowed 'Trans proline' 0 CA--C 1.561 1.847 0 CA-C-N 122.307 3.053 . . . . 0.0 114.295 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -89.13 103.21 15.84 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 159.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.57 -118.75 0.47 Allowed Glycine 0 N--CA 1.472 1.09 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.051 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -141.9 60.59 1.47 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.875 0.845 . . . . 0.0 111.877 -166.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 85.9 p -87.85 150.64 48.42 Favored Pre-proline 0 CA--C 1.572 1.808 0 C-N-CA 124.214 1.005 . . . . 0.0 113.129 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.12 -7.33 46.59 Favored 'Cis proline' 0 CA--C 1.562 1.894 0 N-CA-C 119.552 2.866 . . . . 0.0 119.552 11.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.83 -57.71 9.93 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 120.278 1.399 . . . . 0.0 113.854 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.1 mt -90.28 117.84 68.34 Favored Pre-proline 0 CA--C 1.577 2.003 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.47 161.4 9.57 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 122.875 2.383 . . . . 0.0 116.095 -166.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 131.83 21.4 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 123.138 2.559 . . . . 0.0 112.62 168.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.29 92.0 m-70 71.13 174.65 0.3 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 123.729 0.812 . . . . 0.0 112.306 -170.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.72 118.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.054 1.342 . . . . 0.0 111.964 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.51 97.9 8.67 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.43 149.12 21.85 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.526 0.679 . . . . 0.0 112.749 -171.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.6 p -87.77 147.05 25.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.371 0.668 . . . . 0.0 112.475 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.58 109.31 3.25 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.59 120.65 26.6 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.797 0.808 . . . . 0.0 111.917 -172.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 87.6 t -103.3 109.23 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.6 m -116.17 104.48 11.57 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.1 113.87 7.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.398 0.679 . . . . 0.0 110.664 -175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -85.16 -61.07 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.1 p -142.8 133.27 24.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.21 100.94 10.02 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -118.94 132.38 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.119 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.94 73.22 10.36 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 122.27 1.033 . . . . 0.0 113.766 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 77.5 83.35 0.55 Allowed Glycine 0 CA--C 1.552 2.344 0 CA-C-O 116.787 -2.119 . . . . 0.0 114.472 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.76 106.83 1.5 Allowed 'Trans proline' 0 CA--C 1.56 1.793 0 CA-C-N 122.259 3.029 . . . . 0.0 112.017 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.91 119.52 31.18 Favored 'General case' 0 CA--C 1.566 1.558 0 C-N-CA 123.168 0.587 . . . . 0.0 111.202 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.69 110.17 4.23 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 123.229 1.49 . . . . 0.0 111.013 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 118.845 -0.597 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -77.3 -73.55 0.29 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 118.964 0.802 . . . . 0.0 111.538 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -149.31 116.92 6.18 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 87.8 m95 72.57 134.05 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.504 1.122 . . . . 0.0 113.526 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.53 93.98 7.1 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.17 112.63 17.67 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.483 0.713 . . . . 0.0 111.265 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -64.03 -49.88 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 118.105 -0.95 . . . . 0.0 112.746 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.4 tp -59.1 -61.07 2.91 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 155.8 -71.41 0.26 Allowed Glycine 0 N--CA 1.48 1.576 0 CA-C-N 118.632 0.651 . . . . 0.0 111.763 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -66.62 -72.7 0.15 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.785 0.834 . . . . 0.0 112.025 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.78 72.64 0.03 OUTLIER Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.517 0.599 . . . . 0.0 112.684 171.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.82 -72.98 0.66 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.31 143.71 31.09 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.999 0.92 . . . . 0.0 110.614 172.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -141.19 161.84 36.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.002 0.921 . . . . 0.0 112.473 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.37 150.87 37.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 112.182 164.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -173.48 2.34 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 122.009 0.909 . . . . 0.0 111.591 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.8 m -140.8 97.19 3.14 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 164.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.15 -69.09 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.609 0.764 . . . . 0.0 109.562 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -101.78 131.63 22.62 Favored Pre-proline 0 CA--C 1.573 1.836 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 160.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 175.17 11.7 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.106 2.538 . . . . 0.0 114.53 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.73 115.34 4.96 Favored Glycine 0 CA--C 1.556 2.64 0 CA-C-O 116.879 -2.067 . . . . 0.0 112.066 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.27 169.36 15.52 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 CA-C-N 122.602 3.201 . . . . 0.0 115.597 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.68 -38.6 76.87 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 123.326 2.684 . . . . 0.0 118.182 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.7 87.61 0.94 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 118.968 0.804 . . . . 0.0 111.597 163.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.7 p -144.4 95.53 2.73 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.4 p -91.66 108.62 20.04 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.944 0.878 . . . . 0.0 110.598 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -76.41 126.67 86.02 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.59 -172.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.44 149.62 56.65 Favored 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 115.55 -170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.85 166.87 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.127 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -62.52 118.77 8.02 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.118 0.567 . . . . 0.0 112.438 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.58 58.41 1.13 Allowed Glycine 0 CA--C 1.544 1.861 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.287 -167.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -143.89 135.65 26.22 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -79.28 101.8 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 m -122.68 128.24 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.789 0.804 . . . . 0.0 109.249 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 m -95.13 137.42 34.2 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.913 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.23 144.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.831 0.824 . . . . 0.0 109.461 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -92.05 100.66 13.26 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 163.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.8 tp -86.38 107.05 17.84 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.001 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -102.83 80.25 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 109.519 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.9 m -75.83 129.34 36.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.792 0.837 . . . . 0.0 109.991 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -139.86 164.87 28.82 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.473 1.13 . . . . 0.0 111.621 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.1 tp -78.9 161.68 26.55 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.985 0.914 . . . . 0.0 111.992 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -49.37 -42.08 41.0 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -72.61 -68.47 0.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.596 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.83 83.35 0.05 OUTLIER Glycine 0 N--CA 1.479 1.53 0 CA-C-N 119.117 0.871 . . . . 0.0 112.03 173.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.2 t -159.44 122.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.52 115.02 11.28 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -79.29 -45.89 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -145.43 109.16 4.73 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -94.33 101.64 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.458 0.647 . . . . 0.0 110.113 164.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -92.65 109.29 37.74 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.645 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.14 -51.45 0.6 Allowed 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 123.026 2.484 . . . . 0.0 117.308 -165.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -121.57 94.91 4.47 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.983 0.896 . . . . 0.0 111.551 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.8 tp -97.23 102.98 14.87 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.15 123.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -149.7 149.21 30.26 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -170.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.7 m -75.77 124.27 27.0 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 tt -69.34 114.89 8.0 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.536 0.734 . . . . 0.0 111.004 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.11 18.44 77.9 Favored Glycine 0 CA--C 1.552 2.344 0 N-CA-C 119.64 2.616 . . . . 0.0 119.64 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -132.85 66.25 1.57 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.661 1.73 . . . . 0.0 111.587 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 30.6 t 58.9 78.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -149.78 -66.71 0.21 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.469 0.708 . . . . 0.0 110.833 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.5 m -97.58 167.27 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.733 1.254 . . . . 0.0 112.256 -166.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.2 pt -61.09 159.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.946 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -59.46 -41.34 89.48 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.86 -46.21 71.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 168.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.7 -57.53 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 117.938 -1.03 . . . . 0.0 113.345 168.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -46.58 -58.05 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.35 -32.82 74.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.5 p -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.264 1.7 t -64.22 -49.19 74.35 Favored Pre-proline 0 N--CA 1.505 2.295 0 CA-C-N 122.391 2.36 . . . . 0.0 113.71 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.99 1.08 3.65 Favored 'Trans proline' 0 CA--C 1.572 2.407 0 CA-C-N 125.119 2.864 . . . . 0.0 118.61 169.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt -97.27 -25.78 15.14 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 156.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 12.0 tpp -81.9 105.38 12.97 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.851 1.205 . . . . 0.0 110.441 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.34 167.48 20.83 Favored 'General case' 0 CA--C 1.57 1.715 0 CA-C-O 122.146 0.974 . . . . 0.0 112.095 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 74.3 t -72.96 107.36 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.0 108.746 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.41 14.01 52.14 Favored Glycine 0 CA--C 1.554 2.491 0 N-CA-C 118.148 2.019 . . . . 0.0 118.148 -166.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.27 110.15 22.12 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 119.971 1.885 . . . . 0.0 109.561 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.9 m -94.29 120.36 34.41 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.22 135.31 49.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.553 0.741 . . . . 0.0 109.535 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 tpt -80.86 103.72 10.88 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.8 t -90.96 94.03 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.5 p -89.14 91.43 8.79 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.822 0.82 . . . . 0.0 109.487 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.71 134.87 41.97 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.843 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.9 132.57 47.59 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.908 170.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.476 ' HA ' ' SG ' ' A' ' 121' ' ' CYS . 26.7 t -74.32 75.09 1.86 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 123.26 1.505 . . . . 0.0 112.723 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -172.17 -51.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.072 -1.876 . . . . 0.0 109.481 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -87.87 -56.94 3.13 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.614 1.166 . . . . 0.0 110.179 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 118' ' ' SER . 20.1 p -46.28 -57.18 4.81 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 168.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -124.94 -46.16 1.85 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.609 -169.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 96.97 144.46 17.21 Favored Glycine 0 CA--C 1.555 2.541 0 CA-C-O 117.677 -1.624 . . . . 0.0 112.255 -168.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.88 87.91 1.36 Allowed 'Trans proline' 0 CA--C 1.563 1.946 0 CA-C-N 122.184 2.992 . . . . 0.0 113.05 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -144.67 -66.92 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.75 86.0 1.84 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.604 0.621 . . . . 0.0 111.594 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -91.96 152.47 20.01 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.2 m -68.03 140.16 93.38 Favored Pre-proline 0 CA--C 1.573 1.83 0 CA-C-O 117.707 -1.139 . . . . 0.0 112.729 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.71 -50.25 0.2 OUTLIER 'Cis proline' 0 CA--C 1.562 1.923 0 N-CA-C 117.238 1.976 . . . . 0.0 117.238 11.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -149.92 76.47 1.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 119.506 1.048 . . . . 0.0 109.208 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.77 118.11 49.15 Favored Pre-proline 0 CA--C 1.57 1.73 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.59 142.03 12.71 Favored 'Trans proline' 0 CA--C 1.573 2.428 0 C-N-CA 122.877 2.385 . . . . 0.0 114.303 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.34 125.33 10.66 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 123.131 2.554 . . . . 0.0 112.103 171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.278 97.6 m-70 70.0 172.18 0.31 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 123.708 0.803 . . . . 0.0 112.883 -171.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.18 111.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.999 1.32 . . . . 0.0 111.15 -174.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.23 117.25 8.26 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.43 128.11 33.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.819 0.448 . . . . 0.0 109.8 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.11 98.45 8.88 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.601 0.761 . . . . 0.0 109.355 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.91 107.0 18.03 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.572 0.749 . . . . 0.0 110.575 -172.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -83.4 107.9 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.126 0.965 . . . . 0.0 111.276 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.84 105.97 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.9 m -101.34 122.39 43.63 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -73.07 -74.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 82.1 p -147.45 131.9 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.776 0.716 . . . . 0.0 109.113 -169.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.47 112.51 25.55 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.209 0.604 . . . . 0.0 109.579 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.2 143.4 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.624 0.77 . . . . 0.0 110.109 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -93.67 79.43 4.26 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 122.074 0.94 . . . . 0.0 113.124 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.15 159.26 27.2 Favored Glycine 0 CA--C 1.561 2.937 0 N-CA-C 116.568 1.387 . . . . 0.0 116.568 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.11 164.91 21.96 Favored 'Trans proline' 0 CA--C 1.563 1.941 0 C-N-CA 123.178 2.585 . . . . 0.0 114.335 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.24 96.9 8.01 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.54 0.686 . . . . 0.0 109.994 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -158.01 113.35 2.7 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.32 10.1 pt-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 CA--C 1.551 0.994 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -132.12 -76.43 0.51 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.447 175.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -145.96 95.27 2.6 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.747 1.158 . . . . 0.0 111.766 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.322 14.9 m0 68.92 -135.94 0.08 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.362 1.065 . . . . 0.0 111.581 168.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 tt -138.25 119.31 14.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.64 108.81 2.59 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.39 0.676 . . . . 0.0 112.207 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 pt -104.29 45.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 170.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -58.45 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 125.272 1.429 . . . . 0.0 110.213 172.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.52 -91.3 0.51 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -73.95 -36.32 64.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 171.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.49 78.08 1.35 Allowed Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.441 0.936 . . . . 0.0 115.441 -167.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mp 15.82 63.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 165.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 tp -157.99 117.37 3.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -148.76 115.22 5.89 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.85 -161.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -117.03 133.64 55.75 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -171.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -73.7 143.74 46.07 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.978 0.911 . . . . 0.0 111.661 159.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.5 m -93.45 92.13 7.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 159.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.73 -60.98 2.11 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.774 0.829 . . . . 0.0 113.044 -167.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.5 m -113.82 130.2 24.04 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 157.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.84 170.03 21.27 Favored 'Trans proline' 0 CA--C 1.56 1.82 0 C-N-CA 123.088 2.526 . . . . 0.0 114.97 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 152.39 49.65 Favored Glycine 0 CA--C 1.561 2.925 0 CA-C-O 118.376 -1.236 . . . . 0.0 115.345 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.95 164.58 31.24 Favored 'Trans proline' 0 CA--C 1.574 2.486 0 CA-C-N 121.433 2.616 . . . . 0.0 115.556 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.14 113.58 2.68 Favored 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 123.201 2.601 . . . . 0.0 113.038 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.6 -96.27 0.94 Allowed Glycine 0 CA--C 1.539 1.557 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -163.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.268 82.9 p 53.96 85.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.4 p -79.9 120.62 24.36 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.424 0.63 . . . . 0.0 111.534 -173.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -81.61 124.01 80.25 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.746 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.52 147.9 65.45 Favored 'Trans proline' 0 CA--C 1.561 1.861 0 C-N-CA 123.1 2.533 . . . . 0.0 115.567 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.16 152.74 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.059 0.944 . . . . 0.0 111.842 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.81 118.42 8.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.06 60.48 0.55 Allowed Glycine 0 CA--C 1.543 1.815 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.71 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -146.86 146.0 30.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.364 1.078 . . . . 0.0 108.559 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.1 t -77.3 101.39 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 m -118.81 125.49 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.1 m -107.4 140.29 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.371 0.668 . . . . 0.0 109.308 -175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.7 m -132.27 141.32 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.801 0.841 . . . . 0.0 109.023 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -83.82 101.32 11.54 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 158.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.6 tp -86.26 100.56 12.35 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -93.68 101.38 13.52 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -81.03 117.51 21.69 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -142.58 154.36 44.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.656 0.783 . . . . 0.0 109.566 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.6 mt -120.21 141.54 49.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.858 0.837 . . . . 0.0 111.206 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -57.63 -45.63 85.17 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 157.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -71.18 -58.01 3.96 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.83 54.13 0.75 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 116.906 1.522 . . . . 0.0 116.906 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.472 2.5 t 50.92 -157.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 163.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -79.97 107.37 12.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.211 1.004 . . . . 0.0 111.973 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.5 t -87.2 -71.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.378 0.671 . . . . 0.0 111.26 -165.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.92 111.18 4.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -163.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -93.25 113.11 25.23 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.133 0.573 . . . . 0.0 110.739 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -111.92 91.89 16.48 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.498 -169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.08 -61.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 123.36 2.707 . . . . 0.0 116.047 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 86.33 5.66 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.663 1.12 . . . . 0.0 110.625 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.8 tp -106.88 92.6 4.16 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 165.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.2 139.44 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.533 0.733 . . . . 0.0 110.395 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -159.6 154.65 24.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.516 0.674 . . . . 0.0 111.748 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -74.87 133.1 41.9 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.142 0.577 . . . . 0.0 109.627 171.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.18 111.3 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.129 0.972 . . . . 0.0 111.409 -172.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.35 77.96 0.33 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.015 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.84 157.7 27.12 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-O 122.28 1.038 . . . . 0.0 111.228 -170.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.47 83.56 3.18 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 122.274 1.035 . . . . 0.0 112.253 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -151.39 -66.44 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.32 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -81.61 169.05 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.702 1.239 . . . . 0.0 113.44 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 pt -52.27 151.12 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-N 114.131 -1.395 . . . . 0.0 114.053 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -60.73 -36.78 79.74 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.95 -40.14 83.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.32 -57.78 7.54 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 117.406 -1.283 . . . . 0.0 113.289 165.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -52.49 -39.9 61.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.43 -51.12 68.77 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.6 p -104.54 61.57 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.96 -61.02 0.17 Allowed Pre-proline 0 N--CA 1.498 1.93 0 CA-C-O 115.543 -2.17 . . . . 0.0 108.987 168.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.97 -25.08 59.67 Favored 'Trans proline' 0 C--N 1.376 2.026 0 CA-C-N 124.986 2.816 . . . . 0.0 117.542 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.89 -6.27 5.72 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 167.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.2 mtt -114.44 119.8 38.12 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.935 1.243 . . . . 0.0 109.017 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -64.45 163.3 13.57 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.62 99.72 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 91.21 49.28 3.09 Favored Glycine 0 CA--C 1.55 2.225 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.37 137.99 54.41 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 118.352 1.076 . . . . 0.0 110.741 163.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.3 m -93.5 142.28 27.52 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.29 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.83 123.17 13.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.727 0.411 . . . . 0.0 110.705 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.3 tpt -84.02 101.78 12.01 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.47 125.63 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.9 p -106.35 96.42 6.45 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.843 0.83 . . . . 0.0 109.219 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.19 167.69 15.46 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.965 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.45 42.91 1.12 Allowed 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 59.7 p 35.34 54.79 0.81 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -162.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -151.86 -58.86 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.821 -159.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.9 -45.61 92.98 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 157.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.6 t -90.78 113.6 25.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.821 0.848 . . . . 0.0 111.173 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.287 81.0 m-85 65.2 14.46 9.41 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.17 179.1 25.31 Favored Glycine 0 CA--C 1.559 2.824 0 N-CA-C 116.523 1.369 . . . . 0.0 116.523 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -83.46 62.56 7.34 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 122.921 2.414 . . . . 0.0 113.407 170.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -160.54 -70.69 0.07 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.84 132.82 7.67 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 118.22 0.464 . . . . 0.0 112.038 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -111.34 52.42 0.75 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.9 m 65.46 143.77 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 170.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.03 -40.39 0.85 Allowed 'Cis proline' 0 CA--C 1.563 1.932 0 CA-C-N 122.687 1.996 . . . . 0.0 116.472 -1.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -132.81 67.33 1.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 84.2 mt -115.77 119.64 37.13 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -85.54 159.81 10.87 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 C-N-CA 123.157 2.571 . . . . 0.0 115.196 -173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.08 -39.51 0.87 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 122.959 2.44 . . . . 0.0 117.291 170.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -147.87 72.34 1.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.021 0.828 . . . . 0.0 109.04 -173.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.19 21.3 0.25 Allowed 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 72.68 134.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.3 tt -138.75 123.48 18.65 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -99.48 97.3 8.32 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.877 0.846 . . . . 0.0 110.138 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -94.66 125.59 39.41 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.284 1.034 . . . . 0.0 109.602 -178.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -98.54 103.48 15.43 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.878 0.847 . . . . 0.0 110.298 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.3 t -95.23 109.17 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.7 m -105.26 121.61 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -77.09 105.83 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.91 -66.9 0.76 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 64.5 p -135.06 135.41 41.26 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.44 0.696 . . . . 0.0 109.219 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.86 104.07 11.82 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.03 154.48 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.742 0.782 . . . . 0.0 109.915 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.19 -170.05 0.89 Allowed 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -80.85 117.38 4.41 Favored Glycine 0 CA--C 1.556 2.614 0 CA-C-O 116.874 -2.07 . . . . 0.0 115.021 -173.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.73 147.22 19.33 Favored 'Trans proline' 0 CA--C 1.56 1.804 0 CA-C-N 122.58 3.19 . . . . 0.0 113.774 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.03 168.47 19.83 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.54 159.19 22.86 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.276 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 123.813 0.845 . . . . 0.0 112.146 -171.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.8 ttp-105 -146.84 127.69 14.43 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.162 0.585 . . . . 0.0 111.081 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.27 122.62 20.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.173 0.589 . . . . 0.0 109.746 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.317 98.5 m95 86.54 106.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.709 1.204 . . . . 0.0 109.596 -161.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -97.27 107.33 19.82 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -83.48 116.03 22.35 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-O 121.527 0.679 . . . . 0.0 112.193 -165.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -65.46 -48.83 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 C-N-CA 123.909 0.884 . . . . 0.0 111.413 170.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.38 -60.3 3.75 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.413 1.006 . . . . 0.0 113.143 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.78 -72.63 0.29 Allowed Glycine 0 N--CA 1.48 1.608 0 CA-C-N 118.912 0.778 . . . . 0.0 112.446 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -69.56 -70.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.687 0.795 . . . . 0.0 112.353 -172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.82 64.06 0.09 OUTLIER Glycine 0 N--CA 1.481 1.644 0 CA-C-N 118.393 0.542 . . . . 0.0 111.863 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.1 mt -137.04 -78.74 0.4 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.894 -163.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.7 tp -88.27 124.72 34.16 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 121.022 1.737 . . . . 0.0 107.988 166.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -154.95 113.19 3.49 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.477 -164.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -119.2 115.99 25.37 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.339 1.056 . . . . 0.0 109.127 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -103.8 141.18 36.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.819 -0.551 . . . . 0.0 111.081 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.9 m -80.18 115.35 19.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.9 -69.08 0.63 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.539 0.736 . . . . 0.0 109.293 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.6 134.09 24.72 Favored Pre-proline 0 CA--C 1.578 2.035 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.021 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.04 149.83 29.08 Favored 'Trans proline' 0 CA--C 1.558 1.686 0 C-N-CA 122.851 2.368 . . . . 0.0 114.11 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.79 114.49 4.0 Favored Glycine 0 CA--C 1.555 2.578 0 CA-C-O 116.872 -2.071 . . . . 0.0 113.127 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.83 164.17 36.53 Favored 'Trans proline' 0 CA--C 1.573 2.448 0 CA-C-N 122.775 3.287 . . . . 0.0 116.0 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.09 109.56 2.6 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.272 2.648 . . . . 0.0 111.74 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.81 -66.0 0.52 Allowed Glycine 0 CA--C 1.541 1.684 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.026 -158.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -65.49 135.03 54.65 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.0 m -138.67 146.66 41.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.702 0.763 . . . . 0.0 110.004 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.59 112.46 6.63 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-O 117.998 -1.001 . . . . 0.0 113.362 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.42 166.25 29.88 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.499 2.133 . . . . 0.0 115.942 -161.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.5 m -77.66 162.82 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.22 -168.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 107.52 4.1 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.391 0.676 . . . . 0.0 110.223 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 142.45 -47.84 0.8 Allowed Glycine 0 N--CA 1.483 1.826 0 CA-C-N 115.415 -0.811 . . . . 0.0 113.919 -163.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -63.36 124.05 20.28 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.708 0.803 . . . . 0.0 111.739 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.2 t -85.49 99.25 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -94.49 140.35 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.863 0.839 . . . . 0.0 110.557 -172.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 m -114.41 124.04 50.95 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.15 142.39 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.794 0.837 . . . . 0.0 110.288 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -94.67 99.52 11.62 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 165.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.4 tt -92.25 106.01 18.1 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -99.9 87.92 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.6 m -71.48 125.07 26.08 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.149 0.58 . . . . 0.0 110.562 -170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.0 t -131.38 155.34 47.44 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.098 0.952 . . . . 0.0 110.329 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.1 146.93 30.34 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.612 165.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.59 -33.33 60.18 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.371 3.1 . . . . 0.0 119.371 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -68.16 -63.78 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.96 0.8 . . . . 0.0 112.059 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.5 77.27 0.03 OUTLIER Glycine 0 N--CA 1.479 1.502 0 CA-C-N 119.117 0.871 . . . . 0.0 113.147 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.3 m -149.34 106.61 3.61 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 ttm180 -82.65 105.96 14.12 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.494 0.664 . . . . 0.0 110.217 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.1 m -96.79 -45.3 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -165.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -136.1 87.99 2.35 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 119.847 1.203 . . . . 0.0 110.101 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.38 115.07 26.85 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.322 0.582 . . . . 0.0 111.671 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.13 102.41 48.84 Favored Pre-proline 0 CA--C 1.572 1.822 0 CA-C-O 118.302 -0.856 . . . . 0.0 108.726 -171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -87.22 77.17 2.02 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.633 2.222 . . . . 0.0 114.073 -166.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.461 8.7 pt-20 133.36 94.69 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 127.401 2.281 . . . . 0.0 110.047 174.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.4 tp -117.33 99.56 7.1 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.7 p -92.31 138.22 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.693 -169.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -164.54 149.88 10.1 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.253 0.621 . . . . 0.0 110.683 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -79.46 128.62 33.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.9 tt -67.64 135.1 52.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.563 0.745 . . . . 0.0 112.115 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 52.38 18.4 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.185 1.234 . . . . 0.0 116.185 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.32 -16.71 0.44 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.255 17.0 t 76.2 86.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.44 1.496 . . . . 0.0 110.558 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -132.84 -70.63 0.54 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.062 0.545 . . . . 0.0 110.541 -174.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.68 178.81 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 123.795 0.838 . . . . 0.0 112.521 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.7 pt -54.76 144.2 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 124.361 1.064 . . . . 0.0 113.671 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -57.32 -27.88 62.59 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.37 -47.58 85.19 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 168.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.26 -62.59 1.33 Allowed 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.853 170.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.15 -51.5 42.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.66 -36.14 81.89 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.6 p -74.48 -10.15 59.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.556 2.799 . . . . 0.0 118.556 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -59.88 -50.29 87.28 Favored Pre-proline 0 N--CA 1.5 2.029 0 CA-C-O 115.391 -2.243 . . . . 0.0 114.306 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.16 -30.59 61.64 Favored 'Trans proline' 0 CA--C 1.565 2.059 0 CA-C-N 125.362 2.951 . . . . 0.0 118.283 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.28 65.54 1.43 Allowed 'General case' 0 CA--C 1.567 1.606 0 CA-C-N 119.057 0.844 . . . . 0.0 111.176 163.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.0 ttm -160.23 109.65 1.76 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.38 157.71 20.44 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.071 0.938 . . . . 0.0 112.566 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.9 m -67.14 121.62 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.354 -0.841 . . . . 0.0 111.405 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.433 ' H ' HD12 ' A' ' 143' ' ' LEU . . . 89.72 -3.69 83.32 Favored Glycine 0 CA--C 1.552 2.364 0 N-CA-C 118.49 2.156 . . . . 0.0 118.49 -167.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -74.5 114.26 12.69 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 121.25 2.525 . . . . 0.0 112.147 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.5 m -84.14 124.24 30.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 133.19 21.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.421 0.689 . . . . 0.0 109.579 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.438 ' SD ' ' SG ' ' A' ' 138' ' ' CYS . 26.9 tpp -83.75 137.9 33.52 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.86 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 49.8 t -128.48 125.22 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.5 p -102.74 95.49 6.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.81 127.25 32.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.297 172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.73 59.46 4.66 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.8 p 33.35 64.09 0.32 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -173.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -176.6 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 113.834 -1.53 . . . . 0.0 107.899 -155.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -79.64 -38.76 33.02 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.288 1.435 . . . . 0.0 112.745 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.8 t -62.3 -63.92 1.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 163.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -137.16 -69.41 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.87 0.868 . . . . 0.0 109.665 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 119.63 -166.15 13.37 Favored Glycine 0 CA--C 1.555 2.549 0 CA-C-N 118.938 0.79 . . . . 0.0 113.17 -167.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -64.38 -10.46 24.05 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 N-CA-C 118.573 2.49 . . . . 0.0 118.573 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -105.47 103.27 12.76 Favored 'General case' 0 CA--C 1.558 1.279 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -122.7 157.63 17.3 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 123.685 0.66 . . . . 0.0 112.356 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -87.75 78.21 8.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.242 0.544 . . . . 0.0 112.17 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.1 p -75.69 142.59 73.91 Favored Pre-proline 0 CA--C 1.568 1.668 0 CA-C-O 117.819 -1.086 . . . . 0.0 113.096 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.31 -15.29 32.51 Favored 'Cis proline' 0 CA--C 1.565 2.027 0 N-CA-C 119.397 2.807 . . . . 0.0 119.397 10.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -64.22 -47.86 78.09 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.25 101.01 53.92 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 171.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.34 145.82 66.92 Favored 'Trans proline' 0 CA--C 1.572 2.387 0 C-N-CA 122.525 2.15 . . . . 0.0 113.387 170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.69 -34.55 62.19 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 C-N-CA 123.196 2.597 . . . . 0.0 118.343 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -125.36 157.04 37.77 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.85 0.86 . . . . 0.0 109.905 175.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.262 . . 81.05 128.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.151 1.38 . . . . 0.0 111.569 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.99 153.44 33.8 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 116.374 1.991 . . . . 0.0 116.374 -169.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.77 134.62 54.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.69 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.438 ' SG ' ' SD ' ' A' ' 113' ' ' MET . 42.3 t -90.92 91.93 8.55 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.988 169.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 139' ' ' LEU . 1.7 pt? -79.66 121.12 24.9 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.049 0.928 . . . . 0.0 110.443 173.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -99.46 88.35 3.85 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.839 1.255 . . . . 0.0 109.053 -170.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 95.0 t -84.14 126.25 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -166.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -115.33 118.21 32.62 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 170.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -78.56 108.83 12.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -81.69 -70.3 0.55 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -145.28 135.65 24.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -167.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.87 95.57 5.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.512 0.673 . . . . 0.0 109.301 174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -101.53 158.14 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 124.013 0.925 . . . . 0.0 109.785 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -74.04 -177.7 3.01 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -79.15 120.2 5.22 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-O 116.906 -2.052 . . . . 0.0 113.502 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.46 148.63 26.61 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 CA-C-N 122.589 3.194 . . . . 0.0 114.244 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.35 -30.95 66.77 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 118.47 2.767 . . . . 0.0 118.47 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.98 121.83 25.97 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.268 0.94 . . . . 0.0 109.832 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 123.209 1.48 . . . . 0.0 111.093 179.598 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.267 80.9 mtp180 57.76 37.57 27.19 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -173.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -74.43 -17.84 60.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 118.63 2.826 . . . . 0.0 118.63 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -109.79 136.43 49.13 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.158 0.983 . . . . 0.0 109.774 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.0 tp -145.64 113.44 6.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -77.98 161.37 27.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.9 mm -90.16 -67.74 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 113.618 -1.628 . . . . 0.0 109.427 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.255 2.4 pt? -70.28 -52.96 19.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -171.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.77 56.64 0.05 OUTLIER Glycine 0 N--CA 1.483 1.824 0 C-N-CA 123.73 0.681 . . . . 0.0 113.232 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -150.51 -55.84 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.973 0.909 . . . . 0.0 110.706 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.32 57.77 0.38 Allowed Glycine 0 CA--C 1.544 1.874 0 C-N-CA 124.24 0.924 . . . . 0.0 111.693 -165.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.7 mt -141.18 -59.75 0.49 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.081 0.953 . . . . 0.0 108.896 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 27.9 tp -92.07 89.13 6.82 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 119.222 0.919 . . . . 0.0 108.553 170.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -101.13 96.93 7.54 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.977 0.894 . . . . 0.0 111.565 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -91.77 99.72 12.55 Favored 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.61 0.764 . . . . 0.0 112.185 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -86.37 127.34 34.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.474 -0.766 . . . . 0.0 109.806 164.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 88.2 m -87.47 112.89 22.67 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -80.67 -68.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.82 0.848 . . . . 0.0 110.242 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.2 t -96.03 117.88 66.04 Favored Pre-proline 0 CA--C 1.572 1.79 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.89 167.58 16.29 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.956 2.438 . . . . 0.0 114.937 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.45 170.47 50.58 Favored Glycine 0 CA--C 1.564 3.109 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 170.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.38 169.19 17.56 Favored 'Trans proline' 0 CA--C 1.575 2.549 0 C-N-CA 122.972 2.448 . . . . 0.0 115.844 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.86 113.42 3.22 Favored 'Trans proline' 0 CA--C 1.558 1.723 0 C-N-CA 123.039 2.493 . . . . 0.0 112.326 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.35 -86.1 0.44 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -164.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.285 81.7 p 63.05 113.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 174.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.6 m -92.22 135.93 33.6 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.236 0.541 . . . . 0.0 110.135 172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 143.06 26.01 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.083 0.953 . . . . 0.0 111.421 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.04 145.96 22.55 Favored 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.525 2.15 . . . . 0.0 115.764 -162.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 62' ' ' LYS . 8.3 p -95.71 -179.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 124.578 1.151 . . . . 0.0 111.759 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 61' ' ' VAL . 25.6 tttm -63.66 119.95 10.86 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.73 47.05 2.0 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.88 -173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.45 124.83 26.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.5 t -84.54 99.87 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -103.72 126.54 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.747 0.819 . . . . 0.0 109.17 -171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.4 m -100.86 113.4 26.31 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.69 140.76 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.821 0.848 . . . . 0.0 109.014 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -92.56 100.52 13.03 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.68 106.31 17.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.78 99.82 11.39 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -78.22 119.26 21.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -132.24 145.73 51.52 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.753 0.787 . . . . 0.0 109.945 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.1 mt -69.96 148.78 48.49 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.704 172.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -55.15 -31.34 61.25 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -63.6 -68.04 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.97 0.805 . . . . 0.0 111.682 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.02 77.04 0.02 OUTLIER Glycine 0 CA--C 1.536 1.398 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.0 m -147.57 117.9 7.38 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -74.1 95.74 2.6 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 122.624 1.202 . . . . 0.0 112.903 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.04 -45.39 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -125.11 150.27 47.02 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 122.313 1.054 . . . . 0.0 109.822 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -147.35 79.26 1.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.566 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.89 98.43 5.39 Favored Pre-proline 0 CA--C 1.579 2.069 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.28 -43.92 1.98 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.176 2.584 . . . . 0.0 115.865 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -87.9 77.27 8.53 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.312 1.053 . . . . 0.0 110.067 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.0 tp -100.33 98.01 8.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 167.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.92 135.56 49.68 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -158.56 142.24 15.26 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.459 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 m -80.24 133.3 35.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.46 138.6 57.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.967 0.507 . . . . 0.0 111.97 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.2 -66.01 0.25 Allowed Glycine 0 N--CA 1.478 1.484 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.65 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.09 104.48 5.68 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 121.312 0.577 . . . . 0.0 110.037 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.4 p -89.82 82.84 6.18 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.797 0.808 . . . . 0.0 112.803 -161.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.89 -50.8 14.0 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.122 167.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -63.64 161.05 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 37.1 pt -54.59 151.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 124.829 1.252 . . . . 0.0 114.222 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -65.41 -17.12 64.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 117.4 2.371 . . . . 0.0 117.4 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.67 -36.98 85.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.98 -71.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 117.378 -1.296 . . . . 0.0 111.641 159.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -47.74 -44.34 27.88 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 118.337 2.717 . . . . 0.0 118.337 -168.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.26 -50.18 72.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.5 p -75.49 -12.0 60.15 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 173.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.272 5.7 t -67.79 -46.48 44.5 Favored Pre-proline 0 N--CA 1.497 1.923 0 CA-C-O 115.214 -2.327 . . . . 0.0 114.023 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.22 35.14 0.38 Allowed 'Trans proline' 0 CA--C 1.579 2.74 0 CA-C-N 125.415 2.969 . . . . 0.0 116.672 165.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.3 mt -138.89 -38.75 0.5 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 126.525 1.93 . . . . 0.0 110.495 167.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 42.3 mtt -63.65 123.82 19.82 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.814 1.246 . . . . 0.0 112.768 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -81.67 159.96 23.83 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 122.661 1.22 . . . . 0.0 112.836 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.57 105.15 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.6 62.42 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.685 -1.064 . . . . 0.0 114.296 -170.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -140.27 129.04 23.13 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.477 1.138 . . . . 0.0 112.194 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.9 m -85.62 130.14 34.65 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.98 127.75 14.34 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 120.643 0.259 . . . . 0.0 111.284 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.4 tpp -84.06 108.92 17.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.74 0.781 . . . . 0.0 108.944 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.02 106.58 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 66.0 p -94.69 93.51 7.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.89 154.42 18.06 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -169.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -74.46 153.9 38.96 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.688 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.3 t -75.12 83.82 2.33 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.782 1.277 . . . . 0.0 110.623 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -178.02 -61.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.047 -155.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -77.69 -53.2 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.582 1.153 . . . . 0.0 111.793 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m -81.76 107.75 14.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.86 0.864 . . . . 0.0 110.243 172.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.305 23.8 m-85 70.12 -0.04 2.94 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.27 -179.91 48.24 Favored Glycine 0 CA--C 1.559 2.823 0 CA-C-N 120.26 1.391 . . . . 0.0 115.649 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.95 -46.05 9.24 Favored 'Trans proline' 0 CA--C 1.562 1.898 0 C-N-CA 123.286 2.657 . . . . 0.0 116.325 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -95.43 102.52 14.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 163.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.71 -152.9 11.75 Favored Glycine 0 CA--C 1.548 2.11 0 N-CA-C 116.713 1.445 . . . . 0.0 116.713 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -82.75 66.11 8.2 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 124.114 0.966 . . . . 0.0 112.182 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.5 p -80.21 146.97 63.79 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.384 -175.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.1 -11.98 29.93 Favored 'Cis proline' 0 CA--C 1.565 2.073 0 N-CA-C 119.637 2.899 . . . . 0.0 119.637 7.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -60.55 -58.02 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -96.5 105.03 20.0 Favored Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 104.151 -2.537 . . . . 0.0 104.151 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.29 160.8 48.3 Favored 'Trans proline' 0 CA--C 1.573 2.432 0 C-N-CA 122.711 2.274 . . . . 0.0 113.986 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.98 112.61 2.76 Favored 'Trans proline' 0 CA--C 1.556 1.602 0 C-N-CA 123.031 2.488 . . . . 0.0 112.965 -174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 88.6 m-70 72.92 86.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.71 1.204 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -157.88 121.74 4.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.65 122.98 25.44 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.015 0.526 . . . . 0.0 111.97 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.1 mt -97.84 139.95 32.93 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.696 0.76 . . . . 0.0 111.92 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -102.2 90.74 4.02 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.832 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.86 118.81 37.57 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.706 0.802 . . . . 0.0 110.227 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -89.5 107.43 19.07 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.041 0.924 . . . . 0.0 110.901 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.23 111.47 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -108.98 117.11 33.35 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.07 108.81 10.41 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -89.45 -59.72 2.14 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.254 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 76.1 p -132.93 139.3 47.27 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.654 0.781 . . . . 0.0 109.114 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.67 112.75 17.13 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -128.46 132.16 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.49 119.44 23.74 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.125 0.488 . . . . 0.0 111.619 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -166.88 172.45 42.02 Favored Glycine 0 CA--C 1.557 2.673 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.4 162.61 25.05 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 123.151 2.567 . . . . 0.0 114.594 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.39 -57.58 11.67 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 172.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp 74.78 117.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.262 1.425 . . . . 0.0 113.587 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.496 1.842 0 C-N-CA 124.622 1.169 . . . . 0.0 113.883 170.661 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -151.73 116.28 5.09 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.117 0.567 . . . . 0.0 110.894 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -136.95 89.97 2.49 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.75 0.786 . . . . 0.0 109.065 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 m0 67.91 112.52 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 125.425 1.49 . . . . 0.0 112.928 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.426 ' H ' HD13 ' A' ' 37' ' ' LEU 0.25 0.0 OUTLIER -80.22 128.23 33.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -173.466 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -109.73 148.35 31.56 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.132 0.973 . . . . 0.0 113.589 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.53 80.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 tp -166.07 -70.73 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.29 -75.01 0.27 Allowed Glycine 0 CA--C 1.54 1.594 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -164.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -78.6 -84.75 0.08 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 123.464 0.706 . . . . 0.0 110.694 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 163.21 84.53 0.05 OUTLIER Glycine 0 N--CA 1.476 1.363 0 CA-C-N 118.825 0.739 . . . . 0.0 111.68 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.5 mt -128.08 -58.57 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.803 0.841 . . . . 0.0 109.61 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.5 96.0 7.89 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 119.142 0.883 . . . . 0.0 108.895 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -118.1 90.04 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.075 0.95 . . . . 0.0 109.071 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.263 17.1 ptmt -83.49 123.8 30.08 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -84.78 138.35 32.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 161.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 m -98.62 109.06 21.88 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 165.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.52 -77.92 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.92 125.44 34.56 Favored Pre-proline 0 CA--C 1.576 1.949 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.78 -168.49 0.59 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 123.54 2.827 . . . . 0.0 113.312 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.75 166.6 51.62 Favored Glycine 0 CA--C 1.563 3.089 0 CA-C-O 118.959 -0.911 . . . . 0.0 115.103 163.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.35 167.28 22.71 Favored 'Trans proline' 0 CA--C 1.573 2.461 0 C-N-CA 123.085 2.523 . . . . 0.0 114.931 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.8 109.6 1.5 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 123.125 2.55 . . . . 0.0 111.854 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.07 81.56 1.49 Allowed Glycine 0 CA--C 1.543 1.782 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.992 -157.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.2 p -141.05 116.05 9.82 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 144.53 31.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.462 0.705 . . . . 0.0 112.053 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.5 mtm-85 -93.27 111.81 53.59 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 117.605 -1.188 . . . . 0.0 108.384 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.4 169.31 22.01 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 123.196 2.597 . . . . 0.0 115.938 -165.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.6 160.51 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 123.808 0.843 . . . . 0.0 112.429 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -69.5 110.37 4.73 Favored 'General case' 0 CA--C 1.567 1.633 0 C-N-CA 122.938 0.495 . . . . 0.0 109.995 162.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 135.51 -60.36 0.64 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.887 -157.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -72.87 119.84 17.67 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.233 0.613 . . . . 0.0 110.874 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.01 112.53 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -95.83 139.51 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.295 0.569 . . . . 0.0 110.985 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -101.52 131.41 47.69 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -130.9 138.92 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.032 0.533 . . . . 0.0 111.345 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.72 98.7 9.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.55 127.74 33.63 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 164.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.3 tm0? -116.5 87.36 2.67 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 m -85.75 116.44 24.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.7 m -138.61 33.62 2.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.258 10.3 mt 55.59 167.05 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.91 -43.91 97.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.35 -60.72 2.1 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 141.99 73.94 0.03 OUTLIER Glycine 0 CA--C 1.543 1.783 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -174.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.0 m -152.87 117.03 4.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -76.58 111.01 11.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.8 t -83.69 -63.86 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 124.034 0.934 . . . . 0.0 110.033 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -146.94 103.13 3.59 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -91.96 90.34 7.38 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.305 0.642 . . . . 0.0 109.706 171.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -100.08 107.12 45.51 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 117.769 -1.11 . . . . 0.0 110.892 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.0 -49.84 0.12 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.277 2.652 . . . . 0.0 117.041 -172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.56 84.16 1.92 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.371 0.669 . . . . 0.0 110.316 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.9 tp -103.09 92.19 4.43 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -87.79 128.71 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -157.9 149.09 21.25 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.213 0.605 . . . . 0.0 111.057 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -73.28 126.82 30.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.2 tp -59.67 117.0 4.43 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -159.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.61 40.27 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 117.887 1.915 . . . . 0.0 117.887 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -135.08 178.51 6.97 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.726 1.251 . . . . 0.0 111.483 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 77.4 m -78.19 68.11 4.15 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -167.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -148.89 -54.55 0.18 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.676 1.59 . . . . 0.0 109.278 172.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 36.0 m -71.09 164.65 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 122.545 1.164 . . . . 0.0 112.917 175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.9 pt -62.69 154.77 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.824 1.25 . . . . 0.0 113.276 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.39 -32.53 71.4 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.52 -40.2 74.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 168.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.34 -50.97 63.59 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 169.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -51.66 -45.83 63.55 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.26 -36.36 79.31 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -72.65 -19.07 61.5 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.27 2.1 t -52.35 -51.33 73.41 Favored Pre-proline 0 CA--C 1.578 2.044 0 CA-C-O 115.125 -2.369 . . . . 0.0 116.627 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.08 -41.84 68.95 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 125.216 2.898 . . . . 0.0 118.066 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.558 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -89.81 16.24 8.4 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.9 mtm -81.47 102.45 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 121.023 1.738 . . . . 0.0 110.314 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.96 152.8 35.12 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.044 0.926 . . . . 0.0 111.814 167.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 m -67.04 111.36 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.5 12.68 55.62 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -168.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.09 116.69 17.03 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.709 2.755 . . . . 0.0 112.519 174.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.0 m -100.23 102.78 14.16 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 168.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.13 125.19 22.88 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.139 -166.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.6 tpp -68.14 102.6 1.37 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.773 0.829 . . . . 0.0 111.698 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -98.72 96.16 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.5 t -114.65 116.08 28.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.538 0.735 . . . . 0.0 109.045 -169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.33 155.35 21.29 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.509 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -58.19 152.8 16.29 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.235 150.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 78.6 p -70.04 77.23 0.5 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.326 1.06 . . . . 0.0 112.493 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -52.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.638 -165.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -81.27 -51.38 8.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.063 1.345 . . . . 0.0 111.328 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -64.01 -62.9 1.33 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -133.31 -58.32 0.89 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.52 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.66 179.05 47.89 Favored Glycine 0 CA--C 1.558 2.721 0 CA-C-N 119.319 0.963 . . . . 0.0 114.955 -175.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.45 100.97 0.82 Allowed 'Trans proline' 0 CA--C 1.56 1.812 0 C-N-CA 123.138 2.559 . . . . 0.0 112.57 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -158.08 -71.26 0.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.621 -165.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.94 83.74 1.08 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 118.601 0.637 . . . . 0.0 112.13 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -89.95 152.48 21.2 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-O 121.919 0.866 . . . . 0.0 111.696 175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -75.36 140.67 72.73 Favored Pre-proline 0 CA--C 1.571 1.761 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.892 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.54 -58.68 0.07 OUTLIER 'Cis proline' 0 CA--C 1.563 1.935 0 CA-C-N 122.85 2.053 . . . . 0.0 116.156 10.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -137.44 67.13 1.44 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.005 0.922 . . . . 0.0 109.214 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mt -103.49 114.08 65.14 Favored Pre-proline 0 CA--C 1.567 1.607 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.21 137.93 24.37 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 C-N-CA 122.403 2.068 . . . . 0.0 114.694 -166.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.58 -45.88 8.14 Favored 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 123.207 2.605 . . . . 0.0 116.343 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -128.22 85.78 2.38 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.697 0.799 . . . . 0.0 109.85 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.77 125.19 3.15 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.66 101.66 5.84 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.067 0.547 . . . . 0.0 111.392 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -103.3 143.92 32.04 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.2 m -92.89 136.21 33.45 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.637 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -149.83 106.92 3.58 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.067 0.547 . . . . 0.0 110.478 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -87.31 117.63 26.2 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.486 1.136 . . . . 0.0 113.806 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.5 t -95.78 114.99 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -169.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -96.26 121.9 38.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.26 104.8 11.06 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -81.4 -63.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 -171.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 58.5 p -144.25 132.24 21.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.21 103.63 15.59 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 168.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.53 123.24 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -171.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.75 124.4 28.16 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 112.464 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.96 164.5 35.28 Favored Glycine 0 CA--C 1.559 2.796 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.173 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.54 115.98 4.53 Favored 'Trans proline' 0 CA--C 1.559 1.733 0 C-N-CA 123.071 2.514 . . . . 0.0 113.173 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.64 119.4 24.71 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.455 0.702 . . . . 0.0 111.214 -177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.0 tp -137.8 -77.42 0.38 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.184 0.594 . . . . 0.0 109.693 -172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.95 0.881 . . . . 0.0 109.569 -174.794 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -113.2 107.97 16.64 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 168.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.64 167.38 13.21 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -55.08 121.26 8.36 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -167.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 tp -175.01 154.43 1.82 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.037 -159.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 42.6 t0 68.78 119.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 149.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.1 mm -118.02 -54.66 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.072 0.949 . . . . 0.0 109.23 167.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 tp -73.14 -63.77 1.11 Allowed 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -155.48 -61.7 0.01 OUTLIER Glycine 0 N--CA 1.483 1.809 0 CA-C-N 119.448 1.022 . . . . 0.0 115.259 -171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -90.23 -78.58 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 117.734 0.767 . . . . 0.0 110.777 -172.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 177.0 72.24 0.06 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.9 mt -122.11 -66.32 1.04 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -163.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -80.06 98.54 7.29 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 166.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.19 96.46 7.49 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 122.946 0.498 . . . . 0.0 110.017 -164.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -105.47 132.93 51.02 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -113.36 145.61 40.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.806 -0.559 . . . . 0.0 110.249 152.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.9 m -88.74 108.45 19.49 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 165.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.7 tp -74.29 -67.96 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.586 0.755 . . . . 0.0 111.45 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.8 t -94.05 122.29 62.14 Favored Pre-proline 0 CA--C 1.575 1.917 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.12 167.83 19.41 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 114.586 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.66 123.42 6.68 Favored Glycine 0 CA--C 1.556 2.643 0 CA-C-O 117.049 -1.973 . . . . 0.0 113.351 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.45 167.92 22.64 Favored 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 122.53 3.165 . . . . 0.0 115.607 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.05 112.96 3.1 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 123.105 2.537 . . . . 0.0 111.869 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.48 76.81 1.34 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.473 -160.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.8 t -159.4 108.45 1.85 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.3 m -128.71 118.29 22.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.41 1.1 . . . . 0.0 110.368 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -64.13 132.94 95.45 Favored Pre-proline 0 CA--C 1.578 2.04 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.86 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 164.09 35.25 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.91 2.407 . . . . 0.0 116.31 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.9 t -82.24 150.83 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.947 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -59.09 104.12 0.22 Allowed 'General case' 0 CA--C 1.568 1.666 0 C-N-CA 124.971 1.308 . . . . 0.0 113.31 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.29 62.54 0.34 Allowed Glycine 0 CA--C 1.549 2.188 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.032 -165.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -155.44 138.66 15.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.48 106.89 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.329 -0.857 . . . . 0.0 109.671 -173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.16 118.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 124.128 0.971 . . . . 0.0 108.765 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.5 m -100.31 124.2 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.57 137.29 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.208 0.528 . . . . 0.0 110.459 -173.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -88.71 106.98 18.69 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 165.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 70' ' ' LEU . 2.6 pt? -103.52 121.67 43.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.161 0.585 . . . . 0.0 110.094 173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -103.44 99.17 8.99 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -93.64 99.44 11.87 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.037 0.535 . . . . 0.0 110.7 -165.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -104.57 -169.83 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.3 0.64 . . . . 0.0 111.359 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 tp -114.88 147.82 39.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.705 1.202 . . . . 0.0 109.513 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.322 4.2 pt-20 -60.44 -29.99 69.37 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 117.527 2.418 . . . . 0.0 117.527 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -64.64 -68.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.896 161.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.72 86.08 0.05 OUTLIER Glycine 0 N--CA 1.482 1.756 0 CA-C-N 119.53 1.059 . . . . 0.0 113.107 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.3 m -153.33 122.58 6.6 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -76.52 97.15 4.26 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.041 0.924 . . . . 0.0 111.301 171.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 m -84.99 -47.95 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.138 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -125.04 156.78 37.64 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.842 1.306 . . . . 0.0 110.503 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.86 93.0 2.87 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 161.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -85.24 116.7 66.61 Favored Pre-proline 0 CA--C 1.572 1.791 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.622 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.86 -49.46 0.15 Allowed 'Trans proline' 0 CA--C 1.559 1.765 0 C-N-CA 122.938 2.426 . . . . 0.0 116.56 -168.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -137.84 93.66 2.8 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 119.134 0.879 . . . . 0.0 109.423 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.1 tp -85.4 104.42 15.19 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.74 96.55 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -125.42 147.57 49.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.598 0.759 . . . . 0.0 109.32 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.0 m -100.38 66.51 1.28 Allowed 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 123.012 0.525 . . . . 0.0 110.019 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . 0.401 7.6 mp 61.17 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.25 -94.4 0.18 Allowed Glycine 0 N--CA 1.483 1.816 0 CA-C-O 119.178 -0.79 . . . . 0.0 111.448 165.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 13.5 t70 68.1 150.11 0.07 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.2 t -82.26 72.73 9.32 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.58 1.181 . . . . 0.0 113.445 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -157.74 -61.28 0.09 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.251 1.42 . . . . 0.0 108.982 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.2 m -81.6 152.98 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 122.829 1.3 . . . . 0.0 113.147 -151.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.1 pt -68.94 165.7 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.876 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -57.97 -34.65 70.17 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 171.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.21 86.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.15 -45.77 62.84 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -66.79 -32.36 73.6 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 171.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.11 -15.09 57.86 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 96.3 p -71.05 -36.39 72.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 121.233 1.833 . . . . 0.0 115.37 164.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.0 -53.33 39.21 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 115.897 -2.001 . . . . 0.0 115.027 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.44 -15.0 42.54 Favored 'Trans proline' 0 CA--C 1.567 2.168 0 C-N-CA 123.644 2.896 . . . . 0.0 119.104 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.33 48.55 1.73 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 120.341 1.428 . . . . 0.0 112.869 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 70.8 mtp -143.12 100.15 3.58 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.38 176.05 8.09 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.244 1.021 . . . . 0.0 110.829 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.84 105.89 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.798 -1.189 . . . . 0.0 109.874 -167.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.14 61.16 0.86 Allowed Glycine 0 CA--C 1.546 1.978 0 CA-C-N 115.166 -0.925 . . . . 0.0 113.737 -168.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -140.49 122.19 15.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.656 0.782 . . . . 0.0 110.08 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 42.1 m -94.6 136.24 35.13 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 160.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.08 113.73 9.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 53.3 ttm -84.84 115.01 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.88 128.14 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 -174.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.0 p -94.64 87.53 5.11 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.09 19.16 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.222 -168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.85 144.74 8.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.6 p -54.87 -19.28 6.22 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -59.24 -51.3 70.55 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 161.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -77.89 -48.84 15.45 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.83 1.252 . . . . 0.0 113.511 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.46 174.56 7.48 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.092 1.357 . . . . 0.0 112.94 -177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -73.69 100.89 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.593 0.757 . . . . 0.0 110.711 166.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.93 -87.78 1.96 Allowed Glycine 0 CA--C 1.543 1.839 0 CA-C-O 116.147 -2.474 . . . . 0.0 108.317 163.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.54 52.61 4.15 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 122.675 3.237 . . . . 0.0 114.722 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -132.41 -77.81 0.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.55 112.1 2.02 Favored Glycine 0 N--CA 1.48 1.617 0 CA-C-N 119.685 1.13 . . . . 0.0 113.507 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -104.08 127.49 51.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 157.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 93.6 p -61.23 145.64 89.84 Favored Pre-proline 0 CA--C 1.571 1.767 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -91.23 -64.99 0.03 OUTLIER 'Cis proline' 0 CA--C 1.565 2.047 0 CA-C-N 122.689 1.996 . . . . 0.0 116.701 8.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -115.48 43.95 1.95 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -165.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 36.2 mt -80.31 118.21 71.35 Favored Pre-proline 0 CA--C 1.58 2.121 0 O-C-N 120.643 -1.286 . . . . 0.0 108.113 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.28 160.65 26.11 Favored 'Trans proline' 0 CA--C 1.572 2.376 0 C-N-CA 122.933 2.422 . . . . 0.0 116.242 -166.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.1 136.23 24.29 Favored 'Trans proline' 0 CA--C 1.558 1.699 0 C-N-CA 123.292 2.662 . . . . 0.0 114.251 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.285 97.1 m-70 73.65 162.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.688 1.195 . . . . 0.0 113.828 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 77.24 148.07 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.075 1.35 . . . . 0.0 113.436 -176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.53 148.02 47.14 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 15.4 mt -100.65 123.38 44.78 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.017 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 51.9 t -81.5 84.48 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.335 174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -107.65 120.86 43.39 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.389 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.69 147.81 50.08 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.343 160.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 t -134.21 100.12 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -95.69 123.3 39.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -83.31 104.62 13.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -88.61 -56.81 3.15 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.781 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.1 p -140.15 134.69 31.58 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.381 0.673 . . . . 0.0 109.558 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.82 105.3 12.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 168.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.5 m -136.5 131.16 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.422 0.689 . . . . 0.0 109.249 -166.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -91.88 118.6 30.88 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.046 0.538 . . . . 0.0 110.297 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.38 82.49 0.08 OUTLIER Glycine 0 CA--C 1.547 2.087 0 CA-C-O 117.091 -1.95 . . . . 0.0 111.88 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.22 103.02 0.79 Allowed 'Trans proline' 0 CA--C 1.561 1.832 0 CA-C-N 121.796 2.798 . . . . 0.0 112.336 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -81.52 124.39 29.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.309 0.576 . . . . 0.0 111.414 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.378 6.0 mp 79.37 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.844 1.258 . . . . 0.0 110.297 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -128.61 -74.51 0.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.282 0.633 . . . . 0.0 109.92 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.26 7.5 tp10 55.9 84.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.3 m95 73.36 99.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.901 1.281 . . . . 0.0 110.111 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -83.86 114.07 21.39 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.76 101.33 6.64 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 121.866 0.841 . . . . 0.0 111.066 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt -70.46 -51.89 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 123.982 0.913 . . . . 0.0 111.407 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.2 tp -66.11 -63.96 0.97 Allowed 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.24 -80.08 0.09 OUTLIER Glycine 0 N--CA 1.479 1.561 0 CA-C-N 118.96 0.8 . . . . 0.0 112.102 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -71.37 -66.22 0.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.178 0.591 . . . . 0.0 112.539 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.7 70.15 0.04 OUTLIER Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.401 0.546 . . . . 0.0 112.601 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.9 mt -124.71 -70.32 0.76 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.9 tp -81.91 120.18 24.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 118.822 0.737 . . . . 0.0 109.762 171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.17 152.37 45.99 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.322 1.049 . . . . 0.0 111.443 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.37 117.74 14.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.122 -0.986 . . . . 0.0 112.504 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -96.83 121.14 38.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.993 . . . . 0.0 108.776 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -86.85 115.79 24.49 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.77 -65.56 0.85 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.777 0.831 . . . . 0.0 110.638 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -116.37 140.44 26.55 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-N 119.12 0.873 . . . . 0.0 109.27 165.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.98 171.73 16.73 Favored 'Trans proline' 0 CA--C 1.563 1.958 0 C-N-CA 123.072 2.515 . . . . 0.0 114.443 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.3 103.41 3.04 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-O 116.787 -2.118 . . . . 0.0 109.835 164.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 163.48 35.42 Favored 'Trans proline' 0 CA--C 1.571 2.355 0 CA-C-N 122.734 3.267 . . . . 0.0 116.252 -164.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.41 127.27 15.42 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.273 2.649 . . . . 0.0 113.156 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.56 -71.36 0.39 Allowed Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -159.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.1 p -75.24 102.46 5.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.402 0.681 . . . . 0.0 111.183 168.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -113.09 147.46 37.25 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.969 0.89 . . . . 0.0 111.287 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttp-105 -60.34 128.6 88.06 Favored Pre-proline 0 CA--C 1.579 2.088 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.56 160.14 47.29 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.041 2.494 . . . . 0.0 115.022 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.4 m -85.23 166.43 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.451 174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -53.2 131.13 36.54 Favored 'General case' 0 CA--C 1.573 1.853 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.66 46.76 2.06 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-N 114.123 -1.398 . . . . 0.0 114.716 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.58 136.23 32.6 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.82 100.74 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 m -92.47 110.02 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -92.47 112.55 24.54 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.36 142.08 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.69 0.757 . . . . 0.0 110.44 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -79.05 107.26 11.68 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 162.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.45 107.19 17.95 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -103.61 111.89 24.57 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.98 117.44 28.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 t -133.98 152.66 51.94 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.064 0.935 . . . . 0.0 110.048 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.1 tp -71.62 139.79 49.47 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.563 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.83 -37.95 77.58 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -63.99 -53.05 56.12 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 167.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -72.73 0.05 OUTLIER Glycine 0 CA--C 1.541 1.702 0 CA-C-N 119.743 1.156 . . . . 0.0 114.881 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -63.87 137.75 58.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -160.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -61.56 117.01 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.28 35.6 m -81.59 -47.71 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.672 176.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -145.23 119.79 9.74 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 165.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -106.96 83.6 1.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.542 0.686 . . . . 0.0 110.105 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -111.57 101.84 51.92 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-O 117.869 -1.062 . . . . 0.0 108.651 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.64 50.27 3.5 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.644 2.23 . . . . 0.0 115.905 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -161.51 117.05 2.08 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.809 0.844 . . . . 0.0 109.281 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -150.49 103.91 3.17 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.54 114.26 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -142.6 142.11 32.08 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -78.46 121.26 24.32 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.29 133.59 42.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 118.32 0.509 . . . . 0.0 112.31 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.37 -70.34 0.74 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.925 -167.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -90.71 77.95 6.25 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.77 0.795 . . . . 0.0 110.215 172.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 31.8 p -117.36 126.64 53.02 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.628 -163.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -97.72 70.29 2.19 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.477 1.132 . . . . 0.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.03 177.78 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.411 1.1 . . . . 0.0 110.331 -163.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.6 pt -65.59 150.34 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.833 0.853 . . . . 0.0 112.441 170.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.35 -29.76 71.01 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.09 81.87 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.9 mt -62.93 -54.62 35.78 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 117.436 -1.269 . . . . 0.0 113.96 167.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -53.31 -49.0 67.93 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.7 mt -63.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.6 p -79.3 -8.85 59.37 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 117.684 2.476 . . . . 0.0 117.684 168.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.263 12.8 t -52.44 -48.79 88.67 Favored Pre-proline 0 N--CA 1.501 2.094 0 CA-C-O 115.264 -2.303 . . . . 0.0 114.449 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -62.74 0.59 1.44 Allowed 'Trans proline' 0 CA--C 1.572 2.378 0 CA-C-N 125.114 2.862 . . . . 0.0 119.314 169.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.253 2.0 pt? -149.21 65.81 1.02 Allowed 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 120.079 1.309 . . . . 0.0 111.581 167.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.2 mmt -138.35 99.96 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.39 164.04 12.81 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.146 0.974 . . . . 0.0 113.101 -168.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.27 114.73 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.63 -6.78 45.23 Favored Glycine 0 CA--C 1.552 2.381 0 N-CA-C 117.905 1.922 . . . . 0.0 117.905 -167.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -85.41 126.27 33.65 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 121.132 2.466 . . . . 0.0 113.396 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.9 m -100.45 127.98 46.64 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 158.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.94 124.08 6.3 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.577 0.351 . . . . 0.0 110.165 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.9 ptm -77.8 131.94 37.82 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.124 0.57 . . . . 0.0 110.791 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 85.8 t -113.23 96.2 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -170.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.3 p -85.65 102.21 13.39 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -122.2 138.7 54.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.106 -173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.61 153.24 0.27 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 99.9 p -70.67 76.51 0.6 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.921 1.344 . . . . 0.0 112.153 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -179.03 -61.54 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.867 -152.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -83.17 -50.71 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.443 1.097 . . . . 0.0 112.674 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 97.8 m -68.24 -68.33 0.4 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -138.82 -66.55 0.47 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.798 0.726 . . . . 0.0 109.31 -171.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.4 -147.93 19.78 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 117.867 -1.518 . . . . 0.0 115.391 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -72.72 112.71 3.55 Favored 'Trans proline' 0 CA--C 1.554 1.519 0 C-N-CA 123.096 2.531 . . . . 0.0 112.316 -167.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.253 51.3 mt-30 69.37 92.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.891 1.276 . . . . 0.0 110.271 -164.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.7 169.81 54.8 Favored Glycine 0 CA--C 1.547 2.049 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -101.39 60.09 0.9 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -163.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 40.7 m 66.95 141.78 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 167.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.45 -45.85 0.4 Allowed 'Cis proline' 0 CA--C 1.564 1.992 0 CA-C-N 122.627 1.974 . . . . 0.0 115.705 -3.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -134.42 63.26 1.63 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.703 0.801 . . . . 0.0 110.489 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.1 mt -91.32 121.35 67.72 Favored Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.47 162.4 35.98 Favored 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.918 2.412 . . . . 0.0 116.303 -170.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.85 -46.3 6.78 Favored 'Trans proline' 0 CA--C 1.564 2.014 0 C-N-CA 123.215 2.61 . . . . 0.0 116.598 171.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -97.39 -166.73 1.43 Allowed 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 124.498 1.119 . . . . 0.0 111.689 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.28 128.37 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.248 1.419 . . . . 0.0 113.106 176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.25 101.91 12.91 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.137 0.575 . . . . 0.0 110.921 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.87 143.11 44.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -164.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.7 m -84.7 115.5 22.71 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.002 0.921 . . . . 0.0 110.706 176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -119.19 98.86 6.37 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -171.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -82.94 107.36 15.49 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.238 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.7 93.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.4 m -99.99 112.42 24.71 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.53 102.91 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -73.86 -65.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.155 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.0 p -144.72 130.61 19.25 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.37 103.35 15.28 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.11 153.27 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.543 0.737 . . . . 0.0 110.13 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.39 145.73 55.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.72 90.0 0.43 Allowed Glycine 0 CA--C 1.548 2.097 0 CA-C-O 117.178 -1.901 . . . . 0.0 111.981 -174.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.31 160.25 17.49 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 121.657 2.729 . . . . 0.0 114.389 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.04 125.06 25.67 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.589 0.756 . . . . 0.0 112.712 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -90.69 101.84 14.58 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.384 -173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 N--CA 1.495 1.803 0 C-N-CA 124.622 1.169 . . . . 0.0 113.873 176.53 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.1 ttm . . . . . 0 CA--C 1.556 1.177 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.6 mmt85 -99.56 104.11 15.89 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.801 0.728 . . . . 0.0 110.532 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.89 148.93 45.62 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -76.76 128.42 34.61 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.515 0.726 . . . . 0.0 109.809 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.89 114.2 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.332 0.653 . . . . 0.0 110.692 -169.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.69 127.13 44.52 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.084 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.37 74.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 123.281 0.632 . . . . 0.0 109.679 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -157.58 -72.75 0.09 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.66 0.784 . . . . 0.0 109.018 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.77 -83.34 0.11 Allowed Glycine 0 N--CA 1.478 1.473 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -164.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.55 -70.26 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.239 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 157.52 85.02 0.05 OUTLIER Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.966 0.803 . . . . 0.0 112.971 169.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -133.55 -59.34 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -74.17 114.26 12.3 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.15 0.886 . . . . 0.0 110.489 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -143.46 105.54 4.38 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.716 0.807 . . . . 0.0 109.782 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -101.93 101.42 11.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 112.316 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -79.26 120.0 23.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.852 -1.155 . . . . 0.0 109.515 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.4 m -78.9 115.66 18.73 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.358 0.599 . . . . 0.0 110.141 -174.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.03 -69.0 0.5 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.733 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.48 106.82 52.03 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.45 175.14 11.67 Favored 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 122.651 2.234 . . . . 0.0 114.655 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.94 123.46 24.14 Favored Glycine 0 CA--C 1.558 2.74 0 CA-C-O 117.133 -1.926 . . . . 0.0 112.466 173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.4 161.19 44.33 Favored 'Trans proline' 0 CA--C 1.57 2.309 0 CA-C-N 122.321 3.06 . . . . 0.0 115.29 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 106.74 1.22 Allowed 'Trans proline' 0 CA--C 1.558 1.722 0 C-N-CA 123.181 2.588 . . . . 0.0 112.171 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.72 76.29 1.32 Allowed Glycine 0 CA--C 1.545 1.95 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.591 -159.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.3 p -147.96 117.24 6.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.4 m -79.71 142.37 35.53 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.056 0.542 . . . . 0.0 112.261 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -91.4 116.3 66.16 Favored Pre-proline 0 CA--C 1.574 1.871 0 CA-C-O 117.737 -1.125 . . . . 0.0 111.186 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.93 144.86 31.0 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.703 2.269 . . . . 0.0 114.665 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.18 169.98 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.196 0.999 . . . . 0.0 112.645 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -64.54 120.32 12.12 Favored 'General case' 0 CA--C 1.568 1.648 0 O-C-N 121.713 -0.617 . . . . 0.0 112.084 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.0 40.67 3.72 Favored Glycine 0 CA--C 1.55 2.228 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -138.26 115.55 11.09 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -72.26 109.46 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 123.285 0.634 . . . . 0.0 110.099 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.5 123.98 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.616 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.7 m -102.61 121.32 42.16 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 m -119.94 142.46 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.389 0.675 . . . . 0.0 110.783 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -82.72 104.59 13.09 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 161.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.35 125.43 47.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -133.3 122.15 23.45 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.489 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.8 p -93.0 131.37 38.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.08 0.952 . . . . 0.0 111.558 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.9 m -155.57 131.5 9.98 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.579 0.751 . . . . 0.0 109.708 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.03 157.28 19.15 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -52.7 -40.56 63.08 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -73.36 -64.73 0.92 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.537 0.735 . . . . 0.0 111.142 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 161.8 83.35 0.05 OUTLIER Glycine 0 N--CA 1.478 1.466 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.2 m -146.15 120.82 9.83 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -80.14 119.4 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.864 0.866 . . . . 0.0 111.974 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.0 t -97.41 -69.72 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.585 -166.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -143.83 122.11 12.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -167.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -85.52 94.68 9.08 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 123.456 0.702 . . . . 0.0 110.591 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.12 68.32 46.58 Favored Pre-proline 0 CA--C 1.579 2.068 0 O-C-N 121.384 -0.823 . . . . 0.0 113.163 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 -39.65 3.05 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.355 2.703 . . . . 0.0 117.58 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 76.73 1.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 119.575 1.079 . . . . 0.0 110.391 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.18 95.96 7.44 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.5 t -101.89 114.69 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.27 152.51 40.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 111.323 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.4 m -75.29 128.32 35.15 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -59.94 124.89 21.6 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.032 0.933 . . . . 0.0 111.979 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.64 -41.24 3.06 Favored Glycine 0 CA--C 1.547 2.079 0 N-CA-C 117.505 1.762 . . . . 0.0 117.505 175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.91 107.77 18.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.012 1.406 . . . . 0.0 109.562 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -85.98 81.42 8.51 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -150.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.98 -47.37 52.58 Favored 'General case' 0 CA--C 1.574 1.899 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.105 156.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.08 179.0 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.602 1.161 . . . . 0.0 114.108 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.01 152.09 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.648 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -64.19 -33.46 75.84 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.31 77.06 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 167.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -53.09 38.64 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -58.23 -42.63 86.71 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.86 -34.31 77.66 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -72.82 -22.99 60.72 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 168.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.2 t -57.38 -49.94 90.99 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 114.871 -2.49 . . . . 0.0 115.996 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -53.28 -34.58 70.71 Favored 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 126.12 3.221 . . . . 0.0 118.424 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.3 pt? -101.01 63.74 1.02 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.598 0.759 . . . . 0.0 111.579 168.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -145.28 113.32 6.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -97.02 168.12 10.65 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.878 0.847 . . . . 0.0 111.915 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.76 118.63 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.852 -1.155 . . . . 0.0 108.403 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.09 6.04 72.28 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.144 2.018 . . . . 0.0 118.144 -165.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.12 108.4 19.84 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 120.5 2.15 . . . . 0.0 109.625 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.7 m -109.19 119.71 40.34 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.06 136.93 34.14 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.776 0.798 . . . . 0.0 111.075 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.9 ttm -84.0 103.14 13.0 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.062 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.95 92.6 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.9 p -81.41 126.55 31.77 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.282 0.633 . . . . 0.0 109.769 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.1 136.88 17.08 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.316 -175.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -46.02 133.33 8.96 Favored 'General case' 0 CA--C 1.577 2.015 0 C-N-CA 124.785 1.234 . . . . 0.0 113.983 168.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.4 m -74.55 84.83 2.05 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.279 1.038 . . . . 0.0 110.983 -174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -179.55 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -142.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -68.62 -36.52 78.75 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 162.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.1 m -72.22 -75.12 0.14 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.17 0.895 . . . . 0.0 111.179 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -117.92 -67.71 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 119.263 0.938 . . . . 0.0 110.774 -171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.7 170.72 27.94 Favored Glycine 0 CA--C 1.553 2.45 0 CA-C-N 119.036 0.834 . . . . 0.0 115.088 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.22 10.03 0.35 Allowed 'Trans proline' 0 CA--C 1.571 2.348 0 N-CA-C 119.375 2.798 . . . . 0.0 119.375 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -131.53 -76.65 0.52 Allowed 'General case' 0 CA--C 1.561 1.376 0 CA-C-N 119.527 1.058 . . . . 0.0 108.258 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.56 124.08 1.11 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 119.69 1.132 . . . . 0.0 112.545 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -93.05 39.09 1.04 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.6 m 66.72 139.25 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.79 -50.46 0.17 OUTLIER 'Cis proline' 0 CA--C 1.563 1.964 0 CA-C-N 123.097 2.142 . . . . 0.0 115.896 4.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -132.4 71.76 1.48 Allowed 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.891 0.877 . . . . 0.0 108.855 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.6 mm -99.72 134.55 20.98 Favored Pre-proline 0 CA--C 1.578 2.039 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.927 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.32 162.31 33.88 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.203 2.602 . . . . 0.0 116.215 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.77 -94.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 123.358 2.706 . . . . 0.0 113.094 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -136.51 80.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 120.109 1.322 . . . . 0.0 109.542 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.75 38.55 1.35 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 60.14 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tt -96.58 130.04 43.85 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.562 1.145 . . . . 0.0 110.133 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 21.8 t -100.37 113.36 26.03 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.872 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.15 108.69 20.34 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.32 97.38 9.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 122.003 -0.436 . . . . 0.0 110.189 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.79 111.43 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -168.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 89.1 m -113.79 113.28 24.72 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.04 103.51 9.97 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 120.942 0.401 . . . . 0.0 110.052 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -80.88 -64.46 1.18 Allowed 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -141.78 137.33 31.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.725 0.81 . . . . 0.0 109.008 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.56 107.95 18.65 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 m -135.11 125.43 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -81.39 91.04 6.21 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-O 122.203 1.001 . . . . 0.0 112.957 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.32 86.32 0.82 Allowed Glycine 0 CA--C 1.552 2.344 0 CA-C-O 116.876 -2.069 . . . . 0.0 113.851 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -80.34 130.86 8.29 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 122.224 3.012 . . . . 0.0 112.556 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.76 -77.33 0.12 Allowed 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -99.18 104.1 16.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.72 0.772 . . . . 0.0 109.333 178.876 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -81.73 -3.68 54.35 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -171.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 64.07 86.0 0.13 Allowed 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.607 2.003 . . . . 0.0 113.279 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -141.4 117.43 10.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -100.03 107.82 19.85 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.57 123.94 30.27 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.448 0.642 . . . . 0.0 111.676 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.44 -58.84 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 C-N-CA 123.664 0.786 . . . . 0.0 110.735 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.258 3.7 pp -66.48 -17.63 64.91 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.45 55.86 4.49 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 119.948 1.249 . . . . 0.0 116.034 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -156.13 -81.18 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.33 59.62 0.03 OUTLIER Glycine 0 CA--C 1.541 1.689 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.172 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 mt -136.76 -70.98 0.45 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.0 tp -88.29 102.81 15.2 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 119.495 1.043 . . . . 0.0 108.84 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.0 117.58 31.01 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.363 0.665 . . . . 0.0 110.004 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -122.36 103.62 8.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 0.0 110.266 -168.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -81.02 141.22 34.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.461 -0.775 . . . . 0.0 109.729 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 m -81.65 96.48 7.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 159.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 112' ' ' ALA . 32.1 tp -64.39 -63.08 1.23 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.824 1.25 . . . . 0.0 113.218 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.97 123.89 23.75 Favored Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 162.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.61 165.42 24.96 Favored 'Trans proline' 0 CA--C 1.556 1.591 0 C-N-CA 123.117 2.545 . . . . 0.0 114.844 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.3 171.3 55.17 Favored Glycine 0 CA--C 1.562 2.98 0 N-CA-C 115.35 0.9 . . . . 0.0 115.35 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.41 162.72 39.42 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 123.257 2.638 . . . . 0.0 115.827 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.78 -42.2 48.08 Favored 'Trans proline' 0 CA--C 1.563 1.974 0 C-N-CA 123.423 2.749 . . . . 0.0 116.743 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.97 -176.21 50.58 Favored Glycine 0 CA--C 1.552 2.365 0 CA-C-N 119.04 0.836 . . . . 0.0 113.711 161.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.9 m 62.36 86.19 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.376 1.071 . . . . 0.0 112.613 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.0 p -98.71 153.67 18.55 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -165.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -45.13 128.39 5.65 Favored Pre-proline 0 CA--C 1.581 2.139 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -76.38 165.88 28.48 Favored 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 122.948 2.432 . . . . 0.0 115.843 -173.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.9 t -102.63 159.06 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.912 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.444 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -63.77 132.79 52.03 Favored 'General case' 0 CA--C 1.569 1.693 0 O-C-N 120.805 -1.184 . . . . 0.0 113.588 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 113.34 14.28 9.92 Favored Glycine 0 CA--C 1.557 2.717 0 CA-C-N 113.82 -1.536 . . . . 0.0 115.564 -153.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -138.65 114.87 10.29 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.88 109.55 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.75 134.88 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.594 0.758 . . . . 0.0 110.737 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.6 m -92.71 127.98 38.41 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.2 126.15 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -71.55 107.0 4.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.879 0.872 . . . . 0.0 110.38 171.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.35 131.72 39.69 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.055 0.931 . . . . 0.0 108.975 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -137.66 91.8 2.63 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -87.2 123.76 32.57 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -132.63 179.24 6.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.144 0.978 . . . . 0.0 111.034 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 39.0 tp -94.37 149.27 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.099 -1.001 . . . . 0.0 110.074 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.48 -20.87 61.48 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 117.341 2.349 . . . . 0.0 117.341 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -74.04 -71.79 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 119.223 0.92 . . . . 0.0 110.494 161.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.28 81.75 0.04 OUTLIER Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.494 1.043 . . . . 0.0 112.917 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.3 m -152.9 114.32 4.24 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.298 19.8 ptp180 -78.08 105.54 9.36 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -81.14 -48.54 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -137.79 89.88 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -88.14 96.93 10.72 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.817 0.818 . . . . 0.0 110.192 168.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.14 89.72 17.94 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.88 2.59 6.4 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 N-CA-C 120.139 3.092 . . . . 0.0 120.139 -159.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.301 9.2 pt-20 -151.84 148.75 28.2 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.824 2.102 . . . . 0.0 113.214 154.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.7 tp -142.1 106.44 4.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -165.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.3 t -98.56 106.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -137.55 155.77 48.85 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.378 0.671 . . . . 0.0 111.543 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.4 m -80.75 130.29 35.0 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.366 0.667 . . . . 0.0 109.659 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.61 119.23 10.1 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.73 62.25 3.49 Favored Glycine 0 CA--C 1.545 1.947 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -152.52 144.46 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.148 0.979 . . . . 0.0 110.261 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 28.5 p -76.15 74.8 2.99 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -126.61 -59.44 1.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.093 1.357 . . . . 0.0 109.858 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.16 178.14 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.593 1.157 . . . . 0.0 113.074 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.54 137.92 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.757 0.823 . . . . 0.0 112.011 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -62.07 -29.23 70.16 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.11 84.57 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 165.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -53.48 57.33 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -66.31 -33.92 76.83 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.37 -34.92 79.04 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 165.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.4 p -79.82 2.01 24.72 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 167.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.262 2.5 t -53.08 -48.83 90.54 Favored Pre-proline 0 N--CA 1.502 2.126 0 CA-C-O 115.262 -2.304 . . . . 0.0 114.787 170.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.04 -18.33 22.48 Favored 'Trans proline' 0 CA--C 1.566 2.121 0 CA-C-N 125.38 2.957 . . . . 0.0 119.012 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.84 70.78 0.74 Allowed 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.295 0.952 . . . . 0.0 108.741 166.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.1 mmt -149.44 90.35 1.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -86.36 161.07 18.88 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.294 1.045 . . . . 0.0 111.994 168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -76.83 104.67 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.571 -0.706 . . . . 0.0 109.098 -165.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 110.18 -1.75 29.78 Favored Glycine 0 CA--C 1.556 2.63 0 CA-C-O 117.002 -1.999 . . . . 0.0 117.952 -164.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -76.64 113.72 14.59 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 121.39 2.595 . . . . 0.0 112.761 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -88.73 117.81 27.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' HA ' ' H ' ' A' ' 50' ' ' LEU . . . -140.28 132.88 28.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.416 0.286 . . . . 0.0 111.465 -177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.3 tpp -82.19 106.83 14.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.2 t -101.53 87.55 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -106.06 108.8 20.5 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.2 176.74 4.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.36 1.076 . . . . 0.0 112.167 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.13 157.94 29.9 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 169.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.9 t -75.36 78.5 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 122.631 1.205 . . . . 0.0 110.991 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 179.95 -67.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 113.555 -1.657 . . . . 0.0 106.964 -152.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.65 -41.89 36.71 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.249 1.02 . . . . 0.0 113.082 173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 66.7 m -58.55 -63.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 119.596 1.089 . . . . 0.0 113.011 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -140.71 -76.05 0.32 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.413 1.006 . . . . 0.0 108.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.47 162.96 21.61 Favored Glycine 0 CA--C 1.557 2.714 0 CA-C-O 118.918 -0.935 . . . . 0.0 113.148 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.26 60.83 5.58 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 CA-C-N 121.151 2.475 . . . . 0.0 114.964 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -158.46 -77.14 0.08 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 141.0 95.76 0.27 Allowed Glycine 0 CA--C 1.536 1.396 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -104.64 48.15 0.85 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.8 m 65.68 135.24 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.861 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.22 -51.05 0.16 OUTLIER 'Cis proline' 0 CA--C 1.562 1.92 0 CA-C-N 123.001 2.107 . . . . 0.0 116.271 3.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -141.66 77.87 1.61 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.335 1.064 . . . . 0.0 108.481 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.0 mt -99.57 120.69 56.98 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 144.09 34.09 Favored 'Trans proline' 0 CA--C 1.571 2.357 0 C-N-CA 122.729 2.286 . . . . 0.0 114.349 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.98 122.31 8.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.078 2.519 . . . . 0.0 113.026 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.36 32.1 p80 51.86 67.84 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -151.08 108.27 3.59 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.66 126.75 28.4 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -167.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.6 tp -111.45 127.27 55.63 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.3 -155.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.1 m -74.75 152.2 39.08 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 170.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.12 113.55 3.24 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.08 0.552 . . . . 0.0 109.866 167.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.53 112.13 20.13 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.153 0.977 . . . . 0.0 111.374 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.62 107.7 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.3 m -106.53 117.65 34.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.31 109.87 6.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.176 0.591 . . . . 0.0 110.291 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -78.52 -68.95 0.59 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.404 -0.808 . . . . 0.0 112.457 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.1 p -141.8 131.69 24.41 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.044 0.838 . . . . 0.0 109.752 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.94 109.48 21.84 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.58 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.537 0.684 . . . . 0.0 110.507 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.0 145.52 52.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -70.68 115.95 6.19 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.01 -1.994 . . . . 0.0 114.587 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.53 127.39 4.38 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 CA-C-N 122.294 3.047 . . . . 0.0 113.82 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -82.03 107.54 14.82 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.36 0.6 . . . . 0.0 110.465 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.255 6.4 mp 71.82 95.85 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.914 1.286 . . . . 0.0 109.988 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.495 1.81 0 C-N-CA 124.535 1.134 . . . . 0.0 112.55 179.75 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 21.9 ttt . . . . . 0 CA--C 1.556 1.175 0 CA-C-O 118.591 -0.719 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -117.91 -99.29 0.44 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.016 -0.992 . . . . 0.0 108.966 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.329 27.8 tt0 62.27 -96.87 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 168.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -123.02 106.96 11.28 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.47 108.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.69 122.01 23.36 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 122.554 1.169 . . . . 0.0 114.028 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 pt -100.43 74.45 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.078 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 tp -166.44 -64.73 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 123.87 0.868 . . . . 0.0 109.514 -175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 150.85 -81.52 0.19 Allowed Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -160.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -76.22 -76.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 118.631 -0.7 . . . . 0.0 111.036 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.02 79.94 0.03 OUTLIER Glycine 0 N--CA 1.478 1.44 0 CA-C-N 118.874 0.761 . . . . 0.0 112.087 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.7 mt -130.65 -58.91 1.03 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.435 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.1 tp -81.17 123.15 28.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.087 1.312 . . . . 0.0 108.606 164.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -142.71 131.97 23.39 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 123.387 0.675 . . . . 0.0 111.864 -167.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -122.4 132.19 54.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 0.0 113.392 -175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HZ3' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -110.61 125.34 53.3 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.593 -0.692 . . . . 0.0 109.642 169.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.7 p -81.04 124.41 29.16 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.311 0.505 . . . . 0.0 111.078 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.414 ' HB2' ' HZ3' ' A' ' 48' ' ' LYS . 13.8 tp -87.32 -71.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.509 0.724 . . . . 0.0 110.058 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.89 100.65 53.83 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.14 160.67 42.23 Favored 'Trans proline' 0 CA--C 1.558 1.712 0 C-N-CA 122.741 2.294 . . . . 0.0 113.842 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.22 151.26 52.09 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-O 118.382 -1.232 . . . . 0.0 115.987 -174.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.56 165.07 28.58 Favored 'Trans proline' 0 CA--C 1.572 2.382 0 C-N-CA 123.132 2.555 . . . . 0.0 115.852 -173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.59 115.49 3.93 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 123.139 2.56 . . . . 0.0 112.68 -176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.11 -103.97 1.04 Allowed Glycine 0 CA--C 1.538 1.511 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -167.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.4 m 59.34 100.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.4 m -80.66 128.63 33.84 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.151 0.501 . . . . 0.0 110.126 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -93.12 113.73 60.76 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.808 -1.092 . . . . 0.0 110.495 -171.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.81 150.88 68.47 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.972 2.448 . . . . 0.0 115.274 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.8 166.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 114.893 -1.048 . . . . 0.0 112.857 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -73.09 99.75 2.86 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.762 0.825 . . . . 0.0 110.656 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 147.03 -52.36 0.56 Allowed Glycine 0 CA--C 1.549 2.176 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.333 -155.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -73.76 140.16 45.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.764 0.825 . . . . 0.0 112.201 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.7 t -90.17 112.62 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -105.63 142.88 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.52 1.152 . . . . 0.0 110.481 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -106.43 116.32 31.73 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.37 126.61 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 122.72 0.408 . . . . 0.0 110.21 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -73.62 103.77 4.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 161.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 tp -102.14 100.3 10.51 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -93.62 90.28 6.57 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -90.57 121.68 32.71 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -167.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -124.11 175.88 6.73 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.312 1.045 . . . . 0.0 110.843 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -80.31 -83.54 0.1 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.661 0.784 . . . . 0.0 109.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.05 -69.94 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.602 0.761 . . . . 0.0 109.366 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -98.16 66.63 1.82 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.399 0.619 . . . . 0.0 110.901 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.22 65.28 3.47 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.1 m -132.45 104.35 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -70.63 107.11 3.76 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.6 0.714 . . . . 0.0 112.514 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.25 18.9 m -87.11 -52.49 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 115.131 -0.941 . . . . 0.0 112.856 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.66 82.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.16 114.12 14.47 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.379 0.609 . . . . 0.0 112.452 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -125.63 97.22 36.72 Favored Pre-proline 0 CA--C 1.572 1.79 0 CA-C-O 118.741 -0.647 . . . . 0.0 110.765 -158.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.4 109.01 2.24 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 123.804 3.003 . . . . 0.0 111.037 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.574 1.2 pm0 67.51 81.03 0.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -173.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.59 103.32 6.51 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 156.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.1 t -96.87 121.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 148.67 28.48 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.719 -168.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.5 m -66.8 124.8 23.93 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.9 tt -58.06 103.6 0.15 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.358 1.063 . . . . 0.0 112.952 -163.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.04 -42.89 2.91 Favored Glycine 0 CA--C 1.549 2.162 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 -170.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -55.62 5.98 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -167.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 52.9 t -82.09 108.32 15.47 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.468 0.576 . . . . 0.0 111.675 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.294 2.7 t70 81.01 -51.6 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 170.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -70.78 158.03 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -150.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 168.9 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 113.528 -1.669 . . . . 0.0 113.977 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -61.03 -26.8 67.87 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.61 -49.81 75.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 168.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.68 -49.74 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -56.98 -44.6 82.84 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.6 mt -71.4 -50.77 28.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.6 p -71.91 -45.08 62.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -175.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.2 t -63.46 -39.68 51.3 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 114.919 -2.467 . . . . 0.0 115.462 -169.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -61.05 -33.09 92.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 CA-C-N 126.412 3.326 . . . . 0.0 116.573 168.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.64 -26.49 64.43 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 165.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 69.2 mmm -71.31 129.87 39.95 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 120.003 1.274 . . . . 0.0 111.393 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -74.44 158.57 33.62 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 122.752 1.263 . . . . 0.0 113.614 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.74 108.22 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.019 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.35 23.62 23.86 Favored Glycine 0 CA--C 1.554 2.489 0 N-CA-C 117.476 1.751 . . . . 0.0 117.476 -163.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -98.05 129.59 44.89 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 119.812 1.806 . . . . 0.0 111.184 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 75.6 m -107.33 123.03 47.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 170.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.49 131.53 9.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.918 0.487 . . . . 0.0 110.736 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -78.91 104.68 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.415 0.686 . . . . 0.0 109.369 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.1 t -93.62 96.27 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 -176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 79.5 p -90.16 102.26 14.98 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 124.35 38.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.972 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -63.61 164.78 9.06 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.1 p -74.83 74.16 2.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.525 1.155 . . . . 0.0 113.004 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp 176.96 -65.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.508 1.523 . . . . 0.0 107.113 -158.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -75.18 -34.11 61.53 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.284 1.434 . . . . 0.0 114.031 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 137' ' ' LEU . 34.7 t -68.42 -76.94 0.08 Allowed 'General case' 0 CA--C 1.555 1.154 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.381 171.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -133.93 -80.74 0.46 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.25 -105.13 0.26 Allowed Glycine 0 CA--C 1.547 2.062 0 CA-C-O 116.881 -2.066 . . . . 0.0 111.427 174.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.0 -47.7 0.16 Allowed 'Trans proline' 0 CA--C 1.562 1.923 0 CA-C-N 122.266 3.033 . . . . 0.0 116.399 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -148.33 117.26 6.74 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 133' ' ' PRO . . . -92.46 -120.07 2.7 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 123.205 0.431 . . . . 0.0 112.312 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -128.73 72.01 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.359 0.664 . . . . 0.0 110.103 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.0 t -73.85 135.35 77.58 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.4 -1.286 . . . . 0.0 112.783 -169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.06 -22.18 15.63 Favored 'Cis proline' 0 CA--C 1.565 2.051 0 N-CA-C 119.294 2.767 . . . . 0.0 119.294 9.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -56.06 -41.66 75.41 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.09 104.39 50.67 Favored Pre-proline 0 CA--C 1.574 1.881 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.83 157.07 58.38 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 C-N-CA 123.038 2.492 . . . . 0.0 114.726 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 126' ' ' GLY . 47.7 Cg_endo -70.88 -68.93 0.02 OUTLIER 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.613 2.209 . . . . 0.0 116.623 -157.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -121.77 76.66 1.29 Allowed 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.28 154.07 48.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.345 1.058 . . . . 0.0 109.58 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.73 93.3 8.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 121' ' ' CYS . 9.0 mp -69.05 134.79 49.87 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.726 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 77.5 m -104.25 99.67 9.39 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.16 106.85 10.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.557 0.743 . . . . 0.0 109.713 -167.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -85.15 117.52 24.15 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.803 0.811 . . . . 0.0 112.162 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 79.3 t -88.52 108.02 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.0 m -115.82 108.28 16.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.48 106.87 5.45 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.064 0.546 . . . . 0.0 110.4 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -87.53 -53.01 5.03 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.168 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 62.4 p -145.82 131.97 19.4 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.21 0.914 . . . . 0.0 108.936 173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -101.12 118.64 37.4 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.187 0.595 . . . . 0.0 109.453 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.2 m -132.26 165.46 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.225 1.012 . . . . 0.0 109.687 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.35 -179.11 4.32 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.36 99.79 1.72 Allowed Glycine 0 CA--C 1.55 2.219 0 CA-C-O 116.939 -2.034 . . . . 0.0 110.797 172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -80.67 127.32 6.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 CA-C-N 122.503 3.151 . . . . 0.0 113.722 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -129.01 118.83 23.21 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.754 0.822 . . . . 0.0 108.86 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.257 7.6 mp 73.45 118.68 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.966 1.306 . . . . 0.0 111.346 -176.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 123.284 1.516 . . . . 0.0 111.42 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 25.2 ptm . . . . . 0 CA--C 1.554 1.122 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -147.47 113.63 5.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.51 114.71 12.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.587 -0.695 . . . . 0.0 111.516 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.264 17.1 m0 84.46 120.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.287 1.435 . . . . 0.0 109.504 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 93.1 mt -89.21 117.42 28.17 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.098 0.475 . . . . 0.0 110.779 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.25 150.75 25.98 Favored 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.47 -54.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.488 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.05 -63.2 1.38 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.82 0.78 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 N-CA-C 117.748 1.859 . . . . 0.0 117.748 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -127.63 -82.67 0.6 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.844 1.822 . . . . 0.0 106.195 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.08 76.78 0.05 OUTLIER Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.446 0.566 . . . . 0.0 111.869 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.88 -67.21 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.0 tp -85.83 112.31 21.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.739 0.815 . . . . 0.0 108.818 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -134.9 112.91 11.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.202 0.525 . . . . 0.0 111.386 -170.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -91.79 100.95 13.55 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.253 -0.905 . . . . 0.0 111.687 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -94.45 120.07 34.13 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.38 0.672 . . . . 0.0 109.791 171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.4 m -80.14 114.96 19.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.298 0.57 . . . . 0.0 110.126 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.56 -71.87 0.5 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.124 0.97 . . . . 0.0 109.997 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.0 t -88.51 126.09 61.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.3 162.15 43.42 Favored 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 123.066 2.511 . . . . 0.0 114.817 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.85 122.83 7.2 Favored Glycine 0 CA--C 1.555 2.542 0 CA-C-O 116.964 -2.02 . . . . 0.0 112.941 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.57 165.89 21.51 Favored 'Trans proline' 0 CA--C 1.575 2.569 0 CA-C-N 122.541 3.171 . . . . 0.0 115.51 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.31 120.95 8.42 Favored 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 123.179 2.586 . . . . 0.0 114.002 -170.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.91 -111.65 3.83 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -164.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m 58.99 95.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.5 m -117.72 125.76 51.25 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.379 1.085 . . . . 0.0 109.979 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -68.17 136.47 91.54 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 114.287 171.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.16 179.56 4.85 Favored 'Trans proline' 0 CA--C 1.568 2.187 0 C-N-CA 122.947 2.431 . . . . 0.0 115.449 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.0 m -93.65 175.53 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 124.19 0.996 . . . . 0.0 112.325 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -63.28 128.08 34.19 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.563 0.745 . . . . 0.0 112.856 168.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.36 46.96 4.5 Favored Glycine 0 CA--C 1.548 2.156 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.793 -167.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -148.22 138.81 22.9 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.51 118.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -172.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.4 m -113.04 134.09 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 123.812 0.845 . . . . 0.0 109.351 170.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -99.44 118.21 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 171.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.1 t -119.6 130.95 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -91.64 100.5 13.22 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.657 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -96.51 131.99 42.54 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.196 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -127.57 104.88 8.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -82.23 132.8 35.23 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.049 -169.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -131.03 116.13 17.38 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.6 tp -87.21 94.51 9.68 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.265 12.1 pt-20 -70.39 -26.34 63.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -61.07 -41.43 96.6 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 160.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.33 -104.53 2.89 Favored Glycine 0 CA--C 1.544 1.852 0 CA-C-N 119.398 0.999 . . . . 0.0 112.159 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.3 m -131.31 146.4 52.28 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.019 0.928 . . . . 0.0 108.92 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -62.8 118.46 7.74 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.89 -45.67 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.272 13.8 mm100 75.3 92.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.879 1.671 . . . . 0.0 110.442 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -106.45 159.5 16.11 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-O 122.518 1.152 . . . . 0.0 112.703 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -67.2 139.69 95.17 Favored Pre-proline 0 CA--C 1.58 2.11 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -167.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.34 -13.04 16.98 Favored 'Trans proline' 0 C--N 1.371 1.73 0 N-CA-C 119.862 2.985 . . . . 0.0 119.862 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.13 75.43 1.59 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.908 1.685 . . . . 0.0 110.682 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.34 106.31 18.33 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.05 135.56 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.192 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -159.76 157.85 30.12 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -91.3 131.48 36.78 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.112 0.965 . . . . 0.0 109.729 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.55 142.29 58.48 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 123.618 0.767 . . . . 0.0 113.061 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.66 -60.15 4.84 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 114.354 0.502 . . . . 0.0 114.354 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.79 115.46 7.36 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 124.748 1.219 . . . . 0.0 111.407 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 42.9 t -79.7 77.62 6.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.698 1.237 . . . . 0.0 113.492 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.72 -50.46 17.4 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.882 162.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.4 m -82.29 -178.67 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 C-N-CA 124.815 1.246 . . . . 0.0 113.254 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.2 pt -60.87 161.04 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 124.713 1.205 . . . . 0.0 114.145 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -61.0 -36.63 79.98 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -44.64 97.11 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 169.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.3 mt -65.3 -55.8 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 117.741 -1.124 . . . . 0.0 113.496 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -50.67 -48.81 58.29 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.28 -32.54 74.02 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.1 p -80.13 1.96 25.98 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 117.682 2.475 . . . . 0.0 117.682 166.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.9 t -59.17 -52.49 74.23 Favored Pre-proline 0 N--CA 1.499 2.002 0 CA-C-O 115.044 -2.408 . . . . 0.0 112.683 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.37 39.35 0.54 Allowed 'Trans proline' 0 CA--C 1.574 2.517 0 CA-C-N 124.848 2.767 . . . . 0.0 116.827 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.2 mt -144.99 -46.04 0.23 Allowed 'General case' 0 CA--C 1.563 1.448 0 C-N-CA 125.618 1.567 . . . . 0.0 110.631 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -76.41 113.44 14.0 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.804 1.184 . . . . 0.0 112.35 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.9 163.89 12.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.76 1.267 . . . . 0.0 111.882 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.49 115.74 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.294 -0.879 . . . . 0.0 112.155 -166.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.82 -40.19 2.4 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 117.091 1.596 . . . . 0.0 117.091 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -71.47 134.9 46.88 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 119.58 1.69 . . . . 0.0 115.459 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.9 m -90.98 125.29 35.74 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 154.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.61 121.89 13.06 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.4 ptp -75.8 125.88 29.92 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.404 1.097 . . . . 0.0 110.706 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.9 t -102.08 95.2 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 73.8 p -89.62 102.87 15.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -123.5 143.9 49.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.128 -161.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.82 162.37 4.12 Favored 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 97.1 p -54.02 -34.89 61.14 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 160.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -57.12 -43.91 82.76 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 161.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -86.56 63.91 8.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.899 0.772 . . . . 0.0 110.664 171.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.6 t -171.5 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -137.8 5.47 2.62 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.74 145.79 19.26 Favored Glycine 0 CA--C 1.56 2.885 0 CA-C-N 120.867 1.667 . . . . 0.0 111.892 -160.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.0 80.21 2.73 Favored 'Trans proline' 0 CA--C 1.562 1.876 0 CA-C-N 122.558 3.179 . . . . 0.0 112.279 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -138.21 -74.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.16 0.584 . . . . 0.0 110.022 -164.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 157.42 96.48 0.12 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.91 140.75 49.27 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.287 0.635 . . . . 0.0 110.821 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.2 p -66.86 138.87 95.42 Favored Pre-proline 0 CA--C 1.573 1.831 0 CA-C-O 117.678 -1.153 . . . . 0.0 113.662 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.35 -44.82 0.45 Allowed 'Cis proline' 0 CA--C 1.563 1.934 0 N-CA-C 117.106 1.926 . . . . 0.0 117.106 8.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -155.18 88.73 1.17 Allowed 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 83.4 mt -121.92 86.36 46.1 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -76.66 163.47 31.63 Favored 'Trans proline' 0 CA--C 1.572 2.421 0 C-N-CA 122.68 2.253 . . . . 0.0 115.424 -171.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.84 119.87 6.49 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.162 2.574 . . . . 0.0 113.232 -175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.258 96.1 m-70 66.8 76.66 0.29 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.796 1.239 . . . . 0.0 111.49 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -158.49 116.78 2.99 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.28 127.48 33.68 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.967 0.889 . . . . 0.0 112.844 -171.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.2 mp -102.49 129.76 49.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.398 -1.274 . . . . 0.0 109.264 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.8 m -105.72 94.7 5.34 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.271 0.629 . . . . 0.0 109.372 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.37 121.64 45.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.445 0.698 . . . . 0.0 110.441 -170.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -77.9 100.41 6.37 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.011 0.524 . . . . 0.0 111.586 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.44 109.0 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.9 m -113.86 121.65 44.63 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.66 102.03 10.43 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -84.05 -59.55 2.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 60.1 p -122.46 149.5 43.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.658 0.783 . . . . 0.0 109.749 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.51 107.93 8.32 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.79 170.24 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 124.24 1.016 . . . . 0.0 110.096 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.56 -161.46 0.19 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.86 111.09 3.9 Favored Glycine 0 CA--C 1.555 2.538 0 CA-C-O 116.728 -2.151 . . . . 0.0 112.701 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.94 124.06 3.78 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 CA-C-N 122.712 3.256 . . . . 0.0 113.301 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -92.56 119.3 31.89 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 123.105 0.562 . . . . 0.0 110.083 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.91 -64.13 1.21 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.326 0.651 . . . . 0.0 111.144 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 123.432 0.693 . . . . 0.0 109.885 -177.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -113.61 -48.55 2.93 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -77.38 123.98 27.26 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -160.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 91.6 m95 76.09 94.68 0.07 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.692 1.197 . . . . 0.0 111.564 168.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.87 113.2 26.55 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.93 110.45 5.04 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 122.016 0.912 . . . . 0.0 113.348 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 pt -80.17 -42.11 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.806 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -73.95 -63.38 1.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.501 1.046 . . . . 0.0 111.274 165.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 147.5 -89.64 0.15 Allowed Glycine 0 N--CA 1.477 1.401 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -83.57 -40.53 18.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.04 82.12 1.49 Allowed Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.093 0.861 . . . . 0.0 115.25 -163.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp 40.55 63.31 1.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 162.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.4 tp -162.29 92.74 0.83 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -117.16 117.78 30.54 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.509 0.724 . . . . 0.0 109.247 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -100.79 105.83 17.18 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.51 -0.744 . . . . 0.0 111.331 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 101.48 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.254 166.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.5 p -84.45 110.48 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.56 -59.51 2.72 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.601 0.76 . . . . 0.0 111.827 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.34 103.44 54.99 Favored Pre-proline 0 CA--C 1.57 1.729 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 165.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.65 87.07 1.55 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.989 2.459 . . . . 0.0 112.963 -175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.04 88.41 0.11 Allowed Glycine 0 CA--C 1.553 2.451 0 CA-C-O 116.339 -2.367 . . . . 0.0 113.286 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.82 167.84 16.63 Favored 'Trans proline' 0 CA--C 1.576 2.607 0 CA-C-N 123.154 3.477 . . . . 0.0 115.336 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.46 127.68 21.53 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 123.211 2.608 . . . . 0.0 114.86 -168.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.58 -123.12 6.63 Favored Glycine 0 CA--C 1.546 1.988 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -160.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 m 59.43 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 164.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -123.4 127.28 48.22 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.705 1.241 . . . . 0.0 110.12 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -69.93 122.32 85.64 Favored Pre-proline 0 CA--C 1.574 1.899 0 CA-C-N 113.1 -1.864 . . . . 0.0 113.225 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.45 171.82 16.29 Favored 'Trans proline' 0 CA--C 1.564 1.976 0 C-N-CA 122.795 2.33 . . . . 0.0 115.352 -170.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.95 174.65 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -60.57 133.09 55.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.13 51.1 4.57 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.284 -171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -146.63 131.87 18.45 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 -173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 69.8 t -84.76 113.45 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -114.67 124.77 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -92.97 133.55 36.01 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 m -127.92 145.37 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.629 0.728 . . . . 0.0 110.16 177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -102.73 98.28 8.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 165.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.51 125.72 31.44 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -103.98 73.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -79.46 119.45 22.48 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.9 m -146.91 133.9 20.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.7 tp -67.18 151.91 46.7 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.662 0.785 . . . . 0.0 113.001 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.73 -32.14 12.91 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -77.65 -63.82 1.29 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 119.587 1.085 . . . . 0.0 112.529 168.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.07 76.38 0.02 OUTLIER Glycine 0 N--CA 1.48 1.583 0 CA-C-N 118.786 0.721 . . . . 0.0 111.533 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.1 m -149.39 113.91 5.29 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -74.6 104.23 5.21 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.248 0.477 . . . . 0.0 111.633 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.58 -61.92 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 118.886 -0.578 . . . . 0.0 112.003 -165.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.85 85.81 1.43 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -100.03 91.56 4.85 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 122.845 0.458 . . . . 0.0 110.231 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -98.97 116.33 65.31 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 117.831 -1.08 . . . . 0.0 111.087 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.73 -53.36 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.704 0 C-N-CA 122.875 2.384 . . . . 0.0 115.079 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -98.73 81.25 2.64 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 119.252 0.933 . . . . 0.0 111.192 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 tp -94.72 98.79 11.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.73 109.93 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -165.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -137.46 151.73 48.8 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -88.08 118.98 28.02 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -79.86 145.56 32.67 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.77 -50.0 4.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.71 -2.81 0.89 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 58.2 m 75.41 90.92 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.985 1.314 . . . . 0.0 111.46 169.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.76 -63.01 1.1 Allowed 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.297 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -77.88 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 124.28 1.032 . . . . 0.0 113.396 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 pt -56.57 148.08 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 125.06 1.344 . . . . 0.0 113.171 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -61.7 -26.69 68.2 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.38 -50.45 69.84 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 120.29 1.405 . . . . 0.0 114.74 165.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -44.17 93.3 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.34 -40.35 95.7 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.91 -30.97 72.0 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 167.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -77.62 -0.17 25.53 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.64 -55.41 45.25 Favored Pre-proline 0 N--CA 1.502 2.125 0 CA-C-O 115.329 -2.272 . . . . 0.0 112.708 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.36 24.57 0.23 Allowed 'Trans proline' 0 CA--C 1.574 2.483 0 CA-C-N 124.683 2.708 . . . . 0.0 118.249 174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.8 mp -130.92 -39.14 1.23 Allowed 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 124.97 1.308 . . . . 0.0 111.825 168.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -75.45 123.42 25.39 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.883 1.219 . . . . 0.0 113.566 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.92 170.27 8.18 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.76 1.267 . . . . 0.0 111.771 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.29 111.99 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.313 -0.867 . . . . 0.0 110.112 -157.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.89 2.14 57.22 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 118.282 2.073 . . . . 0.0 118.282 -166.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -75.32 123.42 25.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 121.27 2.535 . . . . 0.0 111.961 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.8 m -103.82 116.73 32.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.53 128.16 10.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.4 tpp -80.79 113.71 19.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.756 0.823 . . . . 0.0 109.569 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -98.13 93.3 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -91.28 109.53 20.8 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -146.96 147.04 30.33 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.881 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -48.15 150.79 1.12 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.0 t -70.52 78.25 0.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.627 1.203 . . . . 0.0 111.491 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -179.76 -67.34 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.455 -1.702 . . . . 0.0 106.639 -156.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -65.87 -55.47 16.84 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.95 0.9 . . . . 0.0 111.718 159.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 71.6 m -73.21 111.5 8.39 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.768 0.713 . . . . 0.0 110.367 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . 0.323 75.7 m-85 80.08 -78.41 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.242 1.017 . . . . 0.0 112.036 170.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.45 162.99 26.33 Favored Glycine 0 CA--C 1.557 2.687 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.085 174.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.21 -22.16 47.17 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 123.183 2.589 . . . . 0.0 118.411 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -80.54 -45.04 18.09 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.92 97.98 1.37 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -171.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -84.14 178.66 7.73 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 122.366 1.079 . . . . 0.0 112.757 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.3 m -75.03 138.1 72.65 Favored Pre-proline 0 CA--C 1.57 1.745 0 CA-C-O 117.938 -1.03 . . . . 0.0 111.643 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.67 -56.36 0.14 OUTLIER 'Cis proline' 0 CA--C 1.562 1.891 0 CA-C-N 122.316 1.863 . . . . 0.0 115.704 6.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -145.96 70.82 1.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 119.14 0.882 . . . . 0.0 109.386 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 14.7 mm -90.6 119.06 69.1 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 117.423 -1.275 . . . . 0.0 107.933 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.65 121.41 5.94 Favored 'Trans proline' 0 CA--C 1.571 2.36 0 C-N-CA 122.716 2.277 . . . . 0.0 112.253 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.64 132.73 20.85 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 123.012 2.475 . . . . 0.0 112.704 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.273 14.9 m170 78.86 148.28 0.1 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 124.61 1.164 . . . . 0.0 110.748 -166.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.26 . . 78.93 136.26 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.841 1.257 . . . . 0.0 112.514 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.32 136.49 33.88 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.54 136.15 37.44 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.816 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 58.9 m -101.11 102.91 13.96 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.432 0.693 . . . . 0.0 109.981 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.01 109.36 18.71 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.289 0.636 . . . . 0.0 111.22 -175.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -83.32 98.74 9.6 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.486 0.66 . . . . 0.0 110.377 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.82 111.66 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.8 m -110.77 114.32 27.58 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.56 120.18 18.81 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.057 0.543 . . . . 0.0 111.014 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -90.11 -65.41 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.488 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 46.6 p -124.77 150.59 46.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.852 0.834 . . . . 0.0 109.847 -166.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -133.79 98.67 4.24 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 169.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.24 164.59 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.934 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.65 -160.58 0.19 Allowed 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -108.68 93.25 0.77 Allowed Glycine 0 CA--C 1.549 2.195 0 CA-C-O 117.075 -1.959 . . . . 0.0 110.824 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.46 137.11 12.9 Favored 'Trans proline' 0 CA--C 1.558 1.687 0 CA-C-N 122.174 2.987 . . . . 0.0 113.244 -173.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -84.08 101.51 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 122.097 0.951 . . . . 0.0 113.083 -175.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.6 mp -105.44 94.72 5.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.878 0.847 . . . . 0.0 110.1 -179.663 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 68.23 132.52 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.15 -67.24 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -156.4 146.59 21.35 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.625 1.17 . . . . 0.0 109.371 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.6 tp -74.31 136.15 42.58 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.259 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -83.47 -178.27 7.0 Favored 'General case' 0 CA--C 1.576 1.968 0 CA-C-O 123.452 1.596 . . . . 0.0 114.928 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 -74.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -75.36 -39.9 58.78 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 110.39 67.94 0.57 Allowed Glycine 0 CA--C 1.539 1.576 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -146.94 -65.54 0.28 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.71 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.43 -50.32 0.83 Allowed Glycine 0 CA--C 1.545 1.957 0 CA-C-N 118.907 0.776 . . . . 0.0 114.074 -164.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -67.69 -56.74 8.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.68 112.83 24.9 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.861 0.755 . . . . 0.0 109.076 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -133.73 148.65 51.45 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.127 0.971 . . . . 0.0 111.444 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -108.55 127.16 53.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.647 -0.658 . . . . 0.0 111.511 167.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.92 -43.1 95.1 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . 0.269 19.5 m 73.5 95.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 174.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.78 -65.62 0.99 Allowed 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.889 . . . . 0.0 110.166 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -120.46 113.01 33.85 Favored Pre-proline 0 CA--C 1.569 1.689 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.3 78.99 3.01 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.87 2.38 . . . . 0.0 113.095 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.34 160.95 17.09 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.14 170.2 20.08 Favored 'Trans proline' 0 CA--C 1.574 2.499 0 C-N-CA 123.266 2.644 . . . . 0.0 114.39 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.35 108.28 1.97 Allowed 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.031 2.487 . . . . 0.0 111.838 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.06 83.34 0.96 Allowed Glycine 0 CA--C 1.544 1.88 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -159.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -100.51 123.63 44.98 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.884 0.474 . . . . 0.0 111.961 -166.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 88.5 p -92.33 138.85 31.17 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.335 0.654 . . . . 0.0 112.218 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -113.12 107.19 54.3 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.76 -1.114 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.4 148.22 29.77 Favored 'Trans proline' 0 CA--C 1.562 1.899 0 C-N-CA 123.022 2.482 . . . . 0.0 114.53 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 m -67.39 147.74 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.0 0.92 . . . . 0.0 112.576 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.42 86.3 2.56 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.74 62.79 0.01 OUTLIER Glycine 0 CA--C 1.54 1.634 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.158 172.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.07 0.938 . . . . 0.0 110.596 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.45 109.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.77 112.02 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 m -93.1 106.84 18.74 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.35 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -171.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -74.41 112.45 10.6 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 165.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.69 105.8 7.74 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -167.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -98.29 100.66 11.97 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -79.47 112.48 16.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.3 t -135.88 149.13 48.89 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.094 0.949 . . . . 0.0 110.306 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.4 tp -58.94 142.32 51.25 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.269 1.028 . . . . 0.0 112.218 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.29 -38.7 28.2 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.602 2.445 . . . . 0.0 117.602 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -66.21 -66.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.598 0.759 . . . . 0.0 111.959 168.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 158.64 79.61 0.03 OUTLIER Glycine 0 N--CA 1.479 1.536 0 CA-C-N 119.012 0.824 . . . . 0.0 112.005 172.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.2 m -151.04 112.96 4.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 102.27 1.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.64 -45.83 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -145.08 105.91 4.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.26 124.54 31.33 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.431 0.634 . . . . 0.0 109.681 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -130.58 78.43 74.03 Favored Pre-proline 0 CA--C 1.574 1.895 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -170.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.81 -44.3 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.095 2.53 . . . . 0.0 116.443 -171.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.12 83.15 2.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.197 0.908 . . . . 0.0 109.803 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.4 tp -101.05 98.51 8.94 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.76 111.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -165.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.8 166.14 33.84 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.652 0.739 . . . . 0.0 111.755 -175.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -82.06 136.02 35.26 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.234 0.613 . . . . 0.0 110.398 178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 tt -68.37 114.13 6.55 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.222 1.009 . . . . 0.0 112.828 -164.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.92 34.8 77.75 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 118.0 1.96 . . . . 0.0 118.0 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -128.44 169.11 14.7 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.44 1.114 . . . . 0.0 110.028 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -75.77 89.91 2.87 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-O 122.603 1.192 . . . . 0.0 113.205 -167.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -149.44 -67.55 0.21 Allowed 'General case' 0 CA--C 1.566 1.585 0 CA-C-N 113.846 -1.524 . . . . 0.0 107.998 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.85 165.29 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 C-N-CA 124.605 1.162 . . . . 0.0 112.988 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.88 159.92 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -30.18 63.77 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.9 -48.82 80.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 170.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.3 -38.4 65.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 173.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -43.29 -48.48 6.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.72 -45.46 58.63 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.6 p -90.27 45.94 1.31 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.67 -55.95 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.913 0 CA-C-O 115.013 -2.423 . . . . 0.0 107.235 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.73 83.32 1.95 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 CA-C-N 125.421 2.972 . . . . 0.0 112.802 171.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.317 4.4 pp 163.0 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 127.194 2.197 . . . . 0.0 111.821 -167.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.23 140.73 38.9 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.98 1.264 . . . . 0.0 112.04 -173.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -71.27 159.81 33.93 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.618 163.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.9 t -78.68 97.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.416 ' H ' ' HB2' ' A' ' 143' ' ' LEU . . . 99.06 39.17 3.61 Favored Glycine 0 CA--C 1.552 2.379 0 CA-C-O 118.494 -1.17 . . . . 0.0 115.981 -162.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.42 99.91 11.75 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 119.064 1.432 . . . . 0.0 109.076 173.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.9 m -83.69 118.05 23.61 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.71 128.31 6.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.768 0.427 . . . . 0.0 110.223 -173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.4 tpp -85.51 107.16 17.32 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.2 t -84.75 99.05 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -91.5 104.26 16.78 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.15 160.64 15.46 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.164 0.983 . . . . 0.0 113.303 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 159.04 22.19 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.663 164.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 90.3 p -73.95 68.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -175.9 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.452 1.501 . . . . 0.0 108.405 -168.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -59.62 -51.03 71.56 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.651 1.18 . . . . 0.0 114.113 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.5 m -66.11 -70.16 0.26 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.821 0.737 . . . . 0.0 112.582 170.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -144.48 -65.49 0.35 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 118.938 0.79 . . . . 0.0 109.39 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.64 -167.93 30.16 Favored Glycine 0 CA--C 1.556 2.623 0 N-CA-C 115.54 0.976 . . . . 0.0 115.54 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.14 102.47 1.6 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.081 2.521 . . . . 0.0 112.441 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -152.95 -69.45 0.15 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.716 -169.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 90.72 95.29 1.23 Allowed Glycine 0 CA--C 1.541 1.683 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -167.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -132.82 148.65 52.31 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.201 1.0 . . . . 0.0 110.667 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.4 m -76.8 140.85 67.7 Favored Pre-proline 0 CA--C 1.57 1.74 0 CA-C-O 117.97 -1.014 . . . . 0.0 112.22 173.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.02 -47.35 0.26 Allowed 'Cis proline' 0 CA--C 1.563 1.939 0 CA-C-N 122.377 1.885 . . . . 0.0 116.909 9.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.33 77.16 1.43 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.76 117.37 46.64 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.8 151.33 27.97 Favored 'Trans proline' 0 CA--C 1.571 2.358 0 C-N-CA 122.813 2.342 . . . . 0.0 114.417 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.15 119.59 6.55 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 123.128 2.552 . . . . 0.0 111.931 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.277 93.9 m-70 76.8 101.42 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.222 1.409 . . . . 0.0 109.478 -165.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.83 88.86 3.0 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.171 0.588 . . . . 0.0 109.634 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.6 76.15 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.38 153.33 20.59 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.443 1.115 . . . . 0.0 112.243 -165.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 28.4 p -91.75 109.6 20.92 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.661 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.37 117.79 32.4 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.304 1.042 . . . . 0.0 108.217 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.16 99.2 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.398 -0.814 . . . . 0.0 110.196 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.06 125.6 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.5 m -142.14 124.33 15.49 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' HB2' ' H ' ' A' ' 109' ' ' GLY . 3.2 mm? -76.47 111.32 11.81 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.384 0.674 . . . . 0.0 110.021 174.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -84.01 -55.95 3.94 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 118.659 -0.686 . . . . 0.0 112.745 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 69.7 p -135.94 133.61 37.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -117.68 106.96 13.63 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 167.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.93 133.48 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 123.439 0.696 . . . . 0.0 110.078 -170.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -86.17 103.96 15.29 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.427 0.691 . . . . 0.0 110.775 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 168.47 93.74 0.09 OUTLIER Glycine 0 CA--C 1.545 1.964 0 CA-C-O 116.801 -2.111 . . . . 0.0 112.08 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.92 131.87 12.48 Favored 'Trans proline' 0 CA--C 1.557 1.675 0 CA-C-N 122.283 3.042 . . . . 0.0 112.62 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 61.17 90.41 0.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 124.477 1.111 . . . . 0.0 112.648 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.61 -63.29 1.42 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -165.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.722 0.772 . . . . 0.0 110.989 -176.513 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 53.17 61.39 3.18 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.11 169.9 20.18 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.693 1.235 . . . . 0.0 113.568 -163.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -79.41 115.44 19.05 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 153.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.46 103.61 15.16 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -163.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.97 103.04 12.13 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.072 0.939 . . . . 0.0 112.331 -176.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 pt -84.23 -176.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.648 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.357 2.6 tt 90.46 -75.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.343 1.457 . . . . 0.0 110.624 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.98 -72.4 0.07 OUTLIER Glycine 0 N--CA 1.478 1.456 0 CA-C-N 118.377 0.535 . . . . 0.0 112.708 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -82.74 -75.36 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 123.179 0.592 . . . . 0.0 111.462 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 168.94 73.54 0.04 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 mt -141.73 -62.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.092 0.957 . . . . 0.0 108.753 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.6 tp -75.77 130.51 38.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.101 0.96 . . . . 0.0 110.753 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -133.41 74.95 1.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -159.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -92.17 86.58 5.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 0.0 112.037 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -75.51 116.88 16.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.481 -0.762 . . . . 0.0 111.071 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 m -74.89 104.62 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.209 0.603 . . . . 0.0 109.404 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.79 -79.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.644 0.777 . . . . 0.0 110.077 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.93 113.38 63.67 Favored Pre-proline 0 CA--C 1.571 1.751 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 169.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.17 175.63 8.97 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.873 2.382 . . . . 0.0 114.889 -174.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 119.37 10.85 Favored Glycine 0 CA--C 1.558 2.738 0 CA-C-O 116.948 -2.029 . . . . 0.0 112.62 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.65 161.91 36.7 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 CA-C-N 122.498 3.149 . . . . 0.0 115.327 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.84 113.64 2.07 Favored 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 123.175 2.584 . . . . 0.0 113.562 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.4 71.67 1.09 Allowed Glycine 0 CA--C 1.546 2.031 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.711 -159.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -157.86 114.52 2.89 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.8 m -126.06 117.74 23.84 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 122.273 1.035 . . . . 0.0 110.086 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 -59.4 134.06 88.46 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.01 144.89 43.71 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.783 2.322 . . . . 0.0 116.568 -158.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.4 m -72.16 155.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.002 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -70.17 110.99 5.49 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -170.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.72 65.08 0.47 Allowed Glycine 0 CA--C 1.544 1.863 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.548 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -150.01 140.74 22.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.0 t -74.19 108.04 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 m -117.87 121.6 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -169.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.5 m -109.75 134.46 51.98 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.63 153.15 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.254 1.026 . . . . 0.0 110.278 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -102.44 91.58 4.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.343 171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.94 147.38 25.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.311 0.576 . . . . 0.0 110.383 163.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.01 92.5 2.88 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 m -83.11 122.11 27.93 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.661 0.743 . . . . 0.0 109.889 -175.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.4 m -140.93 136.62 32.42 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.529 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.19 131.81 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -52.23 -46.82 65.87 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.37 -44.26 12.95 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 163.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.81 80.78 Favored Glycine 0 CA--C 1.551 2.327 0 N-CA-C 120.783 3.073 . . . . 0.0 120.783 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.0 m 77.65 117.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.143 1.972 . . . . 0.0 112.839 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.252 7.3 ttt85 38.86 53.91 2.01 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 160.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.269 21.1 m -74.77 -40.96 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -159.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -146.96 76.3 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.561 1.073 . . . . 0.0 109.055 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -73.39 111.05 8.15 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.609 0.719 . . . . 0.0 111.56 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -130.94 84.06 59.3 Favored Pre-proline 0 CA--C 1.574 1.894 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.91 -46.58 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.906 2.404 . . . . 0.0 117.248 -164.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.95 92.95 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.876 1.216 . . . . 0.0 110.702 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 tp -111.57 81.13 1.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.53 -172.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -89.84 136.44 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.406 0.682 . . . . 0.0 110.884 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -162.81 150.48 13.62 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.947 0.899 . . . . 0.0 110.345 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.5 m -80.77 140.97 35.21 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.94 104.81 5.68 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.38 70.83 0.85 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.032 -159.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -156.63 -66.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 123.734 0.814 . . . . 0.0 110.478 -176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . 0.351 4.8 t 65.94 40.87 3.94 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.59 -47.68 80.49 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.878 -1.139 . . . . 0.0 113.217 152.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.4 m -55.04 166.85 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 125.282 1.433 . . . . 0.0 114.321 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 99' ' ' LEU . 46.4 pt -60.34 151.19 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -35.99 65.93 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.35 94.54 Favored 'General case' 0 CA--C 1.56 1.348 0 N-CA-C 117.176 2.288 . . . . 0.0 117.176 165.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.459 ' H ' HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -63.89 -56.54 14.57 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.907 -1.044 . . . . 0.0 113.138 178.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -49.98 -43.24 50.17 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.38 -39.87 94.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 170.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.1 p -77.91 -4.11 45.16 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.79 -53.05 68.03 Favored Pre-proline 0 N--CA 1.502 2.138 0 CA-C-O 115.388 -2.244 . . . . 0.0 112.62 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.48 0.34 1.47 Allowed 'Trans proline' 0 CA--C 1.569 2.254 0 N-CA-C 119.483 2.839 . . . . 0.0 119.483 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 99.4 mt -128.57 73.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 119.993 1.27 . . . . 0.0 107.982 158.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 38.9 ttm -164.29 96.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -83.06 167.64 17.68 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.322 1.058 . . . . 0.0 113.282 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.0 t -70.41 108.29 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.578 0.751 . . . . 0.0 109.691 -170.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.78 20.2 41.0 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 117.912 1.925 . . . . 0.0 117.912 -167.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 107.59 18.66 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 120.387 2.093 . . . . 0.0 110.476 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.4 m -78.75 113.07 16.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 163.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.79 121.49 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 ttt -83.68 108.12 16.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.024 0.529 . . . . 0.0 110.239 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.34 118.38 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.2 t -129.07 77.04 1.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.61 145.92 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.715 0.769 . . . . 0.0 112.044 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.86 164.65 0.36 Allowed 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.6 p -69.54 81.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 122.832 1.301 . . . . 0.0 111.595 172.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.14 -55.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.888 -147.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -120.11 57.99 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.399 0.68 . . . . 0.0 111.938 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.5 t -110.37 -100.38 0.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -136.14 63.13 1.6 Allowed 'General case' 0 CA--C 1.565 1.526 0 CA-C-N 119.047 0.84 . . . . 0.0 109.414 168.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.24 -156.12 30.42 Favored Glycine 0 CA--C 1.562 2.977 0 N-CA-C 116.671 1.428 . . . . 0.0 116.671 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.25 102.64 1.22 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.95 2.433 . . . . 0.0 110.783 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . 0.272 58.7 tp60 73.24 120.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.088 1.355 . . . . 0.0 111.16 -168.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -95.24 -139.95 10.54 Favored Glycine 0 CA--C 1.537 1.453 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -173.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -93.8 158.85 15.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.293 1.044 . . . . 0.0 111.856 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.8 m -64.52 137.32 97.1 Favored Pre-proline 0 CA--C 1.571 1.756 0 CA-C-O 117.789 -1.1 . . . . 0.0 112.756 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.78 -42.56 0.68 Allowed 'Cis proline' 0 CA--C 1.563 1.96 0 N-CA-C 117.661 2.139 . . . . 0.0 117.661 10.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -168.21 100.69 0.44 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 87.2 mt -111.43 105.63 56.86 Favored Pre-proline 0 CA--C 1.571 1.77 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.86 146.72 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 122.667 2.244 . . . . 0.0 114.747 -174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.61 -54.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 123.292 2.661 . . . . 0.0 115.272 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -65.24 145.61 56.01 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.521 1.128 . . . . 0.0 112.915 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.18 128.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.796 1.238 . . . . 0.0 111.886 -169.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.72 114.08 8.44 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.603 0.761 . . . . 0.0 111.988 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.85 125.49 29.77 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 120.967 0.413 . . . . 0.0 111.301 -170.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.55 118.29 31.98 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.097 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.53 121.72 27.76 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.402 0.681 . . . . 0.0 109.677 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -87.6 98.33 11.35 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.2 0.6 . . . . 0.0 110.768 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.82 126.08 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -169.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.7 m -133.31 125.32 28.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -70.59 111.16 5.88 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.57 0.748 . . . . 0.0 111.184 -176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -77.37 -66.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 174.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -132.81 143.22 49.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.619 0.723 . . . . 0.0 109.321 -168.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.54 96.95 4.25 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 166.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.72 129.06 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -170.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.2 111.48 22.67 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.277 0.56 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 172.0 97.04 0.1 Allowed Glycine 0 CA--C 1.548 2.104 0 CA-C-O 116.764 -2.131 . . . . 0.0 110.633 -175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.8 151.37 31.59 Favored 'Trans proline' 0 CA--C 1.559 1.771 0 CA-C-N 122.359 3.079 . . . . 0.0 114.368 -172.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . 0.259 18.8 t0 68.51 98.85 0.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 124.616 1.166 . . . . 0.0 112.43 -175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -103.63 121.5 43.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.638 0.775 . . . . 0.0 109.039 -170.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.488 1.462 0 C-N-CA 123.238 0.615 . . . . 0.0 110.954 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.82 104.9 4.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -58.57 168.45 1.16 Allowed 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -48.79 120.57 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 124.447 1.099 . . . . 0.0 113.778 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.6 tp -80.36 109.81 15.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.439 0.696 . . . . 0.0 110.99 -164.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.56 101.78 13.52 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.355 1.074 . . . . 0.0 112.634 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.555 ' H ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -71.32 -29.84 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 170.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.23 -48.95 71.51 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.159 1.345 . . . . 0.0 113.68 158.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.44 -36.12 4.44 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.731 1.452 . . . . 0.0 116.731 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -73.1 -71.62 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.397 1.099 . . . . 0.0 111.961 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.11 61.27 0.03 OUTLIER Glycine 0 N--CA 1.481 1.659 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 mt -143.83 -76.2 0.24 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -168.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.4 tp -88.15 119.69 28.78 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.65 0.78 . . . . 0.0 109.203 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -137.79 121.63 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.644 0.778 . . . . 0.0 109.681 -172.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 110.5 16.09 Favored 'General case' 0 CA--C 1.565 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 110.485 -164.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -116.94 130.85 56.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.758 -1.214 . . . . 0.0 110.009 172.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.9 m -93.2 119.25 32.17 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.858 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -85.86 -68.32 0.74 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.517 0.727 . . . . 0.0 110.117 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.4 t -85.08 122.79 74.05 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 156.56 42.42 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 122.925 2.417 . . . . 0.0 114.699 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 121.14 5.32 Favored Glycine 0 CA--C 1.554 2.506 0 CA-C-O 116.924 -2.042 . . . . 0.0 113.071 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.22 144.64 52.2 Favored 'Trans proline' 0 CA--C 1.572 2.392 0 CA-C-N 122.597 3.199 . . . . 0.0 115.0 -172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.43 119.01 5.74 Favored 'Trans proline' 0 CA--C 1.558 1.693 0 C-N-CA 123.241 2.627 . . . . 0.0 112.643 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.28 -81.88 0.22 Allowed Glycine 0 N--CA 1.479 1.543 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -88.71 98.64 11.8 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 61.2 m -148.86 133.23 17.52 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.763 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.273 19.2 mtm180 42.44 74.68 0.72 Allowed Pre-proline 0 CA--C 1.577 2.008 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.97 161.49 32.9 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.726 2.284 . . . . 0.0 114.251 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.19 170.67 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.283 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -71.26 115.9 10.95 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.881 0.848 . . . . 0.0 111.902 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.64 -63.4 0.44 Allowed Glycine 0 CA--C 1.54 1.649 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -155.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -70.67 114.99 9.31 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.433 0.693 . . . . 0.0 110.028 168.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.34 114.04 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 m -92.52 135.74 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.444 -169.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.7 m -120.06 126.11 49.97 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.45 141.43 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.696 0.76 . . . . 0.0 110.98 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -89.92 93.67 9.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 161.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -97.34 143.19 28.34 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.782 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -126.93 90.41 3.15 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -74.53 115.55 14.2 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -140.92 119.15 12.06 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -162.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.6 tp -73.08 137.13 45.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.669 0.387 . . . . 0.0 110.573 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.63 87.41 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.619 1.199 . . . . 0.0 112.608 -170.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -171.25 -75.59 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -170.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 173.14 71.0 0.05 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 168.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.2 t -162.75 141.34 8.63 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.26 0.624 . . . . 0.0 110.05 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 113.63 25.24 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 158.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.264 23.5 m -78.25 -51.18 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -141.02 81.22 1.78 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 119.226 0.921 . . . . 0.0 109.198 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.76 119.39 30.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -122.66 94.34 47.65 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.095 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.64 -44.82 0.63 Allowed 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.084 2.523 . . . . 0.0 117.202 -172.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -106.8 76.36 1.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 119.783 1.174 . . . . 0.0 110.238 173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -99.68 92.67 5.45 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.22 132.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.737 0.78 . . . . 0.0 109.24 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -155.62 142.99 19.42 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.954 -174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.5 m -74.17 133.51 42.75 Favored 'General case' 0 CA--C 1.565 1.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.917 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.9 tt -70.83 109.05 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.336 -165.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.27 67.79 1.48 Allowed Glycine 0 N--CA 1.483 1.829 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.493 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -148.72 145.16 27.53 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.239 1.018 . . . . 0.0 109.739 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 75.8 m -75.72 76.72 2.69 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.647 1.213 . . . . 0.0 111.829 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -129.69 -63.44 0.92 Allowed 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.657 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.16 176.81 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 C-N-CA 124.5 1.12 . . . . 0.0 113.005 174.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.71 140.9 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 124.052 0.941 . . . . 0.0 112.443 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -61.47 -33.72 74.23 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.07 -40.93 70.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 167.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -56.69 10.65 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 123.931 0.892 . . . . 0.0 113.037 170.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -62.57 -39.72 94.59 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.5 mt -61.09 -34.8 75.52 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.1 p -74.35 -11.94 60.39 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 167.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.5 t -56.01 -50.45 87.25 Favored Pre-proline 0 N--CA 1.503 2.191 0 CA-C-O 115.292 -2.29 . . . . 0.0 115.092 175.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -53.32 -26.57 35.27 Favored 'Trans proline' 0 CA--C 1.567 2.165 0 CA-C-N 125.659 3.057 . . . . 0.0 118.549 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -110.09 73.21 0.83 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.087 0.955 . . . . 0.0 109.709 164.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 53.0 tpp -149.61 107.45 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -90.39 161.85 15.39 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 122.681 1.229 . . . . 0.0 113.066 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 t -81.96 103.15 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.27 59.17 1.31 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.932 -170.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -126.06 123.76 39.11 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.57 0.748 . . . . 0.0 109.829 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.9 m -91.49 103.54 16.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.1 120.74 14.27 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.976 0.417 . . . . 0.0 110.433 -164.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.4 ttm -83.6 141.25 31.69 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.99 0.9 . . . . 0.0 110.802 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.27 96.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.6 p -81.72 104.87 12.42 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -135.68 139.23 43.53 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.511 0.724 . . . . 0.0 111.024 -168.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -63.23 149.49 45.38 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.8 m -71.32 81.73 0.75 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 123.273 1.511 . . . . 0.0 110.8 167.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -172.78 -68.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 112.961 -1.927 . . . . 0.0 106.446 -159.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -73.85 -45.61 50.06 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.638 0.775 . . . . 0.0 112.477 161.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.1 m -58.98 -56.55 20.82 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -140.2 -84.41 0.23 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.465 1.029 . . . . 0.0 108.713 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 149.82 -175.35 28.99 Favored Glycine 0 CA--C 1.557 2.718 0 CA-C-N 119.014 0.824 . . . . 0.0 114.651 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -72.53 105.13 1.83 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.483 2.788 . . . . 0.0 112.591 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? 57.84 85.57 0.09 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.202 1.401 . . . . 0.0 112.908 -172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.66 -88.53 1.54 Allowed Glycine 0 CA--C 1.539 1.59 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -122.35 81.66 1.87 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 123.667 0.787 . . . . 0.0 109.96 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.1 p -73.44 145.29 84.97 Favored Pre-proline 0 CA--C 1.571 1.78 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.995 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.8 -16.38 30.09 Favored 'Cis proline' 0 CA--C 1.564 1.984 0 N-CA-C 119.437 2.822 . . . . 0.0 119.437 9.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -64.21 -42.69 96.5 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.73 118.43 68.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.32 163.51 27.41 Favored 'Trans proline' 0 CA--C 1.576 2.62 0 C-N-CA 122.84 2.36 . . . . 0.0 114.082 171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.09 -64.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 123.107 2.538 . . . . 0.0 115.488 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -136.03 94.05 3.0 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.24 125.69 8.81 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.95 108.31 14.51 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.566 0.698 . . . . 0.0 112.385 -173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -92.88 157.84 16.16 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.736 176.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.52 104.73 16.78 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.092 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -104.57 118.7 37.22 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.42 148.5 51.78 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.293 0.568 . . . . 0.0 112.383 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.96 99.96 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.5 m -102.44 109.39 21.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.47 104.15 8.88 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -80.88 -58.47 3.07 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 70.7 p -137.46 134.17 35.51 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.287 0.635 . . . . 0.0 109.64 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.16 94.94 4.86 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.1 m -128.97 123.99 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -166.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.08 115.31 22.81 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.412 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -171.82 -173.68 38.81 Favored Glycine 0 CA--C 1.557 2.7 0 CA-C-O 119.325 -0.708 . . . . 0.0 114.528 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.13 95.02 0.89 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.754 2.303 . . . . 0.0 113.327 -173.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -147.13 113.12 5.79 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.4 tp 70.79 106.86 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.986 1.314 . . . . 0.0 111.702 -173.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.253 0.549 . . . . 0.0 110.198 -178.807 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 62.3 mtp . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . 0.342 19.2 mmt-85 65.73 134.99 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -172.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -89.03 131.03 35.38 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.637 0.976 . . . . 0.0 113.637 -149.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -99.78 133.59 43.91 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.618 161.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . 0.455 0.2 OUTLIER 68.25 163.13 0.21 Allowed 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 171.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . 0.268 14.2 t0 73.19 111.7 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 171.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.4 mm -127.29 -59.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -60.59 -37.46 81.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.78 51.85 0.22 Allowed Glycine 0 CA--C 1.548 2.129 0 C-N-CA 124.621 1.105 . . . . 0.0 113.116 -174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -166.83 -71.84 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.24 61.67 0.07 OUTLIER Glycine 0 CA--C 1.544 1.85 0 C-N-CA 124.317 0.961 . . . . 0.0 111.36 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.0 mt -142.48 -53.87 0.41 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.841 0.856 . . . . 0.0 109.593 -163.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.9 tp -81.0 115.28 20.4 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 154.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -122.61 70.45 1.0 Allowed 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -162.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -88.77 120.08 29.85 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.636 -1.29 . . . . 0.0 113.06 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.15 114.57 24.66 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 161.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 m -75.57 121.2 22.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.128 0.49 . . . . 0.0 110.225 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.65 -69.18 0.34 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.771 0.828 . . . . 0.0 111.791 174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.07 121.89 26.24 Favored Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.42 169.02 23.45 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.811 2.341 . . . . 0.0 113.682 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.02 176.42 40.44 Favored Glycine 0 CA--C 1.562 3.018 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.73 163.45 35.21 Favored 'Trans proline' 0 CA--C 1.573 2.437 0 C-N-CA 123.047 2.498 . . . . 0.0 115.36 -177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.46 107.81 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.219 2.613 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.98 89.85 1.55 Allowed Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -164.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -133.08 109.48 9.54 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 86.7 p -77.99 129.76 35.68 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.176 0.512 . . . . 0.0 112.134 -175.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -92.14 113.0 57.77 Favored Pre-proline 0 CA--C 1.577 2.002 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.818 -173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -68.67 155.02 70.24 Favored 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 122.956 2.437 . . . . 0.0 117.511 -161.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.66 165.31 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.897 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.55 105.23 5.57 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.737 0.779 . . . . 0.0 111.534 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.73 48.6 0.84 Allowed Glycine 0 CA--C 1.55 2.235 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.391 -164.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -154.84 110.95 3.19 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.03 115.16 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 C-N-CA 123.429 0.691 . . . . 0.0 109.826 -163.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.89 129.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 123.528 0.731 . . . . 0.0 110.863 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 m -89.73 129.76 36.09 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 168.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.6 t -144.9 129.08 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -170.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -99.01 101.76 13.25 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.21 1.004 . . . . 0.0 108.463 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.32 127.54 55.09 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.149 0.58 . . . . 0.0 109.742 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -108.97 80.87 1.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 122.908 0.483 . . . . 0.0 110.214 -166.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.83 127.45 32.05 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.437 0.637 . . . . 0.0 110.49 -172.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -148.87 151.18 34.26 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.287 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.32 145.01 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 171.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.57 76.78 8.48 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-O 122.414 1.102 . . . . 0.0 110.277 168.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -172.22 -63.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.197 1.399 . . . . 0.0 107.27 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.62 -62.59 0.16 Allowed Glycine 0 CA--C 1.542 1.742 0 CA-C-O 119.516 -0.602 . . . . 0.0 113.193 -173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 133.98 33.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 117.502 0.651 . . . . 0.0 110.149 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.69 142.68 46.39 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.88 -74.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 173.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -145.12 118.66 9.1 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -97.86 93.0 6.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.632 -0.668 . . . . 0.0 109.948 172.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.4 mp0 -72.92 113.59 23.01 Favored Pre-proline 0 CA--C 1.576 1.971 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.818 -172.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.0 -53.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.991 2.46 . . . . 0.0 116.111 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -125.82 70.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 118.947 0.794 . . . . 0.0 110.705 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.92 113.83 26.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.6 t -106.76 100.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -113.06 146.57 38.9 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.042 0.537 . . . . 0.0 111.08 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.1 m -80.08 128.15 33.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -74.72 110.33 8.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.47 -67.1 0.25 Allowed Glycine 0 N--CA 1.48 1.583 0 CA-C-O 119.406 -0.663 . . . . 0.0 112.955 -167.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.42 85.94 7.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.523 0.678 . . . . 0.0 109.961 172.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 83.9 m -95.38 115.31 27.26 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.432 0.634 . . . . 0.0 112.373 -158.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -58.73 -38.41 78.31 Favored 'General case' 0 CA--C 1.574 1.894 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 159.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.3 m -71.13 164.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.639 1.209 . . . . 0.0 114.157 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.39 171.6 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.569 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -57.16 -40.06 76.49 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.85 -43.63 86.02 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 175.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.92 -49.07 61.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.559 -1.21 . . . . 0.0 114.111 170.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -49.54 -49.84 44.47 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 80.6 mt -60.0 -44.31 94.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.1 p -87.23 49.41 1.81 Allowed 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.3 t -96.56 -57.41 0.19 Allowed Pre-proline 0 CA--C 1.572 1.827 0 CA-C-O 115.226 -2.321 . . . . 0.0 109.195 163.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.85 -7.7 11.91 Favored 'Trans proline' 0 CA--C 1.566 2.087 0 CA-C-N 125.497 2.999 . . . . 0.0 118.776 174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.88 -34.84 15.09 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.77 1.168 . . . . 0.0 113.728 162.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.86 116.51 7.81 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 120.216 1.371 . . . . 0.0 112.806 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -85.73 149.46 25.27 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.129 0.966 . . . . 0.0 112.009 167.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.73 105.32 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 130.84 -33.4 2.84 Favored Glycine 0 CA--C 1.549 2.18 0 CA-C-O 117.351 -1.805 . . . . 0.0 116.763 -164.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -73.31 132.37 43.01 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 120.818 2.309 . . . . 0.0 115.047 -170.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 88.6 m -96.86 122.96 40.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 162.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.42 122.33 9.38 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 120.892 0.377 . . . . 0.0 111.415 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.5 ttt -82.83 105.79 14.13 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.327 0.651 . . . . 0.0 109.834 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 70.0 t -95.14 119.51 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.5 p -94.35 78.22 3.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.41 144.3 49.83 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 152.48 45.34 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.2 t -76.89 69.15 3.18 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.672 1.225 . . . . 0.0 111.689 167.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -176.45 -64.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.477 1.511 . . . . 0.0 108.001 -164.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -79.27 -31.56 43.44 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.5 t -69.0 -75.98 0.1 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 120.166 1.348 . . . . 0.0 112.064 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.97 43.7 2.93 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.281 1.4 . . . . 0.0 112.55 174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.09 176.25 6.69 Favored Glycine 0 CA--C 1.56 2.86 0 N-CA-C 116.467 1.347 . . . . 0.0 116.467 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.6 67.59 8.55 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 CA-C-N 120.979 2.389 . . . . 0.0 111.709 160.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -158.7 -66.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.498 1.119 . . . . 0.0 108.072 -169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 93.17 120.19 2.91 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 118.775 0.716 . . . . 0.0 111.776 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -124.04 67.42 1.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.7 m 67.39 143.53 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 166.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.81 -42.62 0.78 Allowed 'Cis proline' 0 CA--C 1.561 1.827 0 CA-C-N 122.804 2.037 . . . . 0.0 117.111 -1.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -138.15 68.23 1.4 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 119.42 1.009 . . . . 0.0 109.913 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.81 117.07 44.81 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 172.57 13.78 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 C-N-CA 123.006 2.471 . . . . 0.0 114.075 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.0 2.35 2.7 Favored 'Trans proline' 0 CA--C 1.567 2.126 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -148.56 90.24 1.77 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.27 114.28 3.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.99 107.57 13.92 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.287 0.565 . . . . 0.0 109.856 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.5 mt -91.2 125.04 35.85 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 122.015 0.912 . . . . 0.0 110.703 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 29.4 m -97.81 95.4 7.51 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.927 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.7 119.01 37.43 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.196 0.599 . . . . 0.0 110.091 174.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -88.49 103.61 16.04 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.275 1.036 . . . . 0.0 109.841 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.38 103.63 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.295 -1.32 . . . . 0.0 107.653 -170.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -94.06 108.52 20.34 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.02 105.88 12.59 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -77.88 -72.27 0.37 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -144.77 135.84 25.0 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 118.8 0.727 . . . . 0.0 109.886 -169.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -100.64 111.12 23.31 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.2 m -137.96 138.77 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -170.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.05 148.5 50.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -96.3 115.98 5.33 Favored Glycine 0 CA--C 1.551 2.302 0 CA-C-O 116.948 -2.029 . . . . 0.0 113.151 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.66 155.51 31.36 Favored 'Trans proline' 0 CA--C 1.562 1.924 0 CA-C-N 122.445 3.122 . . . . 0.0 113.821 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.13 -83.64 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -172.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 62.76 71.03 0.53 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.687 1.195 . . . . 0.0 113.184 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . 0.327 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 117.128 2.27 . . . . 0.0 117.128 176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 CA--C 1.548 0.903 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -146.4 93.78 2.36 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.788 0.435 . . . . 0.0 109.995 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.23 133.38 35.44 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.136 0.574 . . . . 0.0 111.255 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . 0.25 82.2 m95 75.51 103.11 0.07 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.924 1.289 . . . . 0.0 110.099 -176.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.1 97.48 9.24 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.27 129.79 37.19 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 122.593 1.187 . . . . 0.0 113.365 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.2 pt -103.42 66.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.867 -176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 tp -163.0 -60.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.399 0.68 . . . . 0.0 110.187 -164.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.4 44.49 3.72 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -165.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -161.05 -80.55 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 154.65 58.01 0.01 OUTLIER Glycine 0 CA--C 1.543 1.808 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.248 170.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.5 mt -131.06 -54.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.843 0.857 . . . . 0.0 110.978 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.9 tp -87.01 102.35 14.32 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 108.991 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -108.73 90.06 3.18 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 122.885 0.474 . . . . 0.0 111.375 -161.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.04 93.79 8.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.814 -1.179 . . . . 0.0 111.106 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -99.32 122.91 43.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.356 0.662 . . . . 0.0 109.251 168.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.9 m -80.58 117.03 20.93 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.131 0.572 . . . . 0.0 109.916 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.9 tp -79.87 -71.68 0.44 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.957 0.903 . . . . 0.0 110.512 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -101.14 123.18 45.87 Favored Pre-proline 0 CA--C 1.573 1.845 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.74 157.59 51.77 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 122.921 2.414 . . . . 0.0 114.85 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.37 116.56 4.25 Favored Glycine 0 CA--C 1.55 2.233 0 CA-C-O 116.807 -2.107 . . . . 0.0 112.9 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.11 142.02 37.34 Favored 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 122.658 3.229 . . . . 0.0 114.315 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.89 113.19 3.72 Favored 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 123.045 2.497 . . . . 0.0 112.422 -177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.81 -85.92 0.11 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 t -85.12 109.21 18.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 90.1 p -111.17 172.11 7.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.085 0.945 . . . . 0.0 112.907 -168.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -50.64 122.7 16.62 Favored Pre-proline 0 CA--C 1.582 2.182 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.02 162.09 37.66 Favored 'Trans proline' 0 CA--C 1.562 1.888 0 C-N-CA 123.089 2.526 . . . . 0.0 115.799 -171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.88 167.56 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.465 1.126 . . . . 0.0 112.22 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -64.57 126.72 28.77 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.729 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.31 59.79 1.08 Allowed Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.251 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -146.27 139.69 25.95 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.38 102.9 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.65 120.6 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 m -100.03 142.62 31.27 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.39 0.676 . . . . 0.0 109.444 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.98 141.87 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 123.589 0.756 . . . . 0.0 109.638 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -83.16 109.67 17.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 160.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -95.62 113.18 24.8 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -94.02 91.27 6.78 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 m -82.94 116.94 22.44 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.8 m -145.19 171.59 14.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.303 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.21 130.94 55.75 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -58.61 -38.92 79.04 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -65.29 -48.18 74.04 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 163.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.89 -116.51 4.14 Favored Glycine 0 CA--C 1.541 1.678 0 CA-C-N 119.245 0.929 . . . . 0.0 112.564 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.5 t -153.69 -176.39 5.8 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.77 0.795 . . . . 0.0 111.909 -168.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -61.53 122.69 15.86 Favored 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -91.49 -49.88 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.45 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -146.59 103.42 3.66 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -84.88 82.04 8.62 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.346 1.069 . . . . 0.0 111.459 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.49 112.02 58.75 Favored Pre-proline 0 CA--C 1.576 1.947 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.533 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.33 -61.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.181 2.588 . . . . 0.0 116.364 -169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -97.82 74.08 2.33 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.222 1.374 . . . . 0.0 111.18 -171.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.23 92.39 8.91 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.5 p -98.16 139.07 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.048 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.45 155.39 33.44 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.59 -172.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.7 m -77.97 131.22 37.32 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.42 116.27 4.17 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 123.825 0.85 . . . . 0.0 112.467 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.6 55.26 8.73 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 115.726 1.051 . . . . 0.0 115.726 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -152.28 150.82 30.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.261 1.029 . . . . 0.0 110.081 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.1 p -74.89 81.96 2.16 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-O 122.824 1.297 . . . . 0.0 114.033 -170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -130.92 -60.48 0.97 Allowed 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 113.621 -1.627 . . . . 0.0 109.222 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.52 172.21 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.513 1.125 . . . . 0.0 113.138 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.7 pt -62.67 161.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.28 -45.56 90.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.67 77.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -54.53 17.83 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.998 0.919 . . . . 0.0 112.863 172.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -49.28 -50.92 36.91 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.5 -39.98 77.69 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.2 p -84.22 22.91 1.14 Allowed 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.1 t -74.0 -54.84 3.37 Favored Pre-proline 0 CA--C 1.575 1.915 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.382 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.05 61.4 8.19 Favored 'Trans proline' 0 CA--C 1.568 2.214 0 CA-C-N 125.39 2.961 . . . . 0.0 114.642 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.6 mt -155.96 -48.31 0.08 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 125.628 1.571 . . . . 0.0 109.66 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -76.54 107.12 8.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.818 0.847 . . . . 0.0 110.523 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.79 169.88 17.28 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.961 167.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.05 106.88 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.884 -1.135 . . . . 0.0 108.413 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.0 10.34 46.19 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 117.913 1.925 . . . . 0.0 117.913 -163.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.98 93.99 6.05 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 120.504 2.152 . . . . 0.0 109.812 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.3 m -88.54 136.38 33.02 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.168 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.75 138.19 8.13 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.936 0.494 . . . . 0.0 110.112 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.1 ptm -83.04 124.77 30.75 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.03 71.8 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -84.93 113.76 21.64 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.6 -0.687 . . . . 0.0 109.414 -164.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -113.11 154.23 26.94 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.855 0.862 . . . . 0.0 112.051 -167.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -52.33 147.98 7.25 Favored 'General case' 0 CA--C 1.576 1.956 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 168.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.0 p -68.89 78.14 0.31 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.84 1.305 . . . . 0.0 112.619 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -176.12 -60.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.884 -1.507 . . . . 0.0 108.797 -151.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.02 -51.81 23.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.763 1.225 . . . . 0.0 113.462 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 44.9 m -67.35 -80.34 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -158.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.12 72.3 1.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.32 -142.87 47.75 Favored Glycine 0 CA--C 1.562 3.01 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.78 -164.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -87.78 50.58 1.91 Allowed 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 122.892 2.395 . . . . 0.0 113.661 165.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 56.0 85.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.905 1.282 . . . . 0.0 113.769 -168.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 162.0 74.06 0.02 OUTLIER Glycine 0 N--CA 1.481 1.687 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.544 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.14 69.13 0.33 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.7 m 68.53 127.9 0.03 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 166.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.82 -44.8 0.36 Allowed 'Cis proline' 0 CA--C 1.565 2.029 0 CA-C-N 123.009 2.11 . . . . 0.0 116.39 2.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.29 82.35 1.42 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.57 99.08 46.36 Favored Pre-proline 0 CA--C 1.57 1.745 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 -174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.34 134.08 12.42 Favored 'Trans proline' 0 CA--C 1.567 2.175 0 C-N-CA 122.828 2.352 . . . . 0.0 113.799 -169.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.66 154.31 64.26 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 123.137 2.558 . . . . 0.0 115.297 -172.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.256 15.5 m170 82.2 137.61 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.41 1.084 . . . . 0.0 112.069 172.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . 0.258 . . 73.29 136.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.843 1.257 . . . . 0.0 113.236 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.88 169.73 11.01 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -158.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tt -115.3 125.6 53.47 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.349 1.06 . . . . 0.0 110.33 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.1 t -87.3 118.45 26.74 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.105 0.962 . . . . 0.0 110.971 171.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.22 111.88 11.24 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.73 103.67 15.59 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.119 0.485 . . . . 0.0 110.726 -169.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.8 t -85.25 101.18 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.0 m -109.19 121.89 46.14 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -80.23 105.59 11.6 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.626 0.37 . . . . 0.0 110.162 -174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -78.61 -69.73 0.54 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.8 p -132.37 143.57 49.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.334 0.588 . . . . 0.0 109.59 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -130.32 100.13 5.27 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.44 149.66 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 123.963 0.905 . . . . 0.0 109.002 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -65.59 163.56 15.96 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -117.99 86.43 0.41 Allowed Glycine 0 CA--C 1.548 2.102 0 CA-C-O 117.225 -1.875 . . . . 0.0 113.529 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.49 119.03 3.65 Favored 'Trans proline' 0 CA--C 1.558 1.69 0 CA-C-N 121.702 2.751 . . . . 0.0 111.571 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.98 112.44 10.12 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.693 0.758 . . . . 0.0 112.873 -168.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 50.3 tp -98.6 128.58 44.96 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.996 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 123.162 1.458 . . . . 0.0 111.639 175.834 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.55 0.947 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -143.24 95.92 2.84 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.041 0.536 . . . . 0.0 110.714 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.268 14.7 tp10 68.06 157.8 0.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 160.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -69.76 151.76 45.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.319 -0.863 . . . . 0.0 110.913 167.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.34 98.81 9.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.037 0.535 . . . . 0.0 109.992 -172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.06 120.89 20.27 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 122.058 0.933 . . . . 0.0 112.146 171.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.8 mt -88.21 -80.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -165.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.64 120.9 23.45 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.85 2.74 0.07 OUTLIER Glycine 0 CA--C 1.543 1.81 0 CA-C-O 117.51 -1.717 . . . . 0.0 116.701 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.364 12.5 p30 49.01 56.86 7.13 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 120.281 2.04 . . . . 0.0 114.727 -165.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 54.61 6.57 Favored Glycine 0 CA--C 1.546 1.991 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 -171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 99.4 mt -126.21 -66.47 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 118.478 1.139 . . . . 0.0 110.299 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 tp -82.86 111.44 18.76 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.444 1.02 . . . . 0.0 109.921 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -115.81 144.27 44.23 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.502 0.721 . . . . 0.0 112.606 -173.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.02 136.07 48.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 0.0 112.095 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.8 121.14 40.7 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 158.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.2 m -75.63 109.16 8.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.19 -61.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.736 0.815 . . . . 0.0 112.592 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.68 108.02 56.41 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.66 148.44 17.95 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.952 2.435 . . . . 0.0 113.989 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.49 118.76 7.37 Favored Glycine 0 CA--C 1.555 2.562 0 CA-C-O 116.986 -2.008 . . . . 0.0 114.882 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.33 168.35 23.69 Favored 'Trans proline' 0 CA--C 1.573 2.472 0 CA-C-N 122.306 3.053 . . . . 0.0 115.452 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.7 116.72 4.1 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 123.195 2.597 . . . . 0.0 113.021 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.27 69.75 1.18 Allowed Glycine 0 CA--C 1.545 1.91 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.319 -163.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -150.9 117.51 5.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.9 t -70.53 140.31 51.78 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -117.64 121.27 32.08 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-O 117.73 -1.129 . . . . 0.0 109.389 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.0 145.92 40.69 Favored 'Trans proline' 0 CA--C 1.558 1.689 0 C-N-CA 122.606 2.204 . . . . 0.0 114.657 -170.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.28 154.68 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.63 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -63.24 107.89 1.16 Allowed 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 123.898 0.879 . . . . 0.0 112.425 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.37 69.12 0.87 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.391 -158.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -153.75 127.29 8.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.3 t -77.61 100.12 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.43 140.47 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.945 0.898 . . . . 0.0 109.437 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.9 m -89.22 127.26 35.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 164.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.4 m -125.41 130.3 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.151 0.977 . . . . 0.0 109.244 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -98.12 95.25 7.31 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.7 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -111.59 131.45 55.25 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.547 0.739 . . . . 0.0 109.297 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -139.08 116.09 10.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.8 m -88.06 119.08 28.09 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.296 -168.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -88.95 129.16 35.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.711 0.804 . . . . 0.0 110.599 170.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.76 140.82 37.09 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.444 0.64 . . . . 0.0 109.854 -173.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -52.79 -45.92 67.41 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 171.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -93.16 90.89 7.04 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.06 69.12 1.4 Allowed Glycine 0 CA--C 1.544 1.87 0 N-CA-C 117.411 1.724 . . . . 0.0 117.411 168.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . 0.409 1.7 t 53.51 -168.09 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 158.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . 0.364 9.2 ptp180 -77.14 104.9 7.9 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -170.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.79 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 CA-C-N 112.214 -2.266 . . . . 0.0 116.086 165.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 80.02 112.74 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.041 1.336 . . . . 0.0 111.41 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -116.92 69.03 0.75 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 72.43 96.57 0.04 OUTLIER Pre-proline 0 CA--C 1.578 2.054 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 167.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.13 -19.09 39.61 Favored 'Trans proline' 0 CA--C 1.56 1.819 0 N-CA-C 119.047 2.672 . . . . 0.0 119.047 -172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -136.02 86.03 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.297 1.408 . . . . 0.0 109.259 164.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -87.53 116.68 25.82 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.1 133.53 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 123.434 0.694 . . . . 0.0 109.404 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -158.93 148.93 19.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.119 0.568 . . . . 0.0 111.185 -174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -70.42 130.35 41.69 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.39 0.676 . . . . 0.0 109.563 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.6 tp -51.27 -36.93 44.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -161.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.69 -102.65 0.55 Allowed Glycine 0 CA--C 1.542 1.724 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.472 162.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . 0.42 0.5 OUTLIER 62.2 169.48 0.12 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.16 17.89 23.27 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.37 -51.09 5.6 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 120.288 1.404 . . . . 0.0 113.318 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.8 m -77.0 167.06 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.412 1.101 . . . . 0.0 112.741 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.0 pt -68.08 160.0 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.295 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.58 -36.69 76.72 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.8 73.11 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 167.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.62 -48.98 58.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.44 -37.28 67.5 Favored 'General case' 0 CA--C 1.582 2.181 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.48 -32.66 60.65 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.7 p -75.27 -11.93 60.17 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 165.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.287 1.3 t -54.66 -49.58 90.49 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 115.477 -2.202 . . . . 0.0 115.255 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.19 -13.46 32.21 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 125.127 2.867 . . . . 0.0 119.514 175.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.12 77.96 1.77 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 120.523 1.51 . . . . 0.0 108.886 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -162.45 109.88 1.31 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -88.69 168.36 12.57 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 122.166 0.984 . . . . 0.0 112.283 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.49 124.86 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 112.579 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 3.13 88.4 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 118.986 2.354 . . . . 0.0 118.986 -173.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -110.39 130.04 55.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 120.833 2.316 . . . . 0.0 113.244 -159.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 m -78.05 133.5 37.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.009 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.61 119.24 24.38 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.7 tpt -80.53 106.63 12.69 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -106.9 115.24 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 p -94.58 100.9 12.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.01 125.84 36.86 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.89 -172.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.79 165.24 17.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 95.4 p -53.12 -42.77 66.34 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 162.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.75 -43.87 87.62 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 164.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -103.36 67.34 0.92 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.398 0.679 . . . . 0.0 110.175 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.8 t -148.15 -93.11 0.08 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.59 42.21 3.32 Favored 'General case' 0 CA--C 1.574 1.879 0 CA-C-N 119.758 1.163 . . . . 0.0 111.527 171.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 56.98 -109.17 1.52 Allowed Glycine 0 CA--C 1.557 2.71 0 CA-C-O 117.454 -1.748 . . . . 0.0 115.109 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.34 -50.46 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.933 0 CA-C-N 121.439 2.619 . . . . 0.0 115.782 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? -152.05 133.2 14.36 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.162 0.985 . . . . 0.0 108.54 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.15 -124.6 5.21 Favored Glycine 0 N--CA 1.481 1.643 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.865 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -88.02 68.08 9.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.43 0.692 . . . . 0.0 111.775 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.9 m -75.4 137.11 71.42 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.116 -172.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.04 -6.15 53.88 Favored 'Cis proline' 0 CA--C 1.568 2.216 0 N-CA-C 119.494 2.844 . . . . 0.0 119.494 9.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -57.94 -51.83 68.02 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.45 98.71 11.27 Favored Pre-proline 0 CA--C 1.569 1.683 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 167.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.25 164.06 37.04 Favored 'Trans proline' 0 CA--C 1.572 2.389 0 C-N-CA 122.703 2.269 . . . . 0.0 114.137 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.47 111.25 2.27 Favored 'Trans proline' 0 CA--C 1.557 1.667 0 C-N-CA 123.072 2.515 . . . . 0.0 113.375 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 70.71 99.29 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.687 1.195 . . . . 0.0 111.656 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.6 132.77 16.36 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.252 0.621 . . . . 0.0 110.364 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.89 85.11 4.68 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.289 0.566 . . . . 0.0 109.908 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.11 147.5 41.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.014 0.911 . . . . 0.0 112.642 -161.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 87.2 m -76.55 152.2 36.06 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.84 129.72 4.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.809 0.843 . . . . 0.0 110.218 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -87.67 98.74 11.6 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.588 . . . . 0.0 110.852 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.4 100.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 51.1 m -109.17 123.98 50.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.97 117.37 17.63 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -82.63 -66.19 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.3 p -131.26 147.57 52.6 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.533 0.733 . . . . 0.0 109.405 -169.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.18 107.72 11.53 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 167.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.7 m -138.58 147.31 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.474 -170.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -71.62 144.39 49.47 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -75.82 120.69 6.06 Favored Glycine 0 CA--C 1.556 2.6 0 CA-C-O 116.923 -2.043 . . . . 0.0 114.671 -173.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.77 112.16 2.86 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 CA-C-N 122.466 3.133 . . . . 0.0 112.54 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.51 124.61 34.17 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-O 121.314 0.578 . . . . 0.0 111.476 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.1 tt 71.99 91.92 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.903 1.281 . . . . 0.0 111.085 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.222 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 CA--C 1.551 1.007 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -150.83 136.69 18.2 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.687 0.756 . . . . 0.0 110.887 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 116.29 7.5 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.012 0.925 . . . . 0.0 111.98 173.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 m95 73.11 134.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.383 1.073 . . . . 0.0 111.516 -175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.47 124.24 33.79 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.612 0.765 . . . . 0.0 109.724 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.92 104.46 8.49 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.083 0.953 . . . . 0.0 111.927 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -98.52 130.41 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.436 0.6 OUTLIER 101.15 -66.5 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.231 1.812 . . . . 0.0 111.641 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.57 -70.62 0.08 OUTLIER Glycine 0 N--CA 1.484 1.835 0 CA-C-N 120.034 1.288 . . . . 0.0 114.33 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -73.26 -71.0 0.33 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.65 0.78 . . . . 0.0 111.341 -174.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.89 61.28 0.05 OUTLIER Glycine 0 CA--C 1.541 1.665 0 CA-C-O 119.31 -0.717 . . . . 0.0 112.321 169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.2 -58.72 2.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.638 0.719 . . . . 0.0 110.924 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.51 114.79 29.18 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -115.03 108.87 17.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.84 0.456 . . . . 0.0 111.197 -168.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -99.48 116.0 30.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.992 -1.067 . . . . 0.0 111.987 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -85.77 119.69 26.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.01 -1.057 . . . . 0.0 108.681 158.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.7 m -90.46 108.66 19.93 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mp -71.61 -65.45 0.76 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.166 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.46 136.4 21.47 Favored Pre-proline 0 CA--C 1.571 1.776 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.166 164.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.17 176.91 9.4 Favored 'Trans proline' 0 CA--C 1.561 1.834 0 C-N-CA 123.0 2.467 . . . . 0.0 114.605 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.9 116.16 5.86 Favored Glycine 0 CA--C 1.558 2.729 0 CA-C-O 117.061 -1.966 . . . . 0.0 111.335 164.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -71.64 167.12 27.37 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 CA-C-N 122.55 3.175 . . . . 0.0 115.626 -168.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.98 111.96 2.35 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 123.072 2.515 . . . . 0.0 112.334 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.54 76.3 1.32 Allowed Glycine 0 CA--C 1.544 1.868 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.661 -161.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.1 p -155.28 131.42 10.19 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.423 0.689 . . . . 0.0 109.744 -176.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 p -117.27 119.93 36.69 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 122.457 1.123 . . . . 0.0 112.327 -174.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -73.92 116.67 54.46 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-N 113.691 -1.595 . . . . 0.0 112.143 168.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.03 162.63 40.92 Favored 'Trans proline' 0 CA--C 1.558 1.718 0 C-N-CA 122.867 2.378 . . . . 0.0 116.047 -166.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.2 m -74.01 158.7 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.213 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -83.63 77.74 9.8 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 122.13 0.966 . . . . 0.0 113.356 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.32 47.07 0.01 OUTLIER Glycine 0 CA--C 1.551 2.315 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.053 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 146.43 25.4 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.581 1.19 . . . . 0.0 109.269 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.4 t -74.86 103.68 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.691 0.796 . . . . 0.0 109.858 -170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 m -99.53 113.26 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.9 m -88.48 105.33 17.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 170.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.77 141.86 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -69.64 108.25 3.78 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.17 0.988 . . . . 0.0 109.346 165.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.76 92.57 3.84 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.39 105.8 17.77 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -172.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -85.26 101.96 12.95 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 121.162 0.506 . . . . 0.0 109.743 -173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -121.65 157.07 31.64 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.381 1.073 . . . . 0.0 109.818 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 tt -98.89 103.8 15.78 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.601 -0.687 . . . . 0.0 109.962 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . 0.396 26.3 tt0 68.27 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 169.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.53 61.63 0.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.291 0.636 . . . . 0.0 111.482 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.43 66.29 2.46 Favored Glycine 0 CA--C 1.543 1.804 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -126.02 96.9 4.9 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 173.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -78.38 96.46 5.34 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -165.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.4 m -81.99 -50.25 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -152.75 134.73 14.8 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.909 0.861 . . . . 0.0 109.169 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -91.09 112.79 24.85 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.687 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -116.33 69.06 3.88 Favored Pre-proline 0 CA--C 1.585 2.289 0 O-C-N 121.446 -0.784 . . . . 0.0 110.953 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.96 -54.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.255 2.637 . . . . 0.0 115.487 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.83 76.61 6.51 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 121.4 1.909 . . . . 0.0 112.536 164.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -85.58 97.83 10.3 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 166.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.59 109.01 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 -171.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -136.05 139.64 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.4 m -69.28 132.6 46.71 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 tt -69.57 109.68 4.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 80.24 0.98 Allowed Glycine 0 CA--C 1.54 1.644 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.552 -162.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -149.34 160.7 43.19 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.275 1.036 . . . . 0.0 110.793 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 29.6 p -79.93 71.0 6.6 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.268 1.032 . . . . 0.0 113.433 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -150.58 -62.91 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.479 1.111 . . . . 0.0 110.092 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.84 158.9 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 CA-C-O 123.173 1.463 . . . . 0.0 112.216 -161.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -66.3 152.99 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.726 177.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -57.89 -33.55 68.84 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 168.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.51 -46.76 57.42 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 163.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.44 -57.65 5.54 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 118.16 -0.924 . . . . 0.0 112.473 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -58.52 -34.24 70.75 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.37 -38.0 77.84 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 167.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -70.49 -20.49 62.85 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.258 54.7 t -62.73 -52.45 64.46 Favored Pre-proline 0 CA--C 1.577 1.995 0 CA-C-O 115.726 -2.083 . . . . 0.0 113.629 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.41 10.47 0.44 Allowed 'Trans proline' 0 CA--C 1.572 2.393 0 CA-C-N 124.703 2.715 . . . . 0.0 118.521 171.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.06 -46.28 5.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.245 1.018 . . . . 0.0 111.59 158.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.0 128.92 35.37 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 119.637 1.108 . . . . 0.0 113.013 -173.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -94.97 -147.71 0.28 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 123.153 0.581 . . . . 0.0 111.187 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.97 123.79 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.629 -1.294 . . . . 0.0 110.363 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.77 -103.07 2.97 Favored Glycine 0 CA--C 1.54 1.608 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -168.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 32.57 93.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.083 2.253 . . . . 0.0 117.083 -168.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 m -82.06 115.71 21.32 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.58 123.35 11.91 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.324 0.583 . . . . 0.0 110.01 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.9 ttp -76.98 104.97 7.77 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.705 0.802 . . . . 0.0 110.544 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.7 t -93.91 97.29 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 39.3 m -99.37 104.22 16.08 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.18 37.26 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.794 -161.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -48.91 134.24 17.0 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 165.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -51.04 -39.01 54.92 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.254 14.5 pttp -58.69 -41.26 85.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 164.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -66.9 -49.79 64.48 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 171.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 14.0 t -81.03 -160.71 0.34 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.822 0.849 . . . . 0.0 112.295 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -85.73 101.52 12.84 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.91 -91.6 1.78 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 116.866 -2.075 . . . . 0.0 109.66 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.59 -46.53 3.69 Favored 'Trans proline' 0 CA--C 1.564 2.017 0 CA-C-N 122.073 2.936 . . . . 0.0 116.253 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -91.3 98.64 11.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -90.42 134.43 12.34 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 115.336 -0.847 . . . . 0.0 115.117 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -113.51 91.44 3.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.889 0.476 . . . . 0.0 109.848 175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.4 m 72.68 103.58 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.763 0 CA-C-O 117.476 -1.249 . . . . 0.0 112.003 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.63 -70.07 0.01 OUTLIER 'Cis proline' 0 CA--C 1.565 2.061 0 CA-C-N 122.923 2.08 . . . . 0.0 112.032 8.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.02 78.69 1.62 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 168.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 68.2 mt -67.29 121.96 80.87 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 -162.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.13 155.17 29.42 Favored 'Trans proline' 0 CA--C 1.569 2.267 0 C-N-CA 122.762 2.308 . . . . 0.0 115.214 -170.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.55 146.6 44.37 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.238 2.626 . . . . 0.0 113.459 174.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . 0.267 22.4 m170 77.09 157.7 0.19 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.458 1.103 . . . . 0.0 112.245 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 78.12 127.94 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.984 1.314 . . . . 0.0 111.705 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.14 114.93 15.35 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.684 0.394 . . . . 0.0 112.038 -174.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.14 130.23 34.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.523 0.729 . . . . 0.0 110.895 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.6 p -85.66 93.33 8.81 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.564 0.746 . . . . 0.0 112.444 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.13 107.91 19.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.743 0.817 . . . . 0.0 109.01 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -85.36 105.99 16.41 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.663 0.744 . . . . 0.0 111.184 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 70.5 t -90.74 123.44 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 124.521 1.128 . . . . 0.0 107.969 -173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.9 m -135.94 126.6 27.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 tp -75.45 109.89 9.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.913 -0.492 . . . . 0.0 110.229 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -81.18 -59.54 2.61 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 118.674 -0.679 . . . . 0.0 112.382 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 44.0 p -140.28 132.35 27.92 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.366 0.667 . . . . 0.0 109.388 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -105.52 112.61 25.77 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.48 138.13 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.516 0.674 . . . . 0.0 109.608 -170.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -75.52 155.95 35.61 Favored 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.195 0.997 . . . . 0.0 113.643 177.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.92 120.81 17.46 Favored Glycine 0 CA--C 1.559 2.795 0 CA-C-O 116.963 -2.021 . . . . 0.0 114.189 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.47 121.77 5.76 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 CA-C-N 122.494 3.147 . . . . 0.0 113.717 -168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.35 -60.17 2.3 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.57 123.28 29.6 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.377 0.671 . . . . 0.0 110.648 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.486 1.363 0 C-N-CA 123.142 0.577 . . . . 0.0 109.747 177.178 . . . . . . . . 0 0 . 1 stop_ save_